
<html lang="en"     class="pb-page"  data-request-id="f7f74854-5206-4808-aca3-ba64825f1eaa"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00261;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="The Medicinal Chemistry of Caffeine" /></meta><meta name="dc.Creator" content="Giuseppe  Faudone" /></meta><meta name="dc.Creator" content="Silvia  Arifi" /></meta><meta name="dc.Creator" content="Daniel  Merk" /></meta><meta name="dc.Description" content="The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world and has multiple beneficial pharmacological activities, for example, in neurodegenerative diseases. Howeve..." /></meta><meta name="Description" content="The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world and has multiple beneficial pharmacological activities, for example, in neurodegenerative diseases. Howeve..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 21, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00261" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00261" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00261" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00261" /></link>
        
    
    

<title>The Medicinal Chemistry of Caffeine | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00261" /></meta><meta property="og:title" content="The Medicinal Chemistry of Caffeine" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0016.jpeg" /></meta><meta property="og:description" content="The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world and has multiple beneficial pharmacological activities, for example, in neurodegenerative diseases. However, despite being an extensively studied bioactive natural product, the mechanistic understanding of caffeine’s pharmacological effects is incomplete. While several molecular targets of caffeine such as adenosine receptors and phosphodiesterases have been known for decades and inspired numerous medicinal chemistry programs, new protein interactions of the xanthine are continuously discovered providing potentially improved pharmacological understanding and a molecular basis for future medicinal chemistry. In this Perspective, we gather knowledge on the confirmed protein interactions, structure activity relationship, and chemical biology of caffeine on well-known and upcoming targets. The diversity of caffeine’s molecular activities on receptors and enzymes, many of which are abundant in the CNS, indicates a complex interplay of several mechanisms contributing to neuroprotective effects and highlights new targets as attractive subjects for drug discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00261"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00261">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00261&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00261&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00261&amp;href=/doi/10.1021/acs.jmedchem.1c00261" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 7156-7178</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00154" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.1c00294" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Medicinal Chemistry of Caffeine</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Giuseppe Faudone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giuseppe Faudone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Faudone">Giuseppe Faudone</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Silvia Arifi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Arifi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Arifi">Silvia Arifi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Daniel Merk</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Merk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#9cf1f9eef7dcecf4fdeef1fff4f9f1b2e9f2f5b1faeefdf2f7fae9eee8b2f8f9"><span class="__cf_email__" data-cfemail="046961766f44746c657669676c61692a716a6d296276656a6f627176702a6061">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Merk">Daniel Merk</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5359-8128" title="Orcid link">https://orcid.org/0000-0002-5359-8128</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00261&amp;href=/doi/10.1021%2Facs.jmedchem.1c00261" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 7156–7178</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 21, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 February 2021</li><li><span class="item_label"><b>Published</b> online</span>21 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 June 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00261</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7156%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGiuseppe%2BFaudone%252C%2BSilvia%2BArifi%252C%2BDaniel%2BMerk%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D11%26contentID%3Dacs.jmedchem.1c00261%26title%3DThe%2BMedicinal%2BChemistry%2Bof%2BCaffeine%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7178%26publicationDate%3DJune%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00261"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2843</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00261" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Medicinal Chemistry of Caffeine&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Faudone&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Arifi&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Merk&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;7156-7178&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00261&quot;},&quot;abstract&quot;:&quot;The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world and has multiple beneficial pharmacological activities, for example, in neurodegenerative diseases. However, despite being an extensively studied bioactive natural product, the mechanistic understanding of caffeine’s pharmacological effects is incomplete. While several molecular targets of caffeine such as adenosine receptors and phosphodiesterases have been known for decades and inspired numerous medicinal chemistry programs, new protein interactions of the xanthine are continuously discovered providing potentially improved pharmacological understanding and a molecular basis for future medicinal chemistry. In this Perspective, we gather knowledge on the confirmed protein interactions, structure activity relationship, and chemical biology of caffeine on well-known and upcoming targets. The diversity of caffeine’s molecular activities on receptors and enzymes, many of which are abundant in the CNS, indicates a complex in&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00261&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00261" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00261&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00261" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00261&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00261" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00261&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00261&amp;href=/doi/10.1021/acs.jmedchem.1c00261" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00261" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00261" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00261%26sid%3Dliteratum%253Aachs%26pmid%3D34019396%26genre%3Darticle%26aulast%3DFaudone%26date%3D2021%26atitle%3DThe%2BMedicinal%2BChemistry%2Bof%2BCaffeine%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D11%26spage%3D7156%26epage%3D7178%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/jmcmar.2021.64.issue-11/20210610/jmcmar.2021.64.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world and has multiple beneficial pharmacological activities, for example, in neurodegenerative diseases. However, despite being an extensively studied bioactive natural product, the mechanistic understanding of caffeine’s pharmacological effects is incomplete. While several molecular targets of caffeine such as adenosine receptors and phosphodiesterases have been known for decades and inspired numerous medicinal chemistry programs, new protein interactions of the xanthine are continuously discovered providing potentially improved pharmacological understanding and a molecular basis for future medicinal chemistry. In this Perspective, we gather knowledge on the confirmed protein interactions, structure activity relationship, and chemical biology of caffeine on well-known and upcoming targets. The diversity of caffeine’s molecular activities on receptors and enzymes, many of which are abundant in the CNS, indicates a complex interplay of several mechanisms contributing to neuroprotective effects and highlights new targets as attractive subjects for drug discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The purine alkaloid 1,3,7-trimethylxanthine, better known as caffeine (<b>1</b>, also termed theine, guaranine), is the most widely consumed psychostimulant drug in the world.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It acts as a central stimulant via some well-characterized mechanisms and also has several beneficial therapeutic effects some of which are not yet fully understood on a mechanistic level. Caffeine is naturally contained in seeds, nuts, and leaves of various plants and hence found not only in coffee beans but also, for example, in tea leaves, guarana berries, cocoa beans, and kola beans.</div><div class="NLM_p">Caffeine consumption in the form of tea potentially dates back to 3000 BC in China, whereas evidence for cocoa bean use in ancient Mayan cultures as early as around 600 BC has been found.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Coffee consumption goes back to the 15th century in southern Arabia and northern Africa from where it came to Europe.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In 1819, caffeine was first isolated and termed “Kaffebase” by Friedlieb Ferdinand Runge, while the name caffeine was first used by Pierre-Joseph Pelletier.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Caffeine was later extracted also from tea under the name theine before it was proven to be the same molecule.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Hermann Emil Fischer was the first to synthesize caffeine in 1895 (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and to elucidate its molecular structure, which was part of his work awarded with the Nobel Prize in 1902.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. First Synthesis of Caffeine (1895) According to Fischer<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite many potential pathways to caffeine in plants, only one common caffeine biosynthesis route has been discovered but was found to be catalyzed by differentially specialized enzymes in different species (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Caffeine biosynthesis originates from xanthosine which undergoes enzymatic N7-methylation and concomitant deribosylation to 7-methylxanthine. Another methylation step at N3 then produces theobromine (<b>2</b>) before enzymatic N1-methylation affords caffeine (<b>1</b>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The natural occurrence of caffeine is known in several plant species where it serves as a defense mechanism to kill insects feeding on the plant through inhibition of insect phosphodiesterases, resulting in intracellular accumulation of cyclic adenosine monophosphate.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a></div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Common Pathway of Caffeine Biosynthesis in Plants<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For its stimulant activity, coffee had once been banned in various regions throughout history, for example, in Prussia, Sweden, and Mekka between the 16th and 18th century. Between 1984 and 2004, caffeine was a banned substance in sport competition for (well-documented) performance-enhancing effects but was removed from the World Anti-Doping Agency list in 2004.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Today, the caffeine content of beverages is restricted in some regions (e.g., to max. 0.02% or 200 ppm by the FDA), while caffeine as a powder is not regulated.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">2.  Medicinal Chemistry of Caffeine</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Structurally, caffeine is closely related to the other natural xanthines theobromine (<b>2</b>), theophylline (<b>3</b>), and paraxanthine (<b>4</b>) and to many highly important endogenous (purine) molecules such as the purine bases adenine (<b>5</b>) and guanine (<b>6</b>) and the purine metabolite uric acid (<b>7</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Chemical Structures of Caffeine (<b>1</b>), Related Natural Xanthines <b>2</b>–<b>4</b>, Purines <b>5</b> and <b>6</b>, and Uric Acid (<b>7</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The natural product (and approved drug) caffeine (<b>1</b>) is a very druglike molecule (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). It complies with the rule of five,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> is moderately lipophilic (experimental logP −0.01, other sources logP −0.07),<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> and can pass biological membranes/barriers. Caffeine (<b>1</b>) is well soluble in water (21.7 g/L) with pronounced temperature-dependent solubility (66 g/L in boiling water). All atoms of the two-ring skeleton are sp<sup>2</sup> hybridized, rendering the xanthine structure a flat scaffold (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Properties, structure, and numbering of caffeine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Caffeine also has several roles as a drug. It is found (as caffeine citrate) on the WHO list of essential medicines for its respiratory stimulant action to be used in neonates.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Additionally, caffeine as a weak bronchodilator has been evaluated for asthma treatment, and a modest improvement of airway function in asthma patients has been observed for oral caffeine administration in a number of small clinical trials.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> As an analgesic adjuvant, caffeine has considerable pharmacological relevance in multiple coformulations with nonsteroidal anti-inflammatory drugs (NSAIDs) for pain treatment. This use of caffeine in combination with mostly ibuprofen or paracetamol achieves a small but statistically significant improvement in pain relief.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> It has been speculated that this effect is due to caffeine-mediated changes in bioavailability or pharmacokinetics of NSAIDs, but current evidence indicates that the analgesic adjuvant activity is mainly mediated through adenosine receptor (A<sub>2A</sub>) antagonism.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29">(25−29)</a> In addition, several highly attractive effects of caffeine have been observed for example in the prevention of neurodegenerative diseases<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> and cancer immunotherapy,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> many of which seem to be mainly mediated through effects on adenosinergic signaling (see chapter <a class="ref internalNav" href="#sec3" aria-label="3">3</a>).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1.  ADMET</h3><div class="NLM_p">The pharmacokinetics of caffeine were found to be affected by many factors, such as age, sex, hormone levels, liver health, obesity, smoking, and diets. The half-life, metabolism, and distribution of caffeine can hence vary significantly between individuals (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Owing to its moderate lipophilicity, caffeine can pass biological barriers well. After ingestion, it is rapidly and completely absorbed by the gastrointestinal tract reaching a bioavailability of up to 100%.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> After intake of a high 5–8 mg/kg caffeine dose, peak plasma concentrations of up to 8–10 mg/L are reached after 0.5 to 2 h. Caffeine is an effective brain penetrant, and its stimulant effect arises after 45–60 min. The half-life of caffeine varies remarkably in healthy adults between 2.5 to a maximum of 12 h.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Caffeine is mainly metabolized in the liver by the cytochrome P450 (CYP) enzyme CYP1A2,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> to paraxanthine (<b>4</b>, ∼85%) and small amounts of theobromine (<b>2</b>, ∼10%) and theophylline (<b>3</b>, < 5%).<a onclick="showRef(event, 'ref36 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref39">(36,39)</a> In addition to the main CYP1A2-mediated pathway, caffeine can also be metabolized by xanthine oxidase and N-acetyltransferase 2 (NAT2).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The main caffeine metabolite paraxanthine has similar pharmacodynamic activity on adenosine receptors as caffeine. Theophylline is slightly more active, while theobromine is markedly less active on adenosine receptors (<i>K</i><sub>i</sub> or IC<sub>50</sub> > 100 μM) and, hence, has no stimulant activity.<a onclick="showRef(event, 'ref34 ref41'); return false;" href="javascript:void(0);" class="ref ref34 ref41">(34,41)</a> The metabolites of caffeine are renally excreted, while caffeine itself is strongly reabsorbed in the renal tubulus.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacokinetic Properties of Caffeine (in Adults)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>absorption</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral bioavailability</td><td class="colsep0 rowsep0" align="left">up to 100%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">0.5–2 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>c</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">up to 8–10 mg/L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>distribution</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">volume of distribution</td><td class="colsep0 rowsep0" align="left">0.6 L/kg; brain penetrant</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma protein binding</td><td class="colsep0 rowsep0" align="left">10%–36% (in vitro)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">half-life</td><td class="colsep0 rowsep0" align="left">∼5 h (varying)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>metabolism</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metabolizing enzymes</td><td class="colsep0 rowsep0" align="left">CYP1A2, xanthine oxidase, N-acetyltransferase 2 (NAT2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">main metabolites</td><td class="colsep0 rowsep0" align="left">paraxanthine, (theobromine), (theophylline), 1-methylxanthine, 3,7-dimethyluric acid</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>elimination</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">excretion</td><td class="colsep0 rowsep0" align="left">renal (metabolites), caffeine is reabsorbed in the tubulus</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clearance</td><td class="colsep0 rowsep0" align="left">∼0.078 L/kg/h (varying)</td></tr></tbody></table></div></div><div class="NLM_p">Large interindividual variability in CYP1A2 enzyme activity is the main reason for the remarkable variation in caffeine metabolism and pharmacokinetics.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> CYP1A2 activity can be affected by endogenous factors such as genetic polymorphisms and hormone levels as well as exogenous contributions such as smoking, drug intake, and diet, resulting in the high variability of its enzyme activity.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Through polycyclic aromatic hydrocarbons which enhance liver enzyme activity, smoking causes CYP1A2 induction, which increases its metabolic rate by about 2-fold compared with nonsmokers.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> A study with former smokers discovered that 3 weeks after smoking cessation, caffeine concentration reached a maximum value of 203% compared with caffeine consumers.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Unlike smoking, the use of oral contraceptives (such as lynestrenol, norgestrel, ethynodioldiac, levonorgestrel) may cause almost a doubling of caffeine concentration as hormone levels impact on liver enzyme activity.<a onclick="showRef(event, 'ref36 ref49'); return false;" href="javascript:void(0);" class="ref ref36 ref49">(36,49)</a> Accordingly, caffeine metabolism is also reduced in pregnancy because of the decreased activity of CYP1A2, xanthine oxidase, and NAT2, and the half-life of caffeine can extend to as long as 12–18 h.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> The slowed caffeine metabolism during pregnancy can also affect the unborn child.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Moreover, daily caffeine intake leads to caffeine accumulation in the placenta which may affect the fetus that cannot metabolize caffeine. After caffeine ingestion, caffeine enters the fetal circulation through the blood-placental barrier and neither the blood-placental barrier nor the fetus possess enzymes to break down caffeine leading to accumulation. Epidemiological studies have shown that caffeine consumption during pregnancy may be associated with intrauterine growth retardation, subfertility, and spontaneous abortion.<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53−55)</a> Intake of less than 300 mg of caffeine (per day) were considered safe for pregnant women’s health,<a onclick="showRef(event, 'ref38 ref56'); return false;" href="javascript:void(0);" class="ref ref38 ref56">(38,56)</a> but other results suggest that less than 300 mg caffeine per day can increase the risk for pregnancy failure.<a onclick="showRef(event, 'ref55 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref55 ref57 ref58 ref59">(55,57−59)</a> Even intake of 100–200 mg of caffeine per day was found to increase the risk of miscarriage, fetal growth retardation, and low birth weight in some studies.<a onclick="showRef(event, 'ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63 ref64">(60−64)</a> Moreover, treatment of pregnant rats with caffeine in drinking water (0.1, 0.3, and 1.0 g/L) to mimic coffee consumption decreased birth weight and affected fetal brain development with changes in neuronal gene expression leading to an increased number of neuronal cells. Hence, caffeine consumption in pregnancy has also effects on embryonal brain development in rodents, although the relevance of these findings in humans remains to be confirmed.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Apart from these effects during pregnancy, caffeine has low toxicity and is generally considered safe.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> An LD<sub>50</sub> value of 192 mg/kg has been reported for rats, and 10–14 g (corresponding to about 150–200 mg/kg) is considered a lethal dose in humans.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67,68)</a> Mild drug dependence to caffeine with withdrawal symptoms may develop with repeated consumption.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In the presence of certain pre-existing diseases such as epilepsy, the central stimulant caffeine may have severe adverse effects.<a onclick="showRef(event, 'ref67 ref68 ref70'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref70">(67,68,70)</a></div><div class="NLM_p last">As a substrate and inductor of CYP1A2,<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a> caffeine can interfere with various drugs that are partially or entirely metabolized by this enzyme such as antidepressants, antipsychotics, and cardiovascular drugs. Although relevant interactions with caffeine are rare and restriction of caffeine consumption is not necessary in most cases,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> there are also reports of pharmacologically relevant interference with caffeine.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> For example, episodes of acute mental symptom exacerbations (such as anxiety, agitation, abdominal pain, a feeling of weakness, generalized stiffness, headaches, insomnia, intense paranoid ideation) were observed in a patient with heavy daily caffeine consumption (5–10 cups of coffee per day) under clozapine therapy. Upon discontinuing coffee consumption, these adverse events ceased.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> A small study with seven schizophrenia patients demonstrated that clozapine concentrations decreased significantly after caffeine withdrawal. The greatest effect was observed in patients who were heavy smokers (40 cigarettes per day).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Concomitant caffeine and theophylline ingestion also reduced the elimination of both compounds.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.2.  Molecular Activities of Caffeine</h3><div class="NLM_p">Owing to its profound and very attractive pharmacological activities (see chapter <a class="ref internalNav" href="#sec3" aria-label="3">3</a>) caffeine (<b>1</b>) has been extensively studied in multiple biological and biochemical assays with sometimes contradictory results. More than 300 pharmacological characteristics of caffeine are annotated in ChEMBL<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), some of which describe modulation of protein targets at millimolar concentrations that are not pharmacologically relevant, however. Moreover, caffeine has an aqueous solubility of approximately 100 mM and is very likely to aggregate and precipitate at concentrations above this threshold because of its planar architecture (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Molecular Targets Tested for Caffeine as Annotated in ChEMBL or Reported in the Literature</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">molecular targets of caffeine (pEC<sub>50</sub>, pIC<sub>50</sub>, p<i>K</i><sub>i</sub>)</th><th class="colsep0 rowsep0" align="center">targets where caffeine was found to be inactive</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>confirmed targets</b></td><td class="colsep0 rowsep0" align="left">aldehyde dehydrogenase</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acetylcholinesterase (pIC<sub>50</sub> 5.1)</td><td class="colsep0 rowsep0" align="left">adrenergic receptors Alpha-2a, Alpha-2b, Beta-1, Beta-2, Beta-3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adenosine A1 receptor (p<i>K</i><sub>i</sub> 4.3–5.0)</td><td class="colsep0 rowsep0" align="left">angiotensin II type 2 (AT-2) receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adenosine A2a receptor (p<i>K</i><sub>i</sub> 4.3–5.6)</td><td class="colsep0 rowsep0" align="left">bradykinin B2 receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adenosine A2b receptor (p<i>K</i><sub>i</sub> 4.5–5.0)</td><td class="colsep0 rowsep0" align="left">cannabinoid CB1 receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adenosine A3 receptor (p<i>K</i><sub>i</sub> 4.9)</td><td class="colsep0 rowsep0" align="left">carbonic anhydrase II</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycogen phosporylase (p<i>K</i><sub>i</sub> ∼ 4)</td><td class="colsep0 rowsep0" align="left">caspase-1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Notum (pIC<sub>50</sub> 4–5)</td><td class="colsep0 rowsep0" align="left">cathepsin G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphodiesterases (pIC<sub>50</sub> < 4)</td><td class="colsep0 rowsep0" align="left">C–C chemokine receptors type 2, type 4, type 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ryanodine receptor (pEC<sub>50</sub> < 4)</td><td class="colsep0 rowsep0" align="left">cholecystokinin A receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">COX-1, COX-2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">targets with controversial results or pending confirmation</td><td class="colsep0 rowsep0" align="left">cysteinyl leukotriene receptor 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bile salt export protein (pIC<sub>50</sub> < 4)</td><td class="colsep0 rowsep0" align="left">CYPs 1A2, 2A6, 2B6, 2C19, 2C8, 2C9, 2D6,2E1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">butyrylcholinesterase (pIC<sub>50</sub> < 4)</td><td class="colsep0 rowsep0" align="left">dopamine receptors D1, D2, D4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYPs 2C19, 3A4 (n.d.)</td><td class="colsep0 rowsep0" align="left">dopamine transporter</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GABA<sub>A</sub> receptors (p<i>K</i><sub>i</sub> < 4)</td><td class="colsep0 rowsep0" align="left">endothelin receptor ET-A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">guanine deaminase (p<i>K</i><sub>i</sub> 5.0)</td><td class="colsep0 rowsep0" align="left">estrogen receptors alpha, beta</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HERG (pIC<sub>50</sub> < 4)</td><td class="colsep0 rowsep0" align="left">glucocorticoid receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nicotinic acetylcholine receptors (n.d.)</td><td class="colsep0 rowsep0" align="left">histamine H1 receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3-kinase (pIC<sub>50</sub> ≤ 4.1)</td><td class="colsep0 rowsep0" align="left">HMG-CoA reductase</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">organic anion transporters 1B1, 1B3 (n.d.)</td><td class="colsep0 rowsep0" align="left">interleukin-8 receptor A, B</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tailless homologue receptor (pIC<sub>50</sub> 5.1)</td><td class="colsep0 rowsep0" align="left">leukocyte common antigen</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">leukocyte elastase</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MAP kinases ERK1, ERK2, p38 alpha</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">matrix metalloproteinases 1, 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">melanocortin receptor 3, 4, 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monoamine oxidase A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">muscarinic acetylcholine receptors M1, M2, M3, M4, M5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">neurokinin 2 receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">neuropeptide Y receptor type 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">norepinephrine transporter</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">opioid receptors delta, kappa</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">phosphodiesterase 5A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">receptor protein-tyrosine kinase erbB-2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">retinal dehydrogenase 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serine/threonine protein phosphatase 2B catalytic subunit, alpha</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">serotonin 6 (5-HT<sub>6</sub>) receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">sigma opioid receptor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">sodium channel alpha subunits; brain (types I, II, III)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">thromboxane-A synthase</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">tyrosine-protein kinases FYN, LCK</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">vasoactive intestinal polypeptide receptor 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">vasopressin V1a receptor</td></tr></tbody></table></div></div><div class="NLM_p">The best characterized molecular activity of caffeine is adenosine receptor antagonism of all subtypes with IC<sub>50</sub> values in the range of 10 μM<a onclick="showRef(event, 'ref34 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref34 ref79 ref80">(34,79,80)</a> (A<sub>1</sub>R: 10.7 μM; A<sub>2A</sub>R: 9.6 μM; A<sub>2B</sub>R: 10.4 μM; A<sub>3</sub>R: 13.3 μM; values from ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>). Adenosine receptor antagonism is considered to mediate a majority of caffeine’s known biological effects in human including the analgesic adjuvant activity and neuroprotective properties.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> In addition, recent observations indicate the therapeutic potential of adenosine receptor antagonism in cancer immunotherapy.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Extensive studies have been conducted to elucidate the SAR of caffeine and derivatives on adenosine receptors and led to the development of highly potent adenosine receptor ligands (see chapter <a class="ref internalNav" href="#sec2_2_2" aria-label="2.2.2">2.2.2</a>). Weak inhibition of phosphodiesterases (PDE) is another long known activity of caffeine which has initiated elaborate medicinal chemistry with xanthines as a natural template for the development of potent PDE inhibitors<a onclick="showRef(event, 'ref81 ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref81 ref82 ref83 ref84">(81−84)</a> (see chapter <a class="ref internalNav" href="#sec2_2_3" aria-label="2.2.3">2.2.3</a>). In addition, caffeine was found to modulate GABA<sub>A</sub> receptors through the benzodiazepine binding site<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85−87)</a> and to inhibit acetylcholinesterase<a onclick="showRef(event, 'ref88 ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref88 ref89 ref90 ref91">(88−91)</a> with intermediate to high micromolar potencies which may be involved in CNS effects of caffeine, as well. Inhibition of butyrylcholinesterase by caffeine has been speculated, too, but is controversial.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> A recent study has also reported modulation of nicotinic acetylcholine receptors by caffeine in an allosteric fashion.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Reports suggesting involvement of phosphatidylinositol 3-kinase (PI3K) inhibition by caffeine in its biological/pharmacological activities require further attention and validation.<a onclick="showRef(event, 'ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94">(92−94)</a> Caffeine also is an activating ligand of ryanodine receptors (RyR) which are intracellular Ca<sup>2+</sup>-release channels and essentially important for muscle and neuronal function.<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95,96)</a> While this activity of caffeine has been described decades ago and was only observed at very high concentrations (max. efficacy at ≥10 mM), three recent studies<a onclick="showRef(event, 'ref97 ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99">(97−99)</a> have succeeded in providing a structural basis for RyR modulation by caffeine and confirmed binding sites for caffeine in the pore region, through which it modulates the channel open probability (see chapter <a class="ref internalNav" href="#sec2_2_4" aria-label="2.2.4">2.2.4</a>).</div><div class="NLM_p">Caffeine has also been speculated as weak inhibitor of the transmembrane transporters bile salt export protein, organic anion transporter 1B1 and organic anion transporter 1B3, as well as the cytochrome P450 enzymes 2C19 and 3A4.<a onclick="showRef(event, 'ref100 ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref100 ref101 ref102">(100−102)</a> While these weak activities likely have few pharmacodynamic consequences per se, they can affect the pharmacokinetics of other drugs. Another metabolic enzyme for which an interaction with caffeine was reported is guanine deaminase which was inhibited in vitro by caffeine at intermediate micromolar concentrations.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> In vitro studies have additionally observed a direct inhibition of the human Ether-a-go-go-Related Gene (hERG) potassium channel by caffeine through stabilization of an open state,<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> but the tested concentrations were extremely high (5 and 20 mM); however, no effect was observed at relevant concentrations.</div><div class="NLM_p">An allosteric inhibitory activity of caffeine has also been discovered on glycogen phosphorylase, the rate-limiting enzyme in glucose release from (hepatic) glycogen storages.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105,106)</a> Glycogen phosphorylase has received considerable attention as a potential target for antidiabetic therapy, but interest has faded.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Biochemical and biophysical (SPR) studies have determined a potency/affinity of approximately 100 μM for caffeine in inhibiting glycogen phosphorylase, and cocrystal structures have confirmed and characterized caffeine binding to the enzyme (see chapter <a class="ref internalNav" href="#sec2_2_5" aria-label="2.2.5">2.2.5</a>).<a onclick="showRef(event, 'ref105 ref108'); return false;" href="javascript:void(0);" class="ref ref105 ref108">(105,108)</a> Recent findings characterize caffeine as inhibitor of the Wnt deacylase Notum which acts as negative feedback regulator of Wnt signaling (see chapter <a class="ref internalNav" href="#sec2_2_6" aria-label="2.2.6">2.2.6</a>).<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(109,110)</a> Among a number of activities reported so far, Notum appears to be involved in cancer and in neuronal function.<a onclick="showRef(event, 'ref111 ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref111 ref112 ref113 ref114">(111−114)</a> Very recently, we have discovered modulation of the brain nuclear receptor tailless homologue (TLX) by caffeine and derivatives which may emerge as another protein target involved in the neuroprotective properties of caffeine.</div><div class="NLM_p">In addition to these proteins for which a direct modulation by caffeine has been demonstrated or at least suggested, caffeine was profiled on multiple further molecular targets and found to be inactive (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">2.2.1.  Macromolecular Complex Structures with Bound Caffeine</h4><div class="NLM_p last">As of today, the protein data bank contains 27 macromolecular structures of human proteins with caffeine as ligand. Among them, two structures are stabilized adenosine A<sub>2A</sub>R receptors complexed with caffeine (pdb IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RFM">3RFM</a>, 5MPZ), 19 entries (pdb IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T15">5T15</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9S">5T9S</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9R">5T9R</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9%2520V">5T9 V</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9M">5T9M</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9N">5T9N</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TA3">5TA3</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TAZ">5TAZ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TAS">5TAS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TB4">5TB4</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JI0">6JI0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JII">6JII</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JI8">6JI8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JIU">6JIU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JIY">6JIY</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRS">6JRS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRR">6JRR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JV2">6JV2</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JHN">6JHN</a>) refer to ryanodine receptors with bound caffeine, one structure (pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TV4">6TV4</a>) presents the Notum complex with caffeine bound to the catalytic pocket, and five entries (pdb IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DDS">3DDS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DDW">3DDW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DD1">3DD1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L7X">1L7X</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L5Q">1L5Q</a>) refer to glycogen phosphorylase with caffeine bound to an allosteric inhibitory site.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">2.2.2.  Caffeine as Adenosine Receptor Ligand</h4><div class="NLM_p">Adenosine receptor (ADOR) antagonism—from a medicinal chemistry point of view—is the most intensively studied biochemical activity of caffeine (<b>1</b>). The SAR of the natural product has been evaluated on all ADOR subtypes and caffeine has served as a lead compound for multiple potent and selective ADOR antagonists, some of which have high relevance as tool compounds and as drugs. The SAR and in vitro characterization data of caffeine and descendants as ADOR antagonists are complex and in some cases contradictory, which is partly due to the use of diverse in vitro test system types (radioligand binding, cellular assay, etc.), species differences (human, mouse, guinea pig, rat, etc.),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> and the belated discovery of further adenosine receptors leading to a retrospective reevaluation of potency and selectivity profiles. Medicinal chemistry efforts on ADOR antagonist development and optimization have been immense and have also created several chemotypes with little structural relation to xanthines remaining. The comprehensive SAR and developmental history of ADOR antagonists has been summarized in several reviews<a onclick="showRef(event, 'ref34 ref116 ref117 ref118 ref119 ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref34 ref116 ref117 ref118 ref119 ref120 ref121">(34,116−121)</a> and will not be the topic of this Perspective. However, in the following paragraphs, we provide an overview of the SAR of xanthines as ADOR antagonists and highlight milestone compounds without comprehensively describing the SAR in detail.</div><div class="NLM_p">Shimizu et al.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> reported the first evidence that caffeine affects cAMP generation in guinea pig cerebral cortex, which may occur through the modulation of ADORs. As G-protein coupled receptors (GPCRs), the ADORs consist typically of seven transmembrane helices which recognize small molecules on the extracellular surfaces and translate the ligand signal via G-protein mediated coupling into intracellular effects such as the regulation of intracellular cAMP levels via adenylate cyclase.<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123,124)</a> Four subtypes of ADORs have been identified to date, namely, A<sub>1</sub> (uniprot: P30542), A<sub>2A</sub> (uniprot: P29274), A<sub>2B</sub> (uniprot: P29275), and A<sub>3</sub> (uniprot: P33765).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> A<sub>1</sub> and A<sub>3</sub> are coupled to G<sub>i/o</sub> and therefore inhibit adenylate cyclase, leading to low cAMP levels, low protein kinase A (PKA) activity, and decreased subsequent phosphorylation of the transcriptional activator cyclic AMP response element binding protein (CREBP). A<sub>2A</sub> and A<sub>2B</sub> are coupled to G<sub>s</sub> promoting adenylate cyclase activity, resulting in elevated cAMP levels and higher PKA activity and also to G<sub>q</sub> leading to activation of phospholipase C (PLC) with a subsequent enhancement of protein kinase C (PKC) activity and elevated intracellular Ca<sup>2+</sup> levels.<a onclick="showRef(event, 'ref126 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128">(126−128)</a></div><div class="NLM_p">Extensive medicinal chemistry efforts have been made over the last decades to elucidate the SAR of caffeine and analogues on ADORs involving variations on almost all positions of caffeine. Early stages have focused predominantly on the easily accessible positions 1, 3, 7, and 8 by varying the alkylation patterns at position 1, 3, and 7 and by introducing 8-aryl- and cycloalkyl residues. Early studies on modifications in 7 position indicated that no polar substituents were tolerated, and only minor improvements in potency were achieved by extending the 7-methyl to propyl, allyl or propargyl motifs.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Therefore, SAR elucidation mainly focused on the remaining 1- and 3-positions followed by extensive evaluation of the favored 8-phenyl moiety before further/alternative expansion of caffeine at position 8 was studied. Considerable work has also focused on improving aqueous solubility of the compound class.</div><div id="sec2_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13">2.2.2.1.  A<sub>1</sub> Receptor</h5><div class="NLM_p">Early studies report caffeine and theophylline as nonselective (A<sub>1</sub>/A<sub>2</sub>) antagonists with affinities in the 5–200 μM range depending on species and tissues.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> First, remarkable improvements toward low micromolar affinity were achieved by introduction of a phenyl residue at the 8-position of theophylline resulting in 8-phenyltheophylline (<b>8</b>, IC<sub>50</sub> 0.5 μM, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) and 1,3-diethyl-8-phenylxanthine (<b>9</b>, IC<sub>50</sub> 1 μM).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Only three years later, Bruns et al. reported PACPX (<b>10</b>, 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine) with a <i>K</i><sub>i</sub> value as low as 22 pM corresponding to a factor of 70.000 improvement in potency.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> In a functionalized congener approach of 1,3-dipropyl-8-phenylxanthine, Jacobson et al. discovered further highly active xanthine derivatives with nanomolar affinities for A<sub>1</sub> and for A<sub>2</sub> including XAC (<b>11</b>,<i>N</i>-(2-aminoethyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1<i>H</i>-purin-8-yl)phenoxy]-acetamide), which was also used as an A<sub>1</sub>-selective radioligand in subsequent studies because of its high affinity (0.17–3 nM depending on species).<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132,133)</a> The early SAR results demonstrated that larger linear N-propyl substituents at positions 1 and 3 as well as introduction of an 8-phenyl moiety were favored for A<sub>1</sub> receptor affinity and further potent ligands complying with this pattern were developed (<b>12</b>–<b>14</b>, <b>16</b>). The 8-phenyl substituent was soon successfully replaced with cycloalkyl moieties (<b>15</b>, <b>17</b>–<b>19</b>) leading to potent and selective A<sub>1</sub> receptor antagonists with DPCPX (<b>15</b>,8-cyclopentyl-1,3-dipropylxanthine, <i>K</i><sub>i</sub> 0.46 nM, A<sub>2</sub>/A<sub>1</sub> 740-fold selectivity),<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> KW-3902 (<b>17</b>,1,3-dipropyl-8-(3-noradamantyl)xanthine, <i>K</i><sub>i</sub> 1.3 nM, A<sub>2</sub>/A<sub>1</sub> 290-fold selectivity),<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> and ENX (<b>18</b>,1,3-dipropyI-8 [2-(5,6-epoxy)norbornyI]xanthine, <i>K</i><sub>i</sub> 0.95 nM, A<sub>2</sub>/A<sub>1</sub> 400-fold selectivity)<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> as most notable examples. Simultaneously, the limited aqueous solubility of xanthine-based ADOR antagonists was addressed as a prerequisite for further consideration of the compound class in therapeutic applications. The first potent caffeine derived ADOR antagonist <b>8</b> comprised a low aqueous solubility <10 μM. Early improvements were achieved by introducing polar, ionizable groups such as <i>p</i>-sulfophenyl (<b>13</b>, aqueous solubility >20 mM, <i>K</i><sub>i</sub> 4.5 μM, nonselective) and <i>p-</i>carboxyphenyl (<b>14</b>, aqueous solubility 90 μM, <i>K</i><sub>i</sub> 3.0 μM, nonselective), which also caused a significant loss in potency on ADORs, however.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> A quantitative structure activity relationship (QSAR) approach succeeded in retaining high ADOR affinity and enhanced aqueous solubility with further 1,3-dialkyl-8-<i>p</i>-sulfonamidetheophyllines such as <b>12</b> (<i>K</i><sub>i</sub> 6.5 nM, aqueous solubility 19.9 mg/mL = 43 mM).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Similarly, Daly et al. extended the <i>para</i> substituent of the 8-phenyl residue to obtain 1,3-dipropyl-2-hydroxy-4-[(carbamoylmethyl)oxy]phenylxanthine (<b>16</b>, <i>K</i><sub>i</sub> 6.5 nM, aqueous solubility 5.6 mM, A<sub>2</sub>/A<sub>1</sub> 190-fold selective).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Kiesman et al. prepared a set of 1,3-substituted 8-cyclohexyl- and 8-bicyclo-[2.2.2]octylxanthines and discovered BG9928 (<b>19</b>,3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-<i>1H</i>-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid, <i>K</i><sub>i</sub> 7.4 nM, aqueous solubility 59 mM, A<sub>2A</sub>/A<sub>1</sub> 915-fold selective, A<sub>2B</sub>/A<sub>1</sub> 12-fold selective) as a potent and selective A<sub>1</sub> antagonist with preferable bioavailability profile.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Selected Xanthine-Derived A<sub>1</sub> Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15">2.2.2.2.  A<sub>2A</sub> Receptor</h5><div class="NLM_p">A first tendency toward A<sub>2</sub> selective xanthine derivatives has been reported by Ukena et al. with DMPX (<b>20</b>, 3,7-dimethyl-1-propargylxanthine) and 7-propyl-1,3-dimethylxanthine (<b>21</b>) as A<sub>2</sub> receptor antagonists with an A<sub>1</sub>/A<sub>2</sub> selectivity ratio of 10–20 (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> DMPX also demonstrated improved in vivo efficacy against 5′-<i>N</i>-ethylcarboxamidoadenosine (NECA)-induced hyperthermia compared with caffeine.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Further improvement in A<sub>2</sub> selectivity resulted from 8-cycloalkyl (cyclopentyl and cyclohexyl) caffeine derivatives, which seemed contradictory at a first glance since 8-cycloalkyltheophyllines were predominantly found as A<sub>1</sub>-selective.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Alternatively, an (<i>E</i>)-3,4-dimethoxystyryl group at position 8 of 1,3-dialkyl-7-methylxanthines (<b>22</b>) produced high potency and selectivity toward A<sub>2</sub>, but aqueous solubility was poor (<10 μg/mL).<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144,145)</a> Further SAR elucidation of 8-styryl-1,3,7-alkylxanthines by Jacobson et al. revealed meta substitution on the styryl ring as crucial for potency and selectivity.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> CSC (<b>23</b>, 8-chlorostyrylcaffeine, <i>K</i><sub>i</sub> 54 nM, A<sub>1</sub>/A<sub>2</sub> 520-fold selectivity) emerged as a first potent tool compound for A<sub>2</sub>.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Despite having concomitant monoamine oxidase B (MAO-B) inhibitory potency (∼100 nM),<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> CSC served as lead structure for the development of KW-6002 (<b>24</b>, Istradefylline, (<i>E</i>)-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methylxanthine), which has received considerable attention for its high potency and selectivity toward A<sub>2A</sub>. It is approved in Japan<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> and the United States (trade name Nourianz)<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> to treat “off time” in Parkinson’s Disease. Very recent studies have reported novel pyrimido[2,1-<i>f</i>]purinedione based A<sub>2</sub> antagonists as exemplified by <b>25</b> (<i>K</i><sub>i</sub> 264 nM), which also act as monoamine oxidase B (MAO-B) inhibitors.<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151,152)</a></div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Selected Xanthine-Derived A<sub>2A</sub> Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17">2.2.2.3.  A<sub>2B</sub> Receptor</h5><div class="NLM_p">Enprofylline (<b>26</b>, 3-propylxanthine, <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>) was reported in 1982 as the first xanthine comprising preference for A<sub>2B</sub><a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> but it took until 2000 before the potent caffeine-based A<sub>2B</sub> antagonists MRS 1706 (<b>27</b>, <i>K</i><sub>i</sub> 1.39 nM), MRS 1754 (<b>28</b>, <i>K</i><sub>i</sub> 1.97 nM),<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and PSB-1115 (<b>29</b>, <i>K</i><sub>i</sub> 53.4 nM) derived from XAC (<b>11</b>) were described. The latter example lacks the common 3-propyl substituent and displays favorable aqueous solubility because of its 8-<i>p</i>-sulfophenyl moiety.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Furthermore, bioisosteric replacement of the amide linker of XAC (<b>11</b>) with an 1,2,4-oxadiazole yielded the potent and highly A<sub>2B</sub> selective antagonist CVT-5540 (<b>31</b>, <i>K</i><sub>i</sub> 50 nM, A<sub>1</sub>/A<sub>2B</sub> > 200, A<sub>2A</sub>/A<sub>2B</sub> > 200 and A<sub>3</sub>/A<sub>2B</sub> > 167-fold selectivity).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Concomitantly, Baraldi et al. reported a large series of xanthines comprising a heterocycle in 8-position thereby introducing the <i>N</i>-methylpyrazole as structural feature that was later incorporated in several other ADOR antagonists. MRE2029F20 (<b>30</b>, <i>K</i><sub>i</sub> 5.5 nM) was the most active compound of the series.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Later examples of 8-pyrazolo-1,3-dialkylxanthines include <b>32</b>-<b>35</b>.<a onclick="showRef(event, 'ref159 ref160 ref161 ref162'); return false;" href="javascript:void(0);" class="ref ref159 ref160 ref161 ref162">(159−162)</a><b>34</b> (<i>K</i><sub>i</sub> 4 nM, A<sub>1</sub>/A<sub>2B</sub> 183 fold selectivity, A<sub>2A</sub>,A<sub>3</sub>/A<sub>2B</sub> > 250 fold selectivity) and <b>35</b> (<i>K</i><sub>i</sub> 9.4 nM, A<sub>1</sub>/A<sub>2B</sub> 269 fold selectivity, A<sub>2A</sub>,A<sub>3</sub>/A<sub>2B</sub> > 106 fold selectivity) were obtained by using a comparative molecular field analysis approach (CoMFA) based on 52 8-pyrazoyl xanthines with known biological activity to predict several potent and selective derivatives.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Recent progress in xanthine based A<sub>2B</sub> antagonists has been made in the linker region of the 8-substituent by replacing the previous amide linkers with a linear 1-prop-2-ynyl moiety (<b>36</b>, <i>K</i><sub>i</sub> 13 nM)<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> or with heterocyclic groups (e.g., pyrrolidinone and piperazine, <b>37</b>, <i>K</i><sub>i</sub> 4.5 nM). The latter heterocyclic modifications also provided advantages regarding pharmacokinetics with a bioavailability of 65% for <b>37</b> in mice.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Selected Xanthine-Derived A<sub>2B</sub> Antagonists. Inset Shows 9-Deazaxanthines</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Another notable series of caffeine inspired A<sub>2B</sub> antagonists is based on a 9-deazaxanthine scaffold commonly equipped with an 8-phenyl residue that is further extended with a piperazine or piperidine linked aromatic tail. Several highly potent and selective A<sub>2B</sub> antagonists of this chemotype have been developed such as <b>38</b> (<i>K</i><sub>i</sub> 1 nM, A<sub>1</sub>/A<sub>2B</sub> 183-fold selectivity, A<sub>3</sub>/A<sub>2B</sub> 12660-fold selectivity) and <b>39</b> (<i>K</i><sub>i</sub> 2 nM, A<sub>1</sub>/A<sub>2B</sub> 44-fold selectivity, A<sub>2A</sub>/A<sub>2B</sub> 159-fold selectivity, A<sub>3</sub>/A<sub>2B</sub> 180-fold selectivity).<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165,166)</a></div></div><div id="sec2_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19">2.2.2.4.  A<sub>3</sub> Receptor</h5><div class="NLM_p">Compared to A<sub>1</sub> and A<sub>2</sub> receptors, less SAR knowledge is available on xanthines as A<sub>3</sub> receptor antagonists (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). I-ABOPX (<b>40</b>, 3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine, <i>K</i><sub>i</sub> 18 nM)<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> was one of the first potent A<sub>3</sub> antagonist tool compounds, and N7-ribosylated 1,3-dibutylxanthine was another early reported but rather weak ADOR antagonist (6 μM) with a slight A<sub>3</sub> preference.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Its subsequent structural optimization produced the more potent and selective analogue <b>41</b> (<i>K</i><sub>i</sub> 229 nM, A<sub>1</sub>/A<sub>3</sub> 160-fold selective and A<sub>2A</sub>/A<sub>3</sub> > 400-fold selective) comprising a 5-<i>N</i>-carboxamidoriboside at position 7.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Later xanthine inspired A<sub>3</sub> antagonist generations are based on tricyclic scaffolds such as pyrido[2,1-<i>f</i>]purine-2,4-diones and imidazo[2,1-<i>f</i>]purine-2,4-diones incorporating the former xanthine moiety. <b>42</b> (<i>K</i><sub>i</sub> 4.0 nM)<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> and <b>45</b> (<i>K</i><sub>i</sub> 0.8 nM, selectivity over A<sub>1</sub> and A<sub>2</sub> ≫ 1250)<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> are highly optimized selective A<sub>3</sub> antagonists of these series. Imidazo[2,1-<i>i</i>]purin-5-ones are another noteworthy class of xanthine-derived A<sub>3</sub> antagonists. Because of an additional basic nitrogen, potent A<sub>3</sub> antagonist examples of this series such as PSB-11 (<b>43</b>, <i>K</i><sub>i</sub> 2.3 nM, A<sub>1</sub>/A<sub>3</sub> 190-fold selective, A<sub>2</sub>/A<sub>3</sub> > 900-fold selective)<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> and PSB-10 (<b>44</b>, <i>K</i><sub>i</sub> 0.433 nM, selectivity over A<sub>1</sub> and A<sub>2</sub> > 800)<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> provide improved aqueous solubility. Important progress in A<sub>3</sub> antagonist development has lately been achieved with the pyrido[2,1-<i>f</i>]purine-2,4-dione skeleton of <b>42</b> by studying the residence time (RT) to elucidate structure–kinetics relationships (SKR). <b>46</b> (<i>K</i><sub>i</sub> 0.38 nM, RT = 376 min)<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> emerged as a valuable lead compound with a long RT which is considered as an important feature for in vivo efficacy. Moreover, <b>47</b> (<i>K</i><sub>i</sub> 27 nM)<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> comprising a fluorosulfonyl warhead attached to the xanthine N-3 via a flexible linker, has recently been reported as a covalent A<sub>3</sub> antagonist. It was designed to form a covalent bond with Tyr265 of the A<sub>3</sub> receptor through a nucleophilic substitution at the sulfonyl group which was confirmed by site directed mutagenesis.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Selected Xanthine-Derived A<sub>3</sub> Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21">2.2.2.5.  Xanthine Bound Adenosine Receptor Structures</h5><div class="NLM_p">From the structural biology point of view, A<sub>2A</sub> is the most elucidated adenosine receptor subtype with more than 50 solved cocrystal structures, five of which comprise a bound caffeine derivative as ligand (pdb IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3REY">3REY</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RFM">3RFM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MZJ">5MZJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MZP">5MZP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2R">5N2R</a>). In addition, a cocrystal structure of A<sub>1</sub> complexed with a caffeine derivative has been solved (pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S">5N2S</a>). The xanthine derivative PSB36 has been cocrystallized with both the A<sub>1</sub> and A<sub>2A</sub> subtypes and hence provides a valuable basis for comparative evaluation of the ligand–receptor interactions.<a onclick="showRef(event, 'ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref176 ref177">(176,177)</a> Overall, the caffeine binding sites of A<sub>1</sub> and A<sub>2A</sub> receptors are very similar. In the A<sub>1</sub> receptor binding site, the xanthine scaffold participates in a hydrophobic contact with Leu250 and in π-stacking with Phe171. In addition, the 6-carbonyl oxygen and the 7-nitrogen of the xanthine core form hydrogen bonds to the Asn254 side chain (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This binding mode of the basic xanthine scaffold is conserved in other xanthine bound ADOR cocrystal structures. Interestingly, despite forming one hydrogen bond less to Asn254 due to the N7 methyl substituent, caffeine has comparable adenosine receptor affinity as theophylline.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a></div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PSB36 bound to the A<sub>1</sub> receptor (pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S">5N2S</a>). Interacting amino acids are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compared with A<sub>1</sub>, the A<sub>2A</sub> receptor binding site is narrow, which affects the accommodation of bulky alkyl substituents on N1 and N3. Therefore, PSB36 is shifted deeper into the binding cavity in A<sub>1</sub> than in A<sub>2A</sub>. Steric hindrance by Met270 in A<sub>2A</sub> toward the 8-noradamantyl substituent provides further structural explanation for the accommodation of bulkier ligands by A<sub>1</sub> bearing Thr270 at this position (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Mutagenesis studies have confirmed this assumption.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a></div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superimposed structures of A<sub>1</sub> (green, pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S">5N2S</a>) and A<sub>2A</sub> (gray, pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2R">5N2R</a>) receptor in complex with PSB36. The bulkier Met270 in A<sub>2A</sub> affects binding of bulky 8-substituents, while Thr270 of A<sub>1</sub> provides more space to ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">2.2.3.  Caffeine as Phosphodiesterase Inhibitor</h4><div class="NLM_p">Inhibition of cyclic nucleotide phosphodiesterases (PDE) also was one of the first biological activities of caffeine to be discovered.<a onclick="showRef(event, 'ref178 ref179'); return false;" href="javascript:void(0);" class="ref ref178 ref179">(178,179)</a> It has inspired vast efforts of medicinal chemistry in PDE inhibitor design, leading to the development of potent and selective inhibitors of the 11 PDE isoenzymes in humans. The majority of PDE inhibitors comprises a two-ring scaffold to mimic the purine respectively xanthine structure of PDE substrates and early inhibitors. Caffeine and theophylline were found to inhibit most human PDEs with weak potency in the high micromolar range. After the discovery of caffeine and the related xanthines theophylline and theobromine inhibiting PDEs, multiple alkylxanthines were developed to optimize potency and selectivity.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> 3-Isobutyl-1-methylxanthine (IBMX, <b>48</b>) was the first widely used nonspecific PDE inhibitor that blocks all PDEs except PDE8, PDE9, and PDE11 at low micromolar potency.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Particularly (bulky) substituents in positions 2 and 9 of the underlying purine scaffold were characterized as major switches to tune potency and selectivity toward some PDEs (PDE1, PDE2, PDE4, and PDE5), while among other PDEs, scaffolds have evolved that markedly differ from caffeine/xanthines.<a onclick="showRef(event, 'ref178 ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref178 ref181 ref182">(178,181,182)</a> Notable PDE inhibitors comprising structural elements of caffeine are (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>), for example, pentoxyfylline (<b>49</b>) as a weak nonselective PDE inhibitor, the selective PDE2 inhibitor BAY607550<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> (<b>50</b>, IC<sub>50</sub> (PDE2) 4.7 nM), and the PDE5 selective drugs sildenafil<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> (<b>51</b>, IC<sub>50</sub> (PDE5) ∼ 10 nM) and vardenafil<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> (<b>52</b>, IC<sub>50</sub> (PDE5) < 1 nM).</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0015.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. PDE Inhibitors with Structural Relationship to Caffeine (Examples)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Caffeine has not been cocrystallized with a PDE but structural insight can be obtained from IBMX-bound complex structures of PDE3, PDE4, PDE5, and PDE9 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The xanthine binds close to the catalytic site of PDEs which in PDE5 is composed of His617, His653, Asp654, and Asp764 that complex Mn<sup>2+</sup> and Zn<sup>2+</sup> as the catalytic center. IBMX binds to the same hydrophobic region of the pocket as the adenine or guanine motif of the PDE substrate and forms a π-stacking contact with Phe820. In addition, the carbonyl groups of IBMX participate in three H-bonds involving the side chain of Gln817 and two bound water molecules, which is a rare feature among the characterized xanthine binding sites since π-stacking and hydrophobic contacts usually dominate xanthine binding (see following chapters). Binding modes of IBMX in PDE3, PDE4, and PDE9 are very similar (not shown).</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IBMX (<b>48</b>) bound to PDE5 (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RKP">1RKP</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">2.2.4.  Caffeine as Ryanodine Receptor Modulator</h4><div class="NLM_p">Ryanodine receptors are exceptionally large (∼500 kDa per subunit), tetrameric intracellular Ca<sup>2+</sup> channels located at the endoplasmic or sarcoplasmic reticulum membrane and essential for intracellular Ca<sup>2+</sup> mobilization. Three RyR isoforms have been identified of which the RyR1 is mainly found in skeletal muscle, RyR2 in myocardium, and RyR3 is ubiquitously expressed with high abundance in the CNS. Their activity is particularly important for muscle function in skeletal (RyR1) and cardiac (RyR2) muscles as well as for neuronal activity (RyR1, RyR2, and RyR3) by involving in excitation-contraction coupling and in neurotransmitter release.<a onclick="showRef(event, 'ref97 ref98 ref99 ref186'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99 ref186">(97−99,186)</a> RyR are sensitive to activation by cytosolic Ca<sup>2+</sup> and thus mediate Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Additionally, several cellular signaling molecules are known to modulate RyR such as ATP and adenosine.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Early studies<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95,96)</a> have detected enhanced ryanodine binding to RyR and increased mean open time of RyR in the presence of caffeine, providing a mechanistic basis for previous observations that caffeine can induce muscle contraction<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> and intracellular Ca<sup>2+</sup>-release from endoplasmic reticulum.<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188,189)</a> Therein, caffeine enhanced RyR Ca<sup>2+</sup> affinity and revealed synergistic activity with adenine nucleotides, suggesting different binding sites.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Several studies have demonstrated that caffeine also activates RyR in neuronal cells.<a onclick="showRef(event, 'ref191 ref192 ref193'); return false;" href="javascript:void(0);" class="ref ref191 ref192 ref193">(191−193)</a> These effects were, however, only demonstrated in vitro and observed at supraphysiological concentrations (1–20 mM) so far. Despite the hypothesis that sensitization of RyR by adenosine or other endogenous molecules increases potency of caffeine on RyR,<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> a physiological/pharmacological role of RyR modulation by caffeine remains to be confirmed.</div><div class="NLM_p">Several cryo-EM structures have recently revealed the binding site of caffeine on RyR1 and RyR2 and elucidated activation and gating mechanisms.<a onclick="showRef(event, 'ref97 ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99">(97−99)</a> Caffeine binds to four sites at the cytosolic side of tetrameric RyR (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) on the C-terminal domain which directly interacts with the pore helix. Both Ca<sup>2+</sup> and ATP were discovered at different binding sites but in close proximity to caffeine. Binding of Ca<sup>2+</sup> induces contraction of the central domain serving as a prerequisite for opening of the channel pore in a long-range allosteric mechanism. Caffeine binding leads to a constitutive contraction of the central domain which is further strengthened by ATP binding thereby explaining the synergistic activity of caffeine and adenine nucleotides. The caffeine binding site (one of four as example) is mostly defined by lipophilic amino acids (Phe3715, Trp4646, Ile4927, Tyr4945, Trp4646, Trp4942). Caffeine is sandwiched between Trp4646 and Ile4927 involving π-stacking with Trp4646 as a likely major contribution to binding. The caffeine binding site on RyR provides several opportunities for structural extension and optimization.</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding of caffeine to ryanodine receptor (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRS">6JRS</a>). One binding site is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For their crucial involvement in regulating intracellular Ca<sup>2+</sup> homeostasis and excitation coupling, RyR arise as potential therapeutic targets in multiple diseases such as neurodegeneration, myopathies, malignant hyperthermia, and cardiovascular diseases.<a onclick="showRef(event, 'ref195 ref196 ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref195 ref196 ref197 ref198">(195−198)</a> For several such conditions, an association with mutations in RyR has been observed.<a onclick="showRef(event, 'ref195 ref196 ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref195 ref196 ref197 ref198">(195−198)</a> Apart from the RyR antagonist dantrolene,<a onclick="showRef(event, 'ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref199 ref200">(199,200)</a> tool compounds to pharmacologically validate RyR as therapeutic targets are lacking, however. The recent mechanistic findings on RyR modulation by caffeine and the pharmacological potential of RyR modulation may elicit stronger efforts to develop optimized RyR activators. Recent studies have reported high throughput compatible screening systems to characterize small molecule RyR modulators and discovered novel RyR ligands with higher potency than caffeine.<a onclick="showRef(event, 'ref201 ref202 ref203 ref204 ref205 ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref201 ref202 ref203 ref204 ref205 ref206 ref207">(201−207)</a> This progress provides a very valuable basis for medicinal chemistry toward potent RyR modulators which may also profit from structure-based design using the recently reported macromolecular RyR–caffeine complexes.</div></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">2.2.5.  Caffeine as Ligand of Glycogen Phosphorylase</h4><div class="NLM_p">Glycogen phosphorylase catalyzes the rate-determining step of glycogenolysis and mediates the cleavage of glucose-1-phosphate from glycogen, thereby controlling the release of glucose from (hepatic) stores.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105,106)</a> It is hence considered as a potential drug target to treat type 2 diabetes and related diseases. The enzyme has the special ability to switch between active and inactive states depending on an allosteric regulatory mechanism with several allosteric binding sites.<a onclick="showRef(event, 'ref105 ref208'); return false;" href="javascript:void(0);" class="ref ref105 ref208">(105,208)</a> While AMP activates glycogen phosphorylase, glucose acts as an allosteric inhibitor by stabilizing the enzyme’s inactive state as a negative feedback to block glycogen cleavage.<a onclick="showRef(event, 'ref105 ref108 ref209 ref210'); return false;" href="javascript:void(0);" class="ref ref105 ref108 ref209 ref210">(105,108,209,210)</a> Caffeine was discovered as an allosteric modulator of glycogen phosphorylase and has synergistic activity with glucose.<a onclick="showRef(event, 'ref105 ref108 ref210'); return false;" href="javascript:void(0);" class="ref ref105 ref108 ref210">(105,108,210)</a> It inhibited the enzyme alone and in the presence of the activator AMP.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> An IC<sub>50</sub> of 92 μM has been determined for caffeine alone, while addition of 0.2 mM AMP elevated the IC<sub>50</sub> to 360 μM.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> The combination of glucose and caffeine has been reported to increase potency by 2- to 3-fold in the presence and absence of AMP.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> In accordance with the IC<sub>50</sub>, SPR measurements have revealed an affinity of approximately 100 μM for caffeine binding to the purine binding site of apo glycogen phosphorylase.<a onclick="showRef(event, 'ref105 ref108'); return false;" href="javascript:void(0);" class="ref ref105 ref108">(105,108)</a> The related xanthines <b>2</b> and <b>3</b> have slightly lower affinities. Medicinal chemistry efforts have yielded potent optimized ligands of both the catalytic site and the allosteric purine binding site but the compounds share little structural similarity with caffeine.<a onclick="showRef(event, 'ref107 ref211'); return false;" href="javascript:void(0);" class="ref ref107 ref211">(107,211)</a></div><div class="NLM_p">Caffeine has been cocrystallized bound to the allosteric binding site of glycogen phosphorylase with a variety of synthetic inhibitors bound to the catalytic site. Caffeine binds between two aromatic residues (Phe285 and Tyr613) to engage π-stacking interactions (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Both carbonyl oxygen atoms participate in water-mediated H-bonds to the protein backbone. Caffeine does not fully occupy its ample binding pocket which particularly offers additional space in the 1-, 3-, and 8-positions, and was found to accommodate also markedly larger molecules such as riboflavin.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The glucose binding site is located close to caffeine, rationalizing their synergy in modulating glycogen phosphorylase and a cross-talk between both binding sites.</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Glycogen phosphorylase with bound caffeine (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L5Q">1L5Q</a>). Caffeine is shown in magenta, and <i>N</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-glucopyranosylamine is yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">2.2.6.  Caffeine as Notum Inhibitor</h4><div class="NLM_p">Notum is a hydrolase enzyme found in humans and other metazoans, and was long considered as a secreted phospholipase cleaving, for example, heparan sulfate proteoglycans from cell surfaces, before it was identified as important feedback suppressor of Wnt signaling.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Therein, Notum also acts as a carboxylesterase, removing palmitoleate moieties from Ser187 on Wnt proteins.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Through this deacylation of Wnt proteins, Notum was found to inhibit Wnt signaling since the palmitoleate modification is required for formation of the Wnt-Frizzled complex and subsequent signal transduction.<a onclick="showRef(event, 'ref109 ref212'); return false;" href="javascript:void(0);" class="ref ref109 ref212">(109,212)</a> Caffeine was discovered as an inhibitor of Notum with a binding affinity of 85 μM according to SPR measurements.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Moreover, caffeine blocked the activity of purified Notum with an IC<sub>50</sub> value of 19 μM and restored Wnt signaling in a cellular reporter assay with an EC<sub>50</sub> value of 46 μM.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Related xanthines were reported as markedly less active (theophylline, <i>K</i><sub>d</sub> 7 mM) or inactive (theobromine, paraxanthine).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Co-crystal structure elucidation of Notum in complex with caffeine revealed binding of caffeine at the active site close to the catalytic triad (Ser232, Asp340, and His389, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The alkaloid is bound in a very hydrophobic environment, which accommodates the lipophilic tail of the substrate palmitoleate, and engages a π-stacking interaction with Phe268. The free 8-position of caffeine points toward the catalytic triad. Considerable unoccupied space, and optimization potential seems to be available for development of caffeine derived high potency inhibitors of Notum. Since dysregulation of Wnt signaling has been implicated in various diseases including neurodegeneration and cancer, Notum inhibitors might hold great therapeutic potential. In the field of Alzheimer’s Disease and other neurodegenerative pathologies, brain-penetrant Notum inhibitors need to be developed for which the discovery of caffeine binding to Notum and the associated structural information will be very valuable. In addition, Notum inhibition presents as another potential part of the complex puzzle of pharmacodynamic actions of caffeine, especially regarding its neuroprotective properties.</div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Notum in complex with caffeine (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7TV4">7TV4</a>). Caffeine is shown in magenta, and the catalytic triad of Notum (Ser232, Asp340, and His389) is yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">3.  Pharmacological Effects of Caffeine</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">3.1.  Pain and Headache</h3><div class="NLM_p last">As an analgesic adjuvant, caffeine is found in many OTC formulations usually in combinations with acetaminophen, acetylsalicylic acid, or ibuprofen to treat headache and mild pain. Analgesic adjuvants do not have an analgesic effect on their own but enhance the effect of other analgesic agents.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> It has been suggested that the analgesic adjuvant effect of caffeine may arise from its ability to promote absorption of analgesics by rapidly lowering gastric pH, thus affecting the pharmacokinetics of coadministered drugs.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Current evidence, however, rather points to adenosine-receptor-mediated activity involving the vasoconstrictor effects of A<sub>2A</sub> blockade as a mechanistic basis of analgesic adjuvant properties.<a onclick="showRef(event, 'ref27 ref34 ref214'); return false;" href="javascript:void(0);" class="ref ref27 ref34 ref214">(27,34,214)</a> A meta-analysis of 30 clinical trials with 10 000 patients with postpartum uterine cramping, episiotomy pain, postsurgical pain or headache receiving acetaminophen or acetylsalicylic acid with or without caffeine, found that an approximately 40% higher dose of the analgesic was needed without caffeine to achieve the same effect as the combined treatment.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> In addition to the analgesic adjuvant use, a number of studies also point to moderate analgesic effects of caffeine monotherapy. A dose of 300 mg (oral) or 500 mg (intravenous) caffeine was shown to provide relief for patients with postdural puncture headache compared with placebo.<a onclick="showRef(event, 'ref216 ref217'); return false;" href="javascript:void(0);" class="ref ref216 ref217">(216,217)</a> A moderate analgesic effect was also observed with 100 mg of caffeine in patients with tension-type headache or migraine.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">3.2.  Apnea of Prematurity</h3><div class="NLM_p last">Caffeine and theophylline are important drugs to treat neonatal apnea. Caffeine is preferred for its longer half-life and greater therapeutic index. A<sub>1</sub> and A<sub>2A</sub> antagonism is considered as the main mode-of-action of xanthines in this indication.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> A 2001 Cochrane Review of five clinical trials with a total of 192 preterm infants demonstrated that infants with apnea during the first 2–7 days benefited from treatment with a methylxanthine.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> In a large study involving 2006 infants with birth weights between 500 and 1250 g, the therapeutic use of caffeine (20 mg/kg initial dose, 5 mg/kg maintenance dose) resulted in a lower risk of death or clinical disability and reduced the incidence of cerebral palsy and cognitive delay.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">3.3.  Cardiovascular Health</h3><div class="NLM_p">Effects of caffeine on cardiovascular disease (CVD) have been studied for many years with contradictory results. Depending on the study, caffeine consumption was found to increase, have no effect, or decrease CVD risk. Linking, comparing, and evaluating these multiple studies is difficult, however, because the consumed amount of caffeine differed and was reported in different ways ranging between precise milligram amounts of caffeine to undefined cups of coffee. Another issue of several studies is the lack of placebo control which was in some cases defined as decaffeinated coffee, while other studies compared coffee drinkers and noncoffee drinkers. Potential cardiovascular effects reported for caffeine must hence be evaluated with care.</div><div class="NLM_p last">Nineteen observational cohort studies examined the association of caffeine consumption with CVD risk. The number of participants ranged between approximately 1000 and 100 000 with varying levels of coffee consumption. Caffeine was not taken in pure form but ingested through a beverage. Other ingredients of the drinks might hence be involved in the observed effect. Nonconsumers were analyzed as the control group. One study showed an increase in CVD risk as a function of age in adults who drank one or more cups of coffee compared to participants who consumed less than one cup. The correlation was weak, however, as also noted by the authors.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> Four large cohort studies with participant numbers ranging from 3837 to 82 369 showed a statistically significant reduction of CVD risk in participants who consumed coffee or tea with up to a caffeine intake of >665 mg caffeine/day compared with nonusers or the lowest intake group.<a onclick="showRef(event, 'ref223 ref224 ref225 ref226'); return false;" href="javascript:void(0);" class="ref ref223 ref224 ref225 ref226">(223−226)</a> Five other studies with participant numbers ranging from 6954 to 402 260 showed a protective effect for a caffeine consumption of up to 400 mg/day against CVD in a long follow-up period (8–28 years). No statistically significant change in CVD risk was observed in the group with high caffeine consumption between 400 and 600 mg/day compared with the group with lower consumption and the nonconsumers.<a onclick="showRef(event, 'ref227 ref228 ref229 ref230 ref231'); return false;" href="javascript:void(0);" class="ref ref227 ref228 ref229 ref230 ref231">(227−231)</a> Nine further studies detected no statistically significant changes in CVD risk with caffeine consumption.<a onclick="showRef(event, 'ref232 ref233 ref234 ref235 ref236 ref237 ref238 ref239 ref240'); return false;" href="javascript:void(0);" class="ref ref232 ref233 ref234 ref235 ref236 ref237 ref238 ref239 ref240">(232−240)</a> A 2013 meta-analysis pooled 36 studies with 1 279 804 participants and 36 352 cardiovascular disease cases and found a nonlinear association between coffee consumption and cardiovascular disease risk. The lowest risk of cardiovascular disease occurred with 3–5 cups per day, and no increasing risk was found with heavy coffee consumption.<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a> Overall, moderate caffeine consumption with an intake of 100–400 mg per day might have some CVD protective effect, while evidence for beneficial effects of higher caffeine intake is weak.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">3.4.  Energy Drinks</h3><div class="NLM_p last">Reports on potentially severe adverse cardiovascular effects of energy drink (ED) consumption draw a different picture. In addition to coffee and tea, they have become a major source of caffeine intake and are particularly popular among adolescents and young adults also mixed with alcoholic beverages. The caffeine content of EDs varies between 32 and 134 mg of caffeine per 100 mL,<a onclick="showRef(event, 'ref242'); return false;" href="javascript:void(0);" class="ref ref242">(242)</a> and additionally, EDs usually contain taurine, glucuronolactones, guarana, and vitamins.<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> Although some EDs do not exceed the caffeine content of coffee, caffeine uptake is enhanced since hot coffee is consumed slower and the caffeine is absorbed over a longer period of time.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> Health risks associated with EDs are primarily attributed to the contained caffeine. Caffeine overdoses can cause arrhythmias, tachycardia, hypertension, palpitations, nausea, vomiting, stimulation of the nervous system, metabolic acidosis, convulsions, and in rare cases death.<a onclick="showRef(event, 'ref245'); return false;" href="javascript:void(0);" class="ref ref245">(245)</a> Special care must also be taken when (excessive) caffeine intake is combined with physical exercise since it has been associated with diminished coronary artery flow reserve and enhanced myocardial oxygen demand.<a onclick="showRef(event, 'ref246'); return false;" href="javascript:void(0);" class="ref ref246">(246)</a> A systematic review<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a> has identified 17 cases of severe adverse events including two sudden deaths after ED consumption between 2001 and 2013. Even more alarming, 18 sudden deaths related to the consumption of EDs from various manufacturers were reported to the FDA between January 2004 and October 2012. The reported cases include healthy teenagers who died from cardiac arrhythmias and cardiac arrest but also have various confounding variables such as concomitant drug abuse, genetic predisposition, and heavy exercise.<a onclick="showRef(event, 'ref248'); return false;" href="javascript:void(0);" class="ref ref248">(248)</a> Some recent case reports<a onclick="showRef(event, 'ref249 ref250'); return false;" href="javascript:void(0);" class="ref ref249 ref250">(249,250)</a> provide further evidence for cardiomyopathy and acute kidney injury upon excessive ED consumption (up to 650 mg/d caffeine).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">3.5.  Neurodegenerative Diseases</h3><div class="NLM_p">Several lines of evidence point to a role of caffeine and coffee consumption in neurodegenerative diseases such as Alzheimer’s Disease (AD), and Parkinson’s Disease (PD). Epidemiological studies suggest especially a protective role of caffeine against these pathologies. In a transgenic mouse model of AD, caffeine administration (∼1.5 mg/day) in young adulthood (4 months of age) led to improved memory performance and lower brain amyloid-β protein levels in later life of the mice (9 1/2 months). In addition, transgenic mice (18–19 months of age) that already showed cognitive impairment revealed restored memory function and brain amyloid-β levels after 2–3 months of treatment with caffeine in drinking water (0.3 mg/mL). The result was seen after 1–2 months of treatment with caffeine.<a onclick="showRef(event, 'ref251 ref252'); return false;" href="javascript:void(0);" class="ref ref251 ref252">(251,252)</a> An inverse correlation between moderate caffeine/coffee consumption and risk of developing AD has also been discovered in several longitudinal studies in humans.<a onclick="showRef(event, 'ref31 ref32 ref253 ref254'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref253 ref254">(31,32,253,254)</a> A case-control study<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> examining the caffeine intake of 54 patients with probable AD (73.9 ± 97.9 mg per day) versus 54 cognitively healthy patients (198.7 ± 135.7 mg per day) of matched age and sex over a 20-year period found a significant inverse association of caffeine consumption with AD. In a 10-year prospective cohort study<a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">(254)</a> of 676 participants born between 1900 and 1920, men who drank coffee daily showed less cognitive decline than men who did not drink coffee. The least cognitive decline was seen with three cups of coffee per day. Similar results were obtained in a 21-year cardiovascular risk factors, aging and dementia study<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> with 1409 participants which also detected the lowest risk of developing AD with a daily coffee consumption of 3–5 cups.</div><div class="NLM_p">A connection between caffeine/coffee consumption and lower PD risk is best documented. Multiple studies have shown that moderate consumption of caffeine can reduce the risk of developing PD without significant side effects on the cardiovascular system, bone status, or incidence of cancer.<a onclick="showRef(event, 'ref30 ref52 ref81 ref255 ref256 ref257 ref258 ref259 ref260 ref261 ref262 ref263 ref264'); return false;" href="javascript:void(0);" class="ref ref30 ref52 ref81 ref255 ref256 ref257 ref258 ref259 ref260 ref261 ref262 ref263 ref264">(30,52,81,255−264)</a> One of the first studies in this context involving 8004 participants showed a reduction in the PD risk by 5-fold in participants who drank coffee (>421 mg caffeine per day) compared with noncoffee drinkers. In this study, the PD risk decreased with increasing coffee consumption.<a onclick="showRef(event, 'ref258'); return false;" href="javascript:void(0);" class="ref ref258">(258)</a> A meta-analysis of 13 studies with a total of 901 764 participants also found an association between coffee intake and the risk of developing PD. With each 200 mg/day increase in caffeine consumption, the risk of PD decreased by 17%. The maximum protective effect was found for 3 cups of coffee per day,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and it was found that the effect of coffee on reduced risk of PD is largely due to the contained caffeine.<a onclick="showRef(event, 'ref262'); return false;" href="javascript:void(0);" class="ref ref262">(262)</a></div><div class="NLM_p">The PD risk is not evenly distributed among the sexes and is lower in women than in men.<a onclick="showRef(event, 'ref265'); return false;" href="javascript:void(0);" class="ref ref265">(265)</a> In postmenopausal women, an association was found between coffee consumption, hormone intake, and PD risk. Women with low caffeine intake (68 mg/day) had a lower risk of PD when they received hormone replacement therapy than without hormone intake. Only high caffeine intake (six or more cups of coffee, ≥688 mg/day caffeine) increased the PD risk in women with hormone replacement therapy compared with women who never drank coffee.<a onclick="showRef(event, 'ref263'); return false;" href="javascript:void(0);" class="ref ref263">(263)</a></div><div class="NLM_p">Although some studies failed to detect beneficial effects of caffeine on AD risk,<a onclick="showRef(event, 'ref266 ref267 ref268'); return false;" href="javascript:void(0);" class="ref ref266 ref267 ref268">(266−268)</a> protective effects of caffeine regarding PD risk are well documented, but the promising neuroprotective effects of caffeine require improved mechanistic understanding of the underlying molecular targets and signaling pathways.</div><div class="NLM_p">Several mechanisms have been proposed to be involved in the beneficial effects including antagonism of adenosine receptors, regulation of cerebral blood flow, increase of oxygen consumption, and increase of cerebrospinal fluid production.<a onclick="showRef(event, 'ref269 ref270 ref271 ref272 ref273 ref274 ref275 ref276'); return false;" href="javascript:void(0);" class="ref ref269 ref270 ref271 ref272 ref273 ref274 ref275 ref276">(269−276)</a> Recent studies indicate that interference with adenosinergic signaling, particularly A<sub>2A</sub> blockade, is a key mechanism of the neuroprotective effects of caffeine.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Blockade of A<sub>2A</sub> receptors, which are most abundant in the hippocampus, was found to prevent amyloid-β induced toxicity in the brain.<a onclick="showRef(event, 'ref276 ref277'); return false;" href="javascript:void(0);" class="ref ref276 ref277">(276,277)</a> Accordingly, deletion of A<sub>2A</sub> receptors in a mouse model of AD related tauopathy (THY-Tau22 mice) prevented memory deficits, impairment of hippocampal plasticity, and tau hyperphosphorylation. Similarly, A<sub>2A</sub> antagonist treatment reduced tau hyperphosphorylation and ameliorated disease symptoms.<a onclick="showRef(event, 'ref270'); return false;" href="javascript:void(0);" class="ref ref270">(270)</a></div><div class="NLM_p last">Additionally, decreased cerebral perfusion resulting in hypoxia is a risk factor in AD<a onclick="showRef(event, 'ref278'); return false;" href="javascript:void(0);" class="ref ref278">(278)</a> and two preliminary studies in men showed that administration of caffeine (100 mg) increased blood oxygen levels in certain regions of the brain.<a onclick="showRef(event, 'ref271 ref273'); return false;" href="javascript:void(0);" class="ref ref271 ref273">(271,273)</a> Production and turnover of cerebrospinal fluid (CSF) were also found to be important in neurodegenerative diseases as high CSF turnover helps to transport toxic substances such as amyloid-β from the brain into the blood.<a onclick="showRef(event, 'ref276'); return false;" href="javascript:void(0);" class="ref ref276">(276)</a> Caffeine was found to enhance the expression or activity of Na-K-ATPase, thereby providing another neuroprotective mechanism<a onclick="showRef(event, 'ref279'); return false;" href="javascript:void(0);" class="ref ref279">(279)</a> since Na-K-ATPase plays a crucial role in the production and turnover of CSF.<a onclick="showRef(event, 'ref275'); return false;" href="javascript:void(0);" class="ref ref275">(275)</a> Moreover, recently discovered molecular activities of caffeine such as modulation of the transcriptional regulator TLX, which is mainly found in neural stem cells as well as Notum inhibition resulting potentially in enhanced Wnt signaling, might contribute to protective effects of caffeine against neurodegeneration.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">4.  Summary and Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The purine alkaloid caffeine is widely consumed in beverages for its stimulant properties which have been known for millennia. Caffeine was isolated and identified as the major stimulant constituent of coffee and tea two centuries ago, and its medicinal chemistry and pharmacology have been studied extensively for several decades. While its stimulant activity is well characterized and has been linked to a molecular mechanism in the 1980s when adenosine receptor blockade by caffeine was demonstrated, several other biological effects of caffeine remain at least partly elusive. Caffeine has been tested on multiple protein targets in vitro but part of the reported activities was observed at very high, supra-physiological concentrations. It is, therefore, likely that some reported effects of caffeine are nonspecific artifacts. However, a direct interaction of caffeine has been confirmed, for example, by cocrystal structures, also for proteins where the xanthine exhibits very low potency. Additionally, caffeine was found to synergize with endogenous molecules on some of its molecular targets suggesting potentially higher potency in vivo. It can hence be speculated that many biological effects of caffeine arise from the sum of several weak activities.</div><div class="NLM_p">Medicinal chemistry research on caffeine has widely focused on its adenosine receptor antagonism which has yielded highly potent caffeine descendants as important tools to study the pharmacology of these receptors. The caffeine derivative istradefylline also acting as adenosine receptor antagonist has recently been introduced to the drug market. In addition, the phosphodiesterase inhibitory properties of caffeine have inspired extensive efforts to develop potent and selective PDE inhibitors, some of which have reached drug approval. For other confirmed protein targets, caffeine has not yet been extensively exploited as a lead compound by medicinal chemistry and further potential for drug discovery might rest in caffeine derived ligands for example of glycogen phosphorylase or the ryanodine receptor. Co-crystal structures and mechanistic insights in the modulation by caffeine are available for both proteins to guide medicinal chemistry efforts. The macromolecular data for both proteins provide insights into the caffeine binding sites and enable structure-based design of caffeine analogues with improved potency.</div><div class="NLM_p">A particularly attractive pharmacological effect of caffeine was observed in the protective activity against neurodegenerative diseases that was found in several cohort studies. Despite some controversy regarding reduced AD risk with caffeine intake, the protective potential of caffeine consumption against PD is well documented. Several lines of evidence present adenosine receptor antagonism as a key mechanism underlying neuroprotective effects of caffeine, and accordingly, the caffeine-derived adenosine receptor antagonist istradefylline has recently been approved for PD treatment. Still, further molecular activities of caffeine are likely involved in the alkaloid’s and its derivatives’ neuroprotective properties as part of a complex picture of multiple caffeine actions in the CNS. Improved understanding of the neuroprotective mechanisms and their interplay might open new avenues for drug discovery, for example, in targeting the Wnt deacylase Notum or the ryanodine receptors.</div><div class="NLM_p last">Despite being one of the most widely consumed pharmacologically active molecules in the world, understanding of several aspects in the molecular and biological activities of caffeine is incomplete. While adenosine receptor antagonism has been linked with many of the attractive pharmacological effects of caffeine, additional molecular targets of caffeine are continuously discovered. Hence, several mechanisms likely contribute to pharmacological activities of caffeine, for example, in neurodegeneration. Given the lack of efficient therapeutics for severe health burdens as AD and PD, the macromolecular targets and mechanisms mediating the effects of caffeine appear as very promising avenues toward novel therapeutics especially in the field of neuroprotection. Although it has been in the focus of life-sciences for many decades, caffeine still presents as a very interesting molecule for pharmacological and medicinal chemistry research.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00261" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Merk</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical
Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5359-8128" title="Orcid link">https://orcid.org/0000-0002-5359-8128</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#eb868e9980ab9b838a998688838e86c59e8582c68d998a85808d9e999fc58f8e"><span class="__cf_email__" data-cfemail="86ebe3f4edc6f6eee7f4ebe5eee3eba8f3e8efabe0f4e7e8ede0f3f4f2a8e2e3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Faudone</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical
Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Arifi</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical
Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.F. and S.A. contributed equally to this study</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Giuseppe Faudone</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=BIO-d7e3107-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Giuseppe Faudone</b> obtained Bachelor and Master of Science degrees in Chemistry from Goethe University Frankfurt in 2015 and in 2017, respectively. He then joined the Institute of Pharmaceutical Chemistry at Goethe University Frankfurt as a Ph.D. student, where he currently focuses on the synthesis and characterization of nuclear receptor ligands.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Silvia Arifi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=BIO-d7e3112-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Silvia Arifi</b> studied pharmacy at Goethe University Frankfurt between 2015-2019 and received her license as a pharmacist in 2020. Currently, she is a Ph.D. student in Medicinal Chemistry at the Institute of Pharmaceutical Chemistry at the Goethe University focusing on the development and characterization of nuclear receptor ligands.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Daniel Merk</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=BIO-d7e3117-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel Merk</b> graduated in Pharmaceutical Sciences and Pharmacy from LMU Munich in 2011 and obtained his Ph.D. in Pharmaceutical and Medicinal Chemistry from Goethe University Frankfurt in 2015. He was a Junior Group Leader in Pharmaceutical Chemistry at Goethe University Frankfurt and Postdoctoral ETH Fellowship Scholar at the Institute of Pharmaceutical Sciences of the Swiss Federal Institute of Technology (ETH) Zurich before he finished his Habilitation in Pharmaceutical Chemistry at Goethe University Frankfurt in 2019. Since then, he has been Independent Group Leader in Pharmaceutical Chemistry at Goethe University Frankfurt focusing on the Medicinal Chemistry and Pharmacology of nuclear receptors and their ligands. Recently, Daniel Merk joined LMU Munich as Chair of Pharmaceutical and Medicinal Chemistry.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70624" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70624" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s Disease</p></td></tr><tr><td class="NLM_term">ADOR</td><td class="NLM_def"><p class="first last">adenosine receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CREBP</td><td class="NLM_def"><p class="first last">cyclic AMP response element binding protein</p></td></tr><tr><td class="NLM_term">CVD</td><td class="NLM_def"><p class="first last">cardiovascular disease</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">ED</td><td class="NLM_def"><p class="first last">energy drink</p></td></tr><tr><td class="NLM_term">GABA<sub>A</sub></td><td class="NLM_def"><p class="first last">γ-aminobutyric acid receptor A</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-a-go-go-Related Gene</p></td></tr><tr><td class="NLM_term">NAT2</td><td class="NLM_def"><p class="first last">N-acetyltransferase 2</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s Disease</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">RyR</td><td class="NLM_def"><p class="first last">ryanodine receptor</p></td></tr><tr><td class="NLM_term">TLX</td><td class="NLM_def"><p class="first last">tailless homologue receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 279 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nehlig, A.</span></span> <span> </span><span class="NLM_article-title">Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1124/pr.117.014407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fpr.117.014407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29514871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=384-411&issue=2&author=A.+Nehlig&title=Interindividual+Differences+in+Caffeine+Metabolism+and+Factors+Driving+Caffeine+Consumption&doi=10.1124%2Fpr.117.014407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Interindividual differences in caffeine metabolism and factors driving caffeine consumption</span></div><div class="casAuthors">Nehlig, Astrid</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-411</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  It has been known for decades that the metab., clearance, and pharmacokinetics of caffeine is affected by many factors such as age, sex and hormones, liver disease, obesity, smoking, and diet.  Caffeine also interacts with many medications.  All these factors will be reviewed in the present document and discussed in light of the most recent data concerning the genetic variability affecting caffeine levels and effects at the pharmacokinetic and pharmacodynamic levels that both critically drive the level of caffeine consumption.  The pharmacokinetics of caffeine are highly variable among individuals due to a polymorphism at the level of the CYP1A2 isoform of cytochrome P 450, which metabolizes 95% of the caffeine ingested.  Moreover there is a polymorphism at the level of another crit. enzyme, N-acetyltransferase 2.  At the pharmacodynamic level, there are several polymorphisms at the main brain target of caffeine, the adenosine A2A receptor or ADORA2.  Genetic studies, including genome-wide assocn. studies, identified several loci critically involved in caffeine consumption and its consequences on sleep, anxiety, and potentially in neurodegenerative and psychiatric diseases.  We start reaching a better picture on how a multiplicity of biol. mechanisms seems to drive the levels of caffeine consumption, although much more knowledge is still required to understand caffeine consumption and effects on body functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEvqJTyEt8T7Vg90H21EOLACvtfcHk0lgDCanV6SdZoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsL0%253D&md5=884b0925563405b6293c6f79cc3d4417</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.014407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.014407%26sid%3Dliteratum%253Aachs%26aulast%3DNehlig%26aufirst%3DA.%26atitle%3DInterindividual%2520Differences%2520in%2520Caffeine%2520Metabolism%2520and%2520Factors%2520Driving%2520Caffeine%2520Consumption%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26issue%3D2%26spage%3D384%26epage%3D411%26doi%3D10.1124%2Fpr.117.014407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evan, J. C.</span></span>.  <i>Tea in China: The History of China’s National Drink</i>; <span class="NLM_publisher-name">Praeger Publishers Inc</span>, <span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=J.+C.+Evan&title=Tea+in+China%3A+The+History+of+China%E2%80%99s+National+Drink"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEvan%26aufirst%3DJ.%2BC.%26btitle%3DTea%2520in%2520China%253A%2520The%2520History%2520of%2520China%25E2%2580%2599s%2520National%2520Drink%26pub%3DPraeger%2520Publishers%2520Inc%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span> <i>Chocolate
in Health and Nutrition</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R. R.</span>, <span class="NLM_string-name">Preedy, V. R.</span>, <span class="NLM_string-name">Zibadi, S.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+R.+Watson&author=V.+R.+Preedy&author=S.+Zibadi&title=Chocolate%0Ain+Health+and+Nutrition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DChocolate%250Ain%2520Health%2520and%2520Nutrition%26aulast%3DWatson%26aufirst%3DR.%2BR.%26pub%3DHumana%2520Press%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, B. A.</span>; <span class="NLM_string-name">Bealer, B. K.</span></span>.  <i>The World of Caffeine: The Science and Culture of the World’s Most Popular Drug</i>; <span class="NLM_publisher-name">Routledge</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=B.+A.+Weinberg&author=B.+K.+Bealer&title=The+World+of+Caffeine%3A+The+Science+and+Culture+of+the+World%E2%80%99s+Most+Popular+Drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DB.%2BA.%26btitle%3DThe%2520World%2520of%2520Caffeine%253A%2520The%2520Science%2520and%2520Culture%2520of%2520the%2520World%25E2%2580%2599s%2520Most%2520Popular%2520Drug%26pub%3DRoutledge%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedlieb Ferdinand, Runge</span></span>.  <i>Neueste Phytochemische Entdeckungen Zur Begründung Einer Wissenschaftlichen Phytochemie</i>; <span class="NLM_publisher-name">G. Reimer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">1820</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1820&author=Runge+Friedlieb+Ferdinand&title=Neueste+Phytochemische+Entdeckungen+Zur+Begr%C3%BCndung+Einer+Wissenschaftlichen+Phytochemie"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFriedlieb%2BFerdinand%26aufirst%3DRunge%26btitle%3DNeueste%2520Phytochemische%2520Entdeckungen%2520Zur%2520Begr%25C3%25BCndung%2520Einer%2520Wissenschaftlichen%2520Phytochemie%26pub%3DG.%2520Reimer%26date%3D1820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, G. J.</span></span> <span> </span><span class="NLM_article-title">Ueber Theïn Und Caffeïn</span>. <i>J. Prakt. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1838</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1002/prac.18380150124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fprac.18380150124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1838&pages=280-284&issue=1&author=G.+J.+Mulder&title=Ueber+The%C3%AFn+Und+Caffe%C3%AFn&doi=10.1002%2Fprac.18380150124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fprac.18380150124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.18380150124%26sid%3Dliteratum%253Aachs%26aulast%3DMulder%26aufirst%3DG.%2BJ.%26atitle%3DUeber%2520The%25C3%25AFn%2520Und%2520Caffe%25C3%25AFn%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1838%26volume%3D15%26issue%3D1%26spage%3D280%26epage%3D284%26doi%3D10.1002%2Fprac.18380150124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jobst, C.</span></span> <span> </span><span class="NLM_article-title">Thein Identisch Mit Caffein</span>. <i>Ann. der Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1838</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1002/jlac.18380250106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fjlac.18380250106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1838&pages=63-66&issue=1&author=C.+Jobst&title=Thein+Identisch+Mit+Caffein&doi=10.1002%2Fjlac.18380250106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18380250106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18380250106%26sid%3Dliteratum%253Aachs%26aulast%3DJobst%26aufirst%3DC.%26atitle%3DThein%2520Identisch%2520Mit%2520Caffein%26jtitle%3DAnn.%2520der%2520Pharm.%26date%3D1838%26volume%3D25%26issue%3D1%26spage%3D63%26epage%3D66%26doi%3D10.1002%2Fjlac.18380250106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ach, L.</span></span> <span> </span><span class="NLM_article-title">Synthese Des Caffeïns</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1895</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">3135</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1002/cber.189502803156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcber.189502803156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaD28XovVejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1895&pages=3135-3143&issue=3&author=E.+Fischerauthor=L.+Ach&title=Synthese+Des+Caffe%C3%AFns&doi=10.1002%2Fcber.189502803156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of caffeine</span></div><div class="casAuthors">Fischer, Emil; Ach, Lorenz</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft</span>
        (<span class="NLM_cas:date">1895</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3135-43</span>CODEN:
                <span class="NLM_cas:coden">BDCGAS</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compare this vol., i, 12.  The synthesis of caffeine is effected by means of the following operations: (1) Production of dimethylbarbituric acid from malonic acid and dimethylcarbamide; (2) conversion of dimethylbarbituric acid into dimethylvioluric acid under the influence of nitrous acid; (3) reduction of dimethylvioluric acid to dimethyluramil, and transformation of the latter into dimethylpseudouric acid by means of potassium cyanate; (4) conversion of dimethylpseudouric acid into γ-dimethyluric acid (loc. cit.); (5) formation of chlorotheophylline by the action of phosphorus pentachloride on γ-dimethyluric acid; (6) reduction of chlorotheophylline to theophylline, and conversion of the latter into caffeine.  Chlorotheophylline, (the original abstract includes an equation), is obtained by heating an intimate mixture of γ-dimethyluric acid, phosphorus pentachloride (2 parts) and phosphorus oxychloride (4 parts) in sealed tubes at 150° for 2 1/2 hours; it crystallises from acetone in aggregates of colourless needles, which melt and decompose about 300°.  It is very sparingly soluble in chloroform, but dissolves more freely in acetone, and is readily soluble in hot alcohol; it dissolves in 150 parts of boiling water, forming an acid solution, and is readily soluble in ammonia, alkalis, and concentrated mineral acids.  Chlorine water produces the change characteristic of xanthine and its derivatives.  The sodium and silver derivatives crystallise in slender, white needles, the latter substance being insoluble in water, and gradually becoming dark when exposed to light.  When chlorotheophylline is reduced with hydriodic acid, theophylline is produced (Kossel, Abstr., 1888, 1114); the action of methylic iodide on the silver derivative gives rise to chlorocaffeine.  Bromotheophylline is formed when a mixture of phosphorus pentabromide and phosphorus oxychloride acts on γ-dimethyluric acid, chlorotheophylline being produced at the same time; it is also obtained by heating theophylline with bromine for four hours at 100° and subsequently at 150°.  Bromotheophylline separates from alcohol in colourless crystals, and melts and decomposes at 315-320° (uncorr.); it is very sparingly soluble in hot water, but dissolves readily in ammonia and alkalis.  Hydriodic acid readily converts it into theophylline.  Dimethylbarbituric acid is converted into the sodium derivative of dimethylvioluric acid by adding a concentrated solution of sodium nitrite to an aqueous solution of the acid at 60°; the sodium derivative contains 3H2O (compare Andreasch, Abstr., 1895, i, 337), which is removed at 115°.  Anhydrous dimethylvioluric acid melts at 141°, and in the hydrated condition at 124° (compare loc. cit., and Techow, Abstr., 1895, i, 84).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw4-VkpFnKw7Vg90H21EOLACvtfcHk0lgDCanV6SdZoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaD28XovVejsA%253D%253D&md5=3adb031a9e71b9e69f68d3511cb1cba9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fcber.189502803156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.189502803156%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%26aulast%3DAch%26aufirst%3DL.%26atitle%3DSynthese%2520Des%2520Caffe%25C3%25AFns%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1895%26volume%3D28%26issue%3D3%26spage%3D3135%26epage%3D3143%26doi%3D10.1002%2Fcber.189502803156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E.</span></span> <span> </span><span class="NLM_article-title">Ueber Die Constitution Des Caffeïns, Xanthins, Hypoxanthins Und Verwandter Basen</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1897</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1002/cber.189703001110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcber.189703001110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaD28Xis1Cnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1897&pages=549-559&issue=1&author=E.+Fischer&title=Ueber+Die+Constitution+Des+Caffe%C3%AFns%2C+Xanthins%2C+Hypoxanthins+Und+Verwandter+Basen&doi=10.1002%2Fcber.189703001110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">About the structure of the Caffein, Xanthine, Hypoxanthine and related bases. [machine translation]</span></div><div class="casAuthors">Fischer, Emil</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1897</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">549-59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">[Machine Translation of Descriptors].  After conclusion of a comprehensive investigation of the bases specified in the heading (Liebig's Ann. 215. 253; C. 83. 66) the author for Caffein and Xanthine had set up Formulas I. and II., which stood with all at that time well-known transformations of these compounds in the best agreement; its newer investigations resulted in medico (Liebig's Ann. 175. 243; C. 75. 152) for purely speculative reasons for caffeine and Xanthine Formulas III. and IV., (equation or structure in original text) which derived from Fischer's by permutation of a CO and of a group of CH and different distribution of the bond within the rings differ, which earn advantage.  For the formulas of the author at that time following reasons seemed to speak: 1. From the effect products of C2H5I on the Ag-salt of the Hydroxycaffein (V. after Fischer) left itself excluding ethoxycaffein, however no Tetraalkyluric acid isolate, which one should have expected on the assumption of the formula VI. (of medico), more, since trimethyl uric acids had been transferred by CH3I easily in Tetramethyluric acid.  2. Hydroxycaffein becomes easily converted from alcohol and Br in Diethoxycaffein, with trimethyl- and Tetramethyluric acid did not succeed a similar reaction.  3. The Purine produced from uric acid by PCl5 (Report of the German Chemical Society, 17. 328) was equivalent compound up for the Xanthine compounds, but equipped with other characteristics than these.  Still the closer connection between the xanthine- and uric acid groups seemed to be missing at that time; (equation or structure in original text) particularly by the renewed investigations of the methyl uric acids, numerous and simple transitions between the two connecting rows are admit become, which today, contrary to which earlier conditions of the structure question, make a homogeneous building of the two liaison groups probable.  From these in particular the following observations are possible: 1. Published already (see Report of the German Chemical Society, 28. 3138; C. 96. I. 424) Transformation of γ-Dimethyluric acid turned around in Chlorotheophyllin and the transfer of the Bromotheobromine in δ-Dimethyluric acid (Report of the German Chemical Society, 28. 2482; C. 95. II. 1068).  2. The Hydroxycaffeine is recognized as (1.3.7)-trimethyl uric acid by the fact that it could be synthesized from Trimethyluramil (see the following paper), as well as from uric acid by methylation represented /or further in Tetramethyluric acid was transferable.  Therefore necessary the changes of the formulas of Hydroxycaffeine and Xanthine make naturally also similar modifications in the formulations of the methyl derivatives from which the Heteroxanthine as mono-, Theobromine, Theophyllin are possible here and to experiments the para-xanthine published as Dimethylxanthine; furthermore it must the adenine which 6-Amido-, as well as written the Hypoxanthine, which 6-Oxyxanthine is using the mudico's Xanthine formula, for which author intends to publish the experimental linings.  For all these formulas can be substituted naturally also tautomer; but it is advisable to use for O-containing products of the imide, for the guanine- and Adenine bases, as far as they are insoluble in alkalis, the amide formulas.  In order to be able to formulate all compounds through multiples transition of the linked groups of the uric acid and the Xanthine in uniform way, author makes the following nomenclature suggestions: One proceeds from the double ring available in the Purine body and designates the place of the substitution taken place, as (equation or structure in original text) it is shown by the accompanying pattern.  Purine is then for example the Tetrahydro derivative of this core, Hypoxanthine 6-Oxy-, uric acid 2.6.8-Trioxy-, caffeine 1.3.7-Trimethyl-2.6-dioxypurine.  The same numbering expand since the pseudo uric acids and the derivatives of the Alloxanee.  To conclusion refers to authors that the stated opens the realization in above that uric acid, Xanthine, Hypoxanthine and adenine close related descendants the same basic substance, the Purines are also physiological chemistry in new criteria, and that stands to hope to be able to produce on synthetic ways the same rich material for its research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzwCNGrLzE_bVg90H21EOLACvtfcHk0lg_onM_DG-ETw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaD28Xis1Cnt7k%253D&md5=a4c87335fcb1efe32d35c4f102dcf4a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fcber.189703001110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.189703001110%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%26atitle%3DUeber%2520Die%2520Constitution%2520Des%2520Caffe%25C3%25AFns%252C%2520Xanthins%252C%2520Hypoxanthins%2520Und%2520Verwandter%2520Basen%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1897%26volume%3D30%26issue%3D1%26spage%3D549%26epage%3D559%26doi%3D10.1002%2Fcber.189703001110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barboline, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkman, T. J.</span></span> <span> </span><span class="NLM_article-title">Convergent Evolution of Caffeine in Plants by Co-Option of Exapted Ancestral Enzymes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">10613</span>– <span class="NLM_lpage">10618</span>, <span class="refDoi"> DOI: 10.1073/pnas.1602575113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.1602575113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27638206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWls7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=10613-10618&issue=38&author=R.+Huangauthor=A.+J.+O%E2%80%99Donnellauthor=J.+J.+Barbolineauthor=T.+J.+Barkman&title=Convergent+Evolution+of+Caffeine+in+Plants+by+Co-Option+of+Exapted+Ancestral+Enzymes&doi=10.1073%2Fpnas.1602575113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Convergent evolution of caffeine in plants by co-option of exapted ancestral enzymes</span></div><div class="casAuthors">Huang, Ruiqi; O'Donnell, Andrew J.; Barboline, Jessica J.; Barkman, Todd J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">10613-10618</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Convergent evolution is a process that has occurred throughout the tree of life, but the historical genetic and biochem. context promoting the repeated independent origins of a trait is rarely understood.  The well-known stimulant caffeine, and its xanthine alkaloid precursors, has evolved multiple times in flowering plant history for various roles in plant defense and pollination.  We have shown that convergent caffeine prodn., surprisingly, has evolved by two previously unknown biochem. pathways in chocolate, citrus, and guarana plants using either caffeine synthase- or xanthine methyltransferase-like enzymes.  However, the pathway and enzyme lineage used by any given plant species is not predictable from phylogenetic relatedness alone.  Ancestral sequence resurrection reveals that this convergence was facilitated by co-option of genes maintained over 100 million y for alternative biochem. roles.  The ancient enzymes of the Citrus lineage were exapted for reactions currently used for various steps of caffeine biosynthesis and required very few mutations to acquire modern-day enzymic characteristics, allowing for the evolution of a complete pathway.  Future studies aimed at manipulating caffeine content of plants will require the use of different approaches given the metabolic and genetic diversity revealed by this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtgXD0WAjqqLVg90H21EOLACvtfcHk0lg_onM_DG-ETw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWls7nF&md5=fb98b3bb0fa35c8d5e72af0bfb1895e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1602575113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1602575113%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DA.%2BJ.%26aulast%3DBarboline%26aufirst%3DJ.%2BJ.%26aulast%3DBarkman%26aufirst%3DT.%2BJ.%26atitle%3DConvergent%2520Evolution%2520of%2520Caffeine%2520in%2520Plants%2520by%2520Co-Option%2520of%2520Exapted%2520Ancestral%2520Enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D38%26spage%3D10613%26epage%3D10618%26doi%3D10.1073%2Fpnas.1602575113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathanson, J. A.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Related Methylxanthines: Possible Naturally Occurring Pesticides</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span> (<span class="NLM_issue">4671</span>),  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1126/science.6207592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1126%2Fscience.6207592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6207592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2cXmtVKjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=184-187&issue=4671&author=J.+A.+Nathanson&title=Caffeine+and+Related+Methylxanthines%3A+Possible+Naturally+Occurring+Pesticides&doi=10.1126%2Fscience.6207592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and related methylxanthines:  possible naturally occurring pesticides</span></div><div class="casAuthors">Nathanson, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4671</span>),
    <span class="NLM_cas:pages">184-7</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Natural and synthetic methylxanthines (caffeine  [58-08-2], 3-isobutylmethylxanthine  [28822-58-4], etc.) inhibit insect feeding and are pesticidal at concns. known to occur in plants.  These effects are due primarily to inhibition of phosphodiesterase  [9025-82-5] activity and to an increase in intracellular cAMP  [60-92-4].  At lower concns., methylxanthines are potent synergists of other pesticides known to activate adenylate cyclase in insects.  These data suggest that methylxanthines may function as natural insecticides and that phosphodiesterase inhibitors, alone or in combination with other compds., may be useful in insect control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW4ccMAHlf3LVg90H21EOLACvtfcHk0lg_onM_DG-ETw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtVKjtL4%253D&md5=f5c7af1544f6481ba36362c12633f8a6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.6207592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6207592%26sid%3Dliteratum%253Aachs%26aulast%3DNathanson%26aufirst%3DJ.%2BA.%26atitle%3DCaffeine%2520and%2520Related%2520Methylxanthines%253A%2520Possible%2520Naturally%2520Occurring%2520Pesticides%26jtitle%3DScience%26date%3D1984%26volume%3D226%26issue%3D4671%26spage%3D184%26epage%3D187%26doi%3D10.1126%2Fscience.6207592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frischknecht, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulmer-Dufek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, T. W.</span></span> <span> </span><span class="NLM_article-title">Purine Alkaloid Formation in Buds and Developing Leaflets of Coffea Arabica: Expression of an Optimal Defence Strategy?</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(86)88009-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0031-9422%2886%2988009-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28XhvVegtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=613-616&issue=3&author=P.+M.+Frischknechtauthor=J.+Ulmer-Dufekauthor=T.+W.+Baumann&title=Purine+Alkaloid+Formation+in+Buds+and+Developing+Leaflets+of+Coffea+Arabica%3A+Expression+of+an+Optimal+Defence+Strategy%3F&doi=10.1016%2F0031-9422%2886%2988009-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Purine alkaloid formation in buds and developing leaflets of Coffea arabica:  expression of an optimal defense strategy?</span></div><div class="casAuthors">Frischknecht, Peter M.; Ulmer-Dufek, Jindra; Baumann, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-16</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    </div><div class="casAbstract">In buds and emergent leaflets of C. arabica, formation of the purine alkaloids caffeine and theobromine was studied to characterize the chem. defense strategy of a tissue with a high risk of predation.  As long as the leaflets were fully covered by a resin layer and by 2 stipules, their alkaloid content varied 1-3% dry wt.  With leaflet emergence, the alkaloid formation incredsed and the variation decreased.  Max. content of ∼4% was reached when the leaflets were fully open.  In the subsequent development period alkaloid content decreased.  Comparison between the investment in alkaloid formation with that in primary metabolic processes demonstrated that chem. defense is costly: influx of C atoms into caffeine was 15% of that into respiration.  A defense strategy which is based on an antagonism between mech. and chem. protection is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIie9tNHUN4rVg90H21EOLACvtfcHk0lh061_Lr619Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVegtb0%253D&md5=397630e3e073ccc61a58d78ee6068ee2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2886%2988009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252886%252988009-8%26sid%3Dliteratum%253Aachs%26aulast%3DFrischknecht%26aufirst%3DP.%2BM.%26aulast%3DUlmer-Dufek%26aufirst%3DJ.%26aulast%3DBaumann%26aufirst%3DT.%2BW.%26atitle%3DPurine%2520Alkaloid%2520Formation%2520in%2520Buds%2520and%2520Developing%2520Leaflets%2520of%2520Coffea%2520Arabica%253A%2520Expression%2520of%2520an%2520Optimal%2520Defence%2520Strategy%253F%26jtitle%3DPhytochemistry%26date%3D1986%26volume%3D25%26issue%3D3%26spage%3D613%26epage%3D616%26doi%3D10.1016%2F0031-9422%2886%2988009-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">López-González, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Oliver, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, R.</span></span> <span> </span><span class="NLM_article-title">Acute Caffeine Supplementation in Combat Sports: A Systematic Review</span>. <i>J. Int. Soc. Sports Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/s12970-018-0267-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs12970-018-0267-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30594211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKnurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=60&issue=1&author=L.+M.+L%C3%B3pez-Gonz%C3%A1lezauthor=A.+J.+S%C3%A1nchez-Oliverauthor=F.+Mataauthor=P.+Jodraauthor=J.+Antonioauthor=R.+Dom%C3%ADnguez&title=Acute+Caffeine+Supplementation+in+Combat+Sports%3A+A+Systematic+Review&doi=10.1186%2Fs12970-018-0267-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Acute caffeine supplementation in combat sports: a systematic review</span></div><div class="casAuthors">Lopez-Gonzalez, Luis M.; Sanchez-Oliver, Antonio J.; Mata, Fernando; Jodra, Pablo; Antonio, Jose; Dominguez, Raul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the International Society of Sports Nutrition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">JISSCV</span>;
        ISSN:<span class="NLM_cas:issn">1550-2783</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Caffeine used as a supplement has been shown to improve phys. and cognitive performance in several sport modalities due to its effects on the central nervous system.  This review assesses the direct effects of caffeine supplementation on performance in combat sports.  Using the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Anal.) guidelines, relevant studies were identified through the Medline, Scopus and SPORTDiscus databases.  Of 1053 search results, only 9 articles fulfilled the inclusion criteria.  Of these, three studies detected no ergogenic effect of caffeine supplementation, while six studies did observe a significant pos. effect.  Supplementation with 3-6 mg/kg of caffeine was found to increase the glycolytic contribution to energy metab. during the execution of real or simulated combats, as indicated by elevated blood lactate concns.  Caffeine intake was also noted to improve levels of strength, power and upper arm muscular endurance.  These effects were not paralleled by an increase in the exertion perceived by the athlete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Bnq5DdcIY7Vg90H21EOLACvtfcHk0lh061_Lr619Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKnurjF&md5=092ea9b1f0dc83c3610f3e936a3a90d4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2Fs12970-018-0267-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12970-018-0267-2%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Gonz%25C3%25A1lez%26aufirst%3DL.%2BM.%26aulast%3DS%25C3%25A1nchez-Oliver%26aufirst%3DA.%2BJ.%26aulast%3DMata%26aufirst%3DF.%26aulast%3DJodra%26aufirst%3DP.%26aulast%3DAntonio%26aufirst%3DJ.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DR.%26atitle%3DAcute%2520Caffeine%2520Supplementation%2520in%2520Combat%2520Sports%253A%2520A%2520Systematic%2520Review%26jtitle%3DJ.%2520Int.%2520Soc.%2520Sports%2520Nutr.%26date%3D2018%26volume%3D15%26issue%3D1%26spage%3D60%26doi%3D10.1186%2Fs12970-018-0267-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diel, P.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Doping—What Have We Learned since 2004</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2167</span>, <span class="refDoi"> DOI: 10.3390/nu12082167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3390%2Fnu12082167" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=2167&issue=8&author=P.+Diel&title=Caffeine+and+Doping%E2%80%94What+Have+We+Learned+since+2004&doi=10.3390%2Fnu12082167"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fnu12082167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu12082167%26sid%3Dliteratum%253Aachs%26aulast%3DDiel%26aufirst%3DP.%26atitle%3DCaffeine%2520and%2520Doping%25E2%2580%2594What%2520Have%2520We%2520Learned%2520since%25202004%26jtitle%3DNutrients%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2167%26doi%3D10.3390%2Fnu12082167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">1–3</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&issue=1%E2%80%933&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lh061_Lr619Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26issue%3D1%25E2%2580%25933%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span>; <span class="NLM_string-name">Leo, A.</span>; <span class="NLM_string-name">Hoekman, D. H.</span></span> <i>Exploring QSAR.; ACS professional reference book</i>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=C.+Hansch&author=A.+Leo&author=D.+H.+Hoekman&title=Exploring+QSAR.%3B+ACS+professional+reference+book"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26btitle%3DExploring%2520QSAR.%253B%2520ACS%2520professional%2520reference%2520book%26pub%3DAmerican%2520Chemical%2520Society%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maas, W. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greaves, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Sandt, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, F. M.</span></span> <span> </span><span class="NLM_article-title">Interactions of Skin Thickness and Physicochemical Properties of Test Compounds in Percutaneous Penetration Studies</span>. <i>Int. Arch. Occup. Environ. Health</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1007/s00420-005-0056-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00420-005-0056-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16435152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XislCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=405-413&issue=5&author=S.+C.+Wilkinsonauthor=W.+J.+M.+Maasauthor=J.+B.+Nielsenauthor=L.+C.+Greavesauthor=J.+J.+M.+van+de%0ASandtauthor=F.+M.+Williams&title=Interactions+of+Skin+Thickness+and+Physicochemical+Properties+of+Test+Compounds+in+Percutaneous+Penetration+Studies&doi=10.1007%2Fs00420-005-0056-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies</span></div><div class="casAuthors">Wilkinson, Simon C.; Maas, Wilfred J. M.; Nielsen, Jesper Bo; Greaves, Laura C.; Sandt, Johannes J. M.; Williams, Faith M.</div><div class="citationInfo"><span class="NLM_cas:title">International Archives of Occupational and Environmental Health</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">IAEHDW</span>;
        ISSN:<span class="NLM_cas:issn">0340-0131</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objectives: To det. the effect of skin thickness on the percutaneous penetration and distribution of test compds. with varying physicochem. properties using in vitro systems.  Studies were carried out in accordance with OECD guidelines on skin absorption tests.  Methods: Percutaneous penetration of caffeine (log P -0.01), testosterone (log P 3.32), propoxur (log P 1.52) (finite dose in ethanol to water vehicle ratio) and butoxyethanol (log P 0.83) (undiluted finite dose or as an infinite dose 50% [vol./vol.] aq. soln.) through skin of varying thicknesses under occluded conditions was measured using flow through cells for 8-24 h.  Saline (adjusted to pH 7.4) was used as receptor fluid, with BSA added for studies with testosterone and propoxur.  Following exposure, the remaining surface dose was removed by swabbing and the skin digested prior to scintillation counting.  Results: The max. flux of caffeine was increased with decreasing skin thickness, although these differences were found to be non-significant.  The presence of caffeine in the skin membrane was not altered by skin thickness.  Maximum flux and cumulative dose absorbed of testosterone and butoxyethanol (in both finite and infinite doses) were markedly reduced with full thickness (about 1 mm thick) skin compared with split thickness skin (about 0.5 mm).  Maximum flux of propoxur (dissolved in 60% ethanol) was clearly higher through skin of 0.71 mm than through skin of 1.36 mm, but no difference was found between 0.56 and 0.71 mm.  The proportion of propoxur present in the membrane after 24 h increased significantly over the complete range of thicknesses tested (0.56-1.36 mm).  Conclusions: A complex relationship exists between skin thickness, lipophilicity and percutaneous penetration and distribution.  This has implications for risk assessment studies and for the validation of models with data from different sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgPg32WIZ40LVg90H21EOLACvtfcHk0lg2TajnbqdlJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislCrsb0%253D&md5=802a1f2ab2d8cb3788665e13c96efd96</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs00420-005-0056-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00420-005-0056-5%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BC.%26aulast%3DMaas%26aufirst%3DW.%2BJ.%2BM.%26aulast%3DNielsen%26aufirst%3DJ.%2BB.%26aulast%3DGreaves%26aufirst%3DL.%2BC.%26aulast%3Dvan%2Bde%2BSandt%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DWilliams%26aufirst%3DF.%2BM.%26atitle%3DInteractions%2520of%2520Skin%2520Thickness%2520and%2520Physicochemical%2520Properties%2520of%2520Test%2520Compounds%2520in%2520Percutaneous%2520Penetration%2520Studies%26jtitle%3DInt.%2520Arch.%2520Occup.%2520Environ.%2520Health%26date%3D2006%26volume%3D79%26issue%3D5%26spage%3D405%26epage%3D413%26doi%3D10.1007%2Fs00420-005-0056-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies-Strickleton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span> <span> </span><span class="NLM_article-title">Assessment of the Nail Penetration of Antifungal Agents, with Different Physicochemical Properties</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>), <span class="NLM_elocation-id">e0229414</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0229414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1371%2Fjournal.pone.0229414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=32107486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&issue=2&author=H.+Davies-Strickletonauthor=J.+Cookauthor=S.+Hannamauthor=R.+Bennettauthor=A.+Gibbsauthor=D.+Edwardsauthor=C.+Riddenauthor=J.+Riddenauthor=D.+Cook&title=Assessment+of+the+Nail+Penetration+of+Antifungal+Agents%2C+with+Different+Physicochemical+Properties&doi=10.1371%2Fjournal.pone.0229414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the nail penetration of antifungal agents, with different physico-chemical properties</span></div><div class="casAuthors">Davies-Strickleton, Heather; Cook, Julie; Hannam, Sally; Bennett, Rhys; Gibbs, Alan; Edwards, David; Ridden, Christine; Ridden, John; Cook, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0229414</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Onychomycosis, or fungal nail infection, is a common fungal infection largely caused by dermatophyte fungi, such as Trichophyton rubrum or Trichophyton mentagrophytes, which affects a significant no. of people.  Treatment is either through oral antifungal medicines, which are efficacious but have significant safety concerns, or with topical antifungal treatments that require long treatment regimens and have only limited efficacy.  Thus, an efficacious topical therapy remains an unmet medical need.  Among the barriers to topical delivery through the nail are the physico-chem. properties of the antifungal drugs.  Here, we explore the ability of a range of antifungal compds. with different hydrophilicities to penetrate the nail.  Human nail disks were clamped within static diffusion (Franz) cells and dosed with equimolar concns. of antifungal drugs.  Using LC-MS/MS we quantified the amt. of drug that passed through the nail disk and that which remained assocd. with the nail.  Our data identified increased drug flux through the nail for the more hydrophilic compds. (caffeine as a hydrophilic control and fluconazole, with LogP -0.07 and 0.5, resp.), while less hydrophilic efinaconazole, amorolfine and terbinafine (LogP 2.7, 5.6 and 5.9 resp.) had much lower flux through the nail.  On the other hand, hydrophilicity alone did not account for the amt. of drug assocd. with/bound to the nail itself.  While there are other factors that are likely to combine to dictate nail penetration, this work supports earlier studies that implicate compd. hydrophilicity as a crit. factor for nail penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqavIxtE7TemLVg90H21EOLACvtfcHk0lg2TajnbqdlJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVKmsLs%253D&md5=a5c6d78cf74b66d6b84152c49fee1381</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0229414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0229414%26sid%3Dliteratum%253Aachs%26aulast%3DDavies-Strickleton%26aufirst%3DH.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHannam%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DR.%26aulast%3DGibbs%26aufirst%3DA.%26aulast%3DEdwards%26aufirst%3DD.%26aulast%3DRidden%26aufirst%3DC.%26aulast%3DRidden%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DD.%26atitle%3DAssessment%2520of%2520the%2520Nail%2520Penetration%2520of%2520Antifungal%2520Agents%252C%2520with%2520Different%2520Physicochemical%2520Properties%26jtitle%3DPLoS%2520One%26date%3D2020%26volume%3D15%26issue%3D2%26doi%3D10.1371%2Fjournal.pone.0229414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, R. S.</span></span> <span> </span><span class="NLM_article-title">Caffeine</span>. In  <i>Reproductive and Developmental Toxicology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. C.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier Inc.</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FB978-0-12-382032-7.10027-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=355-364&author=R.+S.+Da+Silvaauthor=R.+C.+Gupta&title=Reproductive+and+Developmental+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-382032-7.10027-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-382032-7.10027-X%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSilva%26aufirst%3DR.%2BS.%26atitle%3DCaffeine%26btitle%3DReproductive%2520and%2520Developmental%2520Toxicology%26aulast%3DGupta%26aufirst%3DR.%2BC.%26pub%3DElsevier%2520Inc%26date%3D2011%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figgitt, D. P.</span></span> <span> </span><span class="NLM_article-title">Caffeine Citrate: A Review of Its Use in Apnoea of Prematurity</span>. <i>Paediatr. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.2165/00128072-200103010-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2165%2F00128072-200103010-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=11220405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3M3isFajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=61-79&issue=1&author=A.+M.+Comerauthor=C.+M.+Perryauthor=D.+P.+Figgitt&title=Caffeine+Citrate%3A+A+Review+of+Its+Use+in+Apnoea+of+Prematurity&doi=10.2165%2F00128072-200103010-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine citrate: a review of its use in apnoea of prematurity</span></div><div class="casAuthors">Comer A M; Perry C M; Figgitt D P</div><div class="citationInfo"><span class="NLM_cas:title">Paediatric drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-79</span>
        ISSN:<span class="NLM_cas:issn">1174-5878</span>.
    </div><div class="casAbstract">UNLABELLED:  Apnoea of prematurity is a common condition in neonates born at less than 37 weeks' gestational age; it affects approximately 90% of premature neonates weighing under 1000 g at birth, and 25% of infants with a birthweight of less than 2500 g.  Caffeine, a methylxanthine which occurs naturally in many plants, has been used for over 20 years to treat apnoea of prematurity.  In a recent double-blind, placebo-controlled trial, apnoea was eliminated or reduced by at least 50% in significantly more neonates receiving caffeine citrate as first-line treatment than those receiving placebo.  In a nonblind trial, caffeine citrate was more effective at reducing apnoeic episodes when compared with neonates receiving no treatment.  Caffeine as first-line treatment demonstrated similar efficacy to theophylline or aminophylline (theophylline ethylenediamine) in 4 small randomised studies.  Caffeine citrate was generally well tolerated in short term clinical trials, with very few adverse events reported.  Caffeine was associated with fewer adverse events than theophylline in randomised trials.  No differences in the incidence of individual adverse events were reported between caffeine citrate and placebo in a double-blind, randomised trial.  Long term tolerability data are not yet available.  CONCLUSIONS:  Caffeine citrate was generally well tolerated by neonates in clinical trials and it decreased the incidence of apnoea of prematurity compared with placebo.  It has demonstrated similar efficacy to theophylline, but is generally better tolerated and has a wider therapeutic index.  Caffeine citrate should, therefore, be considered the drug of choice when pharmacological treatment of apnoea of prematurity is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYck1WoRsGk--MdeMhXAHkfW6udTcc2ebbMPBGXndHybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3isFajsA%253D%253D&md5=1163f61b74a5081ff0a6adbe57bb2abf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2165%2F00128072-200103010-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00128072-200103010-00005%26sid%3Dliteratum%253Aachs%26aulast%3DComer%26aufirst%3DA.%2BM.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26aulast%3DFiggitt%26aufirst%3DD.%2BP.%26atitle%3DCaffeine%2520Citrate%253A%2520A%2520Review%2520of%2520Its%2520Use%2520in%2520Apnoea%2520of%2520Prematurity%26jtitle%3DPaediatr.%2520Drugs%26date%3D2001%26volume%3D3%26issue%3D1%26spage%3D61%26epage%3D79%26doi%3D10.2165%2F00128072-200103010-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cates, C. J.</span></span> <span> </span><span class="NLM_article-title">Caffeine for Asthma</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">CD001112</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD001112.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD001112.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=CD001112&issue=1&author=E.+J.+Welshauthor=A.+Baraauthor=E.+Barleyauthor=C.+J.+Cates&title=Caffeine+for+Asthma&doi=10.1002%2F14651858.CD001112.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD001112.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD001112.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DWelsh%26aufirst%3DE.%2BJ.%26aulast%3DBara%26aufirst%3DA.%26aulast%3DBarley%26aufirst%3DE.%26aulast%3DCates%26aufirst%3DC.%2BJ.%26atitle%3DCaffeine%2520for%2520Asthma%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2010%26volume%3D2010%26issue%3D1%26spage%3DCD001112%26doi%3D10.1002%2F14651858.CD001112.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alfaro, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeiro, C. R.</span></span> <span> </span><span class="NLM_article-title">Chronic Coffee Consumption and Respiratory Disease: A Systematic Review</span>. <i>Clin. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1283</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1111/crj.12662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fcrj.12662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28671769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1cjjvFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=1283-1294&issue=3&author=T.+M.+Alfaroauthor=R.+A.+Monteiroauthor=R.+A.+Cunhaauthor=C.+R.+Cordeiro&title=Chronic+Coffee+Consumption+and+Respiratory+Disease%3A+A+Systematic+Review&doi=10.1111%2Fcrj.12662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic coffee consumption and respiratory disease: A systematic review</span></div><div class="casAuthors">Alfaro Tiago M; Monteiro Rita A; Cordeiro Carlos Robalo; Alfaro Tiago M; Cunha Rodrigo A; Alfaro Tiago M; Cordeiro Carlos Robalo</div><div class="citationInfo"><span class="NLM_cas:title">The clinical respiratory journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1283-1294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The widespread consumption of coffee means that any biological effects from its use can lead to significant public health consequences.  Chronic pulmonary diseases are extremely prevalent and responsible for one of every six deaths on a global level.  METHODS:  Major medical databases for studies reporting on the effects of coffee or caffeine consumption on a wide range of non-malignant respiratory outcomes, including incidence, prevalence, evolution or severity of respiratory disease in adults were searched.  Studies on lung function and respiratory mortality were also considered.  RESULTS:  Fifteen studies, including seven cohort, six cross-sectional, one case control and one randomized control trial were found.  Coffee consumption was generally associated with a reduction in prevalence of asthma.  The association of coffee with natural honey was an effective treatment for persistent post-infectious cough.  One case-control study found higher risk of chronic obstructive pulmonary disease (COPD) with coffee consumption.  No association was found with the evolution of COPD or sarcoidosis.  Coffee was associated with a reduction in respiratory mortality, and one study found improved lung function in coffee consumers.  Smoking was a significant confounder in most studies.  CONCLUSIONS:  Coffee consumption was associated with some positive effects on the respiratory system.  There was however limited available evidence, mostly from cross sectional and retrospective studies.  The only prospective cohort studies were those reporting on respiratory mortality.  These results suggest that coffee consumption may be a part of a healthy lifestyle leading to reduced respiratory morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAIXCrxKVgfIMcDoIzZtNkfW6udTcc2eaui2AaI2D3Q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjjvFygsw%253D%253D&md5=fc02a1772541074dc8075b1b115e0b3a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fcrj.12662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcrj.12662%26sid%3Dliteratum%253Aachs%26aulast%3DAlfaro%26aufirst%3DT.%2BM.%26aulast%3DMonteiro%26aufirst%3DR.%2BA.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DCordeiro%26aufirst%3DC.%2BR.%26atitle%3DChronic%2520Coffee%2520Consumption%2520and%2520Respiratory%2520Disease%253A%2520A%2520Systematic%2520Review%26jtitle%3DClin.%2520Respir.%2520J.%26date%3D2018%26volume%3D12%26issue%3D3%26spage%3D1283%26epage%3D1294%26doi%3D10.1111%2Fcrj.12662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Derry, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. A.</span></span> <span> </span><span class="NLM_article-title">Caffeine as an Analgesic Adjuvant for Acute Pain in Adults</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2017</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">CD009281</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD009281.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD009281.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2014&pages=CD009281&issue=10&author=C.+J.+Derryauthor=S.+Derryauthor=R.+A.+Moore&title=Caffeine+as+an+Analgesic+Adjuvant+for+Acute+Pain+in+Adults&doi=10.1002%2F14651858.CD009281.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD009281.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD009281.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DDerry%26aufirst%3DC.%2BJ.%26aulast%3DDerry%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DR.%2BA.%26atitle%3DCaffeine%2520as%2520an%2520Analgesic%2520Adjuvant%2520for%2520Acute%2520Pain%2520in%2520Adults%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D2017%26issue%3D10%26spage%3DCD009281%26doi%3D10.1002%2F14651858.CD009281.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garas, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K.</span></span> <span> </span><span class="NLM_article-title">Caffeine in the Management of Patients with Headache</span>. <i>J. Headache Pain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107</span>, <span class="refDoi"> DOI: 10.1186/s10194-017-0806-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs10194-017-0806-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29067618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Cqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=107&issue=1&author=R.+B.+Liptonauthor=H.+C.+Dienerauthor=M.+S.+Robbinsauthor=S.+Y.+Garasauthor=K.+Patel&title=Caffeine+in+the+Management+of+Patients+with+Headache&doi=10.1186%2Fs10194-017-0806-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine in the management of patients with headache</span></div><div class="casAuthors">Lipton Richard B; Robbins Matthew S; Diener Hans-Christoph; Garas Sandy Yacoub; Patel Ketu</div><div class="citationInfo"><span class="NLM_cas:title">The journal of headache and pain</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Caffeinated headache medications, either alone or in combination with other treatments, are widely used by patients with headache.  Clinicians should be familiar with their use as well as the chemistry, pharmacology, dietary and medical sources, clinical benefits, and potential safety issues of caffeine.  In this review, we consider the role of caffeine in the over-the-counter treatment of headache.  The MEDLINE and Cochrane databases were searched by combining "caffeine" with the terms "headache," "migraine," and "tension-type." Studies that were not placebo-controlled or that involved medications available only with a prescription, as well as those not assessing patients with migraine and/or tension-type headache (TTH), were excluded.  Compared with analgesic medication alone, combinations of caffeine with analgesic medications, including acetaminophen, acetylsalicylic acid, and ibuprofen, showed significantly improved efficacy in the treatment of patients with TTH or migraine, with favorable tolerability in the vast majority of patients.  The most common adverse events were nervousness (6.5%), nausea (4.3%), abdominal pain/discomfort (4.1%), and dizziness (3.2%).  This review provides evidence for the role of caffeine as an analgesic adjuvant in the acute treatment of primary headache with over-the-counter drugs, caffeine doses of 130 mg enhance the efficacy of analgesics in TTH and doses of ≥100 mg enhance benefits in migraine.  Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCFnfg9pyrBsve_zCu79I8fW6udTcc2eaui2AaI2D3Q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Cqtw%253D%253D&md5=e108a78b1b7fc93c42779aef2fff92b2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1186%2Fs10194-017-0806-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs10194-017-0806-2%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DR.%2BB.%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DRobbins%26aufirst%3DM.%2BS.%26aulast%3DGaras%26aufirst%3DS.%2BY.%26aulast%3DPatel%26aufirst%3DK.%26atitle%3DCaffeine%2520in%2520the%2520Management%2520of%2520Patients%2520with%2520Headache%26jtitle%3DJ.%2520Headache%2520Pain%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D107%26doi%3D10.1186%2Fs10194-017-0806-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, H.</span></span> <span> </span><span class="NLM_article-title">Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1007/s12325-019-0891-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs12325-019-0891-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30758744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWnsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=597-607&issue=3&author=T.+Weiserauthor=H.+Weigmann&title=Effect+of+Caffeine+on+the+Bioavailability+and+Pharmacokinetics+of+an+Acetylsalicylic+Acid-Paracetamol+Combination%3A+Results+of+a+Phase+I+Study&doi=10.1007%2Fs12325-019-0891-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study</span></div><div class="casAuthors">Weiser, Thomas; Weigmann, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-607</span>CODEN:
                <span class="NLM_cas:coden">ADTHE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-238X</span>.
    
            (<span class="NLM_cas:orgname">Springer Healthcare Ltd.</span>)
        </div><div class="casAbstract">Introduction: Caffeine is used as an adjuvant in analgesic combinations to enhance their efficacy.  The present study aimed to det. the effect of caffeine on the pharmacokinetics of acetylsalicylic acid (ASA) and paracetamol when used as a fixed-dose ASA/paracetamol/caffeine combination.  In this single-center, two-way, cross-over phase I study, volunteers fasted overnight (≥ 12 h) and randomly received single oral doses of 250 mg ASA/200 mg paracetamol (ref.) or 250 mg ASA/200 mg paracetamol/50 mg caffeine (test).  Blood samples were collected before and up to 24 h after dosing.  The primary end points were the area under the concn.-time curve from zero to infinity (AUC0-∞) and max. plasma concn. (Cmax) for ASA, salicylic acid (SA) and paracetamol from the two combinations.  The main secondary end points were AUC0-∞ and Cmax of caffeine and time to reach Cmax (tmax) of all drugs.  Eighteen healthy male volunteers (32.5 ± 10.5 years) participated in the study.  The geometric means of Cmax for ASA, SA and paracetamol were similar in the test (3.71, 15.8 and 2.42 μg/mL, resp.) and ref. groups (3.89, 15.8, 2.42 μg/mL, resp.).  The geometric mean of AUC0-∞ for ASA, SA and paracetamol from the test combination was 2.86, 60.5 and 7.68 μg h/mL, resp., and that for the ref. was 2.96, 59.1 and 7.77 μg h/mL, resp.  The medians of tmax for ASA, SA and paracetamol were similar between the two groups.  The point ests. for the ratios of AUC0-∞ and Cmax for test vs. ref. regarding ASA, SA and paracetamol were within the predefined equivalence limits.  The two treatments were well tolerated.  Conclusion: Caffeine did not affect the pharmacokinetics of ASA and paracetamol when used as an adjuvant in ASA/paracetamol fixed-dose combination under fasting conditions, suggesting that caffeine enhances the analgesic efficacy of these drugs by pharmacodynamic rather than pharmacokinetic interactions.  Funding: Sanofi-Aventis Deutschland GmbH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7DmDSopsVzLVg90H21EOLACvtfcHk0lhJ2LvsZ1BE8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWnsbnO&md5=e6b8b57e9304d9b2d37bc23c8ef93835</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs12325-019-0891-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12325-019-0891-5%26sid%3Dliteratum%253Aachs%26aulast%3DWeiser%26aufirst%3DT.%26aulast%3DWeigmann%26aufirst%3DH.%26atitle%3DEffect%2520of%2520Caffeine%2520on%2520the%2520Bioavailability%2520and%2520Pharmacokinetics%2520of%2520an%2520Acetylsalicylic%2520Acid-Paracetamol%2520Combination%253A%2520Results%2520of%2520a%2520Phase%2520I%2520Study%26jtitle%3DAdv.%2520Ther.%26date%3D2019%26volume%3D36%26issue%3D3%26spage%3D597%26epage%3D607%26doi%3D10.1007%2Fs12325-019-0891-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horrigan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, T. J.</span></span> <span> </span><span class="NLM_article-title">Immunomodulatory Effects of Caffeine: Friend or Foe?</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2006.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.pharmthera.2006.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16540173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1SksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2006&pages=877-892&issue=3&author=L.+A.+Horriganauthor=J.+P.+Kellyauthor=T.+J.+Connor&title=Immunomodulatory+Effects+of+Caffeine%3A+Friend+or+Foe%3F&doi=10.1016%2Fj.pharmthera.2006.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory effects of caffeine: Friend or foe?</span></div><div class="casAuthors">Horrigan, Louise A.; Kelly, John P.; Connor, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">877-892</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Caffeine is a member of the methylxanthine family of drugs, and is the most widely consumed behaviorally active substance in the western world.  This article is focused on the impact of caffeine on immune function.  In this regard, a no. of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses.  For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress prodn. of the pro-inflammatory cytokine tumor necrosis factor (TNF)-α from human blood.  Caffeine has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired prodn. of Th1 (interleukin [IL]-2 and interferon [IFN]-γ), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines.  Studies also indicate that caffeine suppresses antibody prodn.  The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cAMP (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concns.  Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, we suggest that many of its immunomodulatory effects occur at concns. that are relevant to normal human consumption.  Finally, the potential of caffeine-induced immunomodulation to significantly impact upon health and well-being are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCGWMi-PmtGrVg90H21EOLACvtfcHk0liEDVXDBZhufQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1SksLw%253D&md5=b363c9e254057ca860196f35df9e156d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHorrigan%26aufirst%3DL.%2BA.%26aulast%3DKelly%26aufirst%3DJ.%2BP.%26aulast%3DConnor%26aufirst%3DT.%2BJ.%26atitle%3DImmunomodulatory%2520Effects%2520of%2520Caffeine%253A%2520Friend%2520or%2520Foe%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2006%26volume%3D111%26issue%3D3%26spage%3D877%26epage%3D892%26doi%3D10.1016%2Fj.pharmthera.2006.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. E.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Headaches</span>. <i>Curr. Pain Headache Rep.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1007/s11916-008-0052-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs11916-008-0052-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18625110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1cvkvFOqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=311-315&issue=4&author=R.+E.+Shapiro&title=Caffeine+and+Headaches&doi=10.1007%2Fs11916-008-0052-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and headaches</span></div><div class="casAuthors">Shapiro Robert E</div><div class="citationInfo"><span class="NLM_cas:title">Current pain and headache reports</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Caffeine is the most widely consumed psychostimulant drug in the world.  With intermittent exposures, caffeine may act as a mild analgesic for headache or as an adjuvant for the actions of other analgesics.  Chronic repetitive exposures to caffeine increase the risks for development of analgesic-overuse headache, chronic daily headache, and physical dependency.  Cessation of caffeine use after chronic exposures leads to a withdrawal syndrome with headache as a dominant symptom.  At dosages achieved by common dietary intake, caffeine acts as a potent antagonist of central and peripheral nervous system adenosine receptors.  The complex effects of caffeine on headache disorders suggest important roles for adenosine in these disorders and in the induction of caffeine dependency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYF9lg_aw9nTUE-swuRqsHfW6udTcc2eZOXiYjGfM4Mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvkvFOqtA%253D%253D&md5=c834ab2b0e7be0f715069f925b3730bf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs11916-008-0052-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11916-008-0052-z%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DR.%2BE.%26atitle%3DCaffeine%2520and%2520Headaches%26jtitle%3DCurr.%2520Pain%2520Headache%2520Rep.%26date%3D2008%26volume%3D12%26issue%3D4%26spage%3D311%26epage%3D315%26doi%3D10.1007%2Fs11916-008-0052-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, F. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pliássova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canas, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinho, P.</span></span> <span> </span><span class="NLM_article-title">Blockade of Adenosine A2A Receptors Recovers Early Deficits of Memory and Plasticity in the Triple Transgenic Mouse Model of Alzheimer’s Disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2018.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.nbd.2018.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29859867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVyqur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=72-81&author=A.+C.+Silvaauthor=C.+Lemosauthor=F.+Q.+Gon%C3%A7alvesauthor=A.+V.+Pli%C3%A1ssovaauthor=N.+J.+Machadoauthor=H.+B.+Silvaauthor=P.+M.+Canasauthor=R.+A.+Cunhaauthor=J.+P.+Lopesauthor=P.+Agostinho&title=Blockade+of+Adenosine+A2A+Receptors+Recovers+Early+Deficits+of+Memory+and+Plasticity+in+the+Triple+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.nbd.2018.05.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Silva, Antonio C.; Lemos, Cristina; Goncalves, Francisco Q.; Pliassova, Anna V.; Machado, Nuno J.; Silva, Henrique B.; Canas, Paula M.; Cunha, Rodrigo A.; Lopes, Joao Pedro; Agostinho, Paula</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) begins with a deficit of synaptic function and adenosine A2A receptors (A2AR) are mostly located in synapses controlling synaptic plasticity.  The over-activation of adenosine A2A receptors (A2AR) causes memory deficits and the blockade of A2AR prevents memory damage in AD models.  We now enquired if this prophylactic role of A2AR might be extended to a therapeutic potential.  We used the triple transgenic model of AD (3xTg-AD) and defined that the onset of memory dysfunction occurred at 4 mo of age in the absence of locomotor or emotional alterations.  At the onset of memory deficits, 3xTg mice displayed a decreased d. of markers of excitatory synapses (10.6±3.8% decrease of vGluT1) without neuronal or glial overt damage and an increase of synaptic A2AR in the hippocampus (130±22%).  After the onset of memory deficits in 3xTg-AD mice, a three weeks treatment with the selective A2AR antagonist normalized the up-regulation of hippocampal A2AR and restored hippocampal-dependent ref. memory, as well as the decrease of hippocampal synaptic plasticity (60.0±3.7% decrease of long-term potentiation amplitude) and the decrease of global (syntaxin-I) and glutamatergic synaptic markers (vGluT1).  These findings show a therapeutic-like ability of A2AR antagonists to recover synaptic and memory dysfunction in early AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW210tEsnrvrVg90H21EOLACvtfcHk0liEDVXDBZhufQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVyqur7F&md5=1aaf05e8fb2905ace7a9a1e4fd308fac</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2018.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2018.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DA.%2BC.%26aulast%3DLemos%26aufirst%3DC.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DF.%2BQ.%26aulast%3DPli%25C3%25A1ssova%26aufirst%3DA.%2BV.%26aulast%3DMachado%26aufirst%3DN.%2BJ.%26aulast%3DSilva%26aufirst%3DH.%2BB.%26aulast%3DCanas%26aufirst%3DP.%2BM.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DLopes%26aufirst%3DJ.%2BP.%26aulast%3DAgostinho%26aufirst%3DP.%26atitle%3DBlockade%2520of%2520Adenosine%2520A2A%2520Receptors%2520Recovers%2520Early%2520Deficits%2520of%2520Memory%2520and%2520Plasticity%2520in%2520the%2520Triple%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2018%26volume%3D117%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.nbd.2018.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cellai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buée, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mériaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Murcia, V.</span></span> <span> </span><span class="NLM_article-title">The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease</span>. <i>Front. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">520</span>, <span class="refDoi"> DOI: 10.3389/fnins.2018.00520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3389%2Ffnins.2018.00520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30123104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ps1elsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=520&author=L.+Cellaiauthor=K.+Carvalhoauthor=E.+Faivreauthor=A.+Deleauauthor=D.+Vieauauthor=L.+Bu%C3%A9eauthor=D.+Blumauthor=C.+M%C3%A9riauxauthor=V.+Gomez-Murcia&title=The+Adenosinergic+Signaling%3A+A+Complex+but+Promising+Therapeutic+Target+for+Alzheimer%E2%80%99s+Disease&doi=10.3389%2Ffnins.2018.00520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease</span></div><div class="casAuthors">Cellai Lucrezia; Carvalho Kevin; Faivre Emilie; Deleau Aude; Vieau Didier; Buee Luc; Blum David; Meriaux Celine; Gomez-Murcia Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">520</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disorder in elderly people.  AD is characterized by a progressive cognitive decline and it is neuropathologically defined by two hallmarks: extracellular deposits of aggregated β-amyloid (Aβ) peptides and intraneuronal fibrillar aggregates of hyper- and abnormally phosphorylated Tau proteins.  AD results from multiple genetic and environmental risk factors.  Epidemiological studies reported beneficial effects of caffeine, a non-selective adenosine receptors antagonist.  In the present review, we discuss the impact of caffeine and of adenosinergic system modulation on AD, in terms of pathology and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSidoXifVQq8fh3YQQtAhNufW6udTcc2eaeqXMGCsRudbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ps1elsQ%253D%253D&md5=2e3d1d744222ca1ead036f4eb3a37139</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2018.00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2018.00520%26sid%3Dliteratum%253Aachs%26aulast%3DCellai%26aufirst%3DL.%26aulast%3DCarvalho%26aufirst%3DK.%26aulast%3DFaivre%26aufirst%3DE.%26aulast%3DDeleau%26aufirst%3DA.%26aulast%3DVieau%26aufirst%3DD.%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DM%25C3%25A9riaux%26aufirst%3DC.%26aulast%3DGomez-Murcia%26aufirst%3DV.%26atitle%3DThe%2520Adenosinergic%2520Signaling%253A%2520A%2520Complex%2520but%2520Promising%2520Therapeutic%2520Target%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFront.%2520Neurosci.%26date%3D2018%26volume%3D12%26spage%3D520%26doi%3D10.3389%2Ffnins.2018.00520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Dose-Response Meta-Analysis on Coffee, Tea and Caffeine Consumption with Risk of Parkinson’s Disease</span>. <i>Geriatr. Gerontol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1111/ggi.12123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fggi.12123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23879665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3sfjt1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=430-439&issue=2&author=H.+Qiauthor=S.+Li&title=Dose-Response+Meta-Analysis+on+Coffee%2C+Tea+and+Caffeine+Consumption+with+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1111%2Fggi.12123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease</span></div><div class="casAuthors">Qi Hui; Li Shixue</div><div class="citationInfo"><span class="NLM_cas:title">Geriatrics & gerontology international</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.  METHODS:  A comprehensive search was carried out to identify eligible studies.  The fixed or random effect model was used based on heterogeneity test.  The dose-response relationship was assessed by restricted cubic spline.  RESULTS:  A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included.  A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81).  A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively.  The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women.  The aforementioned associations were weaker for USA relative to Europe or Asia.  CONCLUSIONS:  A linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall.  Further studies are required to confirm the findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkfKXUVxB-dDQLBVDQn4bCfW6udTcc2eaeqXMGCsRudbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfjt1GgsA%253D%253D&md5=f6e18bb9c111fd23b16778cee7ea5d61</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fggi.12123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fggi.12123%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DDose-Response%2520Meta-Analysis%2520on%2520Coffee%252C%2520Tea%2520and%2520Caffeine%2520Consumption%2520with%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DGeriatr.%2520Gerontol.%2520Int.%26date%3D2014%26volume%3D14%26issue%3D2%26spage%3D430%26epage%3D439%26doi%3D10.1111%2Fggi.12123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngandu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuomilehto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivipelto, M.</span></span> <span> </span><span class="NLM_article-title">Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-0920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2009-0920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19158424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Shs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=85-91&issue=1&author=M.+H.+Eskelinenauthor=T.+Nganduauthor=J.+Tuomilehtoauthor=H.+Soininenauthor=M.+Kivipelto&title=Midlife+Coffee+and+Tea+Drinking+and+the+Risk+of+Late-Life+Dementia%3A+A+Population-Based+CAIDE+Study&doi=10.3233%2FJAD-2009-0920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Midlife coffee and tea drinking and the risk late-life dementia: a population-based CAIDE study</span></div><div class="casAuthors">Eskelinen, Marjo H.; Ngandu, Tiia; Tuomilehto, Jaakko; Soininen, Hilkka; Kivipelto, Miia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-91</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Caffeine stimulates central nervous system on a short term.  However, the long-term impact of caffeine on cognition remains unclear.  We aimed to study the assocn. between coffee and/or tea consumption at midlife and dementia/Alzheimer's disease (AD) risk in late-life.  Participants of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of a population-based cohorts previously surveyed within the North Karelia Project and the FINMONICA study in 1972, 1977, 1982 or 1987 (midlife visit).  After an av. follow-up of 21 years, 1409 individuals (71%) aged 65 to 79 completed the re-examn. in 1998.  A total of 61 cases were identified as demented (48 with AD).  Coffee drinkers at midlife had lower risk of dementia and AD later in life compared with those drinking no or only little coffee adjusted for demog., lifestyle and vascular factors, apolipoprotein E ε4 allele and depressive symptoms.  The lowest risk (65% decreased) was found in people who drank 3-5 cups per day.  Tea drinking was relatively uncommon and was not assocd. with dementia/AD.  Coffee drinking at midlife is assocd. with a decreased risk of dementia/AD later in life.  This finding might open possibilities for prevention of dementia/AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLwiX93ksYmrVg90H21EOLACvtfcHk0ljCJIUJpA1SIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Shs7w%253D&md5=449f5d791c2f76a32c680db749fe3a73</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-0920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-0920%26sid%3Dliteratum%253Aachs%26aulast%3DEskelinen%26aufirst%3DM.%2BH.%26aulast%3DNgandu%26aufirst%3DT.%26aulast%3DTuomilehto%26aufirst%3DJ.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DMidlife%2520Coffee%2520and%2520Tea%2520Drinking%2520and%2520the%2520Risk%2520of%2520Late-Life%2520Dementia%253A%2520A%2520Population-Based%2520CAIDE%2520Study%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D16%26issue%3D1%26spage%3D85%26epage%3D91%26doi%3D10.3233%2FJAD-2009-0920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mendonca, A.</span></span> <span> </span><span class="NLM_article-title">Does Caffeine Intake Protect from Alzheimer’s Disease?</span>. <i>Eur. J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1046/j.1468-1331.2002.00421.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1046%2Fj.1468-1331.2002.00421.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12099922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD38zls12rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=377-382&issue=4&author=L.+Maiaauthor=A.+de+Mendonca&title=Does+Caffeine+Intake+Protect+from+Alzheimer%E2%80%99s+Disease%3F&doi=10.1046%2Fj.1468-1331.2002.00421.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Does caffeine intake protect from Alzheimer's disease?</span></div><div class="casAuthors">Maia L; de Mendonca A</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-82</span>
        ISSN:<span class="NLM_cas:issn">1351-5101</span>.
    </div><div class="casAbstract">Caffeine is the most widely consumed behaviourally active substance in the western world.  Neuroprotective effects of caffeine in low doses, chronically administered, have been shown in different experimental models.  If caffeine intake could protect against neurodegeneration in Alzheimer's disease (AD), then higher levels of caffeine consumption in normal subjects as compared with AD patients should be detectable in the presumably long period before diagnosis when insidious pathogenic changes are taking place.  A case-control study was used: cases were 54 patients with probable AD fulfilling the National Institute of Neurologic and Communicative Disorders and Stroke and the AD and Related Disorders Association criteria, in a Dementia Clinics setting.  Controls were 54 accompanying persons, cognitively normal, matched for age (+/-3 years) and sex.  Patients with AD had an average daily caffeine intake of 73.9 +/- 97.9 mg during the 20 years that preceded diagnosis of AD, whereas the controls had an average daily caffeine intake of 198.7 +/- 135.7 mg during the corresponding 20 years of their lifetimes (P < 0.001, Wilcoxon signed ranks test).  Using a logistic regression model, caffeine exposure during this period was found to be significantly inversely associated with AD (odds ratio=0.40, 95% confidence interval=0.25-0.67), whereas hypertension, diabetes, stroke, head trauma, smoking habits, alcohol consumption, non-steroid anti-inflammatory drugs, vitamin E, gastric disorders, heart disease, education and family history of dementia were not statistically significantly associated with AD.  Caffeine intake was associated with a significantly lower risk for AD, independently of other possible confounding variables.  These results, if confirmed with future prospective studies, may have a major impact on the prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTathl5uVAgi42y4bB4mnvYfW6udTcc2ebbaKVP7S0LvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zls12rug%253D%253D&md5=f59b88a0b6191aa60991a74d3fb7a431</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1046%2Fj.1468-1331.2002.00421.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1468-1331.2002.00421.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DL.%26aulast%3Dde%2BMendonca%26aufirst%3DA.%26atitle%3DDoes%2520Caffeine%2520Intake%2520Protect%2520from%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2002%26volume%3D9%26issue%3D4%26spage%3D377%26epage%3D382%26doi%3D10.1046%2Fj.1468-1331.2002.00421.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powderly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sznol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heist, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choueiri, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, B. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weise, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riese, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emens, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laport, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Aya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renouf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munneke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaffery, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willingham, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span> <span> </span><span class="NLM_article-title">Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-0980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1158%2F2159-8290.CD-19-0980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31732494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtleiurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=40-53&issue=1&author=L.+Fongauthor=A.+Hotsonauthor=J.+D.+Powderlyauthor=M.+Sznolauthor=R.+S.+Heistauthor=T.+K.+Choueiriauthor=S.+Georgeauthor=B.+G.+M.+Hughesauthor=M.+D.+Hellmannauthor=D.+R.+Shepardauthor=B.+I.+Riniauthor=S.+Kummarauthor=A.+M.+Weiseauthor=M.+J.+Rieseauthor=B.+Markmanauthor=L.+A.+Emensauthor=D.+Mahadevanauthor=J.+J.+Lukeauthor=G.+Laportauthor=J.+D.+Brodyauthor=L.+Hernandez-Ayaauthor=P.+Bonomiauthor=J.+W.+Goldmanauthor=L.+Berimauthor=D.+J.+Renoufauthor=R.+A.+Goodwinauthor=B.+Munnekeauthor=P.+Y.+Hoauthor=J.+Hsiehauthor=I.+McCafferyauthor=L.+Kweiauthor=S.+B.+Willinghamauthor=R.+A.+Miller&title=Adenosine+2A+Receptor+Blockade+as+an+Immunotherapy+for+Treatment-Refractory+Renal+Cell+Cancer&doi=10.1158%2F2159-8290.CD-19-0980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer</span></div><div class="casAuthors">Fong, Lawrence; Hotson, Andrew; Powderly, John D.; Sznol, Mario; Heist, Rebecca S.; Choueiri, Toni K.; George, Saby; Hughes, Brett G. M.; Hellmann, Matthew D.; Shepard, Dale R.; Rini, Brian I.; Kummar, Shivaani; Weise, Amy M.; Riese, Matthew J.; Markman, Ben; Emens, Leisha A.; Mahadevan, Daruka; Luke, Jason J.; Laport, Ginna; Brody, Joshua D.; Hernandez-Aya, Leonel; Bonomi, Philip; Goldman, Jonathan W.; Berim, Lyudmyla; Renouf, Daniel J.; Goodwin, Rachel A.; Munneke, Brian; Ho, Po Y.; Hsieh, Jessica; McCaffery, Ian; Kwei, Long; Willingham, Stephen B.; Miller, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-53</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Adenosine mediates immunosuppression within the tumor microenvironment through triggering adenosine 2A receptors (A2AR) on immune cells.  To det. whether this pathway could be targeted as an immunotherapy, we performed a phase I clin. trial with a small-mol. A2AR antagonist.  We find that this mol. can safely block adenosine signaling in vivo.  In a cohort of 68 patients with renal cell cancer (RCC), we also observe clin. responses alone and in combination with an anti-PD-L1 antibody, including subjects who had progressed on PD-1/PD-L1 inhibitors.  Durable clin. benefit is assocd. with increased recruitment of CD8+ T cells into the tumor.  Treatment can also broaden the circulating T-cell repertoire.  Clin. responses are assocd. with an adenosine-regulated gene-expression signature in pretreatment tumor biopsies.  A2AR signaling, therefore, represents a targetable immune checkpoint distinct from PD-1/PD-L1 that restricts antitumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-lTXPk20DrVg90H21EOLACvtfcHk0ljCJIUJpA1SIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtleiurnO&md5=593bc9aef2c7eaa1dd223ae33cfcae4c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-0980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-0980%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DL.%26aulast%3DHotson%26aufirst%3DA.%26aulast%3DPowderly%26aufirst%3DJ.%2BD.%26aulast%3DSznol%26aufirst%3DM.%26aulast%3DHeist%26aufirst%3DR.%2BS.%26aulast%3DChoueiri%26aufirst%3DT.%2BK.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DB.%2BG.%2BM.%26aulast%3DHellmann%26aufirst%3DM.%2BD.%26aulast%3DShepard%26aufirst%3DD.%2BR.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DWeise%26aufirst%3DA.%2BM.%26aulast%3DRiese%26aufirst%3DM.%2BJ.%26aulast%3DMarkman%26aufirst%3DB.%26aulast%3DEmens%26aufirst%3DL.%2BA.%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DLuke%26aufirst%3DJ.%2BJ.%26aulast%3DLaport%26aufirst%3DG.%26aulast%3DBrody%26aufirst%3DJ.%2BD.%26aulast%3DHernandez-Aya%26aufirst%3DL.%26aulast%3DBonomi%26aufirst%3DP.%26aulast%3DGoldman%26aufirst%3DJ.%2BW.%26aulast%3DBerim%26aufirst%3DL.%26aulast%3DRenouf%26aufirst%3DD.%2BJ.%26aulast%3DGoodwin%26aufirst%3DR.%2BA.%26aulast%3DMunneke%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DP.%2BY.%26aulast%3DHsieh%26aufirst%3DJ.%26aulast%3DMcCaffery%26aufirst%3DI.%26aulast%3DKwei%26aufirst%3DL.%26aulast%3DWillingham%26aufirst%3DS.%2BB.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26atitle%3DAdenosine%25202A%2520Receptor%2520Blockade%2520as%2520an%2520Immunotherapy%2520for%2520Treatment-Refractory%2520Renal%2520Cell%2520Cancer%26jtitle%3DCancer%2520Discovery%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D40%26epage%3D53%26doi%3D10.1158%2F2159-8290.CD-19-0980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span>; <span class="NLM_string-name">Gao, Z. G.</span>; <span class="NLM_string-name">Matricon, P.</span>; <span class="NLM_string-name">Eddy, M. T.</span>; <span class="NLM_string-name">Carlsson, J.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2A Receptor Antagonists: From Caffeine to Selective Non-Xanthines</span>.  <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, in press. <span class="refDoi"> DOI: 10.1111/bph.15103</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fbph.15103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=K.+A.+Jacobson&author=Z.+G.+Gao&author=P.+Matricon&author=M.+T.+Eddy&author=J.+Carlsson&title=Adenosine+A2A+Receptor+Antagonists%3A+From+Caffeine+to+Selective+Non-Xanthines&doi=10.1111%2Fbph.15103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fbph.15103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.15103%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAdenosine%2520A2A%2520Receptor%2520Antagonists%253A%2520From%2520Caffeine%2520to%2520Selective%2520Non-Xanthines%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2020%26doi%3D10.1111%2Fbph.15103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawers, S. J. A.</span></span> <span> </span><span class="NLM_article-title">The Absolute Bioavailability of Caffeine in Man</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/BF00613933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00613933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6832208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3sXhsFCrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1983&pages=93-98&issue=1&author=J.+Blanchardauthor=S.+J.+A.+Sawers&title=The+Absolute+Bioavailability+of+Caffeine+in+Man&doi=10.1007%2FBF00613933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The absolute bioavailability of caffeine in man</span></div><div class="casAuthors">Blanchard, J.; Sawers, S. J. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-8</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">The abs. bioavailability of orally administered caffeine (I)  [58-08-2] was investigated in 10 healthy adult male volunteers, aged 18.8 to 30.0 yr.  The subjects were administered a 5 mg/kg dose as either an aq. oral soln. or an i.v. infusion on sep. occasions about 1 wk apart, in a randomized crossover fashion.  Plasma samples were collected for 24 h following each dose and assayed for I content by high-performance liq. chromatog.  The oral absorption was very rapid, reaching a mean peak plasma concn. after 29.8 min.  In addn., the variation in the max. plasma concn. was low, 10.0 μg/mL.  The abs. bioavailability was assessed by comparing the areas under the plasma concn. vs. time curves for the i.v. and oral doses.  The rapid absorption resulted in essentially complete bioavailability of oral I.  The caffeine plasma half-lives varied from 2.7 to 9.9 h, indicating substantial intersubject variability in its elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopPNXYznd0HLVg90H21EOLACvtfcHk0lgPlJkSEGbYOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhsFCrur8%253D&md5=c6497e8f6c49264b7a7083cca9fb8ef0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF00613933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00613933%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DSawers%26aufirst%3DS.%2BJ.%2BA.%26atitle%3DThe%2520Absolute%2520Bioavailability%2520of%2520Caffeine%2520in%2520Man%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1983%26volume%3D24%26issue%3D1%26spage%3D93%26epage%3D98%26doi%3D10.1007%2FBF00613933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, M. J.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Caffeine and Other Components of Coffee</span>. In  <i>Caffeine, Coffee and Health</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, S.</span></span>, Ed.; <span class="NLM_publisher-name">Raven Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=M.+J.+Arnaudauthor=S.+Garattini&title=Caffeine%2C+Coffee+and+Health"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArnaud%26aufirst%3DM.%2BJ.%26atitle%3DMetabolism%2520of%2520Caffeine%2520and%2520Other%2520Components%2520of%2520Coffee%26btitle%3DCaffeine%252C%2520Coffee%2520and%2520Health%26aulast%3DGarattini%26aufirst%3DS.%26pub%3DRaven%2520Press%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benowitz, N. L.</span></span> <span> </span><span class="NLM_article-title">Clinical Pharmacology of Caffeine</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1146/annurev.me.41.020190.001425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1146%2Fannurev.me.41.020190.001425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2184730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3cXktVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1990&pages=277-288&author=N.+L.+Benowitz&title=Clinical+Pharmacology+of+Caffeine&doi=10.1146%2Fannurev.me.41.020190.001425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of caffeine</span></div><div class="casAuthors">Benowitz, Neal L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">277-88</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    </div><div class="casAbstract">A review with 64 refs. discussing the human pharmacol. of caffeine, the evidence for its role in causing human disease including addiction, and its potential usefulness as a therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmiKDTT0MBZrVg90H21EOLACvtfcHk0lgPlJkSEGbYOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVSjs74%253D&md5=a1b4b507b5800039ca2ac271f26d362e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1146%2Fannurev.me.41.020190.001425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.me.41.020190.001425%26sid%3Dliteratum%253Aachs%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26atitle%3DClinical%2520Pharmacology%2520of%2520Caffeine%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D1990%26volume%3D41%26spage%3D277%26epage%3D288%26doi%3D10.1146%2Fannurev.me.41.020190.001425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doepker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Sohemy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, B. T.</span></span> <span> </span><span class="NLM_article-title">Caffeine: Friend or Foe?</span>. <i>Annu. Rev. Food Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1146/annurev-food-041715-033243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1146%2Fannurev-food-041715-033243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26735800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=117-137&author=C.+Doepkerauthor=H.+R.+Liebermanauthor=A.+P.+Smithauthor=J.+D.+Peckauthor=A.+El-Sohemyauthor=B.+T.+Welsh&title=Caffeine%3A+Friend+or+Foe%3F&doi=10.1146%2Fannurev-food-041715-033243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine: Friend or Foe?</span></div><div class="casAuthors">Doepker, Candace; Lieberman, Harris R.; Smith, Andrew Paul; Peck, Jennifer D.; El-Sohemy, Ahmed; Welsh, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Food Science and Technology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-137</span>CODEN:
                <span class="NLM_cas:coden">ARFSBV</span>;
        ISSN:<span class="NLM_cas:issn">1941-1413</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The debate on the safety of and regulatory approaches for caffeine continues among various stakeholders and regulatory authorities.  This decision-making process comes with significant challenges, particularly when considering the complexities of the available scientific data, making the formulation of clear science-based regulatory guidance more difficult.  To allow for discussions of a no. of key issues, the North American Branch of the International Life Sciences Institute (ILSI) convened a panel of subject matter experts for a caffeine-focused session entitled "Caffeine: Friend or Foe," which was held during the 2015 ILSI Annual Meeting.  The panelists' expertise covered topics ranging from the natural occurrence of caffeine in plants and interindividual metab. of caffeine in humans to specific behavioral, reproductive, and cardiovascular effects related to caffeine consumption.  Each presentation highlighted the potential risks, benefits, and challenges that inform whether caffeine exposure warrants concern.  This paper aims to summarize the key topics discussed during the session.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR98_X76IaZ7Vg90H21EOLACvtfcHk0lgPlJkSEGbYOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFGmug%253D%253D&md5=35c21bfe9200408b66889c21793566bb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1146%2Fannurev-food-041715-033243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-food-041715-033243%26sid%3Dliteratum%253Aachs%26aulast%3DDoepker%26aufirst%3DC.%26aulast%3DLieberman%26aufirst%3DH.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BP.%26aulast%3DPeck%26aufirst%3DJ.%2BD.%26aulast%3DEl-Sohemy%26aufirst%3DA.%26aulast%3DWelsh%26aufirst%3DB.%2BT.%26atitle%3DCaffeine%253A%2520Friend%2520or%2520Foe%253F%26jtitle%3DAnnu.%2520Rev.%2520Food%2520Sci.%2520Technol.%26date%3D2016%26volume%3D7%26spage%3D117%26epage%3D137%26doi%3D10.1146%2Fannurev-food-041715-033243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safranow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machoy, Z.</span></span> <span> </span><span class="NLM_article-title">Methylated Purines in Urinary Stones</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2005.048033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1373%2Fclinchem.2005.048033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15919878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvV2gsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2005&pages=1493-1498&issue=8&author=K.+Safranowauthor=Z.+Machoy&title=Methylated+Purines+in+Urinary+Stones&doi=10.1373%2Fclinchem.2005.048033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Methylated purines in urinary stones</span></div><div class="casAuthors">Safranow, Krzysztof; Machoy, Zygmunt</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1493-1498</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">The aim of the study was to measure the content of methylated purines that appear as admixts. in uric acid stones.  We analyzed urinary calculi from 48 residents of Western Pomerania who underwent surgery at the urol. ward in Szczecin.  Stone samples were dissolved in 0.1 mol/L NaOH.  Exts. were dild. in 50 mmol/L KH2PO4 and analyzed by reversed-phase HPLC with UV detection and use of a gradient of methanol concn. and pH.  Uric acid was the main component of 9 stones.  All 9 showed admixts. of 9 other purine derivs.: endogenous purine breakdown products (xanthine, hypoxanthine, and 2,8-dihydroxyadenine) and exogenous Me derivs. of uric acid and xanthine (1-, 3-, and 7-methyluric acid; 1,3-dimethyluric acid; and 3- and 7-methylxanthine).  Amts. of these purine derivs. ranged from the limit of detection to 12 mg/g of stone wt. and showed a strong pos. correlation (Spearman rank correlation coeffs., 0.63-0.94) with the uric acid content of the samples.  The main methylated purine in the stones was 1-methyluric acid.  Urinary purines at concns. below their satn. limits may coppt. in samples supersatd. with uric acid and appear as admixts. in urinary stones.  The amt. of each purine depends on its av. urinary excretion, similarity to the chem. structure of uric acid, and concn. of the latter in the stone.  These findings suggest that purines in stones represent a substitutional solid soln. with uric acid as solvent.  Methylxanthines, which are ubiquitous components of the diet, drugs, and uric acid calculi, may be involved in the pathogenesis of urolithiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTu6TiYKjuCLVg90H21EOLACvtfcHk0ljoOCHZYXVmWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvV2gsLw%253D&md5=0c09ae69b7f450595de8d6a51fcbce79</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2005.048033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2005.048033%26sid%3Dliteratum%253Aachs%26aulast%3DSafranow%26aufirst%3DK.%26aulast%3DMachoy%26aufirst%3DZ.%26atitle%3DMethylated%2520Purines%2520in%2520Urinary%2520Stones%26jtitle%3DClin.%2520Chem.%26date%3D2005%26volume%3D51%26issue%3D8%26spage%3D1493%26epage%3D1498%26doi%3D10.1373%2Fclinchem.2005.048033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.-K.</span></span> <span> </span><span class="NLM_article-title">Use of Caffeine Metabolite Ratios to Explore CYP1A2 and Xanthine Oxidase Activities</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5–1</span>),  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/clpt.1991.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fclpt.1991.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1934864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XhslGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1991&pages=508-519&issue=5%E2%80%931&author=W.+Kalowauthor=B.-K.+Tang&title=Use+of+Caffeine+Metabolite+Ratios+to+Explore+CYP1A2+and+Xanthine+Oxidase+Activities&doi=10.1038%2Fclpt.1991.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities</span></div><div class="casAuthors">Kalow, Werner; Tang, Bing Kou</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">508-19</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Caffeine was used as a metabolic probe to screen healthy subjects for their activities of two enzymes, deduced to be CYP1A2 (an inducible cytochrome P 450) and xanthine oxidase.  A longitudinal study revealed modest effects of caffeine dose, ethanol intake, and time-of-day on the CYP1A2 index, without any effect on the xanthine oxidase index.  The coeffs. of intraindividual variation not accounted for were 5.0% for the xanthine oxidase and 17.2% for the CYP1A2 index.  In a population study, both indexes showed a log normal distribution, with CYP1A2 values of most subjects covering a 6.3-fold range but only a 1.7-fold range with xanthine oxidase.  The CYP1A2 index was 33% decreased in women who used oral contraceptives and substantially increased in cigarette smokers.  Neither the CYP1A2 nor the xanthine oxidase index differed between volunteers of Chinese and European extn.  Four of 178 subjects showed unexplained low xanthine oxidase values (i.e., values several std. deviations below the mean).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvwRV7rZPNbVg90H21EOLACvtfcHk0ljoOCHZYXVmWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhslGhug%253D%253D&md5=111b144fd741d35305154494189fc46a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1991.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1991.176%26sid%3Dliteratum%253Aachs%26aulast%3DKalow%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DB.-K.%26atitle%3DUse%2520of%2520Caffeine%2520Metabolite%2520Ratios%2520to%2520Explore%2520CYP1A2%2520and%2520Xanthine%2520Oxidase%2520Activities%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1991%26volume%3D50%26issue%3D5%25E2%2580%25931%26spage%3D508%26epage%3D519%26doi%3D10.1038%2Fclpt.1991.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitfield, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetterslev, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluud, C.</span></span> <span> </span><span class="NLM_article-title">Pentoxifylline for Alcoholic Hepatitis</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">CD007339</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD007339.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD007339.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=CD007339&issue=4&author=K.+Whitfieldauthor=A.+Rambaldiauthor=J.+Wetterslevauthor=C.+Gluud&title=Pentoxifylline+for+Alcoholic+Hepatitis&doi=10.1002%2F14651858.CD007339.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD007339.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD007339.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DWhitfield%26aufirst%3DK.%26aulast%3DRambaldi%26aufirst%3DA.%26aulast%3DWetterslev%26aufirst%3DJ.%26aulast%3DGluud%26aufirst%3DC.%26atitle%3DPentoxifylline%2520for%2520Alcoholic%2520Hepatitis%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2009%26volume%3D2009%26issue%3D4%26spage%3DCD007339%26doi%3D10.1002%2F14651858.CD007339.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padowski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic Analysis and Comparison of Caffeine Administered Rapidly or Slowly in Coffee Chilled or Hot versus Chilled Energy Drink in Healthy Young Adults</span>. <i>Clin. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.3109/15563650.2016.1146740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3109%2F15563650.2016.1146740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC28bisVSgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=308-312&issue=4&author=J.+R.+Whiteauthor=J.+M.+Padowskiauthor=Y.+Zhongauthor=G.+Chenauthor=S.+Luoauthor=P.+Lazarusauthor=M.+E.+Laytonauthor=S.+McPherson&title=Pharmacokinetic+Analysis+and+Comparison+of+Caffeine+Administered+Rapidly+or+Slowly+in+Coffee+Chilled+or+Hot+versus+Chilled+Energy+Drink+in+Healthy+Young+Adults&doi=10.3109%2F15563650.2016.1146740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults</span></div><div class="casAuthors">White John R Jr; Padowski Jeannie M; Layton Matthew E; Zhong Yili; Chen Gang; Luo Shaman; Lazarus Philip; McPherson Sterling; McPherson Sterling</div><div class="citationInfo"><span class="NLM_cas:title">Clinical toxicology (Philadelphia, Pa.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">308-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  There is a paucity of data describing the impact of type of beverage (coffee versus energy drink), different rates of consumption and different temperature of beverages on the pharmacokinetic disposition of caffeine.  Additionally, there is concern that inordinately high levels of caffeine may result from the rapid consumption of cold energy drinks.  OBJECTIVE:  The objective of this study was to compare the pharmacokinetics of caffeine under various drink temperature, rate of consumption and vehicle (coffee versus energy drink) conditions.  MATERIALS:  Five caffeine (dose = 160 mg) conditions were evaluated in an open-label, group-randomized, crossover fashion.  After the administration of each caffeine dose, 10 serial plasma samples were harvested.  Caffeine concentration was measured via liquid chromatography-mass spectrometry (LC-MS), and those concentrations were assessed by non-compartmental pharmacokinetic analysis.  The calculated mean pharmacokinetic parameters were analyzed statistically by one-way repeated measures analysis of variance (RM ANOVA).  If differences were found, each group was compared to the other by all pair-wise multiple comparison.  RESULTS:  Twenty-four healthy subjects ranging in age from 18 to 30 completed the study.  The mean caffeine concentration time profiles were similar with overlapping SDs at all measured time points.  The ANOVA revealed significant differences in mean Cmax and Vd ss/F, but no pair-wise comparisons reached statistical significance.  No other differences in pharmacokinetic parameters were found.  DISCUSSION:  The results of this study are consistent with previous caffeine pharmacokinetic studies and suggest that while rate of consumption, temperature of beverage and vehicle (coffee versus energy drink) may be associated with slightly different pharmacokinetic parameters, the overall impact of these variables is small.  CONCLUSION:  This study suggests that caffeine absorption and exposure from coffee and energy drink is similar irrespective of beverage temperature or rate of consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxto5WiqPPpn6CEoQgWY10fW6udTcc2eYNw0U00Hk9HLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bisVSgsg%253D%253D&md5=a452e407dd3d27e15d9a723e38c09432</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3109%2F15563650.2016.1146740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15563650.2016.1146740%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DPadowski%26aufirst%3DJ.%2BM.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DLazarus%26aufirst%3DP.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DMcPherson%26aufirst%3DS.%26atitle%3DPharmacokinetic%2520Analysis%2520and%2520Comparison%2520of%2520Caffeine%2520Administered%2520Rapidly%2520or%2520Slowly%2520in%2520Coffee%2520Chilled%2520or%2520Hot%2520versus%2520Chilled%2520Energy%2520Drink%2520in%2520Healthy%2520Young%2520Adults%26jtitle%3DClin.%2520Toxicol.%26date%3D2016%26volume%3D54%26issue%3D4%26spage%3D308%26epage%3D312%26doi%3D10.3109%2F15563650.2016.1146740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. K.</span></span> <span> </span><span class="NLM_article-title">Biotransformation of Caffeine, Paraxanthine, Theobromine and Theophylline by CDNA-Expressed Human CYP1A2 and CYP2E1</span>. <i>Pharmacogenetics</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1097/00008571-199204000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1097%2F00008571-199204000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1302044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFWlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=73-77&issue=2&author=L.+Guauthor=F.+J.+Gonzalezauthor=W.+Kalowauthor=B.+K.+Tang&title=Biotransformation+of+Caffeine%2C+Paraxanthine%2C+Theobromine+and+Theophylline+by+CDNA-Expressed+Human+CYP1A2+and+CYP2E1&doi=10.1097%2F00008571-199204000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of caffeine, paraxanthine, theobromine, and theophylline by cDNA-expressed human CYP1A2 and CYP2E1</span></div><div class="casAuthors">Gu, Lie; Gonzalez, Frank J.; Kalow, Werner; Tang, Bing K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-7</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    </div><div class="casAbstract">Six human cytochrome P450s expressed in HepG2 cells using vaccinia virus cDNA-directed expression, were used to study the biotransformation of caffeine and its metabolites.  CYP1A2 alone was responsible for caffeine 3-demethylation and paraxanthine 7-demethylation; in addn., 1A2 catalyzed virtually all reactions related to caffeine and its metabolites.  The metabolic profile of caffeine biotransformation by CYP1A2 averaged 81.5% for paraxanthine, 10.8% for theobromine and 5.4% for theophylline formation.  It remained quite uniform when caffeine concns. were varied.  The most striking finding was that CYP2E1 (the ethanol-inducible form) had major influences upon caffeine metab.: in particular, it catalyzed the formation of theophylline and theobromine from caffeine.  Thus, the in vivo metabolite profiling of caffeine may reveal CYP2E1 activities in addn. to the previously documented activities of CYP1A2, polymorphic N-acetyltransferase and xanthine oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtyvJD48_tgbVg90H21EOLACvtfcHk0lgy4jfMJTW0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFWlsr8%253D&md5=c833b02680c120f93e04e7f613463909</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2F00008571-199204000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008571-199204000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DL.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DKalow%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DB.%2BK.%26atitle%3DBiotransformation%2520of%2520Caffeine%252C%2520Paraxanthine%252C%2520Theobromine%2520and%2520Theophylline%2520by%2520CDNA-Expressed%2520Human%2520CYP1A2%2520and%2520CYP2E1%26jtitle%3DPharmacogenetics%26date%3D1992%26volume%3D2%26issue%3D2%26spage%3D73%26epage%3D77%26doi%3D10.1097%2F00008571-199204000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faber, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, U.</span></span> <span> </span><span class="NLM_article-title">Assessment of CYP1A2 Activity in Clinical Practice: Why, How, and When?</span>. <i>Basic Clin. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1111/j.1742-7843.2005.pto_973160.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1742-7843.2005.pto_973160.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16128905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVejsb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=125-134&issue=3&author=M.+S.+Faberauthor=A.+Jetterauthor=U.+Fuhr&title=Assessment+of+CYP1A2+Activity+in+Clinical+Practice%3A+Why%2C+How%2C+and+When%3F&doi=10.1111%2Fj.1742-7843.2005.pto_973160.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of CYP1A2 activity in clinical practice: Why, how, and when?</span></div><div class="casAuthors">Faber, Mirko S.; Jetter, Alexander; Fuhr, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The cytochrome P 450 enzyme CYP1A2 mediates the rate-limiting step in the metab. of many drugs including theophylline, clozapine, and tacrine as well as in the bioactivation of procarcinogens.  CYP1A2 activity shows both pronounced intra- and interindividual variability, which is, among other factors, related to smoking causing enzyme induction, to drug intake and to dietary factors which may result in induction or inhibition.  In contrast to these exogenous factors, genetic influences on enzyme activity seem to be less pronounced.  Therefore, phenotyping of CYP1A2, i.e. the detn. of the actual activity of the enzyme in vivo, represents a useful approach both for scientific and clin. applications.  CYP1A2 is almost exclusively expressed in the liver.  Since liver tissue cannot be obtained for direct pheno- typing, a probe drug which is metabolized by CYP1A2 has to be given.  Proposed probe drugs include caffeine, theophylline, and melatonin.  Caffeine is most often used because of the predominating role of CYP1A2 in its overall metab. and the excellent tolerability.  Various urinary, plasma, saliva, and breath based CYP1A2 caffeine metrics have been applied.  While caffeine clearance is considered as the gold std., the salivary or plasma ratio of paraxanthine to caffeine in a sample taken approx. 6 h after a defined dose of caffeine is a more convenient, less expensive but also fully validated CYP1A2 phenotyping metric.  CYP1A2 phenotyping is applied frequently in epidemiol. and drug-drug interaction studies, but its clin. use and usefulness remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIAUShUtDBirVg90H21EOLACvtfcHk0lgy4jfMJTW0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVejsb3L&md5=401cfb163d198a74aaae618fffc8745b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2005.pto_973160.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2005.pto_973160.x%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DM.%2BS.%26aulast%3DJetter%26aufirst%3DA.%26aulast%3DFuhr%26aufirst%3DU.%26atitle%3DAssessment%2520of%2520CYP1A2%2520Activity%2520in%2520Clinical%2520Practice%253A%2520Why%252C%2520How%252C%2520and%2520When%253F%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D97%26issue%3D3%26spage%3D125%26epage%3D134%26doi%3D10.1111%2Fj.1742-7843.2005.pto_973160.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornelis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monda, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paynter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzato, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerwinkle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curhan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landi, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purdue, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimm, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolzenberg-Solomon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chasman, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporaso, N. E.</span></span> <span> </span><span class="NLM_article-title">Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e1002033</span> <span class="refDoi"> DOI: 10.1371/journal.pgen.1002033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1371%2Fjournal.pgen.1002033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21490707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&issue=4&author=M.+C.+Cornelisauthor=K.+L.+Mondaauthor=K.+Yuauthor=N.+Paynterauthor=E.+M.+Azzatoauthor=S.+N.+Bennettauthor=S.+I.+Berndtauthor=E.+Boerwinkleauthor=S.+Chanockauthor=N.+Chatterjeeauthor=D.+Couperauthor=G.+Curhanauthor=G.+Heissauthor=F.+B.+Huauthor=D.+J.+Hunterauthor=K.+Jacobsauthor=M.+K.+Jensenauthor=P.+Kraftauthor=M.+T.+Landiauthor=J.+A.+Nettletonauthor=M.+P.+Purdueauthor=P.+Rajaramanauthor=E.+B.+Rimmauthor=L.+M.+Roseauthor=N.+Rothmanauthor=D.+Silvermanauthor=R.+Stolzenberg-Solomonauthor=A.+Subarauthor=M.+Yeagerauthor=D.+I.+Chasmanauthor=R.+M.+van+Damauthor=N.+E.+Caporaso&title=Genome-Wide+Meta-Analysis+Identifies+Regions+on+7p21+%28AHR%29+and+15q24+%28CYP1A2%29+As+Determinants+of+Habitual+Caffeine+Consumption&doi=10.1371%2Fjournal.pgen.1002033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption</span></div><div class="casAuthors">Cornelis, Marilyn C.; Monda, Keri L.; Yu, Kai; Paynter, Nina; Azzato, Elizabeth M.; Bennett, Siiri N.; Berndt, Sonja I.; Boerwinkle, Eric; Chanock, Stephen; Chatterjee, Nilanjan; Couper, David; Curhan, Gary; Heiss, Gerardo; Hu, Frank B.; Hunter, David J.; Jacobs, Kevin; Jensen, Majken K.; Kraft, Peter; Landi, Maria Teresa; Nettleton, Jennifer A.; Purdue, Mark P.; Rajaraman, Preetha; Rimm, Eric B.; Rose, Lynda M.; Rothman, Nathaniel; Silverman, Debra; Stolzenberg-Solomon, Rachael; Subar, Amy; Yeager, Meredith; Chasman, Daniel I.; van Dam, Rob M.; Caporaso, Neil E.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1002033</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We report the first genome-wide assocn. study of habitual caffeine intake.  We included 47,341 individuals of European descent based on five population-based studies within the United States.  In a meta-anal. adjusted for age, sex, smoking, and eigenvectors of population variation, two loci achieved genome-wide significance: 7p21 (P = 2.4 × 10-19), near AHR, and 15q24 (P = 5.2 × 10-14), between CYP1A1 and CYP1A2.  Both the AHR and CYP1A2 genes are biol. plausible candidates as CYP1A2 metabolizes caffeine and AHR regulates CYP1A2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBu6lhAs0_g7Vg90H21EOLACvtfcHk0lgy4jfMJTW0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVWltb0%253D&md5=ad0355ce77db9599b2e0cb854483ce70</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1002033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1002033%26sid%3Dliteratum%253Aachs%26aulast%3DCornelis%26aufirst%3DM.%2BC.%26aulast%3DMonda%26aufirst%3DK.%2BL.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DPaynter%26aufirst%3DN.%26aulast%3DAzzato%26aufirst%3DE.%2BM.%26aulast%3DBennett%26aufirst%3DS.%2BN.%26aulast%3DBerndt%26aufirst%3DS.%2BI.%26aulast%3DBoerwinkle%26aufirst%3DE.%26aulast%3DChanock%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DN.%26aulast%3DCouper%26aufirst%3DD.%26aulast%3DCurhan%26aufirst%3DG.%26aulast%3DHeiss%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DF.%2BB.%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DM.%2BK.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DLandi%26aufirst%3DM.%2BT.%26aulast%3DNettleton%26aufirst%3DJ.%2BA.%26aulast%3DPurdue%26aufirst%3DM.%2BP.%26aulast%3DRajaraman%26aufirst%3DP.%26aulast%3DRimm%26aufirst%3DE.%2BB.%26aulast%3DRose%26aufirst%3DL.%2BM.%26aulast%3DRothman%26aufirst%3DN.%26aulast%3DSilverman%26aufirst%3DD.%26aulast%3DStolzenberg-Solomon%26aufirst%3DR.%26aulast%3DSubar%26aufirst%3DA.%26aulast%3DYeager%26aufirst%3DM.%26aulast%3DChasman%26aufirst%3DD.%2BI.%26aulast%3Dvan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DCaporaso%26aufirst%3DN.%2BE.%26atitle%3DGenome-Wide%2520Meta-Analysis%2520Identifies%2520Regions%2520on%25207p21%2520%2528AHR%2529%2520and%252015q24%2520%2528CYP1A2%2529%2520As%2520Determinants%2520of%2520Habitual%2520Caffeine%2520Consumption%26jtitle%3DPLoS%2520Genet.%26date%3D2011%26volume%3D7%26issue%3D4%26doi%3D10.1371%2Fjournal.pgen.1002033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neims, A. H.</span></span> <span> </span><span class="NLM_article-title">The Disposition of Caffeine during and after Pregnancy</span>. <i>Semin. Perinatol.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7302604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL38%252FmtF2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1981&pages=310-314&issue=4&author=A.+Aldridgeauthor=J.+Baileyauthor=A.+H.+Neims&title=The+Disposition+of+Caffeine+during+and+after+Pregnancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The disposition of caffeine during and after pregnancy</span></div><div class="casAuthors">Aldridge A; Bailey J; Neims A H</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in perinatology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">310-4</span>
        ISSN:<span class="NLM_cas:issn">0146-0005</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4UhLo9OyvVzslzEEsg76ufW6udTcc2eYb9kx3tSSOnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252FmtF2htg%253D%253D&md5=14e5d10e6a9df125c17d77802da6bbdd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAldridge%26aufirst%3DA.%26aulast%3DBailey%26aufirst%3DJ.%26aulast%3DNeims%26aufirst%3DA.%2BH.%26atitle%3DThe%2520Disposition%2520of%2520Caffeine%2520during%2520and%2520after%2520Pregnancy%26jtitle%3DSemin.%2520Perinatol.%26date%3D1981%26volume%3D5%26issue%3D4%26spage%3D310%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. K.</span></span> <span> </span><span class="NLM_article-title">Caffeine as a Metabolic Probe: Exploration of the Enzyme-Inducing Effect of Cigarette Smoking</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1038/clpt.1991.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fclpt.1991.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1988240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXktVejsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1991&pages=44-48&issue=1&author=W.+Kalowauthor=B.+K.+Tang&title=Caffeine+as+a+Metabolic+Probe%3A+Exploration+of+the+Enzyme-Inducing+Effect+of+Cigarette+Smoking&doi=10.1038%2Fclpt.1991.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine as a metabolic probe:  exploration of the enzyme-inducing effect of cigarette smoking</span></div><div class="casAuthors">Kalow, Werner; Tang, Bing Kou</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-8</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">It has been learned that the primary metab. of caffeine in humans is catalyzed by cytochrome P-450IA2 and that the rate of caffeine metab. can be estd. from a metabolite ratio in a single urine sample.  A population of 178 students, including 19 smokers, was subjected to this caffeine test to establish the P 450IA2 index.  Both stated nos. of cigarettes smoked per day and urinary cotinine levels as a confirmatory measure correlated significantly with enzyme activity showing dose-effect relationships (r = 0.62 and 0.89, resp.).  Nevertheless, more nonsmokers than smokers had the highest enzyme indexes, suggesting that dietary elements or other factors may det. P 450IA2 activities in populations.  Because P 4501IA2 is a monooxygenase that may be confined to the liver, caffeine reveals directly the Ah-receptor-dependent enzyme induction only in liver, but it may also be a signal of induction elsewhere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWhwMJVnaj2bVg90H21EOLACvtfcHk0lhHuKKUkkoIsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVejsLw%253D&md5=08f09098b1187edd2659a14eeb0ce5a4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1991.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1991.8%26sid%3Dliteratum%253Aachs%26aulast%3DKalow%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DB.%2BK.%26atitle%3DCaffeine%2520as%2520a%2520Metabolic%2520Probe%253A%2520Exploration%2520of%2520the%2520Enzyme-Inducing%2520Effect%2520of%2520Cigarette%2520Smoking%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1991%26volume%3D49%26issue%3D1%26spage%3D44%26epage%3D48%26doi%3D10.1038%2Fclpt.1991.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopp, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berk, L. S.</span></span> <span> </span><span class="NLM_article-title">The Impact of Caffeine Use on Tobacco Cessation and Withdrawal</span>. <i>Addict. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/S0306-4603(96)00023-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0306-4603%2896%2900023-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=9022872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK2s7nsFaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=55-68&issue=1&author=J.+A.+Swansonauthor=J.+W.+Leeauthor=J.+W.+Hoppauthor=L.+S.+Berk&title=The+Impact+of+Caffeine+Use+on+Tobacco+Cessation+and+Withdrawal&doi=10.1016%2FS0306-4603%2896%2900023-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of caffeine use on tobacco cessation and withdrawal</span></div><div class="casAuthors">Swanson J A; Lee J W; Hopp J W; Berk L S</div><div class="citationInfo"><span class="NLM_cas:title">Addictive behaviors</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-68</span>
        ISSN:<span class="NLM_cas:issn">0306-4603</span>.
    </div><div class="casAbstract">Continuous caffeine consumption with smoking cessation has been associated with more than doubled caffeine plasma levels.  Such concentrations may be sufficient to produce caffeine toxicity symptoms in smoking abstinence conditions.  To test whether caffeine abstinence influences smoking cessation, 162 caffeine-using smokers were enlisted from American Lung Association smoking cessation programs.  Volunteers were randomly assigned by clinic to caffeine-use and caffeine-abstinence conditions and measured for 3 weeks post-smoking cessation, at 6 months and one year.  Results showed a significant linear increase in caffeine sputum levels across 3 weeks post cessation for those who quit smoking and continued using caffeine.  Three weeks after cessation, concentrations reached 203% of baseline for the caffeine user.  Typical nicotine withdrawal symptoms occurred during the first 16 days of cessation.  The caffeine abstainers, but not continued users of caffeine, reported increased fatigue during the first 3 days of cessation.  Among complete caffeine abstainers, compared with caffeine users, there was a significant increase in fatigue, a decrease in stimulation, and a marginal increase in caffeine craving immediately following tobacco cessation.  There were no differences between the groups on other withdrawal symptoms or in cessation success at 16 days, 6 months, or 12 months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJHacomfZ7VCO2kE7krGOBfW6udTcc2eYb9kx3tSSOnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7nsFaisA%253D%253D&md5=c217976a9a1878611f0efaf6ea893233</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0306-4603%2896%2900023-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4603%252896%252900023-8%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DHopp%26aufirst%3DJ.%2BW.%26aulast%3DBerk%26aufirst%3DL.%2BS.%26atitle%3DThe%2520Impact%2520of%2520Caffeine%2520Use%2520on%2520Tobacco%2520Cessation%2520and%2520Withdrawal%26jtitle%3DAddict.%2520Behav.%26date%3D1997%26volume%3D22%26issue%3D1%26spage%3D55%26epage%3D68%26doi%3D10.1016%2FS0306-4603%2896%2900023-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rietveld, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broekman, M. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houben, J. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskes, T. K. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rossum, J. M.</span></span> <span> </span><span class="NLM_article-title">Rapid Onset of an Increase in Caffeine Residence Time in Young Women Due to Oral Contraceptive Steroids</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1007/BF00548769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00548769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6734698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2cXktFOmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1984&pages=371-373&issue=3&author=E.+C.+Rietveldauthor=M.+M.+M.+Broekmanauthor=J.+J.+G.+Houbenauthor=T.+K.+A.+B.+Eskesauthor=J.+M.+van+Rossum&title=Rapid+Onset+of+an+Increase+in+Caffeine+Residence+Time+in+Young+Women+Due+to+Oral+Contraceptive+Steroids&doi=10.1007%2FBF00548769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids</span></div><div class="casAuthors">Rietveld, E. C.; Broekman, M. M. M.; Houben, J. J. G.; Eskes, T. K. A. B.; Van Rossum, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-3</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">Oral contraceptive steroids (OCS) increased the residence time of caffeine  [58-08-2] in young women by a factor of 2.  The effect was already manifested during the 1st cycle 2 wk after starting OCS and was slightly increased in the 2nd cycle, after 6 wk on OCS.  Toxic effects attributed to OCS may in part be indirect and due to prolonged retention of absorbed toxic agents to which women are exposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodrp9CLkdkVbVg90H21EOLACvtfcHk0lhHuKKUkkoIsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktFOmu74%253D&md5=31b33a79bb69ad09b4afede00b7debfa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2FBF00548769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00548769%26sid%3Dliteratum%253Aachs%26aulast%3DRietveld%26aufirst%3DE.%2BC.%26aulast%3DBroekman%26aufirst%3DM.%2BM.%2BM.%26aulast%3DHouben%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DEskes%26aufirst%3DT.%2BK.%2BA.%2BB.%26aulast%3Dvan%2BRossum%26aufirst%3DJ.%2BM.%26atitle%3DRapid%2520Onset%2520of%2520an%2520Increase%2520in%2520Caffeine%2520Residence%2520Time%2520in%2520Young%2520Women%2520Due%2520to%2520Oral%2520Contraceptive%2520Steroids%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1984%26volume%3D26%26issue%3D3%26spage%3D371%26epage%3D373%26doi%3D10.1007%2FBF00548769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koren, G.</span></span> <span> </span><span class="NLM_article-title">Pregnancy-Induced Changes in Drug Metabolism in Epileptic Women</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>257</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2033516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1WmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1991&pages=735-740&issue=2&author=M.+Bologaauthor=B.+Tangauthor=J.+Kleinauthor=A.+Tesoroauthor=G.+Koren&title=Pregnancy-Induced+Changes+in+Drug+Metabolism+in+Epileptic+Women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pregnancy-induced changes in drug metabolism in epileptic women</span></div><div class="casAuthors">Bologa, Monica; Tang, Bing; Klein, Julia; Tesoro, Angelo; Koren, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">735-40</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The pharmacokinetics of antiepileptic drugs may be altered during pregnancy, resulting in decline of serum concns. and subsequent suboptimal control of seizures.  The authors investigated changes which may occur during pregnancy in hepatic drug handling by comparing metabolic ratios of 15 pregnant epileptic women to 15 nonpregnant epileptic women, as well as 10 pregnant nonepileptic and 10 nonpregnant nonepileptic controls.  The caffeine test was used to describe several enzyme activities: P 450 1A2, xanthine oxidase, n-acetyltransferase and hydroxylation.  For this end, ratios were calcd. among a no. of metabolites of the main demethylation pathway of caffeine.  In addn., D-glucaric acid excretion was measured for specific characterization of antiepileptic drug metab.  Paired comparison of epileptic women in late pregnancy and six to eight weeks post partum revealed statistically significant decreases in P 450 1A2, xanthine oxidase and n-acetyltransferase activities, and a significantly increased hydroxylation activity during pregnancy.  Twenty-one of the 30 epileptic women (70%) were found to be fast acetylators, whereas the normal distribution in the nonepileptic control groups was 50%.  Excretion of D-glucaric acid was significantly increased in all epileptic patient groups as compared to the matched nonepileptic control groups.  Importantly, it was also significantly increased in the pregnant nonepileptic control group as compared to the nonpregnant nonepileptic women.  Overall, the results suggest that enzymic pathways involved in antiepileptic drug metab. tend to be increased during pregnancy as a potential cause for obsd. lower serum concns. of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00V5Sjjlr7LVg90H21EOLACvtfcHk0lgT9zw4RiL4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1WmtbY%253D&md5=3409fdf38b2f145d51675c47dd45f12c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBologa%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DKlein%26aufirst%3DJ.%26aulast%3DTesoro%26aufirst%3DA.%26aulast%3DKoren%26aufirst%3DG.%26atitle%3DPregnancy-Induced%2520Changes%2520in%2520Drug%2520Metabolism%2520in%2520Epileptic%2520Women%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1991%26volume%3D257%26issue%3D2%26spage%3D735%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracken, M. B.</span></span> <span> </span><span class="NLM_article-title">Caffeine Metabolism, Genetics, and Perinatal Outcomes: A Review of Exposure Assessment Considerations during Pregnancy</span>. <i>Ann. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/j.annepidem.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.annepidem.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15967394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2MzhvVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=460-466&issue=6&author=L.+M.+Grossoauthor=M.+B.+Bracken&title=Caffeine+Metabolism%2C+Genetics%2C+and+Perinatal+Outcomes%3A+A+Review+of+Exposure+Assessment+Considerations+during+Pregnancy&doi=10.1016%2Fj.annepidem.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy</span></div><div class="casAuthors">Grosso Laura M; Bracken Michael B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of epidemiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">460-6</span>
        ISSN:<span class="NLM_cas:issn">1047-2797</span>.
    </div><div class="casAbstract">PURPOSE:  To review the methodologic issues complicating caffeine exposure assessment during pregnancy; to discuss maternal and fetal caffeine metabolism, including genetic polymorphisms affecting caffeine metabolism; and to discuss the endogenous and exogenous risk factors known to influence caffeine metabolism.  METHODS:  A review of the relevant literature.  RESULTS:  There is wide inter-individual variation in caffeine metabolism, primarily due to variations in CYP1A2 enzyme activity.  Some variability in CYP1A2 activity is due to genetic polymorphisms in the CYP1A2 gene which can cause increased or decreased inducibility of the enzyme.  Considerable evidence exists that maternal caffeine metabolism is influenced by a variety of endogenous and exogenous factors and studying the genetic polymorphisms may improve understanding of the potential effects of caffeine and its metabolites on perinatal outcomes.  There is substantial evidence that measurement of maternal, fetal, and neonatal caffeine metabolites may allow for a more precise measure of fetal caffeine exposure.  CONCLUSIONS:  Research on the genetic polymorphisms affecting caffeine metabolism may further explain the potential effects of caffeine and its metabolites on perinatal outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdfxHsWBUg242y4bB4mnvYfW6udTcc2eb3qs59tTxPWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzhvVWnsg%253D%253D&md5=28672e7206f538f68687d94a49f668f0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.annepidem.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.annepidem.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DGrosso%26aufirst%3DL.%2BM.%26aulast%3DBracken%26aufirst%3DM.%2BB.%26atitle%3DCaffeine%2520Metabolism%252C%2520Genetics%252C%2520and%2520Perinatal%2520Outcomes%253A%2520A%2520Review%2520of%2520Exposure%2520Assessment%2520Considerations%2520during%2520Pregnancy%26jtitle%3DAnn.%2520Epidemiol.%26date%3D2005%26volume%3D15%26issue%3D6%26spage%3D460%26epage%3D466%26doi%3D10.1016%2Fj.annepidem.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bättig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmén, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehlig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvartau, E. E.</span></span> <span> </span><span class="NLM_article-title">Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10049999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1MXitFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=83-133&issue=1&author=B.+B.+Fredholmauthor=K.+B%C3%A4ttigauthor=J.+Holm%C3%A9nauthor=A.+Nehligauthor=E.+E.+Zvartau&title=Actions+of+Caffeine+in+the+Brain+with+Special+Reference+to+Factors+That+Contribute+to+Its+Widespread+Use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of caffeine in the brain with special reference to factors that contribute to its widespread use</span></div><div class="casAuthors">Fredholm, Bertil B.; Battig, Karl; Holmen, Janet; Nehlig, Astrid; Zvartau, Edwin E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-133</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with ∼500 refs.  In the present review the authors discuss the evidence regarding caffeine and dependence in light of increasing knowledge regarding the actions of caffeine on specific neuronal brain substrates.  Because the use of caffeine is probably related to its diverse effects on several brain functions, these are also briefly presented.  Even though the authors have attempted to cover many of the aspects that are relevant to this complex issue, they are aware of several omissions and also realize that the complex-often somewhat contradictory-literature lends itself to more than one interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5xVwkaA1GLVg90H21EOLACvtfcHk0lgT9zw4RiL4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFWgurk%253D&md5=f690fde42bb886d14986ab75da34cf8a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DB%25C3%25A4ttig%26aufirst%3DK.%26aulast%3DHolm%25C3%25A9n%26aufirst%3DJ.%26aulast%3DNehlig%26aufirst%3DA.%26aulast%3DZvartau%26aufirst%3DE.%2BE.%26atitle%3DActions%2520of%2520Caffeine%2520in%2520the%2520Brain%2520with%2520Special%2520Reference%2520to%2520Factors%2520That%2520Contribute%2520to%2520Its%2520Widespread%2520Use%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26issue%3D1%26spage%3D83%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fenster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskenazi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windham, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, S. H.</span></span> <span> </span><span class="NLM_article-title">Caffeine Consumption during Pregnancy and Fetal Growth</span>. <i>Am. J. Public Health</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.2105/AJPH.81.4.458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2105%2FAJPH.81.4.458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2003624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK3M7ms1Siug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1991&pages=458-461&issue=4&author=L.+Fensterauthor=B.+Eskenaziauthor=G.+C.+Windhamauthor=S.+H.+Swan&title=Caffeine+Consumption+during+Pregnancy+and+Fetal+Growth&doi=10.2105%2FAJPH.81.4.458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine consumption during pregnancy and fetal growth</span></div><div class="casAuthors">Fenster L; Eskenazi B; Windham G C; Swan S H</div><div class="citationInfo"><span class="NLM_cas:title">American journal of public health</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-61</span>
        ISSN:<span class="NLM_cas:issn">0090-0036</span>.
    </div><div class="casAbstract">BACKGROUND:  The purpose of this study was to examine the association between maternal caffeine consumption and low birthweight, intrauterine growth retardation, and prematurity, adjusting for multiple confounders.  METHODS:  Data obtained from birth certificates and interviews on 1,230 women with singleton live births were analyzed to evaluate the potential influence of caffeine consumption during the first trimester on fetal growth.  RESULTS:  The crude odds ratio for intrauterine growth retardation in infants of women reporting heavy caffeine consumption (greater than 300 mg/day) was 3.86 (95% CI = 1.80, 8.40) which decreased to 2.90 (95% CI = 1.23, 6.87) after controlling for confounding factors.  The adjusted odds ratio for low birthweight and heavy maternal caffeine consumption was also elevated (OR = 2.05; 95% CI = 0.86, 4.88).  Women who reduced their caffeine intake from greater than 300 mg/day to less than that early in pregnancy had lower risks of delivering infants with either intrauterine growth retardation or low birthweight than women who continued to consume that amount.  Preterm delivery appeared to be unrelated to caffeine consumption.  CONCLUSIONS:  Taken together with studies reporting similar findings, these results suggest that heavy caffeine consumption increases the risk for fetal growth retardation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNs0s_KwT0gEEksK8CslK8fW6udTcc2eZg0lBVDKGo_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7ms1Siug%253D%253D&md5=13c4facaca1439c344bd00d6ea694716</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2105%2FAJPH.81.4.458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2105%252FAJPH.81.4.458%26sid%3Dliteratum%253Aachs%26aulast%3DFenster%26aufirst%3DL.%26aulast%3DEskenazi%26aufirst%3DB.%26aulast%3DWindham%26aufirst%3DG.%2BC.%26aulast%3DSwan%26aufirst%3DS.%2BH.%26atitle%3DCaffeine%2520Consumption%2520during%2520Pregnancy%2520and%2520Fetal%2520Growth%26jtitle%3DAm.%2520J.%2520Public%2520Health%26date%3D1991%26volume%3D81%26issue%3D4%26spage%3D458%26epage%3D461%26doi%3D10.2105%2FAJPH.81.4.458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, D.</span></span> <span> </span><span class="NLM_article-title">Caffeinated Beverages and Decreased Fertility</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>332</i></span> (<span class="NLM_issue">8626–8627</span>),  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(88)90933-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0140-6736%2888%2990933-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1988&pages=1453-1456&issue=8626%E2%80%938627&author=A.+Wilcoxauthor=C.+Weinbergauthor=D.+Baird&title=Caffeinated+Beverages+and+Decreased+Fertility&doi=10.1016%2FS0140-6736%2888%2990933-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2888%2990933-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252888%252990933-6%26sid%3Dliteratum%253Aachs%26aulast%3DWilcox%26aufirst%3DA.%26aulast%3DWeinberg%26aufirst%3DC.%26aulast%3DBaird%26aufirst%3DD.%26atitle%3DCaffeinated%2520Beverages%2520and%2520Decreased%2520Fertility%26jtitle%3DLancet%26date%3D1988%26volume%3D332%26issue%3D8626%25E2%2580%25938627%26spage%3D1453%26epage%3D1456%26doi%3D10.1016%2FS0140-6736%2888%2990933-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cnattingius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorello, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annerén, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekbom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljunger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blot, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granath, F.</span></span> <span> </span><span class="NLM_article-title">Caffeine Intake and the Risk of First-Trimester Spontaneous Abortion</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>343</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">1839</span>– <span class="NLM_lpage">1845</span>, <span class="refDoi"> DOI: 10.1056/NEJM200012213432503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1056%2FNEJM200012213432503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=11117975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1839-1845&issue=25&author=S.+Cnattingiusauthor=L.+B.+Signorelloauthor=G.+Anner%C3%A9nauthor=B.+Claussonauthor=A.+Ekbomauthor=E.+Ljungerauthor=W.+J.+Blotauthor=J.+K.+McLaughlinauthor=G.+Peterssonauthor=A.+Raneauthor=F.+Granath&title=Caffeine+Intake+and+the+Risk+of+First-Trimester+Spontaneous+Abortion&doi=10.1056%2FNEJM200012213432503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine intake and the risk of first-trimester spontaneous abortion</span></div><div class="casAuthors">Cnattingius, Sven; Signorello, Lisa B.; Anneren, Goran; Clausson, Britt; Ekbom, Anders; Ljunger, Elisabeth; Blot, William J.; McLaughlin, Joseph K.; Petersson, Gunnar; Rane, Anders; Granath, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">1839-1845</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Some epidemiol. studies have suggested that caffeine consumption may increase the risk of spontaneous abortion.  We performed a population-based, case-control study of early spontaneous abortions in 562 women in Sweden.  The women had spontaneous abortion at 6-12 completed weeks of gestation; 953 control women without spontaneous abortion were matched to the case patients according to the weeks of gestation.  Information on the ingestion of caffeine was obtained by interviews.  Blood plasma cotinine levels were measured as an indicator of cigarette smoking and fetal karyotypes were detd. from tissue samples.  Multivariate anal. was used to est. the relative risks assocd. with caffeine ingestion after adjustment for smoking and symptoms of pregnancy, such as nausea, vomiting, and fatigue.  Among nonsmokers, more spontaneous abortions occurred in women who ingested at least 100 mg caffeine/day than in women who ingested <100 mg/day.  There was an increase in the abortion risk pos. related to the caffeine amt. ingested (100-299 mg/day: odds ratio 1.3, 95%CI 0.9-1.8; 300-499 mg/day: odds ratio 1.4, 95%CI 0.9-2.0; ≥500 mg/day: odds ratio 2.2, 95%CI 1.3-3.8).  Among smokers the caffeine ingestion was not assocd. with increased risk of spontaneous abortion.  When the data were stratified according to the karyotyping results, the ingestion of moderate or high levels of caffeine was assocd. with excessive risk of spontaneous abortion when the fetus had a normal or unknown karyotype, but not when the fetal karyotype was abnormal.  Thus, ingestion of caffeine may increase the risk of early spontaneous abortions in nonsmoking women carrying fetuses with normal karyotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtFeK6aT3wB7Vg90H21EOLACvtfcHk0lgFFPBSTnzQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlSlug%253D%253D&md5=9490e16eda8b0eb160554ae868a7d32c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012213432503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012213432503%26sid%3Dliteratum%253Aachs%26aulast%3DCnattingius%26aufirst%3DS.%26aulast%3DSignorello%26aufirst%3DL.%2BB.%26aulast%3DAnner%25C3%25A9n%26aufirst%3DG.%26aulast%3DClausson%26aufirst%3DB.%26aulast%3DEkbom%26aufirst%3DA.%26aulast%3DLjunger%26aufirst%3DE.%26aulast%3DBlot%26aufirst%3DW.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DJ.%2BK.%26aulast%3DPetersson%26aufirst%3DG.%26aulast%3DRane%26aufirst%3DA.%26aulast%3DGranath%26aufirst%3DF.%26atitle%3DCaffeine%2520Intake%2520and%2520the%2520Risk%2520of%2520First-Trimester%2520Spontaneous%2520Abortion%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26issue%3D25%26spage%3D1839%26epage%3D1845%26doi%3D10.1056%2FNEJM200012213432503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wikoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brorby, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenenbein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doepker, C.</span></span> <span> </span><span class="NLM_article-title">Systematic Review of the Potential Adverse Effects of Caffeine Consumption in Healthy Adults, Pregnant Women, Adolescents, and Children</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2017.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.fct.2017.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28438661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFeksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2017&pages=585-648&author=D.+Wikoffauthor=B.+T.+Welshauthor=R.+Hendersonauthor=G.+P.+Brorbyauthor=J.+Brittauthor=E.+Myersauthor=J.+Goldbergerauthor=H.+R.+Liebermanauthor=C.+O%E2%80%99Brienauthor=J.+Peckauthor=M.+Tenenbeinauthor=C.+Weaverauthor=S.+Harveyauthor=J.+Urbanauthor=C.+Doepker&title=Systematic+Review+of+the+Potential+Adverse+Effects+of+Caffeine+Consumption+in+Healthy+Adults%2C+Pregnant+Women%2C+Adolescents%2C+and+Children&doi=10.1016%2Fj.fct.2017.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children</span></div><div class="casAuthors">Wikoff, Daniele; Welsh, Brian T.; Henderson, Rayetta; Brorby, Gregory P.; Britt, Janice; Myers, Esther; Goldberger, Jeffrey; Lieberman, Harris R.; O'Brien, Charles; Peck, Jennifer; Tenenbein, Milton; Weaver, Connie; Harvey, Seneca; Urban, Jonathan; Doepker, Candace</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">585-648</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To date, one of the most heavily cited assessments of caffeine safety in the peer-reviewed literature is that issued by Health Canada (Nawrot et al., 2003).  Since then, >10,000 papers have been published related to caffeine, including hundreds of reviews on specific human health effects; however, to date, none have compared the wide range of topics evaluated by Nawrot et al. (2003).  Thus, as an update to this foundational publication, we conducted a systematic review of data on potential adverse effects of caffeine published from 2001 to June 2015.  Subject matter experts and research team participants developed five PECO (population, exposure, comparator, and outcome) questions to address five types of outcomes (acute toxicity, cardiovascular toxicity, bone and calcium effects, behavior, and development and reprodn.) in four healthy populations (adults, pregnant women, adolescents, and children) relative to caffeine intake doses detd. not to be assocd. with adverse effects by Health Canada (comparators: 400 mg/day for adults [10 g for lethality], 300 mg/day for pregnant women, and 2.5 mg/kg/day for children and adolescents).  The a priori search strategy identified >5000 articles that were screened, with 381 meeting inclusion/exclusion criteria for the five outcomes (pharmacokinetics was addressed contextually, adding 46 more studies).  Data were extd. by the research team and rated for risk of bias and indirectness (internal and external validity).  Selected no- and low-effect intakes were assessed relative to the population-specific comparator.  Conclusions were drawn for the body of evidence for each outcome, as well as endpoints within an outcome, using a wt. of evidence approach.  When the total body of evidence was evaluated and when study quality, consistency, level of adversity, and magnitude of response were considered, the evidence generally supports that consumption of up to 400 mg caffeine/day in healthy adults is not assocd. with overt, adverse cardiovascular effects, behavioral effects, reproductive and developmental effects, acute effects, or bone status.  Evidence also supports consumption of up to 300 mg caffeine/day in healthy pregnant women as an intake that is generally not assocd. with adverse reproductive and developmental effects.  Limited data were identified for child and adolescent populations; the available evidence suggests that 2.5 mg caffeine/kg body wt./day remains an appropriate recommendation.  The results of this systematic review support a shift in caffeine research to focus on characterizing effects in sensitive populations and establishing better quant. characterization of interindividual variability (e.g., epigenetic trends), subpopulations (e.g., unhealthy populations, individuals with preexisting conditions), conditions (e.g., coexposures), and outcomes (e.g., exacerbation of risk-taking behavior) that could render individuals to be at greater risk relative to healthy adults and healthy pregnant women.  This review, being one of the first to apply systematic review methodologies to toxicol. assessments, also highlights the need for refined guidance and frameworks unique to the conduct of systematic review in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHt_MRvc12bVg90H21EOLACvtfcHk0lgFFPBSTnzQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFeksb8%253D&md5=6ebef4642ff03f574e932b56fe4692f1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2017.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DWikoff%26aufirst%3DD.%26aulast%3DWelsh%26aufirst%3DB.%2BT.%26aulast%3DHenderson%26aufirst%3DR.%26aulast%3DBrorby%26aufirst%3DG.%2BP.%26aulast%3DBritt%26aufirst%3DJ.%26aulast%3DMyers%26aufirst%3DE.%26aulast%3DGoldberger%26aufirst%3DJ.%26aulast%3DLieberman%26aufirst%3DH.%2BR.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DPeck%26aufirst%3DJ.%26aulast%3DTenenbein%26aufirst%3DM.%26aulast%3DWeaver%26aufirst%3DC.%26aulast%3DHarvey%26aufirst%3DS.%26aulast%3DUrban%26aufirst%3DJ.%26aulast%3DDoepker%26aufirst%3DC.%26atitle%3DSystematic%2520Review%2520of%2520the%2520Potential%2520Adverse%2520Effects%2520of%2520Caffeine%2520Consumption%2520in%2520Healthy%2520Adults%252C%2520Pregnant%2520Women%252C%2520Adolescents%252C%2520and%2520Children%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2017%26volume%3D109%26spage%3D585%26epage%3D648%26doi%3D10.1016%2Fj.fct.2017.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatch, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracken, M. B.</span></span> <span> </span><span class="NLM_article-title">Association of Delayed Conception with Caffeine Consumption</span>. <i>Am. J. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.aje.a116826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Foxfordjournals.aje.a116826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8266910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK2c%252FptFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1993&pages=1082-1092&issue=12&author=E.+E.+Hatchauthor=M.+B.+Bracken&title=Association+of+Delayed+Conception+with+Caffeine+Consumption&doi=10.1093%2Foxfordjournals.aje.a116826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Association of delayed conception with caffeine consumption</span></div><div class="casAuthors">Hatch E E; Bracken M B</div><div class="citationInfo"><span class="NLM_cas:title">American journal of epidemiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1082-92</span>
        ISSN:<span class="NLM_cas:issn">0002-9262</span>.
    </div><div class="casAbstract">This cross-sectional study investigated the relation between intake of caffeine-containing beverages and time to conception in a population of 1,909 married women in New Haven, Connecticut, between May 12, 1980 and March 12, 1982.  Women were interviewed shortly after the first prenatal visit regarding the length of time taken to conceive the index pregnancy, consumption of caffeine during pregnancy, and other exposures occurring prior to and during pregnancy.  In logistic regression analyses, intake of caffeine from coffee, tea, and caffeinated soft drinks was associated with an increased risk of a delay of conception of 1 year or more.  Compared with no caffeine use, consumption of 1-150 mg/day of caffeine resulted in an odds ratio for delayed conception of 1.39 (95% confidence interval (CI) 0.90-2.13), consumption of 151-300 mg/day of caffeine was associated with an odds ratio of 1.88 (95% CI 1.13-3.11), and that of over 300 mg/day (the equivalent of approximately three cups of coffee) resulted in an odds ratio of 2.24 (95% CI 1.06-4.73), after controlling for last method of birth control used, parity, and number of cigarettes per day.  When the risk of conception for each cycle was examined using a discrete analogue of the Cox proportional hazards model, women who reported drinking over 300 mg/day of caffeine had a 27% lower chance of conceiving for each cycle, and those who reported drinking less than 300 mg/day had a 10% reduction in per cycle conception rates compared with women who consumed no caffeine.  Risks for coffee, tea, and colas were examined simultaneously in logistic models and were found not to improve the fit of a model that contained a variable for total caffeine intake from all sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFcGMC9lRoZK-9TkgmBqTqfW6udTcc2eaynBtiF2UM87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FptFaktg%253D%253D&md5=34e6a95423f3c8d4a334db58cfb074b1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.aje.a116826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.aje.a116826%26sid%3Dliteratum%253Aachs%26aulast%3DHatch%26aufirst%3DE.%2BE.%26aulast%3DBracken%26aufirst%3DM.%2BB.%26atitle%3DAssociation%2520of%2520Delayed%2520Conception%2520with%2520Caffeine%2520Consumption%26jtitle%3DAm.%2520J.%2520Epidemiol.%26date%3D1993%26volume%3D138%26issue%3D12%26spage%3D1082%26epage%3D1092%26doi%3D10.1093%2Foxfordjournals.aje.a116826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyngsø, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramlau-Hansen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingerslev, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesmodel, U. S.</span></span> <span> </span><span class="NLM_article-title">Association between Coffee or Caffeine Consumption and Fecundity and Fertility: A Systematic Review and Dose-Response Meta-Analysis</span>. <i>Clinical Epidemiology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">699</span>, <span class="refDoi"> DOI: 10.2147/CLEP.S146496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2147%2FCLEP.S146496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29276412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1MzltVSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=699&author=J.+Lyngs%C3%B8author=C.+H.+Ramlau-Hansenauthor=B.+Bayauthor=H.+J.+Ingerslevauthor=A.+Hulmanauthor=U.+S.+Kesmodel&title=Association+between+Coffee+or+Caffeine+Consumption+and+Fecundity+and+Fertility%3A+A+Systematic+Review+and+Dose-Response+Meta-Analysis&doi=10.2147%2FCLEP.S146496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis</span></div><div class="casAuthors">Lyngso Julie; Ramlau-Hansen Cecilia Host; Hulman Adam; Bay Bjorn; Ingerslev Hans Jakob; Hulman Adam; Kesmodel Ulrik Schioler</div><div class="citationInfo"><span class="NLM_cas:title">Clinical epidemiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-719</span>
        ISSN:<span class="NLM_cas:issn">1179-1349</span>.
    </div><div class="casAbstract">Objective:  The aim was to investigate whether coffee or caffeine consumption is associated with reproductive endpoints among women with natural fertility (ie, time to pregnancy [TTP] and spontaneous abortion [SAB]) and among women in fertility treatment (ie, clinical pregnancy rate or live birth rate).  Design:  This study was a systematic review and dose-response meta-analysis including data from case-control and cohort studies.  Methods:  An extensive literature search was conducted in MEDLINE and Embase, with no time and language restrictions.  Also, reference lists were searched manually.  Two independent reviewers assessed the manuscript quality using the Newcastle-Ottawa Scale (NOS).  A two-stage dose-response meta-analysis was applied to assess a potential association between coffee/caffeine consumption and the outcomes: TTP, SAB, clinical pregnancy, and live birth.  Heterogeneity between studies was assessed using Cochrane Q-test and I(2) statistics.  Publication bias was assessed using Egger's regression test.  Results:  The pooled results showed that coffee/caffeine consumption is associated with a significantly increased risk of SAB for 300 mg caffeine/day (relative risk [RR]: 1.37, 95% confidence interval [95% CI]: 1.19; 1.57) and for 600 mg caffeine/day (RR: 2.32, 95% CI: 1.62; 3.31).  No association was found between coffee/caffeine consumption and outcomes of fertility treatment (based on two studies).  No clear association was found between exposure to coffee/caffeine and natural fertility as measured by fecundability odds ratio (based on three studies) or waiting TTP (based on two studies).  Conclusion:  Results from this meta-analysis support the growing evidence of an association between coffee/caffeine intake and the risk of SAB.  However, viewing the reproductive capacity in a broader perspective, there seems to be little, if any, association between coffee/caffeine consumption and fecundity.  In general, results from this study are supportive of a precautionary principle advised by health organizations such as European Food Safety Authority (EFSA) and World Health Organization (WHO), although the advised limit of a maximum of two to three cups of coffee/200-300 mg caffeine per day may be too high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4SBByurJQWt1QT_1O5WBYfW6udTcc2eaynBtiF2UM87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzltVSqsQ%253D%253D&md5=7c51637a1e9c2c02badee3e27a3091e3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2147%2FCLEP.S146496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCLEP.S146496%26sid%3Dliteratum%253Aachs%26aulast%3DLyngs%25C3%25B8%26aufirst%3DJ.%26aulast%3DRamlau-Hansen%26aufirst%3DC.%2BH.%26aulast%3DBay%26aufirst%3DB.%26aulast%3DIngerslev%26aufirst%3DH.%2BJ.%26aulast%3DHulman%26aufirst%3DA.%26aulast%3DKesmodel%26aufirst%3DU.%2BS.%26atitle%3DAssociation%2520between%2520Coffee%2520or%2520Caffeine%2520Consumption%2520and%2520Fecundity%2520and%2520Fertility%253A%2520A%2520Systematic%2520Review%2520and%2520Dose-Response%2520Meta-Analysis%26jtitle%3DClinical%2520Epidemiology%26date%3D2017%26volume%3D9%26spage%3D699%26doi%3D10.2147%2FCLEP.S146496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sengpiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elind, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacelis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grove, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myhre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meltzer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brantsæter, A. L.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Intake during Pregnancy Is Associated with Birth Weight but Not with Gestational Length: Results from a Large Prospective Observational Cohort Study</span>. <i>BMC Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">42</span>, <span class="refDoi"> DOI: 10.1186/1741-7015-11-42</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2F1741-7015-11-42" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23421532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVaks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=42&issue=1&author=V.+Sengpielauthor=E.+Elindauthor=J.+Bacelisauthor=S.+Nilssonauthor=J.+Groveauthor=R.+Myhreauthor=M.+Haugenauthor=H.+M.+Meltzerauthor=J.+Alexanderauthor=B.+Jacobssonauthor=A.+L.+Brants%C3%A6ter&title=Maternal+Caffeine+Intake+during+Pregnancy+Is+Associated+with+Birth+Weight+but+Not+with+Gestational+Length%3A+Results+from+a+Large+Prospective+Observational+Cohort+Study&doi=10.1186%2F1741-7015-11-42"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study</span></div><div class="casAuthors">Sengpiel, Verena; Elind, Elisabeth; Bacelis, Jonas; Nilsson, Staffan; Grove, Jakob; Myhre, Ronny; Haugen, Margaretha; Meltzer, Helle Margrete; Alexander, Jan; Jacobsson, Bo; Brantsaeter, Anne-Lise</div><div class="citationInfo"><span class="NLM_cas:title">BMC Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42</span>CODEN:
                <span class="NLM_cas:coden">BMMECZ</span>;
        ISSN:<span class="NLM_cas:issn">1741-7015</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Pregnant women consume caffeine daily.  The aim of this study was to examine the assocn. between maternal caffeine intake from different sources and (a) gestational length, particularly the risk for spontaneous preterm delivery (PTD) and (b) birth wt. (BW) and the baby being small for gestational age (SGA).  Methods: This study is based on the Norwegian Mother and Child Cohort Study conducted by the Norwegian Institute of Public Health.  A total of 59,123 women with uncomplicated pregnancies giving birth to a live singleton were identified.  Caffeine intake from different sources was self-reported at gestational weeks 17, 22 and 30.  Spontaneous PTD was defined as spontaneous onset of delivery between 22+0 and 36+6 weeks (n = 1,451).  As there is no consensus, SGA was defined according to ultrasound-based (Marsal, n = 856), population-based (Skjaerven, n = 4,503) and customized (Gardosi, n = 4,733) growth curves.  Results: The main caffeine source was coffee, but tea and chocolate were the main sources in women with low caffeine intake.  Median pre-pregnancy caffeine intake was 126 mg/day (IQR 40 to 254), 44 mg/day (13 to 104) at gestational week 17 and 62 mg/day (21 to 130) at gestational week 30.  Coffee caffeine, but not caffeine from other sources, was assocd. with prolonged gestation (8 h/100 mg/day, P<10-7).  Neither total nor coffee caffeine was assocd. with spontaneous PTD risk.  Caffeine intake from different sources, measured repeatedly during pregnancy, was assocd. with lower BW (Marsal-28 g, Skjaerven-25 g, Gardosi-21 g per 100 mg/day addnl. total caffeine for a baby with expected BW 3,600 g, P<10-25).  Caffeine intake of 200 to 300 mg/day increased the odds for SGA (OR Marsal 1.62, Skjaerven 1.44, Gardosi 1.27, P<0.05), compared to 0 to 50 mg/day.  Conclusions: Coffee, but not caffeine, consumption was assocd. with marginally increased gestational length but not with spontaneous PTD risk.  Caffeine intake was consistently assocd. with decreased BW and increased odds of SGA.  The assocn. was strengthened by concordant results for caffeine sources, time of survey and different SGA definitions.  This might have clin. implications as even caffeine consumption below the recommended max. (200 mg/day in the Nordic countries and USA, 300 mg/day according to the World Health Organization (WHO)) was assocd. with increased risk for SGA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbGNyGRK_aFbVg90H21EOLACvtfcHk0ljH42N7jKUiog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVaks7s%253D&md5=33982510eca48576aae531c04bde3ce0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-11-42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-11-42%26sid%3Dliteratum%253Aachs%26aulast%3DSengpiel%26aufirst%3DV.%26aulast%3DElind%26aufirst%3DE.%26aulast%3DBacelis%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DGrove%26aufirst%3DJ.%26aulast%3DMyhre%26aufirst%3DR.%26aulast%3DHaugen%26aufirst%3DM.%26aulast%3DMeltzer%26aufirst%3DH.%2BM.%26aulast%3DAlexander%26aufirst%3DJ.%26aulast%3DJacobsson%26aufirst%3DB.%26aulast%3DBrants%25C3%25A6ter%26aufirst%3DA.%2BL.%26atitle%3DMaternal%2520Caffeine%2520Intake%2520during%2520Pregnancy%2520Is%2520Associated%2520with%2520Birth%2520Weight%2520but%2520Not%2520with%2520Gestational%2520Length%253A%2520Results%2520from%2520a%2520Large%2520Prospective%2520Observational%2520Cohort%2520Study%26jtitle%3DBMC%2520Med.%26date%3D2013%26volume%3D11%26issue%3D1%26spage%3D42%26doi%3D10.1186%2F1741-7015-11-42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odouli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. K.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Consumption during Pregnancy and the Risk of Miscarriage: A Prospective Cohort Study</span>. <i>Am. J. Obstet. Gynecol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>198</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">279.e1</span>– <span class="NLM_lpage">279.e8</span>, <span class="refDoi"> DOI: 10.1016/j.ajog.2007.10.803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ajog.2007.10.803" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2008&pages=279.e1-279.e8&issue=3&author=X.+Wengauthor=R.+Odouliauthor=D.+K.+Li&title=Maternal+Caffeine+Consumption+during+Pregnancy+and+the+Risk+of+Miscarriage%3A+A+Prospective+Cohort+Study&doi=10.1016%2Fj.ajog.2007.10.803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ajog.2007.10.803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajog.2007.10.803%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DX.%26aulast%3DOdouli%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DD.%2BK.%26atitle%3DMaternal%2520Caffeine%2520Consumption%2520during%2520Pregnancy%2520and%2520the%2520Risk%2520of%2520Miscarriage%253A%2520A%2520Prospective%2520Cohort%2520Study%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D2008%26volume%3D198%26issue%3D3%26spage%3D279.e1%26epage%3D279.e8%26doi%3D10.1016%2Fj.ajog.2007.10.803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">CARE
Study Group</span> <span> </span><span class="NLM_article-title">Maternal Caffeine
Intake during Pregnancy and Risk of Fetal Growth Restriction: A Large
Prospective Observational Study</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>337</i></span> (<span class="NLM_issue">7682</span>),  <span class="NLM_fpage">1334</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1136/bmj.a2332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1136%2Fbmj.a2332" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2008&pages=1334-1338&issue=7682&author=CARE%0AStudy+Group&title=Maternal+Caffeine%0AIntake+during+Pregnancy+and+Risk+of+Fetal+Growth+Restriction%3A+A+Large%0AProspective+Observational+Study&doi=10.1136%2Fbmj.a2332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1136%2Fbmj.a2332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.a2332%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DMaternal%2520Caffeine%250AIntake%2520during%2520Pregnancy%2520and%2520Risk%2520of%2520Fetal%2520Growth%2520Restriction%253A%2520A%2520Large%250AProspective%2520Observational%2520Study%26jtitle%3DBMJ.%26date%3D2008%26volume%3D337%26issue%3D7682%26spage%3D1334%26epage%3D1338%26doi%3D10.1136%2Fbmj.a2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, M. F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, R. M.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Intake during Pregnancy Is Associated with Risk of Low Birth Weight: A Systematic Review and Dose-Response Meta-Analysis</span>. <i>BMC Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">174</span>, <span class="refDoi"> DOI: 10.1186/s12916-014-0174-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs12916-014-0174-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25238871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jtFSisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=174&issue=1&author=L.+W.+Chenauthor=Y.+Wuauthor=N.+Neelakantanauthor=M.+F.+F.+Chongauthor=A.+Panauthor=R.+M.+van+Dam&title=Maternal+Caffeine+Intake+during+Pregnancy+Is+Associated+with+Risk+of+Low+Birth+Weight%3A+A+Systematic+Review+and+Dose-Response+Meta-Analysis&doi=10.1186%2Fs12916-014-0174-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis</span></div><div class="casAuthors">Chen Ling-Wei; Wu Yi; Neelakantan Nithya; Chong Mary Foong-Fong; Pan An; van Dam Rob M</div><div class="citationInfo"><span class="NLM_cas:title">BMC medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Considerable controversy exists regarding the relation between maternal caffeine intake during pregnancy and risk of low birth weight (birth weight <2,500 g).  We aim to assess this association using a systematic review and dose-response meta-analysis of prospective studies.  METHODS:  Potential articles were identified by searching MEDLINE and SCOPUS databases through 17 July 2013.  Two authors independently extracted information on study design, participant characteristics and estimates of associations.  Random-effects models were used to derive the summary relative risks (RRs) and corresponding 95% confidence intervals (CIs).  Dose-response relationships were assessed using generalized least-squares trend estimation.  RESULTS:  In our meta-analysis, we included 13 prospective studies: 9 with low birth weight as a binary outcome variable (90,747 participants and 6,303 cases) and 6 with birth weight as a continuous outcome variable (10,015 participants; 2 studies reported both types of outcomes).  Compared with the reference category with no or very low caffeine intake, the RR (95% CI) of low birth weight was 1.13 (1.06 to 1.21; I 2 0.0%) for low intake (50 to 149 mg/day), 1.38 (1.18 to 1.62; I 2 31.9%) for moderate intake (150 to 349 mg/day), and 1.60 (1.24 to 2.08; I 2 65.8%) for high intake (≥350 mg/day).  In the dose-response analysis, each 100-mg/day increment in maternal caffeine intake (around one cup of coffee) was associated with 13% (RR 1.13, 1.06 to 1.21) higher risk of low birth weight.  The association persisted in strata defined according to various study characteristics.  Moderate (-33 g, 95% CI -63 to -4; I 2 0.3%) and high (-69 g, 95% CI -102 to -35; I 2 0.0%) caffeine intakes were also associated with a significantly lower birth weight as compared with the reference category.  CONCLUSIONS:  Higher maternal caffeine intake during pregnancy was associated with a higher risk of delivering low birth weight infants.  These findings support recommendations to restrict caffeine intake during pregnancy to low levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbXRvTXTiIAtts4TFFB11gfW6udTcc2eZ3Z_rSAfEVmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jtFSisg%253D%253D&md5=12bee1b413af1c1f311088a300daeefa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2Fs12916-014-0174-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12916-014-0174-6%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DNeelakantan%26aufirst%3DN.%26aulast%3DChong%26aufirst%3DM.%2BF.%2BF.%26aulast%3DPan%26aufirst%3DA.%26aulast%3Dvan%2BDam%26aufirst%3DR.%2BM.%26atitle%3DMaternal%2520Caffeine%2520Intake%2520during%2520Pregnancy%2520Is%2520Associated%2520with%2520Risk%2520of%2520Low%2520Birth%2520Weight%253A%2520A%2520Systematic%2520Review%2520and%2520Dose-Response%2520Meta-Analysis%26jtitle%3DBMC%2520Med.%26date%3D2014%26volume%3D12%26issue%3D1%26spage%3D174%26doi%3D10.1186%2Fs12916-014-0174-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldenburg, C. E.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0132334</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0132334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1371%2Fjournal.pone.0132334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26193706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOlurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&issue=7&author=J.+Rheeauthor=R.+Kimauthor=Y.+Kimauthor=M.+Tamauthor=Y.+Laiauthor=N.+N.+Keumauthor=C.+E.+Oldenburg&title=Maternal+Caffeine+Consumption+during+Pregnancy+and+Risk+of+Low+Birth+Weight%3A+A+Dose-Response+Meta-Analysis+of+Observational+Studies&doi=10.1371%2Fjournal.pone.0132334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal caffeine consumption during pregnancy and risk of low birth weight: a dose-response meta-analysis of observational studies</span></div><div class="casAuthors">Rhee, Jongeun; Kim, Rockli; Kim, Yongjoo; Tam, Melanie; Lai, Yizhen; Keum, Na Na; Oldenburg, Catherine Elizabeth</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0132334/1-e0132334/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Epidemiol. studies have shown inconsistent conclusions about the effect of caffeine intake during pregnancy on the risk of low birth wt. (LBW).  We performed a meta-anal. and linear-dose response anal. examg. the assocn. between caffeine consumption during pregnancy and risk of LBW.  PubMed and EMBASE were searched for relevant articles published up to March 2014.  Eight cohort and four case-control studies met all inclusion criteria.  Using a random-effects model of the twelve studies, the pooled odds ratio (OR) for the risk of LBW comparing the highest vs. lowest level of caffeine intake during pregnancy was 1.38 (95% CI: 1.10, 1.73).  Linear dose-response anal. showed that every addnl. 100 mg of caffeine intake (1 cup of coffee or 2 cups of tea) per day during pregnancy was assocd. with a 3.0% increase in OR for LBW.  There was a moderate level of overall heterogeneity with an I-squared value of 55% (95% CI: 13, 76%), and no evidence of publication bias based on Egger's test (P = 0.20) and the funnel plot.  Thus, high caffeine intake during pregnancy is assocd. with a significant increase in the risk of LBW, and this risk appears to increase linearly as caffeine intake increases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSETANNwXBhbVg90H21EOLACvtfcHk0liDOME_ctPFbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOlurnL&md5=05682508948aaeae5c4a6a28bce8478c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132334%26sid%3Dliteratum%253Aachs%26aulast%3DRhee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DKeum%26aufirst%3DN.%2BN.%26aulast%3DOldenburg%26aufirst%3DC.%2BE.%26atitle%3DMaternal%2520Caffeine%2520Consumption%2520during%2520Pregnancy%2520and%2520Risk%2520of%2520Low%2520Birth%2520Weight%253A%2520A%2520Dose-Response%2520Meta-Analysis%2520of%2520Observational%2520Studies%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0132334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehegan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C. M.</span></span> <span> </span><span class="NLM_article-title">Associations of Maternal Caffeine Intake with Birth Outcomes: Results from the Lifeways Cross Generation Cohort Study</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1301</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1093/ajcn/nqy219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fajcn%2Fnqy219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30339199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB3cvhtFehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2018&pages=1301-1308&issue=6&author=L.+W.+Chenauthor=R.+Fitzgeraldauthor=C.+M.+Murrinauthor=J.+Meheganauthor=C.+C.+Kelleherauthor=C.+M.+Phillips&title=Associations+of+Maternal+Caffeine+Intake+with+Birth+Outcomes%3A+Results+from+the+Lifeways+Cross+Generation+Cohort+Study&doi=10.1093%2Fajcn%2Fnqy219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study</span></div><div class="casAuthors">Chen Ling-Wei; Murrin Celine M; Mehegan John; Kelleher Cecily C; Phillips Catherine M; Fitzgerald Roisin</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1301-1308</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background:  Maternal caffeine intake is associated with adverse birth outcomes, but in most studies the primary caffeine source is coffee; the influence of tea caffeine remains unclear.  Objective:  The aim of the study was to examine the association between maternal caffeine intake and birth outcomes in a population with tea as the predominant caffeine source.  Design:  Data from 941 Irish mother-child pairs of the Lifeways Cross Generation Cohort Study were examined.  Maternal dietary intakes in early pregnancy were assessed using a validated food-frequency questionnaire.  Caffeine intake was derived from coffee, tea, soft drinks, and cocoa-containing foods and beverages.  Associations of maternal caffeine intake with continuous (birth weight, birth length, and gestational age) and binary [low birth weight (LBW) (<2500 g) and preterm birth (PB) (<37 wk gestational age)] birth outcomes were investigated using multiple linear and logistic regressions, respectively, with adjustment for potential confounders.  Results:  Tea was the predominant caffeine source (48%), followed by coffee (39%).  In the fully adjusted model, maternal caffeine intake was associated with lower birth weight [β (95% CI): -71.9 (-105.4, -38.4) g · 100 mg-1 · d-1 caffeine increment], shorter birth length [-0.30 (-0.49, -0.11) cm], smaller head circumference [-0.12 (-0.24, -0.01) cm], and shorter gestational age [-0.13 (-0.25, -0.02) wk]; higher risks for LBW [OR (95% CI): 1.47 (1.14, 1.90)] and PB [1.36 (1.07, 1.74)] were also observed (all P < 0.05).  The associations were robust to the exclusion of participants with pregnancy complications and in never smokers.  Similar higher risks of adverse birth outcomes were observed for the highest caffeine intake categories from coffee [ORLBW: 3.10 (1.08, 8.89); ORPB: 2.74 (1.05, 7.16)] and tea [ORLBW: 2.47 (1.02, 6.01); ORPB: 2.56 (1.14, 5.75)], compared with the lowest intake categories (all P < 0.05).  Conclusions:  Maternal caffeine intake from both coffee and tea is associated with adverse birth outcomes.  This prospective observational study was registered at ISRCTN Registry as ISRCTN16537904.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCK5v2qz4tkhBrI9DTGjC0fW6udTcc2eayCw8StLwpmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvhtFehug%253D%253D&md5=715b3984927f8148419b98d39ade4450</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2Fnqy219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252Fnqy219%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DFitzgerald%26aufirst%3DR.%26aulast%3DMurrin%26aufirst%3DC.%2BM.%26aulast%3DMehegan%26aufirst%3DJ.%26aulast%3DKelleher%26aufirst%3DC.%2BC.%26aulast%3DPhillips%26aufirst%3DC.%2BM.%26atitle%3DAssociations%2520of%2520Maternal%2520Caffeine%2520Intake%2520with%2520Birth%2520Outcomes%253A%2520Results%2520from%2520the%2520Lifeways%2520Cross%2520Generation%2520Cohort%2520Study%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2018%26volume%3D108%26issue%3D6%26spage%3D1301%26epage%3D1308%26doi%3D10.1093%2Fajcn%2Fnqy219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mioranzza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioreze, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botton, P. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porciúncula, L. O.</span></span> <span> </span><span class="NLM_article-title">Prenatal Caffeine Intake Differently Affects Synaptic Proteins during Fetal Brain Development</span>. <i>Int. J. Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.ijdevneu.2014.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ijdevneu.2014.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24862851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqt7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=45-52&author=S.+Mioranzzaauthor=F.+Nunesauthor=D.+M.+Marquesauthor=G.+T.+Fiorezeauthor=A.+S.+Rochaauthor=P.+H.+S.+Bottonauthor=M.+S.+Costaauthor=L.+O.+Porci%C3%BAncula&title=Prenatal+Caffeine+Intake+Differently+Affects+Synaptic+Proteins+during+Fetal+Brain+Development&doi=10.1016%2Fj.ijdevneu.2014.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Prenatal caffeine intake differently affects synaptic proteins during fetal brain development</span></div><div class="casAuthors">Mioranzza, Sabrina; Nunes, Fernanda; Marques, Daniela M.; Fioreze, Gabriela T.; Rocha, Andreia S.; Botton, Paulo Henrique S.; Costa, Marcelo S.; Porciuncula, Lisiane O.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Developmental Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">IJDND6</span>;
        ISSN:<span class="NLM_cas:issn">0736-5748</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Caffeine is the psychostimulant most consumed worldwide.  However, little is known about its effects during fetal brain development.  In this study, adult female Wistar rats received caffeine in drinking water (0.1, 0.3 and 1.0 g/L) during the active cycle in weekdays, two weeks before mating and throughout pregnancy.  Cerebral cortex and hippocampus from embryonic stages 18 or 20 (E18 or E20, resp.) were collected for immunodetection of the following synaptic proteins: brain-derived neurotrophic factor (BDNF), TrkB receptor, Sonic Hedgehog (Shh), Growth Assocd. Protein 43 (GAP-43) and Synaptosomal-assocd. Protein 25 (SNAP-25).  Besides, the estn. of NeuN-stained nuclei (mature neurons) and non-neuronal nuclei was verified in both brain regions and embryonic periods.  Caffeine (1.0 g/L) decreased the body wt. of embryos at E20.  Cortical BDNF at E18 was decreased by caffeine (1.0 g/L), while it increased at E20, with no major effects on TrkB receptors.  In the hippocampus, caffeine decreased TrkB receptor only at E18, with no effects on BDNF.  Moderate and high doses of caffeine promoted an increase in Shh in both brain regions at E18, and in the hippocampus at E20.  Caffeine (0.3 g/L) decreased GAP-43 only in the hippocampus at E18.  The NeuN-stained nuclei increased in the cortex at E20 by lower dose and in the hippocampus at E18 by moderate dose.  Our data revealed that caffeine transitorily affect synaptic proteins during fetal brain development.  The increased no. of NeuN-stained nuclei by prenatal caffeine suggests a possible acceleration of the telencephalon maturation.  Although some modifications in the synaptic proteins were transient, our data suggest that caffeine even in lower doses may alter the fetal brain development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos5KPs_5Z3DLVg90H21EOLACvtfcHk0lhxHxNJHqrwlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqt7jP&md5=668315a50ebc90e6fa92783cd20da286</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2014.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2014.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMioranzza%26aufirst%3DS.%26aulast%3DNunes%26aufirst%3DF.%26aulast%3DMarques%26aufirst%3DD.%2BM.%26aulast%3DFioreze%26aufirst%3DG.%2BT.%26aulast%3DRocha%26aufirst%3DA.%2BS.%26aulast%3DBotton%26aufirst%3DP.%2BH.%2BS.%26aulast%3DCosta%26aufirst%3DM.%2BS.%26aulast%3DPorci%25C3%25BAncula%26aufirst%3DL.%2BO.%26atitle%3DPrenatal%2520Caffeine%2520Intake%2520Differently%2520Affects%2520Synaptic%2520Proteins%2520during%2520Fetal%2520Brain%2520Development%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2014%26volume%3D36%26spage%3D45%26epage%3D52%26doi%3D10.1016%2Fj.ijdevneu.2014.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mejia, E. G.</span></span> <span> </span><span class="NLM_article-title">Caffeine (1, 3, 7-Trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters</span>. <i>J. Food Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">R77</span>– <span class="NLM_lpage">R87</span>, <span class="refDoi"> DOI: 10.1111/j.1750-3841.2010.01561.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1750-3841.2010.01561.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20492310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFOrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=R77-R87&issue=3&author=M.+A.+Heckmanauthor=J.+Weilauthor=E.+G.+de+Mejia&title=Caffeine+%281%2C+3%2C+7-Trimethylxanthine%29+in+Foods%3A+A+Comprehensive+Review+on+Consumption%2C+Functionality%2C+Safety%2C+and+Regulatory+Matters&doi=10.1111%2Fj.1750-3841.2010.01561.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters</span></div><div class="casAuthors">Heckman, Melanie A.; Weil, Jorge; Gonzalez de Mejia, Elvira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Food Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">R77-R87</span>CODEN:
                <span class="NLM_cas:coden">JFDSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1147</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Caffeine ranks as one of the top most commonly consumed dietary ingredients throughout the world.  It is naturally found in coffee beans, cacao beans, kola nuts, guarana berries, and tea leaves including yerba mate.  The total daily intake, as well as the major source of caffeine varies globally; however, coffee and tea are the 2 most prominent sources.  Soft drinks are also a common source of caffeine as well as energy drinks, a category of functional beverages.  Moderate caffeine consumption is considered safe and its use as a food ingredient has been approved, within certain limits, by numerous regulatory agencies around the world.  Performance benefits attributed to caffeine include phys. endurance, redn. of fatigue, and enhancing mental alertness and concn.  Caffeine has also been recently linked to wt. loss and consequent redn. of the overall risks for developing the metabolic syndrome.  However, the caloric contribution of caffeine-sweetened beverages needs to be considered in the overall energy balance.  Despite all these benefits the potential neg. effects of excessive caffeine intake should also be considered, particularly in children and pregnant women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_By0pNCLVbVg90H21EOLACvtfcHk0lhxHxNJHqrwlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFOrsrg%253D&md5=362fdeccf4490cb8e0c20525fdc3e8ac</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3841.2010.01561.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3841.2010.01561.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DM.%2BA.%26aulast%3DWeil%26aufirst%3DJ.%26aulast%3Dde%2BMejia%26aufirst%3DE.%2BG.%26atitle%3DCaffeine%2520%25281%252C%25203%252C%25207-Trimethylxanthine%2529%2520in%2520Foods%253A%2520A%2520Comprehensive%2520Review%2520on%2520Consumption%252C%2520Functionality%252C%2520Safety%252C%2520and%2520Regulatory%2520Matters%26jtitle%3DJ.%2520Food%2520Sci.%26date%3D2010%26volume%3D75%26issue%3D3%26spage%3DR77%26epage%3DR87%26doi%3D10.1111%2Fj.1750-3841.2010.01561.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djoumbou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neveu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dame, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, D. S.</span></span> <span> </span><span class="NLM_article-title">DrugBank 4.0: Shedding New Light on Drug Metabolism</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D1091</span>– <span class="NLM_lpage">D1097</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fnar%2Fgkt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24203711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Kh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=D1091-D1097&issue=D1&author=V.+Lawauthor=C.+Knoxauthor=Y.+Djoumbouauthor=T.+Jewisonauthor=A.+C.+Guoauthor=Y.+Liuauthor=A.+Maciejewskiauthor=D.+Arndtauthor=M.+Wilsonauthor=V.+Neveuauthor=A.+Tangauthor=G.+Gabrielauthor=C.+Lyauthor=S.+Adamjeeauthor=Z.+T.+Dameauthor=B.+Hanauthor=Y.+Zhouauthor=D.+S.+Wishart&title=DrugBank+4.0%3A+Shedding+New+Light+on+Drug+Metabolism&doi=10.1093%2Fnar%2Fgkt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank 4.0: shedding new light on drug metabolism</span></div><div class="casAuthors">Law, Vivian; Knox, Craig; Djoumbou, Yannick; Jewison, Tim; Guo, An Chi; Liu, Yifeng; Maciejewski, Adam; Arndt, David; Wilson, Michael; Neveu, Vanessa; Tang, Alexandra; Gabriel, Geraldine; Ly, Carol; Adamjee, Sakina; Dame, Zerihun T.; Han, Beomsoo; Zhou, You; Wishart, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1091-D1097</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank (http://www.drugbank.ca) is a comprehensive online database contg. extensive biochem. and pharmacol. information about drugs, their mechanisms and their targets.  Since it was first described in 2006, DrugBank has rapidly evolved, both in response to user requests and in response to changing trends in drug research and development.  Previous versions of DrugBank have been widely used to facilitate drug and in silico drug target discovery.  The latest update, DrugBank 4.0, has been further expanded to contain data on drug metab., absorption, distribution, metab., excretion and toxicity (ADMET) and other kinds of quant. structure activity relationships (QSAR) information.  These enhancements are intended to facilitate research in xenobiotic metab. (both prediction and characterization), pharmacokinetics, pharmacodynamics and drug design/discovery.  For this release, >1200 drug metabolites (including their structures, names, activity, abundance and other detailed data) have been added along with >1300 drug metab. reactions (including metabolizing enzymes and reaction types) and dozens of drug metab. pathways.  Another 30 predicted or measured ADMET parameters have been added to each DrugCard, bringing the av. no. of quant. ADMET values for Food and Drug Administration-approved drugs close to 40.  Referential NMR and MS spectra have been added for almost 400 drugs as well as spectral and mass matching tools to facilitate compd. identification.  This expanded collection of drug information is complemented by a no. of new or improved search tools, including one that provides a simple analyses of drug-target, -enzyme and -transporter assocns. to provide insight on drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_BsUO1phm7Vg90H21EOLACvtfcHk0lja7jhZ0MVj-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Kh&md5=0da9f3ecfc2061f814803cf4b070e54e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1068%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DV.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DDjoumbou%26aufirst%3DY.%26aulast%3DJewison%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaciejewski%26aufirst%3DA.%26aulast%3DArndt%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DNeveu%26aufirst%3DV.%26aulast%3DTang%26aufirst%3DA.%26aulast%3DGabriel%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%26aulast%3DAdamjee%26aufirst%3DS.%26aulast%3DDame%26aufirst%3DZ.%2BT.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWishart%26aufirst%3DD.%2BS.%26atitle%3DDrugBank%25204.0%253A%2520Shedding%2520New%2520Light%2520on%2520Drug%2520Metabolism%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26issue%3DD1%26spage%3DD1091%26epage%3DD1097%26doi%3D10.1093%2Fnar%2Fgkt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feunang, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayeeda, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assempour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iynkkaran, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIejewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Di</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span> <span> </span><span class="NLM_article-title">DrugBank 5.0: A Major Update to the DrugBank Database for 2018</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D1074</span>– <span class="NLM_lpage">D1082</span>, <span class="refDoi"> DOI: 10.1093/nar/gkx1037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fnar%2Fgkx1037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29126136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGisbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=D1074-D1082&issue=D1&author=D.+S.+Wishartauthor=Y.+D.+Feunangauthor=A.+C.+Guoauthor=E.+J.+Loauthor=A.+Marcuauthor=J.+R.+Grantauthor=T.+Sajedauthor=D.+Johnsonauthor=C.+Liauthor=Z.+Sayeedaauthor=N.+Assempourauthor=I.+Iynkkaranauthor=Y.+Liuauthor=A.+MacIejewskiauthor=N.+Galeauthor=A.+Wilsonauthor=L.+Chinauthor=R.+Cummingsauthor=Di+Leauthor=A.+Ponauthor=C.+Knoxauthor=M.+Wilson&title=DrugBank+5.0%3A+A+Major+Update+to+the+DrugBank+Database+for+2018&doi=10.1093%2Fnar%2Fgkx1037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank 5.0: a major update to the DrugBank database for 2018</span></div><div class="casAuthors">Wishart, David S.; Feunang, Yannick D.; Guo, An C.; Lo, Elvis J.; Marcu, Ana; Grant, Jason R.; Sajed, Tanvir; Johnson, Daniel; Li, Carin; Sayeeda, Zinat; Assempour, Nazanin; Iynkkaran, Ithayavani; Liu, Yifeng; Maciejewski, Adam; Gale, Nicola; Wilson, Alex; Chin, Lucy; Cummings, Ryan; Le, Diana; Pon, Allison; Knox, Craig; Wilson, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1074-D1082</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a web-enabled database contg. comprehensivemol. information about drugs, their mechanisms, their interactions and their targets.  First described in 2006, Drug- Bank has continued to evolve over the past 12 years in response to marked improvements to web stds. and changing needs for drug research and development.  This year's update, DrugBank 5.0, represents the most significant upgrade to the database in more than 10 years.  In many cases, existing data content has grown by 100% or more over the last update.  For instance, the total no. of investigational drugs in the database has grown by almost 300%, the no. of drug-drug interactions has grown by nearly 600% and the no. of SNP-assocd. drug effects has grown more than 3000%.  Significant improvements have been made to the quantity, quality and consistency of drug indications, drug binding data as well as drug-drug and drug-food interactions.  A great deal of brand new data have also been added to DrugBank 5.0.  This includes information on the influence of hundreds of drugs on metabolite levels (pharmacometabolomics), gene expression levels (pharmacotranscriptomics) and protein expression levels (pharmacoproteomics).  New data have also been added on the status of hundreds of newdrug clin. trials and existing drug repurposing trials.  Many other important improvements in the content, interface and performance of the DrugBank website have been made and these should greatly enhance its ease of use, utility and potential applications in many areas of pharmacol. research, pharmaceutical science and drug education.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc8rfBoMOOyLVg90H21EOLACvtfcHk0lja7jhZ0MVj-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGisbvI&md5=986b28c7ea546596a26dd3ba38f05fee</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkx1037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkx1037%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DFeunang%26aufirst%3DY.%2BD.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DLo%26aufirst%3DE.%2BJ.%26aulast%3DMarcu%26aufirst%3DA.%26aulast%3DGrant%26aufirst%3DJ.%2BR.%26aulast%3DSajed%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSayeeda%26aufirst%3DZ.%26aulast%3DAssempour%26aufirst%3DN.%26aulast%3DIynkkaran%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMacIejewski%26aufirst%3DA.%26aulast%3DGale%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DDi%26aulast%3DPon%26aufirst%3DA.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DM.%26atitle%3DDrugBank%25205.0%253A%2520A%2520Major%2520Update%2520to%2520the%2520DrugBank%2520Database%2520for%25202018%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26issue%3DD1%26spage%3DD1074%26epage%3DD1082%26doi%3D10.1093%2Fnar%2Fgkx1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. R.</span></span> <span> </span><span class="NLM_article-title">A Critical Review of Caffeine Withdrawal: Empirical Validation of Symptoms and Signs, Incidence, Severity, and Associated Features</span>. <i>Psychopharmacology (Berl).</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-2000-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00213-004-2000-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15448977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1aitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2004&pages=1-29&issue=1&author=L.+M.+Julianoauthor=R.+R.+Griffiths&title=A+Critical+Review+of+Caffeine+Withdrawal%3A+Empirical+Validation+of+Symptoms+and+Signs%2C+Incidence%2C+Severity%2C+and+Associated+Features&doi=10.1007%2Fs00213-004-2000-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features</span></div><div class="casAuthors">Juliano, Laura M.; Griffiths, Roland R.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Although reports of caffeine withdrawal in the medical literature date back more than 170 yr, the most rigorous exptl. investigations of the phenomenon were conducted only recently.  The purpose of this paper is to provide a comprehensive review and anal. of the literature regarding human caffeine withdrawal to empirically validate specific symptoms and signs, and to appraise important features of the syndrome.  A literature search identified 57 exptl. and 9 survey studies on caffeine withdrawal that met inclusion criteria.  The methodol. features of each study were examd. to assess the validity of the effects.  Of 49 symptom categories identified, the following 10 fulfilled validity criteria: headache, fatigue, decreased energy/activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concg., irritability, and foggy/not clearheaded.  In addn., flu-like symptoms, nausea/vomiting, and muscle pain/stiffness were judged likely to represent valid symptom categories.  In exptl. studies, the incidence of headache was 50 and the incidence of clin. significant distress or functional impairment was 13.  Typically, onset of symptoms occurred 12-24 h after abstinence, with peak intensity at 20-51 h, and for a duration of 2-9 days.  In general, the incidence or severity of symptoms increased with increases in daily dose; abstinence from doses as low as 100 mg/day produced symptoms.  Research is reviewed indicating that expectancies are not a prime determinant of caffeine withdrawal and that avoidance of withdrawal symptoms plays a central role in habitual caffeine consumption.  The caffeine-withdrawal syndrome was well characterized and there is sufficient empirical evidence to warrant inclusion of caffeine withdrawal as a disorder in the DSM and revision of diagnostic criteria in the ICD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotTkwQg8zkLbVg90H21EOLACvtfcHk0lja7jhZ0MVj-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot1aitL0%253D&md5=fdaa8e51d3ab3ce523377ef316aa21fe</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-2000-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-2000-x%26sid%3Dliteratum%253Aachs%26aulast%3DJuliano%26aufirst%3DL.%2BM.%26aulast%3DGriffiths%26aufirst%3DR.%2BR.%26atitle%3DA%2520Critical%2520Review%2520of%2520Caffeine%2520Withdrawal%253A%2520Empirical%2520Validation%2520of%2520Symptoms%2520and%2520Signs%252C%2520Incidence%252C%2520Severity%252C%2520and%2520Associated%2520Features%26jtitle%3DPsychopharmacology%2520%2528Berl%2529.%26date%3D2004%26volume%3D176%26issue%3D1%26spage%3D1%26epage%3D29%26doi%3D10.1007%2Fs00213-004-2000-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cappelletti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daria, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aromatario, M.</span></span> <span> </span><span class="NLM_article-title">Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.2174/1570159X13666141210215655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2174%2F1570159X13666141210215655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26074744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=71-88&issue=1&author=S.+Cappellettiauthor=P.+Dariaauthor=G.+Saniauthor=M.+Aromatario&title=Caffeine%3A+Cognitive+and+Physical+Performance+Enhancer+or+Psychoactive+Drug%3F&doi=10.2174%2F1570159X13666141210215655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?</span></div><div class="casAuthors">Cappelletti, Simone; Daria, Piacentino; Sani, Gabriele; Aromatario, Mariarosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-88</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Caffeine use is increasing worldwide.  The underlying motivations are mainly concn. and memory enhancement and phys. performance improvement.  Coffee and caffeine-contg. products affect the cardiovascular system, with their pos. inotropic and chronotropic effects, and the central nervous system, with their locomotor activity stimulation and anxiogenic-like effects.  Thus, it is of interest to examine whether these effects could be detrimental for health.  Furthermore, caffeine abuse and dependence are becoming more and more common and can lead to caffeine intoxication, which puts individuals at risk for premature and unnatural death.  The present review summarizes the main findings concerning caffeine's mechanisms of action (focusing on adenosine antagonism, intracellular calcium mobilization, and phosphodiesterases inhibition), use, abuse, dependence, intoxication, and lethal effects.  It also suggests that the concepts of toxic and LDs are relative, since doses below the toxic and/or lethal range may play a causal role in intoxication or death.  This could be due to caffeine's interaction with other substances or to the individuals' preexisting metab. alterations or diseases.be due to caffeine's interaction with other substances or to individuals' pre-existing diseases or metab. alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo2IZfYdKij7Vg90H21EOLACvtfcHk0lhimC4eJLil0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqtL4%253D&md5=e3f6b6342332a669d5beed115a8f5fff</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.2174%2F1570159X13666141210215655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X13666141210215655%26sid%3Dliteratum%253Aachs%26aulast%3DCappelletti%26aufirst%3DS.%26aulast%3DDaria%26aufirst%3DP.%26aulast%3DSani%26aufirst%3DG.%26aulast%3DAromatario%26aufirst%3DM.%26atitle%3DCaffeine%253A%2520Cognitive%2520and%2520Physical%2520Performance%2520Enhancer%2520or%2520Psychoactive%2520Drug%253F%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2015%26volume%3D13%26issue%3D1%26spage%3D71%26epage%3D88%26doi%3D10.2174%2F1570159X13666141210215655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goasduff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dréano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ménez, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthou, F.</span></span> <span> </span><span class="NLM_article-title">Induction of Liver and Kidney CYP1A1/1A2 by Caffeine in Rat</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1919</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(96)00522-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0006-2952%2896%2900522-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8951351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK28XnsFGms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=1915-1919&issue=12&author=T.+Goasduffauthor=Y.+Dr%C3%A9anoauthor=B.+Guilloisauthor=J.+F.+M%C3%A9nezauthor=F.+Berthou&title=Induction+of+Liver+and+Kidney+CYP1A1%2F1A2+by+Caffeine+in+Rat&doi=10.1016%2FS0006-2952%2896%2900522-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of liver and kidney CYP1A1/1A2 by caffeine in rat</span></div><div class="casAuthors">Goasduff, Thierry; Dreano, Yvonne; Guillois, Bernard; Menez, Jean-Francois; Berthou, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1915-1919</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Caffeine metab. by hepatic microsomal P 450 enzymes is well documented in exptl. animals and humans.  However, it induction effect on P 450 enzymes has not been thoroughly studied.  In a preliminary expt., the time-dependent incubation of 1 mM caffeine with rat hepatocyte culture resulted in an increase of its own metabolic rate.  The dose-dependent expression of rat hepatic and renal cytochromes (CYP) 1A1/1A2 was then investigated after per os administration of caffeine.  P 450 expression was monitored by using specific enzymic activities and Northern Blot anal.  Caffeine caused a dose-dependent elevation of hepatic CYP1A1/1A2 activities in microsomal prepns., which ranged from 1.7- to 6-fold for ethoxyresorufin O-deethylase and 3- to 8.9-fold for methoxyresorufin O-demethylase according to the dose regimen of 50 and 150 mg caffeine/kg/day for 3 days, resp.  Northern blot anal. demonstrated that caffeine treatment increased liver CYP1A1 and CYP1A2 mRNA levels over the dose regimen of 50-150 mg caffeine/kg/day for 3 days, resp.  The result of this study demonstrates that caffeine increases its own metab. in a dose-dependent manner and induces CYP1A1/1A2 expression through either transcriptional activation or mRNA stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriw9Wmg6PRLbVg90H21EOLACvtfcHk0lhimC4eJLil0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFGms74%253D&md5=16502972548696659c4dff65978d16f2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2896%2900522-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252896%252900522-9%26sid%3Dliteratum%253Aachs%26aulast%3DGoasduff%26aufirst%3DT.%26aulast%3DDr%25C3%25A9ano%26aufirst%3DY.%26aulast%3DGuillois%26aufirst%3DB.%26aulast%3DM%25C3%25A9nez%26aufirst%3DJ.%2BF.%26aulast%3DBerthou%26aufirst%3DF.%26atitle%3DInduction%2520of%2520Liver%2520and%2520Kidney%2520CYP1A1%252F1A2%2520by%2520Caffeine%2520in%2520Rat%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D52%26issue%3D12%26spage%3D1915%26epage%3D1919%26doi%3D10.1016%2FS0006-2952%2896%2900522-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badawy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.2174/1389200221999210101233135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2174%2F1389200221999210101233135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33397254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3MXnvFKqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2021&pages=40-49&issue=1&author=J.+Guoauthor=X.+Zhuauthor=S.+Badawyauthor=A.+Ihsanauthor=Z.+Liuauthor=C.+Xieauthor=X.+Wang&title=Metabolism+and+Mechanism+of+Human+Cytochrome+P450+Enzyme+1A2&doi=10.2174%2F1389200221999210101233135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2</span></div><div class="casAuthors">Guo, Jingchao; Zhu, Xiaohui; Badawy, Sara; Ihsan, Awais; Liu, Zhenli; Xie, Changqing; Wang, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-49</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human cytochrome P 450 enzyme 1A2 (CYP1A2) is one of the most important cytochrome P 450 (CYP) enzymes in the liver, accounting for 13% to 15% of hepatic CYP enzymes.  CYP1A2 metabolises many clin. drugs, such as phenacetin, caffeine, clozapine, tacrine, propranolol, and mexiletine.  CYP1A2 also metabolises certain precarcinogens such as aflatoxins, mycotoxins, nitrosamines, and endogenous substances such as steroids.  The regulation of CYP1A2 is influenced by many factors.  The transcription of CYP1A2 involves not only the arom. hydrocarbon receptor pathway but also many addnl. transcription factors, and CYP1A2 expression may be affected by transcription coactivators and compression factors.  Degrdn. of CYP1A2 mRNA and protein, alternative splicing, RNA stability, regulatory microRNAs, and DNA methylation are also known to affect the regulation of CYP1A2.  Many factors can lead to changes in the activity of CYP1A2.  Smoking, polycyclic arom. hydrocarbon ingestion, and certain drugs (e.g., omeprazole) increase its activity, while many clin. drugs such as theophylline, fluvoxamine, quinolone antibiotics, verapamil, cimetidine, and oral contraceptives can inhibit CYP1A2 activity.  Here, we review the drugs metabolised by CYP1A2, the metabolic mechanism of CYP1A2, and various factors that influence CYP1A2 metab.  The metabolic mechanism of CYP1A2 is of great significance in the development of personalised medicine and CYP1A2 target-based drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUP-Kq8Tl7TrVg90H21EOLACvtfcHk0lhimC4eJLil0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXnvFKqu74%253D&md5=6f52d0e40e54b352afb3fe7a39561565</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F1389200221999210101233135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200221999210101233135%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBadawy%26aufirst%3DS.%26aulast%3DIhsan%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMetabolism%2520and%2520Mechanism%2520of%2520Human%2520Cytochrome%2520P450%2520Enzyme%25201A2%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2021%26volume%3D22%26issue%3D1%26spage%3D40%26epage%3D49%26doi%3D10.2174%2F1389200221999210101233135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitez, J.</span></span> <span> </span><span class="NLM_article-title">Clinically Significant Pharmacokinetic Interactions between Dietary Caffeine and Medications</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.2165/00003088-200039020-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2165%2F00003088-200039020-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10976659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVemtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=127-153&issue=2&author=J.+A.+Carrilloauthor=J.+Benitez&title=Clinically+Significant+Pharmacokinetic+Interactions+between+Dietary+Caffeine+and+Medications&doi=10.2165%2F00003088-200039020-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Clinically significant pharmacokinetic interactions between dietary caffeine and medications</span></div><div class="casAuthors">Carrillo, Juan A.; Benitez, Julio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-153</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 268 refs. Caffeine from dietary sources (mainly coffee, tea and soft drinks) is the most frequently and widely consumed central nervous system (CNS) stimulant in the world today.  Because of its enormous popularity, the consumption of caffeine is generally thought to be safe and long-term caffeine intake may be disregarded as a medical problem.  However, it is clear that this compd. has many of the features usually assocd. with a drug of abuse.  Furthermore, physicians should be aware of the possible contribution of dietary caffeine to the signs and symptoms of patients.  The toxic effects of caffeine are extensions of their pharmacol. effects.  The most serious caffeine-related CNS effects include seizures and delirium.  Other symptoms affecting the cardiovascular system range from moderate increases in heart rate to more severe cardiac arrhythmia.  Although tolerance develops to many of the pharmacol. effects of caffeine, tolerance may be overwhelmed by the nonlinear accumulation of caffeine when its metab. becomes satd.  This might occur with high levels of consumption or as the result of pharmacokinetic interaction between caffeine and over-the-counter or prescription drugs.  The polycyclic arom. hydrocarbon-inducible cytochrome P 450 (CYP) 1A2 participates in the metab. of caffeine as well as of a no. of clin. important drugs.  A no. of drugs, including certain selective serotonin reuptake inhibitors (particularly fluvoxamine), antiarrhythmics (mexiletine), antipsychotics (clozapine), psoralens, idrocilamide and phenylpropanolamine, bronchodilators (furafylline and theophylline) and quinolones (enoxacin), have been reported to be potent inhibitors of this isoenzyme.  This has important clin. implications, since drugs that are metabolized by, or bind to, the same CYP isoenzyme have a high potential for pharmacokinetic interactions due to inhibition of drug metab.  Thus, pharmacokinetic interactions at the CYP1A2 enzyme level may cause toxic effects during concomitant administration of caffeine and certain drugs used for cardiovascular, CNS (an excessive dietary intake of caffeine has also been obsd. in psychiatric patients), gastrointestinal, infectious, respiratory and skin disorders.  Unless a lack of interaction has already been demonstrated for the potentially interacting drug, dietary caffeine intake should be considered when planning, or assessing response to, drug therapy.  Some of the reported interactions of caffeine, irresp. of clin. relevance, might inadvertently cause athletes to exceed the urinary caffeine concn. limit set by sports authorities at 12 mg/L.  Finally, caffeine is a useful and reliable probe drug for the assessment of CYP1A2 activity, which is of considerable interest for metabolic studies in human populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9dl0kTNxhlrVg90H21EOLACvtfcHk0lhimC4eJLil0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVemtrg%253D&md5=7aef9272a802b5fc43381a466d6ffd25</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2165%2F00003088-200039020-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200039020-00004%26sid%3Dliteratum%253Aachs%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26aulast%3DBenitez%26aufirst%3DJ.%26atitle%3DClinically%2520Significant%2520Pharmacokinetic%2520Interactions%2520between%2520Dietary%2520Caffeine%2520and%2520Medications%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2000%26volume%3D39%26issue%3D2%26spage%3D127%26epage%3D153%26doi%3D10.2165%2F00003088-200039020-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yartsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peisah, C.</span></span> <span> </span><span class="NLM_article-title">Caffeine-Clozapine Interaction Associated with Severe Toxicity and Multiorgan System Failure: A Case Report</span>. <i>BMC Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">192</span>, <span class="refDoi"> DOI: 10.1186/s12888-021-03199-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs12888-021-03199-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33849480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3MXhtFeiu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2021&pages=192&issue=1&author=A.+Yartsevauthor=C.+Peisah&title=Caffeine-Clozapine+Interaction+Associated+with+Severe+Toxicity+and+Multiorgan+System+Failure%3A+A+Case+Report&doi=10.1186%2Fs12888-021-03199-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report</span></div><div class="casAuthors">Yartsev, Alex; Peisah, Carmelle</div><div class="citationInfo"><span class="NLM_cas:title">BMC Psychiatry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192</span>CODEN:
                <span class="NLM_cas:coden">BPMSCU</span>;
        ISSN:<span class="NLM_cas:issn">1471-244X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Background: Caffeine is a known inhibitor of Clozapine metab. mediated by inhibition of CYP1A2.  Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clin. manifestations of toxicity resulting from their interaction.  We present a case of severe toxicity assocd. with the co-consumption of caffeine and Clozapine culminating in life-threatening complications requiring management in Intensive Care.  Case presentation: A 34 yr old male with a history of chronic schizophrenia, who had been managed stably on 400 mg Clozapine for the previous 5 years, changed his dietary behavior and began consuming caffeine-contg. energy drinks over the course of 3 wk.  The total daily dose of caffeine was estd. as 600 mg/day (four cans of Red Bull).  He subsequently presented to the Emergency Department with life-threatening Clozapine toxicity, resulting in a decreased level of consciousness, severe metabolic acidosis, acute respiratory failure, raised inflammatory markers and acute renal failure attributed to interstitial nephritis.  Maximum recorded Clozapine level was 1796 ng/mL.  Conclusions: This case describes the interaction between a common caffeine-contg. beverage and a commonly prescribed antipsychotic medication, assocd. with severe adverse effects.  We call for clin. and scientific attention to the possible interaction between these substances and draw attention to the implications for prescribing practices and patient counselling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Kkofylq2ZLVg90H21EOLACvtfcHk0lgwvEGGvVQ4Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhtFeiu7nN&md5=7e2a133ec89a37442ffae566f7b7be34</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2Fs12888-021-03199-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12888-021-03199-x%26sid%3Dliteratum%253Aachs%26aulast%3DYartsev%26aufirst%3DA.%26aulast%3DPeisah%26aufirst%3DC.%26atitle%3DCaffeine-Clozapine%2520Interaction%2520Associated%2520with%2520Severe%2520Toxicity%2520and%2520Multiorgan%2520System%2520Failure%253A%2520A%2520Case%2520Report%26jtitle%3DBMC%2520Psychiatry%26date%3D2021%26volume%3D21%26issue%3D1%26spage%3D192%26doi%3D10.1186%2Fs12888-021-03199-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vainer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, G.</span></span> <span> </span><span class="NLM_article-title">Interaction between Caffeine and Clozapine</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1097/00004714-199408000-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1097%2F00004714-199408000-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7962690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK2M%252FltFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=284-285&issue=4&author=J.+L.+Vainerauthor=G.+Chouinard&title=Interaction+between+Caffeine+and+Clozapine&doi=10.1097%2F00004714-199408000-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between caffeine and clozapine</span></div><div class="casAuthors">Vainer J L; Chouinard G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">284-5</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlp3PdZ1FYL4YPsCkJIw00fW6udTcc2eb5ux5evwlMzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FltFOjtA%253D%253D&md5=5b89faaebcfde2542e88ab8b62f18731</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1097%2F00004714-199408000-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199408000-00014%26sid%3Dliteratum%253Aachs%26aulast%3DVainer%26aufirst%3DJ.%2BL.%26aulast%3DChouinard%26aufirst%3DG.%26atitle%3DInteraction%2520between%2520Caffeine%2520and%2520Clozapine%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1994%26volume%3D14%26issue%3D4%26spage%3D284%26epage%3D285%26doi%3D10.1097%2F00004714-199408000-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benítez, J.</span></span> <span> </span><span class="NLM_article-title">Effects of Caffeine Withdrawal from the Diet on the Metabolism of Clozapine in Schizophrenic Patients</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1097/00004714-199808000-00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1097%2F00004714-199808000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=9690697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1cXltFSms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=311-316&issue=4&author=J.+A.+Carrilloauthor=A.+G.+Herraizauthor=S.+I.+Ramosauthor=J.+Ben%C3%ADtez&title=Effects+of+Caffeine+Withdrawal+from+the+Diet+on+the+Metabolism+of+Clozapine+in+Schizophrenic+Patients&doi=10.1097%2F00004714-199808000-00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients</span></div><div class="casAuthors">Carrillo, Juan A.; Herraiz, Angustias G.; Ramos, Sara I.; Benitez, Julio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-314</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Both clozapine (CLZ) and caffeine are CYP1A2 substrates.  This study raises the hypothesis of whether caffeine withdrawal from the diet alters the metab. and/or clin. status of patients receiving CLZ.  Seven schizophrenic patients (six men and one woman) receiving monotherapy with CLZ at 271±102 mg/day (3.73±1.4 mg/kg) participated in the study.  CLZ, norclozapine (NOR), and clozapine-N-oxide (NOX) were assayed in plasma by high-performance liq. chromatog. at three different time points: A, with concomitant intake of caffeine from the diet; B, after caffeine withdrawal for 5 days; and C, after 2 wk of rechallenge to habitual caffeine intake.  The CYP1A2 activity was detd. by means of a urinary caffeine test.  After a caffeine-free diet for 5 days, CLZ concns. relative to time point A decreased from 486 to 306 ng/mL (-47%) (p < 0.02), NOX levels decreased from 66 to 49 ng/mL (-31%) (p < 0.03), and the NOR/CLZ ratio significantly increased from 0.47 to 1.04 (185%) (p < 0.02).  All parameters returned to initial figures at time point C.  The NOR/CLZ ratio was significantly correlated to the CYP1A2 index (rs = 0.96, p < 0.0005).  In conclusion, changes in the habitual caffeine intake alter the metab. of CLZ in schizophrenic patients.  Thus, patient intake of caffeine should be medically supervised, and the monitoring of CLZ and metabolite levels may be warranted.  Furthermore, in those patients who receive therapy with CLZ, the NOR/CLZ ratio may provide an addnl. and valuable est. of CYP1A2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooVUmmDypjk7Vg90H21EOLACvtfcHk0lgwvEGGvVQ4Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFSms7k%253D&md5=b023962024ae113ee8283f70550e848f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1097%2F00004714-199808000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199808000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26aulast%3DHerraiz%26aufirst%3DA.%2BG.%26aulast%3DRamos%26aufirst%3DS.%2BI.%26aulast%3DBen%25C3%25ADtez%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520Caffeine%2520Withdrawal%2520from%2520the%2520Diet%2520on%2520the%2520Metabolism%2520of%2520Clozapine%2520in%2520Schizophrenic%2520Patients%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1998%26volume%3D18%26issue%3D4%26spage%3D311%26epage%3D316%26doi%3D10.1097%2F00004714-199808000-00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umetsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span> <span> </span><span class="NLM_article-title">Influence of Usual Intake of Dietary Caffeine on Single-Dose Kinetics of Theophylline in Healthy Human Subjects</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1007/BF00271376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00271376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8491248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXks1ant74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=295-298&issue=3&author=J.+Satoauthor=H.+Nakataauthor=E.+Owadaauthor=T.+Kikutaauthor=M.+Umetsuauthor=K.+Ito&title=Influence+of+Usual+Intake+of+Dietary+Caffeine+on+Single-Dose+Kinetics+of+Theophylline+in+Healthy+Human+Subjects&doi=10.1007%2FBF00271376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects</span></div><div class="casAuthors">Sato, J.; Nakata, H.; Owada, E.; Kikuta, T.; Umetsu, M.; Ito, K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-80</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">The influence of usual multiple ingestions of dietary caffeine on oral single-dose pharmacokinetics of theophylline has been investigated in 6 healthy male subjects.  The subjects consumed 2 to 7 cups of regular instant coffee during the 24 h study period.  Their mean serum concns. of caffeine varied from 1.2 to 3.1 mg/L.  After their usual intake of dietary caffeine, the serum concns. of theophylline from 3 to 24 h after administration were significantly higher than after deprivation of dietary caffeine.  The apparent elimination of theophylline half-life was prolonged from 6.3 (0.61) h (mean with (SEM)) to 8.3 (0.47) h (32% increase, P < 0.01) and the total body clearance was reduced from 55.0 (1.31) mL·h-1·kg-1 to 42.5 (2.63) mL·h-1·kg-1 (23% decrease, P < 0.001).  Satn. of theophylline metab. and/or competition between theophylline and caffeine metab. in addn. to theophylline derived from caffeine may be the cause of the delayed elimination of theophylline.  The present study has indicated that a significant redn. in theophylline metab. may be caused by a conventional intake of dietary caffeine.  In bronchodilator therapy with theophylline, therefore, the daily consumption of caffeine should be taken into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeMtRI7J42ZLVg90H21EOLACvtfcHk0lgQkWPYoRC0yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1ant74%253D&md5=c6aa742ce54a2eacfc8be04d1e039840</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2FBF00271376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00271376%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DJ.%26aulast%3DNakata%26aufirst%3DH.%26aulast%3DOwada%26aufirst%3DE.%26aulast%3DKikuta%26aufirst%3DT.%26aulast%3DUmetsu%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DK.%26atitle%3DInfluence%2520of%2520Usual%2520Intake%2520of%2520Dietary%2520Caffeine%2520on%2520Single-Dose%2520Kinetics%2520of%2520Theophylline%2520in%2520Healthy%2520Human%2520Subjects%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1993%26volume%3D44%26issue%3D3%26spage%3D295%26epage%3D298%26doi%3D10.1007%2FBF00271376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlinchey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">The {ChEMBL} Bioactivity Database: An Update</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D1083</span>– <span class="NLM_lpage">D1090</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fnar%2Fgkt1031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24214965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslWl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=D1083-D1090&issue=D1&author=A.+P.+Bentoauthor=A.+Gaultonauthor=A.+Herseyauthor=L.+J.+Bellisauthor=J.+Chambersauthor=M.+Daviesauthor=F.+A.+Kr%C3%BCgerauthor=Y.+Lightauthor=L.+Makauthor=S.+McGlincheyauthor=M.+Nowotkaauthor=G.+Papadatosauthor=R.+Santosauthor=J.+P.+Overington&title=The+%7BChEMBL%7D+Bioactivity+Database%3A+An+Update&doi=10.1093%2Fnar%2Fgkt1031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL bioactivity database: an update</span></div><div class="casAuthors">Bento, A. Patricia; Gaulton, Anna; Hersey, Anne; Bellis, Louisa J.; Chambers, Jon; Davies, Mark; Krueger, Felix A.; Light, Yvonne; Mak, Lora; McGlinchey, Shaun; Nowotka, Michal; Papadatos, George; Santos, Rita; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1083-D1090</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 Nucleic Acids Research Database Issue.  Since then, a variety of new data sources and improvements in functionality have contributed to the growth and utility of the resource.  In particular, more comprehensive tracking of compds. from research stages through clin. development to market is provided through the inclusion of data from United States Adopted Name applications; a new richer data model for representing drug targets has been developed; and a no. of methods have been put in place to allow users to more easily identify reliable data.  Finally, access to ChEMBL is now available via a new Resource Description Framework format, in addn. to the web-based interface, data downloads and web services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXb5k1IvJNaLVg90H21EOLACvtfcHk0lgQkWPYoRC0yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslWl&md5=31b832d03d56ea3065d7aa29618362bc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1031%26sid%3Dliteratum%253Aachs%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DKr%25C3%25BCger%26aufirst%3DF.%2BA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMak%26aufirst%3DL.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520%257BChEMBL%257D%2520Bioactivity%2520Database%253A%2520An%2520Update%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26issue%3DD1%26spage%3DD1083%26epage%3DD1090%26doi%3D10.1093%2Fnar%2Fgkt1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Gubareff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleator, W.</span></span> <span> </span><span class="NLM_article-title">Effects of Caffeine on Mammalian Atrial Muscle, and Its Interaction with Adexosine and Calcium</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=14301011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1965&pages=202-214&issue=2&author=T.+De%0AGubareffauthor=W.+Sleator&title=Effects+of+Caffeine+on+Mammalian+Atrial+Muscle%2C+and+Its+Interaction+with+Adexosine+and+Calcium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of caffeine on mammalian atrial muscle and its interaction with adenosine and calcium</span></div><div class="casAuthors">De Gubareff, Taisija; Sleator, William, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Caffeine (I), at 0.25-1.5 mM, exerted a pos. inotropic effect on isolated guinea pig atrium, while at higher concns. the contraction decreased.  The increased duration of transmembranal action potentials induced by I was proportional to drug concn., and at 2.5 mM was twice normal.  I probably releases catechol amines from the normal heart, but not following pretreatment with reserpine; however, the inotropic activity of I is not via this process.  The marked effect of I on the duration of the action potential as well as on contraction was dependent upon Ca in the medium, such that when both are present the strength of contraction and duration of action potential increase at a low frequency of elec. stimulation.  I antagonized the depressant effect of adenosine on contraction and action potential of the guinea pig and human atria, probably by altering the functions of Ca within the muscle cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphQKAWx4q3t7Vg90H21EOLACvtfcHk0li3pbJOaN_VMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D&md5=0ae31bc64f3f2a047e6be43a8d0a184a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGubareff%26aufirst%3DT.%26aulast%3DSleator%26aufirst%3DW.%26atitle%3DEffects%2520of%2520Caffeine%2520on%2520Mammalian%2520Atrial%2520Muscle%252C%2520and%2520Its%2520Interaction%2520with%2520Adexosine%2520and%2520Calcium%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1965%26volume%3D148%26issue%3D2%26spage%3D202%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Galen, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors: Pharmacology, Structure-Activity Relationships, and Therapeutic Potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1021/jm00081a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00081a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XpvVOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=407-422&issue=3&author=K.+A.+Jacobsonauthor=P.+J.+M.+van+Galenauthor=M.+Williams&title=Adenosine+Receptors%3A+Pharmacology%2C+Structure-Activity+Relationships%2C+and+Therapeutic+Potential&doi=10.1021%2Fjm00081a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors:  pharmacology, structure-activity relationships, and therapeutic potential</span></div><div class="casAuthors">Jacobson, Kenneth A.; Van Galen, Philip J. M.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-22</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review with 166 refs.  In the present perspective, advances in knowledge related to adenosine function at the mol. level is reviewed together with information on the structure-activity relationships for a no. of pharmacophore series interacting with adenosine receptors.  Therapeutic areas where improved adenosine ligands may represent potentially important therapeutic agents are also indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXuxlPOO4sJ7Vg90H21EOLACvtfcHk0li3pbJOaN_VMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvVOjsg%253D%253D&md5=b8120746a1b51bd727273454342d7d5a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm00081a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00081a001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3Dvan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DAdenosine%2520Receptors%253A%2520Pharmacology%252C%2520Structure-Activity%2520Relationships%252C%2520and%2520Therapeutic%2520Potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26issue%3D3%26spage%3D407%26epage%3D422%26doi%3D10.1021%2Fjm00081a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Caffeine Analogs: Biomedical Impact</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2153</span>– <span class="NLM_lpage">2169</span>, <span class="refDoi"> DOI: 10.1007/s00018-007-7051-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00018-007-7051-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17514358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVaisb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=2153-2169&issue=16&author=J.+W.+Daly&title=Caffeine+Analogs%3A+Biomedical+Impact&doi=10.1007%2Fs00018-007-7051-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine analogs: biomedical impact</span></div><div class="casAuthors">Daly, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2153-2169</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Caffeine, widely consumed in beverages, and many xanthine analogs have had a major impact on biomedical research.  Caffeine and various analogs, the latter designed to enhance potency and selectivity toward specific biol. targets, have played key roles in defining the nature and role of adenosine receptors, phosphodiesterases, and calcium release channels in physiol. processes.  Such xanthines and other caffeine-inspired heterocycles now provide important research tools and potential therapeutic agents for intervention in Alzheimer's disease, asthma, cancer, diabetes, and Parkinson's disease.  Such compds. also have activity as analgesics, antiinflammatories, antitussives, behavioral stimulants, diuretics/natriuretics, and lipolytics.  Adverse effects can include anxiety, hypertension, certain drug interactions, and withdrawal symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8c4-7mtTda7Vg90H21EOLACvtfcHk0li3pbJOaN_VMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVaisb%252FP&md5=9eb88ab530fe86279b4d352d1fed7447</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7051-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7051-9%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCaffeine%2520Analogs%253A%2520Biomedical%2520Impact%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26issue%3D16%26spage%3D2153%26epage%3D2169%26doi%3D10.1007%2Fs00018-007-7051-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Theophylline Analogues: Correlation of Behavioral Effects with Activity as Adenosine Receptor Antagonists and as Phosphodiesterase Inhibitors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(88)90517-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2888%2990517-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2456442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1cXkvVKitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1988&pages=387-398&issue=5&author=O.+H.+Choiauthor=M.+T.+Shamimauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Caffeine+and+Theophylline+Analogues%3A+Correlation+of+Behavioral+Effects+with+Activity+as+Adenosine+Receptor+Antagonists+and+as+Phosphodiesterase+Inhibitors&doi=10.1016%2F0024-3205%2888%2990517-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and theophylline analogs:  correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors</span></div><div class="casAuthors">Choi, Oksoon H.; Shamim, Mah T.; Padgett, William L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-98</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">The effects of caffeine analogs on open field behavior of mice and potencies as antagonists of adenosine receptors and as inhibitors of 3 classes of brain phosphodiesterase(PDE) have been compared.  1,7-Dimethyl-3-propargylxanthine, 1,3,7-tripropargylxanthine, and 3,7-dimethyl-1-propargylxanthine, which have high affinity for adenosine receptors and weaker activity as PDE inhibitors, all increase behavioral activity.  In contrast, 1,3,7-tripropylxanthine, a more potent inhibitor of the brain Ca-independent PDEs than 1,3,7-tripropargylxanthine, produces behavioral depression, even though both analogs are potent adenosine receptor antagonists.  7-Benzyl-3-isobutyl-1-methylxanthine, an active receptor antagonist and selective inhibitor of a brain Ca-dependent PDE, produces a slight behavioral activation.  Xanthines that are potent adenosine receptor antagonists and relatively weak inhibitors of the Ca-independent PDEs reverse the depressant effects of N6-cyclohexyladenosine, whereas xanthines, such as 1,3,7-tripropylxanthine, that are potent inhibitors of the Ca-independent PDEs, do not.  Apparently, the behavioral effects of xanthines may be detd. primarily by relative activity as adenosine receptor antagonists and as inhibitors of brain Ca-independent PDEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfmOYilDLJuLVg90H21EOLACvtfcHk0liwKjYC78XIEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvVKitLs%253D&md5=d07acfd7fcc81fa7007a518e0208df58</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2888%2990517-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252888%252990517-6%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DO.%2BH.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCaffeine%2520and%2520Theophylline%2520Analogues%253A%2520Correlation%2520of%2520Behavioral%2520Effects%2520with%2520Activity%2520as%2520Adenosine%2520Receptor%2520Antagonists%2520and%2520as%2520Phosphodiesterase%2520Inhibitors%26jtitle%3DLife%2520Sci.%26date%3D1988%26volume%3D43%26issue%3D5%26spage%3D387%26epage%3D398%26doi%3D10.1016%2F0024-3205%2888%2990517-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, W.</span></span> <span> </span><span class="NLM_article-title">Adenosine 3′,5′-Phosphate in Biological Materials. I. Purification and Properties of Cyclic 3′,5′-Nucleotide Phosphodiesterase and Use of This Enzyme to Characterize Adenosine 3′,5′-Phosphate in Human Urine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)60316-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0021-9258%2818%2960316-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=13875173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaF3sXhsFKmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1962&pages=1244-1250&author=R.+Butcherauthor=W.+Sutherland&title=Adenosine+3%E2%80%B2%2C5%E2%80%B2-Phosphate+in+Biological+Materials.+I.+Purification+and+Properties+of+Cyclic+3%E2%80%B2%2C5%E2%80%B2-Nucleotide+Phosphodiesterase+and+Use+of+This+Enzyme+to+Characterize+Adenosine+3%E2%80%B2%2C5%E2%80%B2-Phosphate+in+Human+Urine&doi=10.1016%2FS0021-9258%2818%2960316-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic-3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine</span></div><div class="casAuthors">Butcher, R. W.; Sutherland, Earl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1244-50</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Steps leading to at least 80-fold purification of the sol. cyclic-3',5'-nucleotide phosphodiesterase from beef heart were described.  The enzyme required Mg, was stimulated by imidazole in an unknown fashion, and was inhibited competitively by the methyl xanthines, theophylline being approx. 6 times more potent than caffeine or theobromine.  The enzyme was specific for the 3',5'-cyclic bond.  The enzyme was found in all tissues contg. adenyl cyclase except avian red cells.  Approx. 60% of the total homogenate activity was found in the particulate fraction upon low-speed centrifugation.  This activity appeared identical with the sol. form by enzymic criteria, but was not elutable under the conditions used.  The cyclic 3',5'-nucleotide phosphodiesterase was a major (and to date the only) mechanism for the destruction of adenosine 3',5'-phosphate (I.).  The purified soluble enzyme was used in the detection of I from biol. sources, in which the low concns. of this compd. and the presence of known and unidentified interfering materials made identification by the standard I activity assay described above very difficult.  I was isolated from human urine and identified.  Daily levels of 2-7 micromoles were found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrCViBifWmvrVg90H21EOLACvtfcHk0liwKjYC78XIEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXhsFKmsg%253D%253D&md5=6641bf56c4868abd5761f2143a41473f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2960316-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252960316-3%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DR.%26aulast%3DSutherland%26aufirst%3DW.%26atitle%3DAdenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Phosphate%2520in%2520Biological%2520Materials.%2520I.%2520Purification%2520and%2520Properties%2520of%2520Cyclic%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Nucleotide%2520Phosphodiesterase%2520and%2520Use%2520of%2520This%2520Enzyme%2520to%2520Characterize%2520Adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Phosphate%2520in%2520Human%2520Urine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1962%26volume%3D237%26spage%3D1244%26epage%3D1250%26doi%3D10.1016%2FS0021-9258%2818%2960316-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifsnyder, D. H.</span></span> <span> </span><span class="NLM_article-title">Primary Sequence of Cyclic Nucleotide Phosphodiesterase Isozymes and the Design of Selective Inhibitors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(90)90066-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0165-6147%2890%2990066-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2159198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3cXksFCksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=150-155&issue=4&author=J.+A.+Beavoauthor=D.+H.+Reifsnyder&title=Primary+Sequence+of+Cyclic+Nucleotide+Phosphodiesterase+Isozymes+and+the+Design+of+Selective+Inhibitors&doi=10.1016%2F0165-6147%2890%2990066-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors</span></div><div class="casAuthors">Beavo, Joseph A.; Reifsnyder, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">150-5</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 35 refs. on the unique sequences of phosphodiesterase isoenzyme catalytic and regulatory domains as well as the selective expression of isoenzymes in different cell types.  This information is discussed with regard to drug design and why many attempts to isolate isoenzyme-selective inhibitors may have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8XnjbS0pjALVg90H21EOLACvtfcHk0liwKjYC78XIEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFCksL0%253D&md5=5641d6c3c21eb7c85893f8cd62dd6fd4</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2890%2990066-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252890%252990066-H%26sid%3Dliteratum%253Aachs%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DReifsnyder%26aufirst%3DD.%2BH.%26atitle%3DPrimary%2520Sequence%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%2520Isozymes%2520and%2520the%2520Design%2520of%2520Selective%2520Inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1990%26volume%3D11%26issue%3D4%26spage%3D150%26epage%3D155%26doi%3D10.1016%2F0165-6147%2890%2990066-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Caffeine Analogs: Effects on Ryanodine-Sensitive Calcium-Release Channels and GABAA Receptors</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1023/A:1023688604792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1023%2FA%3A1023688604792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12825831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=331-347&issue=3&author=D.+Shiauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Caffeine+Analogs%3A+Effects+on+Ryanodine-Sensitive+Calcium-Release+Channels+and+GABAA+Receptors&doi=10.1023%2FA%3A1023688604792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine analogs: Effects on ryanodine-sensitive calcium-release channels and GABAA receptors</span></div><div class="casAuthors">Shi, Dan; Padgett, William L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-347</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Caffeine at 0.3-10 mM enhanced the binding of [3H]ryanodine to calcium-release channels of rabbit muscle sarcoplasmic reticulum.  A variety of other xanthines were as efficacious as caffeine or nearly so, but none appeared markedly more potent.  Caffeine at 1 mM markedly inhibited binding of [3H]diazepam to GABAA receptors in rat cerebral cortical membranes.  Other xanthines also inhibited binding with certain dimethylpropargylxanthines being nearly fivefold more potent than caffeine.  Caffeine at 1 mM stimulated binding of [35S]TBPS to GABAA receptors as did certain other xanthines.  The dimethylpropargylxanthines had little effect.  1,3-Dipropy1-8-cyclopentylxan- thine at 100 μM had no effect on [3H]diazepam binding, but markedly inhibited [35S]TBPS binding.  Structure-activity relationships for xanthines do differ for calcium-release channels and for different sites on GABAA receptors, but no highly selective lead compds. were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUykeJpdK-ZrVg90H21EOLACvtfcHk0liqUQ8zSn-Tow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFWisbc%253D&md5=bf43cd8c8298c8d947642f271e779eea</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023688604792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023688604792%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DD.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCaffeine%2520Analogs%253A%2520Effects%2520on%2520Ryanodine-Sensitive%2520Calcium-Release%2520Channels%2520and%2520GABAA%2520Receptors%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2003%26volume%3D23%26issue%3D3%26spage%3D331%26epage%3D347%26doi%3D10.1023%2FA%3A1023688604792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marangos, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parma, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syapin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">Purinergic Inhibition of Diazepam Binding to Rat Brain (in Vitro)</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(79)90369-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2879%2990369-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=449624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE1MXhsl2qsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1979&pages=851-857&issue=9&author=P.+J.+Marangosauthor=S.+M.+Paulauthor=A.+M.+Parmaauthor=F.+K.+Goodwinauthor=P.+Syapinauthor=P.+Skolnick&title=Purinergic+Inhibition+of+Diazepam+Binding+to+Rat+Brain+%28in+Vitro%29&doi=10.1016%2F0024-3205%2879%2990369-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic inhibition of diazepam binding to rat brain (in vitro)</span></div><div class="casAuthors">Marangos, P. J.; Paul, S. M.; Parma, A. M.; Goodwin, F. K.; Syapin, P.; Skolnick, P.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">851-7</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">A wide spectrum of purines were able to inhibit specific 3H-labeled diazepam (I)  [439-14-5] binding by rat brain synaptosomes, whereas pyrimidines were inactive.  Preliminary structure activity relations indicated that the 2'-deoxypurines were more potent in I binding inhibition as were the 1-Me compds., whereas the 7-Me purines were inactive.  The xanthine stimulants caffeine  [58-08-2], theophylline  [58-55-9], and theobromine  [83-67-0] as well as the central nervous system convulsant pentylenetetrazol  [54-95-5] all competitively inhibited I-3H binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUqORNPO0XBbVg90H21EOLACvtfcHk0liqUQ8zSn-Tow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhsl2qsL8%253D&md5=83a0fe01eefa3d326d5ed9cda8871b29</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2879%2990369-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252879%252990369-2%26sid%3Dliteratum%253Aachs%26aulast%3DMarangos%26aufirst%3DP.%2BJ.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DParma%26aufirst%3DA.%2BM.%26aulast%3DGoodwin%26aufirst%3DF.%2BK.%26aulast%3DSyapin%26aufirst%3DP.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DPurinergic%2520Inhibition%2520of%2520Diazepam%2520Binding%2520to%2520Rat%2520Brain%2520%2528in%2520Vitro%2529%26jtitle%3DLife%2520Sci.%26date%3D1979%26volume%3D24%26issue%3D9%26spage%3D851%26epage%3D857%26doi%3D10.1016%2F0024-3205%2879%2990369-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nehlig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daval, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debry, G.</span></span> <span> </span><span class="NLM_article-title">Caffeine and the Central Nervous System: Mechanisms of Action, Biochemical, Metabolic and Psychostimulant Effects</span>. <i>Brain Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/0165-0173(92)90012-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0165-0173%2892%2990012-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1356551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1GlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1992&pages=139-170&issue=2&author=A.+Nehligauthor=J.+L.+Davalauthor=G.+Debry&title=Caffeine+and+the+Central+Nervous+System%3A+Mechanisms+of+Action%2C+Biochemical%2C+Metabolic+and+Psychostimulant+Effects&doi=10.1016%2F0165-0173%2892%2990012-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and the central nervous system:  mechanisms of action, biochemical, metabolic and psychostimulant effects</span></div><div class="casAuthors">Nehlig, Astrid; Daval, Jean Luc; Debry, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-70</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    </div><div class="casAbstract">A review with 656 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTsanrJialBbVg90H21EOLACvtfcHk0liqUQ8zSn-Tow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1GlsL0%253D&md5=327793efd92bd01cb0accf3572739d6c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2F0165-0173%2892%2990012-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0173%252892%252990012-B%26sid%3Dliteratum%253Aachs%26aulast%3DNehlig%26aufirst%3DA.%26aulast%3DDaval%26aufirst%3DJ.%2BL.%26aulast%3DDebry%26aufirst%3DG.%26atitle%3DCaffeine%2520and%2520the%2520Central%2520Nervous%2520System%253A%2520Mechanisms%2520of%2520Action%252C%2520Biochemical%252C%2520Metabolic%2520and%2520Psychostimulant%2520Effects%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D1992%26volume%3D17%26issue%3D2%26spage%3D139%26epage%3D170%26doi%3D10.1016%2F0165-0173%2892%2990012-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabiani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corradi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antollini, S. S.</span></span> <span> </span><span class="NLM_article-title">A Novel Pharmacological Activity of Caffeine in the Cholinergic System</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.03.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2018.03.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29614315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntlSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2018&pages=464-473&author=C.+Fabianiauthor=A.+P.+Murrayauthor=J.+Corradiauthor=S.+S.+Antollini&title=A+Novel+Pharmacological+Activity+of+Caffeine+in+the+Cholinergic+System&doi=10.1016%2Fj.neuropharm.2018.03.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pharmacological activity of caffeine in the cholinergic system</span></div><div class="casAuthors">Fabiani, Camila; Murray, Ana Paula; Corradi, Jeremias; Antollini, Silvia Susana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">464-473</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cholinergic deficit is regarded as an important factor responsible for Alzheimer's disease (AD) symptoms.  Acetylcholinesterase (AChE) and nicotinic receptor (AChR) are two mol. targets for the treatment of this disease.  We found here that methanolic exts. of Camellia sinensis exhibited anticholinesterase activity and induced AChR conformational changes.  From bioguided fractionation we confirmed that caffeine was the active compd. exerting such effects.  It is well-known that caffeine acts as an inhibitor of AChE and here we explored the effect of caffeine on the AChR by combining single channel recordings and fluorescent measurements.  From single channel recordings we obsd. that caffeine activated both muscle and α7 AChRs at low concns., and behaved as an open channel blocker which was evident at high concns.  Fluorescent measurements were performed with the conformational sensitive probe crystal violet (CrV) and AChR rich membranes from Torpedo californica.  Caffeine induced changes in the KD value of CrV in a concn.-dependent manner taking the AChR closer to a desensitized state.  In the presence of α-bungarotoxin, an AChR competitive antagonist, high concns. of caffeine increased the KD value of CrV, compatible with a competition with CrV mols. for the luminal channel.  Our electrophysiol. and fluorescent expts. show that caffeine has a dual effect on nicotinic receptors, behaving as an agonist and an ion channel blocker, probably through distinct AChR sites with quite different affinities.  Thus, caffeine or its derivs. can be considered for the design of promising multitarget-directed drugs for AD treatment by modulation of different targets in the cholinergic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUTOmUBsp6PrVg90H21EOLACvtfcHk0liqUQ8zSn-Tow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntlSnsr4%253D&md5=aeb5d4e6254dd36441e953d56830d962</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.03.041%26sid%3Dliteratum%253Aachs%26aulast%3DFabiani%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DA.%2BP.%26aulast%3DCorradi%26aufirst%3DJ.%26aulast%3DAntollini%26aufirst%3DS.%2BS.%26atitle%3DA%2520Novel%2520Pharmacological%2520Activity%2520of%2520Caffeine%2520in%2520the%2520Cholinergic%2520System%26jtitle%3DNeuropharmacology%26date%3D2018%26volume%3D135%26spage%3D464%26epage%3D473%26doi%3D10.1016%2Fj.neuropharm.2018.03.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okello, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leylabi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougall, G. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Acetylcholinesterase by Green and White Tea and Their Simulated Intestinal Metabolites</span>. <i>Food Funct.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1039/c2fo10174b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1039%2Fc2fo10174b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22418730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=651-661&issue=6&author=E.+J.+Okelloauthor=R.+Leylabiauthor=G.+J.+McDougall&title=Inhibition+of+Acetylcholinesterase+by+Green+and+White+Tea+and+Their+Simulated+Intestinal+Metabolites&doi=10.1039%2Fc2fo10174b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites</span></div><div class="casAuthors">Okello, Edward J.; Leylabi, Ramin; McDougall, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Food & Function</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">651-661</span>CODEN:
                <span class="NLM_cas:coden">FFOUAI</span>;
        ISSN:<span class="NLM_cas:issn">2042-6496</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">By 2034 it is forecast that 5% of the global population will be aged 85 years or over-approx. two and half fold increase on present day figures-which will inevitably lead to an increase in age-assocd. disorders such as Alzheimer's disease.  There is mounting evidence that green tea (Camellia sinensis) possesses numerous health-promoting properties, and may potentially be beneficial to those suffering from Alzheimer's and other diseases, including cardiovascular disease and cancer.  These beneficial properties are largely attributed to the high polyphenol content, particularly the catechins.  In this study, we measured acetylcholinesterase inhibition by white and green teas and their simulated intestinal digests.  We found that the potency with which the white and green tea exts. inhibited acetylcholinesterase varied through the simulated digestion procedure.  Initially, in the undigested ext. form, potency was high with IC50 values of 7.20 μg mL-1 and 8.06 μg mL-1 for green and white tea resp.  However, this decreased significantly after gastric digestion but activity was recovered after pancreatic digestion which could be related to relative increases in the levels of caffeine and specific phenolic components.  Of the pure tea compds. tested, EGCG was the most potent with an IC50 of 0.0096 μmol mL-1 but its breakdown product; γ-valerolactone was the least potent analyte.  Particularly interesting were the results of caffeine, which exhibited a strong inhibitory activity and pyrogallol, which recorded a much stronger potency than its parent compd. gallic acid, suggesting a pro-drug-like relationship.  Overall, the results indicate that further research is necessary to det. the full potential of digestion of tea and its metabolites and how inter-individual variation may indicate that some sections of society could potentially benefit more from drinking tea as a strategy to prevent the development of dementia.  We have also shown the activities of a no. of metabolites, however, further research is required to det. their potential bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUaWJGGhBfDbVg90H21EOLACvtfcHk0lgZIYZEto9r9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOlt7Y%253D&md5=61e6c2a7024187d8236fa654cac5bd61</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1039%2Fc2fo10174b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2fo10174b%26sid%3Dliteratum%253Aachs%26aulast%3DOkello%26aufirst%3DE.%2BJ.%26aulast%3DLeylabi%26aufirst%3DR.%26aulast%3DMcDougall%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520Acetylcholinesterase%2520by%2520Green%2520and%2520White%2520Tea%2520and%2520Their%2520Simulated%2520Intestinal%2520Metabolites%26jtitle%3DFood%2520Funct.%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D651%26epage%3D661%26doi%3D10.1039%2Fc2fo10174b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohanka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobes, P.</span></span> <span> </span><span class="NLM_article-title">Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">9873</span>– <span class="NLM_lpage">9882</span>, <span class="refDoi"> DOI: 10.3390/ijms14059873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3390%2Fijms14059873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23698772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSktb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=9873-9882&issue=5&author=M.+Pohankaauthor=P.+Dobes&title=Caffeine+Inhibits+Acetylcholinesterase%2C+But+Not+Butyrylcholinesterase&doi=10.3390%2Fijms14059873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase</span></div><div class="casAuthors">Pohanka, Miroslav; Dobes, Petr</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">9873-9882, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Caffeine is an alkaloid with a stimulant effect in the body.  It can interfere in transmissions based on acetylcholine, epinephrine, norepinephrine, serotonin, dopamine and glutamate.  Clin. studies indicate that it can be involved in the slowing of Alzheimer disease pathol. and some other effects.  The effects are not well understood.  In the present work, we focused on the question whether caffeine can inhibit acetylcholinesterase (AChE) and/or butyrylcholinesterase (BChE), the two enzymes participating in cholinergic neurotransmission.  A std. Ellman test with human AChE and BChE was done for altering concns. of caffeine.  The test was supported by an in silico examn. as well.  Donepezil and tacrine were used as stds.  In compliance with Dixon's plot, caffeine was proved to be a non-competitive inhibitor of AChE and BChE.  However, inhibition of BChE was quite weak, as the inhibition const., Ki, was 13.9 ± 7.4 mol/L.  Inhibition of AChE was more relevant, as Ki was found to be 175 ± 9 μmol/L.  The predicted free energy of binding was -6.7 kcal/mol.  The proposed binding orientation of caffeine can interact with Trp86 and it can be stabilize by Tyr337 in comparison to the smaller Ala328 in the case of human BChE; thus, it can explain the lower binding affinity of caffeine for BChE with ref. to AChE.  The biol. relevance of the findings is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiLIqEGl-YA7Vg90H21EOLACvtfcHk0lgZIYZEto9r9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSktb7F&md5=3cf094a17811a64e5bd15c9000bf3487</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3390%2Fijms14059873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms14059873%26sid%3Dliteratum%253Aachs%26aulast%3DPohanka%26aufirst%3DM.%26aulast%3DDobes%26aufirst%3DP.%26atitle%3DCaffeine%2520Inhibits%2520Acetylcholinesterase%252C%2520But%2520Not%2520Butyrylcholinesterase%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26issue%3D5%26spage%3D9873%26epage%3D9882%26doi%3D10.3390%2Fijms14059873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karadsheh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linthicum, D. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Acetylcholinesterase by Caffeine, Anabasine, Methyl Pyrrolidine and Their Derivatives</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/0378-4274(91)90015-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0378-4274%2891%2990015-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2003276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1991&pages=335-342&issue=3&author=N.+Karadshehauthor=P.+Kussieauthor=D.+S.+Linthicum&title=Inhibition+of+Acetylcholinesterase+by+Caffeine%2C+Anabasine%2C+Methyl+Pyrrolidine+and+Their+Derivatives&doi=10.1016%2F0378-4274%2891%2990015-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase by caffeine, anabasine, methylpyrrolidine and their derivatives</span></div><div class="casAuthors">Karadsheh, Naif; Kussie, Paul; Linthicum, D. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-42</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    </div><div class="casAbstract">The inhibition of acetylcholinesterase (AChE) by caffeine, anabasine, methylpyrrolidine, and several related compds. was examd.  Most of the compds. had moderate inhibitory activity, with I50 values in the range of 87-480 μM.  A structural feature common to these compds. is the N-Me determinant of the pyrrolidine ring, which may be important in binding to the AChE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptiFAHUP4DWLVg90H21EOLACvtfcHk0lgZIYZEto9r9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrurc%253D&md5=0ec9b3f063d2fd07bdc4b037e25e6e28</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2891%2990015-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252891%252990015-X%26sid%3Dliteratum%253Aachs%26aulast%3DKaradsheh%26aufirst%3DN.%26aulast%3DKussie%26aufirst%3DP.%26aulast%3DLinthicum%26aufirst%3DD.%2BS.%26atitle%3DInhibition%2520of%2520Acetylcholinesterase%2520by%2520Caffeine%252C%2520Anabasine%252C%2520Methyl%2520Pyrrolidine%2520and%2520Their%2520Derivatives%26jtitle%3DToxicol.%2520Lett.%26date%3D1991%26volume%3D55%26issue%3D3%26spage%3D335%26epage%3D342%26doi%3D10.1016%2F0378-4274%2891%2990015-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Small Molecules Targeting Phosphoinositide 3-Kinases</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1039/c2md20044a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1039%2Fc2md20044a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1337-1355&issue=11&author=P.+Wuauthor=Y.+Hu&title=Small+Molecules+Targeting+Phosphoinositide+3-Kinases&doi=10.1039%2Fc2md20044a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules targeting phosphoinositide 3-kinases</span></div><div class="casAuthors">Wu, Peng; Hu, Yongzhou</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1337-1355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is one of the most important signaling cascades in cancer, and PI3K is a well established target for anticancer therapy.  Since the discovery of the first two compds. that inhibit PI3K, wortmannin and LY294002, a wealth of PI3K inhibitors of various chemotypes have been identified, and nearly twenty of them are currently in various stages of clin. trials.  This review outlines the current landscape of the development of small mol. PI3K inhibitors with a focus on structure-activity relationships (SAR) and discussion of co-crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXN_CEz4XeS7Vg90H21EOLACvtfcHk0lgHC0Z2bODBmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrbN&md5=ada3308c67affb76bbfd051b96109103</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1039%2Fc2md20044a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20044a%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSmall%2520Molecules%2520Targeting%2520Phosphoinositide%25203-Kinases%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D1337%26epage%3D1355%26doi%3D10.1039%2Fc2md20044a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasazawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawajiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanida, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span> <span> </span><span class="NLM_article-title">Caffeine Induces Apoptosis by Enhancement of Autophagy via PI3K/Akt/MTOR/P70S6K Inhibition</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.4161/auto.7.2.14074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4161%2Fauto.7.2.14074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21081844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=176-187&issue=2&author=S.+Saikiauthor=Y.+Sasazawaauthor=Y.+Imamichiauthor=S.+Kawajiriauthor=T.+Fujimakiauthor=I.+Tanidaauthor=H.+Kobayashiauthor=F.+Satoauthor=S.+Satoauthor=K.+I.+Ishikawaauthor=M.+Imotoauthor=N.+Hattori&title=Caffeine+Induces+Apoptosis+by+Enhancement+of+Autophagy+via+PI3K%2FAkt%2FMTOR%2FP70S6K+Inhibition&doi=10.4161%2Fauto.7.2.14074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition</span></div><div class="casAuthors">Saiki, Shinji; Sasazawa, Yukiko; Imamichi, Yoko; Kawajiri, Sumihiro; Fujimaki, Takahiro; Tanida, Isei; Kobayashi, Hiroki; Sato, Fumiaki; Sato, Shigeto; Ishikawa, Kei-ichi; Imoto, Masaya; Hattori, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-187</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Caffeine is one of the most frequently ingested neuroactive compds.  All known mechanisms of apoptosis induced by caffeine act through cell cycle modulation or p53 induction.  It is currently unknown whether caffeine-induced apoptosis is assocd. with other cell death mechanisms, such as autophagy.  Herein we show that caffeine increases both the levels of microtubule-assocd. protein 1 light chain 3-II and the no. of autophagosomes, through the use of western blotting, electron microscopy and immunocytochem. techniques.  Phosphorylated p70 ribosomal protein S6 kinase (Thr389), S6 ribosomal protein (Ser235/236), 4E-BP1 (Thr37/46) and Akt (Ser473) were significantly decreased by caffeine.  In contrast, ERK1/2 (Thr202/204) was increased by caffeine, suggesting an inhibition of the Akt/mTOR/p70S6K pathway and activation of the ERK1/2 pathway.  Although insulin treatment phosphorylated Akt (Ser473) and led to autophagy suppression, the effect of insulin treatment was completely abolished by caffeine addn.  Caffeine-induced autophagy was not completely blocked by inhibition of ERK1/2 by U0126.  Caffeine induced redn. of mitochondrial membrane potentials and apoptosis in a dose-dependent manner, which was further attenuated by the inhibition of autophagy with 3-methyladenine or Atg7 siRNA knockdown.  Furthermore, there was a reduced no. of early apoptotic cells (annexin V pos., propidium iodide neg.) among autophagy-deficient mouse embryonic fibroblasts treated with caffeine than in their wild-type counterparts.  These results support previous studies on the use of caffeine in the treatment of human tumors and indicate a potential new target in the regulation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNgkWto6w8rVg90H21EOLACvtfcHk0lgHC0Z2bODBmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSmu7g%253D&md5=6663d3e93235ddc1846ea055c7d27bb4</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.2.14074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.2.14074%26sid%3Dliteratum%253Aachs%26aulast%3DSaiki%26aufirst%3DS.%26aulast%3DSasazawa%26aufirst%3DY.%26aulast%3DImamichi%26aufirst%3DY.%26aulast%3DKawajiri%26aufirst%3DS.%26aulast%3DFujimaki%26aufirst%3DT.%26aulast%3DTanida%26aufirst%3DI.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DF.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DK.%2BI.%26aulast%3DImoto%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DN.%26atitle%3DCaffeine%2520Induces%2520Apoptosis%2520by%2520Enhancement%2520of%2520Autophagy%2520via%2520PI3K%252FAkt%252FMTOR%252FP70S6K%2520Inhibition%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26issue%3D2%26spage%3D176%26epage%3D187%26doi%3D10.4161%2Fauto.7.2.14074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tariqul
Islam, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scavello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotfi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charest, P. G.</span></span> <span> </span><span class="NLM_article-title">Caffeine Inhibits PI3K and MTORC2 in Dictyostelium and Differentially Affects Multiple Other CAMP Chemoattractant Signaling Effectors</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>457</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1007/s11010-019-03520-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs11010-019-03520-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30879206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1Gkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2019&pages=157-168&issue=1%E2%80%932&author=A.+F.+M.+Tariqul%0AIslamauthor=M.+Scavelloauthor=P.+Lotfiauthor=D.+Danielauthor=P.+Haldemanauthor=P.+G.+Charest&title=Caffeine+Inhibits+PI3K+and+MTORC2+in+Dictyostelium+and+Differentially+Affects+Multiple+Other+CAMP+Chemoattractant+Signaling+Effectors&doi=10.1007%2Fs11010-019-03520-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits PI3K and mTORC2 in Dictyostelium and differentially affects multiple other cAMP chemoattractant signaling effectors</span></div><div class="casAuthors">Tariqul Islam, A. F. M.; Scavello, Margarethakay; Lotfi, Pouya; Daniel, Dustin; Haldeman, Pearce; Charest, Pascale G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">157-168</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Caffeine is commonly used in Dictyostelium to inhibit the synthesis of the chemoattractant cAMP and, therefore, its secretion and the autocrine stimulation of cells, in order to prevent its interference with the study of chemoattractant-induced responses.  However, the mechanism through which caffeine inhibits cAMP synthesis in Dictyostelium has not been characterized.  Here, we report the effects of caffeine on the cAMP chemoattractant signaling network.  We found that caffeine inhibits phosphatidylinositol 3-kinase (PI3K) and mechanistic target of rapamycin complex 2 (mTORC2).  Both PI3K and mTORC2 are essential for the chemoattractant-stimulated cAMP prodn., thereby providing a mechanism for the caffeine-mediated inhibition of cAMP synthesis.  Our results also reveal that caffeine treatment of cells leads to an increase in cAMP-induced RasG and Rap1 activation, and inhibition of the PKA, cGMP, MyoII, and ERK1 responses.  Finally, we obsd. that caffeine has opposite effects on F-actin and ERK2 depending on the assay and Dictyostelium strain used, resp.  Altogether, our findings reveal that caffeine considerably affects the cAMP-induced chemotactic signaling pathways in Dictyostelium, most likely acting through multiple targets that include PI3K and mTORC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rg6bgrVZz7Vg90H21EOLACvtfcHk0lgHC0Z2bODBmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1Gkt70%253D&md5=27cd3654e94ab6f29fd22478f2e99fa1</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1007%2Fs11010-019-03520-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-019-03520-z%26sid%3Dliteratum%253Aachs%26aulast%3DTariqul%2BIslam%26aufirst%3DA.%2BF.%2BM.%26aulast%3DScavello%26aufirst%3DM.%26aulast%3DLotfi%26aufirst%3DP.%26aulast%3DDaniel%26aufirst%3DD.%26aulast%3DHaldeman%26aufirst%3DP.%26aulast%3DCharest%26aufirst%3DP.%2BG.%26atitle%3DCaffeine%2520Inhibits%2520PI3K%2520and%2520MTORC2%2520in%2520Dictyostelium%2520and%2520Differentially%2520Affects%2520Multiple%2520Other%2520CAMP%2520Chemoattractant%2520Signaling%2520Effectors%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2019%26volume%3D457%26issue%3D1%25E2%2580%25932%26spage%3D157%26epage%3D168%26doi%3D10.1007%2Fs11010-019-03520-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McPhersonx, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdivia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takekura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzini-Armstrong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coronadot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, K. P.</span></span> <span> </span><span class="NLM_article-title">The Brain Ryanodine Receptor: A Caffeine-Sensitive Calcium Release Channel</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/0896-6273(91)90070-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0896-6273%2891%2990070-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1648939" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1991&pages=17-25&issue=1&author=P.+S.+McPhersonxauthor=Y.+K.+Kimauthor=H.+Valdiviaauthor=C.+M.+Knudsonauthor=H.+Takekuraauthor=C.+Franzini-Armstrongauthor=R.+Coronadotauthor=K.+P.+Campbell&title=The+Brain+Ryanodine+Receptor%3A+A+Caffeine-Sensitive+Calcium+Release+Channel&doi=10.1016%2F0896-6273%2891%2990070-G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2891%2990070-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252891%252990070-G%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhersonx%26aufirst%3DP.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DValdivia%26aufirst%3DH.%26aulast%3DKnudson%26aufirst%3DC.%2BM.%26aulast%3DTakekura%26aufirst%3DH.%26aulast%3DFranzini-Armstrong%26aufirst%3DC.%26aulast%3DCoronadot%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DK.%2BP.%26atitle%3DThe%2520Brain%2520Ryanodine%2520Receptor%253A%2520A%2520Caffeine-Sensitive%2520Calcium%2520Release%2520Channel%26jtitle%3DNeuron%26date%3D1991%26volume%3D7%26issue%3D1%26spage%3D17%26epage%3D25%26doi%3D10.1016%2F0896-6273%2891%2990070-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pessah, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stambuk, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Ca2+-Activated Ryanodine Binding: Mechanisms of Sensitivity and Intensity Modulation by Mg2+, Caffeine, and Adenine Nucleotides</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2436032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2sXitV2ksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1987&pages=232-238&issue=3&author=I.+N.+Pessahauthor=R.+A.+Stambukauthor=J.+E.+Casida&title=Ca2%2B-Activated+Ryanodine+Binding%3A+Mechanisms+of+Sensitivity+and+Intensity+Modulation+by+Mg2%2B%2C+Caffeine%2C+and+Adenine+Nucleotides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-activated ryanodine binding:  mechanisms of sensitivity and intensity modulation by magnesium, caffeine, and adenine nucleotides</span></div><div class="casAuthors">Pessah, Isaac N.; Stambuk, Roxanne A.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The Ca2+-ryanodine receptor complex is a functional unit at the terminal cisternae (TC) of the sarcoplasmic reticulum (SR) whose proteins comprise the Ca2+-release channels which may be involved in excitation-contraction coupling.  Ca2+, Mg2+, caffeine, and adenine nucleotides, but not inositol 1,4,5-trisphosphate, may exert their inotropic effects on skeletal muscle SR by direct allosteric modulation of the [3H]ryanodine-binding site.  Micromolar Ca2+ is primarily responsible for activating [3H]ryanodine binding by regulating receptor site d., affinity, and cooperativity.  Mg2+ reduces the sensitivity to Ca2+ activation by directly competing with Ca2+ for the activator site.  However, inhibition by Mg2+ is overcome in the presence of β,γ-methyleneadenosine 5'-triphosphate (AMP-PCP; 1 mM) or caffeine (20 mM).  Caffeine dramatically increases the affinity of the Ca2+ activator site for Ca2+, whereas AMP-PCP or cAMP enhances the gating efficiency or the lifetime of the open state of the TC SR channel.  A kinetic model is proposed for 4 functional domains of the Ca2+-ryanodine receptor complex: (1) the Ca2+-regulatory domain which binds Ca2+ with micromolar affinity is primarily responsible for gating the Ca2+ channel of the TC SR in a cooperative manner and is inhibited by millimolar Mg2+ by direct competition for the activator site, which appears to contain crit. SH groups; (2) a Ca2+-activated alkaloid binding domain in close proximity to the channel which binds ryanodine with nanomolar affinity and rapidly occludes upon complex formation; (3) a domain which binds caffeine with low (greater than millimolar) affinity and directly influences the sensitivity of the Ca2+-regulatory site; and (4) a domain which binds adenine nucleotides with intermediate affinity (less than millimolar), does not require phosphorylation, and intensifies the Ca2+ signal which triggers opening of the Ca2+-release channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTZK2wcR8B37Vg90H21EOLACvtfcHk0lhdnjHhd8vvzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXitV2ksL0%253D&md5=f6ca1a1771d3306f70c02ce31e99fd1a</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPessah%26aufirst%3DI.%2BN.%26aulast%3DStambuk%26aufirst%3DR.%2BA.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DCa2%252B-Activated%2520Ryanodine%2520Binding%253A%2520Mechanisms%2520of%2520Sensitivity%2520and%2520Intensity%2520Modulation%2520by%2520Mg2%252B%252C%2520Caffeine%252C%2520and%2520Adenine%2520Nucleotides%26jtitle%3DMol.%2520Pharmacol.%26date%3D1987%26volume%3D31%26issue%3D3%26spage%3D232%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">des
Georges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassucci, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Gating and Activation of RyR1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.08.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.cell.2016.08.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27662087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmtbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=145-157&issue=1&author=A.+des%0AGeorgesauthor=O.+B.+Clarkeauthor=R.+Zalkauthor=Q.+Yuanauthor=K.+J.+Condonauthor=R.+A.+Grassucciauthor=W.+A.+Hendricksonauthor=A.+R.+Marksauthor=J.+Frank&title=Structural+Basis+for+Gating+and+Activation+of+RyR1&doi=10.1016%2Fj.cell.2016.08.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Gating and Activation of RyR1</span></div><div class="casAuthors">des Georges, Amedee; Clarke, Oliver B.; Zalk, Ran; Yuan, Qi; Condon, Kendall J.; Grassucci, Robert A.; Hendrickson, Wayne A.; Marks, Andrew R.; Frank, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-157.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The type-1 ryanodine receptor (RyR1) is an intracellular calcium (Ca2+) release channel required for skeletal muscle contraction.  Here, we present cryo-EM reconstructions of RyR1 in multiple functional states revealing the structural basis of channel gating and ligand-dependent activation.  Binding sites for the channel activators Ca2+, ATP, and caffeine were identified at interdomain interfaces of the C-terminal domain.  Either ATP or Ca2+ alone induces conformational changes in the cytoplasmic assembly ("priming"), without pore dilation.  In contrast, in the presence of all three activating ligands, high-resoln. reconstructions of open and closed states of RyR1 were obtained from the same sample, enabling analyses of conformational changes assocd. with gating.  Gating involves global conformational changes in the cytosolic assembly accompanied by local changes in the transmembrane domain, which include bending of the S6 transmembrane segment and consequent pore dilation, displacement, and deformation of the S4-S5 linker and conformational changes in the pseudo-voltage-sensor domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiOulWfvkFxbVg90H21EOLACvtfcHk0lhdnjHhd8vvzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmtbfP&md5=8fc42f8314d5a22cb145219f5cf965fc</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.08.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.08.075%26sid%3Dliteratum%253Aachs%26aulast%3Ddes%2BGeorges%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DO.%2BB.%26aulast%3DZalk%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DQ.%26aulast%3DCondon%26aufirst%3DK.%2BJ.%26aulast%3DGrassucci%26aufirst%3DR.%2BA.%26aulast%3DHendrickson%26aufirst%3DW.%2BA.%26aulast%3DMarks%26aufirst%3DA.%2BR.%26aulast%3DFrank%26aufirst%3DJ.%26atitle%3DStructural%2520Basis%2520for%2520Gating%2520and%2520Activation%2520of%2520RyR1%26jtitle%3DCell%26date%3D2016%26volume%3D167%26issue%3D1%26spage%3D145%26epage%3D157%26doi%3D10.1016%2Fj.cell.2016.08.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis for Allosteric Regulation of the Type 2 Ryanodine Receptor Channel Gating by Key Modulators</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">25575</span>– <span class="NLM_lpage">25582</span>, <span class="refDoi"> DOI: 10.1073/pnas.1914451116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.1914451116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31792195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1Kjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=25575-25582&issue=51&author=X.+Chiauthor=D.+Gongauthor=K.+Renauthor=G.+Zhouauthor=G.+Huangauthor=J.+Leiauthor=Q.+Zhouauthor=N.+Yan&title=Molecular+Basis+for+Allosteric+Regulation+of+the+Type+2+Ryanodine+Receptor+Channel+Gating+by+Key+Modulators&doi=10.1073%2Fpnas.1914451116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for allosteric regulation of the type 2 ryanodine receptor channel gating by key modulators</span></div><div class="casAuthors">Chi, Ximin; Gong, Deshun; Ren, Kang; Zhou, Gewei; Huang, Gaoxingyu; Lei, Jianlin; Zhou, Qiang; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">25575-25582</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The type 2 ryanodine receptor (RyR2) is responsible for releasing Ca2+ from the sarcoplasmic reticulum of cardiomyocytes, subsequently leading to muscle contraction.  Here, we report 4 cryo-electron microscopy (cryo-EM) structures of porcine RyR2 bound to distinct modulators that, together with our published structures, provide mechanistic insight into RyR2 regulation.  Ca2+ alone induces a contraction of the central domain that facilitates the dilation of the S6 bundle but is insufficient to open the pore.  The small-mol. agonist PCB95 helps Ca2+ to overcome the barrier for opening.  FKBP12.6 induces a relaxation of the central domain that decouples it from the S6 bundle, stabilizing RyR2 in a closed state even in the presence of Ca2+ and PCB95.  Although the channel is open when PCB95 is replaced by caffeine and ATP, neither of the modulators alone can sufficiently counter the antagonistic effect to open the channel.  Our study marks an important step toward mechanistic understanding of the sophisticated regulation of this key channel whose aberrant activity engenders life-threatening cardiac disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPg0k5Ov7yLVg90H21EOLACvtfcHk0lhdnjHhd8vvzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1Kjtr0%253D&md5=0beff6206fe0c6a0ea1797f51f4d6211</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1914451116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1914451116%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DMolecular%2520Basis%2520for%2520Allosteric%2520Regulation%2520of%2520the%2520Type%25202%2520Ryanodine%2520Receptor%2520Channel%2520Gating%2520by%2520Key%2520Modulators%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D51%26spage%3D25575%26epage%3D25582%26doi%3D10.1073%2Fpnas.1914451116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Modulation of Cardiac Ryanodine Receptor 2 by Calmodulin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>572</i></span> (<span class="NLM_issue">7769</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1377-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fs41586-019-1377-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31278385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlalsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=572&publication_year=2019&pages=347-351&issue=7769&author=D.+Gongauthor=X.+Chiauthor=J.+Weiauthor=G.+Zhouauthor=G.+Huangauthor=L.+Zhangauthor=R.+Wangauthor=J.+Leiauthor=S.+R.+W.+Chenauthor=N.+Yan&title=Modulation+of+Cardiac+Ryanodine+Receptor+2+by+Calmodulin&doi=10.1038%2Fs41586-019-1377-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cardiac ryanodine receptor 2 by calmodulin</span></div><div class="casAuthors">Gong, Deshun; Chi, Ximin; Wei, Jinhong; Zhou, Gewei; Huang, Gaoxingyu; Zhang, Lin; Wang, Ruiwu; Lei, Jianlin; Chen, S. R. Wayne; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">572</span>
        (<span class="NLM_cas:issue">7769</span>),
    <span class="NLM_cas:pages">347-351</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The high-conductance intracellular calcium (Ca2+) channel RyR2 is essential for the coupling of excitation and contraction in cardiac muscle.  Among various modulators, calmodulin (CaM) regulates RyR2 in a Ca2+-dependent manner.  Here we reveal the regulatory mechanism by which porcine RyR2 is modulated by human CaM through the structural detn. of RyR2 under eight conditions.  Apo-CaM and Ca2+-CaM bind to distinct but overlapping sites in an elongated cleft formed by the handle, helical and central domains.  The shift in CaM-binding sites on RyR2 is controlled by Ca2+ binding to CaM, rather than to RyR2.  Ca2+-CaM induces rotations and intradomain shifts of individual central domains, resulting in pore closure of the PCB95 and Ca2+-activated channel.  By contrast, the pore of the ATP, caffeine and Ca2+-activated channel remains open in the presence of Ca2+-CaM, which suggests that Ca2+-CaM is one of the many competing modulators of RyR2 gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorBb4kRKtSmrVg90H21EOLACvtfcHk0lim2xujVwPe2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlalsL%252FE&md5=60af055b5123ddc58afdf25f4462dc42</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1377-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1377-y%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DD.%26aulast%3DChi%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%2BR.%2BW.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DModulation%2520of%2520Cardiac%2520Ryanodine%2520Receptor%25202%2520by%2520Calmodulin%26jtitle%3DNature%26date%3D2019%26volume%3D572%26issue%3D7769%26spage%3D347%26epage%3D351%26doi%3D10.1038%2Fs41586-019-1377-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantin, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noeske, T.</span></span> <span> </span><span class="NLM_article-title">Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs: Opportunities Provided by Physicochemical Property Modulation, in Silico Modeling, and Structural Modification</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2332</span>– <span class="NLM_lpage">2341</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.047068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fdmd.112.047068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22961681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslyjsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2332-2341&issue=12&author=D.+J.+Warnerauthor=H.+Chenauthor=L.+D.+Cantinauthor=J.+G.+Kennaauthor=S.+Stahlauthor=C.+L.+Walkerauthor=T.+Noeske&title=Mitigating+the+Inhibition+of+Human+Bile+Salt+Export+Pump+by+Drugs%3A+Opportunities+Provided+by+Physicochemical+Property+Modulation%2C+in+Silico+Modeling%2C+and+Structural+Modification&doi=10.1124%2Fdmd.112.047068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification</span></div><div class="casAuthors">Warner, Daniel J.; Chen, Hongming; Cantin, Louis-David; Kenna, J. Gerry; Stahl, Simone; Walker, Clare L.; Noeske, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2332-2341</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human bile salt export pump (BSEP) is a membrane protein expressed on the canalicular plasma membrane domain of hepatocytes, which mediates active transport of unconjugated and conjugated bile salts from liver cells into bile.  BSEP activity therefore plays an important role in bile flow.  In humans, genetically inherited defects in BSEP expression or activity cause cholestatic liver injury, and many drugs that cause cholestatic drug-induced liver injury (DILI) in humans have been shown to inhibit BSEP activity in vitro and in vivo.  These findings suggest that inhibition of BSEP activity by drugs could be one of the mechanisms that initiate human DILI.  To gain insight into the chem. features responsible for BSEP inhibition, we have used a recently described in vitro membrane vesicle BSEP inhibition assay to quantify transporter inhibition for a set of 624 compds.  The relationship between BSEP inhibition and mol. physicochem. properties was investigated, and our results show that lipophilicity and mol. size are significantly correlated with BSEP inhibition.  This data set was further used to build predictive BSEP classification models through multiple quant. structure-activity relationship modeling approaches.  The highest level of predictive accuracy was provided by a support vector machine model (accuracy = 0.87, κ = 0.74).  These analyses highlight the potential value that can be gained by combining computational methods with exptl. efforts in early stages of drug discovery projects to minimize the propensity of drug candidates to inhibit BSEP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBacqKvVpIzrVg90H21EOLACvtfcHk0lim2xujVwPe2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslyjsrbN&md5=99d21620afb687aa3fc4cea7a1c136b3</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.047068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.047068%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCantin%26aufirst%3DL.%2BD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DC.%2BL.%26aulast%3DNoeske%26aufirst%3DT.%26atitle%3DMitigating%2520the%2520Inhibition%2520of%2520Human%2520Bile%2520Salt%2520Export%2520Pump%2520by%2520Drugs%253A%2520Opportunities%2520Provided%2520by%2520Physicochemical%2520Property%2520Modulation%252C%2520in%2520Silico%2520Modeling%252C%2520and%2520Structural%2520Modification%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2332%26epage%3D2341%26doi%3D10.1124%2Fdmd.112.047068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Bruyn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Westen, G. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustijns, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annaert, P. P.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Identification of Oatp1b1/3 Inhibitorss</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1124/mol.112.084152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.112.084152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23571415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=1257-1267&issue=6&author=T.+De+Bruynauthor=G.+J.+P.+Van+Westenauthor=A.+P.+Ijzermanauthor=B.+Stiegerauthor=P.+De+Witteauthor=P.+F.+Augustijnsauthor=P.+P.+Annaert&title=Structure-Based+Identification+of+Oatp1b1%2F3+Inhibitorss&doi=10.1124%2Fmol.112.084152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based identification of OATP1B1/3 inhibitors</span></div><div class="casAuthors">De Bruyn, Tom; van Western, Gerard J. P.; IJzerman, Adriaan P.; Stieger, Bruno; de Witte, Peter; Augustijns, Patrick F.; Annaert, Pieter P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1257-1267</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Several recent studies show that inhibition of the hepatic transport proteins org. anion-transporting polypeptide 1B1 (OATP1B1) and 1B3 (OATP1B3) can result in clin. relevant drug-drug interactions (DDI).  To avoid late-stage development drug failures due to OATP1B-mediated DDI, predictive in vitro and in silico methods should be implemented at an early stage of the drug candidate evaluation process.  In the present study, we first developed a high-throughput in vitro transporter inhibition assay for the OATP1B subfamily.  A total of 2000 compds. were tested as potential modulators of the uptake of the OATP1B substrate sodium fluorescein, in OATP1B1- or 1B3-transfected Chinese hamster ovary cells.  At an equimolar substrate-inhibitor concn. of 10 μM, 212 and 139 mols. were identified as OATP1B1 and OATP1B3 inhibitors, resp. (min. 50% inhibition).  For 69 compds., previously not identified as OATP1B inhibitors, concn.-dependent inhibition was also detd., yielding Ki values ranging from 0.06 to 6.5 μM.  Based on these in vitro data, we subsequently developed a proteochemometrics-based in silico model, which predicted OATP1B inhibitors in the test group (20% of the dataset) with high specificity (86%) and sensitivity (78%).  Moreover, several physicochem. compd. properties and substructures related to OATP1B1/1B3 inhibition or inactivity were identified.  Finally, model performance was prospectively verified with a set of 54 compds. not included in the original dataset.  This validation indicated that 80 and 74% of the compds. were correctly classified for OATP1B1 and OATP1B3 inhibition, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoktLtqKIqWh7Vg90H21EOLACvtfcHk0lim2xujVwPe2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgtr8%253D&md5=bbf1617e8efba061f65b8f643baa5b98</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.084152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.084152%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruyn%26aufirst%3DT.%26aulast%3DVan%2BWesten%26aufirst%3DG.%2BJ.%2BP.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStieger%26aufirst%3DB.%26aulast%3DDe%2BWitte%26aufirst%3DP.%26aulast%3DAugustijns%26aufirst%3DP.%2BF.%26aulast%3DAnnaert%26aufirst%3DP.%2BP.%26atitle%3DStructure-Based%2520Identification%2520of%2520Oatp1b1%252F3%2520Inhibitorss%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26issue%3D6%26spage%3D1257%26epage%3D1267%26doi%3D10.1124%2Fmol.112.084152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakatis, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reese, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baines, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellens, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroso, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovatt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrton, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. E.</span></span> <span> </span><span class="NLM_article-title">Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for > 200 Compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1021/tx300075j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300075j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=2067-2082&issue=10&author=M.+Z.+Sakatisauthor=M.+J.+Reeseauthor=A.+W.+Harrellauthor=M.+A.+Taylorauthor=I.+A.+Bainesauthor=L.+Chenauthor=J.+C.+Bloomerauthor=E.+Y.+Yangauthor=H.+M.+Ellensauthor=J.+L.+Ambrosoauthor=C.+A.+Lovattauthor=A.+D.+Ayrtonauthor=S.+E.+Clarke&title=Preclinical+Strategy+to+Reduce+Clinical+Hepatotoxicity+Using+in+Vitro+Bioactivation+Data+for+%3E+200+Compounds&doi=10.1021%2Ftx300075j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds</span></div><div class="casAuthors">Sakatis, Melanie Z.; Reese, Melinda J.; Harrell, Andrew W.; Taylor, Maxine A.; Baines, Ian A.; Chen, Liangfu; Bloomer, Jackie C.; Yang, Eric Y.; Ellens, Harma M.; Ambroso, Jeffrey L.; Lovatt, Cerys A.; Ayrton, Andrew D.; Clarke, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2067-2082</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced liver injury is the most common cause of market withdrawal of pharmaceuticals, and thus, there is considerable need for better prediction models for DILI early in drug discovery.  We present a study involving 223 marketed drugs (51% assocd. with clin. hepatotoxicity; 49% non-hepatotoxic) to assess the concordance of in vitro bioactivation data with clin. hepatotoxicity and have used these data to develop a decision tree to help reduce late-stage candidate attrition.  Data to assess P 450 metab.-dependent inhibition (MDI) for all common drug-metabolizing P 450 enzymes were generated for 179 of these compds., GSH adduct data generated for 190 compds., covalent binding data obtained for 53 compds., and clin. dose data obtained for all compds.  Individual data for all 223 compds. are presented here and interrogated to det. what level of an alert to consider termination of a compd.  The anal. showed that 76% of drugs with a daily dose of <100 mg were non-hepatotoxic (p < 0.0001).  Drugs with a daily dose of ≥100 mg or with GSH adduct formation, marked P 450 MDI, or covalent binding ≥200 pmol eq/mg protein tended to be hepatotoxic (∼ 65% in each case).  Combining dose with each bioactivation assay increased this assocn. significantly (80-100%, p < 0.0001).  These analyses were then used to develop the decision tree and the tree tested using 196 of the compds. with sufficient data (49% hepatotoxic; 51% non-hepatotoxic).  The results of these outcome analyses demonstrated the utility of the tree in selectively terminating hepatotoxic compds. early; 45% of the hepatotoxic compds. evaluated using the tree were recommended for termination before candidate selection, whereas only 10% of the non-hepatotoxic compds. were recommended for termination.  An independent set of 10 GSK compds. with known clin. hepatotoxicity status were also assessed using the tree, with similar results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGEqQ7gmJubVg90H21EOLACvtfcHk0ljKjvOevFIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzJ&md5=d18465cd8981dfac512527bb04de3605</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Ftx300075j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300075j%26sid%3Dliteratum%253Aachs%26aulast%3DSakatis%26aufirst%3DM.%2BZ.%26aulast%3DReese%26aufirst%3DM.%2BJ.%26aulast%3DHarrell%26aufirst%3DA.%2BW.%26aulast%3DTaylor%26aufirst%3DM.%2BA.%26aulast%3DBaines%26aufirst%3DI.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBloomer%26aufirst%3DJ.%2BC.%26aulast%3DYang%26aufirst%3DE.%2BY.%26aulast%3DEllens%26aufirst%3DH.%2BM.%26aulast%3DAmbroso%26aufirst%3DJ.%2BL.%26aulast%3DLovatt%26aufirst%3DC.%2BA.%26aulast%3DAyrton%26aufirst%3DA.%2BD.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26atitle%3DPreclinical%2520Strategy%2520to%2520Reduce%2520Clinical%2520Hepatotoxicity%2520Using%2520in%2520Vitro%2520Bioactivation%2520Data%2520for%2520%253E%2520200%2520Compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D10%26spage%3D2067%26epage%3D2082%26doi%3D10.1021%2Ftx300075j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, B. L.</span></span> <span> </span><span class="NLM_article-title">Identification of Small Molecule Compounds with Higher Binding Affinity to Guanine Deaminase (Cypin) than Guanine</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6755</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2010.07.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20716488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6748-6755&issue=18&author=J.+R.+Fern%C3%A1ndezauthor=E.+S.+Sweetauthor=W.+J.+Welshauthor=B.+L.+Firestein&title=Identification+of+Small+Molecule+Compounds+with+Higher+Binding+Affinity+to+Guanine+Deaminase+%28Cypin%29+than+Guanine&doi=10.1016%2Fj.bmc.2010.07.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine</span></div><div class="casAuthors">Fernandez, Jose R.; Sweet, Eric S.; Welsh, William J.; Firestein, Bonnie L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6748-6755</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Guanine deaminase (GDA; cypin) is an important metalloenzyme that processes the first step in purine catabolism, converting guanine to xanthine by hydrolytic deamination.  In higher eukaryotes, GDA also plays an important role in the development of neuronal morphol. by regulating dendritic arborization.  In addn. to its role in the maturing brain, GDA is thought to be involved in proper liver function since increased levels of GDA activity have been correlated with liver disease and transplant rejection.  Although mammalian GDA is an attractive and potential drug target for treatment of both liver diseases and cognitive disorders, prospective novel inhibitors and/or activators of this enzyme have not been actively pursued.  In this study, we employed the combination of protein structure anal. and exptl. kinetic studies to seek novel potential ligands for human guanine deaminase.  Using virtual screening and biochem. anal., we identified common small mol. compds. that demonstrate a higher binding affinity to GDA than does guanine.  In vitro anal. demonstrates that these compds. inhibit guanine deamination, and more surprisingly, affect GDA (cypin)-mediated microtubule assembly.  The results in this study provide evidence that an in silico drug discovery strategy coupled with in vitro validation assays can be successfully implemented to discover compds. that may possess therapeutic value for the treatment of diseases and disorders where GDA activity is abnormal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyxCCWhr_WrLVg90H21EOLACvtfcHk0ljKjvOevFIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamt77E&md5=9deb171280c1ee8d9fb48174faca84a2</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.054%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DJ.%2BR.%26aulast%3DSweet%26aufirst%3DE.%2BS.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26aulast%3DFirestein%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520Small%2520Molecule%2520Compounds%2520with%2520Higher%2520Binding%2520Affinity%2520to%2520Guanine%2520Deaminase%2520%2528Cypin%2529%2520than%2520Guanine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26issue%3D18%26spage%3D6748%26epage%3D6755%26doi%3D10.1016%2Fj.bmc.2010.07.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitcheson, J. S.</span></span> <span> </span><span class="NLM_article-title">Direct Block of Human Ether-a-Go-Go-Related Gene Potassium Channels by Caffeine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>316</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.094755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fjpet.105.094755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16227470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=860-868&issue=2&author=S.+L.+Cockerillauthor=J.+S.+Mitcheson&title=Direct+Block+of+Human+Ether-a-Go-Go-Related+Gene+Potassium+Channels+by+Caffeine&doi=10.1124%2Fjpet.105.094755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Direct block of human ether-a-go-go-related gene potassium channels by caffeine</span></div><div class="casAuthors">Cockerill, S. L.; Mitcheson, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">860-868</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human ether-a-go-go-related gene (hERG) potassium channel is expressed in a variety of cell types, including neurons, tumor cells, and cardiac myocytes.  In the heart, it is important for repolarization of the cardiac action potential.  Attenuation of hERG current can cause long QT syndrome and cardiac arrhythmias such as torsades de pointes.  Caffeine is frequently used as a pharmacol. tool to study calcium-dependent transduction pathways in cellular prepns.  It raises cytosolic calcium by opening ryanodine receptors and may also inhibit phosphodiesterases to increase cytosolic cAMP.  In this study, we show 5 mM caffeine rapidly and reversibly attenuates hERG currents expressed in human embryonic kidney 293 cells to 61.1 ± 2.2% of control.  Caffeine-dependent inhibition of hERG current is not altered by raising cAMP with forskolin, buffering cytosolic calcium with BAPTA, or inhibition of protein kinase C.  Thus, the effects of caffeine are unlikely to be mediated by cAMP or intracellular calcium-dependent mechanisms.  Further expts. showed caffeine directly blocks hERG in an open state-dependent manner.  Furthermore, caffeine inhibition is greatly reduced by the pore mutants Y562A and F656A hERG, which disrupt block of most previously tested hERG antagonists.  Thus, caffeine attenuates hERG currents by binding to a drug receptor located within the inner cavity of the channel.  Dietary intake of caffeine is unlikely to cause long QT syndrome because plasma concns. do not reach sufficiently high levels to significantly inhibit hERG currents.  However, the effects of caffeine have implications for its use in examing calcium-dependent pathways in cellular prepns. expressing hERG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyYdul8sWTtLVg90H21EOLACvtfcHk0ljKjvOevFIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqt7Y%253D&md5=c0da3b4b41da9abd6f8a4c8e149b0e03</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.094755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.094755%26sid%3Dliteratum%253Aachs%26aulast%3DCockerill%26aufirst%3DS.%2BL.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DDirect%2520Block%2520of%2520Human%2520Ether-a-Go-Go-Related%2520Gene%2520Potassium%2520Channels%2520by%2520Caffeine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26issue%3D2%26spage%3D860%26epage%3D868%26doi%3D10.1124%2Fjpet.105.094755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauly, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carty, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeller, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treadway, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletterick, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, Y. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myszka, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, V. L.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(02)00186-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS1074-5521%2802%2900186-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12204691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=915-924&issue=8&author=J.+L.+Ekstromauthor=T.+A.+Paulyauthor=M.+D.+Cartyauthor=W.+C.+Soellerauthor=J.+Culpauthor=D.+E.+Danleyauthor=D.+J.+Hooverauthor=J.+L.+Treadwayauthor=E.+M.+Gibbsauthor=R.+J.+Fletterickauthor=Y.+S.+N.+Dayauthor=D.+G.+Myszkaauthor=V.+L.+Rath&title=Structure-Activity+Analysis+of+the+Purine+Binding+Site+of+Human+Liver+Glycogen+Phosphorylase&doi=10.1016%2FS1074-5521%2802%2900186-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase</span></div><div class="casAuthors">Ekstrom, Jennifer L.; Pauly, Thomas A.; Carty, Maynard D.; Soeller, Walter C.; Culp, Jeff; Danley, Dennis E.; Hoover, Dennis J.; Treadway, Judith L.; Gibbs, E. Michael; Fletterick, Robert J.; Day, Yasmina S. N.; Myszka, David G.; Rath, Virginia L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">915-924</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human liver glycogen phosphorylase (HLGP) catalyzes the breakdown of glycogen to maintain serum glucose levels and is a therapeutic target for diabetes.  HLGP is regulated by multiple interacting allosteric sites, each of which is a potential drug binding site.  We used surface plasmon resonance (SPR) to screen for compds. that bind to the purine allosteric inhibitor site.  We detd. the affinities of a series of compds. and solved the crystal structures of three representative ligands with KD values from 17-550 μM. The crystal structures reveal that the affinities are partly detd. by ligand-specific water-mediated hydrogen bonds and side chain movements.  These effects could not be predicted; both crystallog. and SPR studies were required to understand the important features of binding and together provide a basis for the design of new allosteric inhibitors targeting this site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX0KNJxlGrt7Vg90H21EOLACvtfcHk0ljKjvOevFIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVCiu7g%253D&md5=53286b2a1386828dad2b9c6a6a0254a5</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900186-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900186-2%26sid%3Dliteratum%253Aachs%26aulast%3DEkstrom%26aufirst%3DJ.%2BL.%26aulast%3DPauly%26aufirst%3DT.%2BA.%26aulast%3DCarty%26aufirst%3DM.%2BD.%26aulast%3DSoeller%26aufirst%3DW.%2BC.%26aulast%3DCulp%26aufirst%3DJ.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26aulast%3DTreadway%26aufirst%3DJ.%2BL.%26aulast%3DGibbs%26aufirst%3DE.%2BM.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26aulast%3DDay%26aufirst%3DY.%2BS.%2BN.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DRath%26aufirst%3DV.%2BL.%26atitle%3DStructure-Activity%2520Analysis%2520of%2520the%2520Purine%2520Binding%2520Site%2520of%2520Human%2520Liver%2520Glycogen%2520Phosphorylase%26jtitle%3DChem.%2520Biol.%26date%3D2002%26volume%3D9%26issue%3D8%26spage%3D915%26epage%3D924%26doi%3D10.1016%2FS1074-5521%2802%2900186-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickett, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucheron, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peat, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheckler, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiel, J. E.</span></span> <span> </span><span class="NLM_article-title">Anthranilimide Based Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes. Part 3: X-Ray Crystallographic Characterization, Core and Urea Optimization and in Vivo Efficacy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2008.12.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19138846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1177-1182&issue=4&author=S.+A.+Thomsonauthor=P.+Bankerauthor=D.+M.+Bickettauthor=J.+A.+Boucheronauthor=H.+L.+Carterauthor=D.+C.+Clancyauthor=J.+P.+Cooperauthor=S.+H.+Dickersonauthor=D.+M.+Garridoauthor=R.+T.+Nolteauthor=A.+J.+Peatauthor=L.+R.+Shecklerauthor=S.+M.+Sparksauthor=F.+X.+Tavaresauthor=L.+Wangauthor=T.+Y.+Wangauthor=J.+E.+Weiel&title=Anthranilimide+Based+Glycogen+Phosphorylase+Inhibitors+for+the+Treatment+of+Type+2+Diabetes.+Part+3%3A+X-Ray+Crystallographic+Characterization%2C+Core+and+Urea+Optimization+and+in+Vivo+Efficacy&doi=10.1016%2Fj.bmcl.2008.12.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy</span></div><div class="casAuthors">Thomson, Stephen A.; Banker, Pierette; Bickett, D. Mark; Boucheron, Joyce A.; Carter, H. Luke; Clancy, Daphne C.; Cooper, Joel P.; Dickerson, Scott H.; Garrido, Dulce M.; Nolte, Robert T.; Peat, Andrew J.; Sheckler, Lauren R.; Sparks, Steven M.; Tavares, Francis X.; Wang, Liping; Wang, Tony Y.; Weiel, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1177-1182</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Key binding interactions of the anthranilimide based glycogen phosphorylase a (GPa) inhibitor 2 (I) from X-ray crystallog. studies are described.  This series of compds. bind to the AMP site of GP.  Using the binding information the core and the Ph urea moieties were optimized.  This work culminated in the identification of compds. with single nanomolar potency as well as in vivo efficacy in a diabetic model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphRT7sQox7cbVg90H21EOLACvtfcHk0lg5UjsAO752Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wrtbs%253D&md5=17be0404e673b2ced3c0a4cbdd80a9ca</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.085%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DS.%2BA.%26aulast%3DBanker%26aufirst%3DP.%26aulast%3DBickett%26aufirst%3DD.%2BM.%26aulast%3DBoucheron%26aufirst%3DJ.%2BA.%26aulast%3DCarter%26aufirst%3DH.%2BL.%26aulast%3DClancy%26aufirst%3DD.%2BC.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DGarrido%26aufirst%3DD.%2BM.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DPeat%26aufirst%3DA.%2BJ.%26aulast%3DSheckler%26aufirst%3DL.%2BR.%26aulast%3DSparks%26aufirst%3DS.%2BM.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%2BY.%26aulast%3DWeiel%26aufirst%3DJ.%2BE.%26atitle%3DAnthranilimide%2520Based%2520Glycogen%2520Phosphorylase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes.%2520Part%25203%253A%2520X-Ray%2520Crystallographic%2520Characterization%252C%2520Core%2520and%2520Urea%2520Optimization%2520and%2520in%2520Vivo%2520Efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D4%26spage%3D1177%26epage%3D1182%26doi%3D10.1016%2Fj.bmcl.2008.12.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnier-Maréchal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, S.</span></span> <span> </span><span class="NLM_article-title">Glycogen Phosphorylase Inhibitors: A Patent Review (2013–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1131268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1517%2F13543776.2016.1131268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26666989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvV2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=199-212&issue=2&author=M.+Donnier-Mar%C3%A9chalauthor=S.+Vidal&title=Glycogen+Phosphorylase+Inhibitors%3A+A+Patent+Review+%282013%E2%80%932015%29&doi=10.1517%2F13543776.2016.1131268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen phosphorylase inhibitors: a patent review (2013 - 2015)</span></div><div class="casAuthors">Donnier-Marechal, Marion; Vidal, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-212</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Control of glycemia is crucial in the treatment of type 2 diabetes complications.  Glycogen phosphorylase (GP) releases glucose from the liver into the blood stream.  Design of potent GP inhibitors is a therapeutic strategy in the context of type 2 diabetes.: Glucose-based inhibitors have found potential applications since they now reach low nanomolar Ki values.  Another set of patents disclose cholic acid/7-aza-indole conjugates for targeted drug delivery to the liver.  A series of benzazepinones have also been reported as potent GP inhibitors.  In vitro data are reported for GP inhibition but the in vivo biol. data at the cellular or animal levels are often missing, even though the literature reported for these mols. is also discussed.  A structural analogy between glucose-based GP inhibitors and C-glucosides targeting sodium glucose co-transporter 2 (SGLT2) is intriguing.  Cholic acid/7-aza-indole conjugates are promising in vivo drug delivery systems to the liver.  Benzazepinones were very recently described and no assocd. literature is available, making it very difficult to comment at present.  While industry has slowed down on GP inhibitors design, academic groups are pursuing investigations and have provided potential drug candidates which will resuscitate the interest for GP, including its potential for targeting cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Kt29l6dTNrVg90H21EOLACvtfcHk0lg5UjsAO752Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvV2isg%253D%253D&md5=87f2746aa24058fcf3e0117a41b789fd</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1131268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1131268%26sid%3Dliteratum%253Aachs%26aulast%3DDonnier-Mar%25C3%25A9chal%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DS.%26atitle%3DGlycogen%2520Phosphorylase%2520Inhibitors%253A%2520A%2520Patent%2520Review%2520%25282013%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D199%26epage%3D212%26doi%3D10.1517%2F13543776.2016.1131268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Withers, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasvinsky, P. J.</span></span> <span> </span><span class="NLM_article-title">Identical Structural Changes Induced in Glycogen Phosphorylase by Two Nonexclusive Allosteric Inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">5342</span>– <span class="NLM_lpage">5348</span>, <span class="refDoi"> DOI: 10.1021/bi00591a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00591a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3cXitlKh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=5342-5348&issue=24&author=S.+G.+Withersauthor=B.+D.+Sykesauthor=N.+B.+Madsenauthor=P.+J.+Kasvinsky&title=Identical+Structural+Changes+Induced+in+Glycogen+Phosphorylase+by+Two+Nonexclusive+Allosteric+Inhibitors&doi=10.1021%2Fbi00591a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Identical structural changes induced in glycogen phosphorylase by two nonexclusive allosteric inhibitors</span></div><div class="casAuthors">Withers, Stephen G.; Sykes, Brian D.; Madsen, Neil B.; Kasvinsky, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5342-8</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Recent kinetic studies on the regulation of glycogen phosphorylase by the synergistic inhibitors, caffeine and glucose, in conjunction with x-ray crystallog. data, led to the proposal of a mol. mechanism for this process in which the 2 effectors bind at sep. sites.  These effects were studied in soln. at 2 different structural levels by other techniques.  Ultracentrifugation studies of the quaternary structure of phosphorylase a showed the formation of dimers from tetramers on addn. of these ligands independently and cooperative promotion of dimer formation when added together.  The effect of the ligands on tertiary structure was investigated by studying the protection against iodoacetamide inactivation of enzyme activity afforded by these ligands.  31P NMR studies of the catalytically essential pyridoxal phosphate residue of AMP-activated phosphorylase b indicated a conversion from the active to the inactive form, possibly involving a protonation of the coenzyme phosphate, on addn. of either of these ligands.  This suggests a similar active-site environment in the 2 cases, identical with that obsd. in the absence of the activator, AMP.  The effect of these ligands on the 31P resonance of the analogous 5'-thioadenosine 5'-phosphate activator was also similar.  Despite sep. and distant binding sites for the 2 inhibitors, the effects on the gross structure of the enzyme at the quaternary and tertiary levels and their effect on a catalytically essential group are both identical and cooperative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr__RpvvV3337Vg90H21EOLACvtfcHk0lhLmqfNsNvrbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXitlKh&md5=c657e7a0bc75559d84fec38011340f8b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fbi00591a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00591a013%26sid%3Dliteratum%253Aachs%26aulast%3DWithers%26aufirst%3DS.%2BG.%26aulast%3DSykes%26aufirst%3DB.%2BD.%26aulast%3DMadsen%26aufirst%3DN.%2BB.%26aulast%3DKasvinsky%26aufirst%3DP.%2BJ.%26atitle%3DIdentical%2520Structural%2520Changes%2520Induced%2520in%2520Glycogen%2520Phosphorylase%2520by%2520Two%2520Nonexclusive%2520Allosteric%2520Inhibitors%26jtitle%3DBiochemistry%26date%3D1979%26volume%3D18%26issue%3D24%26spage%3D5342%26epage%3D5348%26doi%3D10.1021%2Fbi00591a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kakugawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langton, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bineva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijders, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span> <span> </span><span class="NLM_article-title">Notum Deacylates Wnt Proteins to Suppress Signalling Activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>519</i></span> (<span class="NLM_issue">7542</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1038/nature14259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fnature14259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25731175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=2015&pages=187-192&issue=7542&author=S.+Kakugawaauthor=P.+F.+Langtonauthor=M.+Zebischauthor=S.+A.+Howellauthor=T.+H.+Changauthor=Y.+Liuauthor=T.+Feiziauthor=G.+Binevaauthor=N.+O%E2%80%99Reillyauthor=A.+P.+Snijdersauthor=E.+Y.+Jonesauthor=J.+P.+Vincent&title=Notum+Deacylates+Wnt+Proteins+to+Suppress+Signalling+Activity&doi=10.1038%2Fnature14259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Notum deacylates Wnt proteins to suppress signalling activity</span></div><div class="casAuthors">Kakugawa, Satoshi; Langton, Paul F.; Zebisch, Matthias; Howell, Steven A.; Chang, Tao-Hsin; Liu, Yan; Feizi, Ten; Bineva, Ganka; O'Reilly, Nicola; Snijders, Ambrosius P.; Jones, E. Yvonne; Vincent, Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">519</span>
        (<span class="NLM_cas:issue">7542</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Signalling by Wnt proteins is finely balanced to ensure normal development and tissue homeostasis while avoiding diseases such as cancer.  This is achieved in part by Notum, a highly conserved secreted feedback antagonist.  Notum has been thought to act as a phospholipase, shedding glypicans and assocd. Wnt proteins from the cell surface.  However, this view fails to explain specificity, as glypicans bind many extracellular ligands.  Here we provide genetic evidence in Drosophila that Notum requires glypicans to suppress Wnt signalling, but does not cleave their glycophosphatidylinositol anchor.  Structural analyses reveal glycosaminoglycan binding sites on Notum, which probably help Notum to co-localize with Wnt proteins.  They also identify, at the active site of human and Drosophila Notum, a large hydrophobic pocket that accommodates palmitoleate.  Kinetic and mass spectrometric analyses of human proteins show that Notum is a carboxylesterase that removes an essential palmitoleate moiety from Wnt proteins and thus constitutes the first known extracellular protein deacylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqffMMn2oxsbLVg90H21EOLACvtfcHk0lhLmqfNsNvrbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCnsb4%253D&md5=0668dc3cdc07e4bd527551424c4b91d4</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnature14259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14259%26sid%3Dliteratum%253Aachs%26aulast%3DKakugawa%26aufirst%3DS.%26aulast%3DLangton%26aufirst%3DP.%2BF.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DHowell%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DT.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DBineva%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DN.%26aulast%3DSnijders%26aufirst%3DA.%2BP.%26aulast%3DJones%26aufirst%3DE.%2BY.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26atitle%3DNotum%2520Deacylates%2520Wnt%2520Proteins%2520to%2520Suppress%2520Signalling%2520Activity%26jtitle%3DNature%26date%3D2015%26volume%3D519%26issue%3D7542%26spage%3D187%26epage%3D192%26doi%3D10.1038%2Fnature14259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span> <span> </span><span class="NLM_article-title">Caffeine Inhibits Notum Activity by Binding at the Catalytic Pocket</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">555</span>, <span class="refDoi"> DOI: 10.1038/s42003-020-01286-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fs42003-020-01286-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33033363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVagtLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=555&issue=1&author=Y.+Zhaoauthor=J.+Renauthor=J.+Hillierauthor=W.+Luauthor=E.+Y.+Jones&title=Caffeine+Inhibits+Notum+Activity+by+Binding+at+the+Catalytic+Pocket&doi=10.1038%2Fs42003-020-01286-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits Notum activity by binding at the catalytic pocket</span></div><div class="casAuthors">Zhao, Yuguang; Ren, Jingshan; Hillier, James; Lu, Weixian; Jones, Edith Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Communications Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">555</span>CODEN:
                <span class="NLM_cas:coden">CBOIDQ</span>;
        ISSN:<span class="NLM_cas:issn">2399-3642</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Notum inhibits Wnt signalling via enzymic delipidation of Wnt ligands.  Restoration of Wnt signalling by small mol. inhibition of Notum may be of therapeutic benefit in a no. of pathologies including Alzheimer's disease.  Here we report Notum activity can be inhibited by caffeine (IC50 19μM), but not by demethylated caffeine metabolites: paraxanthine, theobromine and theophylline.  Cellular luciferase assays show Notum-suppressed Wnt3a function can be restored by caffeine with an EC50 of 46μM.  The dissocn. const. (Kd) between Notum and caffeine is 85μM as measured by surface plasmon resonance.  High-resoln. crystal structures of Notum complexes with caffeine and its minor metabolite theophylline show both compds. bind at the center of the enzymic pocket, overlapping the position of the natural substrate palmitoleic lipid, but using different binding modes.  The structural information reported here may be of relevance for the design of more potent brain-accessible Notum inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNuUwQPa65-LVg90H21EOLACvtfcHk0lhLmqfNsNvrbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVagtLbK&md5=b0691d717c92ae19707ac18226deadfc</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fs42003-020-01286-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-020-01286-5%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHillier%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DE.%2BY.%26atitle%3DCaffeine%2520Inhibits%2520Notum%2520Activity%2520by%2520Binding%2520at%2520the%2520Catalytic%2520Pocket%26jtitle%3DCommun.%2520Biol.%26date%3D2020%26volume%3D3%26issue%3D1%26spage%3D555%26doi%3D10.1038%2Fs42003-020-01286-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopke, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadie, K.</span></span> <span> </span><span class="NLM_article-title">Notum Coordinates Synapse Development via Extracellular Regulation of Wingless Trans-Synaptic Signaling</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>144</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3499</span>– <span class="NLM_lpage">3510</span>, <span class="refDoi"> DOI: 10.1242/dev.148130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1242%2Fdev.148130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28860114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVGhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2017&pages=3499-3510&issue=19&author=D.+L.+Kopkeauthor=S.+C.+Limaauthor=C.+Alexandreauthor=K.+Broadie&title=Notum+Coordinates+Synapse+Development+via+Extracellular+Regulation+of+Wingless+Trans-Synaptic+Signaling&doi=10.1242%2Fdev.148130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Notum coordinates synapse development via extracellular regulation of Wingless trans-synaptic signaling</span></div><div class="casAuthors">Kopke, Danielle L.; Lima, Sofia C.; Alexandre, Cyrille; Broadie, Kendal</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3499-3510</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">1477-9129</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Synaptogenesis requires orchestrated communication between preand postsynaptic cells via coordinated trans-synaptic signaling across the extracellular synaptomatrix.  The first Wnt signaling ligand discovered, Drosophila Wingless (Wg; Wnt1 in mammals), plays crucial roles in synaptic development, regulating synapse architecture as well as functional differentiation.  Here, we investigate synaptogenic functions of the secreted extracellular deacylase Notum, which restricts Wg signaling by cleaving an essential palmitoleate moiety.  At the glutamatergic neuromuscular junction (NMJ) synapse, we find that Notum secreted from the postsynaptic muscle acts to strongly modulate synapse growth, structural architecture, ultrastructural development and functional differentiation.  In Notum null flies, we find upregulated extracellular Wg ligand and nuclear trans-synaptic signal transduction, as well as downstream misregulation of both pre- and postsynaptic mol. assembly.  Structural, functional and mol. synaptogenic defects are all phenocopied by Wg overexpression, suggesting that Notum acts solely by inhibiting Wg trans-synaptic signaling.  Moreover, these synaptic development phenotypes are suppressed by genetically correcting Wg levels in Notum null mutants, indicating that Notum normally functions to coordinate synaptic structural and functional differentiation via neg. regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3bUmmo78O57Vg90H21EOLACvtfcHk0lhLmqfNsNvrbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVGhsrk%253D&md5=81000278c27a5e13b8c815ab23cc280b</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1242%2Fdev.148130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.148130%26sid%3Dliteratum%253Aachs%26aulast%3DKopke%26aufirst%3DD.%2BL.%26aulast%3DLima%26aufirst%3DS.%2BC.%26aulast%3DAlexandre%26aufirst%3DC.%26aulast%3DBroadie%26aufirst%3DK.%26atitle%3DNotum%2520Coordinates%2520Synapse%2520Development%2520via%2520Extracellular%2520Regulation%2520of%2520Wingless%2520Trans-Synaptic%2520Signaling%26jtitle%3DDevelopment%26date%3D2017%26volume%3D144%26issue%3D19%26spage%3D3499%26epage%3D3510%26doi%3D10.1242%2Fdev.148130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amado, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abreu, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Notum Is Required for Neural and Head Induction via Wnt Deacylation, Oxidation, and Inactivation</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.devcel.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25771893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=719-730&issue=6&author=X.+Zhangauthor=S.+M.+Cheongauthor=N.+G.+Amadoauthor=A.+H.+Reisauthor=B.+T.+MacDonaldauthor=M.+Zebischauthor=E.+Y.+Jonesauthor=J.+G.+Abreuauthor=X.+He&title=Notum+Is+Required+for+Neural+and+Head+Induction+via+Wnt+Deacylation%2C+Oxidation%2C+and+Inactivation&doi=10.1016%2Fj.devcel.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Notum Is Required for Neural and Head Induction via Wnt Deacylation, Oxidation, and Inactivation</span></div><div class="casAuthors">Zhang, Xinjun; Cheong, Seong-Moon; Amado, Nathalia G.; Reis, Alice H.; MacDonald, Bryan T.; Zebisch, Matthias; Jones, E. Yvonne; Abreu, Jose Garcia; He, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Secreted Wnt morphogens are essential for embryogenesis and homeostasis and require a lipid/palmitoleoylate modification for receptor binding and activity.  Notum is a secreted Wnt antagonist that belongs to the α/β hydrolase superfamily, but its mechanism of action and roles in vertebrate embryogenesis are not fully understood.  Here, we report that Notum hydrolyzes the Wnt palmitoleoylate adduct extracellularly, resulting in inactivated Wnt proteins that form oxidized oligomers incapable of receptor binding.  Thus, Notum is a Wnt deacylase, and palmitoleoylation is obligatory for the Wnt structure that maintains its active monomeric conformation.  Notum is expressed in naive ectoderm and neural plate in Xenopus and is required for neural and head induction.  These findings suggest that Notum is a prerequisite for the "default" neural fate and that distinct mechanisms of Wnt inactivation by the Tiki protease in the Organizer and the Notum deacylase in presumptive neuroectoderm orchestrate vertebrate brain development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxen8RtuF37Vg90H21EOLACvtfcHk0lji8yKpIBP6vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVaisLk%253D&md5=2f5bd637c5b10522452933e9592a888b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCheong%26aufirst%3DS.%2BM.%26aulast%3DAmado%26aufirst%3DN.%2BG.%26aulast%3DReis%26aufirst%3DA.%2BH.%26aulast%3DMacDonald%26aufirst%3DB.%2BT.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DE.%2BY.%26aulast%3DAbreu%26aufirst%3DJ.%2BG.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DNotum%2520Is%2520Required%2520for%2520Neural%2520and%2520Head%2520Induction%2520via%2520Wnt%2520Deacylation%252C%2520Oxidation%252C%2520and%2520Inactivation%26jtitle%3DDev.%2520Cell%26date%3D2015%26volume%3D32%26issue%3D6%26spage%3D719%26epage%3D730%26doi%3D10.1016%2Fj.devcel.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. G.</span></span> <span> </span><span class="NLM_article-title">NOTUM Is Involved in the Progression of Colorectal Cancer</span>. <i>Cancer Genomics Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.21873/cgp.20107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.21873%2Fcgp.20107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30343282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWlsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=485-497&issue=6&author=J.+H.+Yoonauthor=D.+Kimauthor=J.+Kimauthor=H.+Leeauthor=J.+Ghimauthor=B.+J.+Kangauthor=P.+Songauthor=P.+G.+Suhauthor=S.+H.+Ryuauthor=T.+G.+Lee&title=NOTUM+Is+Involved+in+the+Progression+of+Colorectal+Cancer&doi=10.21873%2Fcgp.20107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">NOTUM Is involved in the progression of colorectal cancer</span></div><div class="casAuthors">Yoon, Jong Hyuk; Kim, Dayea; Kim, Jaeyoon; Lee, Hyeongjoo; Ghim, Jaewang; Kang, Byung Jun; Song, Parkyong; Suh, Pann-Ghill; Ryu, Sung Ho; Lee, Taehoon G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Genomics & Proteomics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">485-497</span>CODEN:
                <span class="NLM_cas:coden">CGPAC7</span>;
        ISSN:<span class="NLM_cas:issn">1790-6245</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: There are limitations to current colorectal cancer (CRC)-specific diagnostic methods and therapies.  Tumorigenesis proceeds because of interaction between cancer cells and various surrounding cells; discovering new mol. mediators through studies of the CRC secretome is a promising approach for the development of CRC diagnostics and therapies.  Materials and Methods: A comparative secretomic anal. was performed using primary and metastatic human isogenic CRC cells.  Proliferation was detd. by MTT and thymidine incorporation assay, migration was detd. by wound-healing assay (ELISA).  The level of palmitoleoyl-protein carboxylesterase (NOTUM) in plasma from patients with CRC was detd. by ELISA.  Results: NOTUM expression was increased in metastatic cells.  Proliferation was suppressed by inhibiting expression of NOTUM.  Knockdown of NOTUM genes inhibited proliferation as well as migration, with possible involvement of p38 and c-JUN N-terminal kinase in this process.  The result was verified in patients with CRC.  Conclusion: NOTUM may be a new candidate for diagnostics and therapy of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUMxJxU9DSy7Vg90H21EOLACvtfcHk0lji8yKpIBP6vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWlsr%252FM&md5=9970defbfb6dc7da63d869e2ba28909f</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.21873%2Fcgp.20107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fcgp.20107%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DGhim%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DB.%2BJ.%26aulast%3DSong%26aufirst%3DP.%26aulast%3DSuh%26aufirst%3DP.%2BG.%26aulast%3DRyu%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BG.%26atitle%3DNOTUM%2520Is%2520Involved%2520in%2520the%2520Progression%2520of%2520Colorectal%2520Cancer%26jtitle%3DCancer%2520Genomics%2520Proteomics%26date%3D2018%26volume%3D15%26issue%3D6%26spage%3D485%26epage%3D497%26doi%3D10.21873%2Fcgp.20107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Robertis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arigoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loiacono, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feodorova, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashkova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belovejdov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signori, E.</span></span> <span> </span><span class="NLM_article-title">Novel Insights into Notum and Glypicans Regulation in Colorectal Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">41237</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.5652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.18632%2Foncotarget.5652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26517809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC28zmvFWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=41237-41257&issue=38&author=M.+De+Robertisauthor=M.+Arigoniauthor=L.+Loiaconoauthor=F.+Riccardoauthor=R.+A.+Calogeroauthor=Y.+Feodorovaauthor=D.+Tashkovaauthor=V.+Belovejdovauthor=V.+Sarafianauthor=F.+Cavalloauthor=E.+Signori&title=Novel+Insights+into+Notum+and+Glypicans+Regulation+in+Colorectal+Cancer&doi=10.18632%2Foncotarget.5652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insights into Notum and glypicans regulation in colorectal cancer</span></div><div class="casAuthors">De Robertis Mariangela; Signori Emanuela; De Robertis Mariangela; Signori Emanuela; Arigoni Maddalena; Riccardo Federica; Calogero Raffaele Adolfo; Cavallo Federica; Loiacono Luisa; Loiacono Luisa; Feodorova Yana; Sarafian Victoria; Feodorova Yana; Sarafian Victoria; Tashkova Dessislava; Belovejdov Vesselin</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">41237-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The connection between colorectal cancer (CRC) and Wnt signaling pathway activation is well known, but full elucidation of the underlying regulation of the Wnt/β-catenin pathway and its biological functions in CRC pathogenesis is still needed.  Here, the azoxymethane/dextran sulfate sodium salt (AOM/DSS) murine model has been used as an experimental platform able to mimic human sporadic CRC development with predictable timing.  We performed genome-wide expression profiling of AOM/DSS-induced tumors and normal colon mucosa to identify potential novel CRC biomarkers.  Remarkably, the enhanced expression of Notum, a conserved feedback antagonist of Wnt, was observed in tumors along with alterations in Glypican-1 and Glypican-3 levels.  These findings were confirmed in a set of human CRC samples.  Here, we provide the first demonstration of significant changes in Notum and glypicans gene expression during CRC development and present evidence to suggest them as potential new biomarkers of CRC pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0GkyBU1_ZNzUE-swuRqsHfW6udTcc2ea6U-Vypo6hKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zmvFWmtA%253D%253D&md5=69b67b7e73f637ec243dfb8e98d39a6d</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5652%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRobertis%26aufirst%3DM.%26aulast%3DArigoni%26aufirst%3DM.%26aulast%3DLoiacono%26aufirst%3DL.%26aulast%3DRiccardo%26aufirst%3DF.%26aulast%3DCalogero%26aufirst%3DR.%2BA.%26aulast%3DFeodorova%26aufirst%3DY.%26aulast%3DTashkova%26aufirst%3DD.%26aulast%3DBelovejdov%26aufirst%3DV.%26aulast%3DSarafian%26aufirst%3DV.%26aulast%3DCavallo%26aufirst%3DF.%26aulast%3DSignori%26aufirst%3DE.%26atitle%3DNovel%2520Insights%2520into%2520Notum%2520and%2520Glypicans%2520Regulation%2520in%2520Colorectal%2520Cancer%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26issue%3D38%26spage%3D41237%26epage%3D41257%26doi%3D10.18632%2Foncotarget.5652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olssont, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Species Differences in Structure-Activity Relationships of Adenosine Agonists and Xanthine Antagonists at Brain A1 Adenosine Receptors</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(86)81096-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0014-5793%2886%2981096-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3803571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2sXnvVamtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=1986&pages=122-128&issue=1&author=D.+Ukenaauthor=K.+A.+Jacobsonauthor=W.+L.+Padgettauthor=C.+Ayalaauthor=M.+T.+Shamimauthor=K.+L.+Kirkauthor=R.+O.+Olssontauthor=J.+W.+Daly&title=Species+Differences+in+Structure-Activity+Relationships+of+Adenosine+Agonists+and+Xanthine+Antagonists+at+Brain+A1+Adenosine+Receptors&doi=10.1016%2F0014-5793%2886%2981096-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors</span></div><div class="casAuthors">Ukena, Dieter; Jacobson, Kenneth A.; Padgett, William L.; Ayala, Cristina; Shamim, Mah T.; Kirk, Kenneth L.; Olsson, Ray O.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-8</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">A series of 28 adenosine analogs and 17 xanthines were assessed as inhibitors of N6-[-[3H]phenylisopropyladenosine binding to A1 adenosine receptors in membranes from rat, calf, and guinea pig brain.  Potencies of N6-alkyl- and N6-cycloalkyladenosines are similar in the different species.  However, the presence of an aryl or heteroaryl moiety in the N6 substituent results in marked species differences with certain such analogs being about 30-fold more potent at receptors in calf than in guinea pig brain.  Potencies at receptors in rat brain are intermediate.  Conversely, 2-chloroadenosine  [146-77-0] and 5'-N-ethylcarboxamidoadenosine  [35920-39-9] are ∼10-fold less potent at receptors in calf brain than in guinea pig brain.  Potencies of xanthines, such as theophylline  [58-55-9], caffeine  [58-08-2] and 1,3-dipropylxanthine  [31542-62-8] are similar in the different species.  However, the presence of an 8-Ph or 8-cycloalkyl substituent results in marked species differences.  For example, a xanthine amine conjugate of 1,3-dipropyl-8-phenylxanthine is 9-fold more potent at receptors in calf than in rat brain and 110-fold more potent in calf than in guinea pig brain.  Such differences indicate that brain A1 adenosine receptors are not identical in recognition sites for either agonists or antagonists in different mammalian species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxPjE91iDPdbVg90H21EOLACvtfcHk0liECNHDwMx6Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXnvVamtw%253D%253D&md5=e99c7825a1091b93962cdbec36bb7c13</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2886%2981096-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252886%252981096-1%26sid%3Dliteratum%253Aachs%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DAyala%26aufirst%3DC.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DOlssont%26aufirst%3DR.%2BO.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DSpecies%2520Differences%2520in%2520Structure-Activity%2520Relationships%2520of%2520Adenosine%2520Agonists%2520and%2520Xanthine%2520Antagonists%2520at%2520Brain%2520A1%2520Adenosine%2520Receptors%26jtitle%3DFEBS%2520Lett.%26date%3D1986%26volume%3D209%26issue%3D1%26spage%3D122%26epage%3D128%26doi%3D10.1016%2F0014-5793%2886%2981096-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of P2 and Adenosine Receptors: Common Scaffolds Adapted for Multiple Targets</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">114311</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2020.114311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bcp.2020.114311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33130128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlClsb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2021&pages=114311&author=K.+A.+Jacobsonauthor=A.+P.+Ijzermanauthor=C.+E.+M%C3%BCller&title=Medicinal+Chemistry+of+P2+and+Adenosine+Receptors%3A+Common+Scaffolds+Adapted+for+Multiple+Targets&doi=10.1016%2Fj.bcp.2020.114311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets</span></div><div class="casAuthors">Jacobson, Kenneth A.; IJzerman, Adriaan P.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114311</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prof. Geoffrey Burnstock originated the concept of purinergic signaling.  He demonstrated the interactions and biol. roles of ionotropic P2X and metabotropic P2Y receptors.  This review paper traces the historical origins of many currently used antagonists and agonists for P2 receptors, as well as adenosine receptors, in early attempts to identify ligands for these receptors - prior to the use of chem. libraries for screening.  Rather than presenting a general review of current purinergic ligands, we focus on common chem. scaffolds (privileged scaffolds) that can be adapted for multiple receptor targets.  By carefully analyzing the structure activity relationships, one can direct the selectivity of these scaffolds toward different receptor subtypes.  For example, the weak and non-selective P2 antagonist reactive blue 2 (RB-2) was derivatized using combinatorial synthetic approaches, leading to the identification of selective P2Y2, P2Y4, P2Y12 or P2X2 receptor antagonists.  A P2X4 antagonist NC-2600 is in a clin. trial, and A3 adenosine agonists show promise, for chronic pain.  P2X7 antagonists have been in clin. trials for depression (JNJ-54175446), inflammatory bowel disease (IBD), Crohn's disease, rheumatoid arthritis, inflammatory pain and chronic obstructive pulmonary disease (COPD).  P2X3 antagonists are in clin. trials for chronic cough, and an antagonist named after Burnstock, gefapixant, is expected to be the first P2X3 antagonist filed for approval.  We are seeing that the vision of Prof.  Burnstock to use purinergic signaling modulators, most recently at P2XRs, for treating disease is coming to fruition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fR4w2iV3LrVg90H21EOLACvtfcHk0liECNHDwMx6Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlClsb7P&md5=cd6be9012dde12c5ea9856473968fbe3</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2020.114311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2020.114311%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520Chemistry%2520of%2520P2%2520and%2520Adenosine%2520Receptors%253A%2520Common%2520Scaffolds%2520Adapted%2520for%2520Multiple%2520Targets%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2021%26volume%3D187%26spage%3D114311%26doi%3D10.1016%2Fj.bcp.2020.114311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of Adenosine, P2Y and P2X Receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26686393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=31-49&author=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=Medicinal+Chemistry+of+Adenosine%2C+P2Y+and+P2X+Receptors&doi=10.1016%2Fj.neuropharm.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine, P2Y and P2X receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-49</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pharmacol. tool compds. are now available to define action at the adenosine (ARs), P2Y and P2X receptors.  We present a selection of the most commonly used agents to study purines in the nervous system.  Some of these compds., including A1 and A3 AR agonists, P2Y1R and P2Y12R antagonists, and P2X3, P2X4 and P2X7 antagonists, are potentially of clin. use in treatment of disorders of the nervous system, such as chronic pain, neurodegeneration and brain injury.  Agonists of the A2AAR and P2Y2R are already used clin., P2Y12R antagonists are widely used antithrombotics and an antagonist of the A2AAR is approved in Japan for treating Parkinson's disease.  The selectivity defined for some of the previously introduced compds. has been revised with updated pharmacol. characterization, for example, various AR agonists and antagonists were deemed A1AR or A3AR selective based on human data, but species differences indicated a redn. in selectivity ratios in other species.  Also, many of the P2R ligands still lack bioavailability due to charged groups or hydrolytic (either enzymic or chem.) instability.  X-ray crystallog. structures of AR and P2YRs have shifted the mode of ligand discovery to structure-based approaches rather than previous empirical approaches.  The X-ray structures can be utilized either for in silico screening of chem. diverse libraries for the discovery of novel ligands or for enhancement of the properties of known ligands by chem. modification.  Although X-ray structures of the zebrafish P2X4R have been reported, there is scant structural information about ligand recognition in these trimeric ion channels.  In summary, there are definitive, selective agonists and antagonists for all of the ARs and some of the P2YRs; while the pharmacochem. of P2XRs is still in nascent stages.  The therapeutic potential of selectively modulating these receptors is continuing to gain interest in such fields as cancer, inflammation, pain, diabetes, ischemic protection and many other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfj6lh6K1FbLVg90H21EOLACvtfcHk0liECNHDwMx6Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF&md5=ffcb23c7e271df86ef6b24d88aef2d82</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Adenosine%252C%2520P2Y%2520and%2520P2X%2520Receptors%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D104%26spage%3D31%26epage%3D49%26doi%3D10.1016%2Fj.neuropharm.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span>; <span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Xanthines as Adenosine Receptor Antagonists</span>.  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">199</span>. <span class="refDoi"> DOI: 10.1007/978-3-642-13443-2_6</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2F978-3-642-13443-2_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=151-199&author=C.+E.+M%C3%BCller&author=K.+A.+Jacobson&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-13443-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-13443-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DXanthines%2520as%2520Adenosine%2520Receptor%2520Antagonists%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D2011%26spage%3D151%26epage%3D199%26doi%3D10.1007%2F978-3-642-13443-2_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2A Receptor as a Drug Discovery Target</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3623</span>– <span class="NLM_lpage">3650</span>, <span class="refDoi"> DOI: 10.1021/jm4011669</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011669" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3623-3650&issue=9&author=M.+De+Lera+Ruizauthor=Y.+H.+Limauthor=J.+Zheng&title=Adenosine+A2A+Receptor+as+a+Drug+Discovery+Target&doi=10.1021%2Fjm4011669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A Receptor as a Drug Discovery Target</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Lim, Yeon-Hee; Zheng, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3623-3650</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications.  Herein the authors describe adenosine A2A receptor distribution, signaling pathways, pharmacol., and mol. structure, followed by a summary and SAR discussion of the most relevant series of adenosine A2A agonists and antagonists.  This review also provides an update of the A2A ligands that are undergoing or have undergone clin. studies, including the two currently marketed agonists adenosine and regadenoson.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQUPGC7zBCkbVg90H21EOLACvtfcHk0li_dbcHL0d_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7bJ&md5=846641d1ac3ad16b6335af6b4df15f08</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm4011669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011669%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DY.%2BH.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DAdenosine%2520A2A%2520Receptor%2520as%2520a%2520Drug%2520Discovery%2520Target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D9%26spage%3D3623%26epage%3D3650%26doi%3D10.1021%2Fjm4011669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span> <span> </span><span class="NLM_article-title">The A3 Adenosine Receptor: History and Perspectives</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1124/pr.113.008540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fpr.113.008540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25387804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=74-102&issue=1&author=P.+A.+Boreaauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Merighiauthor=S.+Gessi&title=The+A3+Adenosine+Receptor%3A+History+and+Perspectives&doi=10.1124%2Fpr.113.008540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: history and perspectives</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Merighi, Stefania; Gessi, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-102, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  By general consensus, the omnipresent purine nucleoside adenosine is considered a major regulator of local tissue function, esp. when energy supply fails to meet cellular energy demand.  Adenosine mediation involves activation of a family of four G protein-coupled adenosine receptors (ARs): A1, A2A, A2B, and A3.  The A3 adenosine receptor (A3AR) is the only adenosine subtype to be overexpressed in inflammatory and cancer cells, thus making it a potential target for therapy.  Originally isolated as an orphan receptor, A3AR presented a twofold nature under different pathophysiol. conditions: it appeared to be protective/harmful under ischemic conditions, pro/anti-inflammatory, and pro/antitumoral depending on the systems investigated.  Until recently, the greatest and most intriguing challenge has been to understand whether, and in which cases, selective A3 agonists or antagonists would be the best choice.  Today, the choice has been made and A3AR agonists are now under clin. development for some disorders including rheumatoid arthritis, psoriasis, glaucoma, and hepatocellular carcinoma.  More specifically, the interest and relevance of these new agents derives from clin. data demonstrating that A3AR agonists are both effective and safe.  Thus, it will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTebUcia2x7Vg90H21EOLACvtfcHk0li_dbcHL0d_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D&md5=152673d44c951624ccb2ef090ffc670c</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008540%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26atitle%3DThe%2520A3%2520Adenosine%2520Receptor%253A%2520History%2520and%2520Perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26issue%3D1%26spage%3D74%26epage%3D102%26doi%3D10.1124%2Fpr.113.008540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, X.</span></span> <span> </span><span class="NLM_article-title">Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson’s Disease: A Recent Update and Challenge</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=783-791&issue=2&author=J.+Zhengauthor=X.+Zhangauthor=X.+Zhen&title=Development+of+Adenosine+A2A+Receptor+Antagonists+for+the+Treatment+of+Parkinson%E2%80%99s+Disease%3A+A+Recent+Update+and+Challenge&doi=10.1021%2Facschemneuro.8b00313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson's Disease: A Recent Update and Challenge</span></div><div class="casAuthors">Zheng, Jiyue; Zhang, Xiaohu; Zhen, Xuechu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">783-791</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurodegenerative disease with significant unmet medical needs.  The current dopamine-centered treatments aim to restore motor functions of patients without slowing the disease progression.  Long-term usage of these drugs is assocd. with diminished efficacy, motor fluctuation, and dyskinesia.  Furthermore, the nonmotor features assocd. with PD such as sleep disorder, pain, and psychiatric symptoms are poorly addressed by the dopaminergic treatments.  Adenosine receptor A2A antagonists have emerged as potential treatment for PD in the past decade.  Here we summarize the recent work (2015-2018) on adenosine receptor A2A antagonists and discuss the challenge and opportunity for the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBNiUzkD86SbVg90H21EOLACvtfcHk0li_dbcHL0d_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OktL7J&md5=10474b8ad7c20097676b02ee797a589e</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00313%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhen%26aufirst%3DX.%26atitle%3DDevelopment%2520of%2520Adenosine%2520A2A%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520Recent%2520Update%2520and%2520Challenge%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26issue%3D2%26spage%3D783%26epage%3D791%26doi%3D10.1021%2Facschemneuro.8b00313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creveling, C. R.</span></span> <span> </span><span class="NLM_article-title">A Radioisotopic Method for Measuring the Formation of Adenosine 3′,5′-Cyclic Monophosphate in Incubated Slices of Brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1609</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1969.tb10360.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1471-4159.1969.tb10360.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=4314281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE3cXlt1KgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1969&pages=1609-1619&issue=12&author=H.+Shimizuauthor=J.+W.+Dalyauthor=C.+R.+Creveling&title=A+Radioisotopic+Method+for+Measuring+the+Formation+of+Adenosine+3%E2%80%B2%2C5%E2%80%B2-Cyclic+Monophosphate+in+Incubated+Slices+of+Brain&doi=10.1111%2Fj.1471-4159.1969.tb10360.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain</span></div><div class="casAuthors">Shimizu, Hirotoshi; Daly, J. W.; Creveling, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1609-19</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">A simple and sensitive method for measuring the effect of neurohormones and other chem. agents on the formation of adenosine 3',5'-cyclic monophos phate (cyclic 3',5'-AMP) in incubated slices of brain was developed.  The principle of the method depends on pulse-labeling of adenosine 5'-triphosphate in slices of brain with adenine-8-14C followed by incubation in a medium contg. the test substance, sepn. by thin-layer chromatog. of the cyclic nucleotide formed in the slices, and radioassay.  The purity of the cyclic nucleotide was confirmed by chromatog. in a variety of systems and by hydrolysis with a specific, bovine-heart phosphodiesterase.  The method was used to study the effect of histamine, norepinephrine, and adenosine on the accumulation of 3',5'-AMP in incubated slices of brain .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrf9x4k6NIrVg90H21EOLACvtfcHk0li_dbcHL0d_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXlt1KgtQ%253D%253D&md5=fa236193917a4d30f4b7ace1c4a79f5b</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1969.tb10360.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1969.tb10360.x%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DCreveling%26aufirst%3DC.%2BR.%26atitle%3DA%2520Radioisotopic%2520Method%2520for%2520Measuring%2520the%2520Formation%2520of%2520Adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Cyclic%2520Monophosphate%2520in%2520Incubated%2520Slices%2520of%2520Brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1969%26volume%3D16%26issue%3D12%26spage%3D1609%26epage%3D1619%26doi%3D10.1111%2Fj.1471-4159.1969.tb10360.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Londos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, J.</span></span> <span> </span><span class="NLM_article-title">Two Distinct Adenosine-Sensitive Sites on Adenylate Cyclase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5482</span>– <span class="NLM_lpage">5486</span>, <span class="refDoi"> DOI: 10.1073/pnas.74.12.5482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.74.12.5482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=271970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE1cXosFWrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1977&pages=5482-5486&issue=12&author=C.+Londosauthor=J.+Wolff&title=Two+Distinct+Adenosine-Sensitive+Sites+on+Adenylate+Cyclase&doi=10.1073%2Fpnas.74.12.5482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Two distinct adenosine-sensitive sites on adenylate cyclase</span></div><div class="casAuthors">Londos, Constantine; Wolff, J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5482-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The effects of adenosine and adenosine analogs on adenylate cyclases from several tissues were examd.  2 Adenosine-reactive sites were identified: (1) the R site, occupancy of which usually leads to activation of cyclase and which requires integrity of the ribose ring for activity, and (2) the P site, which mediates inhibition and requires integrity of the purine ring for activity.  Biphasic effects of adenosine are explained by the presence of both sites on a single adenylate cyclase.  Comparison of these data with those in the literature indicates that adenosine-reactive P and R sites are present generally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXNkjWLZ6CubVg90H21EOLACvtfcHk0lhXuqH9bbpqmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXosFWrtQ%253D%253D&md5=602aba5d60ff5da9cfeb70a3513f44df</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1073%2Fpnas.74.12.5482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.74.12.5482%26sid%3Dliteratum%253Aachs%26aulast%3DLondos%26aufirst%3DC.%26aulast%3DWolff%26aufirst%3DJ.%26atitle%3DTwo%2520Distinct%2520Adenosine-Sensitive%2520Sites%2520on%2520Adenylate%2520Cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1977%26volume%3D74%26issue%3D12%26spage%3D5482%26epage%3D5486%26doi%3D10.1073%2Fpnas.74.12.5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamprecht, B.</span></span> <span> </span><span class="NLM_article-title">Adenosine Regulates Via Two Different Types of Receptors, the Accumulation of Cyclic Amp in Cultured Brain Cells</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">999</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1979.tb05236.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1471-4159.1979.tb05236.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=228008" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1979&pages=999-1005&issue=5&author=D.+Calkerauthor=M.+M%C3%BCllerauthor=B.+Hamprecht&title=Adenosine+Regulates+Via+Two+Different+Types+of+Receptors%2C+the+Accumulation+of+Cyclic+Amp+in+Cultured+Brain+Cells&doi=10.1111%2Fj.1471-4159.1979.tb05236.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1979.tb05236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1979.tb05236.x%26sid%3Dliteratum%253Aachs%26aulast%3DCalker%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DAdenosine%2520Regulates%2520Via%2520Two%2520Different%2520Types%2520of%2520Receptors%252C%2520the%2520Accumulation%2520of%2520Cyclic%2520Amp%2520in%2520Cultured%2520Brain%2520Cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1979%26volume%3D33%26issue%3D5%26spage%3D999%26epage%3D1005%26doi%3D10.1111%2Fj.1471-4159.1979.tb05236.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbracchio, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">IV. Nomenclature and Classification of Purinoreceptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7938164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=143-156&issue=2&author=B.+Bertilauthor=M.+P.+Abbracchioauthor=G.+Burnstockauthor=J.+W.+Dalyauthor=K.+T.+Hardenauthor=K.+A.+Jacobsonauthor=P.+Leffauthor=M.+Williams&title=IV.+Nomenclature+and+Classification+of+Purinoreceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertil%26aufirst%3DB.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DHarden%26aufirst%3DK.%2BT.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DIV.%2520Nomenclature%2520and%2520Classification%2520of%2520Purinoreceptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D1994%26volume%3D46%26issue%3D2%26spage%3D143%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butts-Lamb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W.</span></span> <span> </span><span class="NLM_article-title">Subclasses of Adenosine Receptors in the Central Nervous System: Interaction with Caffeine and Related Methylxanthines</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1007/BF00734999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00734999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6309393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1983&pages=69-80&issue=1&author=J.+W.+Dalyauthor=P.+Butts-Lambauthor=W.+Padgett&title=Subclasses+of+Adenosine+Receptors+in+the+Central+Nervous+System%3A+Interaction+with+Caffeine+and+Related+Methylxanthines&doi=10.1007%2FBF00734999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Subclasses of adenosine receptors in the central nervous system:  interaction with caffeine and related methylxanthines</span></div><div class="casAuthors">Daly, John W.; Butts-Lamb, Pamela; Padgett, William</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    </div><div class="casAbstract">The potencies of caffeine (I)  [58-08-2] and related methylxanthines as adenosine antagonists were assessed with respect to 3 apparent subtypes of adenosine receptors in rat brain prepns.: (1) the A1-adenosine receptor which binds with a very high affinity the ligand [3H]cyclohexyladenosine in rat brain membranes; (2) a ubiquitous low-affinity A2-adenosine receptor which activates cyclic AMP  [60-92-4] accumulation in rat brain slices, and (3) a relatively high-affinity A2-adenosine receptor which activates adenylate cyclase  [9012-42-4] in rat striatal membranes (this A2-adenosine system is present in striatal but not in cerebral cortical membranes).  Caffeine and other methylxanthines, thus, antagonize effectively both A1- and A2-adenosine receptors in brain prepns.  Theobromine  [83-67-0] appears less effective vs. A2-receptors than vs. A1-receptors.  The functional significance of antagonism of such adenosine receptors by caffeine in situ will depend both on the local levels of adenosine and on the affinity for adenosine for the receptor, since antagonism by xanthines is competitive in nature.  In addn., the functional significance of xanthine action will depend on the degree of inhibition of adenosine input which is required to alter the output signal.  For a stimulatory input to adenylate cyclase via an A2-adenosine receptor, profound antagonism by methylxanthines is probably required to alter the cyclic AMP-mediated output signal, while for inhibitory input to adenylate cyclase via an A1-adenosine receptor, presumably a lesser degree of antagonism by methylamines may be required to alter the cyclic AMP-mediated output signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDacfOvNrNcbVg90H21EOLACvtfcHk0lhXuqH9bbpqmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D&md5=94132d6b898b052e58f965cd417889b2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1007%2FBF00734999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00734999%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DButts-Lamb%26aufirst%3DP.%26aulast%3DPadgett%26aufirst%3DW.%26atitle%3DSubclasses%2520of%2520Adenosine%2520Receptors%2520in%2520the%2520Central%2520Nervous%2520System%253A%2520Interaction%2520with%2520Caffeine%2520and%2520Related%2520Methylxanthines%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D1983%26volume%3D3%26issue%3D1%26spage%3D69%26epage%3D80%26doi%3D10.1007%2FBF00734999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Characterization of an Adenosine Receptor: The A3 Adenosine Receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7432</span>– <span class="NLM_lpage">7436</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.16.7432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.89.16.7432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1323836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1Sqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=7432-7436&issue=16&author=Q.+Y.+Zhouauthor=L.+I.+Liauthor=M.+E.+Olahauthor=R.+A.+Johnsonauthor=G.+L.+Stilesauthor=O.+Civelli&title=Molecular+Cloning+and+Characterization+of+an+Adenosine+Receptor%3A+The+A3+Adenosine+Receptor&doi=10.1073%2Fpnas.89.16.7432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of an adenosine receptor:  The A3 adenosine receptor</span></div><div class="casAuthors">Zhou, Qun Yong; Li, Chuanyu; Olah, Mark E.; Johnson, Robert A.; Stiles, Gary L.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7432-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The authors have previously reported the selective amplification of several rat striatal cDNA sequences that encode guanine nucleotide-binding regulatory protein (G protein)-coupled receptors.  One of these sequences (R226) exhibited high sequence identity (58%) with the two previously cloned adenosine receptors.  A full-length cDNA clone for R226 has been isolated from a rat brain cDNA library.  The cDNA clone encodes a protein of 320 amino acids that can be organized into seven transmembrane stretches.  R226 has been expressed in COS-7 and CHO cells and membranes from the transfected cells were screened with adenosine receptor radioligands.  R226 could bind the nonselective adenosine agonist tritiated N-ethyladenosine 5'-uronic acid ([3H]NECA) and the A1-selective agonist radioiodinated N6-2-(4-amino-3-iodophenyl)-ethyladenosine ([125I]APNEA) but not the A1-selective antagonists tritiated 1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX) or 8-{4-[({[(2-aminoethyl)amino]carbonyl}methyl)oxy]-phenyl}-1,3-dipropylxanthine ([3H]XAC) or the A2-selective agonist ligands tritiated 2-[4-(2-carboxyethyl)phenyl]ethylamino 5'-N-ethylcarboxamidoadenosine ([3H]CGS21680) or radioiodinated 2-[4-({2-[(4-aminophenyl)methylcarbonylamino]ethylaminocarbonyl}ethyl)phenyl]ethylamino 5'-N-ethylcarboxamidoadenosine.  Extensive characterization with [125I]APNEA showed that R226 binds [125I]APNEA with high affinity (Kd = 15.5 nM) and the specific [125I]APNEA binding could be inhibited by adenosine ligands with a potency order of (R)-N6-phenyl-2-propyladenosine (R-PIA) = NECA > S-PIA > adenosine > ATP = ADP but not by antagonists XAC, isobutylmethylxanthine, and DPCPX.  In R226 stably transfected CHO cells, adenosine agonists R-PIA, NECA, and CGS21680 inhibited by 40-50% the forskolin-stimulated cAMP accumulation through a pertussis toxin-sensitive G protein with an EC50 of 18 nM, 23 nM, and 144 nM, resp.  Based on these observations the authors conclude that R226 encodes an adenosine receptor with non-A1 and non-A2 specificity, and name it the A3 adenosine receptor.  The mRNA analyses revealed that the highest expression of R226 was in the testis and low-level mRNAs were also found in the lung, kidneys, heart, and some parts of the central nervous system such as cortex, striatum, and olfactory bulb.  The high-expression level of the A3 receptor in the testis suggests a possible role for adenosine in reprodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB0MXPtRUdFrVg90H21EOLACvtfcHk0lgCfiJNqF2lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1Sqsr0%253D&md5=8f00a5d4bc8e43bb8f1574e05006d0ae</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.16.7432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.16.7432%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DL.%2BI.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DMolecular%2520Cloning%2520and%2520Characterization%2520of%2520an%2520Adenosine%2520Receptor%253A%2520The%2520A3%2520Adenosine%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26issue%3D16%26spage%3D7432%26epage%3D7436%26doi%3D10.1073%2Fpnas.89.16.7432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haskó, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csóka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Németh, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptors in Immunity and Inflammation</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/j.it.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.it.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19427267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=263-270&issue=6&author=G.+Hask%C3%B3author=B.+Cs%C3%B3kaauthor=Z.+H.+N%C3%A9methauthor=E.+S.+Viziauthor=P.+Pacher&title=A2B+Adenosine+Receptors+in+Immunity+and+Inflammation&doi=10.1016%2Fj.it.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptors in immunity and inflammation</span></div><div class="casAuthors">Hasko, Gyoergy; Csoka, Balazs; Nemeth, Zoltan H.; Vizi, E. Sylvester; Pacher, Pal</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A2B adenosine receptors are increasingly recognized as important orchestrators of inflammation.  A2B receptor activation promotes the inflammatory response of mast cells, epithelial cells, smooth muscle cells and fibroblasts, thereby contributing to the pathophysiol. of asthma and colitis.  A2B receptor stimulation limits endothelial cell inflammatory responses and permeability and suppresses macrophage activation thereby preventing tissue injury after episodes of hypoxia and ischemia.  A2B receptor stimulation also promotes the prodn. of angiogenic cytokines by endothelial cells, mast cells and dendritic cells, aiding granuloma tissue formation and inflammatory resoln., but can also contribute to tumor growth.  A2B receptors are, thus, potentially important pharmacol. targets in treating immune system dysfunction and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5JA17dyrT7Vg90H21EOLACvtfcHk0lgCfiJNqF2lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D&md5=4aebd9d9b7d823dcc0a89f94b539d127</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHask%25C3%25B3%26aufirst%3DG.%26aulast%3DCs%25C3%25B3ka%26aufirst%3DB.%26aulast%3DN%25C3%25A9meth%26aufirst%3DZ.%2BH.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26aulast%3DPacher%26aufirst%3DP.%26atitle%3DA2B%2520Adenosine%2520Receptors%2520in%2520Immunity%2520and%2520Inflammation%26jtitle%3DTrends%2520Immunol.%26date%3D2009%26volume%3D30%26issue%3D6%26spage%3D263%26epage%3D270%26doi%3D10.1016%2Fj.it.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hide, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M.</span></span> <span> </span><span class="NLM_article-title">Caffeine Analogs: Structure Activity Relationship at Adenosine Receptors</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1159/000138813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1159%2F000138813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1658821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXlt1Kgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1991&pages=309-321&author=J.+W.+Dalyauthor=I.+Hideauthor=C.+E.+M%C3%BCllerauthor=M.+Shamim&title=Caffeine+Analogs%3A+Structure+Activity+Relationship+at+Adenosine+Receptors&doi=10.1159%2F000138813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine analogs:  structure-activity relationships at adenosine receptors</span></div><div class="casAuthors">Daly, John W.; Hide, Izumi; Muller, Christa E.; Shamim, Mah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">309-21</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    </div><div class="casAbstract">Caffeine and analogs (I, e.g., R1, R2, R3 = Me, Et, Pr, allyl, propargyl) were antagonists at the 2 major classes (A1 and A2) of adenosine receptors.  Potency at both receptors increased as methyls were replaced with larger substituents.  Certain analogs with only one of the 3 Me groups of caffeine replaced by larger substituents were somewhat selective for A2 receptors.  None of the analogs were particularly selective for A1 receptors.  The presence of polar entities in the substituent at the 1- or 7-position was poorly tolerated at adenosine receptors.  Activity of caffeine analogs at A1 and A2 adenosine receptors in a variety of systems and cell types is presented and summarized.  Methods of prepn. (alkylation of the corresponding xanthines) are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrIiF_tALZLVg90H21EOLACvtfcHk0lgCfiJNqF2lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt1Kgu70%253D&md5=34fd29aa4fa5b47a1a1dbf9b93a2e14a</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1159%2F000138813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000138813%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DHide%26aufirst%3DI.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DShamim%26aufirst%3DM.%26atitle%3DCaffeine%2520Analogs%253A%2520Structure%2520Activity%2520Relationship%2520at%2520Adenosine%2520Receptors%26jtitle%3DPharmacology%26date%3D1991%26volume%3D42%26spage%3D309%26epage%3D321%26doi%3D10.1159%2F000138813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors in Brain Membranes: Binding of N6-Cyclohexyl[3H]Adenosine and 1,3-Diethyl-8-[3H]Phenylxanthine</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5547</span>– <span class="NLM_lpage">5551</span>, <span class="refDoi"> DOI: 10.1073/pnas.77.9.5547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.77.9.5547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6254090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3MXisFKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1980&pages=5547-5551&issue=9&author=R.+F.+Brunsauthor=J.+W.+Dalyauthor=S.+H.+Snyder&title=Adenosine+Receptors+in+Brain+Membranes%3A+Binding+of+N6-Cyclohexyl%5B3H%5DAdenosine+and+1%2C3-Diethyl-8-%5B3H%5DPhenylxanthine&doi=10.1073%2Fpnas.77.9.5547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in brain membranes:  Binding of N6-cyclohexyl[3H]-adenosine and 1,3-diethyl-8-[3H]-phenylxanthine</span></div><div class="casAuthors">Bruns, Robert F.; Daly, John W.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5547-51</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">3H-labeled N6-cyclohexyladenosine (CHA) (I)  [36396-99-3] and 3H-labeled 1,3-diethyl-8-phenylxanthene (DPX) (II)  [75922-48-4] bind to adenosine  [58-61-7] receptors in brain membranes.  The agonist [3H]CHA has high affinity in both bovine and guinea pig brain (Kd 0.7 nM and 6 nM, resp.).  [3H]CHA binding kinetics are slow (dissocn. half-time (dt2) 60 min); binding is much higher at 25° than at 0° and is inhibited by guanine nucleotides.  Potencies of nucleosides and xanthines in cometing for [3H]CHA sites indicate that specific binding is entirely to A1 adenosine receptors.  In bovine brain, the antagonist [3H]DPX exhibits high-affinity binding (Kd, 5 nM) to the same A1 receptors that bind [3H]CHA.  Binding kinetics are rapid (dt2, 1 min), and binding is moderately higher at 0° than at 25°.  In guinea pig brain, [3H]DPX binding has only moderate affinity (Kd, 50 nM), and ∼60% of specific binding is to sites that resemble A2 adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ysUJP8-uhbVg90H21EOLACvtfcHk0lgCfiJNqF2lyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXisFKitw%253D%253D&md5=96131f75411af9eaff377fee23ccd0e5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.77.9.5547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.77.9.5547%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DAdenosine%2520Receptors%2520in%2520Brain%2520Membranes%253A%2520Binding%2520of%2520N6-Cyclohexyl%255B3H%255DAdenosine%2520and%25201%252C3-Diethyl-8-%255B3H%255DPhenylxanthine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1980%26volume%3D77%26issue%3D9%26spage%3D5547%26epage%3D5551%26doi%3D10.1073%2Fpnas.77.9.5547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Binding: Structure-Activity Analysis Generates Extremely Potent Xanthine Antagonists</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2077</span>– <span class="NLM_lpage">2080</span>, <span class="refDoi"> DOI: 10.1073/pnas.80.7.2077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.80.7.2077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6300892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3sXksVOmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=2077-2080&issue=7&author=R.+F.+Brunsauthor=J.+W.+Dalyauthor=S.+H.+Snyder&title=Adenosine+Receptor+Binding%3A+Structure-Activity+Analysis+Generates+Extremely+Potent+Xanthine+Antagonists&doi=10.1073%2Fpnas.80.7.2077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor binding:  Structure-activity analysis generates extremely potent xanthine antagonists</span></div><div class="casAuthors">Bruns, Robert F.; Daly, John W.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2077-80</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Structure-activity anal. of alkylxanthine derivs. at adenosine  [58-61-7] receptor binding sites was employed in the designing of potent adenosine receptor antagonists.  Receptor affinities of xanthines were detd. by measuring inhibition of the binding of N6-[3H]cyclohexyladenosine to bovine brain membranes.  1,3-Di-Pr substitutions enhance potency compared to the 1,3-di-Me substitution in theophylline.  An 8-Ph substituent produces a considerable increase in potency, which is augmented by certain para substitutions on the 8-Ph ring.  Combining an ortho amino with a para-chloro substituent on the 8-Ph ring affords further increases in potency.  Combining all of these substituents results in 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (I)  [85872-51-1] a compd. of extraordinary receptor affinity, with a Ki for adenosine A1 receptors of 22 pM.  It is 4,000,000 times more potent than xanthine  [69-89-6] itself and 70,000 times more potent than theophylline  [58-55-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-hoXimS0Jv7Vg90H21EOLACvtfcHk0lhZm3vymqbJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksVOmsbc%253D&md5=b7ee3f5a1beaafbb6a44646bcfd1ecf9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.7.2077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.7.2077%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DAdenosine%2520Receptor%2520Binding%253A%2520Structure-Activity%2520Analysis%2520Generates%2520Extremely%2520Potent%2520Xanthine%2520Antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26issue%3D7%26spage%3D2077%26epage%3D2080%26doi%3D10.1073%2Fpnas.80.7.2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Functionalized Congeners of 1,3-Dipropyl-8-Phenylxanthine: Potent Antagonists for Adenosine Receptors That Modulate Membrane Adenylate Cyclase in Pheochromocytoma Cells, Platelets and Fat Cells</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(86)90596-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2886%2990596-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3005794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28XhsVais78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1986&pages=797-807&author=D.+Ukenaauthor=J.+W.+Dalyauthor=K.+L.+Kirkauthor=K.+A.+Jacobson&title=Functionalized+Congeners+of+1%2C3-Dipropyl-8-Phenylxanthine%3A+Potent+Antagonists+for+Adenosine+Receptors+That+Modulate+Membrane+Adenylate+Cyclase+in+Pheochromocytoma+Cells%2C+Platelets+and+Fat+Cells&doi=10.1016%2F0024-3205%2886%2990596-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized congeners of 1,3-dipropyl-8-phenylxanthine:  potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells</span></div><div class="casAuthors">Ukena, Dieter; Daly, John W.; Kirk, Kenneth L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">797-807</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">Amine, amino acid and peptide derivs. derived from 1,3-dipropyl-8-(p-carboxymethylphenyl)xanthine (I; R = H, D-Lys, L-Met, D-Tyr-D-Lys, etc.), a functionalized congener of 1,3-dipropyl-8-phenylxanthine, were investigated as antagonists at A2 adenosine receptors stimulatory to adenylate cyclase  [9012-42-4] in membranes from rat pheochromocytoma PC 12 cells and human platelets and at A1 adenosine receptors inhibitory to adenylate cyclase from rat fat cells.  The congeners and conjugates have affinity consts. ranging from 80 to 310 nM at A2 receptors of PC 12 cells and from 25 to 135 nM at those of platelets.  The affinity of the xanthine derivs. at A1 receptors of fat cells are in the 15-30 nM range.  Thus, the amino acid and peptide conjugates have high potencies at both receptor subclasses and show some selectivity toward A1 adenosine receptors.  Derivs. of the congeners should be useful as receptor probes and as radioiodinated ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSANp1xgCdIrVg90H21EOLACvtfcHk0lhZm3vymqbJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhsVais78%253D&md5=82e5ca7ff00c8efaa17c904ef50b4665</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2886%2990596-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252886%252990596-5%26sid%3Dliteratum%253Aachs%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionalized%2520Congeners%2520of%25201%252C3-Dipropyl-8-Phenylxanthine%253A%2520Potent%2520Antagonists%2520for%2520Adenosine%2520Receptors%2520That%2520Modulate%2520Membrane%2520Adenylate%2520Cyclase%2520in%2520Pheochromocytoma%2520Cells%252C%2520Platelets%2520and%2520Fat%2520Cells%26jtitle%3DLife%2520Sci.%26date%3D1986%26volume%3D38%26spage%3D797%26epage%3D807%26doi%3D10.1016%2F0024-3205%2886%2990596-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">[3H]Xanthine Amine Congener of 1,3-Dipropyl-8-Phenylxanthine: An Antagonist Radioligand for Adenosine Receptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4089</span>– <span class="NLM_lpage">4093</span>, <span class="refDoi"> DOI: 10.1073/pnas.83.11.4089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.83.11.4089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3012550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28Xls1Gmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=4089-4093&issue=11&author=K.+A.+Jacobsonauthor=D.+Ukenaauthor=K.+L.+Kirkauthor=J.+W.+Daly&title=%5B3H%5DXanthine+Amine+Congener+of+1%2C3-Dipropyl-8-Phenylxanthine%3A+An+Antagonist+Radioligand+for+Adenosine+Receptors&doi=10.1073%2Fpnas.83.11.4089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]Xanthine amine congener of 1,3-dipropyl-8-phenylxanthine:  an antagonist radioligand for adenosine receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Ukena, Dieter; Kirk, Kenneth L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4089-93</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">An amine-functionalized deriv. of 1,3-dipropyl-8-phenylxanthine  [85872-53-3] was prepd. as a 3H xanthine amine congener ([3H]XAC)  [104557-18-8] for use as an antagonist radioligand for adenosine receptors.  [3H]XAC has higher receptor affinity, higher specific activity, lower nonspecific membrane binding, and more favorable hydrophilicity than 3H-labeled 1,3-diethyl-8-phenylxanthine  [75922-48-4], the xanthine commonly used for adenosine receptor binding.  In rat cerebral cortical membranes, [3H]XAC exhibits saturable, specific binding with a dissocn. const. (Kd) of 1.23 nM and max. binding of 580 fmol/mg protein at 37°.  N6-(R-phenylisopropyl)adenosine  [38594-96-6] is a more potent inhibitor of [3H]XAC binding than is 5-N-ethylcarboxamidoadenosine  [35920-39-9], indicating that binding is to an A1-adenosine receptor.  In the absence of GTP  [86-01-1], the inhibition curves for adenosine agonists vs. [3H]XAC binding are biphasic, indicating that [3H]XAC is binding to low- and high-affinity agonist states of the A1 receptor.  In the presence of GTP, adenosine analogs exhibit monophasic, low-affinity inhibition of binding of [3H]XAC.  Inhibition of [3H]XAC binding by theophylline  [58-55-9] or by various 8-phenylxanthines is monophasic, and the potencies are commensurate with the potencies of these xanthines as adenosine receptor antagonists.  The receptor sites in calf brain membranes exhibit a higher affinity (Kd = 0.17 nM) for [3H]XAC, whereas sites in guinea pig exhibit a slightly lower affinity (Kd = 3.0 nM).  Densities of [3H]XAC binding sites are similar in brain membranes from all species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA69dnrLJszrVg90H21EOLACvtfcHk0lhZm3vymqbJvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xls1Gmurk%253D&md5=5efa97d5bb9be6f9387b745199ac466d</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.11.4089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.11.4089%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D%255B3H%255DXanthine%2520Amine%2520Congener%2520of%25201%252C3-Dipropyl-8-Phenylxanthine%253A%2520An%2520Antagonist%2520Radioligand%2520for%2520Adenosine%2520Receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26issue%3D11%26spage%3D4089%26epage%3D4093%26doi%3D10.1073%2Fpnas.83.11.4089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fergus, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristol, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santay, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hays, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span> <span> </span><span class="NLM_article-title">Binding of the A1-Selective Adenosine Antagonist 8-Cyclopentyl-1,3-Dipropylxanthine to Rat Brain Membranes</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>335</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1007/BF00165037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00165037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3574492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2sXhsV2gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1987&pages=59-63&issue=1&author=R.+F.+Brunsauthor=J.+H.+Fergusauthor=E.+W.+Badgerauthor=J.+A.+Bristolauthor=L.+A.+Santayauthor=J.+D.+Hartmanauthor=S.+J.+Haysauthor=C.+C.+Huang&title=Binding+of+the+A1-Selective+Adenosine+Antagonist+8-Cyclopentyl-1%2C3-Dipropylxanthine+to+Rat+Brain+Membranes&doi=10.1007%2FBF00165037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes</span></div><div class="casAuthors">Bruns, Robert F.; Fergus, James H.; Badger, Edward W.; Bristol, James A.; Santay, Lisa A.; Hartman, Jon D.; Hays, Sheryl J.; Huang, Che C.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">PD 116948 (8-cyclopentyl-1,3-dipropylxanthine)(I)  [102146-07-6] is a very potent, very A1-selective adenosine antagonist, with a Ki of 0.46 nM for A1 receptors in rat whole-brain membranes and 340 nM for A2 receptors in rat striatal membranes.  Its 740-fold A1-selectivity is the highest reported for an adenosine antagonist.  3H-PD 116948  [107478-32-0] (117 Ci/mmol) was prepd. by redn. of the diallyl analog.  3H-PD 116948 bound to a single site in rat whole-brain membranes, with a Bmax of 46 pmol/g and Kd of 0.42 nM.  Nonspecific binding was extremely low, amounting to about 3% of total binding under std. conditions and <1% when higher tissue concns. were used.  Affinities of compds. for inhibition of 3H-PD 116948 binding were highly consistent with an A1 adenosine receptor.  Antagonists were equally potent in 3H-PD 116948 binding and in [3H]N6-cyclohexyladenosine (CHA) binding, whereas agonists were consistently about 12-fold more potent in CHA binding.  Hill coeffs. were 1.0 for antagonists and about 0.65 for agonists.  3H-PD 116948 should be a useful antagonist ligand for adenosine A1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAoGVLUcIm0rVg90H21EOLACvtfcHk0ljDiJMrSLDvGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsV2gs7s%253D&md5=016a6dfd75371e5be52e44e98ab27a91</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1007%2FBF00165037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00165037%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DFergus%26aufirst%3DJ.%2BH.%26aulast%3DBadger%26aufirst%3DE.%2BW.%26aulast%3DBristol%26aufirst%3DJ.%2BA.%26aulast%3DSantay%26aufirst%3DL.%2BA.%26aulast%3DHartman%26aufirst%3DJ.%2BD.%26aulast%3DHays%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26atitle%3DBinding%2520of%2520the%2520A1-Selective%2520Adenosine%2520Antagonist%25208-Cyclopentyl-1%252C3-Dipropylxanthine%2520to%2520Rat%2520Brain%2520Membranes%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1987%26volume%3D335%26issue%3D1%26spage%3D59%26epage%3D63%26doi%3D10.1007%2FBF00165037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, A.</span></span> <span> </span><span class="NLM_article-title">8-Polycycloalkyl-1,3-Dipropylxanthines as Potent and Selective Antagonists for A1-Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/jm00083a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00083a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XhvVOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=924-930&issue=5&author=J.+Shimadaauthor=F.+Suzukiauthor=H.+Nonakaauthor=A.+Ishii&title=8-Polycycloalkyl-1%2C3-Dipropylxanthines+as+Potent+and+Selective+Antagonists+for+A1-Adenosine+Receptors&doi=10.1021%2Fjm00083a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors</span></div><div class="casAuthors">Shimada, Junichi; Suzuki, Fumio; Nonaka, Hiromi; Ishii, Akio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">924-30</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">With the aim of characterizing the hydrophobic interactions between xanthines and the A1 receptor site, 1,3-dipropyl-8-substituted xanthines (I, R = e.g., heteraryl, alkyl, alicyclic, or noradamantyl group) were prepd.  Introduction of a quaternary carbon and the conformationally restricted cyclopental moiety into the 8-position of xanthine enhanced the adenosine A1 antagonism.  1,3-Dipropyl-8-(3-noradamantyl)xanthine was identified to be a selective and the most potent A1 receptor antagonist reported to date.  Under the structure-activity relation study, the 8-substituent of xanthine antagonists and the N6-substituent of adenosine agonists appears to bind to the same region of the A1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1zxD_KlyFpLVg90H21EOLACvtfcHk0ljDiJMrSLDvGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhvVOntbY%253D&md5=fad39d18bb9720d99c31dbbe9b808b2c</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm00083a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00083a018%26sid%3Dliteratum%253Aachs%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DA.%26atitle%3D8-Polycycloalkyl-1%252C3-Dipropylxanthines%2520as%2520Potent%2520and%2520Selective%2520Antagonists%2520for%2520A1-Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26issue%3D5%26spage%3D924%26epage%3D930%26doi%3D10.1021%2Fjm00083a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belardinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyrpock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammels, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">S. P, B.</span></span> <span> </span><span class="NLM_article-title">1,3-Dipropyl-8-[2-(5,6-Epoxy)Norbornyl]Xanthine, a Potent, Specific and Selective A1 Adenosine Receptor Antagonist in the Guinea Pig Heart and Brain and in DDT1MF-2 Cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8531078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK28XhvVylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=1167-1176&author=L.+Belardinelliauthor=J.+C.+Shyrpockauthor=Y.+Zhangauthor=P.+J.+Scammelsauthor=R.+Olssonauthor=D.+Dennisauthor=P.+Milnerauthor=J.+Pfisterauthor=B.+S.+P&title=1%2C3-Dipropyl-8-%5B2-%285%2C6-Epoxy%29Norbornyl%5DXanthine%2C+a+Potent%2C+Specific+and+Selective+A1+Adenosine+Receptor+Antagonist+in+the+Guinea+Pig+Heart+and+Brain+and+in+DDT1MF-2+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells</span></div><div class="casAuthors">Belardinelli, Luiz; Shryock, John C.; Zhang, Yi; Schammells, Peter J.; Olsson, Ray; Dennis, Donn; Milner, Peter; Pfister, Juerg; Baker, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1167-76</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The objective of this study was to characterize the adenosine receptor (AdoR) antagonistic properties of a newly synthesized alkylxanthine, 1,3-dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine (ENX), and compare them to those of 1,3-dipropyl-8-(cyclopentyl)xanthine (CPX), 1,3-dipropyl-8-(3-noradamantyl)xanthine (NAX) and (±)-N6-endo-norbornan-2-yl-9-methyladenine (N-0861).  The potencies and selectivities of ENX, CPX, NAX and N-0861 were detd. by functional studies of guinea pig isolated perfused hearts, and by radioligand binding assays for A1 and A2a AdoRs in the guinea pig forebrain and striatum.  ENX competitively antagonized A1 AdoR-mediated prolongations of atrioventricular nodal conduction time caused by Ado or by 2-chloro-N6-cyclopentyladenosine, but not those caused by carbachol (0.14 μM) or MgCl2 (3 mM).  Schild anal. of 2-chloro-N6-cyclopentyladenosine-antagonist competition curves yielded pA2 values for ENX, CPX and NAX of 8.45, 8.55 and 8.79, resp.  ENX (30 μM) and N-0861 (30 μM) did not attenuate the A2 AdoR-mediated increase in coronary conductance caused by adenosine.  CPX and NAX attenuated the coronary vasodilation caused by adenosine with IC50 values of 1.5 and 7.1 μM, resp.  Radioligand binding assays revealed that ENX, CPX and NAX and N-0861 had a 400-, 209-, 110- and 10-fold greater affinity, resp., for A1 than for A2a AdoRs of guinea pig brain membranes.  Thus, ENX was equipotent with CPX and NAX and more potent than N-0861 (pA2 = 6.2) as an antagonist at A1 AdoRs, but had lower affinity for A2 AdoRs in guinea pig hearts and brain striatum than did either CPX or NAX.  In DDT1 MF-2 cells, all three alkylxanthines had similar affinities for A1 AdoRs, whereas the affinity of N-0861 for A1 AdoRs was significantly lower.  ENX appears to be the most A1 AdoR subtype-selective of the alkylxanthine class of AdoR antagonists reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0V5u05phkDrVg90H21EOLACvtfcHk0ljDiJMrSLDvGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVylsw%253D%253D&md5=bba1e92023b4bbbed94d8c655e087e34</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShyrpock%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DScammels%26aufirst%3DP.%2BJ.%26aulast%3DOlsson%26aufirst%3DR.%26aulast%3DDennis%26aufirst%3DD.%26aulast%3DMilner%26aufirst%3DP.%26aulast%3DPfister%26aufirst%3DJ.%26aulast%3DS.%2BP%26aufirst%3DB.%26atitle%3D1%252C3-Dipropyl-8-%255B2-%25285%252C6-Epoxy%2529Norbornyl%255DXanthine%252C%2520a%2520Potent%252C%2520Specific%2520and%2520Selective%2520A1%2520Adenosine%2520Receptor%2520Antagonist%2520in%2520the%2520Guinea%2520Pig%2520Heart%2520and%2520Brain%2520and%2520in%2520DDT1MF-2%2520Cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D1167%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butts-Lamb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, J.</span></span> <span> </span><span class="NLM_article-title">1,3-Dialkyl-8-(p-Sulfophenyl)Xanthines: Potent Water-Soluble Antagonists for A1 -and A2-Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1021/jm00382a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00382a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2MXhtlWrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=487-492&issue=4&author=J.+W.+Dalyauthor=W.+Padgettauthor=M.+T.+Shamimauthor=P.+Butts-Lambauthor=J.+Waters&title=1%2C3-Dialkyl-8-%28p-Sulfophenyl%29Xanthines%3A+Potent+Water-Soluble+Antagonists+for+A1+-and+A2-Adenosine+Receptors&doi=10.1021%2Fjm00382a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Dialkyl-8-(p-sulfophenyl)xanthines:  potent water-soluble antagonists for A1- and A2-adenosine receptors</span></div><div class="casAuthors">Daly, John W.; Padgett, W.; Shamim, M. T.; Butts-Lamb, P.; Waters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-92</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">8-Aryl-1,3-dialkylxanthines I (R-R2 = Me, R3 = H, Ph; R = R1 = Me, Pr, R2 = H, R3 = substituted Ph; R = CH2CH2CHMe2, R1 = CH2CHMe2, R2 = H, R3 = H, Ph, 4-HO3SC6H4) were prepd.  These and some related compds. were tested for their potency and selectivity as A1- and A2-adenosine receptor antagonists.  Structure-activity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4iTyBT2D7ErVg90H21EOLACvtfcHk0lifXdNG8cTR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtlWrsr0%253D&md5=e3a4454b7bbd6268db6b067e7b3def67</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm00382a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00382a018%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DPadgett%26aufirst%3DW.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DButts-Lamb%26aufirst%3DP.%26aulast%3DWaters%26aufirst%3DJ.%26atitle%3D1%252C3-Dialkyl-8-%2528p-Sulfophenyl%2529Xanthines%253A%2520Potent%2520Water-Soluble%2520Antagonists%2520for%2520A1%2520-and%2520A2-Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26issue%3D4%26spage%3D487%26epage%3D492%26doi%3D10.1021%2Fjm00382a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristol, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haleen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, R. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Xanthines as Adenosine Antagonists, a Practical Quantitative Structure-Activity Relationship Application</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1021/jm00146a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00146a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2MXktlWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1071-1079&issue=8&author=H.+W.+Hamiltonauthor=D.+F.+Ortwineauthor=D.+F.+Worthauthor=E.+W.+Badgerauthor=J.+A.+Bristolauthor=R.+F.+Brunsauthor=S.+J.+Haleenauthor=R.+P.+Steffen&title=Synthesis+of+Xanthines+as+Adenosine+Antagonists%2C+a+Practical+Quantitative+Structure-Activity+Relationship+Application&doi=10.1021%2Fjm00146a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application</span></div><div class="casAuthors">Hamilton, Harriet W.; Ortwine, Daniel F.; Worth, Donald F.; Badger, Edward W.; Bristol, James A.; Bruns, Robert F.; Haleen, Stephen J.; Steffen, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1071-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The title xanthines I (R = C1-3 or allyl; R1 = NH2, SO2NH2, NMe2, SO2-morpholino, SO2NHCH2CH(OH)Me, etc.) were prepd. by treatment of appropriate diaminouracil with substituted benzoic acid to the amine amids followed by cyclization to either the phenylxanthine directly or the sulfonic acid which in turn was converted to the sulfonyl chloride and then reacted without isolation with amines to yield the (phenylsulfonamido)xanthines I; these and other previously prepd. xanthines were evaluated for adenosine A1 receptor binding affinity using rat and bovine brain membranes.  High potency as predicted by QSAR anal. was maintained by I; aq. soly. of these compds was also increased.  In vitro antagonism of adenosine receptors was demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2TI1qdEMzLbVg90H21EOLACvtfcHk0lifXdNG8cTR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktlWqt7o%253D&md5=71b69160bfbdb3e7bc7dfa3bafe84b83</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm00146a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00146a016%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DH.%2BW.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DWorth%26aufirst%3DD.%2BF.%26aulast%3DBadger%26aufirst%3DE.%2BW.%26aulast%3DBristol%26aufirst%3DJ.%2BA.%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DHaleen%26aufirst%3DS.%2BJ.%26aulast%3DSteffen%26aufirst%3DR.%2BP.%26atitle%3DSynthesis%2520of%2520Xanthines%2520as%2520Adenosine%2520Antagonists%252C%2520a%2520Practical%2520Quantitative%2520Structure-Activity%2520Relationship%2520Application%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26issue%3D8%26spage%3D1071%26epage%3D1079%26doi%3D10.1021%2Fjm00146a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">8-Aryl- and 8-Cycloalkyl-1,3-Dipropylxanthines: Further Potent and Selective Antagonists for A1-Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1021/jm00398a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00398a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1cXpsVGisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=613-617&issue=3&author=M.+T.+Shamimauthor=D.+Ukenaauthor=W.+L.+Padgettauthor=O.+Hongauthor=J.+W.+Daly&title=8-Aryl-+and+8-Cycloalkyl-1%2C3-Dipropylxanthines%3A+Further+Potent+and+Selective+Antagonists+for+A1-Adenosine+Receptors&doi=10.1021%2Fjm00398a020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">8-Aryl- and 8-cycloalkyl-1,3-dipropylxanthines:  further potent and selective antagonists for A1-adenosine receptors</span></div><div class="casAuthors">Shamim, M. T.; Ukena, D.; Padgett, W. L.; Hong, O.; Daly, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 1,3-dipropylxanthines were prepd. with a variety of substituents, including aryl and cycloalkyl groups, at the 8-position.  Polar carboxylate and carboxamide moieties were introduced as aryl substituents to increase H2O soly.  1,3-Dipropyl-8-[2-hydroxy-4-[(carboxymethyl)oxy]phenyl]xanthine (I) is a functionalized congener with high potency (Ki = 37 nM) and selectivity (54-fold) for A1-adenosine receptors.  I was used to prep. a series of other analogs, some with higher potency and some with higher selectivity.  8-Cyclopentyl- and 8-cyclohexyl-1,3-dipropylxanthines were both very potent (Ki = 1-1.5 nM) and selective for A1 receptors, while 8-cycloalkylmethyl analogs were 10-fold less potent, but still very selective for A1 receptors.  8-Piperidinyl and 8-pyrazinyl analogs had very low activities as adenosine receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUnTSAgAEe5bVg90H21EOLACvtfcHk0lifXdNG8cTR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXpsVGisA%253D%253D&md5=120b988d865b01fb8319c1630fba44f7</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fjm00398a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00398a020%26sid%3Dliteratum%253Aachs%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DHong%26aufirst%3DO.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D8-Aryl-%2520and%25208-Cycloalkyl-1%252C3-Dipropylxanthines%253A%2520Further%2520Potent%2520and%2520Selective%2520Antagonists%2520for%2520A1-Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26issue%3D3%26spage%3D613%26epage%3D617%26doi%3D10.1021%2Fjm00398a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiesman, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutterodt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fure, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span> <span> </span><span class="NLM_article-title">Potent and Orally Bioavailable 8-Bicyclo[2.2.2]Octylxanthines as Adenosine A1 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7119</span>– <span class="NLM_lpage">7131</span>, <span class="refDoi"> DOI: 10.1021/jm0605381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOjs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7119-7131&issue=24&author=W.+F.+Kiesmanauthor=J.+Zhaoauthor=P.+R.+Conlonauthor=J.+E.+Dowlingauthor=R.+C.+Petterauthor=F.+Lutterodtauthor=X.+Jinauthor=G.+Smitsauthor=M.+Fureauthor=A.+Jayarajauthor=J.+Kimauthor=G.+Sullivanauthor=J.+Linden&title=Potent+and+Orally+Bioavailable+8-Bicyclo%5B2.2.2%5DOctylxanthines+as+Adenosine+A1+Receptor+Antagonists&doi=10.1021%2Fjm0605381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists</span></div><div class="casAuthors">Kiesman, William F.; Zhao, Jin; Conlon, Patrick R.; Dowling, James E.; Petter, Russell C.; Lutterodt, Frank; Jin, Xiaowei; Smits, Glenn; Fure, Mary; Jayaraj, Andrew; Kim, John; Sullivan, Gail; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7119-7131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the search for a selective adenosine A1 receptor antagonist with greater aq. soly. than the compds. currently in clin. trials as diuretics, a series of 1,4-substituted 8-cyclohexyl and 8-bicyclo[2.2.2]octylxanthines were investigated.  The binding affinities of a variety of cyclohexyl and bicyclo[2.2.2]octylxanthines for the rat and human adenosine A1, A2A, A2B, and A3 receptors are presented.  Bicyclo[2.2.2]octylxanthine (I) exhibited good pharmaceutical properties and in vivo activity in a rat diuresis model (ED50 = 0.3 mg/kg po).  Optimization of the bridgehead substituent led to propionic acid 29 (BG9928), which retained high potency (hA1, Ki = 7 nM) and selectivity for the adenosine A1 receptor (915-fold vs. adenosine A2A receptor; 12-fold vs. adenosine A2B receptor) with improved oral efficacy in the rat diuresis model (ED50 = 0.01 mg/kg) as well as high oral bioavailability in rat, dog, and cynomolgus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEOLB4TaAywLVg90H21EOLACvtfcHk0lgmzijHd8Ad1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOjs7nO&md5=4b4ba095879893ab5da18665ecc81b0a</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm0605381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605381%26sid%3Dliteratum%253Aachs%26aulast%3DKiesman%26aufirst%3DW.%2BF.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DConlon%26aufirst%3DP.%2BR.%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DLutterodt%26aufirst%3DF.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DSmits%26aufirst%3DG.%26aulast%3DFure%26aufirst%3DM.%26aulast%3DJayaraj%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSullivan%26aufirst%3DG.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DPotent%2520and%2520Orally%2520Bioavailable%25208-Bicyclo%255B2.2.2%255DOctylxanthines%2520as%2520Adenosine%2520A1%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D24%26spage%3D7119%26epage%3D7131%26doi%3D10.1021%2Fjm0605381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Analogs of Caffeine: Antagonists with Selectivity for A2 Adenosine Receptors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(86)90023-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2886%2990023-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3016449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28Xlt1Oltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1986&pages=743-750&author=D.+Ukenaauthor=M.+T.+Shamimauthor=W.+Padgettauthor=J.+W.+Daly&title=Analogs+of+Caffeine%3A+Antagonists+with+Selectivity+for+A2+Adenosine+Receptors&doi=10.1016%2F0024-3205%2886%2990023-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of caffeine:  antagonists with selectivity for A2 adenosine receptors</span></div><div class="casAuthors">Ukena, D.; Shamim, M. T.; Padgett, W.; Daly, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">743-50</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">Several analogs of caffeine  [58-08-2] were investigated as antagonists at A2 adenosine receptors stimulatory to adenylate cyclase  [9012-42-4] in membranes from rat pheochromocytoma PC12 cells and human platelets and at A1 adenosine receptors inhibitory to adenylate cyclase from rat fat cells.  1-Propargyl-3,7-dimethylxanthine  [14114-46-6] was 4-7-fold and 7-propyl-1,3-dimethylxanthine  [27760-74-3] was 3-4-fold more potent than caffeine at A2 receptors of PC12 cells and platelets.  At A1 receptors of fat cells, both compds. were about 50% as potent as caffeine.  These caffeine analogs are the first selective A2 receptor antagonists yet reported, and these results may provide the basis for the further development of highly potent and highly selective A2 adenosine receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr55ep6uG8QebVg90H21EOLACvtfcHk0lgmzijHd8Ad1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xlt1Oltr8%253D&md5=b7baf3552679918528c41df5be36dc31</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2886%2990023-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252886%252990023-8%26sid%3Dliteratum%253Aachs%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DPadgett%26aufirst%3DW.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DAnalogs%2520of%2520Caffeine%253A%2520Antagonists%2520with%2520Selectivity%2520for%2520A2%2520Adenosine%2520Receptors%26jtitle%3DLife%2520Sci.%26date%3D1986%26volume%3D39%26spage%3D743%26epage%3D750%26doi%3D10.1016%2F0024-3205%2886%2990023-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seale, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abla, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carney, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">3,7-Dimethyl-1-Propargylxanthine: A Potent and Selective in Vivo Antagonist of Adenosine Analogs</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(88)90478-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2888%2990478-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3193854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1988&pages=1671-1684&author=T.+W.+Sealeauthor=K.+A.+Ablaauthor=M.+T.+Shamimauthor=J.+M.+Carneyauthor=J.+W.+Daly&title=3%2C7-Dimethyl-1-Propargylxanthine%3A+A+Potent+and+Selective+in+Vivo+Antagonist+of+Adenosine+Analogs&doi=10.1016%2F0024-3205%2888%2990478-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">3,7-Dimethyl-1-propargylxanthine:  a potent and selective in vivo antagonist of adenosine analogs</span></div><div class="casAuthors">Seale, Thomas W.; Abla, Kathleen A.; Shamim, Mah T.; Carney, John M.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1671-84</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">3,7-Dimethyl-1-propargylxanthine (DMPX), a caffeine analog that exhibits in vivo selectivity for A2-adenosine receptors, compared to A1-adenosine receptors, was investigated with respect to in vivo potency and selectivity.  DMPX potently and selectively blocked the actions of the potent A2 adenosine agonist, 5'-N-ethylcarboxamidoadenosine (NECA), in DBA/2 mice, compared to blockade of the same responses elicited by the selective A1-adenosine agonist, N6-cyclohexyladenosine (CHA).  DMPX was 57-fold more potent against NECA-induced hypothermia than against CHA-induced hypothermia and 11-fold more potent against NECA-induced behavioral depression than against CHA-induced behavioral depression.  The hypothermia is mediated by peripheral receptors, based on blockade by 8-(p-sulfophenyl)theophylline (PSPT), while the behavioral depression is centrally mediated, based on lack of blockade by PSPT.  DMPX was 28- and 15-fold more potent than caffeine in blocking peripheral and central NECA responses, resp.  DMPX was equipotent with caffeine vs. CHA-induced hypothermia and 2.5-fold more potent than caffeine vs. CHA-induced behavioral depression.  The motor stimulating potency of DMPX (ED50 10 μmol/kg) was slightly greater than caffeine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF3qkqws9GZLVg90H21EOLACvtfcHk0ljgJnYM64uJEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVCjsA%253D%253D&md5=60748b0f23a6f20df61abf6f7157c16f</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2888%2990478-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252888%252990478-X%26sid%3Dliteratum%253Aachs%26aulast%3DSeale%26aufirst%3DT.%2BW.%26aulast%3DAbla%26aufirst%3DK.%2BA.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D3%252C7-Dimethyl-1-Propargylxanthine%253A%2520A%2520Potent%2520and%2520Selective%2520in%2520Vivo%2520Antagonist%2520of%2520Adenosine%2520Analogs%26jtitle%3DLife%2520Sci.%26date%3D1988%26volume%3D43%26spage%3D1671%26epage%3D1684%26doi%3D10.1016%2F0024-3205%2888%2990478-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Effects of 8-Phenyl and 8-Cycloalkyl Substituents on the Activity of Mono-, Di-, and Trisubstituted Alkylxanthines with Substitution at the 1-, 3-, and 7-Positions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1231</span>– <span class="NLM_lpage">1237</span>, <span class="refDoi"> DOI: 10.1021/jm00126a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00126a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Cqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1231-1237&issue=6&author=M.+T.+Shamimauthor=D.+Ukenaauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Effects+of+8-Phenyl+and+8-Cycloalkyl+Substituents+on+the+Activity+of+Mono-%2C+Di-%2C+and+Trisubstituted+Alkylxanthines+with+Substitution+at+the+1-%2C+3-%2C+and+7-Positions&doi=10.1021%2Fjm00126a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions</span></div><div class="casAuthors">Shamim, Mah T.; Ukena, Dieter; Padgett, William L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1231-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The effects of 8-Ph and 8-cycloalkyl substituents on the activity of theophylline, caffeine, 1,3-dipropylxanthine, 1,3-dipropyl-7-methylxanthine, 3-propylxanthine, and 1-propylxanthine at A1 adenosine receptors of rat brain and fat cells and at A2 adenosine receptors of rat pheochromocytoma PC12 cells and human platelets were compared.  An 8-Ph substituent had little effect on the activity of caffeine or 1,3-dipropyl-7-methylxanthine at adenosine receptors, while markedly increasing the activity of theophylline, 1,3-dipropylxanthine, 1-isoamyl-3-isobutylxanthine, 1-methylxanthine, and 3-propylxanthine.  8-Phenyl-1-propylxanthine was potent (Ki = 20-70 nM) at all receptors.  A p-carboxy or p-sulfo substituent, which was introduced on the 8-Ph ring to increase water soly., in most cases decreased the activity and selectivity for the A1 receptor.  Among the 8-p-sulfo analogs, only 8-(p-sulfophenyl)theophylline and 1,3-dipropyl-8-(p-sulfophenyl)xanthine were selective for the A1 receptors.  The 8-p-sulfophenyl derivs. of caffeine, 1,3-dipropyl-7-methylxanthine, and 3-propylxanthine were somewhat selective for the A2 receptors.  8-Cycloalkyl substituents (cyclopentyl, cyclohexyl) markedly increased the activity of caffeine and 1,3-dipropyl-7-methylxanthine at the A2 receptor.  8-Cyclohexylcaffeine was potent (Ki = 190 nM) and very selective for the human platelet A2 receptor, but was not as selective for the rat PC12 A2 receptor.  Such A2 selectivity is in contrast to the marked A1 selectivity of 8-cycloalkyltheophyllines and 8-cycloalkyl-1,3-dipropylxanthines.  The apparent selectivity of certain xanthines is dependent on the assay systems that are compared.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVZkaAS8EWbrVg90H21EOLACvtfcHk0ljgJnYM64uJEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Cqurc%253D&md5=51d806cb8b544b2e48ef403ca604c2b5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm00126a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00126a014%26sid%3Dliteratum%253Aachs%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DEffects%2520of%25208-Phenyl%2520and%25208-Cycloalkyl%2520Substituents%2520on%2520the%2520Activity%2520of%2520Mono-%252C%2520Di-%252C%2520and%2520Trisubstituted%2520Alkylxanthines%2520with%2520Substitution%2520at%2520the%25201-%252C%25203-%252C%2520and%25207-Positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26issue%3D6%26spage%3D1231%26epage%3D1237%26doi%3D10.1021%2Fjm00126a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichikawa, S.</span></span> <span> </span><span class="NLM_article-title">(E)-1,3-Dialkyl-7-Methyl-8-(3,4,5-Trimethoxystyryl)Xanthines: Potent and Selective Adenosine A2 Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2342</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1021/jm00090a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00090a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XktF2qs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2342-2345&author=J.+Shimadaauthor=F.+Suzukiauthor=H.+Nonakaauthor=A.+Ishiiauthor=S.+Ichikawa&title=%28E%29-1%2C3-Dialkyl-7-Methyl-8-%283%2C4%2C5-Trimethoxystyryl%29Xanthines%3A+Potent+and+Selective+Adenosine+A2+Antagonists&doi=10.1021%2Fjm00090a027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">(E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines:  potent and selective adenosine A2 antagonists</span></div><div class="casAuthors">Shimada, Junichi; Suzuki, Fumio; Nonaka, Hiromi; Ishii, Akio; Ichikawa, Shunji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2342-5</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 8-substituted 1,3,7-trialkylxanthines was tested for their hydrophobic interactions with the adenosine A2 receptor.  (E)-Styryl substitution at the 8-position increased the affinity at the A2 receptor and A2 selectivity.  Furthermore introduction of dimethoxy or trimethoxy group into the 8-styryl substituent of 1,3-dipropyl-7-methylxanthines enhanced the A2 selectivity in general.  No apparent differences in the affinity at the A2 receptor were obsd. among a series of (E)-1,3-dialkyl-7-methyl-8-(3,5,6-trimethoxystyryl)xanthine derivs.  This result is greatly contrasting with that of 1,3-disubstituted 8-alkyl- or 8-polycycloalkylxanthine derivs. where 1,3-disubstituents dramatically influenced affinity at the A1 receptor and its selectivity.  The most potent A2 antagonist, (E)-1,3-dipropyl-7-methyl-8-(3,4-dimethoxystyryl)xanthine (I) (Ki = 7.8 nM, A1/A2 = 190) produced a much larger shift of the NECA dose-response curve for blood pressure (A2) than for heart rate (A1) at the oral dose of 30 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJzjx_yPGaSrVg90H21EOLACvtfcHk0ljgJnYM64uJEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktF2qs7c%253D&md5=33d11a3027e9e5318aff945318919872</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjm00090a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00090a027%26sid%3Dliteratum%253Aachs%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DA.%26aulast%3DIchikawa%26aufirst%3DS.%26atitle%3D%2528E%2529-1%252C3-Dialkyl-7-Methyl-8-%25283%252C4%252C5-Trimethoxystyryl%2529Xanthines%253A%2520Potent%2520and%2520Selective%2520Adenosine%2520A2%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2342%26epage%3D2345%26doi%3D10.1021%2Fjm00090a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kase, H.</span></span> <span> </span><span class="NLM_article-title">KF17837 ((E)-8-(3,4-Dimethoxystyryl)- 1,3-Dipropyl-7-Methylxanthine), a Potent and Selective Adenosine A 2 Receptor Antagonist</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(94)90159-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0922-4106%2894%2990159-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8088373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1994&pages=335-341&author=H.+Nonakaauthor=M.+Ichimuraauthor=M.+Takedaauthor=Y.+Nonakaauthor=J.+Shimadaauthor=F.+Suzukiauthor=K.+Yamaguchiauthor=H.+Kase&title=KF17837+%28%28E%29-8-%283%2C4-Dimethoxystyryl%29-+1%2C3-Dipropyl-7-Methylxanthine%29%2C+a+Potent+and+Selective+Adenosine+A+2+Receptor+Antagonist&doi=10.1016%2F0922-4106%2894%2990159-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist</span></div><div class="casAuthors">Nonaka, Hiromi; Ichimura, Michio; Takeda, Masami; Nonaka, Yoshiko; Shimada, Jyunichi; Suzuki, Fumio; Yamaguchi, Kazuo; Kase, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-41</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">8-(3,4-Dimethoxystyryl)-1,3-dipropyl-7-methylxanthine exhibited high affinity and selectivity for adenosine A2A receptors in binding assay using rat striatal A2A receptors labeled with [3H]2-[p-(2-carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680).  The affinity was stereo selective: the E isomer, KF17837, showed a Ki value of 1.0±0.057 nM for the A2A receptors, whereas the Z isomer showed much lower affinity.  KF17837 had 62-fold selectivity for the A2A receptors vs. rat forebrain A1 receptors labeled with [3H]N6-cyclohexyladenosine (CHA).  KF17837 was rapidly photoisomerized to form a stable equil. mixt. (18% E - 82% Z), KF17837S, which showed Ki values of 7.9±0.055 nM and 390±68 nM for the A2A and A1 receptors, resp.  The inhibition type was competitive for [3H]CGS21680 binding.  In rat pheochromocytoma PC12 cells KF17837S antagonized cAMP accumulation induced by 1 μM CGS21680 via the A2A receptors, with an IC50 value of 53±10 nM. cAMP accumulation induced by 10 μM 5'-N-ethylcarboxamidoadenosine via the A2B receptors in Jurkat cells (human T-cell line) was inhibited by KF17837S with an IC50 value of 1500±290 nM.  These results indicate that KF17837S (and hence KF17837) is a highly potent and selective adenosine A2A receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaycIuJFo4rLVg90H21EOLACvtfcHk0ljgJnYM64uJEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kkt7w%253D&md5=7e8b90e1b5caca1113d9ffb5f3e321f9</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990159-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990159-7%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DIchimura%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKase%26aufirst%3DH.%26atitle%3DKF17837%2520%2528%2528E%2529-8-%25283%252C4-Dimethoxystyryl%2529-%25201%252C3-Dipropyl-7-Methylxanthine%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Adenosine%2520A%25202%2520Receptor%2520Antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1994%26volume%3D267%26spage%3D335%26epage%3D341%26doi%3D10.1016%2F0922-4106%2894%2990159-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bergen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Galen, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karton, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of 8-Styrylxanthines as A2-Selective Adenosine Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1342</span>, <span class="refDoi"> DOI: 10.1021/jm00062a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00062a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXisFCls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1333-1342&issue=10&author=K.+A.+Jacobsonauthor=C.+Gallo-Rodriguezauthor=N.+Melmanauthor=B.+Fischerauthor=M.+Maillardauthor=A.+Van+Bergenauthor=P.+J.+M.+Van+Galenauthor=Y.+Karton&title=Structure-Activity+Relationships+of+8-Styrylxanthines+as+A2-Selective+Adenosine+Antagonists&doi=10.1021%2Fjm00062a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gallo-Rodriguez, Carola; Melman, Neli; Fischer, Bilha; Maillard, Michel; van Bergen, Andrew; van Galen, Philip J. M.; Karton, Yishai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1333-42</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of substituted 8-styryl derivs. of 1,3,7-alkylxanthines I [i.e., R-R2 = H, Me, R3 = (un)substituted Ph]was synthesized as potential A2-selective adenosine receptor antagonists, and the potency at rat brain A1- and A2-receptors was studied in radioligand binding expts.  At the xanthine 7-position, only small hydrophobic substituents were tolerated in receptor binding.  7-Me analogs were roughly 1 order of magnitude more selective for A2 vs. A1 receptors than the corresponding 7-H analogs.  1,3-Dimethylxanthine derivs. tended to be more selective for A2-receptors than the corresponding 1,3-diallyl, di-Et, or di-Pr derivs.  Substitutions of the Ph ring at the 3-(monosubstituted) and 3,5-(disubstituted) positions were favored.  I (R - R2 = Me, R3 = 3-ClC6H4) was a moderately potent and high A2-selective adenosine antagonist.  I (R - R2 = Me, R3 = 3-HO2CCH2CH2CONHC6H4) was highly A2-selective and had enhanced water soly.  I [R, R1 = Pr, R2 = Me, R3 = 3,5-(MeO)2C6H3] was a potent and very A2-selective adenosine antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIguFj7oPkLVg90H21EOLACvtfcHk0lhLgPAu3w_SJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisFCls7k%253D&md5=73e0889d05bd90ec0b3fa745054a92ca</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm00062a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00062a005%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DVan%2BBergen%26aufirst%3DA.%26aulast%3DVan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DKarton%26aufirst%3DY.%26atitle%3DStructure-Activity%2520Relationships%2520of%25208-Styrylxanthines%2520as%2520A2-Selective%2520Adenosine%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D10%26spage%3D1333%26epage%3D1342%26doi%3D10.1021%2Fjm00062a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikodijević, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">8-(3-Chlorostyryl)Caffeine (CSC) Is a Selective A2-Adenosine Antagonist in Vitro and in Vivo</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>323</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)81466-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0014-5793%2893%2981466-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8495727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXksVSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=1993&pages=141-144&issue=1%E2%80%932&author=K.+A.+Jacobsonauthor=O.+Nikodijevi%C4%87author=W.+L.+Padgettauthor=C.+Gallo-Rodriguezauthor=M.+Maillardauthor=J.+W.+Daly&title=8-%283-Chlorostyryl%29Caffeine+%28CSC%29+Is+a+Selective+A2-Adenosine+Antagonist+in+Vitro+and+in+Vivo&doi=10.1016%2F0014-5793%2893%2981466-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo</span></div><div class="casAuthors">Jacobson, Kenneth A.; Nikodijevic, Olga; Padgett, William L.; Gallo-Rodriguez, Carola; Maillard, Michel; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">141-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">An adenosine antagonist, 8-(3-chlorostyryl)caffeine (CSC), was shown previously to be 520-fold selective for A2a-adenosine receptors in radioligand binding assays in the rat brain.  In reversing agonist effects on adenylate cyclase, CSC was 22-fold selective for A2a receptors in rat pheochromocytoma cells (Kb 60 nM) vs. A1 receptors in rat adipocytes (Kb 1.3 μM).  Administered i.p. in NIH mice at a dose of 1 mg/kg, CSC shifted the curve for locomotor depression elicited by the A2a-selective agonist 2-[(2-aminoethylamino)carbonylethylphenylethylamino]-5'-N-ethylcarboxamidoadenosine (APEC) to the right (ED50 value for APEC shifted from 20 μg/kg i.p. to 190 μg/kg).  CSC had no effect on locomotor depression elicited by an ED50 dose of the A1-selective agonist N6-cyclohexyladenosine (CHA).  CSC alone at a dose of 5 mg/kg stimulated locomotor activity by 22% over control values.  Coadministration of CSC and the A1-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX), both at non-stimulatory doses, increased activity by 37% (P < 0.001) over CSC alone, suggesting a behavioral synergism of A1- and A2-antagonist effects in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobFlWRPu5O1rVg90H21EOLACvtfcHk0lhLgPAu3w_SJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVSrs70%253D&md5=cb3a114dbe97c33b56690662b20bfd25</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2981466-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252981466-D%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DNikodijevi%25C4%2587%26aufirst%3DO.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D8-%25283-Chlorostyryl%2529Caffeine%2520%2528CSC%2529%2520Is%2520a%2520Selective%2520A2-Adenosine%2520Antagonist%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D323%26issue%3D1%25E2%2580%25932%26spage%3D141%26epage%3D144%26doi%3D10.1016%2F0014-5793%2893%2981466-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Schyf, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonsalla, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzschild, M. A.</span></span> <span> </span><span class="NLM_article-title">8-(3-Chlorostyryl) Caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">36040</span>– <span class="NLM_lpage">36044</span>, <span class="refDoi"> DOI: 10.1074/jbc.M206830200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1074%2Fjbc.M206830200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12130655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=36040-36044&issue=39&author=J.+F.+Chenauthor=S.+Steynauthor=R.+Staalauthor=J.+P.+Petzerauthor=K.+Xuauthor=C.+J.+Van+Der+Schyfauthor=K.+Castagnoliauthor=P.+K.+Sonsallaauthor=N.+Castagnoliauthor=M.+A.+Schwarzschild&title=8-%283-Chlorostyryl%29+Caffeine+May+Attenuate+MPTP+Neurotoxicity+through+Dual+Actions+of+Monoamine+Oxidase+Inhibition+and+A2A+Receptor+Antagonism&doi=10.1074%2Fjbc.M206830200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism</span></div><div class="casAuthors">Chen, Jiang-Fan; Steyn, Salome; Staal, Roland; Petzer, Jacobus P.; Xu, Kui; Van der Schyf, Cornelis J.; Castagnoli, Kay; Sonsalla, Patricia K.; Castagnoli, Neal, Jr.; Schwarzschild, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36040-36044</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Caffeine and more specific antagonists of the adenosine A2A receptor recently have been found to be neuroprotective in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease.  Here we show that 8-(3-chlorostyryl)caffeine (CSC), a specific A2A antagonist closely related to caffeine, also attenuates MPTP-induced neurotoxicity.  Because the neurotoxicity of MPTP relies on its oxidative metab. to the mitochondrial toxin MPP+, we investigated the actions of CSC on striatal MPTP metab. in vivo.  CSC elevated striatal levels of MPTP but lowered levels of the oxidative intermediate MPDP+ and of MPP+, suggesting that CSC blocks the conversion of MPTP to MPDP+ in vivo.  In assessing the direct effects of CSC and A2A receptors on monoamine oxidase (MAO) activity, we found that CSC potently and specifically inhibited mouse brain mitochondrial MAO-B activity in vitro with a Ki value of 100 nm, whereas caffeine and another relatively specific A2A antagonist produced little or no inhibition.  The A2A receptor independence of MAO-B inhibition by CSC was further supported by the similarity of brain MAO activities derived from A2A receptor knockout and wild-type mice and was confirmed by demonstrating potent inhibition of A2A receptor knockout-derived MAO-B by CSC.  Together, these data indicate that CSC possesses dual actions of MAO-B inhibition and A2A receptor antagonism, a unique combination suggesting a new class of compds. with the potential for enhanced neuroprotective properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8ESRi-__yrVg90H21EOLACvtfcHk0lhLgPAu3w_SJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCjs7Y%253D&md5=27154cad8b81538a593504f7ca2f42ec</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M206830200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M206830200%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DVan%2BDer%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3D8-%25283-Chlorostyryl%2529%2520Caffeine%2520May%2520Attenuate%2520MPTP%2520Neurotoxicity%2520through%2520Dual%2520Actions%2520of%2520Monoamine%2520Oxidase%2520Inhibition%2520and%2520A2A%2520Receptor%2520Antagonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D39%26spage%3D36040%26epage%3D36044%26doi%3D10.1074%2Fjbc.M206830200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dungo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Istradefylline: First Global Approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1007/s40265-013-0066-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs40265-013-0066-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23700273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=875-882&issue=8&author=R.+Dungoauthor=E.+D.+Deeks&title=Istradefylline%3A+First+Global+Approval&doi=10.1007%2Fs40265-013-0066-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Istradefylline: First Global Approval</span></div><div class="casAuthors">Dungo, Rosselle; Deeks, Emma D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">875-882</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Kyowa Hakko Kirin is developing istradefylline, a selective adenosine A2A receptor antagonist, for the once-daily oral treatment of Parkinson's disease (PD).  Adenosine A2A receptors are considered to be present particularly in the basal ganglia of the brain; the degeneration or abnormality obsd. in PD is believed to occur in the basal ganglia, which is recognized to play a significant role in motor control.  Com. available dopamine replacement therapies effectively treat the early motor symptoms of PD; however, these agents are assocd. with development of motor complications, limiting usefulness in late stages of the disease.  Istradefylline is proposed to possess a clearly distinct action site from existing agents which act on dopamine metab. or dopamine receptors.  Kyowa Hakko Kirin has received approval for istradefylline in the adjunctive treatment of PD in Japan.  A New Drug Application was filed in the USA, but the FDA issued a non-approvable letter in Feb. 2008.  This article summarizes the milestones in the development of istradefylline leading to its first approval for the treatment of patients with PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsHgSlibdiR7Vg90H21EOLACvtfcHk0lhSWGHONM74RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmsL7L&md5=4933d804adda96e4447e3c3bc526e12e</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1007%2Fs40265-013-0066-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-013-0066-7%26sid%3Dliteratum%253Aachs%26aulast%3DDungo%26aufirst%3DR.%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DIstradefylline%253A%2520First%2520Global%2520Approval%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26issue%3D8%26spage%3D875%26epage%3D882%26doi%3D10.1007%2Fs40265-013-0066-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">FDA</span>. <span> </span><span class="NLM_article-title">Initial U.S. Approval for Nourianz</span>. <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease" class="extLink">https://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease</a>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=FDA&title=Initial+U.S.+Approval+for+Nourianz"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DInitial%2520U.S.%2520Approval%2520for%2520Nourianz%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Załuski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabikowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latacz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz-Maciej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaśko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroz-Płonka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcmdc.201900717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=32162782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlCis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=772-786&issue=9&author=K.+J.+Kuderauthor=M.+Za%C5%82uskiauthor=J.+Schabikowskiauthor=G.+Lataczauthor=A.+Olejarz-Maciejauthor=P.+Ja%C5%9Bkoauthor=A.+Doroz-P%C5%82onkaauthor=A.+Brockmannauthor=C.+E.+M%C3%BCllerauthor=K.+Kie%C4%87-Kononowicz&title=Novel%2C+Dual+Target-Directed+Annelated+Xanthine+Derivatives+Acting+on+Adenosine+Receptors+and+Monoamine+Oxidase+B&doi=10.1002%2Fcmdc.201900717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B</span></div><div class="casAuthors">Kuder, Kamil J.; Zaluski, Michal; Schabikowski, Jakub; Latacz, Gniewomir; Olejarz-Maciej, Agnieszka; Jasko, Piotr; Doroz-Plonka, Agata; Brockmann, Andreas; Mueller, Christa E.; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">772-786</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Annelated purinedione derivs. have been shown to act as possible multiple-target ligands, addressing adenosine receptors and monoaminooxidases.  In this study, based on our previous results, novel annelated pyrimido- and diazepino[2,1-f]purinedione derivs. were designed as dual-target-directed ligands combining A2A adenosine receptor (AR) antagonistic activity with blocking monoamine oxidase B.  A library of 19 novel compds. was synthesized and biol. evaluated in radioligand binding studies at AR subtypes and for their ability to inhibit MAO-B.  This allowed 9-(2-chloro-6-fluorobenzyl)-3-ethyl-1-methyl-6,7,8,9-tetrahydropyrimido[2,1-f]purine-2,4(1H,3H)-dione (13 e; Ki human A2AAR: 264 nM and IC50 human MAO-B: 243 nM) to be identified as the most potent dual-acting ligand from this series.  ADMET parameters were estd. in vitro, and anal. of the structure-activity relationships was complemented by mol.-docking studies based on previously published X-ray structures of the protein targets.  Such dual-acting ligands, by selectively blocking A2A AR, accompanied by the inhibition of dopamine metabolizing enzyme MAO-B, might provide symptomatic and neuroprotective effects in, among others, the treatment of Parkinson disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Lk4PTzMribVg90H21EOLACvtfcHk0lhSWGHONM74RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlCis70%253D&md5=204271fa4c0b287fddc0d277aeb35997</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900717%26sid%3Dliteratum%253Aachs%26aulast%3DKuder%26aufirst%3DK.%2BJ.%26aulast%3DZa%25C5%2582uski%26aufirst%3DM.%26aulast%3DSchabikowski%26aufirst%3DJ.%26aulast%3DLatacz%26aufirst%3DG.%26aulast%3DOlejarz-Maciej%26aufirst%3DA.%26aulast%3DJa%25C5%259Bko%26aufirst%3DP.%26aulast%3DDoroz-P%25C5%2582onka%26aufirst%3DA.%26aulast%3DBrockmann%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DNovel%252C%2520Dual%2520Target-Directed%2520Annelated%2520Xanthine%2520Derivatives%2520Acting%2520on%2520Adenosine%2520Receptors%2520and%2520Monoamine%2520Oxidase%2520B%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26issue%3D9%26spage%3D772%26epage%3D786%26doi%3D10.1002%2Fcmdc.201900717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Załuski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabikowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz-Maciej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latacz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zygmunt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Synak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Novel Multi-Target Directed Ligands Based on Annelated Xanthine Scaffold with Aromatic Substituents Acting on Adenosine Receptor and Monoamine Oxidase B. Synthesis, in Vitro and in Silico Studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30808606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1GnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=1195-1210&issue=7&author=M.+Za%C5%82uskiauthor=J.+Schabikowskiauthor=M.+Schlenkauthor=A.+Olejarz-Maciejauthor=B.+Kubasauthor=T.+Karczauthor=K.+Kuderauthor=G.+Lataczauthor=M.+Zygmuntauthor=D.+Synakauthor=S.+Hinzauthor=C.+E.+M%C3%BCllerauthor=K.+Kie%C4%87-Kononowicz&title=Novel+Multi-Target+Directed+Ligands+Based+on+Annelated+Xanthine+Scaffold+with+Aromatic+Substituents+Acting+on+Adenosine+Receptor+and+Monoamine+Oxidase+B.+Synthesis%2C+in+Vitro+and+in+Silico+Studies&doi=10.1016%2Fj.bmc.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies</span></div><div class="casAuthors">Zaluski, Michal; Schabikowski, Jakub; Schlenk, Miriam; Olejarz-Maciej, Agnieszka; Kubas, Bartlomiej; Karcz, Tadeusz; Kuder, Kamil; Latacz, Gniewomir; Zygmunt, Malgorzata; Synak, David; Hinz, Sonja; Muller, Christa E.; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1195-1210</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N9-Benzyl-substituted imidazo-, pyrimido- and 1,3-diazepino[2,1-f]purinediones were designed as dual-target-directed ligands combining A2A adenosine receptor (AR) antagonistic activity with blockade of monoamine oxidase B (MAO-B).  A library of 37 novel compds. was synthesized and biol. evaluated in radioligand binding studies at AR subtypes and for their ability to inhibit MAO-B.  A systematic modification of the tricyclic structures based on a xanthine core by enlargement of the third heterocyclic ring or attachment of various substituted benzyl moieties resulted in the development of 9-(2-chloro-6-fluorobenzyl)-1,3-dimethyl-6,7,8,9-tetrahydropyrimido[2,1-f]purine-2,4(1H,3H)-dione (9u; Ki human A2AAR: 189 nM and IC50 human MAO-B: 570 nM) as the most potent dual acting ligand of the series displaying high selectivity vs. related targets.  Moreover, some potent, selective MAO-B inhibitors were identified in the group of pyrimido- and 1,3-diazepino[2,1-f]purinediones.  Compd. 10d (10-(3,4-dichlorobenzyl)-1,3-dimethyl-7,8,9,10-tetrahydro-1H-[1,3]diazepino[2,1-f]purine-2,4(3H,6H)-dione) displayed an IC50 value at human MAO-B of 83 nM.  Anal. of structure-activity relationships was complemented by mol. docking studies based on previously published x-ray structures of the protein targets.  An extended biol. profile was detd. for selected compds. including in vitro evaluation of potential hepatotoxicity calcd. in silico and antioxidant properties as an addnl. desirable activity.  The new mols. acting as dual target drugs may provide symptomatic relief as well as disease-modifying effects for neurodegenerative diseases, in particular Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqr5lfVzqb-rVg90H21EOLACvtfcHk0lhvIjZqM8gZUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1GnsL0%253D&md5=45348a790e9af9f60749f6255ba68284</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DZa%25C5%2582uski%26aufirst%3DM.%26aulast%3DSchabikowski%26aufirst%3DJ.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DOlejarz-Maciej%26aufirst%3DA.%26aulast%3DKubas%26aufirst%3DB.%26aulast%3DKarcz%26aufirst%3DT.%26aulast%3DKuder%26aufirst%3DK.%26aulast%3DLatacz%26aufirst%3DG.%26aulast%3DZygmunt%26aufirst%3DM.%26aulast%3DSynak%26aufirst%3DD.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DNovel%2520Multi-Target%2520Directed%2520Ligands%2520Based%2520on%2520Annelated%2520Xanthine%2520Scaffold%2520with%2520Aromatic%2520Substituents%2520Acting%2520on%2520Adenosine%2520Receptor%2520and%2520Monoamine%2520Oxidase%2520B.%2520Synthesis%252C%2520in%2520Vitro%2520and%2520in%2520Silico%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1195%26epage%3D1210%26doi%3D10.1016%2Fj.bmc.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, C. G. A.</span></span> <span> </span><span class="NLM_article-title">Xanthine Derivatives as Adenosine Receptor Antagonists</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(82)90359-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0014-2999%2882%2990359-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6288418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL38XlsFKmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1982&pages=673-676&issue=4&author=B.+B.+Fredholmauthor=C.+G.+A.+Persson&title=Xanthine+Derivatives+as+Adenosine+Receptor+Antagonists&doi=10.1016%2F0014-2999%2882%2990359-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthine derivatives as adenosine receptor antagonists</span></div><div class="casAuthors">Fredholm, Bertil B.; Persson, Carl G. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">673-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The potency of a series of xanthine derivs. as adenosine  [58-61-7] antagonists was studied in fat cells (A1-receptors) and hippocampal slices (A2-receptors) and on L-[3H]phenylisopropyladenosine (PIA) binding in membranes from rat cortex.  The order of potency in all 3 tests systems was: 1,3-diethyl-8-phenylxanthine  [75922-48-4] > 8-phenyltheophylline  [961-45-5] > 8-p-sulfophenyltheophylline  [80206-91-3] > verophylline  [66172-75-6] > 1-isobutyl-3-methylxanthine  [76054-34-7] > theophylline  [58-55-9] > caffeine  [58-08-2] > theobromine  [83-67-0] ≃ pentoxifylline  [6493-05-6].  The alkylxanthines were somewhat more potent in the fat cell system than in the other 2 systems.  enprofylline  [41078-02-8] Was 20-30 times more potent in the hippocampal than in the other 2 systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprInbW0AGODrVg90H21EOLACvtfcHk0lhvIjZqM8gZUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlsFKmsrY%253D&md5=57875dcc6eab45293d4ee93b1e481a59</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2882%2990359-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252882%252990359-4%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DPersson%26aufirst%3DC.%2BG.%2BA.%26atitle%3DXanthine%2520Derivatives%2520as%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1982%26volume%3D81%26issue%3D4%26spage%3D673%26epage%3D676%26doi%3D10.1016%2F0014-2999%2882%2990359-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feoktistov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polosa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holgate, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biaggioni, I.</span></span> <span> </span><span class="NLM_article-title">Adenosine A 2B Receptors: A Novel Therapeutic Target in Asthma? A Putative Role for Adenosine in Airway Inflammation</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(98)01179-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0165-6147%2898%2901179-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=9612090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1ams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=148-153&author=I.+Feoktistovauthor=R.+Polosaauthor=S.+T.+Holgateauthor=I.+Biaggioni&title=Adenosine+A+2B+Receptors%3A+A+Novel+Therapeutic+Target+in+Asthma%3F+A+Putative+Role+for+Adenosine+in+Airway+Inflammation&doi=10.1016%2FS0165-6147%2898%2901179-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B receptors: a novel therapeutic target in asthma?</span></div><div class="casAuthors">Feoktistov, Igor; Polosa, Riccardo; Holgate, Stephen T.; Biaggiioni, Italo</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">148-153</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 67 refs.  Adenosine is an endogenous nucleoside that modulates many physiol. processes.  Its actions are mediated by interaction with specific cell membrane receptors.  Four subtypes of adenosine receptor have been cloned: A1, A2A, A2B and A3.  Significant advancement has been made in our understanding of the mol. pharmacol. and physiol. relevance of adenosine receptors but our knowledge of A2B receptors lags behind that of other receptor types.  Only recently have potentially important functions been discovered for the A2B receptors, prompting a renewed interest in this receptor types.  A2B receptors have been implicated in the regulation of vascular smooth muscle tone, cell growth, intestinal function and neurosecretion.  In this review, the authors focus on the role of A2B receptors in mast cell activation and the potential relevance of this action on asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSnNJf_gBTB7Vg90H21EOLACvtfcHk0lhc4tcxEHx_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1ams7k%253D&md5=ed92009a354ed2b5d5557e4f3e73a501</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2898%2901179-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252898%252901179-1%26sid%3Dliteratum%253Aachs%26aulast%3DFeoktistov%26aufirst%3DI.%26aulast%3DPolosa%26aufirst%3DR.%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DBiaggioni%26aufirst%3DI.%26atitle%3DAdenosine%2520A%25202B%2520Receptors%253A%2520A%2520Novel%2520Therapeutic%2520Target%2520in%2520Asthma%253F%2520A%2520Putative%2520Role%2520for%2520Adenosine%2520in%2520Airway%2520Inflammation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D148%26epage%3D153%26doi%3D10.1016%2FS0165-6147%2898%2901179-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A(2B) Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1021/jm990421v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990421v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1165-1172&issue=6&author=Y.+C.+Kimauthor=X.+D.+Jiauthor=N.+Melmanauthor=J.+Lindenauthor=K.+A.+Jacobson&title=Anilide+Derivatives+of+an+8-Phenylxanthine+Carboxylic+Congener+Are+Highly+Potent+and+Selective+Antagonists+at+Human+A%282B%29+Adenosine+Receptors&doi=10.1021%2Fjm990421v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors</span></div><div class="casAuthors">Kim, Yong-Chul; Ji, Xiao-duo; Melman, Neli; Linden, Joel; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">No highly selective antagonists of the A2B adenosine receptor (AR) have been reported; however such antagonists have therapeutic potential as antiasthmatic agents.  Here the synthesis of potent and selective A2B receptor Antagonists is reported.  The structure-activity relationships (SAR) of 8-phenyl-1,3-di-(n-propyl)xanthine derivs. in binding to recombinant human A2B ARs in HEK-293 cells (HEK-A2B) and at other AR subtypes were explored.  Various amide derivs. of 8-[4-[[carboxymethyl]oxy]phenyl]-1,3-di(n-propyl)xanthine, I (R1 = n-Pr, X = OCH2, R2 = OH) (II), were synthesized.  A comparison of aryl, alkyl, and aralkyl amides demonstrated that simple anilides, particularly those substituted in the para-position with electron-withdrawing groups, such as nitro, cyano, and acetyl, bind selectively to human A2B receptors in the range of 1-3 nM.  The unsubstituted anilide I (R1 = n-Pr, X = OCH2, R2 = NHPh) had a Ki value at A2B receptors of 1.48 nM but was only moderately selective vs. human A1/A2A receptors and nonselective vs. rat A1 receptors.  Highly potent and selective A2B antagonists were a p-aminoacetophenone deriv. I (R1 = n-Pr, X = OCH2, R2 = 4-MeOC6H4NH) (Ki value 1.39 nM) and a p-cyanoanilide I (R1 = n-Pr, X = OCH2, R2 = NHC6H4CN-4) (III) (Ki value 1.97 nM).  Compd. III was 400-, 245-, and 123-fold selective for human A2B receptors vs. human A1/A2A/A3 receptors, resp., and 8.5- and 310-fold selective vs. rat A1/A2A receptors, resp.  Substitution of the 1,3-di-Pr groups with 1,3-di-Et offered no disadvantage for selectivity, and high affinities at A2B receptors were maintained.  Substitution of the p-carboxymethyloxy group of II and its amides with acrylic acid decreased affinity at A2B receptors while increasing affinity at A1 receptors. 1,3-Di(cyclohexylmethyl) groups greatly reduced affinity at ARs, although the p-carboxymethyloxy deriv. I (R1 = cyclohexylmethyl, X = CH:CH, R2 = OH) was moderately selective for A2B receptors.  Several selective A2B antagonists inhibited NECA-stimulated calcium mobilization in HEK-A2B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1SbbnjfBwjbVg90H21EOLACvtfcHk0lhc4tcxEHx_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D&md5=af987bb9429d31d6b9aa660744185832</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm990421v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990421v%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAnilide%2520Derivatives%2520of%2520an%25208-Phenylxanthine%2520Carboxylic%2520Congener%2520Are%2520Highly%2520Potent%2520and%2520Selective%2520Antagonists%2520at%2520Human%2520A%25282B%2529%2520Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D6%26spage%3D1165%26epage%3D1172%26doi%3D10.1021%2Fjm990421v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayallah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval-Ramírez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1500</span>– <span class="NLM_lpage">1510</span>, <span class="refDoi"> DOI: 10.1021/jm011049y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011049y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1500-1510&issue=7&author=A.+M.+Hayallahauthor=J.+Sandoval-Ram%C3%ADrezauthor=U.+Reithauthor=U.+Schobertauthor=B.+Preissauthor=B.+Schumacherauthor=J.+W.+Dalyauthor=C.+E.+M%C3%BCller&title=1%2C8-Disubstituted+Xanthine+Derivatives%3A+Synthesis+of+Potent+A2B-Selective+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm011049y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span></div><div class="casAuthors">Hayallah, Alaa M.; Sandoval-Ramirez, Jesus; Reith, Ulrike; Schobert, Ulrike; Preiss, Birgit; Schumacher, Britta; Daly, John W.; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1500-1510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Unsubstituted xanthine derivs. bearing a cyclopentyl or a Ph residue in the 8-position were synthesized and developed as A2B adenosine receptor antagonists.  Compds. bearing polar substituents were prepd. to obtain water-sol. derivs.  1-Alkyl-8-phenylxanthine derivs. were found to exhibit high affinity for A2B adenosine receptors (ARs).  1,8-Disubstituted xanthine derivs. were equipotent to or more potent than 1,3,8-trisubstituted xanthines at A2B ARs, but generally less potent at A1 and A2A, and much less potent at A3 ARs.  Thus, the new compds. exhibited increased A2B selectivity vs. all other AR subtypes.  9-Deazaxanthines (pyrrolo[2,3-d]pyrimidindiones) appeared to be less potent at A2B ARs than the corresponding xanthine derivs.  1-Propyl-8-p-sulfophenylxanthine (I) was the most selective compd. of the present series, exhibiting a Ki value of 53 nM at human A2B ARs and showing greater than 180-fold selectivity vs. human A1 ARs.  Compd. I was also highly selective vs. rat A1 ARs (41-fold) and vs. the other human AR subtypes (A2A > 400-fold and A3 > 180-fold).  The compd. is highly water-sol. due to its sulfonate function.  1-Butyl-8-p-carboxyphenylxanthine, another polar analog bearing a carboxylate function, exhibited a Ki value of 24 nM for A2B ARs, 49-fold selectivity vs. human and 20-fold selectivity vs. rat A1 ARs, and greater than 150-fold selectivity vs. human A2A and A3 ARs.  8-[4-[(2-Hydroxyethylamino)-2-oxoethoxy]phenyl]-1-propylxanthine (II) and 1-butyl-8-[4-[(4-benzylpiperazino)-2-oxoethoxy]phenyl]xanthine (III) were among the most potent A2B antagonists showing Ki values at A2B ARs of 1 nM, 57-fold for II and 94-fold for III selectivity vs. human A1, ca. 30-fold selectivity vs. rat A1, and greater than 400-fold selectivity vs. human A2A and A3 ARs.  The new potent, selective, water-sol. A2B antagonists may be useful research tools for investigating A2B receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8eeBzBfHfLVg90H21EOLACvtfcHk0lhc4tcxEHx_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D&md5=759d610ad10c658403730fc7f00f6054</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm011049y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011049y%26sid%3Dliteratum%253Aachs%26aulast%3DHayallah%26aufirst%3DA.%2BM.%26aulast%3DSandoval-Ram%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DU.%26aulast%3DSchobert%26aufirst%3DU.%26aulast%3DPreiss%26aufirst%3DB.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D1%252C8-Disubstituted%2520Xanthine%2520Derivatives%253A%2520Synthesis%2520of%2520Potent%2520A2B-Selective%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D7%26spage%3D1500%26epage%3D1510%26doi%3D10.1021%2Fjm011049y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varkhedkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscopio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span> <span> </span><span class="NLM_article-title">The Discovery of a Selective, High Affinity A2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2004.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15664822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsVKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=609-612&issue=3&author=J.+Zablockiauthor=R.+Kallaauthor=T.+Perryauthor=V.+Palleauthor=V.+Varkhedkarauthor=D.+Xiaoauthor=A.+Piscopioauthor=T.+Maaauthor=A.+Gimbelauthor=J.+Haoauthor=N.+Chuauthor=K.+Leungauthor=D.+Zeng&title=The+Discovery+of+a+Selective%2C+High+Affinity+A2B+Adenosine+Receptor+Antagonist+for+the+Potential+Treatment+of+Asthma&doi=10.1016%2Fj.bmcl.2004.11.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma</span></div><div class="casAuthors">Zablocki, Jeff; Kalla, Rao; Perry, Thao; Palle, Venkata; Varkhedkar, Vaibhav; Xiao, Dengming; Piscopio, Anthony; Maa, Tenning; Gimbel, Art; Hao, Jia; Chu, Nancy; Leung, Kwan; Zeng, Dewan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">609-612</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine has been suggested to play a role in asthma, possibly via activation of A2B adenosine receptors on mast cells and other pulmonary cells.  We describe our initial efforts to discover a xanthine based selective A2B AdoR antagonist that resulted in the discovery of CVT-5440, a high affinity A2B AdoR antagonist with good selectivity (A2B AdoR Ki = 50 nM, selectivity A1 > 200: A2A > 200: A3 > 167).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbPzsAX_kykbVg90H21EOLACvtfcHk0lgUVr8hh6MyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsVKlug%253D%253D&md5=db2f9819adad03ad0e504247a379248c</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DZablocki%26aufirst%3DJ.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DPiscopio%26aufirst%3DA.%26aulast%3DMaa%26aufirst%3DT.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DD.%26atitle%3DThe%2520Discovery%2520of%2520a%2520Selective%252C%2520High%2520Affinity%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%2520for%2520the%2520Potential%2520Treatment%2520of%2520Asthma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D3%26spage%3D609%26epage%3D612%26doi%3D10.1016%2Fj.bmcl.2004.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttarolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaid, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2B Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1434</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1021/jm0309654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0309654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht1Gisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1434-1447&issue=6&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=D.+Pretiauthor=A.+Boveroauthor=R.+Romagnoliauthor=F.+Fruttaroloauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=K.+Varaniauthor=S.+Gessiauthor=S.+Merighiauthor=P.+A.+Borea&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+New+8-Heterocyclic+Xanthine+Derivatives+as+Highly+Potent+and+Selective+Human+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm0309654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Preti, Delia; Bovero, Andrea; Romagnoli, Romeo; Fruttarolo, Francesca; Zaid, Naser Abdel; Moorman, Allan R.; Varani, Katia; Gessi, Stefania; Merighi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1434-1447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of 8-heterocycle-substituted xanthines as potent and selective A2B adenosine receptor antagonists was reported.  The structure-activity relationships (SAR) of the xanthines synthesized in binding to recombinant human A2B adenosine receptors (ARs) in HEK-293 cells (HEK-A2B) and at other AR subtypes were explored.  The synthesized compds. showed A2B adenosine receptor affinity in the nanomolar range and good levels of selectivity evaluated in radioligand binding assays at human (h) A1, A2A, A2B, and A3 ARs.  Several heterocycles, such as pyrazole, isoxazole, pyridine, and pyridazine, were introduced at the 8-position of the xanthine nucleus and different spacers (substituted acetamide, oxyacetamide, and urea moieties) were investigated.  Various groups at the 3- and 4-positions of phenylacetamide moiety were studied.  This study allowed us to identify 2-(3,4-dimethoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide (MRE2028F20) [Ki(hA2B) = 38 nM, Ki(hA1,hA2A,hA3) >1000 nM], N-1,3-benzodioxol-5-yl-2-[[1-methyl-5-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-1H-pyrazol-3-yl]oxy]acetamide (I, MRE2029F20) [Ki(hA2B) = 5.5 nM, Ki(hA1,hA2A,hA3) > 1000 nM], and N-(3,4-dimethoxyphenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yloxy]acetamide (MRE2030F20) [Ki(hA2B) = 12 nM, Ki(hA1,hA2A, hA3) > 1000 nM], which showed high affinity at the A2B receptor subtype and very good selectivity vs the other ARs.  Substitution of the acetamide with an urea moiety afforded bioisosteric xanthines with good affinity and selectivity comparable to the acetamide derivs.  Substitution at the para-position of a 4-benzyloxy group of the phenylacetamido chain enhanced affinity at the A2B receptor but did not favor selectivity.  The derivs. with higher affinity at human A2B AR proved to be antagonists, in the cAMP assay, capable of inhibiting the stimulatory effect of NECA (100 nM) with IC50 values in the nanomolar range, a trend similar to that obsd. in the binding assay for I (IC50 = 38 nM) for MRE2029F20 (IC50 = 46 nM).  In conclusion, the 8-pyrazolo-1,3-dipropyl-1H-purine-2,6-dione derivs. described herein represent a new family of selective antagonists for the adenosine A2B receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSk9RD57PV_7Vg90H21EOLACvtfcHk0lgUVr8hh6MyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht1Gisr8%253D&md5=57188de913c339eb31b9f51cd4e61e7a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm0309654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309654%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBovero%26aufirst%3DA.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520New%25208-Heterocyclic%2520Xanthine%2520Derivatives%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Human%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D6%26spage%3D1434%26epage%3D1447%26doi%3D10.1021%2Fjm0309654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varkhedkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Novel 1,3-Disubstituted 8-(1-Benzyl-1H-Pyrazol-4-Yl) Xanthines: High Affinity and Selective A 2B Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3682</span>– <span class="NLM_lpage">3692</span>, <span class="refDoi"> DOI: 10.1021/jm051268+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051268%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3682-3692&author=R.+V.+Kallaauthor=E.+Elzeinauthor=T.+Perryauthor=X.+Liauthor=V.+Palleauthor=V.+Varkhedkarauthor=A.+Gimbelauthor=T.+Maaauthor=D.+Zengauthor=J.+Zablocki&title=Novel+1%2C3-Disubstituted+8-%281-Benzyl-1H-Pyrazol-4-Yl%29+Xanthines%3A+High+Affinity+and+Selective+A+2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm051268%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists</span></div><div class="casAuthors">Kalla, Rao V.; Elzein, Elfatih; Perry, Thao; Li, Xiaofen; Palle, Venkata; Varkhedkar, Vaibhav; Gimbel, Arthur; Maa, Tennig; Zeng, Dewan; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3682-3692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine has been suggested to induce bronchial hyperresponsiveness in asthmatics, which is believed to be an A2B adenosine receptor (AdoR) mediated pathway.  The authors hypothesize that a selective, high-affinity A2B AdoR antagonist may provide therapeutic benefit in the treatment of asthma.  In an attempt to identify a high-affinity, selective antagonist for the A2B AdoR, we synthesized 8-(C-4-pyrazolyl) xanthines.  Compd. I (R = H), 8-(1H-pyrazol-4-yl)-1,3-dipropylxanthine, is a N-1 unsubstituted pyrazole deriv. that has favorable binding affinity (Ki = 9 nM) for the A2B AdoR, but it is only 2-fold selective vs. the A1 AdoR.  Introduction of a benzyl group at the N-1-pyrazole position of I (R = H) resulted in I (R = CH2Ph), which had moderate selectivity.  The initial focus of the SAR study was on the prepn. of substituted benzyl derivs. of I (R = CH2Ph) because the corresponding Ph, phenethyl, and phenpropyl derivs. showed a decrease in A2B AdoR affinity and selectivity relative to I (R = CH2Ph).  The preferred substitution on the Ph ring of I (R = CH2Ph) contains an electron-withdrawing group, specifically F or CF3 at the m-position, as in I (R = CH2C6H4F-3) and I (R = CH2C6H4CF3-3) resp., increases the selectivity while retaining the affinity for the A2B AdoR.  Exploring disubstitutions on the Ph ring of the latter two derivs. led to the 2-chloro-5-trifluoromethylphenyl deriv., which retained the A2B AdoR affinity but enhanced the selectivity relative to I (R = CH2C6H4CF3-3).  After optimization of the substitution on the 8-pyrazole xanthine, 1,3-disubstitution of the xanthine core was explored with Me, Et, Bu, and iso-Bu groups.  In comparison to the corresponding di-Pr analogs, the smaller 1,3-dialkyl groups (Me and ethyl) increased the A2B AdoR binding selectivity of the xanthine derivs. while retaining the affinity.  However, the larger 1,3-dialkyl groups (iso-Bu and butyl) resulted in a decrease in both A2B AdoR affinity and selectivity.  This final SAR optimization led to the discovery of 1,3-di-Me deriv. II, 8-(1-(3-(trifluoromethyl) benzyl)-1H-pyrazol-4-yl)-1,3-dimethyl xanthine, a high-affinity (Ki = 1 nM) A2B AdoR antagonist with high selectivity (990-, 690-, and 1000-) for the human A1, A2A, and A3 AdoRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphOU_sdPwkFLVg90H21EOLACvtfcHk0lgUVr8hh6MyBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKht7k%253D&md5=fcacb4bd15ff892c08c7c98d27455022</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm051268%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051268%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DMaa%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DNovel%25201%252C3-Disubstituted%25208-%25281-Benzyl-1H-Pyrazol-4-Yl%2529%2520Xanthines%253A%2520High%2520Affinity%2520and%2520Selective%2520A%25202B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3682%26epage%3D3692%26doi%3D10.1021%2Fjm051268%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2278</span>, <span class="refDoi"> DOI: 10.1021/jm7014815</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7014815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivV2hur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2267-2278&issue=7&author=E.+Elzeinauthor=R.+V.+Kallaauthor=X.+Liauthor=T.+Perryauthor=A.+Gimbelauthor=D.+Zengauthor=D.+Lustigauthor=K.+Leungauthor=J.+Zablocki&title=Discovery+of+a+Novel+A2B+Adenosine+Receptor+Antagonist+as+a+Clinical+Candidate+for+Chronic+Inflammatory+Airway+Diseases&doi=10.1021%2Fjm7014815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases</span></div><div class="casAuthors">Elzein, Elfatih; Kalla, Rao V.; Li, Xiaofen; Perry, Thao; Gimbel, Art; Zeng, Dewan; Lustig, David; Leung, Kwan; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2267-2278</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, the authors have reported a series of new 1,3-sym. (R1 = R3) substituted xanthines which have high affinity and selectivity for the human adenosine A2B receptors (hA2B-AdoR).  Unfortunately, this class of compds. had poor pharmacokinetic properties.  This prompted us to investigate the effect of differential alkyl substitution at the N-1 and N-3 positions (N1-R ≠ N3-R) on A2B-AdoR affinity and selectivity; the authors had the dual objectives of enhancing affinity and selectivity for the A2B-AdoR, as well as improving oral bioavailability.  This effort has led to the discovery of compd. (I), that displayed high affinity and selectivity for the hA2B-AdoR (Ki = 22 nM).  In addn., compd. I showed high functional potency in inhibiting the accumulation of cAMP induced by 5'-N-ethylcarboxamidoadenosine in HEK-A2B-AdoR and NIH3T3 cells with KB values of 6 and 2 nM, resp.  In a single ascending-dose phase I clin. study, compd. I had no serious adverse events and was well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzXnSletOZqrVg90H21EOLACvtfcHk0ljNk6aY-egyIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivV2hur4%253D&md5=e7b70a1caa958d5daea329c01c66ccf4</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm7014815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7014815%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DLustig%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%2520as%2520a%2520Clinical%2520Candidate%2520for%2520Chronic%2520Inflammatory%2520Airway%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D7%26spage%3D2267%26epage%3D2278%26doi%3D10.1021%2Fjm7014815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Selective, High Affinity A2B Adenosine Receptor Antagonists: N-1 Monosubstituted 8-(Pyrazol-4-Yl)Xanthines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2008.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18226896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlaisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1397-1401&issue=4&author=R.+V.+Kallaauthor=E.+Elzeinauthor=T.+Perryauthor=X.+Liauthor=A.+Gimbelauthor=M.+Yangauthor=D.+Zengauthor=J.+Zablocki&title=Selective%2C+High+Affinity+A2B+Adenosine+Receptor+Antagonists%3A+N-1+Monosubstituted+8-%28Pyrazol-4-Yl%29Xanthines&doi=10.1016%2Fj.bmcl.2008.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Selective, high affinity A2B adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines</span></div><div class="casAuthors">Kalla, Rao V.; Elzein, Elfatih; Perry, Thao; Li, Xiaofen; Gimbel, Art; Yang, Ming; Zeng, Dewan; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1397-1401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of N-1 monosubstituted 8-pyrazolyl xanthines have been synthesized and evaluated for their affinity for the adenosine receptors (AdoRs).  Two compds. I (CVT-7124) and II (CVT-6694) display good affinity for the A2B AdoR (Ki = 6 nM and 7 nM, resp.) and greater selectivity for the human A1, A2A, and A3 AdoRs (>1000-, >830-, and >1500-fold; >850-, >700-, and >1280-fold, resp.).  Compd. II has been shown to block the release of interleukin-6 and monocyte chemotactic protein-1 from bronchial smooth muscle cells (BSMC), a process believed to be promoted by activation of A2B AdoR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLgURZDRagVLVg90H21EOLACvtfcHk0ljNk6aY-egyIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlaisL0%253D&md5=b4a481f1341763cff12a2d3375a5fcd4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DSelective%252C%2520High%2520Affinity%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%253A%2520N-1%2520Monosubstituted%25208-%2528Pyrazol-4-Yl%2529Xanthines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D4%26spage%3D1397%26epage%3D1401%26doi%3D10.1016%2Fj.bmcl.2008.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccagli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaid, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel 1,3-Dipropyl-8-(3-Benzimidazol-2-Yl-Methoxy-1-Methylpyrazol-5-Yl) Xanthines as Potent and Selective A2B Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1021/jm201292w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201292w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=797-811&issue=2&author=P.+G.+Baraldiauthor=S.+Baraldiauthor=G.+Saponaroauthor=D.+Pretiauthor=R.+Romagnoliauthor=L.+Piccagliauthor=A.+Cavalliauthor=M.+Recanatiniauthor=A.+R.+Moormanauthor=A.+N.+Zaidauthor=K.+Varaniauthor=P.+A.+Boreaauthor=M.+A.+Tabrizi&title=Novel+1%2C3-Dipropyl-8-%283-Benzimidazol-2-Yl-Methoxy-1-Methylpyrazol-5-Yl%29+Xanthines+as+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm201292w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Baraldi, Stefania; Saponaro, Giulia; Preti, Delia; Romagnoli, Romeo; Piccagli, Laura; Cavalli, Andrea; Recanatini, Maurizio; Moorman, Allan R.; Abdel  Zaid, Naser; Varani, Katia; Borea, Pier Andrea; Tabrizi, Mojgan Aghazadeh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-811</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists of the A2B adenosine receptor with known biol. activity were performed to identify the three-dimensional features responsible for A2B adenosine receptor antagonist activity.  On the basis of these and previous results on the potent antagonist effect of 8-pyrazolyl-xanthines at human A2BAR, a new series of compds. was synthesized and evaluated in binding studies against the human A1, A2A, A3, and A2BARs.  A remarkable improvement in selectivity with respect to the previous series, maintaining the potency at human A2B receptor, was achieved, as exemplified by the 8-[3-(4-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl-methoxy)-1-methyl-1H-pyrazol-5-yl]-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (I): Ki A2B = 9.4 nM, IC50 hA2B = 26 nM hA1/hA2B = 269, hA2A/hA2B > 106, hA3/hA2B >106.  This study also led to the identification of a series of pyrazole-xanthine compds. with a simplified structure, exemplified by 8-(3-hydroxy-1-methyl-1H-pyrazol-5-yl)-xanthine (II) displaying very high affinity at A2BAR with good selectivity over AR subtypes (Ki = 4.0 nM, IC50 hA2B = 20 nM hA1/hA2B = 183, hA2A,hA3/hA2B > 250).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNTK9UeGa9jbVg90H21EOLACvtfcHk0ljNk6aY-egyIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurrM&md5=c678e6895a09485ed65d35d90eb66894</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm201292w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201292w%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPiccagli%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DZaid%26aufirst%3DA.%2BN.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26atitle%3DNovel%25201%252C3-Dipropyl-8-%25283-Benzimidazol-2-Yl-Methoxy-1-Methylpyrazol-5-Yl%2529%2520Xanthines%2520as%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D2%26spage%3D797%26epage%3D811%26doi%3D10.1021%2Fjm201292w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barawkar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramdas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naykodi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quraishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouduri, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Novel Xanthine Derivatives as Potent and Selective A2B Adenosine Receptor Antagonists for the Treatment of Chronic Inflammatory Airway Diseases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ejmech.2017.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28415011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=218-229&author=S.+Basuauthor=D.+A.+Barawkarauthor=V.+Ramdasauthor=M.+Patelauthor=Y.+Wamanauthor=A.+Panmandauthor=S.+Kumarauthor=S.+Thoratauthor=M.+Naykodiauthor=A.+Goswamiauthor=B.+S.+Reddyauthor=V.+Prasadauthor=S.+Chaturvediauthor=A.+Quraishiauthor=S.+Menonauthor=S.+Paliwalauthor=A.+Kulkarniauthor=V.+Karandeauthor=I.+Ghoshauthor=S.+Mustafaauthor=S.+Deauthor=V.+Jainauthor=E.+R.+Banerjeeauthor=S.+R.+Rouduriauthor=V.+P.+Palleauthor=A.+Chughauthor=K.+A.+Mookhtiar&title=Design+and+Synthesis+of+Novel+Xanthine+Derivatives+as+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists+for+the+Treatment+of+Chronic+Inflammatory+Airway+Diseases&doi=10.1016%2Fj.ejmech.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases</span></div><div class="casAuthors">Basu, Sujay; Barawkar, Dinesh A.; Ramdas, Vidya; Patel, Meena; Waman, Yogesh; Panmand, Anil; Kumar, Santosh; Thorat, Sachin; Naykodi, Minakshi; Goswami, Arnab; Reddy, B. Srinivasa; Prasad, Vandna; Chaturvedi, Sandhya; Quraishi, Azfar; Menon, Suraj; Paliwal, Shalini; Kulkarni, Abhay; Karande, Vikas; Ghosh, Indraneel; Mustafa, Syed; De, Siddhartha; Jain, Vaibhav; Banerjee, Ena Ray; Rouduri, Sreekanth R.; Palle, Venkata P.; Chugh, Anita; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The identification of novel, potent and selective A2B adenosine receptor (A2BAdoR) antagonists has been shown to be potentially beneficial for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).  Towards this effort, the authors explored several prop-2-ynylated C8-aryl or heteroaryl substitutions on xanthine chemotype and found that 1-prop-2-ynyl-1H-pyrazol-4-yl moiety was better tolerated at the C8 position.  Compd. I (R1 = H, R2 = n-Pr), exhibited binding affinity (Ki) of 62 nM but was non-selective for A2BAdoR over other AdoRs.  Incorporation of substituted Ph on the terminal acetylene increased the binding affinity (Ki) significantly to <10 nM.  Various substitutions on terminal Ph group and different alkyl substitutions on N-1 and N-3 were explored to improve the potency, selectivity for A2BAdoR and the soly.  In general, compds. with meta-substituted Ph provided better selectivity for A2BAdoR compared to that of para-substituted analogs.  Substitutions such as basic amines like pyrrolidine, piperidine, piperazine or cycloalkyls with polar group were tried on terminal acetylene, keeping in mind the poor soly. of xanthine analogs in general.  However, these substitutions led to a decrease in affinity compared to compd. I (R1 = H, R2 = n-Pr).  Subsequent SAR optimization resulted in identification of compd. I [R1 = 3-(CF3O)C6H4, R2 = Et(II)] with high human A2BAdoR affinity (Ki = 13 nM), selectivity against other AdoR subtypes and with good pharmacokinetic properties.  It was found to be a potent functional A2BAdoR antagonist with a Ki of 8 nM in cAMP assay in hA2B-HEK293 cells and an IC50 of 107 nM in IL6 assay in NIH-3T3 cells.  Docking study was performed to rationalize the obsd. affinity data.  Structure-activity relationship (SAR) studies also led to identification of compd. I (R1 = 3-HO2CC6H4, R2 = n-Pr) as a potent A2BAdoR antagonist with Ki of 1.8 nM in cAMP assay and good aq. soly. of 529 μM at neutral pH.  Compd. II was further tested for in vivo efficacy and found to be efficacious in ovalbumin-induced allergic asthma model in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8O-mETdHU7LVg90H21EOLACvtfcHk0ljfw0XmnlwDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D&md5=208780bfe877de2b9d9457b8e9d74376</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBarawkar%26aufirst%3DD.%2BA.%26aulast%3DRamdas%26aufirst%3DV.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DWaman%26aufirst%3DY.%26aulast%3DPanmand%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DThorat%26aufirst%3DS.%26aulast%3DNaykodi%26aufirst%3DM.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DQuraishi%26aufirst%3DA.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DKarande%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DBanerjee%26aufirst%3DE.%2BR.%26aulast%3DRouduri%26aufirst%3DS.%2BR.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%2520Xanthine%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Inflammatory%2520Airway%2520Diseases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D218%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barawkar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramdas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonagiri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quraishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusange, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouduri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span> <span> </span><span class="NLM_article-title">A2B adenosine Receptor Antagonists: Design, Synthesis and Biological Evaluation of Novel Xanthine Derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ejmech.2016.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27842891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVChsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=986-996&author=S.+Basuauthor=D.+A.+Barawkarauthor=V.+Ramdasauthor=Y.+Wamanauthor=M.+Patelauthor=A.+Panmandauthor=S.+Kumarauthor=S.+Thoratauthor=R.+Bonagiriauthor=D.+Jadhavauthor=P.+Mukhopadhyayauthor=V.+Prasadauthor=B.+S.+Reddyauthor=A.+Goswamiauthor=S.+Chaturvediauthor=S.+Menonauthor=A.+Quraishiauthor=I.+Ghoshauthor=S.+Dusangeauthor=S.+Paliwalauthor=A.+Kulkarniauthor=V.+Karandeauthor=R.+Thakreauthor=G.+Bedseauthor=S.+Rouduriauthor=J.+Gunduauthor=V.+P.+Palleauthor=A.+Chughauthor=K.+A.+Mookhtiar&title=A2B+adenosine+Receptor+Antagonists%3A+Design%2C+Synthesis+and+Biological+Evaluation+of+Novel+Xanthine+Derivatives&doi=10.1016%2Fj.ejmech.2016.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives</span></div><div class="casAuthors">Basu, Sujay; Barawkar, Dinesh A.; Ramdas, Vidya; Waman, Yogesh; Patel, Meena; Panmand, Anil; Kumar, Santosh; Thorat, Sachin; Bonagiri, Rajesh; Jadhav, Dilip; Mukhopadhyay, Partha; Prasad, Vandna; Reddy, B. Srinivasa; Goswami, Arnab; Chaturvedi, Sandhya; Menon, Suraj; Quraishi, Azfar; Ghosh, Indraneel; Dusange, Sushant; Paliwal, Shalini; Kulkarni, Abhay; Karande, Vikas; Thakre, Rhishikesh; Bedse, Gaurav; Rouduri, Sreekanth; Gundu, Jayasagar; Palle, Venkata P.; Chugh, Anita; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A2BAdoR is a low affinity adenosine receptor that functions by Gs mediated elevation of cAMP and subsequent downstream signaling.  The receptor has been implicated in lung inflammatory disorders like COPD and asthma.  Several potent and selective A2BAdoR antagonists have been reported in literature, however most of the compds. suffer from poor pharmacokinetic profile.  Therefore, with the aim to identify novel, potent and selective A2BAdoR antagonists with improved pharmacokinetic properties, the authors first explored more constrained form of MRS-1754.  To improve the metabolic stability, several linker modifications were attempted as replacement of amide linker along with different Ph or other heteroaryls between C8 position of xanthine head group and terminal Ph ring.  SAR optimization resulted in identification of two novel A2BAdoR antagonists I and II, with high binding affinity (Ki = 1 and 1.5 nM, resp.) and selectivity for A2BAdoR with very good functional potency of 0.9 nM and 4 nM, resp.  Compd. I and II also displayed good pharmacokinetic properties in mice with 27% and 65% oral bioavailability resp.  When evaluated in in vivo mice model of asthma, compd. II also inhibited airway inflammation and airway reactivity in ovalbumin induced allergic asthma at 3 mpk dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBa8gZOKDU1rVg90H21EOLACvtfcHk0ljfw0XmnlwDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVChsr%252FF&md5=ea13897bebb3cdce835603352e71098a</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBarawkar%26aufirst%3DD.%2BA.%26aulast%3DRamdas%26aufirst%3DV.%26aulast%3DWaman%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPanmand%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DThorat%26aufirst%3DS.%26aulast%3DBonagiri%26aufirst%3DR.%26aulast%3DJadhav%26aufirst%3DD.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DQuraishi%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DI.%26aulast%3DDusange%26aufirst%3DS.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DKarande%26aufirst%3DV.%26aulast%3DThakre%26aufirst%3DR.%26aulast%3DBedse%26aufirst%3DG.%26aulast%3DRouduri%26aufirst%3DS.%26aulast%3DGundu%26aufirst%3DJ.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DA2B%2520adenosine%2520Receptor%2520Antagonists%253A%2520Design%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Xanthine%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.ejmech.2016.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárdenas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozoya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, B.</span></span> <span> </span><span class="NLM_article-title">New Pyrrolopyrimidin-6-Yl Benzenesulfonamides: Potent A2B Adenosine Receptor Antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3642</span>– <span class="NLM_lpage">3645</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2006.04.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16697192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVykt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3642-3645&issue=14&author=C.+Esteveauthor=A.+Nuedaauthor=J.+L.+D%C3%ADazauthor=J.+Beletaauthor=A.+C%C3%A1rdenasauthor=E.+Lozoyaauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=H.+Ryderauthor=B.+Vidal&title=New+Pyrrolopyrimidin-6-Yl+Benzenesulfonamides%3A+Potent+A2B+Adenosine+Receptor+Antagonists&doi=10.1016%2Fj.bmcl.2006.04.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">New pyrrolopyrimidin-6-yl benzenesulfonamides: Potent A2B adenosine receptor antagonists</span></div><div class="casAuthors">Esteve, Cristina; Nueda, Arsenio; Diaz, Jose Luis; Beleta, Jorge; Cardenas, Alvaro; Lozoya, Estrella; Cadavid, Maria Isabel; Loza, Maria Isabel; Ryder, Hamish; Vidal, Bernat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3642-3645</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new series of 4-(1,3-dialkyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)benzenesulfonamides has been identified as potent A2B adenosine receptor antagonists.  The products have been evaluated for their binding affinities for the human A2B, A1 and A3 adenosine receptors.  6-(4-[[4-(4-Bromobenzyl)-1-piperazinyl]sulfonyl]phenyl)-1,3-dimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione showed a high affinity for the A2B adenosine receptor (IC50 = 1 nM) and selectivity (A1: 183x; A3: 12660x).  Synthesis and SAR of this novel class of compds. showing improved absorption properties is presented herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhwXqSuUEXLVg90H21EOLACvtfcHk0lh5BY4tPxITnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVykt7s%253D&md5=a04df7f78252a5f6096272cc0a228bde</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.074%26sid%3Dliteratum%253Aachs%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DA.%26aulast%3DLozoya%26aufirst%3DE.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DRyder%26aufirst%3DH.%26aulast%3DVidal%26aufirst%3DB.%26atitle%3DNew%2520Pyrrolopyrimidin-6-Yl%2520Benzenesulfonamides%253A%2520Potent%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D14%26spage%3D3642%26epage%3D3645%26doi%3D10.1016%2Fj.bmcl.2006.04.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centeno, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raviña, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segarra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span> <span> </span><span class="NLM_article-title">1-, 3- and 8-Substituted-9-Deazaxanthines as Potent and Selective Antagonists at the Human A2B Adenosine Receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2852</span>– <span class="NLM_lpage">2869</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2008.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18226909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFersL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2852-2869&issue=6&author=A.+Stefanachiauthor=J.+M.+Breaauthor=M.+I.+Cadavidauthor=N.+B.+Centenoauthor=C.+Esteveauthor=M.+I.+Lozaauthor=A.+Martinezauthor=R.+Nietoauthor=E.+Ravi%C3%B1aauthor=F.+Sanzauthor=V.+Segarraauthor=E.+Soteloauthor=B.+Vidalauthor=A.+Carotti&title=1-%2C+3-+and+8-Substituted-9-Deazaxanthines+as+Potent+and+Selective+Antagonists+at+the+Human+A2B+Adenosine+Receptor&doi=10.1016%2Fj.bmc.2008.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">1-, 3- And 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor</span></div><div class="casAuthors">Stefanachi, Angela; Brea, Jose Manuel; Cadavid, Maria Isabel; Centeno, Nuria B.; Esteve, Cristina; Loza, Maria Isabel; Martinez, Ana; Nieto, Rosa; Ravina, Enrique; Sanz, Ferran; Segarra, Victor; Sotelo, Eddy; Vidal, Bernat; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2852-2869</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A large series of piperazin-, piperidin- and tetrahydroisoquinolinamides of 4-(1,3-dialkyl-9-deazaxanthin-8-yl)phenoxyacetic acid were prepd. through conventional or multiple parallel syntheses and evaluated for their binding affinity at the recombinant human adenosine receptors, chiefly at the hA2B and hA2A receptor subtypes.  Several ligands endowed with high binding affinity at hA2B receptors, excellent selectivity over hA2A and hA3 and a significant, but lower, selectivity over hA1 were identified.  Among them, piperazinamide derivs. (I and II), and piperidinamide deriv. (III) proved highly potent at hA2B (Ki = 11, 2 and 5.5 nM, resp.) and selective towards hA2A (hA2A/hA2B SI = 912, 159 and 630, resp.), hA3 (hA3/hA2B SI = > 100, 3090 and >180, resp.) and hA1 (hA1/hA2B SI = > 100, 44 and 120, resp.), SI being the selectivity index.  A no. of selected ligands tested in functional assays in vitro showed very interesting antagonist activities and efficacies at both A2A and A2B receptor subtypes, with pA2 values close to the corresponding pKis.  Structure-affinity and structure-selectivity relationships suggested that the binding potency at the hA2B receptor may be increased by lipophilic substituents at the N4-position of piperazinamides and that an ortho-methoxy substituent at the 8-Ph ring and alkyl groups at N1 larger than the ones at N3, in the 9-deazaxanthine ring, may strongly enhance the hA2A/hA2B SI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtlInuQjh9C7Vg90H21EOLACvtfcHk0lh5BY4tPxITnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFersL0%253D&md5=457827960ff1b6818e352566f3f48b13</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%2BM.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DCenteno%26aufirst%3DN.%2BB.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DNieto%26aufirst%3DR.%26aulast%3DRavi%25C3%25B1a%26aufirst%3DE.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DSotelo%26aufirst%3DE.%26aulast%3DVidal%26aufirst%3DB.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3D1-%252C%25203-%2520and%25208-Substituted-9-Deazaxanthines%2520as%2520Potent%2520and%2520Selective%2520Antagonists%2520at%2520the%2520Human%2520A2B%2520Adenosine%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D6%26spage%3D2852%26epage%3D2869%26doi%3D10.1016%2Fj.bmc.2008.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvatore, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. G.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Characterization of the Human A3 Adenosine Receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">10365</span>– <span class="NLM_lpage">10369</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.21.10365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.90.21.10365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8234299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXps1Gqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=10365-10369&issue=21&author=C.+A.+Salvatoreauthor=M.+A.+Jacobsonauthor=H.+E.+Taylorauthor=J.+Lindenauthor=R.+G.+Johnson&title=Molecular+Cloning+and+Characterization+of+the+Human+A3+Adenosine+Receptor&doi=10.1073%2Fpnas.90.21.10365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of the human A3 adenosine receptor</span></div><div class="casAuthors">Salvatore, Christopher A.; Jacobson, Marlene A.; Taylor, Heidi E.; Linden, Joel; Johnson, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">10365-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The human A3 adenosine receptor was cloned from a striatal cDNA library using a probe derived from the homologous rat sequence.  The cDNA encodes a protein of 318 amino acids and exhibits 72% and 85% overall identity with the rat and sheep A3 adenosine receptor sequences, resp.  Specific and saturable binding of the adenosine receptor agonist N6-(4-amino-3-[125I]iodobenzyl)adenosine [125I]ABA was measured on the human A3 receptor stably expressed in Chinese hamster ovary cells with a Kd = 10 nM.  The potency order for adenosine receptor agonists was N-ethylcarboxamidoadenosine (NECA) ≥ (R)-N6-phenyl-2-propyladenosine [(R)-PIA] > N6-cyclopentyladenosine (CPA) > (S)-N6-phenyl-2-propyladenosine [(S)-PIA].  The human receptor was blocked by xanthine antagonists, most potently by 3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine (I-ABOPX) with a potency order of I-ABOPX > 1,3-dipropyl-8-(4-acrylate)phenylxanthine ≥ xanthine amino congener >> 1,3-dipropyl-8-cyclopentylxanthine.  Adenosine, NECA, (R)- and (S)-PIA, and CPA inhibited forskolin-stimulated cAMP accumulation by 30-40% in stably transfected cells; I-ABA is a partial agonist.  When measured in the presence of antagonists, the dose-response curves of NECA-induced inhibition of forskolin-stimulated cAMP accumulation were right-shifted.  Antagonist potencies detd. by Schild analyses correlated well with those established by competition for radioligand binding.  The A3 adenosine receptor transcript is widespread and, in contrast to the A1, A2a, and A2b transcripts, the most abundant expression is found in the lung and liver.  The tissue distribution of A3 mRNA is more similar to the widespread profile found in sheep than to the restricted profile found in the rat.  This raises the possibility that numerous physiol. effects of adenosine may be mediated by A3 adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNKbZQGAUkSLVg90H21EOLACvtfcHk0lh5BY4tPxITnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXps1Gqtg%253D%253D&md5=7f663d6084176c057a12a655b2b6f157</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.21.10365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.21.10365%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DTaylor%26aufirst%3DH.%2BE.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26atitle%3DMolecular%2520Cloning%2520and%2520Characterization%2520of%2520the%2520Human%2520A3%2520Adenosine%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26issue%3D21%26spage%3D10365%26epage%3D10369%26doi%3D10.1073%2Fpnas.90.21.10365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Galen, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bergen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">A Binding Site Model and Structure-Activity Relationships for the Rat A3 Adenosine Receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8022403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXltVSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=1101-1111&issue=6&author=P.+J.+M.+Van+Galenauthor=A.+H.+Van+Bergenauthor=C.+Gallo-Rodriguezauthor=N.+Melmanauthor=M.+E.+Olahauthor=A.+D.+P.+Ijzermanauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=A+Binding+Site+Model+and+Structure-Activity+Relationships+for+the+Rat+A3+Adenosine+Receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">A binding site model and structure-activity relationships for the rat A3 adenosine receptor</span></div><div class="casAuthors">van Galen, Philip J. M.; van Bergen, Andrew H.; Gallo-Rodriguez, Carola; Melman, Neli; Olah, Mark E.; Ijzerman, Ad P.; Stiles, Gary L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1101-11</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">A novel adenosine receptor, the A3 receptor, has recently been cloned.  The authors have systematically investigated the hitherto largely unexplored structure-activity relationships (SARs) for binding at A3 receptors, using 125I-N6-2-(4-aminophenyl)ethyladenosine as a radioligand and membranes from Chinese hamster ovary cells stably transfected with the rat A3-cDNA.  As is the case for A1 and A2a receptors, substitutions at the N6 and 5' positions of adenosine, the prototypic agonist ligand, may yield fairly potent compds.  However, the highest affinity and A3 selectivity is found for N6,5'-disubstituted compds., in contrast to A2 and A2a receptors.  Thus, N6-benzyladenosine-5'-N-ethylcarboxamide is highly potent (Ki, 6.8 nM) and moderately selective (13- and 14-fold vs. A1 and A2a).  The N6 region of the A3 receptor also appears to tolerate hydrophilic substitutions, in sharp contrast to the other subtypes.  Potencies of N6,5'-disubstituted compds. in inhibition of adenylate cyclase via A3 receptors parallel their high affinity in the binding assay.  None of the typical xanthine or nonxanthine (A1/A2) antagonists tested show any appreciable affinity for rat A3 receptors.  1,3-Dialkylxanthines did not antagonize the A3 agonist-induced inhibition of adenylate cyclase.  A His residue in helix 6 that is absent in A3 receptors but present in A1/A2 receptors may be causal in this respect.  In a mol. model for the rat A3 receptor, this mutation, together with an increased bulkiness of residues surrounding the ligand, make antagonist binding unfavorable when compared with a previously developed A1 receptor model.  Second, this A3 receptor model predicted similarities with A1 and A2 receptors in the binding requirements for the ribose moiety and that xanthine-7-ribosides would bind to rat A3 receptors.  This hypothesis was supported exptl. by the moderate affinity (Ki, 6 μM) of 7-riboside of 1,3-dibutylxanthine, which appears to be a partial agonist at rat A3 receptors.  The model presented here which is consistent with the detailed SAR found in this study, may serve to suggest future chem. modification, site-directed mutagenesis, and SAR studies to further define essential characteristics of the ligand-receptor interaction and to develop even more potent and selective A3 receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsMJrWbI3Jj7Vg90H21EOLACvtfcHk0lhBRBDkIZkj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVSjt7o%253D&md5=3d5617160ac27215f47f172f0e82be52</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DVan%2BBergen%26aufirst%3DA.%2BH.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DIjzerman%26aufirst%3DA.%2BD.%2BP.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA%2520Binding%2520Site%2520Model%2520and%2520Structure-Activity%2520Relationships%2520for%2520the%2520Rat%2520A3%2520Adenosine%2520Receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26issue%3D6%26spage%3D1101%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.-d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of 1,3-Dialkylxanthine Derivatives at Rat A3 Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3373</span>– <span class="NLM_lpage">3382</span>, <span class="refDoi"> DOI: 10.1021/jm00046a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00046a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFSksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3373-3382&issue=20&author=H.+O.+Kimauthor=X.-d.+Jiauthor=N.+Melmanauthor=M.+E.+Olahauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=Structure-Activity+Relationships+of+1%2C3-Dialkylxanthine+Derivatives+at+Rat+A3+Adenosine+Receptors&doi=10.1021%2Fjm00046a022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of 1,3-Dialkylxanthine Derivatives at Rat A3 Adenosine Receptors</span></div><div class="casAuthors">Kim, Hea Ok; Ji, Xiao-duo; Melman, Neli; Olah, Mark E.; Stiles, Gary L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3373-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">1,3-Dialkylxanthine analogs contg. carboxylic acid and other charged groups on 8-position substituents were synthesized.  These derivs. were examd. for affinity in radioligand binding assays at rat brain A3 adenosine receptors stably expressed in CHO cells using the new radioligand [125I]AB-MECA (N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide), and at rat brain A1 and A2a receptors using [3H]PIA and [3H]CGS 21680, resp.  A synthetic strategy for introducing multiple carboxylate groups at the 8-position using iminodiacetic acid derivs. was explored.  The presence of a sulfonate, a carboxylate, or multiple carboxylate groups did not result in a significant enhancement of affinity at rat A3 receptors, although as previously obsd. an anionic group tended to diminish potency at A1 and A2a receptors.  The rat A3 receptor affinity was not highly dependent on the distance of a carboxylate group from the xanthine pharmacophore.  2-Thio vs 2-oxo substitution favored A3 potency, and 8-alkyl vs 8-aryl substitution favored A3 selectivity, although few derivs. were truly selective for rat A3 receptors.  1,3-Dimethyl-8-(3-carboxypropyl)-2-thioxanthine was 7-fold selective for A3 vs A2a receptors.  1,3,7-Trimethyl-8-(trans-2-carboxyvinyl)xanthine was somewhat selective for A3 vs A1 receptors.  For 8-arylxanthines affinity at A3 receptors was enhanced by 1,3-dialkyl substituents, in the order di-Bu > di-Pr > diallyl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBQ4LLbrICcrVg90H21EOLACvtfcHk0lhBRBDkIZkj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFSksA%253D%253D&md5=7b196fe5655f2507ac2a8da74ee506be</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm00046a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00046a022%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJi%26aufirst%3DX.-d.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-Activity%2520Relationships%2520of%25201%252C3-Dialkylxanthine%2520Derivatives%2520at%2520Rat%2520A3%2520Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D20%26spage%3D3373%26epage%3D3382%26doi%3D10.1021%2Fjm00046a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priego, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Frijtag Drabbe Kuenzel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Pérez, M. J.</span></span> <span> </span><span class="NLM_article-title">Pyrido[2,1-f]Purine-2,4-Dione Derivatives as a Novel Class of Highly Potent Human A3 Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3337</span>– <span class="NLM_lpage">3344</span>, <span class="refDoi"> DOI: 10.1021/jm0208469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0208469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFCkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3337-3344&issue=16&author=E.+M.+Priegoauthor=J.+Von+Frijtag+Drabbe+Kuenzelauthor=A.+P.+Ijzermanauthor=M.+J.+Camarasaauthor=M.+J.+P%C3%A9rez-P%C3%A9rez&title=Pyrido%5B2%2C1-f%5DPurine-2%2C4-Dione+Derivatives+as+a+Novel+Class+of+Highly+Potent+Human+A3+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm0208469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[2,1-f]purine-2,4-dione Derivatives as a Novel Class of Highly Potent Human A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Priego, Eva-Maria; von Kuenzel, Jacobien; Ijzerman, Ad P.; Camarasa, Maria-Jose; Perez-Perez, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3337-3344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyridopurinediones I [R = H, MeO, Me3C, Ph; R1 = H, Et, EtCH2, c-C3H5CH2, Me2CHCH2, c-C6H11CH2, H2C:CHCH2, HC≡CCH2, (E)-MeO2CCH:CHCH2, 3-(phthalimido)propyl, H2N(CH2)3, PhCH2, 4-MeOC6H4CH2 ; R2 = H, Me, PhCH2, 4-MeOC6H4CH2, 3-BrC6H4CH2] were prepd. and evaluated as human adenosine receptors antagonists selective for the human adenosine A3 receptor.  I were prepd. in two steps from aminopyrimidinedione II (R2 = PhCH2).  In the key step, II was treated with N-bromosuccinimide in acetonitrile to give a presumed 5,5-dibromo-6-iminopyrimidinedione which was not isolated but treated with 4-substituted pyridines 4-RC5H4N (R = H, MeO, Me3C, Ph) to provide pyridopurines I (R = H, MeO, Me3C, Ph; R1 = H; R2 = PhCH2) in 58-74% yields.  I (R = H, MeO, Me3C, Ph; R1 = H; R2 = PhCH2) were alkylated with a variety of alkylating agents with DBU as the base in acetonitrile to give I.  When II (R2 = Me) was used, the difficultly isolated products I (R1 = H, EtCH2; R2 = Me) were prepd.  Debenzylation of I (R = H; R1 = EtCH2; R2 = PhCH2) with aluminum chloride in toluene gave I (R = R2 = H; R1 = EtCH2) which was alkylated with 4-MeOC6H4CH2Br and 3-MeC6H4CH2Br to give I (R = H; R1 = EtCH2; R2 = 4-MeOC6H4CH2, 3-MeC6H4CH2).  I act as adenosine receptor antagonists with selectivities for the human adenosine A3 receptor and binding affinities for adenosine receptors in the low nanomolar range.  E.g., I (R = H; R1 = EtCH2; R2 = PhCH2), a potential lead compd. for the development of adenosine A3 receptor antagonists, exhibited a Ki value of 4.0 ± 0.3 nM against the hA3 receptor.  While xanthine derivs. have traditionally been considered poor A3 antagonists, the described pyrido[2,1-f]purine-2,4-dione derivs. represent a new family of adenosine receptor antagonists which deserves further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq07sRZ55ABobVg90H21EOLACvtfcHk0lhBRBDkIZkj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFCkuro%253D&md5=bd0ec10c561e266c06786951906fe4d9</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm0208469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208469%26sid%3Dliteratum%253Aachs%26aulast%3DPriego%26aufirst%3DE.%2BM.%26aulast%3DVon%2BFrijtag%2BDrabbe%2BKuenzel%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DM.%2BJ.%26atitle%3DPyrido%255B2%252C1-f%255DPurine-2%252C4-Dione%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Highly%2520Potent%2520Human%2520A3%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D16%26spage%3D3337%26epage%3D3344%26doi%3D10.1021%2Fjm0208469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttarolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaid, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span> <span> </span><span class="NLM_article-title">New Pyrrolo[2,1-f]Purine-2,4-Dione and Imidazo[2,1-f]Purine-2,4-Dione Derivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4697</span>– <span class="NLM_lpage">4701</span>, <span class="refDoi"> DOI: 10.1021/jm058008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlyrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4697-4701&issue=14&author=P.+G.+Baraldiauthor=D.+Pretiauthor=M.+A.+Tabriziauthor=F.+Fruttaroloauthor=R.+Romagnoliauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=S.+Merighiauthor=K.+Varaniauthor=P.+A.+Borea&title=New+Pyrrolo%5B2%2C1-f%5DPurine-2%2C4-Dione+and+Imidazo%5B2%2C1-f%5DPurine-2%2C4-Dione+Derivatives+as+Potent+and+Selective+Human+A3+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm058008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">New Pyrrolo[2,1-f]purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione Derivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Preti, Delia; Tabrizi, Mojgan Aghazadeh; Fruttarolo, Francesca; Romagnoli, Romeo; Zaid, Naser Abdel; Moorman, Allan R.; Merighi, Stefania; Varani, Katia; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4697-4701</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. presenting an addnl. fused ring on the xanthine nucleus have been reported to exhibit antagonistic activity with various levels of affinity and selectivity toward the four adenosine receptors subtypes A1, A2A, A2B, and A3.  This paper reports synthesis and biol. evaluation of new 1-benzyl-3-propyl-1H,6H-pyrrolo[2,1-f]purine-2,4-diones and 1-benzyl-3-propyl-1H,8H-imidazo[2,1-f]purine-2,4-diones, among which we identified potent and selective A3 adenosine receptors antagonists.  In particular, 1-benzyl-7-methyl-3-propyl-1H,8H-imidazo[2,1-f]purine-2,4-dione (I) shows a Ki (hA3) value from binding assay of 0.8 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJWWi0pAc7zbVg90H21EOLACvtfcHk0lhrKN4VYvo8jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlyrsLY%253D&md5=9448663f56a0b82f395ccb0100ae6353</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm058008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058008c%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%2520Pyrrolo%255B2%252C1-f%255DPurine-2%252C4-Dione%2520and%2520Imidazo%255B2%252C1-f%255DPurine-2%252C4-Dione%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520Human%2520A3%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D14%26spage%3D4697%26epage%3D4701%26doi%3D10.1021%2Fjm058008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catarzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabri, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenzi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filacchioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincavelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tralli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montopoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span> <span> </span><span class="NLM_article-title">2-Aryl-8-Chloro-1,2,4-Triazolo[1,5-a]Quinoxalin-4-Amines as Highly Potent A 1 and A 3 Adenosine Receptor Antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2004.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15653338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=705-715&issue=3&author=D.+Catarziauthor=V.+Colottaauthor=F.+Varanoauthor=F.+R.+Calabriauthor=O.+Lenziauthor=G.+Filacchioniauthor=L.+Trincavelliauthor=C.+Martiniauthor=A.+Tralliauthor=C.+Montopoliauthor=S.+Moro&title=2-Aryl-8-Chloro-1%2C2%2C4-Triazolo%5B1%2C5-a%5DQuinoxalin-4-Amines+as+Highly+Potent+A+1+and+A+3+Adenosine+Receptor+Antagonists&doi=10.1016%2Fj.bmc.2004.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists</span></div><div class="casAuthors">Catarzi, Daniela; Colotta, Vittoria; Varano, Flavia; Calabri, Francesca Romana; Lenzi, Ombretta; Filacchioni, Guido; Trincavelli, Letizia; Martini, Claudia; Tralli, Andrea; Montopoli, Christian; Moro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-715</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Some 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxaline derivs., obtained by introducing different substituents on either the 4-amino moiety (acyl or carbamoyl groups) or the 2-Ph ring (4-OCH3) of previously reported 8-chloro-2-phenyl-1,2,4-triazolo[1,5-a]quinoxalin-4-amine, have been synthesized and tested in radioligand binding assays at bovine A1 and A2A and at cloned human A1 and A3 adenosine receptors.  The rationally designed 8-chloro-2-(4-methoxy-phenyl)-1,2,4-triazolo[1,5-a]quinoxalin-4-acetylamine can be considered one of the most potent and hA3 vs. hA1 selective AR antagonists reported till now.  The structure-activity relationships of these compds. are in agreement with those of previously reported 2-aryl-1,2,4-triazolo[4,3-a]quinoxalines (series A) and 2-arylpyrazolo[3,4-c]quinolines (series B), thus suggesting a similar AR binding mode.  In fact, the importance for the A3 receptor-ligand interaction of both a strong acidic NH proton donor and a C=O proton acceptor at position-4, able to engage hydrogen-bonding interactions with specific sites on the A3 AR, has been confirmed.  Using our recently published hA3 receptor model, to better elucidate our exptl. results, we decided to theor. depict the putative TM binding motif of the herein reported 1,2,4-triazolo[1,5-a]quinoxaline derivs. on human A3 receptor.  Structure-activity relationships have been explained analyzing the three-dimensional structure of the antagonist-receptor models obtained by mol. docking simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJz8GN4HAYbVg90H21EOLACvtfcHk0lhrKN4VYvo8jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVanug%253D%253D&md5=67a6bcd7a854fd7eedd2fc8caca9da11</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DCalabri%26aufirst%3DF.%2BR.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DTralli%26aufirst%3DA.%26aulast%3DMontopoli%26aufirst%3DC.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3D2-Aryl-8-Chloro-1%252C2%252C4-Triazolo%255B1%252C5-a%255DQuinoxalin-4-Amines%2520as%2520Highly%2520Potent%2520A%25201%2520and%2520A%25203%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D3%26spage%3D705%26epage%3D715%26doi%3D10.1016%2Fj.bmc.2004.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diekmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qurishi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">2-Phenylimidazo[2,1-i]Purin-5-Ones: Structure-Activity Relationships and Characterization of Potent and Selective Inverse Agonists at Human A3 Adenosine Receptors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00456-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0968-0896%2802%2900456-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12517430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvV2k" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=347-356&issue=3&author=V.+Ozolaauthor=M.+Thorandauthor=M.+Diekmannauthor=R.+Qurishiauthor=B.+Schumacherauthor=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=2-Phenylimidazo%5B2%2C1-i%5DPurin-5-Ones%3A+Structure-Activity+Relationships+and+Characterization+of+Potent+and+Selective+Inverse+Agonists+at+Human+A3+Adenosine+Receptors&doi=10.1016%2FS0968-0896%2802%2900456-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">2-Phenylimidazo[2,1-i]purin-5-ones Structure-Activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors</span></div><div class="casAuthors">Ozola, Vita; Thorand, Mark; Diekmann, Martina; Qurishi, Ramatullah; Schumacher, Britta; Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Structure-activity relationships of 2-phenyl-imidazo[2,1-i]purin-5-ones as ligands for human A3 adenosine receptors (ARs) were investigated.  An Et group in the 8-position of the imidazoline ring of 4-methyl-2-phenyl-imidazopurinone leading to chiral compds. was found to increase affinity for human A3 ARs by several thousand-fold.  Pr substitution instead of Me at N4 decreased A3 affinity but increased A1 affinity leading to potent A1-selective AR antagonists.  The most potent A1 antagonist of the present series was (S)-8-ethyl-2-phenyl-4-propyl-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one exhibiting a Ki value of 7.4 nM at rat A1 ARs and greater than 100-fold selectivity vs. rat A2A and human A3 ARs.  At human A1 ARs 2-phenylimidazo[2,1-i]purin-5-ones were generally less potent and therefore less A1-selective (S-3: Ki=98 nM).  2-, 3-, Or 4-Mono-chlorination of the 2-Ph ring reduced A3 affinity but led to an increase in affinity for A1 ARs, whereas di- (3,4-dichloro) or polychlorination (2,3,5-trichloro) increased A3 affinity.  The most potent and selective A3 antagonist of the present series was the trichlorophenyl deriv. (R)-8-ethyl-4-methyl-2-(2,3,5-trichlorophenyl)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one exhibiting a subnanomolar Ki value at human A3 ARs and greater than 800-fold selectivity vs. the other AR subtypes.  Methylation of 4-alkyl-2-phenyl-substituted imidazo[2,1-i]purin-5-ones led exclusively to the N9-Me derivs., which exhibited largely reduced AR affinities as compared to the unmethylated compds.  [35S]GTPγS binding studies of the most potent 2-phenyl-imidazo[2,1-i]purin-5-ones at membranes of Chinese hamster ovary cells expressing the human A3 AR revealed that the compds. were inverse agonists at A3 receptors under std. test conditions.  Due to their high A3 affinity, selectivity, and relatively high water-soly., 2-phenyl-imidazo[2,1-i]purin-5-ones may become useful research tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiZMo1EGPgHrVg90H21EOLACvtfcHk0liKko99t6Vj7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvV2k&md5=1c9f9a31339f3a9e03d2155dcdbe64d6</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900456-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900456-X%26sid%3Dliteratum%253Aachs%26aulast%3DOzola%26aufirst%3DV.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DQurishi%26aufirst%3DR.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D2-Phenylimidazo%255B2%252C1-i%255DPurin-5-Ones%253A%2520Structure-Activity%2520Relationships%2520and%2520Characterization%2520of%2520Potent%2520and%2520Selective%2520Inverse%2520Agonists%2520at%2520Human%2520A3%2520Adenosine%2520Receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26issue%3D3%26spage%3D347%26epage%3D356%26doi%3D10.1016%2FS0968-0896%2802%2900456-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, W. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhoven, J. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duijl, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenselink, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paasman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]Purine-2,4-Dione Derivatives as Human Adenosine A3 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7555</span>– <span class="NLM_lpage">7568</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00950</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00950" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtleht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7555-7568&issue=17&author=L.+Xiaauthor=W.+A.+C.+Burgerauthor=J.+P.+D.+Van+Veldhovenauthor=B.+J.+Kuiperauthor=T.+T.+Van+Duijlauthor=E.+B.+Lenselinkauthor=E.+Paasmanauthor=L.+H.+Heitmanauthor=A.+P.+Ijzerman&title=Structure-Affinity+Relationships+and+Structure-Kinetics+Relationships+of+Pyrido%5B2%2C1-f%5DPurine-2%2C4-Dione+Derivatives+as+Human+Adenosine+A3+Receptor+Antagonists&doi=10.1021%2Facs.jmedchem.7b00950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists</span></div><div class="casAuthors">Xia, Lizi; Burger, Wessel A. C.; van Veldhoven, Jacobus P. D.; Kuiper, Boaz J.; van Duijl, Tirsa T.; Lenselink, Eelke B.; Paasman, Ellen; Heitman, Laura H.; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7555-7568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivs. as human adenosine A3 receptor (hA3R) antagonists to det. their kinetic profiles and affinities.  Many compds. showed high affinities and a diverse range of kinetic profiles.  We found hA3R antagonists with very short residence time (RT) at the receptor (2.2 min for II 5) and much longer RTs (e.g., 376 min for I or 391 min for 31).  Two representative antagonists (I) and (II) were tested in [35S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism.  From a kon-koff-KD kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA3R antagonists.  Addnl., we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compds.' binding kinetics.  Knowledge of target binding kinetics appears useful for developing and triaging new hA3R antagonists in the early phase of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgiyuuEVYMqbVg90H21EOLACvtfcHk0liKko99t6Vj7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtleht7fN&md5=a5e396ed21c6d4349d8128e5a590e21b</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00950%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DL.%26aulast%3DBurger%26aufirst%3DW.%2BA.%2BC.%26aulast%3DVan%2BVeldhoven%26aufirst%3DJ.%2BP.%2BD.%26aulast%3DKuiper%26aufirst%3DB.%2BJ.%26aulast%3DVan%2BDuijl%26aufirst%3DT.%2BT.%26aulast%3DLenselink%26aufirst%3DE.%2BB.%26aulast%3DPaasman%26aufirst%3DE.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DStructure-Affinity%2520Relationships%2520and%2520Structure-Kinetics%2520Relationships%2520of%2520Pyrido%255B2%252C1-f%255DPurine-2%252C4-Dione%2520Derivatives%2520as%2520Human%2520Adenosine%2520A3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D17%26spage%3D7555%26epage%3D7568%26doi%3D10.1021%2Facs.jmedchem.7b00950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhoven, J. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offringa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenselink, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Es, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3552</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b02026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b02026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3539-3552&issue=7&author=X.+Yangauthor=J.+P.+D.+Van+Veldhovenauthor=J.+Offringaauthor=B.+J.+Kuiperauthor=E.+B.+Lenselinkauthor=L.+H.+Heitmanauthor=D.+Van+Der+Esauthor=A.+P.+Ijzerman&title=Development+of+Covalent+Ligands+for+G+Protein-Coupled+Receptors%3A+A+Case+for+the+Human+Adenosine+A3+Receptor&doi=10.1021%2Facs.jmedchem.8b02026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 Receptor</span></div><div class="casAuthors">Yang, Xue; van Veldhoven, Jacobus P. D.; Offringa, Jelle; Kuiper, Boaz J.; Lenselink, Eelke B.; Heitman, Laura H.; van der Es, Daan; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3539-3552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of covalent ligands for G protein-coupled receptors (GPCRs) is not a trivial process.  Here, we report a streamlined workflow thereto from synthesis to validation, exemplified by the discovery of a covalent antagonist for the human adenosine A3 receptor (hA3AR).  Based on the 1H,3H-pyrido[2,1-f]purine-2,4-dione scaffold, a series of ligands bearing a fluorosulfonyl warhead and a varying linker was synthesized.  This series was subjected to an affinity screen, revealing compd. I as the most potent antagonist.  In addn., a nonreactive methylsulfonyl deriv. was developed as a reversible control compd.  A series of assays, comprising time-dependent affinity detn., washout expts., and [35S]GTPγS binding assays, then validated I as the covalent antagonist.  A combined in silico hA3AR-homol. model and site-directed mutagenesis study was performed to demonstrate that amino acid residue Y2657.36 was the unique anchor point of the covalent interaction.  This workflow might be applied to other GPCRs to guide the discovery of covalent ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbDNSsfDVVrVg90H21EOLACvtfcHk0lhryL5YoUTubw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D&md5=47d46258dd0c33b21b5cc2e140684a40</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b02026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b02026%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DVan%2BVeldhoven%26aufirst%3DJ.%2BP.%2BD.%26aulast%3DOffringa%26aufirst%3DJ.%26aulast%3DKuiper%26aufirst%3DB.%2BJ.%26aulast%3DLenselink%26aufirst%3DE.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DVan%2BDer%2BEs%26aufirst%3DD.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DDevelopment%2520of%2520Covalent%2520Ligands%2520for%2520G%2520Protein-Coupled%2520Receptors%253A%2520A%2520Case%2520for%2520the%2520Human%2520Adenosine%2520A3%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D7%26spage%3D3539%26epage%3D3552%26doi%3D10.1021%2Facs.jmedchem.8b02026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deflorian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Errey, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiez-Vandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, R. M.</span></span> <span> </span><span class="NLM_article-title">Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1016/j.str.2017.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.str.2017.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28712806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOlsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1275-1285&issue=8&author=R.+K.+Y.+Chengauthor=E.+Segalaauthor=N.+Robertsonauthor=F.+Deflorianauthor=A.+S.+Dor%C3%A9author=J.+C.+Erreyauthor=C.+Fiez-Vandalauthor=F.+H.+Marshallauthor=R.+M.+Cooke&title=Structures+of+Human+A1+and+A2A+Adenosine+Receptors+with+Xanthines+Reveal+Determinants+of+Selectivity&doi=10.1016%2Fj.str.2017.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human A1 and A2a Adenosine Receptors with Xanthines Reveal Determinants of Selectivity</span></div><div class="casAuthors">Cheng, Robert K. Y.; Segala, Elena; Robertson, Nathan; Deflorian, Francesca; Dore, Andrew S.; Errey, James C.; Fiez-Vandal, Cedric; Marshall, Fiona H.; Cooke, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1275-1285.e4</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The adenosine A1 and A2a receptors belong to the purinergic family of G protein-coupled receptors, and regulate diverse functions of the cardiovascular, respiratory, renal, inflammation, and CNS.  Xanthines such as caffeine and theophylline are weak, non-selective antagonists of adenosine receptors.  Here we report the structure of a thermostabilized human A1 receptor at 3.3 Å resoln. with PSB36, an A1-selective xanthine-based antagonist.  This is compared with structures of the A2a receptor with PSB36 (2.8 Å resoln.), caffeine (2.1 Å), and theophylline (2.0 Å) to highlight features of ligand recognition which are common across xanthines.  The structures of A1R and A2aR were analyzed to identify the differences that are important selectivity determinants for xanthine ligands, and the role of T2707.35 in A1R (M2707.35 in A2aR) in conferring selectivity was confirmed by mutagenesis.  The structural differences confirmed to lead to selectivity can be utilized in the design of new subtype-selective A1R or A2aR antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDdYCktAYdKLVg90H21EOLACvtfcHk0lhryL5YoUTubw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOlsbfJ&md5=e759fd60b25beac2d9429809f3b51b02</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2017.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2017.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DR.%2BK.%2BY.%26aulast%3DSegala%26aufirst%3DE.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26atitle%3DStructures%2520of%2520Human%2520A1%2520and%2520A2A%2520Adenosine%2520Receptors%2520with%2520Xanthines%2520Reveal%2520Determinants%2520of%2520Selectivity%26jtitle%3DStructure%26date%3D2017%26volume%3D25%26issue%3D8%26spage%3D1275%26epage%3D1285%26doi%3D10.1016%2Fj.str.2017.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Errey, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurrell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span> <span> </span><span class="NLM_article-title">Structure of the Adenosine A 2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1283</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.1016/j.str.2011.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.str.2011.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21885291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1283-1293&issue=9&author=A.+S.+Dor%C3%A9author=N.+Robertsonauthor=J.+C.+Erreyauthor=I.+Ngauthor=K.+Hollensteinauthor=B.+Tehanauthor=E.+Hurrellauthor=K.+Bennettauthor=M.+Congreveauthor=F.+Magnaniauthor=C.+G.+Tateauthor=M.+Weirauthor=F.+H.+Marshall&title=Structure+of+the+Adenosine+A+2A+Receptor+in+Complex+with+ZM241385+and+the+Xanthines+XAC+and+Caffeine&doi=10.1016%2Fj.str.2011.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine</span></div><div class="casAuthors">Dore, Andrew S.; Robertson, Nathan; Errey, James C.; Ng, Irene; Hollenstein, Kaspar; Tehan, Ben; Hurrell, Edward; Bennett, Kirstie; Congreve, Miles; Magnani, Francesca; Tate, Christopher G.; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1283-1293</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Methylxanthines, including caffeine and theophylline, are among the most widely consumed stimulant drugs in the world.  These effects are mediated primarily via blockade of adenosine receptors.  Xanthine analogs with improved properties have been developed as potential treatments for diseases such as Parkinson's disease.  Here we report the structures of a thermostabilized adenosine A2A receptor in complex with the xanthines xanthine amine congener and caffeine, as well as the A2A selective inverse agonist ZM241385.  The receptor is crystd. in the inactive state conformation as defined by the presence of a salt bridge known as the ionic lock.  The complete third intracellular loop, responsible for G protein coupling, is visible consisting of extended helixes 5 and 6.  The structures provide new insight into the features that define the ligand binding pocket of the adenosine receptor for ligands of diverse chemotypes as well as the cytoplasmic regions that interact with signal transduction proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsexwFu6LD7Vg90H21EOLACvtfcHk0lhryL5YoUTubw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaru7fE&md5=a25db14aa70c2b42b9c3eb98c3c16bae</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2011.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2011.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DI.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMagnani%26aufirst%3DF.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DStructure%2520of%2520the%2520Adenosine%2520A%25202A%2520Receptor%2520in%2520Complex%2520with%2520ZM241385%2520and%2520the%2520Xanthines%2520XAC%2520and%2520Caffeine%26jtitle%3DStructure%26date%3D2011%26volume%3D19%26issue%3D9%26spage%3D1283%26epage%3D1293%26doi%3D10.1016%2Fj.str.2011.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekhar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cyclic Nucleotide Phosphodiesterases by Methylxanthines and Related Compounds</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-13443-2_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2F978-3-642-13443-2_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2011&pages=93-133&author=S.+H.+Francisauthor=K.+R.+Sekharauthor=H.+Keauthor=J.+D.+Corbin&title=Inhibition+of+Cyclic+Nucleotide+Phosphodiesterases+by+Methylxanthines+and+Related+Compounds&doi=10.1007%2F978-3-642-13443-2_4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds</span></div><div class="casAuthors">Francis, Sharron H.; Sekhar, Konjeti R.; Ke, Hengming; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">Methylxanthines</span>),
    <span class="NLM_cas:pages">93-133</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Naturally occurring methylxanthines were the first inhibitors of cyclic nucleotide (cN) phosphodiesterases (PDEs) to be discovered.  To improve potency and specificity for inhibition of various PDEs in research and for treatment of diseases, thousands of compds. with related structures have now been synthesized.  All known PDE inhibitors contain one or more rings that mimic the purine in the cN substrate and directly compete with cN for access to the catalytic site; this review focuses on inhibitors that contain a nucleus that is closely related to the xanthine ring of theophylline and caffeine and the purine ring of cNs.  The specificity and potency of these compds. for blocking PDE action have been improved by appending groups at positions on the rings as well as by modification of the no. and distribution of nitrogens and carbons in those rings.  Several of these inhibitors are highly selective for particular PDEs; potent and largely selective PDE5 inhibitors are used clin. for treatment of erectile dysfunction [sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra)] and pulmonary hypertension [sildenafil (Revatio) and tadalafil (Adenocirca)].  Related compds. target other PDEs and show therapeutic promise for a no. of maladies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6BhLDIuIfLLVg90H21EOLACvtfcHk0lhXjkd58kOdnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOns7k%253D&md5=022fb1b7ad6cc60fab1690c8ad0f7158</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-13443-2_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-13443-2_4%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DSekhar%26aufirst%3DK.%2BR.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DInhibition%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%2520by%2520Methylxanthines%2520and%2520Related%2520Compounds%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2011%26volume%3D200%26spage%3D93%26epage%3D133%26doi%3D10.1007%2F978-3-642-13443-2_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meskini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Némoz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okyayuz-Baklouti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigent, A. F.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase Inhibitory Profile of Some Related Xanthine Derivatives Pharmacologically Active on the Peripheral Microcirculation</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(94)90477-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0006-2952%2894%2990477-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8135854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXitlGktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1994&pages=781-788&issue=5&author=N.+Meskiniauthor=G.+N%C3%A9mozauthor=I.+Okyayuz-Bakloutiauthor=M.+Lagardeauthor=A.+F.+Prigent&title=Phosphodiesterase+Inhibitory+Profile+of+Some+Related+Xanthine+Derivatives+Pharmacologically+Active+on+the+Peripheral+Microcirculation&doi=10.1016%2F0006-2952%2894%2990477-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation</span></div><div class="casAuthors">Meskini, Nadia; Nemoz, Georges; Okyayuz-Baklouti, Ismahan; Lagarde, Michel; Prigent, Annie France</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-8</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The cyclic nucleotide phosphodiestrerase (PDE) inhibitory profile of four related xanthine derivs.: pentoxifylline (BL 191), propentofylline (HWA 285), torbafylline (HWA 448) and albifylline (HWA 138), pharmacol. active on the peripheral and/or cerebral microcirculation was established using the four main PDE isoforms present in rat heart cytosol.  HPLC on a Mono Q ion-exchange column resolved four sep. cyclic nucleotide PDE activities: a calmodulin-activated fraction (PDEI), a cGMP-stimulated fraction (PDE III).  Among the four compds. studied, only torbafylline and pentoxifylline inhibited more efficiently the calcium plus calmodulin-stimulated than the basal activity of PDE I.  The four xanthine derivs. inhibited more potently the cGMP-stimulated than the basal activity of the cGMP-stimulated PDE II, propentofylline being the most inhibitory (IC50: 20 μM).  Except for propentofylline, which exhibited a marked selectivity toward the rolipram-sensitive PDE IV vs. the cGMP-inhibited PDE III, the other xanthines modestly (IC50 in the 10-4 M range) inhibited both cAMP-specific isoforms with similar potency.  Propentofylline proved to be the best inhibitor whatever the considered isoform whereas torbafylline exhibited the weakest inhibitory potency with, however, some selectivity for PDE I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7ocyhzeb1G7Vg90H21EOLACvtfcHk0lhXjkd58kOdnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlGktLo%253D&md5=e9a43a2fe5aa80cd60feb26880f966e1</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2894%2990477-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252894%252990477-4%26sid%3Dliteratum%253Aachs%26aulast%3DMeskini%26aufirst%3DN.%26aulast%3DN%25C3%25A9moz%26aufirst%3DG.%26aulast%3DOkyayuz-Baklouti%26aufirst%3DI.%26aulast%3DLagarde%26aufirst%3DM.%26aulast%3DPrigent%26aufirst%3DA.%2BF.%26atitle%3DPhosphodiesterase%2520Inhibitory%2520Profile%2520of%2520Some%2520Related%2520Xanthine%2520Derivatives%2520Pharmacologically%2520Active%2520on%2520the%2520Peripheral%2520Microcirculation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1994%26volume%3D47%26issue%3D5%26spage%3D781%26epage%3D788%26doi%3D10.1016%2F0006-2952%2894%2990477-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garst, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. N.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Separated Forms of Phosphodiesterases from Pig Coronary Arteries by Uracils and by 7-Substituted Derivatives of 1-Methyl-3-Isobutylxanthine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/jm00226a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00226a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE28XhtlSisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1976&pages=499-503&issue=4&author=J.+E.+Garstauthor=G.+L.+Kramerauthor=Y.+J.+Wuauthor=J.+N.+Wells&title=Inhibition+of+Separated+Forms+of+Phosphodiesterases+from+Pig+Coronary+Arteries+by+Uracils+and+by+7-Substituted+Derivatives+of+1-Methyl-3-Isobutylxanthine&doi=10.1021%2Fjm00226a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of separated forms of phosphodiesterases from pig coronary arteries by uracils and by 7-substituted derivatives of 1-methyl-3-isobutylxanthine</span></div><div class="casAuthors">Garst, J. E.; Kramer, G. L.; Wu, Y. J.; Wells, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-503</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 15 title xanthine derivs. (I; R = alkyl, aralkyl, alicyclicalkyl, propargyl, 4-picolyl), prepd. by alkylation of 1-methyl-3-isobutylxanthine (I, R = H)(MIX) [28822-58-4] were tested for specificity of inhibition of chromatog.-sepd. cyclic nucleotide phosphodiesterase [50812-31-2] activity fractions I and II.  I were generally much less potent than MIX as inhibitors of activity fraction II, but some retained the potency of MIX as inhibitors of activity fraction I.  1-Methyl-3-isobutyl-7-benzylxanthine (I, R = PhCH2) [58481-23-5] was 20-30 times more potent as an inhibitor of activity fraction I than of II, while retaining the potency of MIX against activity fraction I.  A series of 1,3-dialkyluracils had low potency as phosphodiesterase inhibitors.  Structure-activity relations were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpACF8c5N-9frVg90H21EOLACvtfcHk0lhXjkd58kOdnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XhtlSisb0%253D&md5=dc68ab852947fee03f7faf5a37071d6a</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fjm00226a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00226a010%26sid%3Dliteratum%253Aachs%26aulast%3DGarst%26aufirst%3DJ.%2BE.%26aulast%3DKramer%26aufirst%3DG.%2BL.%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BN.%26atitle%3DInhibition%2520of%2520Separated%2520Forms%2520of%2520Phosphodiesterases%2520from%2520Pig%2520Coronary%2520Arteries%2520by%2520Uracils%2520and%2520by%25207-Substituted%2520Derivatives%2520of%25201-Methyl-3-Isobutylxanthine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1976%26volume%3D19%26issue%3D4%26spage%3D499%26epage%3D503%26doi%3D10.1021%2Fjm00226a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manallack, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span> <span> </span><span class="NLM_article-title">The next Generation of Phosphodiesterase Inhibitors: Structural Clues to Ligand and Substrate Selectivity of Phosphodiesterases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3449</span>– <span class="NLM_lpage">3462</span>, <span class="refDoi"> DOI: 10.1021/jm040217u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040217u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVCqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3449-3462&issue=10&author=D.+T.+Manallackauthor=R.+A.+Hughesauthor=P.+E.+Thompson&title=The+next+Generation+of+Phosphodiesterase+Inhibitors%3A+Structural+Clues+to+Ligand+and+Substrate+Selectivity+of+Phosphodiesterases&doi=10.1021%2Fjm040217u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Next Generation of Phosphodiesterase Inhibitors: Structural Clues to Ligand and Substrate Selectivity of Phosphodiesterases</span></div><div class="casAuthors">Manallack, David T.; Hughes, Richard A.; Thompson, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3449-3462</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of phosphodiesterase isoforms and their inhibitors based on information provided by crystallog. data as it relates to homol. and structural alignment, cyclic nucleotide substrate specificity, inhibitor selectivity, and the prospects for the design of isoform-selective PDE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrNnu36vgL0LVg90H21EOLACvtfcHk0lhvVw8CJ0TJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVCqtLs%253D&md5=42d23b20ec29971e7e3556bc0183803c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Fjm040217u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040217u%26sid%3Dliteratum%253Aachs%26aulast%3DManallack%26aufirst%3DD.%2BT.%26aulast%3DHughes%26aufirst%3DR.%2BA.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3DThe%2520next%2520Generation%2520of%2520Phosphodiesterase%2520Inhibitors%253A%2520Structural%2520Clues%2520to%2520Ligand%2520and%2520Substrate%2520Selectivity%2520of%2520Phosphodiesterases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D10%26spage%3D3449%26epage%3D3462%26doi%3D10.1021%2Fjm040217u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanev, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Graaf, C.</span></span> <span> </span><span class="NLM_article-title">PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7065</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7029-7065&issue=15&author=C.+Jansenauthor=A.+J.+Kooistraauthor=G.+K.+Kanevauthor=R.+Leursauthor=I.+J.+P.+De+Eschauthor=C.+De+Graaf&title=PDEStrIAn%3A+A+Phosphodiesterase+Structure+and+Ligand+Interaction+Annotated+Database+As+a+Tool+for+Structure-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.5b01813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design</span></div><div class="casAuthors">Jansen, Chimed; Kooistra, Albert J.; Kanev, Georgi K.; Leurs, Rob; de Esch, Iwan J. P.; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7029-7065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A systematic anal. is presented of the 220 phosphodiesterase (PDE) catalytic domain crystal structures present in the Protein Data Bank (PDB) with a focus on PDE-ligand interactions.  The consistent structural alignment of 57 PDE ligand binding site residues enables the systematic anal. of PDE-ligand interaction fingerprints (IFPs), the identification of subtype-specific PDE-ligand interaction features, and the classification of ligands according to their binding modes.  We illustrate how systematic mining of this phosphodiesterase structure and ligand interaction annotated (PDEStrIAn) database provides new insights into how conserved and selective PDE interaction hot spots can accommodate the large diversity of chem. scaffolds in PDE ligands.  A substructure anal. of the cocrystd. PDE ligands in combination with those in the ChEMBL database provides a toolbox for scaffold hopping and ligand design.  These analyses lead to an improved understanding of the structural requirements of PDE binding that will be useful in future drug discovery studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1I6fmiCv-rVg90H21EOLACvtfcHk0lhvVw8CJ0TJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCju7k%253D&md5=67669586d18089a73f4e7de21cf7c33b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01813%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DC.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DKanev%26aufirst%3DG.%2BK.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DDe%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DDe%2BGraaf%26aufirst%3DC.%26atitle%3DPDEStrIAn%253A%2520A%2520Phosphodiesterase%2520Structure%2520and%2520Ligand%2520Interaction%2520Annotated%2520Database%2520As%2520a%2520Tool%2520for%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D15%26spage%3D7029%26epage%3D7065%26doi%3D10.1021%2Facs.jmedchem.5b01813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Staveren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Phosphodiesterase 2 Increases Neuronal CGMP, Synaptic Plasticity and Memory Performance</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2004.07.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15555642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSltLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&issue=7&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.+J.+Van+Der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+Van+Staverenauthor=J.+De+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+Phosphodiesterase+2+Increases+Neuronal+CGMP%2C+Synaptic+Plasticity+and+Memory+Performance&doi=10.1016%2Fj.neuropharm.2004.07.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance</span></div><div class="casAuthors">Boess, Frank G.; Hendrix, Martin; van der Staay, Franz-Josef; Erb, Christina; Schreiber, Rudy; van Staveren, Wilma; de Vente, Jan; Prickaerts, Jos; Blokland, Arjan; Koenig, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1081-1092</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An essential element of the signaling cascade leading to synaptic plasticity is the intracellular second messenger mol. cGMP.  Using the novel, potent, and selective inhibitor Bay 60-7550, the authors show that the enzyme 3',5'-cyclic nucleotide phosphodiesterase type 2 (PDE2) is responsible for the degrdn. of newly synthesized cGMP in cultured neurons and hippocampal slices.  Inhibition of PDE2 enhanced long-term potentiation of synaptic transmission without altering basal synaptic transmission.  Inhibition of PDE2 also improved the performance of rats in social and object recognition memory tasks, and reversed MK801-induced deficits in spontaneous alternation in mice in a T-maze.  The authors' data provide strong evidence that inhibition of PDE2 can improve memory functions by enhancing neuronal plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZrzoDQq-IbVg90H21EOLACvtfcHk0lhvVw8CJ0TJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSltLnO&md5=3bcff5e6acf5fa371255587f9e40beb8</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3DVan%2BDer%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DVan%2BStaveren%26aufirst%3DW.%26aulast%3DDe%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520Phosphodiesterase%25202%2520Increases%2520Neuronal%2520CGMP%252C%2520Synaptic%2520Plasticity%2520and%2520Memory%2520Performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26issue%3D7%26spage%3D1081%26epage%3D1092%26doi%3D10.1016%2Fj.neuropharm.2004.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turko, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related Compounds</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/mol.56.1.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.56.1.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10385692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1MXksFOmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=124-130&issue=1&author=I.+V.+Turkoauthor=S.+A.+Ballardauthor=S.+H.+Francisauthor=J.+D.+Corbin&title=Inhibition+of+Cyclic+GMP-Binding+Cyclic+GMP-Specific+Phosphodiesterase+%28Type+5%29+by+Sildenafil+and+Related+Compounds&doi=10.1124%2Fmol.56.1.124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds</span></div><div class="casAuthors">Turko, Illarion V.; Ballard, Stephen A.; Francis, Sharron H.; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-130</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The cGMP-binding cGMP-specific phosphodiesterase (PDE5) degrades cGMP and regulates the intracellular level of cGMP in many tissues, including the smooth muscle of the corpus cavernosum of the penis.  Sildenafil (Viagra), a specific PDE5 inhibitor, promotes penile erection by blocking the activity of PDE5, which causes cGMP to accumulate in the corpus cavernosum.  In the present study, sildenafil, like other PDE5 inhibitors, stimulates cGMP binding to the allosteric sites of PDE5 by interacting at the catalytic site of this enzyme, but the drug does not compete with cGMP for binding at the allosteric sites.  Both sildenafil and zaprinast are competitive inhibitors of PDE5, and double-inhibition anal. shows that these two inhibitors added together interact with the catalytic site of PDE5 in a mutually exclusive manner.  After site-directed mutagenesis of each of 23 conserved amino acid residues in the catalytic domain of PDE5, the pattern of changes in the IC50 values for sildenafil or UK-122764 is similar to that found for zaprinast.  However, among the three inhibitors, sildenafil exhibits the most similar pattern of changes in the IC50 to that found for the affinity of cGMP, implying similar interactions with the catalytic domain.  This may explain in part the stronger inhibitory potency of sildenafil for wild-type PDE5 compared with the other inhibitors [sildenafil (Ki = 1 nM) > UK-122764 (Ki = 5 nM) > zaprinast (Ki = 130 nM)].  The affinity of each of these inhibitors for PDE5 is much higher than that of cGMP itself (Km = 2000 nM).  It is concluded that residues such as Tyr602, His607, His643, and Asp754 may form important interactions for sildenafil in PDE5, but because these amino acids are conserved in all mammalian PDEs, the selectivity and potency of sildenafil is likely to be provided by a nonconserved residue or residues in the PDE5 catalytic domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhinP8Q5VgrVg90H21EOLACvtfcHk0ljpAaHEAnnKUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFOmt7s%253D&md5=71f697fb049ca955fdb18253d5747ada</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1124%2Fmol.56.1.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.56.1.124%26sid%3Dliteratum%253Aachs%26aulast%3DTurko%26aufirst%3DI.%2BV.%26aulast%3DBallard%26aufirst%3DS.%2BA.%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DInhibition%2520of%2520Cyclic%2520GMP-Binding%2520Cyclic%2520GMP-Specific%2520Phosphodiesterase%2520%2528Type%25205%2529%2520by%2520Sildenafil%2520and%2520Related%2520Compounds%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D56%26issue%3D1%26spage%3D124%26epage%3D130%26doi%3D10.1124%2Fmol.56.1.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asberom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemulapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamanda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Optimization of Purine Based PDE1/PDE5 Inhibitors to a Potent and Selective PDE5 Inhibitor for the Treatment of Male ED</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2365</span>– <span class="NLM_lpage">2369</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.02.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2005.02.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15837326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2365-2369&issue=9&author=C.+D.+Boyleauthor=R.+Xuauthor=T.+Asberomauthor=S.+Chackalamannilauthor=J.+W.+Claderauthor=W.+J.+Greenleeauthor=H.+Guzikauthor=Y.+Huauthor=Z.+Huauthor=C.+M.+Lankinauthor=D.+A.+Pissarnitskiauthor=A.+W.+Stamfordauthor=Y.+Wangauthor=J.+Skellauthor=S.+Kurowskiauthor=S.+Vemulapalliauthor=J.+Palamandaauthor=M.+Chintalaauthor=P.+Wuauthor=J.+Myersauthor=P.+Wang&title=Optimization+of+Purine+Based+PDE1%2FPDE5+Inhibitors+to+a+Potent+and+Selective+PDE5+Inhibitor+for+the+Treatment+of+Male+ED&doi=10.1016%2Fj.bmcl.2005.02.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED</span></div><div class="casAuthors">Boyle, Craig D.; Xu, Ruo; Asberom, Theodros; Chackalamannil, Samuel; Clader, John W.; Greenlee, William J.; Guzik, Henry; Hu, Yuequing; Hu, Zhiyong; Lankin, Claire M.; Pissarnitski, Dmitri A.; Stamford, Andrew W.; Wang, Yuguang; Skell, Jeffrey; Kurowski, Stanley; Vemulapalli, Subbarao; Palamanda, Jairam; Chintala, Madhu; Wu, Ping; Myers, Joyce; Wang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2365-2369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In search of a PDE5 inhibitor for erectile dysfunction, an SAR was developed from a PDE1/PDE5 purine series of leads, which had modest PDE5 potency and poor isoenzyme selectivity.  A compd. (I) with PDE5 inhibition and in vivo activity similar to sildenafil was discovered from this effort.  In addn., purine I demonstrated superior overall PDE isoenzyme selectivity when compared to the approved PDE5 inhibitors sildenafil, vardenafil, and tadalafil, which may result in a more favorable side-effect profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkcOMSHgdvhLVg90H21EOLACvtfcHk0ljpAaHEAnnKUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWqtr8%253D&md5=6733bdb0a77c94d339fdbba2ed9b8d8e</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.02.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.02.083%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DGuzik%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLankin%26aufirst%3DC.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSkell%26aufirst%3DJ.%26aulast%3DKurowski%26aufirst%3DS.%26aulast%3DVemulapalli%26aufirst%3DS.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DChintala%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DOptimization%2520of%2520Purine%2520Based%2520PDE1%252FPDE5%2520Inhibitors%2520to%2520a%2520Potent%2520and%2520Selective%2520PDE5%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Male%2520ED%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D9%26spage%3D2365%26epage%3D2369%26doi%3D10.1016%2Fj.bmcl.2005.02.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerreiro, S.</span>; <span class="NLM_string-name">Marien, M.</span>; <span class="NLM_string-name">Michel, P. P.</span></span> <span> </span><span class="NLM_article-title">Methylxanthines and Ryanodine Receptor Channels</span>.  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">150</span>. <span class="refDoi"> DOI: 10.1007/978-3-642-13443-2_5</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2F978-3-642-13443-2_5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=135-150&author=S.+Guerreiro&author=M.+Marien&author=P.+P.+Michel&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-13443-2_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-13443-2_5%26sid%3Dliteratum%253Aachs%26aulast%3DGuerreiro%26aufirst%3DS.%26atitle%3DMethylxanthines%2520and%2520Ryanodine%2520Receptor%2520Channels%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D2011%26spage%3D135%26epage%3D150%26doi%3D10.1007%2F978-3-642-13443-2_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Caffeine Contracture</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">903</span>, <span class="refDoi"> DOI: 10.1073/pnas.46.6.897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.46.6.897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16590687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD28zitF2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=897-903&issue=6&author=D.+Conwayauthor=T.+Sakai&title=Caffeine+Contracture&doi=10.1073%2Fpnas.46.6.897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">CAFFEINE CONTRACTURE</span></div><div class="casAuthors">Conway D; Sakai T</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">897-903</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtFsnkpUn5Fg5nADWVYHg1fW6udTcc2eYfQrrRWwpSL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zitF2msw%253D%253D&md5=c57fa1c2c5f92250b871888e3651ca2f</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.6.897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.6.897%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DD.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DCaffeine%2520Contracture%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D6%26spage%3D897%26epage%3D903%26doi%3D10.1073%2Fpnas.46.6.897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span> <span> </span><span class="NLM_article-title">Calcium Release from the Sarcoplasmic Reticulum</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1152/physrev.1977.57.1.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1152%2Fphysrev.1977.57.1.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=13441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE2sXhtVWqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1977&pages=71-108&issue=1&author=M.+Endo&title=Calcium+Release+from+the+Sarcoplasmic+Reticulum&doi=10.1152%2Fphysrev.1977.57.1.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium release from the sarcoplasmic reticulum</span></div><div class="casAuthors">Endo, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-108</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    </div><div class="casAbstract">A review with 198 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFj7N17UF3orVg90H21EOLACvtfcHk0liqDaU3-eTH4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtVWqtL4%253D&md5=cae2cf0c5c9d75b37f074c5e61c24e06</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1977.57.1.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1977.57.1.71%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DM.%26atitle%3DCalcium%2520Release%2520from%2520the%2520Sarcoplasmic%2520Reticulum%26jtitle%3DPhysiol.%2520Rev.%26date%3D1977%26volume%3D57%26issue%3D1%26spage%3D71%26epage%3D108%26doi%3D10.1152%2Fphysrev.1977.57.1.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabiato, A.</span></span> <span> </span><span class="NLM_article-title">Calcium-Induced Release of Calcium from the Cardiac Sarcoplasmic Reticulum</span>. <i>Am. J. Physiol. - Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>245</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">C1</span>– <span class="NLM_lpage">C14</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.1983.245.1.C1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1152%2Fajpcell.1983.245.1.C1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1983&pages=C1-C14&issue=1&author=A.+Fabiato&title=Calcium-Induced+Release+of+Calcium+from+the+Cardiac+Sarcoplasmic+Reticulum&doi=10.1152%2Fajpcell.1983.245.1.C1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.1983.245.1.C1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.1983.245.1.C1%26sid%3Dliteratum%253Aachs%26aulast%3DFabiato%26aufirst%3DA.%26atitle%3DCalcium-Induced%2520Release%2520of%2520Calcium%2520from%2520the%2520Cardiac%2520Sarcoplasmic%2520Reticulum%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Cell%2520Physiol.%26date%3D1983%26volume%3D245%26issue%3D1%26spage%3DC1%26epage%3DC14%26doi%3D10.1152%2Fajpcell.1983.245.1.C1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. J.</span></span> <span> </span><span class="NLM_article-title">Adenosine Discriminates between the Caffeine and Adenine Nucleotide Sites on the Sheep Cardiac Sarcoplasmic Reticulum Calcium-Release Channel</span>. <i>J. Membr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1007/BF00233486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00233486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7516436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXitFSrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1994&pages=169-177&issue=2&author=S.+J.+McGarryauthor=A.+J.+Williams&title=Adenosine+Discriminates+between+the+Caffeine+and+Adenine+Nucleotide+Sites+on+the+Sheep+Cardiac+Sarcoplasmic+Reticulum+Calcium-Release+Channel&doi=10.1007%2FBF00233486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel</span></div><div class="casAuthors">McGarry, S. J.; Williams, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-77</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    </div><div class="casAbstract">Calcium-release channels of sheep cardiac sarcoplasmic reticulum were incorporated into phosphatidylethanolamine bilayers and single channel currents were recorded under voltage-clamp conditions.  The effect of adenosine on single channel conductance and gating was investigated, as were the interactions between adenosine and caffeine and adenosine and α,β-methylene ATP.  Addn. of adenosine (0.5-5 mM) to the cytosolic but not the luminal side of the membrane increased the open probability of single calcium-activated calcium-release channels by increasing the frequency and duration of open events, yielding an EC50 of 0.75 mM at 10 μM activating Ca2+.  Addn. of 1 mM caffeine potentiated the effects of adenosine at 10 or 100 μM-activating cytosolic calcium, but had no effect on the inability of adenosine to activate the channel at 80 pM calcium, suggesting discrete sites of action on the calcium-release channel for adenosine and caffeine.  In contrast, addn. of 100 μM α,β-methylene-ATP decreased single channel open probability in the presence of adenosine, suggesting that these compds. act on the same site on the channel.  Activation of single channel opening by adenosine, or by adenosine together with caffeine, had no effect on single channel conductance or the Ca2+/Tris+ permeability ratio.  Channels activated by adenosine were characteristically modified by ryanodine and blocked by micromolar ruthenium red or millimolar magnesium.  These results show that adenosine activates the sheep cardiac sarcoplasmic reticulum Ca2+-release channel by increasing the frequency and duration of open events in a Ca2+-dependent manner.  The receptor site on the channel for adenosine is distinct from that for caffeine but probably the same as that for adenine nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHZZOcP9pPrrVg90H21EOLACvtfcHk0liqDaU3-eTH4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFSrurc%253D&md5=5fb132c81172118ba6d302686223ce17</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1007%2FBF00233486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00233486%26sid%3Dliteratum%253Aachs%26aulast%3DMcGarry%26aufirst%3DS.%2BJ.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26atitle%3DAdenosine%2520Discriminates%2520between%2520the%2520Caffeine%2520and%2520Adenine%2520Nucleotide%2520Sites%2520on%2520the%2520Sheep%2520Cardiac%2520Sarcoplasmic%2520Reticulum%2520Calcium-Release%2520Channel%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1994%26volume%3D137%26issue%3D2%26spage%3D169%26epage%3D177%26doi%3D10.1007%2FBF00233486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garaschuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhratsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, A.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor-mediated Intracellular Calcium Release in Rat Cerebellar Purkinje Neurones</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>487</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1113/jphysiol.1995.sp020857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1113%2Fjphysiol.1995.sp020857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7473240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVWltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=1995&pages=1-16&issue=1&author=M.+Kanoauthor=O.+Garaschukauthor=A.+Verkhratskyauthor=A.+Konnerth&title=Ryanodine+Receptor-mediated+Intracellular+Calcium+Release+in+Rat+Cerebellar+Purkinje+Neurones&doi=10.1113%2Fjphysiol.1995.sp020857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurons</span></div><div class="casAuthors">Kano, Masanobu; Garaschuk, Olga; Verkhratsky, Alexej; Konnerth, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Ryanodine receptor-mediated Ca2+ release was investigated in Purkinje neurons of rat cerebellar slices by using whole-cell patch-clamp recordings combined with fluorometric digital imaging of cytoplasmic Ca2+ concn. ([Ca2+]i).  Caffeine caused a transient increase in [Ca2+]i in the somata and dendrites of Purkinje neurons.  Caffeine-induced Ca2+ transients were not assocd. with a membrane inward current and persisted in Ca2+-free external solns., indicating that they are caused by Ca2+ released from intracellular stores.  The amplitudes of the caffeine-mediated elevations in [Ca2+]i were strongly dependent on the baseline level of [Ca2+]i.  Intracellular application of Ruthenium Red through the patch pipet blocked caffeine-induced Ca2+ transients in Purkinje neurons.  Ryanodine when applied either intra- or extracellularly caused a use-dependent block of caffeine-induced Ca2+ release.  Depolarization-induced Ca2+ transients were strongly prolonged by caffeine.  Several lines of evidence suggest that these prolongations reflect Ca2+-induced Ca2+ release.  Despite the presence of skeletal muscle type ryanodine receptors in Purkinje neurons, depolarizing pulses failed to induce any changes in [Ca2+]i when the influx of Ca2+ through voltage-gated channels was prevented by using Ca2+-free soln., or when applying blockers of voltage-gated Ca2+ channels.  Dendritic Ca2+ transients produced by stimulation of the excitatory climbing fiber synaptic input were also prolonged by caffeine, indicating that ryanodine receptor-mediated release of Ca2+ may be involved in synaptic signaling in cerebellar Purkinje neurons.  Ryanodine receptor-mediated release of Ca2+ in cerebellar Purkinje neurons can be explained by a model in which release of Ca2+ is strongly facilitated by the co-operative action of Ca2+, caffeine and/or ryanodine.  The results suggest that Ca2+ release in these central neurons becomes prominent only during episodes of intensive elec. activity assocd. with increased Ca2+ entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDlewuwaPUVbVg90H21EOLACvtfcHk0liqDaU3-eTH4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVWltL0%253D&md5=00e3b73480a1b2222080c6d22599877f</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.1995.sp020857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.1995.sp020857%26sid%3Dliteratum%253Aachs%26aulast%3DKano%26aufirst%3DM.%26aulast%3DGaraschuk%26aufirst%3DO.%26aulast%3DVerkhratsky%26aufirst%3DA.%26aulast%3DKonnerth%26aufirst%3DA.%26atitle%3DRyanodine%2520Receptor-mediated%2520Intracellular%2520Calcium%2520Release%2520in%2520Rat%2520Cerebellar%2520Purkinje%2520Neurones%26jtitle%3DJ.%2520Physiol.%26date%3D1995%26volume%3D487%26issue%3D1%26spage%3D1%26epage%3D16%26doi%3D10.1113%2Fjphysiol.1995.sp020857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkovsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avshalumov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, M. E.</span></span> <span> </span><span class="NLM_article-title">Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6568</span>– <span class="NLM_lpage">6579</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0181-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1523%2FJNEUROSCI.0181-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19458227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFent7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=6568-6579&issue=20&author=J.+C.+Patelauthor=P.+Witkovskyauthor=M.+V.+Avshalumovauthor=M.+E.+Rice&title=Mobilization+of+Calcium+from+Intracellular+Stores+Facilitates+Somatodendritic+Dopamine+Release&doi=10.1523%2FJNEUROSCI.0181-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release</span></div><div class="casAuthors">Patel, Jyoti C.; Witkovsky, Paul; Avshalumov, Marat V.; Rice, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6568-6579</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Somatodendritic dopamine (DA) release in the substantia nigra pars compacta (SNc) shows a limited dependence on extracellular calcium concn. ([Ca2+]o), suggesting the involvement of intracellular Ca2+ stores.  Here, using immunocytochem. we demonstrate the presence of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2 (SERCA2) that sequesters cytosolic Ca2+ into the endoplasmic reticulum (ER), as well as inositol 1,4,5-triphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) in DAergic neurons.  Notably, RyRs were clustered at the plasma membrane, poised for activation by Ca2+ entry.  Using fast-scan cyclic voltammetry to monitor evoked extracellular DA concn. ([DA]o) in midbrain slices, we found that SERCA inhibition by cyclopiazonic acid (CPA) decreased evoked [DA]o in the SNc, indicating a functional role for ER Ca2+ stores in somatodendritic DA release.  Implicating IP3R-dependent stores, an IP3R antagonist, 2-APB, also decreased evoked [DA]o.  Moreover, DHPG, an agonist of group I metabotropic glutamate receptors (mGluR1s, which couple to IP3 prodn.), increased somatodendritic DA release, whereas CPCCOEt, an mGluR1 antagonist, suppressed it.  Release suppression by mGluR1 blockade was prevented by 2-APB or CPA, indicating facilitation of DA release by endogenous glutamate acting via mGluR1s and IP3R-gated Ca2+ stores.  Similarly, activation of RyRs by caffeine increased [Ca2+]i and elevated evoked [DA]o.  The increase in DA release was prevented by a RyR blocker, dantrolene, and by CPA.  Importantly, the efficacy of dantrolene was enhanced in low [Ca2+]o, suggesting a mechanism for maintenance of somatodendritic DA release with limited Ca2+ entry.  Thus, both mGluR1-linked IP3R- and RyR-dependent ER Ca2+ stores facilitate somatodendritic DA release in the SNC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozPtqTNkN8r7Vg90H21EOLACvtfcHk0lhjTtTh4TUIwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFent7w%253D&md5=7ddfd25ed499f21e5ba1c7158fb15e4f</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0181-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0181-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DWitkovsky%26aufirst%3DP.%26aulast%3DAvshalumov%26aufirst%3DM.%2BV.%26aulast%3DRice%26aufirst%3DM.%2BE.%26atitle%3DMobilization%2520of%2520Calcium%2520from%2520Intracellular%2520Stores%2520Facilitates%2520Somatodendritic%2520Dopamine%2520Release%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26issue%3D20%26spage%3D6568%26epage%3D6579%26doi%3D10.1523%2FJNEUROSCI.0181-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayaraghavan, S.</span></span> <span> </span><span class="NLM_article-title">Modulation of Presynaptic Store Calcium Induces Release of Glutamate and Postsynaptic Firing</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(03)00322-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0896-6273%2803%2900322-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12818178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFanu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=929-939&issue=6&author=G.+Sharmaauthor=S.+Vijayaraghavan&title=Modulation+of+Presynaptic+Store+Calcium+Induces+Release+of+Glutamate+and+Postsynaptic+Firing&doi=10.1016%2FS0896-6273%2803%2900322-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing</span></div><div class="casAuthors">Sharma, Geeta; Vijayaraghavan, Sukumar</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Action potential-independent transmitter release is random and produces small depolarizations in the postsynaptic neuron.  This process is, therefore, not thought to play a significant role in impulse propagation across synapses.  Here we show that calcium flux through presynaptic neuronal nicotinic receptors leads to mobilization of store calcium by calcium-induced calcium release.  Recruitment of store calcium induces vesicular release of glutamate in a manner consistent with synchronization across multiple active zones in the CA3 region of the rat hippocampus.  This modulation of action potential-independent release of glutamate is sufficient to drive the postsynaptic pyramidal cell above its firing threshold, thus providing a mechanism for impulse propagation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWdXbptOfIcbVg90H21EOLACvtfcHk0lhjTtTh4TUIwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFanu7c%253D&md5=145a0950c72034047ef044a2f0137aa9</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900322-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900322-2%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DVijayaraghavan%26aufirst%3DS.%26atitle%3DModulation%2520of%2520Presynaptic%2520Store%2520Calcium%2520Induces%2520Release%2520of%2520Glutamate%2520and%2520Postsynaptic%2520Firing%26jtitle%3DNeuron%26date%3D2003%26volume%3D38%26issue%3D6%26spage%3D929%26epage%3D939%26doi%3D10.1016%2FS0896-6273%2803%2900322-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magkos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavouras, S. A.</span></span> <span> </span><span class="NLM_article-title">Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1080/1040-830491379245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1080%2F1040-830491379245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16371327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlakt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=535-562&issue=7%E2%80%938&author=F.+Magkosauthor=S.+A.+Kavouras&title=Caffeine+Use+in+Sports%2C+Pharmacokinetics+in+Man%2C+and+Cellular+Mechanisms+of+Action&doi=10.1080%2F1040-830491379245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action</span></div><div class="casAuthors">Magkos, Faidon; Kavouras, Stavros A.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">535-562</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Caffeine is the most widely consumed psychoactive drug' in the world and probably one of the most commonly used stimulants in sports.  This is not surprising, since it is one of the few ergogenic aids with documented efficiency and minimal side effects.  Caffeine is rapidly and completely absorbed by the gastrointestinal tract and is readily distributed throughout all tissues of the body.  Peak plasma concns. after normal consumption are usually around 50 μM, and half-lives for elimination range between 2.5-10 h.  The parent compd. is extensively metabolized in the liver microsomes to more than 25 derivs., while considerably less than 5% of the ingested dose is excreted unchanged in the urine.  There is, however, considerable inter-individual variability in the handling of caffeine by the body, due to both environmental and genetic factors.  Evidence from in vitro studies provides a wealth of different cellular actions that could potentially contribute to the obsd. effects of caffeine in humans in vivo.  These include potentiation of muscle contractility via induction of sarcoplasmic reticulum calcium release, inhibition of phosphodiesterase isoenzymes and concomitant cyclic monophosphate accumulation, inhibition of glycogen phosphorylase enzymes in liver and muscle, non-selective adenosine receptor antagonism, stimulation of the cellular membrane sodium/potassium pump, impairment of phosphoinositide metab., as well as other, less thoroughly characterized actions.  Not all, however, seem to account for the obsd. effects in vivo, although a variable degree of contribution cannot be readily discounted on the basis of exptl. data.  The most physiol. relevant mechanism of action is probably the blockade of adenosine receptors, but evidence suggests that, at least under certain conditions, other biochem. mechanisms may also be operational.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wG3KDOhjELVg90H21EOLACvtfcHk0lgmtCq23FOddA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlakt7%252FP&md5=78c8ace2edd019067154b02c839ef9db</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1080%2F1040-830491379245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1040-830491379245%26sid%3Dliteratum%253Aachs%26aulast%3DMagkos%26aufirst%3DF.%26aulast%3DKavouras%26aufirst%3DS.%2BA.%26atitle%3DCaffeine%2520Use%2520in%2520Sports%252C%2520Pharmacokinetics%2520in%2520Man%252C%2520and%2520Cellular%2520Mechanisms%2520of%2520Action%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2005%26volume%3D45%26issue%3D7%25E2%2580%25938%26spage%3D535%26epage%3D562%26doi%3D10.1080%2F1040-830491379245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span>; <span class="NLM_string-name">Wei, H.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease</span>.  <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, in press. <span class="refDoi"> DOI: 10.1007/s10571-020-00936-w</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs10571-020-00936-w" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Sun&author=H.+Wei&title=Ryanodine+Receptors%3A+A+Potential+Treatment+Target+in+Various+Neurodegenerative+Disease&doi=10.1007%2Fs10571-020-00936-w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1007%2Fs10571-020-00936-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-020-00936-w%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DRyanodine%2520Receptors%253A%2520A%2520Potential%2520Treatment%2520Target%2520in%2520Various%2520Neurodegenerative%2520Disease%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2020%26doi%3D10.1007%2Fs10571-020-00936-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaaban, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos-Platt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilles, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Girolami, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engle, E. C.</span></span> <span> </span><span class="NLM_article-title">RYR1Mutations as a Cause of Ophthalmoplegia, Facial Weakness, and Malignant Hyperthermia</span>. <i>JAMA Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1532</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.1001/jamaophthalmol.2013.4392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjamaophthalmol.2013.4392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24091937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Slsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2013&pages=1532-1540&issue=12&author=S.+Shaabanauthor=L.+Ramos-Plattauthor=F.+H.+Gillesauthor=W.+M.+Chanauthor=C.+Andrewsauthor=U.+De+Girolamiauthor=J.+Demerauthor=E.+C.+Engle&title=RYR1Mutations+as+a+Cause+of+Ophthalmoplegia%2C+Facial+Weakness%2C+and+Malignant+Hyperthermia&doi=10.1001%2Fjamaophthalmol.2013.4392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">RYB1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia</span></div><div class="casAuthors">Shaaban, Sherin; Ramos-Platt, Leigh; Gilles, Floyd H.; Chan, Wai-Man; Andrews, Caroline; De Girolami, Umberto; Demer, Joseph; Engle, Elizabeth C.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA Ophthalmology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1532-1540</span>CODEN:
                <span class="NLM_cas:coden">JOAPB7</span>;
        ISSN:<span class="NLM_cas:issn">2168-6165</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Importance: Total ophthalmoplegia can result from ryanodine receptor 1 (RYR1) mutations without overt assocd. skeletal myopathy.  Patients carrying RYR1 mutations are at high risk of developing malignant hyperthermia.  Ophthalmologists should be familiar with these important clin. assocns.  Objective: To det. the genetic cause of congenital ptosis, ophthalmoplegia, facial paralysis, and mild hypotonia segregating in 2 pedigrees diagnosed with atypical Moebius syndrome or congenital fibrosis of the extraocular muscles.  Design, setting, and participants: Clin. data including medical and family histories were collected at research labs. at Boston Children's Hospital and Jules Stein Eye Institute (Engle and Demer labs) for affected and unaffected family members from 2 pedigrees in which patients presented with total ophthalmoplegia, facial weakness, and myopathy.  Intervention Homozygosity mapping and whole-exome sequencing were conducted to identify causative mutations in affected family members.  Histories, phys. examns., and clin. data were reviewed.  Main outcome and measure: Mutations in RYR1.  Results: Missense mutations resulting in 2 homozygous RYR1 amino acid substitutions (E989G and R3772W) and 2 compd. heterozygous RYR1 substitutions (H283R and R3772W) were identified in a consanguineous and a nonconsanguineous pedigree, resp.  Orbital magnetic resonance imaging revealed marked hypoplasia of extraocular muscles and intraorbital cranial nerves.  Skeletal muscle biopsy specimens revealed nonspecific myopathic changes.  Clin., the patients' ophthalmoplegia and facial weakness were far more significant than their hypotonia and limb weakness and were accompanied by an unrecognized susceptibility to malignant hyperthermia.  Conclusions and relevance: Affected children presenting with severe congenital ophthalmoplegia and facial weakness in the setting of only mild skeletal myopathy harbored recessive mutations in RYR1, encoding the ryanodine receptor 1, and were susceptible to malignant hyperthermia.  While ophthalmoplegia occurs rarely in RYR1-related myopathies, these children were atypical because they lacked significant weakness, respiratory insufficiency, orscoliosis.  RYR1-assocd. myopathies should be included in the differential diagnosis of congenital ophthalmoplegia and facial weakness, even without clin. skeletal myopathy.  These patients should also be considered susceptible to malignant hyperthermia, a life-threatening anesthetic complication avoidable if anticipated presurgically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HKzsbF-fSLVg90H21EOLACvtfcHk0lgmtCq23FOddA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Slsw%253D%253D&md5=5a032ff9eab9370f3b642c85574aeb71</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1001%2Fjamaophthalmol.2013.4392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaophthalmol.2013.4392%26sid%3Dliteratum%253Aachs%26aulast%3DShaaban%26aufirst%3DS.%26aulast%3DRamos-Platt%26aufirst%3DL.%26aulast%3DGilles%26aufirst%3DF.%2BH.%26aulast%3DChan%26aufirst%3DW.%2BM.%26aulast%3DAndrews%26aufirst%3DC.%26aulast%3DDe%2BGirolami%26aufirst%3DU.%26aulast%3DDemer%26aufirst%3DJ.%26aulast%3DEngle%26aufirst%3DE.%2BC.%26atitle%3DRYR1Mutations%2520as%2520a%2520Cause%2520of%2520Ophthalmoplegia%252C%2520Facial%2520Weakness%252C%2520and%2520Malignant%2520Hyperthermia%26jtitle%3DJAMA%2520Ophthalmol.%26date%3D2013%26volume%3D131%26issue%3D12%26spage%3D1532%26epage%3D1540%26doi%3D10.1001%2Fjamaophthalmol.2013.4392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawal, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witherspoon, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bönnemann, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meilleur, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, R. T.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor 1-Related Disorders: An Historical Perspective and Proposal for a Unified Nomenclature</span>. <i>Skeletal Muscle</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>, <span class="refDoi"> DOI: 10.1186/s13395-020-00243-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs13395-020-00243-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33190635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFOrs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=32&issue=1&author=T.+A.+Lawalauthor=J.+J.+Toddauthor=J.+W.+Witherspoonauthor=C.+G.+B%C3%B6nnemannauthor=J.+J.+Dowlingauthor=S.+L.+Hamiltonauthor=K.+G.+Meilleurauthor=R.+T.+Dirksen&title=Ryanodine+Receptor+1-Related+Disorders%3A+An+Historical+Perspective+and+Proposal+for+a+Unified+Nomenclature&doi=10.1186%2Fs13395-020-00243-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature</span></div><div class="casAuthors">Lawal, Tokunbor A.; Todd, Joshua J.; Witherspoon, Jessica W.; Bonnemann, Carsten G.; Dowling, James J.; Hamilton, Susan L.; Meilleur, Katherine G.; Dirksen, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Skeletal Muscle</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32</span>CODEN:
                <span class="NLM_cas:coden">SMKUAK</span>;
        ISSN:<span class="NLM_cas:issn">2044-5040</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: The RYR1 gene, which encodes the sarcoplasmic reticulum calcium release channel or type 1 ryanodine receptor (RyR1) of skeletal muscle, was sequenced in 1988 and RYR1 variations that impair calcium homeostasis and increase susceptibility to malignant hyperthermia were first identified in 1991.  Since then, RYR1-related myopathies (RYR1-RM) have been described as rare, histopathol. and clin. heterogeneous, and slowly progressive neuromuscular disorders.  RYR1 variants can lead to dysfunctional RyR1-mediated calcium release, malignant hyperthermia susceptibility, elevated oxidative stress, deleterious post-translational modifications, and decreased RyR1 expression.  RYR1-RM-affected individuals can present with delayed motor milestones, contractures, scoliosis, ophthalmoplegia, and respiratory insufficiency.  Historically, RYR1-RM-affected individuals were diagnosed based on morphol. features obsd. in muscle biopsies including central cores, cores and rods, central nuclei, fiber type disproportion, and multi-minicores.  However, these histopathol. features are not always specific to RYR1-RM and often change over time.  As addnl. phenotypes were assocd. with RYR1 variations (including King-Denborough syndrome, exercise-induced rhabdomyolysis, lethal multiple pterygium syndrome, adult-onset distal myopathy, atypical periodic paralysis with or without myalgia, mild calf-predominant myopathy, and dusty core disease) the overlap among diagnostic categories is ever increasing.  With the continuing emergence of new clin. subtypes along the RYR1 disease spectrum and reports of adult-onset phenotypes, nuanced nomenclatures have been reported (RYR1- [related, related congenital, congenital] myopathies).  In this narrative review, we provide historical highlights of RYR1 research, accounts of the main diagnostic disease subtypes and propose RYR1-related disorders (RYR1-RD) as a unified nomenclature to describe this complex and evolving disease spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1p69qhbebr7Vg90H21EOLACvtfcHk0lgmtCq23FOddA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFOrs7fN&md5=ed3045f95d7d7ba0fddc21e40dd5d6df</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1186%2Fs13395-020-00243-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13395-020-00243-4%26sid%3Dliteratum%253Aachs%26aulast%3DLawal%26aufirst%3DT.%2BA.%26aulast%3DTodd%26aufirst%3DJ.%2BJ.%26aulast%3DWitherspoon%26aufirst%3DJ.%2BW.%26aulast%3DB%25C3%25B6nnemann%26aufirst%3DC.%2BG.%26aulast%3DDowling%26aufirst%3DJ.%2BJ.%26aulast%3DHamilton%26aufirst%3DS.%2BL.%26aulast%3DMeilleur%26aufirst%3DK.%2BG.%26aulast%3DDirksen%26aufirst%3DR.%2BT.%26atitle%3DRyanodine%2520Receptor%25201-Related%2520Disorders%253A%2520An%2520Historical%2520Perspective%2520and%2520Proposal%2520for%2520a%2520Unified%2520Nomenclature%26jtitle%3DSkeletal%2520Muscle%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D32%26doi%3D10.1186%2Fs13395-020-00243-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawal, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meilleur, K. G.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1007/s13311-018-00677-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs13311-018-00677-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30406384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB3cvnvVaksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=885-899&issue=4&author=T.+A.+Lawalauthor=J.+J.+Toddauthor=K.+G.+Meilleur&title=Ryanodine+Receptor+1-Related+Myopathies%3A+Diagnostic+and+Therapeutic+Approaches&doi=10.1007%2Fs13311-018-00677-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches</span></div><div class="casAuthors">Lawal Tokunbor A; Todd Joshua J; Meilleur Katherine G</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-899</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ryanodine receptor type 1-related myopathies (RYR1-RM) are the most common class of congenital myopathies.  Historically, RYR1-RM classification and diagnosis have been guided by histopathologic findings on muscle biopsy.  Main histological subtypes of RYR1-RM include central core disease, multiminicore disease, core-rod myopathy, centronuclear myopathy, and congenital fiber-type disproportion.  A range of RYR1-RM clinical phenotypes has also emerged more recently and includes King Denborough syndrome, RYR1 rhabdomyolysis-myalgia syndrome, atypical periodic paralysis, congenital neuromuscular disease with uniform type 1 fibers, and late-onset axial myopathy.  This expansion of the RYR1-RM disease spectrum is due, in part, to implementation of next-generation sequencing methods, which include the entire RYR1 coding sequence rather than being restricted to hotspot regions.  These methods enhance diagnostic capabilities, especially given historic limitations of histopathologic and clinical overlap across RYR1-RM.  Both dominant and recessive modes of inheritance have been documented, with the latter typically associated with a more severe clinical phenotype.  As with all congenital myopathies, no FDA-approved treatments exist to date.  Here, we review histopathologic, clinical, imaging, and genetic diagnostic features of the main RYR1-RM subtypes.  We also discuss the current state of treatments and focus on disease-modulating (nongenetic) therapeutic strategies under development for RYR1-RM.  Finally, perspectives for future approaches to treatment development are broached.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnjQX0Y77ZcbmQt-ICR3qNfW6udTcc2eZIkvZRQOaGhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvnvVaksQ%253D%253D&md5=4bd3c9e663cf88b2f2a8264f3df685a6</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1007%2Fs13311-018-00677-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-018-00677-1%26sid%3Dliteratum%253Aachs%26aulast%3DLawal%26aufirst%3DT.%2BA.%26aulast%3DTodd%26aufirst%3DJ.%2BJ.%26aulast%3DMeilleur%26aufirst%3DK.%2BG.%26atitle%3DRyanodine%2520Receptor%25201-Related%2520Myopathies%253A%2520Diagnostic%2520and%2520Therapeutic%2520Approaches%26jtitle%3DNeurotherapeutics%26date%3D2018%26volume%3D15%26issue%3D4%26spage%3D885%26epage%3D899%26doi%3D10.1007%2Fs13311-018-00677-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangopadhyay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parness, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemoto, N.</span></span> <span> </span><span class="NLM_article-title">Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">6580</span>– <span class="NLM_lpage">6587</span>, <span class="refDoi"> DOI: 10.1074/jbc.M408375200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1074%2Fjbc.M408375200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15611117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsV2qsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=6580-6587&issue=8&author=S.+Kobayashiauthor=M.+L.+Bannisterauthor=J.+P.+Gangopadhyayauthor=T.+Hamadaauthor=J.+Parnessauthor=N.+Ikemoto&title=Dantrolene+Stabilizes+Domain+Interactions+within+the+Ryanodine+Receptor&doi=10.1074%2Fjbc.M408375200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor</span></div><div class="casAuthors">Kobayashi, Shigeki; Bannister, Mark L.; Gangopadhyay, Jaya P.; Hamada, Tomoyo; Parness, Jerome; Ikemoto, Noriaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">6580-6587</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Interdomain interactions between N-terminal and central domains serving as a "domain switch" are believed to be essential to the functional regulation of the skeletal muscle ryanodine receptor-1 Ca2+ channel.  Mutational destabilization of the domain switch in malignant hyperthermia (MH), a genetic sensitivity to volatile anesthetics, causes functional instability of the channel.  Dantrolene, a drug used to treat MH, binds to a region within this proposed domain switch.  To explore its mechanism of action, the effect of dantrolene on MH-like channel activation by the synthetic domain peptide DP4 or anti-DP4 antibody was examd.  A fluorescence probe, methylcoumarin acetate, was covalently attached to the domain switch using DP4 as a delivery vehicle.  The magnitude of domain unzipping was detd. from the accessibility of methylcoumarin acetate to a macromol. fluorescence quencher.  The Stern-Volmer quenching const. (Kq) increased with the addn. of DP4 or anti-DP4 antibody.  This increase was reversed by dantrolene at both 37 °C and 22 °C and was unaffected by calmodulin.  [3H]Ryanodine binding to the sarcoplasmic reticulum and activation of sarcoplasmic reticulum Ca2+ release, both measures of channel activation, were enhanced by DP4.  These activities were inhibited by dantrolene at 37 °C, yet required the presence of calmodulin at 22 °C.  These results suggest that the mechanism of action of dantrolene involves stabilization of domain-domain interactions within the domain switch, preventing domain unzipping-induced channel dysfunction.  We suggest that temp. and calmodulin primarily affect the coupling between the domain switch and the downstream mechanism of regulation of Ca2+ channel opening rather than the domain switch itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHRQCHl_S5tbVg90H21EOLACvtfcHk0ljKH8m0zTx6Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsV2qsLk%253D&md5=bf78a6332752bca9981e2b265298c0bf</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M408375200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M408375200%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DBannister%26aufirst%3DM.%2BL.%26aulast%3DGangopadhyay%26aufirst%3DJ.%2BP.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DParness%26aufirst%3DJ.%26aulast%3DIkemoto%26aufirst%3DN.%26atitle%3DDantrolene%2520Stabilizes%2520Domain%2520Interactions%2520within%2520the%2520Ryanodine%2520Receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D8%26spage%3D6580%26epage%3D6587%26doi%3D10.1074%2Fjbc.M408375200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diszházi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, Z. É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mótyán, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csernoch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jóna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nánási, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almássy, J.</span></span> <span> </span><span class="NLM_article-title">Dantrolene Requires MG2+ and ATP to Inhibit the Ryanodine Receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>96</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1124/mol.119.116475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.119.116475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31337666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVCqsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2019&pages=401-407&issue=3&author=G.+Diszh%C3%A1ziauthor=Z.+%C3%89.+Magyarauthor=J.+A.+M%C3%B3ty%C3%A1nauthor=L.+Csernochauthor=I.+J%C3%B3naauthor=P.+P.+N%C3%A1n%C3%A1siauthor=J.+Alm%C3%A1ssy&title=Dantrolene+Requires+MG2%2B+and+ATP+to+Inhibit+the+Ryanodine+Receptor&doi=10.1124%2Fmol.119.116475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Dantrolene requires Mg2+ and ATP To inhibit the ryanodine receptor</span></div><div class="casAuthors">Diszhazi, Gyula; Magyar, Zsuzsanna Edua; Motyan, Janos Andras; Csernoch, Laszlo; Jona, Istvan; Nanasi, Peter Pal; Almassy, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-407</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome.  Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca2+ release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers.  Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purifn. procedure of RyR.  Recently, Mg2+ was demonstrated to be the essential factor for dantrolene to inhibit Ca2+ release in skinned muscle fibers.  The aim of the present study was to confirm these results in Ca2+ release and bilayer expts., using SR vesicles and solubilized channels, resp.  Our Ca2+ release expts. demonstrated that the effect of dantrolene and Mg2+ was cooperative and that ATP enhanced the inhibiting effect of dantrolene.  Namely, 10μM dantrolene reduced RyR channel open probability by ~ 50% in the presence of 3 mM free Mg2+ and 1 mM ATP, whereas channel activity further decreased to ~ 20% of control when [ATP] was increased to 2 mM.  Our data provide important complementary information that supports the direct, Mg2+-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGoZEK4fzkd7Vg90H21EOLACvtfcHk0ljKH8m0zTx6Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVCqsbrN&md5=b5d97a62139c30d22dd44b0280f71f66</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1124%2Fmol.119.116475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.119.116475%26sid%3Dliteratum%253Aachs%26aulast%3DDiszh%25C3%25A1zi%26aufirst%3DG.%26aulast%3DMagyar%26aufirst%3DZ.%2B%25C3%2589.%26aulast%3DM%25C3%25B3ty%25C3%25A1n%26aufirst%3DJ.%2BA.%26aulast%3DCsernoch%26aufirst%3DL.%26aulast%3DJ%25C3%25B3na%26aufirst%3DI.%26aulast%3DN%25C3%25A1n%25C3%25A1si%26aufirst%3DP.%2BP.%26aulast%3DAlm%25C3%25A1ssy%26aufirst%3DJ.%26atitle%3DDantrolene%2520Requires%2520MG2%252B%2520and%2520ATP%2520to%2520Inhibit%2520the%2520Ryanodine%2520Receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2019%26volume%3D96%26issue%3D3%26spage%3D401%26epage%3D407%26doi%3D10.1124%2Fmol.119.116475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, N.</span></span> <span> </span><span class="NLM_article-title">Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases</span>. <i>Curr. Protoc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e71</span> <span class="refDoi"> DOI: 10.1002/cpph.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcpph.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31834676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVyhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&issue=1&author=T.+Murayamaauthor=N.+Kurebayashi&title=Assays+for+Modulators+of+Ryanodine+Receptor+%28RyR%29%2FCa2%2B+Release+Channel+Activity+for+Drug+Discovery+for+Skeletal+Muscle+and+Heart+Diseases&doi=10.1002%2Fcpph.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases</span></div><div class="casAuthors">Murayama, Takashi; Kurebayashi, Nagomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Protocols in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e71</span>CODEN:
                <span class="NLM_cas:coden">CPPUCS</span>;
        ISSN:<span class="NLM_cas:issn">1934-8290</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The ryanodine receptor (RyR) is a Ca2+ release channel that is present in the sarcoplasmic reticulum and endoplasmic reticulum (ER) and that plays a central role in excitation-contraction coupling in skeletal and cardiac muscle.  Hyperactivation of RyR by genetic mutations or posttranslational modification can cause various skeletal muscle and arrhythmogenic heart diseases.  Inhibitors of RyR are therefore expected to be potential drugs for treatment of such diseases.  This article describes assays to evaluate RyR channel activity, including an ER Ca2+ measurement assay that is compatible with high-throughput screening and a [3H]-ryanodine binding assay that provides a quant. measure of RyR channel activity as a second screen for compd. hits by John Wiley & Sons, Inc.  Basic Protocol 1: [Ca2+]ER assay for ryanodine receptor (RyR) channel activity Support Protocol 1: Detn. of dose dependence and isoform selectivity of RyR inhibitors using [Ca2+]ER assay Basic Protocol 2: [3H]-Ryanodine binding assay for RyR channel activity Support Protocol 2: Isolation of microsomes from RyR-expressing HEK293 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzpPh_EWql3bVg90H21EOLACvtfcHk0lgZm-DXQ2pj2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVyhsA%253D%253D&md5=5d4b7b637c0cef86386a8e1c470abde3</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1002%2Fcpph.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpph.71%26sid%3Dliteratum%253Aachs%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DKurebayashi%26aufirst%3DN.%26atitle%3DAssays%2520for%2520Modulators%2520of%2520Ryanodine%2520Receptor%2520%2528RyR%2529%252FCa2%252B%2520Release%2520Channel%2520Activity%2520for%2520Drug%2520Discovery%2520for%2520Skeletal%2520Muscle%2520and%2520Heart%2520Diseases%26jtitle%3DCurr.%2520Protoc.%2520Pharmacol.%26date%3D2019%26volume%3D87%26issue%3D1%26doi%3D10.1002%2Fcpph.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigami-Yuasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akima, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanemaru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyamada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span> <span> </span><span class="NLM_article-title">Efficient High-Throughput Screening by Endoplasmic Reticulum Ca 2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca 2+ -Release Channels</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1124/mol.117.111468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.117.111468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29674523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVGgtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2018&pages=722-730&issue=1&author=T.+Murayamaauthor=N.+Kurebayashiauthor=M.+Ishigami-Yuasaauthor=S.+Moriauthor=Y.+Suzukiauthor=R.+Akimaauthor=H.+Ogawaauthor=J.+Suzukiauthor=K.+Kanemaruauthor=H.+Oyamadaauthor=Y.+Kiuchiauthor=M.+Iinoauthor=H.+Kagechikaauthor=T.+Sakurai&title=Efficient+High-Throughput+Screening+by+Endoplasmic+Reticulum+Ca+2%2B+Measurement+to+Identify+Inhibitors+of+Ryanodine+Receptor+Ca+2%2B+-Release+Channels&doi=10.1124%2Fmol.117.111468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+ -release channels</span></div><div class="casAuthors">Murayama, Takashi; Kurebayashi, Nagomi; Ishigami-Yuasa, Mari; Mori, Shuichi; Suzuki, Yukina; Akima, Ryunosuke; Ogawa, Haruo; Suzuki, Junji; Kanemaru, Kazunori; Oyamada, Hideto; Kiuchi, Yuji; Iino, Masamitsu; Kagechika, Hiroyuki; Sakurai, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">722-730</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Genetic mutations in ryanodine receptors (RyRs), Ca2+ -release channels in the sarcoplasmic reticulum essential for muscle contractions, cause various skeletal muscle and cardiac diseases.  Because the main underlying mechanism of the pathogenesis is overactive Ca2+ release by gain-of-function of the RyR channel, inhibition of RyRs is expected to be a promising treatment of these diseases.  Here, to identify inhibitors specific to skeletal muscle type 1 RyR (RyR1), we developed a novel high-throughput screening (HTS) platform using time-lapse fluorescence measurement of Ca2+ concns. in the endoplasmic reticulum (ER) ([Ca2+]ER).  Because expression of RyR1 carrying disease-assocd. mutation reduces [Ca2+]ER in HEK293 cells through Ca2+ leakage from RyR1 channels, specific drugs that inhibit RyR1 will increase [Ca2+]ER by preventing such Ca2+ leakage.  RyR1 carrying the R2163C mutation and R-CEPIA1er, a genetically encoded ER Ca2+ indicator, were stably expressed in HEK293 cells, and timelapse fluorescence was measured using a fluorometer.  False positives were effectively excluded by using cells expressing wild-type (WT) RyR1.  By screening 1535 compds. in a library of well characterized drugs, we successfully identified four compds. that significantly increased [Ca2+]ER.  They include dantrolene, a known RyR1 inhibitor, and three structurally different compds.: oxolinic acid, 9-aminoacridine, and alexidine.  All the hit compds., except for oxolinic acid, inhibited [3H]ryanodine binding of WT and mutant RyR1.  Interestingly, they showed different dose dependencies and isoform specificities.  The highly quant. nature and good correlation with the channel activity validated this HTS platform by [Ca2+]ER measurement to explore drugs for RyR-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFnmIb-2uFbLVg90H21EOLACvtfcHk0lgZm-DXQ2pj2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVGgtrbN&md5=3e1b82bea234058403fb5486dbc20349</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1124%2Fmol.117.111468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.117.111468%26sid%3Dliteratum%253Aachs%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DKurebayashi%26aufirst%3DN.%26aulast%3DIshigami-Yuasa%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DAkima%26aufirst%3DR.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DJ.%26aulast%3DKanemaru%26aufirst%3DK.%26aulast%3DOyamada%26aufirst%3DH.%26aulast%3DKiuchi%26aufirst%3DY.%26aulast%3DIino%26aufirst%3DM.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DSakurai%26aufirst%3DT.%26atitle%3DEfficient%2520High-Throughput%2520Screening%2520by%2520Endoplasmic%2520Reticulum%2520Ca%25202%252B%2520Measurement%2520to%2520Identify%2520Inhibitors%2520of%2520Ryanodine%2520Receptor%2520Ca%25202%252B%2520-Release%2520Channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2018%26volume%3D94%26issue%3D1%26spage%3D722%26epage%3D730%26doi%3D10.1124%2Fmol.117.111468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebbeck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essawy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitu, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillispie, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bers, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornea, R. L.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1177/1087057116674312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1177%2F1087057116674312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27760856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=176-186&issue=2&author=R.+T.+Rebbeckauthor=M.+M.+Essawyauthor=F.+R.+Nituauthor=B.+D.+Grantauthor=G.+D.+Gillispieauthor=D.+D.+Thomasauthor=D.+M.+Bersauthor=R.+L.+Cornea&title=High-Throughput+Screens+to+Discover+Small-Molecule+Modulators+of+Ryanodine+Receptor+Calcium+Release+Channels&doi=10.1177%2F1087057116674312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels</span></div><div class="casAuthors">Rebbeck, Robyn T.; Essawy, Maram M.; Nitu, Florentin R.; Grant, Benjamin D.; Gillispie, Gregory D.; Thomas, David D.; Bers, Donald M.; Cornea, Razvan L.</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-186</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Using time-resolved fluorescence resonance energy transfer (FRET), we have developed and validated the first high-throughput screening (HTS) method to discover compds. that modulate an intracellular Ca2+ channel, the ryanodine receptor (RyR), for therapeutic applications.  Intracellular Ca2+ regulation is crit. for striated muscle function, and RyR is a central player.  At resting [Ca2+], an increased propensity of channel opening due to RyR dysregulation is assocd. with severe cardiac and skeletal myopathies, diabetes, and neurol. disorders.  This leaky state of the RyR is an attractive target for pharmacol. agents to treat such pathologies.  Our FRET-based HTS detects RyR binding of accessory proteins calmodulin (CaM) or FKBP12.6.  Under conditions that mimic a pathol. state, we carried out a screen of the 727-compd. NIH Clin. Collection, which yielded six compds. that reproducibly changed FRET by >3 SD.  Dose-response of FRET and [3H]ryanodine binding readouts reveal that five hits reproducibly alter RyR1 structure and activity.  One compd. increased FRET and inhibited RyR1, which was only significant at nM [Ca2+], and accentuated without CaM present.  These properties characterize a compd. that could mitigate RyR1 leak.  An excellent Z' factor and the tight correlation between structural and functional readouts validate this first HTS method to identify RyR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq49RRx7DV_OLVg90H21EOLACvtfcHk0lgZm-DXQ2pj2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKks7g%253D&md5=7cb6c96a25212ff69c187245097a2d57</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1177%2F1087057116674312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057116674312%26sid%3Dliteratum%253Aachs%26aulast%3DRebbeck%26aufirst%3DR.%2BT.%26aulast%3DEssawy%26aufirst%3DM.%2BM.%26aulast%3DNitu%26aufirst%3DF.%2BR.%26aulast%3DGrant%26aufirst%3DB.%2BD.%26aulast%3DGillispie%26aufirst%3DG.%2BD.%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DBers%26aufirst%3DD.%2BM.%26aulast%3DCornea%26aufirst%3DR.%2BL.%26atitle%3DHigh-Throughput%2520Screens%2520to%2520Discover%2520Small-Molecule%2520Modulators%2520of%2520Ryanodine%2520Receptor%2520Calcium%2520Release%2520Channels%26jtitle%3DSLAS%2520Discovery%26date%3D2017%26volume%3D22%26issue%3D2%26spage%3D176%26epage%3D186%26doi%3D10.1177%2F1087057116674312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebbeck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janicek, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bers, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launikonis, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornea, R. L.</span></span> <span> </span><span class="NLM_article-title">RyR1-Targeted Drug Discovery Pipeline Integrating FRET-Based High-Throughput Screening and Human Myofiber Dynamic Ca2+ Assays</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1791</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-58461-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fs41598-020-58461-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=32019969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVWqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=1791&issue=1&author=R.+T.+Rebbeckauthor=D.+P.+Singhauthor=K.+A.+Janicekauthor=D.+M.+Bersauthor=D.+D.+Thomasauthor=B.+S.+Launikonisauthor=R.+L.+Cornea&title=RyR1-Targeted+Drug+Discovery+Pipeline+Integrating+FRET-Based+High-Throughput+Screening+and+Human+Myofiber+Dynamic+Ca2%2B+Assays&doi=10.1038%2Fs41598-020-58461-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca2+ assays</span></div><div class="casAuthors">Rebbeck, Robyn T.; Singh, Daniel P.; Janicek, Kevyn A.; Bers, Donald M.; Thomas, David D.; Launikonis, Bradley S.; Cornea, Razvan L.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1791</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Elevated cytoplasmic [Ca2+] is characteristic in severe skeletal and cardiac myopathies, diabetes, and neurodegeneration, and partly results from increased Ca2+ leak from sarcoplasmic reticulum stores via dysregulated ryanodine receptor (RyR) channels.  Consequently, RyR is recognized as a high-value target for drug discovery to treat such pathologies.  Using a FRET-based high-throughput screening assay that we previously reported, we identified small-mol. compds. that modulate the skeletal muscle channel isoform (RyR1) interaction with calmodulin and FK506 binding protein 12.6.  Two such compds., chloroxine and myricetin, increase FRET and inhibit [3H]ryanodine binding to RyR1 at nanomolar Ca2+.  Both compds. also decrease RyR1 Ca2+ leak in human skinned skeletal muscle fibers.  Furthermore, we identified compd. concns. that reduced leak by > 50% but only slightly affected Ca2+ release in excitation-contraction coupling, which is essential for normal muscle contraction.  This report demonstrates a pipeline that effectively filters small-mol. RyR1 modulators towards clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9YDeOX50NT7Vg90H21EOLACvtfcHk0lgZNSpBw0B5xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVWqtrk%253D&md5=392c447e24fc668a1970f4f282921519</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-58461-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-58461-1%26sid%3Dliteratum%253Aachs%26aulast%3DRebbeck%26aufirst%3DR.%2BT.%26aulast%3DSingh%26aufirst%3DD.%2BP.%26aulast%3DJanicek%26aufirst%3DK.%2BA.%26aulast%3DBers%26aufirst%3DD.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DLaunikonis%26aufirst%3DB.%2BS.%26aulast%3DCornea%26aufirst%3DR.%2BL.%26atitle%3DRyR1-Targeted%2520Drug%2520Discovery%2520Pipeline%2520Integrating%2520FRET-Based%2520High-Throughput%2520Screening%2520and%2520Human%2520Myofiber%2520Dynamic%2520Ca2%252B%2520Assays%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D1791%26doi%3D10.1038%2Fs41598-020-58461-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iinuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigami-Yuasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span> <span> </span><span class="NLM_article-title">Structural Development of a Type-1 Ryanodine Receptor (RyR1) Ca2+-Release Channel Inhibitor Guided by Endoplasmic Reticulum Ca2+ Assay</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.06.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ejmech.2019.06.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31299492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKltLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2019&pages=837-848&author=S.+Moriauthor=H.+Iinumaauthor=N.+Manakaauthor=M.+Ishigami-Yuasaauthor=T.+Murayamaauthor=Y.+Nishijimaauthor=A.+Sakuraiauthor=R.+Araiauthor=N.+Kurebayashiauthor=T.+Sakuraiauthor=H.+Kagechika&title=Structural+Development+of+a+Type-1+Ryanodine+Receptor+%28RyR1%29+Ca2%2B-Release+Channel+Inhibitor+Guided+by+Endoplasmic+Reticulum+Ca2%2B+Assay&doi=10.1016%2Fj.ejmech.2019.06.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay</span></div><div class="casAuthors">Mori, Shuichi; Iinuma, Hiroto; Manaka, Noriaki; Ishigami-Yuasa, Mari; Murayama, Takashi; Nishijima, Yoshiaki; Sakurai, Akiko; Arai, Ryota; Kurebayashi, Nagomi; Sakurai, Takashi; Kagechika, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">837-848</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Type-1 ryanodine receptor (RyR1) is a calcium-release channel localized on sarcoplasmic reticulum (SR) of the skeletal muscle, and mediates muscle contraction by releasing Ca2+ from the SR.  Genetic mutations of RyR1 are assocd. with skeletal muscle diseases such as malignant hyperthermia and central core diseases, in which over-activation of RyR1 causes leakage of Ca2+ from the SR.  We recently developed an efficient high-throughput screening system based on the measurement of Ca2+ in endoplasmic reticulum, and used it to identify oxolinic acid (1) as a novel RyR1 channel inhibitor.  Here, we designed and synthesized a series of quinolone derivs. based on 1 as a lead compd.  Derivs. bearing a long alkyl chain at the nitrogen atom of the quinolone ring and having a suitable substituent at the 7-position of quinolone exhibited potent RyR1 channel-inhibitory activity.  Among the synthesized compds., 14h showed more potent activity than dantrolene, a known RyR1 inhibitor, and exhibited high RyR1 selectivity over RyR2 and RyR3.  These compds. may be promising leads for clin. applicable RyR1 channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofK-KQdzPVg7Vg90H21EOLACvtfcHk0lgZNSpBw0B5xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKltLrP&md5=109b86328b161ee79c377d3a773cadc8</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.06.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.06.076%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DS.%26aulast%3DIinuma%26aufirst%3DH.%26aulast%3DManaka%26aufirst%3DN.%26aulast%3DIshigami-Yuasa%26aufirst%3DM.%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DNishijima%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DArai%26aufirst%3DR.%26aulast%3DKurebayashi%26aufirst%3DN.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DStructural%2520Development%2520of%2520a%2520Type-1%2520Ryanodine%2520Receptor%2520%2528RyR1%2529%2520Ca2%252B-Release%2520Channel%2520Inhibitor%2520Guided%2520by%2520Endoplasmic%2520Reticulum%2520Ca2%252B%2520Assay%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D179%26spage%3D837%26epage%3D848%26doi%3D10.1016%2Fj.ejmech.2019.06.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, C. C.</span></span> <span> </span><span class="NLM_article-title">The Insecticide Chlorantraniliprole Is a Weak Activator of Mammalian Skeletal Ryanodine Receptor/Ca 2+ Release Channel</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>508</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.11.180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bbrc.2018.11.180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30527809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSnsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2019&pages=633-639&issue=2&author=J.+Chenauthor=L.+Xueauthor=R.+Weiauthor=S.+Liuauthor=C.+C.+Yin&title=The+Insecticide+Chlorantraniliprole+Is+a+Weak+Activator+of+Mammalian+Skeletal+Ryanodine+Receptor%2FCa+2%2B+Release+Channel&doi=10.1016%2Fj.bbrc.2018.11.180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">The insecticide chlorantraniliprole is a weak activator of mammalian skeletal ryanodine receptor/Ca2+ release channel</span></div><div class="casAuthors">Chen, Jian; Xue, Liang; Wei, Risheng; Liu, Shangzhong; Yin, Chang-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">633-639</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chlorantraniliprobe (Chlo), a potent insecticide, demolishes intracellular Ca2+ homeostasis of insects by inducing uncontrolled Ca2+ release through ryanodine receptors (RyRs).  Chlo is lethal to insects but has low toxicity to mammals.  In this study, we investigated the effects of Chlo on RyR1 from mammalian skeletal muscle.  Ca2+ release assay indicated that Chlo at high concns. promoted Ca2+ release from sarcoplasmic reticulum through RyR1 channels.  Single channel recording of purified RyR1 showed that Chlo activated RyR1 channel, increased channel open probability Po, reduced channel mean close time Tc, but did not change the channel mean open time To, suggesting that Chlo destabilized the closed RyR1 channel, rendered the channel easy to open.  The dissocn. const. Kd values of Chlo for RyR1 were of micromolar level, approx. 100-fold larger than that for insect RyR.  The Kd values were smaller for open states than for closed/blocked states of the RyR1 channel.  The maximal binding capacity Bmax did not change in the presence of either channel activators or inhibitors/blockers.  Our results demonstrate that the insecticide Chlo is a weak activator of mammalian RyR1.  It can interact with mammalian RyR1 and activate RyR1 channel but with much lower affinity compared with insect RyR; Chlo has a binding site distinct from all known RyR channel modulators and represents a novel type of RyR channel modulator.  Our data provide biochem. and pharmacol. insights into its high specificity to insect RyR and high selectivity of poisoning to insects over mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4TKEDjR1hoLVg90H21EOLACvtfcHk0lgZNSpBw0B5xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSnsL3P&md5=0f46200977b88b1f3522d76a57256a63</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.11.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.11.180%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYin%26aufirst%3DC.%2BC.%26atitle%3DThe%2520Insecticide%2520Chlorantraniliprole%2520Is%2520a%2520Weak%2520Activator%2520of%2520Mammalian%2520Skeletal%2520Ryanodine%2520Receptor%252FCa%25202%252B%2520Release%2520Channel%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2019%26volume%3D508%26issue%3D2%26spage%3D633%26epage%3D639%26doi%3D10.1016%2Fj.bbrc.2018.11.180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Sylvester, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juettner, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copello, J. A.</span></span> <span> </span><span class="NLM_article-title">Eudistomin D and Penaresin Derivatives as Modulators of Ryanodine Receptor Channels and Sarcoplasmic Reticulum Ca2+ ATPase in Striated Muscle</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.113.089342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24423447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=564-575&issue=4&author=P.+L.+Diaz-Sylvesterauthor=M.+Portaauthor=V.+V.+Juettnerauthor=Y.+Lvauthor=S.+Fleischerauthor=J.+A.+Copello&title=Eudistomin+D+and+Penaresin+Derivatives+as+Modulators+of+Ryanodine+Receptor+Channels+and+Sarcoplasmic+Reticulum+Ca2%2B+ATPase+in+Striated+Muscle&doi=10.1124%2Fmol.113.089342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Eudistomin D and penaresin derivatives as modulators of ryanodine receptor channels and sarcoplasmic reticulum Ca2+ ATPase in striated muscle</span></div><div class="casAuthors">Diaz-Sylvester, Paula L.; Porta, Maura; Juettner, Vanessa V.; Lv, Yuanzhao; Fleischer, Sidney; Copello, Julio A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-575, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Eudistomin D (EuD) and penaresin (Pen) derivs. are bioactive alkaloids from marine sponges found to induce Ca2+ release from striated muscle sarcoplasmic reticulum (SR).  Although these alkaloids are believed to affect ryanodine receptor (RyR) gating in a "caffeine-like" manner, no single-channel study confirmed this assumption.  Here, EuD and MBED (9-methyl-7-bromoeudistomin D) were contrasted against caffeine on their ability to modulate the SR Ca2+ loading/leak from cardiac and skeletal muscle SR microsomes as well as the function of RyRs in planar bilayers.  The effects of these alkaloids on [3H]ryanodine binding and SR Ca2+ ATPase (SERCA) activity were also tested.  MBED (1-5 μM) fully mimicked maximal activating effects of caffeine (20 mM) on SR Ca2+ leak.  At the single-channel level, MBED mimicked the agonistic action of caffeine on cardiac RyR gating (i.e., stabilized long openings characteristic of "high-open-probability" mode).  EuD was a partial agonist at the maximal doses tested.  The tested Pen derivs. displayed mild to no agonism on RyRs, SR Ca2+ leak, or [3H]ryanodine binding studies.  Unlike caffeine, EuD and some Pen derivs. significantly inhibited SERCA at concns. required to modulate RyRs.  Instead, MBED's affinity for RyRs (EC50 ∼ 0.5 μM)wasmuch larger than forSERCA (IC50>285 μM).  In conclusion, MBED is a potent RyR agonist and, potentially, a better choice than caffeine for microsomal and cell studies due to its reported lack of effects on adenosine receptors and phosphodiesterases.  As a high-affinity caffeine-like probe, MBED could also help identify the caffeine-binding site in RyRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94X4V1opkCrVg90H21EOLACvtfcHk0ljXw4Uyj01tBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVyntbk%253D&md5=4eb34b00a4ca2d4b8e8c1e5f84be3179</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089342%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz-Sylvester%26aufirst%3DP.%2BL.%26aulast%3DPorta%26aufirst%3DM.%26aulast%3DJuettner%26aufirst%3DV.%2BV.%26aulast%3DLv%26aufirst%3DY.%26aulast%3DFleischer%26aufirst%3DS.%26aulast%3DCopello%26aufirst%3DJ.%2BA.%26atitle%3DEudistomin%2520D%2520and%2520Penaresin%2520Derivatives%2520as%2520Modulators%2520of%2520Ryanodine%2520Receptor%2520Channels%2520and%2520Sarcoplasmic%2520Reticulum%2520Ca2%252B%2520ATPase%2520in%2520Striated%2520Muscle%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26issue%3D4%26spage%3D564%26epage%3D575%26doi%3D10.1124%2Fmol.113.089342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oikonomakos, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skamnaki, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsitsanou, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavalas, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span> <span> </span><span class="NLM_article-title">A New Allosteric Site in Glycogen Phosphorylase b as a Target for Drug Interactions</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(00)00144-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0969-2126%2800%2900144-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10873856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Kktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=575-584&issue=6&author=N.+G.+Oikonomakosauthor=V.+T.+Skamnakiauthor=K.+E.+Tsitsanouauthor=N.+G.+Gavalasauthor=L.+N.+Johnson&title=A+New+Allosteric+Site+in+Glycogen+Phosphorylase+b+as+a+Target+for+Drug+Interactions&doi=10.1016%2FS0969-2126%2800%2900144-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">A new allosteric site in glycogen phosphorylase b as a target for drug interactions</span></div><div class="casAuthors">Oikonomakos, Nikos G.; Skamnaki, Vicky T.; Tsitsanou, Katerina E.; Gavalas, Nikos G.; Johnson, Louise N.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">575-584</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: In muscle and liver, glycogen concns. are regulated by the coordinated activities of glycogen phosphorylase (GP) and glycogen synthase.  GP exists in two forms: the dephosphorylated low-activity form GPb and the phosphorylated high-activity form GPa.  In both forms, allosteric effectors can promote equil. between a less active T state and a more active R state.  GP is a possible target for drugs that aim to prevent unwanted glycogen breakdown and to stimulate glycogen synthesis in non-insulin-dependent diabetes.  As a result of a data bank search, 5-chloro-1H-indole-2-carboxylic acid (1-(4-fluorobenzyl)-2-(4-hydroxypiperidin-1-yl)-2-oxoethyl)amide, CP320626, was identified as a potent inhibitor of human liver GP.  Structural studies have been carried out in order to establish the mechanism of this unusual inhibitor.  Results: The structure of the cocrystd. GPb-CP320626 complex has been detd. to 2.3 Å resoln.  CP320626 binds at a site located at the subunit interface in the region of the central cavity of the dimeric structure.  The site has not previously been obsd. to bind ligands and is some 15 Å from the AMP allosteric site and 33 Å from the catalytic site.  The contacts between GPb and CP320626 comprise six hydrogen bonds and extensive van der Waals interactions that create a tight binding site in the T-state conformation of GPb.  In the R-state conformation of GPa these interactions are significantly diminished.  Conclusions: CP320626 inhibits GPb by binding at a new allosteric site.  Although over 30 Å from the catalytic site, the inhibitor exerts its effects by stabilizing the T state at the expense of the R state and thereby shifting the allosteric equil. between the two states.  The new allosteric binding site offers a further recognition site in the search for improved GP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxgArGOkliWrVg90H21EOLACvtfcHk0ljXw4Uyj01tBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Kktbw%253D&md5=f04106a022d7bcb3013d131d4a974a10</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2900144-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252900144-1%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomakos%26aufirst%3DN.%2BG.%26aulast%3DSkamnaki%26aufirst%3DV.%2BT.%26aulast%3DTsitsanou%26aufirst%3DK.%2BE.%26aulast%3DGavalas%26aufirst%3DN.%2BG.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26atitle%3DA%2520New%2520Allosteric%2520Site%2520in%2520Glycogen%2520Phosphorylase%2520b%2520as%2520a%2520Target%2520for%2520Drug%2520Interactions%26jtitle%3DStructure%26date%3D2000%26volume%3D8%26issue%3D6%26spage%3D575%26epage%3D584%26doi%3D10.1016%2FS0969-2126%2800%2900144-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonka, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, D. J.</span></span> <span> </span><span class="NLM_article-title">The Effect of Glucose on the Sedimentation and Catalytic Activity of Glycogen Phosphorylase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(65)90895-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0006-291X%2865%2990895-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=14265745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaF2MXksFaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1965&pages=131-135&issue=1&author=J.+H.+Wangauthor=M.+L.+Shonkaauthor=D.+J.+Graves&title=The+Effect+of+Glucose+on+the+Sedimentation+and+Catalytic+Activity+of+Glycogen+Phosphorylase&doi=10.1016%2F0006-291X%2865%2990895-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of glucose on the sedimentation and catalytic activity of glycogen phosphorylase</span></div><div class="casAuthors">Wang, Jerry H.; Shonka, Mary Louise; Graves, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Phosphorylase activity was measured according to Krebs, et al. (CA 61, 5968e), and expressed as micromoles of PO43- released after 30 sec. of reaction.  Inclusion of 0.025M glucose in the assay inhibited phosphorylase a activity 60% at 20°; stimulation of activity by 3-fold could be achieved if the enzyme was preincubated in 0.05M glucose at 20°.  No increase in activity was observed with preincubation without glucose.  Two boundaries with s20,w of 8.9 and 13.9 S appeared during centrifugation at 20°with the enzyme in 0.05M glucose.  In the absence of glucose, only 13.9 S is evident.  These data suggest that activation is related to the conversion of the tetrameric form of phosphorylase a to dimeric species.  The incubation with glucose was unsuccessful at 30°.  Addn. of 0.032M glucose 1-phosphate (I) or 10-3M AMP to incubated enzyme results in a slow decrease of catalytic activity and a decrease in the amt. of the 8.9 S component.  AMP had the greater effect.  Activation and the relative amts. of the 2 components were dependent on concn. of glucose and I; with 0.16M I and 0.05M glucose at 20° no activation or 8.9 S component could be detected, suggesting that glucose and I compete for a single binding site.  Inhibition by AMP may be due to the binding of AMP to a different site, resulting in decreased affinity of enzyme for glucose and (or) decrease in the Km for I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowpGQWVkxrcLVg90H21EOLACvtfcHk0ljXw4Uyj01tBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXksFaruw%253D%253D&md5=776cd05cbbae6210835ccbc47abec3b7</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2865%2990895-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252865%252990895-8%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DShonka%26aufirst%3DM.%2BL.%26aulast%3DGraves%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Effect%2520of%2520Glucose%2520on%2520the%2520Sedimentation%2520and%2520Catalytic%2520Activity%2520of%2520Glycogen%2520Phosphorylase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1965%26volume%3D18%26issue%3D1%26spage%3D131%26epage%3D135%26doi%3D10.1016%2F0006-291X%2865%2990895-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardern, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loxham, S. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poucher, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, A. D.</span></span> <span> </span><span class="NLM_article-title">Sensitivity of Glycogen Phosphorylase Isoforms to Indole Site Inhibitors Is Markedly Dependent on the Activation State of the Enzyme</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.bjp.0706925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17016495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=775-785&issue=6&author=S.+Freemanauthor=J.+B.+Bartlettauthor=G.+Conveyauthor=I.+Hardernauthor=J.+L.+Teagueauthor=S.+J.+G.+Loxhamauthor=J.+M.+Allenauthor=S.+M.+Poucherauthor=A.+D.+Charles&title=Sensitivity+of+Glycogen+Phosphorylase+Isoforms+to+Indole+Site+Inhibitors+Is+Markedly+Dependent+on+the+Activation+State+of+the+Enzyme&doi=10.1038%2Fsj.bjp.0706925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme</span></div><div class="casAuthors">Freeman, S.; Bartlett, J. B.; Convey, G.; Hardern, I.; Teague, J. L.; Loxham, S. J. G.; Allen, J. M.; Poucher, S. M.; Charles, A. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of hepatic glycogen phosphorylase is a potential treatment for glycemic control in type 2 diabetes.  Selective inhibition of the liver phosphorylase isoform could minimize adverse effects in other tissues.  The authors investigated the potential selectivity of two indole site phosphorylase inhibitors, GPi688 and GPi819.  The activity of glycogen phosphorylase was modulated using the allosteric effectors glucose or caffeine to promote the less active T state, and AMP to promote the more active R state.  In vitro potency of indole site inhibitors against liver and muscle glycogen phosphorylase a was examd. at different effector concns. using purified recombinant enzymes.  The potency of GPi819 was compared with its in vivo efficacy at raising glycogen concns. in liver and muscle of Zucker (fa/fa) rats.  In vitro potency of indole site inhibitors depended upon the activity state of phosphorylase a.  Both inhibitors showed selectivity for liver phosphorylase a when the isoform specific activities were equal.  After 5 days dosing of GPi819 (37.5 μmol kg-1), where free compd. levels in plasma and tissue were at steady state, glycogen elevation was 1.5-fold greater in soleus muscle than in liver (P<0.05).  The in vivo selectivity of GPi819 did not match that seen in vitro when the specific activities of phosphorylase a isoforms are equal.  This suggests T state promoters may be important physiol. regulators in skeletal muscle.  The greater efficacy of indole site inhibitors in skeletal muscle has implications for the overall safety profile of such drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_FYUITO7qMbVg90H21EOLACvtfcHk0lhGFp2szLi33g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbvM&md5=372b2bb8776afac052129887cac654f1</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706925%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DS.%26aulast%3DBartlett%26aufirst%3DJ.%2BB.%26aulast%3DConvey%26aufirst%3DG.%26aulast%3DHardern%26aufirst%3DI.%26aulast%3DTeague%26aufirst%3DJ.%2BL.%26aulast%3DLoxham%26aufirst%3DS.%2BJ.%2BG.%26aulast%3DAllen%26aufirst%3DJ.%2BM.%26aulast%3DPoucher%26aufirst%3DS.%2BM.%26aulast%3DCharles%26aufirst%3DA.%2BD.%26atitle%3DSensitivity%2520of%2520Glycogen%2520Phosphorylase%2520Isoforms%2520to%2520Indole%2520Site%2520Inhibitors%2520Is%2520Markedly%2520Dependent%2520on%2520the%2520Activation%2520State%2520of%2520the%2520Enzyme%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26issue%3D6%26spage%3D775%26epage%3D785%26doi%3D10.1038%2Fsj.bjp.0706925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriaud-Kolar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A. L.</span></span> <span> </span><span class="NLM_article-title">Glycogen Phosphorylase Inhibitors: A Patent Review (2008–2012)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1017</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.794790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1517%2F13543776.2013.794790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23627914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1017-1032&issue=8&author=N.+Gaboriaud-Kolarauthor=A.+L.+Skaltsounis&title=Glycogen+Phosphorylase+Inhibitors%3A+A+Patent+Review+%282008%E2%80%932012%29&doi=10.1517%2F13543776.2013.794790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen phosphorylase inhibitors: a patent review (2008 - 2012)</span></div><div class="casAuthors">Gaboriaud-Kolar, Nicolas; Skaltsounis, Alexios-Leandros</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1017-1032</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Glycogen phosphorylase (GP) is the enzyme responsible for the synthesis of glucose-1-phosphate, the source of energy for muscles and the rest of the body.  The binding of different ligands in catalytic or allosteric sites assures activation and deactivation of the enzyme.  A description of the regulation mechanism and the implications in glycogen metab. are given.  Areas covered: Deregulation of GP has been obsd. in diseases such as diabetes mellitus or cancers.  Therefore, it appears as an attractive therapeutic target for the treatment of such pathologies.  Nos. of inhibitors have been published in academic literature or patented in the last two decades.  This review presents the main patent claims published between 2008 and 2012.  Expert opinion: Good inhibitors with interesting IC50 and in vivo results are presented.  However, such therapeutic strategy raises questions and some answers are proposed to bring new insights in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHR9-NDBkHybVg90H21EOLACvtfcHk0lhGFp2szLi33g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsbzF&md5=4706aeb5cbacef7727fe06e52b505e55</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.794790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.794790%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriaud-Kolar%26aufirst%3DN.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26atitle%3DGlycogen%2520Phosphorylase%2520Inhibitors%253A%2520A%2520Patent%2520Review%2520%25282008%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26issue%3D8%26spage%3D1017%26epage%3D1032%26doi%3D10.1517%2F13543776.2013.794790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janda, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, K. C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Wnt Recognition by Frizzled</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>337</i></span> (<span class="NLM_issue">6090</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1126/science.1222879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1126%2Fscience.1222879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22653731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=59-64&issue=6090&author=C.+Y.+Jandaauthor=D.+Waghrayauthor=A.+M.+Levinauthor=C.+Thomasauthor=K.+C.+Garcia&title=Structural+Basis+of+Wnt+Recognition+by+Frizzled&doi=10.1126%2Fscience.1222879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Wnt Recognition by Frizzled</span></div><div class="casAuthors">Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6090</span>),
    <span class="NLM_cas:pages">59-64</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Wnts are lipid-modified morphogens that play crit. roles in development, principally through engagement of Frizzled receptors.  The 3.25 angstrom structure of Xenopus Wnt8 (XWnt8) in complex with mouse Frizzled-8 (Fz8) cysteine-rich domain (CRD) reveals an unusual two-domain Wnt structure, not obviously related to known protein folds, resembling a "hand" with "thumb" and "index" fingers extended to grasp the Fz8-CRD at two distinct binding sites.  One site is dominated by a palmitoleic acid lipid group projecting from serine 187 at the tip of Wnt's thumb into a deep groove in the Fz8-CRD.  In the second binding site, the conserved tip of Wnt's "index finger" forms hydrophobic amino acid contacts with a depression on the opposite side of the Fz8-CRD.  The conservation of amino acids in both interfaces appears to facilitate ligand-receptor cross-reactivity, which has important implications for understanding Wnt's functional pleiotropy and for developing Wnt-based drugs for cancer and regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKMgZd5hKMfLVg90H21EOLACvtfcHk0lhGFp2szLi33g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D&md5=8a32c44b73fe281cccedc285311759ce</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222879%26sid%3Dliteratum%253Aachs%26aulast%3DJanda%26aufirst%3DC.%2BY.%26aulast%3DWaghray%26aufirst%3DD.%26aulast%3DLevin%26aufirst%3DA.%2BM.%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DStructural%2520Basis%2520of%2520Wnt%2520Recognition%2520by%2520Frizzled%26jtitle%3DScience%26date%3D2012%26volume%3D337%26issue%3D6090%26spage%3D59%26epage%3D64%26doi%3D10.1126%2Fscience.1222879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawynok, J.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>152</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">726</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2010.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.pain.2010.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21041029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M3pvFCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=726-729&issue=4&author=J.+Sawynok&title=Caffeine+and+Pain&doi=10.1016%2Fj.pain.2010.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and pain</span></div><div class="casAuthors">Sawynok Jana</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">726-729</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrp1qUka64qOQ4Pl9hzjQhfW6udTcc2eb17V3oo76h6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3pvFCqsA%253D%253D&md5=8661c777a4201623d3177f96d5ad96eb</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DSawynok%26aufirst%3DJ.%26atitle%3DCaffeine%2520and%2520Pain%26jtitle%3DPain%26date%3D2011%26volume%3D152%26issue%3D4%26spage%3D726%26epage%3D729%26doi%3D10.1016%2Fj.pain.2010.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawynok, J.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Targets for Pain</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2015.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroscience.2015.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26500181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWrtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2016&pages=1-18&author=J.+Sawynok&title=Adenosine+Receptor+Targets+for+Pain&doi=10.1016%2Fj.neuroscience.2015.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor targets for pain</span></div><div class="casAuthors">Sawynok, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The main focus for the development of adenosine targets as analgesics to date has been A1Rs due to its antinociceptive profile in various preclin. pain models.  The usefulness of systemic A1R agonists may be limited by other effects (cardiovascular, motor), but enhanced selectivity for pain might occur with partial agonists, potent and highly selective agonists, or allosteric modulators.  A2AR agonists exhibit some peripheral pronociceptive effects, but also act on immune cells to suppress inflammation and on spinal glia to suppress pain signaling and may be useful for inflammatory and neuropathic pain.  A2BR agonists exhibit peripheral proinflammatory effects on immune cells, but also spinal antinociceptive effects similar to A2AR agonists.  A3Rs are now demonstrated to produce antinociception in several preclin. neuropathic pain models, with mechanistic actions on glial cells, and may be useful for neuropathic pain.  Endogenous adenosine levels can be augmented by inhibition of metab. (via adenosine kinase) or increased generation (via nucleotidases), and these approaches have implications for pain.  Endogenous adenosine contributes to antinociception by several pharmacol. agents, herbal remedies, acupuncture, transcutaneous elec. nerve stimulation, exercise, joint mobilization, and water immersion via spinal and/or peripheral effects, such that this system appears to constitute a major pain regulatory system.  Finally, caffeine inhibits A1-, A2A- and A3Rs with similar potency, and dietary caffeine intake will need attention in trials of: (a) agonists and/or modulators acting at these receptors, (b) some pharmacol. and herbal analgesics, and (c) manipulations that enhance endogenous adenosine levels, all of which are inhibited by caffeine and/or A1R antagonists in preclin. studies.  All adenosine receptors have effects on spinal glial cells in regulating nociception, and gender differences in the involvement of such cells in chronic neuropathic pain indicate gender may also need attention in preclin. and human trials evaluating the efficacy of adenosine-based analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQGeFtvKD2HLVg90H21EOLACvtfcHk0lj3OxRi_oPgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWrtb%252FJ&md5=753380b50c812db8e53e2d67f7e80818</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2015.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2015.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DSawynok%26aufirst%3DJ.%26atitle%3DAdenosine%2520Receptor%2520Targets%2520for%2520Pain%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D338%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.neuroscience.2015.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laska, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvers, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, A.</span></span> <span> </span><span class="NLM_article-title">Caffeine as an Analgesic Adjuvant</span>. <i>JAMA J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>251</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1001/jama.1984.03340370043028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.1984.03340370043028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6366275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL2c7jvFWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1984&pages=1711-1718&issue=13&author=E.+M.+Laskaauthor=A.+Sunshineauthor=F.+Muellerauthor=W.+B.+Elversauthor=C.+Siegelauthor=A.+Rubin&title=Caffeine+as+an+Analgesic+Adjuvant&doi=10.1001%2Fjama.1984.03340370043028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine as an analgesic adjuvant</span></div><div class="casAuthors">Laska E M; Sunshine A; Mueller F; Elvers W B; Siegel C; Rubin A</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1711-8</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">Thirty clinical studies involving more than 10,000 patients conducted during the last 20 years have been analyzed to assess the value of caffeine as an analgesic adjuvant.  Although most studies included patients with postpartum uterine cramping or episiotomy pain, some involved patients with pain from oral surgery or headache.  In 21 of 26 studies, the relative potency estimates of an analgesic with caffeine to an analgesic without caffeine is greater than one.  The pooled relative potency estimates in each of several major categories of combination analgesics are significantly greater than one.  The overall pooled relative potency estimate is 1.41, with 95% confidence limits of 1.23 to 1.63; that is, to obtain the same amount of response from an analgesic without caffeine requires a dose that is approximately 40% greater than one with caffeine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCcEoxVZT2GiA3UY9EwTNrfW6udTcc2eb5A0apwDgZObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7jvFWjtA%253D%253D&md5=e58efd67b06f2ea2b7a4f1328e757e54</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1001%2Fjama.1984.03340370043028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.1984.03340370043028%26sid%3Dliteratum%253Aachs%26aulast%3DLaska%26aufirst%3DE.%2BM.%26aulast%3DSunshine%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DF.%26aulast%3DElvers%26aufirst%3DW.%2BB.%26aulast%3DSiegel%26aufirst%3DC.%26aulast%3DRubin%26aufirst%3DA.%26atitle%3DCaffeine%2520as%2520an%2520Analgesic%2520Adjuvant%26jtitle%3DJAMA%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1984%26volume%3D251%26issue%3D13%26spage%3D1711%26epage%3D1718%26doi%3D10.1001%2Fjama.1984.03340370043028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camann, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mushlin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. H.</span></span> <span> </span><span class="NLM_article-title">Effects of Oral Caffeine on Postdural Puncture Headache. A Double-Blind, Placebo-Controlled Trial</span>. <i>Anesth. Analg.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1213/00000539-199002000-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1213%2F00000539-199002000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2405733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK3c7ksFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1990&pages=181-184&issue=2&author=W.+R.+Camannauthor=R.+S.+Murrayauthor=P.+S.+Mushlinauthor=D.+H.+Lambert&title=Effects+of+Oral+Caffeine+on+Postdural+Puncture+Headache.+A+Double-Blind%2C+Placebo-Controlled+Trial&doi=10.1213%2F00000539-199002000-00009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial</span></div><div class="casAuthors">Camann W R; Murray R S; Mushlin P S; Lambert D H</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia and analgesia</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-4</span>
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    </div><div class="casAbstract">Forty postpartum patients with postdural puncture headache (PDPH) were randomly assigned to receive oral caffeine (300 mg) or a placebo.  Intensity of headache, quantitated using a visual analogue pain scale (VAS), was assessed immediately before drug administration and 4 and 24 h later.  Relief of PDPH measured as delta VAS (initial VAS - VAS at 4 h) was significantly better in the caffeine than in the placebo group (P = 0.014).  Six patients (30%) whose PDPH was relieved by caffeine at 4 h had recurrence of symptoms the following day.  Our study demonstrates that caffeine administered orally provides relief, albeit if sometimes transient, from PDPH with minimal side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVPZePAWGMbskU0YCbOU3EfW6udTcc2eYWB4fiisyVfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7ksFKhsw%253D%253D&md5=665bdfbf57ca69c06b709169eda9aaa9</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1213%2F00000539-199002000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252F00000539-199002000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DCamann%26aufirst%3DW.%2BR.%26aulast%3DMurray%26aufirst%3DR.%2BS.%26aulast%3DMushlin%26aufirst%3DP.%2BS.%26aulast%3DLambert%26aufirst%3DD.%2BH.%26atitle%3DEffects%2520of%2520Oral%2520Caffeine%2520on%2520Postdural%2520Puncture%2520Headache.%2520A%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial%26jtitle%3DAnesth.%2520Analg.%26date%3D1990%26volume%3D70%26issue%3D2%26spage%3D181%26epage%3D184%26doi%3D10.1213%2F00000539-199002000-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sechzer, P. H.</span></span> <span> </span><span class="NLM_article-title">Post-Spinal Anesthesia Headache Treated with Caffeine. Part II: Intracranial Vascular Distention, a Key Factor</span>. <i>Curr. Ther. Res. - Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1979&pages=440-448&issue=4&author=P.+H.+Sechzer&title=Post-Spinal+Anesthesia+Headache+Treated+with+Caffeine.+Part+II%3A+Intracranial+Vascular+Distention%2C+a+Key+Factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSechzer%26aufirst%3DP.%2BH.%26atitle%3DPost-Spinal%2520Anesthesia%2520Headache%2520Treated%2520with%2520Caffeine.%2520Part%2520II%253A%2520Intracranial%2520Vascular%2520Distention%252C%2520a%2520Key%2520Factor%26jtitle%3DCurr.%2520Ther.%2520Res.%2520-%2520Clin.%2520Exp.%26date%3D1979%26volume%3D26%26issue%3D4%26spage%3D440%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrath, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pageler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span> <span> </span><span class="NLM_article-title">The Fixed Combination of Acetylsalicylic Acid, Paracetamol and Caffeine Is More Effective than Single Substances and Dual Combination for the Treatment of Headache: A Multicentre, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Parallel Group St</span>. <i>Cephalalgia</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1111/j.1468-2982.2005.00948.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1468-2982.2005.00948.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16162254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2MvptFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=776-787&issue=10&author=H.+C.+Dienerauthor=V.+Pfaffenrathauthor=L.+Pagelerauthor=H.+Peilauthor=B.+Aicher&title=The+Fixed+Combination+of+Acetylsalicylic+Acid%2C+Paracetamol+and+Caffeine+Is+More+Effective+than+Single+Substances+and+Dual+Combination+for+the+Treatment+of+Headache%3A+A+Multicentre%2C+Randomized%2C+Double-Blind%2C+Single-Dose%2C+Placebo-Controlled+Parallel+Group+St&doi=10.1111%2Fj.1468-2982.2005.00948.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study</span></div><div class="casAuthors">Diener H C; Pfaffenrath V; Pageler L; Peil H; Aicher B</div><div class="citationInfo"><span class="NLM_cas:title">Cephalalgia : an international journal of headache</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">776-87</span>
        ISSN:<span class="NLM_cas:issn">0333-1024</span>.
    </div><div class="casAbstract">We investigated efficacy, safety, and tolerability of two tablets of the fixed combination of 250 mg acetylsalicylic acid (ASA) + 200 mg paracetamol + 50 mg caffeine (Thomapyrin) in comparison with two tablets of 250 mg ASA + 200 mg paracetamol, two tablets of 500 mg ASA, two tablets of 500 mg paracetamol, two tablets of 50 mg caffeine, and placebo in patients who were used to treating their episodic tension-type headache or migraine attacks with non-prescription analgesics.  For the primary endpoint "time to 50% pain relief" in the intention-to-treat dataset (n = 1743 patients), the fixed combination of ASA, paracetamol and caffeine was statistically significantly superior to the combination without caffeine (P = 0.0181), the mono-substances ASA (P = 0.0398), paracetamol (P = 0.0016), caffeine (P < 0.0001) and placebo (P < 0.0001).  All active treatments except caffeine differed significantly (P < 0.0001) from placebo.  The superior efficacy of the triple combination could also be shown for all secondary endpoints such as time until reduction of pain intensity to 10 mm, weighted sum of pain intensity difference (%SPIDweighted), extent of impairment of daily activities, global assessment of efficacy.  All treatments were well tolerated.  The incidence of adverse events observed was low.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVaif3jmcvKy-bLEOO4dYpfW6udTcc2eYWB4fiisyVfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvptFGqtg%253D%253D&md5=376f63ffc3b7b19b26b1ac2b6de44632</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-2982.2005.00948.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-2982.2005.00948.x%26sid%3Dliteratum%253Aachs%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DPfaffenrath%26aufirst%3DV.%26aulast%3DPageler%26aufirst%3DL.%26aulast%3DPeil%26aufirst%3DH.%26aulast%3DAicher%26aufirst%3DB.%26atitle%3DThe%2520Fixed%2520Combination%2520of%2520Acetylsalicylic%2520Acid%252C%2520Paracetamol%2520and%2520Caffeine%2520Is%2520More%2520Effective%2520than%2520Single%2520Substances%2520and%2520Dual%2520Combination%2520for%2520the%2520Treatment%2520of%2520Headache%253A%2520A%2520Multicentre%252C%2520Randomized%252C%2520Double-Blind%252C%2520Single-Dose%252C%2520Placebo-Controlled%2520Parallel%2520Group%2520St%26jtitle%3DCephalalgia%26date%3D2005%26volume%3D25%26issue%3D10%26spage%3D776%26epage%3D787%26doi%3D10.1111%2Fj.1468-2982.2005.00948.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eichenwald, E. C.</span></span> <span> </span><span class="NLM_article-title">Apnea of Prematurity</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e20153757</span> <span class="refDoi"> DOI: 10.1542/peds.2015-3757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1542%2Fpeds.2015-3757" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2016&issue=1&author=E.+C.+Eichenwald&title=Apnea+of+Prematurity&doi=10.1542%2Fpeds.2015-3757"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1542%2Fpeds.2015-3757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1542%252Fpeds.2015-3757%26sid%3Dliteratum%253Aachs%26aulast%3DEichenwald%26aufirst%3DE.%2BC.%26atitle%3DApnea%2520of%2520Prematurity%26jtitle%3DPediatrics%26date%3D2016%26volume%3D137%26issue%3D1%26doi%3D10.1542%2Fpeds.2015-3757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson-Smart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Paoli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughton, D.</span></span> <span> </span><span class="NLM_article-title">Methylxanthine Treatment for Apnoea in Preterm Infants</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">CD000140</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD000140.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD000140.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=CD000140&issue=12&author=D.+J.+Henderson-Smartauthor=A.+G.+De+Paoliauthor=D.+Haughton&title=Methylxanthine+Treatment+for+Apnoea+in+Preterm+Infants&doi=10.1002%2F14651858.CD000140.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD000140.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD000140.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson-Smart%26aufirst%3DD.%2BJ.%26aulast%3DDe%2BPaoli%26aufirst%3DA.%2BG.%26aulast%3DHaughton%26aufirst%3DD.%26atitle%3DMethylxanthine%2520Treatment%2520for%2520Apnoea%2520in%2520Preterm%2520Infants%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2010%26volume%3D2010%26issue%3D12%26spage%3DCD000140%26doi%3D10.1002%2F14651858.CD000140.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrington, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solimano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tin, W.</span></span> <span> </span><span class="NLM_article-title">Caffeine Therapy for Apnea of Prematurity</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>354</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">2112</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa054065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1056%2FNEJMoa054065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16707748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=2112-2121&issue=20&author=B.+Schmidtauthor=R.+S.+Robertsauthor=P.+Davisauthor=L.+W.+Doyleauthor=K.+J.+Barringtonauthor=A.+Ohlssonauthor=A.+Solimanoauthor=W.+Tin&title=Caffeine+Therapy+for+Apnea+of+Prematurity&doi=10.1056%2FNEJMoa054065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine therapy for apnea of prematurity</span></div><div class="casAuthors">Schmidt, Barbara; Roberts, Robin S.; Davis, Peter; Doyle, Lex W.; Barrington, Keith J.; Ohisson, Arne; Solimano, Alfonso; Tin, Win</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2112-2121</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Methylxanthines reduce the frequency of apnea of prematurity and the need for mech. ventilation during the first seven days of therapy.  It is uncertain whether methylxanthines have other short- and long-term benefits or risks in infants with very low birth wt.  We randomly assigned 2006 infants with birth wts. of 500 to 1250 g during the first 10 days of life to receive either caffeine or placebo, until drug therapy for apnea of prematurity was no longer needed.  We evaluated the short-term outcomes before the first discharge home.  Of 963 infants who were assigned to caffeine and who remained alive at a postmenstrual age of 36 wk, 350 (36 %) received supplemental oxygen, as did 447 of the 954 infants (47 %) assigned to placebo (adjusted odds ratio, 0.63; 95 % confidence interval, 0.52 to 0.76; P < 0.001).  Pos. airway pressure was discontinued one week earlier in the infants assigned to caffeine (median postmenstrual age, 31.0 wk; interquartile range, 29.4 to 33.0) than in the infants in the placebo group (median postmenstrual age, 32.0 wk; interquartile range, 30.3 to 34.0; P < 0.001).  Caffeine reduced wt. gain temporarily.  The mean difference in wt. gain between the group receiving caffeine and the group receiving placebo was greatest after two weeks (mean difference, -23 g; 95 % confidence interval, -32 to -13; P < 0.001).  The rates of death, ultrasonog. signs of brain injury, and necrotizing enterocolitis did not differ significantly between the two groups.  Caffeine therapy for apnea of prematurity reduces the rate of bronchopulmonary dysplasia in infants with very low birth wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNSIdmBG-w6bVg90H21EOLACvtfcHk0lhB490ZUythqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCku7Y%253D&md5=f220f76e59c2997ad5c489ec96b02b55</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa054065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa054065%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DR.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DDoyle%26aufirst%3DL.%2BW.%26aulast%3DBarrington%26aufirst%3DK.%2BJ.%26aulast%3DOhlsson%26aufirst%3DA.%26aulast%3DSolimano%26aufirst%3DA.%26aulast%3DTin%26aufirst%3DW.%26atitle%3DCaffeine%2520Therapy%2520for%2520Apnea%2520of%2520Prematurity%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26issue%3D20%26spage%3D2112%26epage%3D2121%26doi%3D10.1056%2FNEJMoa054065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsted, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzma, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. L.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Cause-Specific Mortality Association with Age at Death and Compression of Mortality</span>. <i>J. Clin. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1016/0895-4356(92)90051-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0895-4356%2892%2990051-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1619453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK38zhsl2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1992&pages=733-742&issue=7&author=K.+D.+Lindstedauthor=J.+W.+Kuzmaauthor=J.+L.+Anderson&title=Coffee+Consumption+and+Cause-Specific+Mortality+Association+with+Age+at+Death+and+Compression+of+Mortality&doi=10.1016%2F0895-4356%2892%2990051-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality</span></div><div class="casAuthors">Lindsted K D; Kuzma J W; Anderson J L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical epidemiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">733-42</span>
        ISSN:<span class="NLM_cas:issn">0895-4356</span>.
    </div><div class="casAbstract">The relationship between reported coffee consumption and specific causes of death was examined in 9484 males enrolled in the Adventist Mortality Study in 1960 and followed through 1985.  Coffee consumption was divided into three levels: less than 1 cup per day, 1-2 cups per day, and greater than or equal to 3 cups per day.  Approximately one third of the subjects did not drink coffee.  Cause-specific mortality rates were compared using survival analysis including Cox's proportional hazard model, and controlling for potential confounders such as body mass index, heart disease and hypertension at baseline, race, physical activity, marital status, educational level, smoking history, and dietary pattern.  Inclusion of interaction terms between coffee consumption and attained age as time-dependent covariates allowed the hazard ratio to vary with age.  Univariate analyses showed a statistically significant association (p less than 0.05) for coffee consumption and mortality for most endpoints.  Multivariate analyses showed a small but statistically significant association between coffee consumption and mortality from ischemic heart disease, other cardiovascular diseases, all cardiovascular diseases, and all causes of death.  For the major causes of death, the hazard ratios decreased from about 2.5 at 30 years of age to 1.0 around 95 years of age.  These results indicate that abstinence from coffee leads to compression of mortality rather than an increase in lifespan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRU5pswIOAcyxjv2lLSLOxFfW6udTcc2eanz_4W8XJ7Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zhsl2ksA%253D%253D&md5=2fa8c808bf4130b53fc3d01ec01bcae9</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1016%2F0895-4356%2892%2990051-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0895-4356%252892%252990051-N%26sid%3Dliteratum%253Aachs%26aulast%3DLindsted%26aufirst%3DK.%2BD.%26aulast%3DKuzma%26aufirst%3DJ.%2BW.%26aulast%3DAnderson%26aufirst%3DJ.%2BL.%26atitle%3DCoffee%2520Consumption%2520and%2520Cause-Specific%2520Mortality%2520Association%2520with%2520Age%2520at%2520Death%2520and%2520Compression%2520of%2520Mortality%26jtitle%3DJ.%2520Clin.%2520Epidemiol.%26date%3D1992%26volume%3D45%26issue%3D7%26spage%3D733%26epage%3D742%26doi%3D10.1016%2F0895-4356%2892%2990051-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bidel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jousilahti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antikainen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuomilehto, J.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Risk of Total and Cardiovascular Mortality among Patients with Type 2 Diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2618</span>– <span class="NLM_lpage">2626</span>, <span class="refDoi"> DOI: 10.1007/s00125-006-0435-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00125-006-0435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17019600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2618-2626&issue=11&author=S.+Bidelauthor=G.+Huauthor=Q.+Qiaoauthor=P.+Jousilahtiauthor=R.+Antikainenauthor=J.+Tuomilehto&title=Coffee+Consumption+and+Risk+of+Total+and+Cardiovascular+Mortality+among+Patients+with+Type+2+Diabetes&doi=10.1007%2Fs00125-006-0435-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes</span></div><div class="casAuthors">Bidel, S.; Hu, G.; Qiao, Q.; Jousilahti, P.; Antikainen, R.; Tuomilehto, J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2618-2626</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Aims/hypothesis: Higher habitual coffee drinking has been assocd. with a lower risk of developing type 2 diabetes.  The relation between coffee consumption and risk of cardiovascular disease (CVD) has been examd. in many studies, but the issue remains controversial.  This study was designed to assess the assocn. between coffee consumption and CVD mortality among patients with type 2 diabetes.  Methods: We prospectively followed 3,837 randomly ascertained Finnish patients with type 2 diabetes aged 25 to 74 years.  Coffee consumption and other study parameters were detd. at baseline.  The International Classification of Diseases was used to identify CHD, CVD and stroke cases using computerized record linkage to the national Death Registry.  The assocns. between coffee consumption at baseline and risk of total, CVD, CHD, and stroke mortality were analyzed by using Cox proportional hazards models.  Results: During the av. follow-up of 20.8 years, 1,471 deaths were recorded, of which 909 were coded as CVD, 598 as CHD and 210 as stroke.  The resp. multivariate-adjusted hazard ratios in participants who drank 0-2, 3-4, 5-6, and ≥7 cups of coffee daily were 1.00, 0.77, 0.68 and 0.70 for total mortality (P<0.001 for trend), 1.00, 0.79, 0.70 and 0.71 for CVD mortality (P=0.006 for trend), 1.00, 0.78, 0.70 and 0.63 for CHD mortality (p=0.01 for trend), and 1.00, 0.77, 0.64 and 0.90 for stroke mortality (p=0.12 for trend).  Conclusions/interpretation: In this large prospective study we found that in type 2 diabetic patients coffee drinking is assocd. with reduced total, CVD and CHD mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1FT1Qo9pV9LVg90H21EOLACvtfcHk0lhB490ZUythqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrvP&md5=afea74c732ea9c3b2026c1151dfc3eeb</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1007%2Fs00125-006-0435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-006-0435-9%26sid%3Dliteratum%253Aachs%26aulast%3DBidel%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DJousilahti%26aufirst%3DP.%26aulast%3DAntikainen%26aufirst%3DR.%26aulast%3DTuomilehto%26aufirst%3DJ.%26atitle%3DCoffee%2520Consumption%2520and%2520Risk%2520of%2520Total%2520and%2520Cardiovascular%2520Mortality%2520among%2520Patients%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetologia%26date%3D2006%26volume%3D49%26issue%3D11%26spage%3D2618%26epage%3D2626%26doi%3D10.1007%2Fs00125-006-0435-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsugane, S.</span></span> <span> </span><span class="NLM_article-title">The Impact of Green Tea and Coffee Consumption on the Reduced Risk of Stroke Incidence in Japanese Population: The Japan Public Health Center-Based Study Cohort</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1374</span>, <span class="refDoi"> DOI: 10.1161/STROKEAHA.111.677500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FSTROKEAHA.111.677500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23493733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1ehtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=1369-1374&issue=5&author=Y.+Kokuboauthor=H.+Isoauthor=I.+Saitoauthor=K.+Yamagishiauthor=H.+Yatsuyaauthor=J.+Ishiharaauthor=M.+Inoueauthor=S.+Tsugane&title=The+Impact+of+Green+Tea+and+Coffee+Consumption+on+the+Reduced+Risk+of+Stroke+Incidence+in+Japanese+Population%3A+The+Japan+Public+Health+Center-Based+Study+Cohort&doi=10.1161%2FSTROKEAHA.111.677500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of Green Tea and Coffee Consumption on the Reduced Risk of Stroke Incidence in Japanese Population: The Japan Public Health Center-Based Study Cohort</span></div><div class="casAuthors">Kokubo, Yoshihiro; Iso, Hiroyasu; Saito, Isao; Yamagishi, Kazumasa; Yatsuya, Hiroshi; Ishihara, Junko; Inoue, Manami; Tsugane, Shoichiro</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1369-1374</span>CODEN:
                <span class="NLM_cas:coden">SJCCA7</span>;
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND AND PURPOSE-: Few prospective studies have examd. the impact of both green tea and coffee consumption on strokes.  We investigated the assocn. of the combination of those consumption with stroke incidence in a general population.  METHODS-: We studied 82 369 Japanese (aged 45-74 years; without cardiovascular disease [CVD] or cancer in 1995 and 1998 for Cohort I and II, resp.) who received 13 years of mean follow-up through the end of 2007.  Green tea and coffee consumption was assessed by self-administered food frequency questionnaire at baseline.  RESULTS-: In the 1 066 718 person-years of follow-up, we documented the incidence of strokes (n=3425) and coronary heart disease (n=910).  Compared with seldom drinking green tea, the multivariable-adjusted hazard ratios (95% confidence intervals) of all strokes were 0.86 (0.78-0.95) and 0.80 (0.73-0.89) in green tea 2 to 3 and ≥4 cups/d, resp.  Higher green tea consumption was assocd. with inverse risks of CVD and strokes subtypes.  Compared with seldom drinking coffee, the multivariable-adjusted hazard ratios (95% confidence intervals) of all strokes were 0.89 (0.80-0.99), 0.80 (0.72-0.90), and 0.81 (0.72-0.91) for coffee 3 to 6 times/wk and 1 and ≥2 times/day, resp.  Coffee consumption was assocd. with an inverse risk of CVD and cerebral infarction.  Higher green tea or coffee consumption reduced the risks of CVD and stroke subtypes (esp. in intracerebral hemorrhage, P for interaction between green tea and coffee=0.04).  None of the significant assocn. was obsd. in coronary heart disease.  CONCLUSIONS-: Higher green tea and coffee consumption were inversely assocd. with risk of CVD and stroke in general population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpET44sXcXut7Vg90H21EOLACvtfcHk0ljk5426kvfYxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1ehtb4%253D&md5=d0a0eca5139ea00b8daa4674464cd0a6</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1161%2FSTROKEAHA.111.677500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FSTROKEAHA.111.677500%26sid%3Dliteratum%253Aachs%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DI.%26aulast%3DYamagishi%26aufirst%3DK.%26aulast%3DYatsuya%26aufirst%3DH.%26aulast%3DIshihara%26aufirst%3DJ.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DTsugane%26aufirst%3DS.%26atitle%3DThe%2520Impact%2520of%2520Green%2520Tea%2520and%2520Coffee%2520Consumption%2520on%2520the%2520Reduced%2520Risk%2520of%2520Stroke%2520Incidence%2520in%2520Japanese%2520Population%253A%2520The%2520Japan%2520Public%2520Health%2520Center-Based%2520Study%2520Cohort%26jtitle%3DStroke%26date%3D2013%26volume%3D44%26issue%3D5%26spage%3D1369%26epage%3D1374%26doi%3D10.1161%2FSTROKEAHA.111.677500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, I.</span></span> <span> </span><span class="NLM_article-title">Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in Japan: The Ohsaki Study</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1001/jama.296.10.1255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.296.10.1255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1GmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=1255-1265&issue=10&author=S.+Kuriyamaauthor=T.+Shimazuauthor=K.+Ohmoriauthor=N.+Kikuchiauthor=N.+Nakayaauthor=Y.+Nishinoauthor=Y.+Tsubonoauthor=I.+Tsuji&title=Green+Tea+Consumption+and+Mortality+Due+to+Cardiovascular+Disease%2C+Cancer%2C+and+All+Causes+in+Japan%3A+The+Ohsaki+Study&doi=10.1001%2Fjama.296.10.1255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. The Ohsaki Study</span></div><div class="casAuthors">Kuriyama, Shinichi; Shimazu, Taichi; Ohmori, Kaori; Kikuchi, Nobutaka; Nakaya, Naoki; Nishino, Yoshikazu; Tsubono, Yoshitaka; Tsuji, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1255-1265</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Green tea polyphenols have been extensively studied as cardiovascular disease and cancer chemopreventive agents in vitro and in animal studies.  However, the effects of green tea consumption in humans remain unclear.  The assocns. between green tea consumption and all-cause and cause-specific mortality was investigated.  The Ohsaki National Health Insurance Cohort Study, a population-based, prospective cohort study initiated in 1994 among 40 530 Japanese adults aged 40 to 79 years without history of stroke, coronary heart disease, or cancer at baseline.  Participants were followed up for up to 11 years (1995-2005) for all-cause mortality and for up to 7 years (1995-2001) for cause-specific mortality.  Mortality due to cardiovascular disease, cancer, and all causes were measured.  Over 11 years of follow-up (follow-up rate, 86.1%), 4209 participants died, and over 7 years of follow-up (follow-up rate, 89.6%), 892 participants died of cardiovascular disease and 1134 participants died of cancer.  Green tea consumption was inversely assocd. with mortality due to all causes and due to cardiovascular disease.  The inverse assocn. with all-cause mortality was stronger in women (P = .03 for interaction with sex).  In men, the multivariate hazard ratios of mortality due to all causes assocd. with different green tea consumption frequencies were 1.00 (ref.) for less than 1 cup/d, 0.93 (95% confidence interval [CI], 0.83-1.05) for 1 to 2 cups/d, 0.95 (95% CI, 0.85-1.06) for 3 to 4 cups/d, and 0.88 (95% CI, 0.79-0.98) for 5 or more cups/d, resp. (P = .03 for trend).  The corresponding data for women were 1.00, 0.98 (95% CI, 0.84-1.15), 0.82 (95% CI, 0.70-0.95), and 0.77 (95% CI, 0.67-0.89), resp. (P < .001 for trend).  The inverse assocn. with cardiovascular disease mortality was stronger than that with all-cause mortality.  This inverse assocn. was also stronger in women (P = .08 for interaction with sex).  In women, the multivariate hazard ratios of cardiovascular disease mortality across increasing green tea consumption categories were 1.00, 0.84 (95% CI, 0.63-1.12), 0.69 (95% CI, 0.52-0.93), and 0.69 (95% CI, 0.53-0.90), resp. (P = .004 for trend).  Among the types of cardiovascular disease mortality, the strongest inverse assocn. was obsd. for stroke mortality.  In contrast, the hazard ratios of cancer mortality were not significantly different from 1.00 in all green tea categories compared with the lowest-consumption category.  Green tea consumption is assocd. with reduced mortality due to all causes and due to cardiovascular disease but not with reduced mortality due to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA23k72VL9TrVg90H21EOLACvtfcHk0ljk5426kvfYxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1GmsL8%253D&md5=c8a1794a12ca0991889b23f89d45423a</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1001%2Fjama.296.10.1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.296.10.1255%26sid%3Dliteratum%253Aachs%26aulast%3DKuriyama%26aufirst%3DS.%26aulast%3DShimazu%26aufirst%3DT.%26aulast%3DOhmori%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DN.%26aulast%3DNakaya%26aufirst%3DN.%26aulast%3DNishino%26aufirst%3DY.%26aulast%3DTsubono%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DI.%26atitle%3DGreen%2520Tea%2520Consumption%2520and%2520Mortality%2520Due%2520to%2520Cardiovascular%2520Disease%252C%2520Cancer%252C%2520and%2520All%2520Causes%2520in%2520Japan%253A%2520The%2520Ohsaki%2520Study%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26issue%3D10%26spage%3D1255%26epage%3D1265%26doi%3D10.1001%2Fjama.296.10.1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yorifuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa-Takata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, H.</span></span> <span> </span><span class="NLM_article-title">Green Tea Consumption and Mortality among Japanese Elderly People: The Prospective Shizuoka Elderly Cohort</span>. <i>Ann. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/j.annepidem.2009.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.annepidem.2009.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19628408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1Mngs1ehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=732-739&issue=10&author=E.+Suzukiauthor=T.+Yorifujiauthor=S.+Takaoauthor=H.+Komatsuauthor=M.+Sugiyamaauthor=T.+Ohtaauthor=K.+Ishikawa-Takataauthor=H.+Doi&title=Green+Tea+Consumption+and+Mortality+among+Japanese+Elderly+People%3A+The+Prospective+Shizuoka+Elderly+Cohort&doi=10.1016%2Fj.annepidem.2009.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort</span></div><div class="casAuthors">Suzuki Etsuji; Yorifuji Takashi; Takao Soshi; Komatsu Hirokazu; Sugiyama Masumi; Ohta Toshiki; Ishikawa-Takata Kazuko; Doi Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Annals of epidemiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">732-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To investigate the association between green tea consumption and mortality from all causes, cancer, and cardiovascular disease (CVD) among elderly people.  METHODS:  In a population-based, prospective cohort study, a total of 14,001 elderly residents (aged 65-84 years), randomly chosen from all 74 municipalities in Shizuoka, Japan, completed questionnaires that included items about frequency of green tea consumption.  They were followed for up to 6 years, from December 1999 to March 2006.  Consequently, 12,251 subjects were analyzed to estimate the hazard ratios (HRs) for all-cause mortality, cancer, and CVD.  RESULTS:  Among 64,002 person-years, 1,224 deaths were identified (follow-up rate, 71.6%).  The multivariate HRs and 95% confidence intervals (CIs) for CVD mortality compared those who consumed seven or more cups per day with those who consumed less than one cup per day, were 0.24 (0.14-0.40), 0.30 (0.15-0.61), and 0.18 (0.08-0.40) for total participants, men, and women, respectively.  Although green tea consumption was not inversely associated with cancer mortality, green tea consumption and colorectal cancer mortality were inversely associated with a moderate dose-response relationship.  CONCLUSIONS:  Green tea consumption is associated with reduced mortality from all causes and CVD.  This study also suggests that green tea could have protective effects against colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtuwNXKmMdGjAEfvC7EH1LfW6udTcc2eY_A2WYp0JC87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mngs1ehsA%253D%253D&md5=f17f41909d39dd684b3f973edca6389f</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.annepidem.2009.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.annepidem.2009.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DE.%26aulast%3DYorifuji%26aufirst%3DT.%26aulast%3DTakao%26aufirst%3DS.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DIshikawa-Takata%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26atitle%3DGreen%2520Tea%2520Consumption%2520and%2520Mortality%2520among%2520Japanese%2520Elderly%2520People%253A%2520The%2520Prospective%2520Shizuoka%2520Elderly%2520Cohort%26jtitle%3DAnn.%2520Epidemiol.%26date%3D2009%26volume%3D19%26issue%3D10%26spage%3D732%26epage%3D739%26doi%3D10.1016%2Fj.annepidem.2009.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satija, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhupathiraju, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Garcia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Association of Coffee Consumption with Total and Cause-Specific Mortality in 3 Large Prospective Cohorts</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2305</span>– <span class="NLM_lpage">2315</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.115.017341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FCIRCULATIONAHA.115.017341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26572796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2015&pages=2305-2315&issue=24&author=M.+Dingauthor=A.+Satijaauthor=S.+N.+Bhupathirajuauthor=Y.+Huauthor=Q.+Sunauthor=J.+Hanauthor=E.+Lopez-Garciaauthor=W.+Willettauthor=R.+M.+Van+Damauthor=F.+B.+Hu&title=Association+of+Coffee+Consumption+with+Total+and+Cause-Specific+Mortality+in+3+Large+Prospective+Cohorts&doi=10.1161%2FCIRCULATIONAHA.115.017341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts</span></div><div class="casAuthors">Ding, Ming; Satija, Ambika; Bhupathiraju, Shilpa N.; Hu, Yang; Sun, Qi; Han, Jiali; Lopez-Garcia, Esther; Willett, Walter; van Dam, Rob M.; Hu, Frank B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2305-2315</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: The assocn. between consumption of caffeinated and decaffeinated coffee and risk of mortality remains inconclusive.  METHODS AND RESULTS-: We examd. the assocns. of consumption of total, caffeinated, and decaffeinated coffee with risk of subsequent total and cause-specific mortality among 74 890 women in the Nurses' Health Study (NHS), 93 054 women in the Nurses' Health Study II, and 40 557 men in the Health Professionals Follow-up Study.  Coffee consumption was assessed at baseline using a semiquant. food frequency questionnaire.  During 4 690 072 person-years of follow-up, 19 524 women and 12 432 men died.  Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly assocd. with mortality.  Compared with nondrinkers, coffee consumption of 1 to 5 cups per day was assocd. with lower risk of mortality, whereas coffee consumption of more than 5 cups per day was not assocd. with risk of mortality.  However, when restricting to never smokers compared with nondrinkers, the hazard ratios (and 95% confidence intervals) of mortality were 0.94 (0.89-0.99) for 1.0 or less cup per day, 0.92 (0.87-0.97) for 1.1 to 3.0 cups per day, 0.85 (0.79-0.92) for 3.1 to 5.0 cup per day, and 0.88 (0.78-0.99) for more than 5.0 cup per day (P value for nonlinearity = 0.32; P value for trend < 0.001).  Significant inverse assocns. were obsd. for caffeinated (P value for trend < 0.001) and decaffeinated coffee (P value for trend = 0.022).  Significant inverse assocns. were obsd. between coffee consumption and deaths attributed to cardiovascular disease, neurol. diseases, and suicide.  No significant assocn. between coffee consumption and total cancer mortality was found.  CONCLUSIONS-: Higher consumption of total coffee, caffeinated coffee, and decaffeinated coffee was assocd. with lower risk of total mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKaIIbk2_pELVg90H21EOLACvtfcHk0li5JK40bOaGYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrtr3M&md5=81fb65afad8b2c5bbf85a7cec25663a5</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.115.017341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.115.017341%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DM.%26aulast%3DSatija%26aufirst%3DA.%26aulast%3DBhupathiraju%26aufirst%3DS.%2BN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLopez-Garcia%26aufirst%3DE.%26aulast%3DWillett%26aufirst%3DW.%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DAssociation%2520of%2520Coffee%2520Consumption%2520with%2520Total%2520and%2520Cause-Specific%2520Mortality%2520in%25203%2520Large%2520Prospective%2520Cohorts%26jtitle%3DCirculation%26date%3D2015%26volume%3D132%26issue%3D24%26spage%3D2305%26epage%3D2315%26doi%3D10.1161%2FCIRCULATIONAHA.115.017341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abnet, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, R.</span></span> <span> </span><span class="NLM_article-title">Association of Coffee Drinking with Total and Cause-Specific Mortality</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>366</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1891</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1112010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1056%2FNEJMoa1112010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22591295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38Xntlalsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=1891-1904&issue=20&author=N.+D.+Freedmanauthor=Y.+Parkauthor=C.+C.+Abnetauthor=A.+R.+Hollenbeckauthor=R.+Sinha&title=Association+of+Coffee+Drinking+with+Total+and+Cause-Specific+Mortality&doi=10.1056%2FNEJMoa1112010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Association of coffee drinking with total and cause-specific mortality</span></div><div class="casAuthors">Freedman, Neal D.; Park, Yikyung; Abnet, Christian C.; Hollenbeck, Albert R.; Sinha, Rashmi</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1891-1904</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Coffee is one of the most widely consumed beverages, but the assocn. between coffee consumption and the risk of death remains unclear.  METHODS We examd. the assocn. of coffee drinking with subsequent total and cause-specific mortality among 229,119 men and 173,141 women in the National Institutes of Health-AARP Diet and Health Study who were 50 to 71 years of age at baseline.  Participants with cancer, heart disease, and stroke were excluded.  Coffee consumption was assessed once at baseline.  RESULTS During 5,148,760 person-years of follow-up between 1995 and 2008, a total of 33,731 men and 18,784 women died.  In age-adjusted models, the risk of death was increased among coffee drinkers.  However, coffee drinkers were also more likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders, there was a significant inverse assocn. between coffee consumption and mortality.  Adjusted hazard ratios for death among men who drank coffee as compared with those who did not were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for drinking less than 1 cup per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups of coffee per day (P<0.001 for trend); the resp. hazard ratios among women were 1.01 (95% CI, 0.96 to 1.07), 0.95 (95% CI, 0.90 to 1.01), 0.87 (95% CI, 0.83 to 0.92), 0.84 (95% CI, 0.79 to 0.90), and 0.85 (95% CI, 0.78 to 0.93) (P<0.001 for trend).  Inverse assocns. were obsd. for deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections, but not for deaths due to cancer.  Results were similar in subgroups, including persons who had never smoked and persons who reported very good to excellent health at baseline.  CONCLUSIONS In this large prospective study, coffee consumption was inversely assocd. with total and cause-specific mortality.  Whether this was a causal or associational finding cannot be detd. from our data.  (Funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiol. and Genetics.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvkpzgWBJMnrVg90H21EOLACvtfcHk0li5JK40bOaGYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xntlalsr4%253D&md5=37ff9c15b8d4a508e67e23230185397f</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1112010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1112010%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DN.%2BD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DAbnet%26aufirst%3DC.%2BC.%26aulast%3DHollenbeck%26aufirst%3DA.%2BR.%26aulast%3DSinha%26aufirst%3DR.%26atitle%3DAssociation%2520of%2520Coffee%2520Drinking%2520with%2520Total%2520and%2520Cause-Specific%2520Mortality%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26issue%3D20%26spage%3D1891%26epage%3D1904%26doi%3D10.1056%2FNEJMoa1112010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnoll, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokolis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokolis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassotis, J.</span></span> <span> </span><span class="NLM_article-title">Caffeinated Beverage Intake and the Risk of Heart Disease Mortality in the Elderly: A Prospective Analysis</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1093/ajcn/85.2.392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fajcn%2F85.2.392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17284734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=392-398&issue=2&author=J.+A.+Greenbergauthor=C.+C.+Dunbarauthor=R.+Schnollauthor=R.+Kokolisauthor=S.+Kokolisauthor=J.+Kassotis&title=Caffeinated+Beverage+Intake+and+the+Risk+of+Heart+Disease+Mortality+in+the+Elderly%3A+A+Prospective+Analysis&doi=10.1093%2Fajcn%2F85.2.392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis</span></div><div class="casAuthors">Greenberg, James A.; Dunbar, Christopher C.; Schnoll, Roseanne; Kokolis, Rodamanthos; Kokolis, Spyro; Kassotis, John</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">392-398</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Motivated by the possibility that caffeine could ameliorate the effect of postprandial hypotension on a high risk of coronary events and mortality in aging, we hypothesized that caffeinated beverage consumption decreases the risk of cardiovascular disease (CVD) mortality in the elderly.  The objective of the study was to use prospective cohort study data to test whether the consumption of caffeinated beverages exhibits this protective effect.  Cox regression analyses were conducted for 426 CVD deaths that occurred during an 8.8-y follow-up in the prospective first National Health and Nutrition Examn. Survey Epidemiol. Follow-up Study.  The anal. involved 6594 participants aged 32-86 y with no history of CVD at baseline.  Participants aged ≥65 y with higher caffeinated beverage intake exhibited lower relative risk of CVD and heart disease mortality than did participants with lower caffeinated beverage intake.  It was a dose-response protective effect: the relative risk (95% CI) for heart disease mortality was 1.00 (referent), 0.77 (0.54, 1.10), 0.68 (0.49, 0.94), and 0.47 (0.32, 0.69) for <0.5, 0.5-2, 2-4, and ≥4 servings/d, resp. (P for trend = 0.003).  A similar protective effect was found for caffeine intake in mg/d.  The protective effective was found only in participants who were not severely hypertensive.  No significant protective effect was found in participants aged <65 y or in cerebrovascular disease mortality for those aged ≥65 y.  Habitual intake of caffeinated beverages provided protection against the risk of heart disease mortality among elderly participants in this prospective epidemiol. anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfC9DNc-TbrVg90H21EOLACvtfcHk0li5JK40bOaGYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFWhu78%253D&md5=67b584f2901c7ef8485360eb0f72597d</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F85.2.392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F85.2.392%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberg%26aufirst%3DJ.%2BA.%26aulast%3DDunbar%26aufirst%3DC.%2BC.%26aulast%3DSchnoll%26aufirst%3DR.%26aulast%3DKokolis%26aufirst%3DR.%26aulast%3DKokolis%26aufirst%3DS.%26aulast%3DKassotis%26aufirst%3DJ.%26atitle%3DCaffeinated%2520Beverage%2520Intake%2520and%2520the%2520Risk%2520of%2520Heart%2520Disease%2520Mortality%2520in%2520the%2520Elderly%253A%2520A%2520Prospective%2520Analysis%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2007%26volume%3D85%26issue%3D2%26spage%3D392%26epage%3D398%26doi%3D10.1093%2Fajcn%2F85.2.392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mineharu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamakoshi, A.</span></span> <span> </span><span class="NLM_article-title">Coffee, Green Tea, Black Tea and Oolong Tea Consumption and Risk of Mortality from Cardiovascular Disease in Japanese Men and Women</span>. <i>J. Epidemiol. Community Health</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1136/jech.2009.097311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1136%2Fjech.2009.097311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19996359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=230-240&issue=3&author=Y.+Mineharuauthor=A.+Koizumiauthor=Y.+Wadaauthor=H.+Isoauthor=Y.+Watanabeauthor=C.+Dateauthor=A.+Yamamotoauthor=S.+Kikuchiauthor=Y.+Inabaauthor=H.+Toyoshimaauthor=T.+Kondoauthor=A.+Tamakoshi&title=Coffee%2C+Green+Tea%2C+Black+Tea+and+Oolong+Tea+Consumption+and+Risk+of+Mortality+from+Cardiovascular+Disease+in+Japanese+Men+and+Women&doi=10.1136%2Fjech.2009.097311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women</span></div><div class="casAuthors">Mineharu Yohei; Koizumi Akio; Wada Yasuhiko; Iso Hiroyasu; Watanabe Yoshiyuki; Date Chigusa; Yamamoto Akio; Kikuchi Shogo; Inaba Yutaka; Toyoshima Hideaki; Kondo Takaaki; Tamakoshi Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of epidemiology and community health</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The effects of coffee and green, black and oolong teas and caffeine intake on cardiovascular disease (CVD) mortality have not been well defined in Asian countries.  METHODS:  To examine the relationship between the consumption of these beverages and risk of mortality from CVD, 76,979 individuals aged 40-79 years free of stroke, coronary heart disease (CHD) and cancer at entry were prospectively followed.  The daily consumption of beverages was assessed by questionnaires.  RESULTS:  1362 deaths were documented from strokes and 650 deaths from CHD after 1,010,787 person-years of follow-up.  Compared with non-drinkers of coffee, the multivariable HR and 95% CI for those drinking 1-6 cups/week, 1-2 cups/day and ≥ 3 cups/day were 0.78 (0.50 to 1.20), 0.67 (0.47 to 0.96) and 0.45 (0.17 to 0.87) for strokes among men (p = 0.009 for trend).  Compared with non-drinkers of green tea, the multivariable HR for those drinking 1-6 cups/week, 1-2 cups/day, 3-5 cups/day and ≥ 6 cups/day were 0.34 (0.06-1.75), 0.28 (0.07-1.11), 0.39 (0.18-0.85) and 0.42 (0.17-0.88) for CHD among women (p = 0.038 for trend).  As for oolong tea, the multivariable HR of those drinking 1-6 cups/week and ≥ 1 cups/day were 1.00 (0.65-1.55) and 0.39 (0.17-0.88) for total CVD among men (p = 0.049 for trend).  Risk reduction for total CVD across categories of caffeine intake was most prominently observed in the second highest quintile, with a 38% lower risk among men and 22% among women.  CONCLUSIONS:  Consumption of coffee, green tea and oolong tea and total caffeine intake was associated with a reduced risk of mortality from CVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfNcJfxKztMeb6AVA-44PTfW6udTcc2eYSUlIciCV-7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvVehtg%253D%253D&md5=809c5f892219634630a7093aad3a87de</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1136%2Fjech.2009.097311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjech.2009.097311%26sid%3Dliteratum%253Aachs%26aulast%3DMineharu%26aufirst%3DY.%26aulast%3DKoizumi%26aufirst%3DA.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DDate%26aufirst%3DC.%26aulast%3DYamamoto%26aufirst%3DA.%26aulast%3DKikuchi%26aufirst%3DS.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DToyoshima%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DTamakoshi%26aufirst%3DA.%26atitle%3DCoffee%252C%2520Green%2520Tea%252C%2520Black%2520Tea%2520and%2520Oolong%2520Tea%2520Consumption%2520and%2520Risk%2520of%2520Mortality%2520from%2520Cardiovascular%2520Disease%2520in%2520Japanese%2520Men%2520and%2520Women%26jtitle%3DJ.%2520Epidemiol.%2520Community%2520Health%26date%3D2011%26volume%3D65%26issue%3D3%26spage%3D230%26epage%3D240%26doi%3D10.1136%2Fjech.2009.097311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakizaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori-Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hozawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, I.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Japanese Women</span>. <i>J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.3945/jn.109.109314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3945%2Fjn.109.109314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20335629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=1007-1013&issue=5&author=K.+Sugiyamaauthor=S.+Kuriyamaauthor=M.+Akhterauthor=M.+Kakizakiauthor=N.+Nakayaauthor=K.+Ohmori-Matsudaauthor=T.+Shimazuauthor=M.+Nagaiauthor=Y.+Sugawaraauthor=A.+Hozawaauthor=A.+Fukaoauthor=I.+Tsuji&title=Coffee+Consumption+and+Mortality+Due+to+All+Causes%2C+Cardiovascular+Disease%2C+and+Cancer+in+Japanese+Women&doi=10.3945%2Fjn.109.109314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women</span></div><div class="casAuthors">Sugiyama, Kemmyo; Kuriyama, Shinichi; Akhter, Munira; Kakizaki, Masako; Nakaya, Naoki; Ohmori-Matsuda, Kaori; Shimazu, Taichi; Nagai, Masato; Sugawara, Yumi; Hozawa, Atsushi; Fukao, Akira; Tsuji, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1007-1013</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Coffee contains various compds. that have recently been reported to exert beneficial health effects.  However, the conclusion of its relation with mortality has not yet been reached.  In this study, we aimed to investigate the assocns. between coffee consumption and all-cause and cause-specific mortality in Japan.  We included 37,742 participants (18,287 men and 19,455 women) aged 40-64 y without a history of cancer, myocardial infarction, or stroke at baseline in our anal., based on the Miyagi Cohort Study initiated in 1990.  The outcomes were mortality due to all causes, cardiovascular disease (CVD), and cancer.  During the 10.3 y of follow-up, 2454 participants died, including 426 due to CVD and 724 due to cancer.  In women, the multivariate hazard ratios (HR) (95% CI) for all-cause mortality in participants who drank coffee never, occasionally, 1-2 cups (150-300 mL)/d, and ≥3 cups/d were 1.00, 0.88 (0.73-1.06), 0.82 (0.66-1.02), and 0.75 (0.53-1.05), resp. (P-trend = 0.04).  For CVD mortality in women, the multivariate HR (95% CI) were 1.00, 0.56 (0.36-0.86), 0.48 (0.29-0.80), and 0.45 (0.20-1.03), resp. (P-trend = 0.006).  Of the specific CVD diseases, there was a strong inverse assocn. between coffee consumption and mortality due to coronary heart disease (CHD) in women (P-trend = 0.02) but not in men.  Death due to cancer was not assocd. with coffee consumption in either men or women, except for colorectal cancer in women.  Our results suggest that coffee may have favorable effects on morality due to all causes and to CVD, esp. CHD, in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgzgfVUXlWjrVg90H21EOLACvtfcHk0liMqqkIDUqdbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWrtr4%253D&md5=3654dc2f8c3d4620d3369a843276162a</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.3945%2Fjn.109.109314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3945%252Fjn.109.109314%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DK.%26aulast%3DKuriyama%26aufirst%3DS.%26aulast%3DAkhter%26aufirst%3DM.%26aulast%3DKakizaki%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DN.%26aulast%3DOhmori-Matsuda%26aufirst%3DK.%26aulast%3DShimazu%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DM.%26aulast%3DSugawara%26aufirst%3DY.%26aulast%3DHozawa%26aufirst%3DA.%26aulast%3DFukao%26aufirst%3DA.%26aulast%3DTsuji%26aufirst%3DI.%26atitle%3DCoffee%2520Consumption%2520and%2520Mortality%2520Due%2520to%2520All%2520Causes%252C%2520Cardiovascular%2520Disease%252C%2520and%2520Cancer%2520in%2520Japanese%2520Women%26jtitle%3DJ.%2520Nutr.%26date%3D2010%26volume%3D140%26issue%3D5%26spage%3D1007%26epage%3D1013%26doi%3D10.3945%2Fjn.109.109314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomhoff, R.</span></span> <span> </span><span class="NLM_article-title">Consumption of Coffee Is Associated with Reduced Risk of Death Attributed to Inflammatory and Cardiovascular Diseases in the Iowa Women’s Health Study</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1093/ajcn/83.5.1039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fajcn%2F83.5.1039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16685044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvFOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1039-1046&issue=5&author=L.+F.+Andersenauthor=D.+R.+Jacobsauthor=M.+H.+Carlsenauthor=R.+Blomhoff&title=Consumption+of+Coffee+Is+Associated+with+Reduced+Risk+of+Death+Attributed+to+Inflammatory+and+Cardiovascular+Diseases+in+the+Iowa+Women%E2%80%99s+Health+Study&doi=10.1093%2Fajcn%2F83.5.1039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study</span></div><div class="casAuthors">Andersen, Lene Frost; Jacobs, David R., Jr.; Carlsen, Monica H.; Blomhoff, Rune</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1039-1046</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Coffee is the major source of dietary antioxidants.  The assocn. between coffee consumption and risk of death from diseases assocd. with inflammatory or oxidative stress has not been studied.  We studied the relation of coffee drinking with total mortality and mortality attributed to cardiovascular disease, cancer, and other diseases with a major inflammatory component.  A total of 41,836 postmenopausal women aged 55-69 yr at baseline were followed for 15 yr.  After exclusions for cardiovascular disease, cancer, diabetes, colitis, and liver cirrhosis at baseline, 27,312 participants remained, resulting in 410,235 person-years of follow-up and 4265 deaths.  The major outcome measure was disease-specific mortality.  In the fully adjusted model, similar to the relation of coffee intake to total mortality, the hazard ratio of death attributed to cardiovascular disease was 0.76 (95% CI: 0.64, 0.91) for consumption of 1-3 cups/d, 0.81 (95% CI: 0.66, 0.99) for 4-5 cups/d, and 0.87 (95% CI: 0.69, 1.09) for ≥6 cups/d.  The hazard ratio for death from other inflammatory diseases was 0.72 (95% CI: 0.55, 0.93) for consumption of 1-3 cups/d, 0.67 (95% CI: 0.50, 0.90) for 4-5 cups/d, and 0.68 (95% CI: 0.49, 0.94) for ≥6 cups/d.  Consumption of coffee, a major source of dietary antioxidants, may inhibit inflammation and thereby reduce the risk of cardiovascular and other inflammatory diseases in postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmMzFvNbakKrVg90H21EOLACvtfcHk0liMqqkIDUqdbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvFOrsLk%253D&md5=6f50c58baa8fad9a2ca123db4e4683eb</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F83.5.1039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F83.5.1039%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DL.%2BF.%26aulast%3DJacobs%26aufirst%3DD.%2BR.%26aulast%3DCarlsen%26aufirst%3DM.%2BH.%26aulast%3DBlomhoff%26aufirst%3DR.%26atitle%3DConsumption%2520of%2520Coffee%2520Is%2520Associated%2520with%2520Reduced%2520Risk%2520of%2520Death%2520Attributed%2520to%2520Inflammatory%2520and%2520Cardiovascular%2520Diseases%2520in%2520the%2520Iowa%2520Women%25E2%2580%2599s%2520Health%2520Study%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2006%26volume%3D83%26issue%3D5%26spage%3D1039%26epage%3D1046%26doi%3D10.1093%2Fajcn%2F83.5.1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Happonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Läärä, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltunen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luukinen, H.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Mortality in a 14-Year Follow-up of an Elderly Northern Finnish Population</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1354</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1017/S0007114507871650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1017%2FS0007114507871650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18062826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFaku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1354-1361&issue=6&author=P.+Happonenauthor=E.+L%C3%A4%C3%A4r%C3%A4author=L.+Hiltunenauthor=H.+Luukinen&title=Coffee+Consumption+and+Mortality+in+a+14-Year+Follow-up+of+an+Elderly+Northern+Finnish+Population&doi=10.1017%2FS0007114507871650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population</span></div><div class="casAuthors">Happonen, Pertti; Laara, Esa; Hiltunen, Liisa; Luukinen, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1354-1361</span>CODEN:
                <span class="NLM_cas:coden">BJNUAV</span>;
        ISSN:<span class="NLM_cas:issn">0007-1145</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The present study assessed the relationship between coffee consumption and mortality in a home-dwelling elderly population.  A population-based cohort of 817 men and women born in 1920 or earlier and living in northern Finland provided complete data on daily coffee consumption and other variables at the baseline examn. in 1991-1992.  Deaths were monitored through to the end of 2005 by national death certificates, resulting in 6960 person-years of follow-up.  Hazard rate ratios for mortality by daily coffee intake were estd. by Poisson regression models adjusted for some known predictors of mortality.  During 14·5 years of follow-up, 623 deaths occurred.  The total mortality rate was inversely related to the no. of cups (av. vol., 125 mL) of coffee consumed daily.  After adjustment for age, sub-period of follow-up, sex, marital status, basic educational level, previous occupational group, current smoking, BMI, history of myocardial infarction, self-rated health and presence of diabetes, cognitive impairment or phys. disability, the estd. relative risk redn. of total mortality per an increment of one more cup of coffee per d reported at baseline was 4 (95 % CI 0, 8) %.  The obsd. assocns. between coffee consumption and mortality from CVD, cancer, and other or unknown causes, resp., were qual. similar to that of total mortality but the ests. were less precise.  The effect of coffee consumption at baseline appeared to attenuate after 10 years since the start of follow-up.  The present study provides evidence for daily (caffeine-contg.) coffee intake being inversely assocd. with mortality in the elderly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTpEr5OWHtQbVg90H21EOLACvtfcHk0lg1TkBFFgr1Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFaku7g%253D&md5=ef15536217a98d44fcfb24e4fbc864f3</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1017%2FS0007114507871650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114507871650%26sid%3Dliteratum%253Aachs%26aulast%3DHapponen%26aufirst%3DP.%26aulast%3DL%25C3%25A4%25C3%25A4r%25C3%25A4%26aufirst%3DE.%26aulast%3DHiltunen%26aufirst%3DL.%26aulast%3DLuukinen%26aufirst%3DH.%26atitle%3DCoffee%2520Consumption%2520and%2520Mortality%2520in%2520a%252014-Year%2520Follow-up%2520of%2520an%2520Elderly%2520Northern%2520Finnish%2520Population%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2008%26volume%3D99%26issue%3D6%26spage%3D1354%26epage%3D1361%26doi%3D10.1017%2FS0007114507871650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjelke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuch, I.</span></span> <span> </span><span class="NLM_article-title">Coffee Drinking, Mortality, and Cancer Incidence: Results from a Norwegian Prospective Study</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1093/jnci/76.5.823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fjnci%2F76.5.823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3457969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL283gtFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1986&pages=823-831&issue=5&author=B.+K.+Jacobsenauthor=E.+Bjelkeauthor=G.+Kvaleauthor=I.+Heuch&title=Coffee+Drinking%2C+Mortality%2C+and+Cancer+Incidence%3A+Results+from+a+Norwegian+Prospective+Study&doi=10.1093%2Fjnci%2F76.5.823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study</span></div><div class="casAuthors">Jacobsen B K; Bjelke E; Kvale G; Heuch I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-31</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">Relationships between coffee consumption and occurrence of cancer as well as mortality were explored in a Norwegian study of 13,664 men and 2,891 women who in 1967-69 reported their coffee consumption.  No statistically significant positive associations were found between coffee consumption and disease.  A weak negative association was found with total cancer incidence even when the first 4 of the 11 1/2 years of follow-up were excluded, and strong negative associations with coffee drinking were noted for cancer of the kidney and nonmelanoma skin cancer.  For cancer of the pancreas and bladder, no increase in incidence was found among those with a high coffee consumption.  In subjects less than 65 years of age at start of follow-up, coffee drinking showed a significant inverse association with colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmloqQcarDdEodMGTatQ7LfW6udTcc2ebOlOklG1kzSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL283gtFajsg%253D%253D&md5=1fd5c742c3860b3d5444db3ed4d65f6c</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F76.5.823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F76.5.823%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DB.%2BK.%26aulast%3DBjelke%26aufirst%3DE.%26aulast%3DKvale%26aufirst%3DG.%26aulast%3DHeuch%26aufirst%3DI.%26atitle%3DCoffee%2520Drinking%252C%2520Mortality%252C%2520and%2520Cancer%2520Incidence%253A%2520Results%2520from%2520a%2520Norwegian%2520Prospective%2520Study%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1986%26volume%3D76%26issue%3D5%26spage%3D823%26epage%3D831%26doi%3D10.1093%2Fjnci%2F76.5.823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazbec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šimić, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čorović, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraković, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlović, M.</span></span> <span> </span><span class="NLM_article-title">Impact of Coffee and Other Selected Factors on General Mortality and Mortality Due to Cardiovascular Disease in Croatia</span>. <i>J. Heal. Popul. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.3329/jhpn.v21i4.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3329%2Fjhpn.v21i4.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15038588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2c7ksFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=332-340&issue=4&author=A.+Jazbecauthor=D.+%C5%A0imi%C4%87author=N.+%C4%8Corovi%C4%87author=Z.+Durakovi%C4%87author=M.+Pavlovi%C4%87&title=Impact+of+Coffee+and+Other+Selected+Factors+on+General+Mortality+and+Mortality+Due+to+Cardiovascular+Disease+in+Croatia&doi=10.3329%2Fjhpn.v21i4.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia</span></div><div class="casAuthors">Jazbec Anamarija; Simic Diana; Corovic Naima; Durakovic Zijad; Pavlovic Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of health, population, and nutrition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-40</span>
        ISSN:<span class="NLM_cas:issn">1606-0997</span>.
    </div><div class="casAbstract">In Croatia, the mortality rate is higher than that in the countries of the European Union (EU), and consumption of coffee is moderate compared to the EU countries.  The study examined the effects of coffee consumption on all-cause (general) mortality, mortality due to cardiovascular disease, and survival.  Analyses were based on data obtained from an epidemiological longitudinal study started in 1969 with follow-ups in 1972, including 1,571 men and 1,793 women aged 35-59 years, and in 1982, including 1,093 men and 1,330 women.  The sample was age- and gender-stratified and included urban and rural populations from three coastal and three continental regions of Croatia.  During the observation period from spring 1972 to the end of 1999, 568 men and 382 women died.  In total, 254 men and 181 women died due to cardiovascular disease.  The sample was classified in 4 groups: non-drinkers, consumption of coffee sometimes, regularly 1-2 cup(s), and regularly more than 2 cups per day.  Apart from coffee, the effects of diastolic blood pressure, smoking habit, well-being, stomach ulcer, and resident status were analyzed.  Data on general mortality and mortality due to cardiovascular disease were also analyzed.  The influence of region and the effects of diastolic pressure and smoking habit on general mortality and cardiovascular disease-associated mortality were confirmed in both the sexes.  No significant effects of coffee consumption on general mortality and mortality due to cardiovascular disease were found among men.  Positive effects of coffee on general mortality (p = 0.0089) but not on cardiovascular disease-associated mortality were observed among women.  Women who regularly drank coffee 1-2 cup(s) per day had a significantly lower risk of all-cause death adjusted for age, region, smoking, diastolic blood pressure, feeling of well-being, and history of stomach ulcer (relative risk = 0.631; p = 0.0033; confidence interval: 0.464-0.857).  The role of coffee consumption on mortality was less relevant than other variables.  However, it cannot be completely neglected in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnYoqWgtS-nzC850By6mxpfW6udTcc2ebOlOklG1kzSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7ksFeitQ%253D%253D&md5=460b78ae3ba531a9fc51ac5ad34d7935</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.3329%2Fjhpn.v21i4.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3329%252Fjhpn.v21i4.226%26sid%3Dliteratum%253Aachs%26aulast%3DJazbec%26aufirst%3DA.%26aulast%3D%25C5%25A0imi%25C4%2587%26aufirst%3DD.%26aulast%3D%25C4%258Corovi%25C4%2587%26aufirst%3DN.%26aulast%3DDurakovi%25C4%2587%26aufirst%3DZ.%26aulast%3DPavlovi%25C4%2587%26aufirst%3DM.%26atitle%3DImpact%2520of%2520Coffee%2520and%2520Other%2520Selected%2520Factors%2520on%2520General%2520Mortality%2520and%2520Mortality%2520Due%2520to%2520Cardiovascular%2520Disease%2520in%2520Croatia%26jtitle%3DJ.%2520Heal.%2520Popul.%2520Nutr.%26date%3D2003%26volume%3D21%26issue%3D4%26spage%3D332%26epage%3D340%26doi%3D10.3329%2Fjhpn.v21i4.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Garcia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Artalejo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">The Relationship of Coffee Consumption with Mortality</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-148-12-200806170-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.7326%2F0003-4819-148-12-200806170-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18559841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1czpt12gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2008&pages=904-914&issue=12&author=E.+Lopez-Garciaauthor=R.+M.+Van+Damauthor=T.+Y.+Liauthor=F.+Rodriguez-Artalejoauthor=F.+B.+Hu&title=The+Relationship+of+Coffee+Consumption+with+Mortality&doi=10.7326%2F0003-4819-148-12-200806170-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of coffee consumption with mortality</span></div><div class="casAuthors">Lopez-Garcia Esther; van Dam Rob M; Li Tricia Y; Rodriguez-Artalejo Fernando; Hu Frank B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">904-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Coffee consumption has been linked to various beneficial and detrimental health effects, but data on its relation with mortality are sparse.  OBJECTIVE:  To assess the association between coffee consumption and mortality from cardiovascular disease (CVD), cancer, and all causes during 18 years of follow-up in men and 24 years of follow-up in women.  DESIGN:  Sex-specific Cox proportional hazard models were used to investigate the association between coffee consumption and incidence of all-cause and disease-specific mortality in a prospective cohort study.  SETTING:  Health Professionals Follow-up Study and Nurses' Health Study.  PARTICIPANTS:  41,736 men and 86,214 women with no history of CVD or cancer at baseline.  MEASUREMENTS:  Coffee consumption was assessed first in 1986 for men and in 1980 for women and then every 2 to 4 years through 2004.  Investigators documented 6888 deaths (2049 due to CVD and 2491 due to cancer) among men and 11,095 deaths (2368 due to CVD and 5011 due to cancer) among women.  RESULTS:  After adjustment for age, smoking, and other CVD and cancer risk factors, the relative risks for all-cause mortality in men across categories of coffee consumption (<1 cup per month, 1 cup per month to 4 cups per week, 5 to 7 cups per week, 2 to 3 cups per day, 4 to 5 cups per day, and >or=6 cups per day) were 1.0, 1.07 (95% CI, 0.99 to 1.16), 1.02 (CI, 0.95 to 1.11), 0.97 (CI, 0.89 to 1.05), 0.93 (CI, 0.81 to 1.07), and 0.80 (CI, 0.62 to 1.04), respectively (P for trend = 0.008).  For women, the relative risks were 1.0, 0.98 (CI, 0.91 to 1.05), 0.93 (CI, 0.87 to 0.98), 0.82 (CI, 0.77 to 0.87), 0.74 (CI, 0.68 to 0.81), and 0.83 (CI, 0.73 to 0.95), respectively (P for trend < 0.001).  This inverse association was mainly due to a moderately reduced risk for CVD mortality and was independent of caffeine intake.  By contrast, coffee consumption was not statistically significantly associated with risk for cancer death after adjustment for potential confounders.  Decaffeinated coffee consumption was associated with a small reduction in all-cause and CVD mortality.  LIMITATION:  Coffee consumption was estimated from self-report; thus, some measurement error is inevitable.  CONCLUSION:  Regular coffee consumption was not associated with an increased mortality rate in either men or women.  The possibility of a modest benefit of coffee consumption on all-cause and CVD mortality needs to be further investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnsiFnd6fIPOxsqfvU0ziafW6udTcc2eYg2pET8X03NLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czpt12gtw%253D%253D&md5=67b57e5b9753dd234c00b53eba7b0fa9</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-148-12-200806170-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-148-12-200806170-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Garcia%26aufirst%3DE.%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DLi%26aufirst%3DT.%2BY.%26aulast%3DRodriguez-Artalejo%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DThe%2520Relationship%2520of%2520Coffee%2520Consumption%2520with%2520Mortality%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2008%26volume%3D148%26issue%3D12%26spage%3D904%26epage%3D914%26doi%3D10.7326%2F0003-4819-148-12-200806170-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annegers, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curb, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span> <span> </span><span class="NLM_article-title">Mortality Patterns among Hypertensives by Reported Level of Caffeine Consumption</span>. <i>Prev. Med.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/0091-7435(88)90006-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0091-7435%2888%2990006-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3043418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL1czgtlyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1988&pages=310-320&issue=3&author=J.+B.+Martinauthor=J.+F.+Annegersauthor=J.+D.+Curbauthor=S.+Heydenauthor=C.+Howsonauthor=E.+S.+Leeauthor=M.+Lee&title=Mortality+Patterns+among+Hypertensives+by+Reported+Level+of+Caffeine+Consumption&doi=10.1016%2F0091-7435%2888%2990006-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality patterns among hypertensives by reported level of caffeine consumption</span></div><div class="casAuthors">Martin J B; Annegers J F; Curb J D; Heyden S; Howson C; Lee E S; Lee M</div><div class="citationInfo"><span class="NLM_cas:title">Preventive medicine</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-20</span>
        ISSN:<span class="NLM_cas:issn">0091-7435</span>.
    </div><div class="casAbstract">The effect of caffeine consumption on mortality was evaluated in a historical cohort study of 10,064 diagnosed hypertensive individuals participating in the Hypertension Detection and Follow-up Program from 1973 to 1979.  Total caffeine intake level from beverages (coffee and tea) and certain medications, was estimated at the 1-year visit.  No evidence was found supporting an association between increased level of caffeine consumption and increased all-cause mortality or cardiovascular disease mortality during the following 4 years.  Cigarette smoking was significantly associated with mortality; the association being more pronounced among non- and low-caffeine consumers for all-cause mortality and among non-caffeine consumers for all cardiovascular mortality except cerebrovascular mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGHrYRt2cOHBJ5E29YNGvQfW6udTcc2eYg2pET8X03NLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1czgtlyhsw%253D%253D&md5=b559d6238e1b36021179a0f36c9ddc78</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1016%2F0091-7435%2888%2990006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-7435%252888%252990006-0%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DJ.%2BB.%26aulast%3DAnnegers%26aufirst%3DJ.%2BF.%26aulast%3DCurb%26aufirst%3DJ.%2BD.%26aulast%3DHeyden%26aufirst%3DS.%26aulast%3DHowson%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DM.%26atitle%3DMortality%2520Patterns%2520among%2520Hypertensives%2520by%2520Reported%2520Level%2520of%2520Caffeine%2520Consumption%26jtitle%3DPrev.%2520Med.%26date%3D1988%26volume%3D17%26issue%3D3%26spage%3D310%26epage%3D320%26doi%3D10.1016%2F0091-7435%2888%2990006-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paganini-Hill, A.</span></span> <span> </span><span class="NLM_article-title">Lifestyle Practices and Cardiovascular Disease Mortality in the Elderly: The Leisure World Cohort Study</span>. <i>Cardiol. Res. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">983764</span>, <span class="refDoi"> DOI: 10.4061/2011/983764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4061%2F2011%2F983764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21274456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ltVCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=983764&issue=1&author=A.+Paganini-Hill&title=Lifestyle+Practices+and+Cardiovascular+Disease+Mortality+in+the+Elderly%3A+The+Leisure+World+Cohort+Study&doi=10.4061%2F2011%2F983764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Lifestyle practices and cardiovascular disease mortality in the elderly: the leisure world cohort study</span></div><div class="casAuthors">Paganini-Hill Annlia</div><div class="citationInfo"><span class="NLM_cas:title">Cardiology research and practice</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">983764</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Modifiable behavioral risk factors are major contributing causes of death, but whether the effects are maintained in older adults is uncertain.  We explored the association of smoking, alcohol consumption, caffeine intake, physical activity, and body mass index on cardiovascular disease (CVD) mortality in 13,296 older adults and calculated risk estimates using Cox regression analysis in four age groups (<70, 70-74, 75-79, and 80+ years).  The most important factor was current smoking, which increased risk in all age-sex groups.  In women, alcohol consumption (≤3 drinks/day) was related to decreased (15-30%) risk in those <80 years old; in men, 4+ drinks/day was associated with reduced (15-30%) risk.  Active 70+ year olds had 20-40% lower risk.  Both underweight and obese women were at increased risk.  Lifestyle practices impact CVD death rates in older adults, even those aged 80+ years.  Not smoking, moderate alcohol consumption, physical activity, and normal weight are important health promoters in our aging population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3q23NVQS6dsvLc4ARHEmzfW6udTcc2eYg2pET8X03NLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ltVCitg%253D%253D&md5=e45d54216f419c343364204a77356ab5</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.4061%2F2011%2F983764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F983764%26sid%3Dliteratum%253Aachs%26aulast%3DPaganini-Hill%26aufirst%3DA.%26atitle%3DLifestyle%2520Practices%2520and%2520Cardiovascular%2520Disease%2520Mortality%2520in%2520the%2520Elderly%253A%2520The%2520Leisure%2520World%2520Cohort%2520Study%26jtitle%3DCardiol.%2520Res.%2520Pract.%26date%3D2011%26volume%3D2011%26issue%3D1%26spage%3D983764%26doi%3D10.4061%2F2011%2F983764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silletta, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfisi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levantesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boccanelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chieffo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggioni, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchioli, R.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Risk of Cardiovascular Events after Acute Myocardial Infarction: Results from the GISSI (Gruppo Italiano per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico)-Prevenzione Trial</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">2944</span>– <span class="NLM_lpage">2951</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.712976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FCIRCULATIONAHA.107.712976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18056527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWjsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=2944-2951&issue=25&author=M.+G.+Sillettaauthor=R.+Marfisiauthor=G.+Levantesiauthor=A.+Boccanelliauthor=C.+Chieffoauthor=M.+Franzosiauthor=E.+Geraciauthor=A.+P.+Maggioniauthor=G.+Nicolosiauthor=C.+Schweigerauthor=L.+Tavazziauthor=G.+Tognoniauthor=R.+Marchioli&title=Coffee+Consumption+and+Risk+of+Cardiovascular+Events+after+Acute+Myocardial+Infarction%3A+Results+from+the+GISSI+%28Gruppo+Italiano+per+Lo+Studio+Della+Sopravvivenza+Nell%E2%80%99Infarto+Miocardico%29-Prevenzione+Trial&doi=10.1161%2FCIRCULATIONAHA.107.712976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and risk of cardiovascular events after acute myocardial infarction: Results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione Trial</span></div><div class="casAuthors">Silletta, Maria Giuseppina; Marfisi, RosaMaria; Levantesi, Giacomo; Boccanelli, Alessandro; Chieffo, Carmelo; Franzosi, MariaGrazia; Geraci, Enrico; Maggioni, Aldo Pietro; Nicolosi, Gianluigi; Schweiger, Carlo; Tavazzi, Luigi; Tognoni, Gianni; Marchioli, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2944-2951</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background- The relation between coffee consumption and cardiovascular disease has been studied extensively, but results are still debated.  In addn., little evidence is available on patients with established coronary heart disease.  Methods and Results- Prospectively ascertained information among 11 231 Italian patients (9584 males and 1647 females) with recent (≤3 mo) myocardial infarction enrolled in the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial was used.  Usual dietary habits were assessed at baseline and updated at 0.5 and 1.5 years.  Coffee consumption was categorized as never/almost never, <2 cups per day, 2 to 4 cups per day, and >4 cups per day.  Medication use and fasting glucose were assessed at 0.5, 1, 1.5, 2.5, and 3.5 years.  Risk was evaluated with Cox proportional hazards with time-varying covariates.  The main outcome measure was the cumulative incidence of cardiovascular events (cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke).  A total of 1167 cardiovascular events occurred during 36 961 person-years of follow-up.  After multivariable adjustment for potential confounders in the time-dependent anal., the relative risk of cardiovascular events across categories of coffee consumption was 1.02 (95% CI 0.87 to 1.20) for <2 cups per day, 0.91 (95% CI 0.75 to 1.09) for 2 to 4 cups per day, and 0.88 (95% CI 0.64 to 1.20) for >4 cups per day compared with abstainers (P for trend=0.18).  Ultimately, coffee consumption did not change the risk of coronary heart disease events, stroke, and sudden death.  Conclusions- No assocn. between moderate coffee intake and cardiovascular events was obsd. in post-myocardial infarction patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGognzT3a-JLUbVg90H21EOLACvtfcHk0lhFXLmCVGGLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWjsr7I&md5=6f040d8dfb6ca43dd327a5ecf35e3a32</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.712976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.712976%26sid%3Dliteratum%253Aachs%26aulast%3DSilletta%26aufirst%3DM.%2BG.%26aulast%3DMarfisi%26aufirst%3DR.%26aulast%3DLevantesi%26aufirst%3DG.%26aulast%3DBoccanelli%26aufirst%3DA.%26aulast%3DChieffo%26aufirst%3DC.%26aulast%3DFranzosi%26aufirst%3DM.%26aulast%3DGeraci%26aufirst%3DE.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26aulast%3DNicolosi%26aufirst%3DG.%26aulast%3DSchweiger%26aufirst%3DC.%26aulast%3DTavazzi%26aufirst%3DL.%26aulast%3DTognoni%26aufirst%3DG.%26aulast%3DMarchioli%26aufirst%3DR.%26atitle%3DCoffee%2520Consumption%2520and%2520Risk%2520of%2520Cardiovascular%2520Events%2520after%2520Acute%2520Myocardial%2520Infarction%253A%2520Results%2520from%2520the%2520GISSI%2520%2528Gruppo%2520Italiano%2520per%2520Lo%2520Studio%2520Della%2520Sopravvivenza%2520Nell%25E2%2580%2599Infarto%2520Miocardico%2529-Prevenzione%2520Trial%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26issue%3D25%26spage%3D2944%26epage%3D2951%26doi%3D10.1161%2FCIRCULATIONAHA.107.712976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannel, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelli, W. P.</span></span> <span> </span><span class="NLM_article-title">Is Coffee Consumption a Contributor to Cardiovascular Disease? Insights from the Framingham Study</span>. <i>Arch. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1001/archinte.149.5.1169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Farchinte.1989.00390050125025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2719508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL1M3ksF2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1989&pages=1169-1172&issue=5&author=P.+W.+F.+Wilsonauthor=R.+J.+Garrisonauthor=W.+B.+Kannelauthor=D.+L.+McGeeauthor=W.+P.+Castelli&title=Is+Coffee+Consumption+a+Contributor+to+Cardiovascular+Disease%3F+Insights+from+the+Framingham+Study&doi=10.1001%2Farchinte.149.5.1169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study</span></div><div class="casAuthors">Wilson P W; Garrison R J; Kannel W B; McGee D L; Castelli W P</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1169-72</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">Reported coffee consumption during 1954 to 1958 and 1971 to 1973 was used to test for association with cardiovascular disease (CVD) incidence and lipid values in the Framingham cohort.  Multivariate analysis was employed, regressing CVD on age, systolic pressure, cigarette use, body mass index, total cholesterol, and coffee intake.  In pooled analyses (2648 men with 549 CVD cases and 3566 women with 462 CVD cases) coffee intake was not associated with CVD incidence in either smokers or nonsmokers, irrespective of sex.  Similarly, multivariate analyses for individuals with existing cardiovascular disease showed no association between coffee intake and subsequent cardiovascular disease.  In men significant negative associations between coffee and total cholesterol, and very-low-density lipoprotein cholesterol were seen, whereas in women positive associations with low-density lipoprotein cholesterol were observed.  Although inconsistent effects on the lipid profile were seen, no increase in primary or secondary CVD was seen with coffee drinking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIus0oc_XleCnGiHuhFGv8fW6udTcc2ebiBcMs2Zd307ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ksF2hsA%253D%253D&md5=a4fb53a024886eee0d82d3aea5cda608</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1001%2Farchinte.1989.00390050125025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.1989.00390050125025%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DP.%2BW.%2BF.%26aulast%3DGarrison%26aufirst%3DR.%2BJ.%26aulast%3DKannel%26aufirst%3DW.%2BB.%26aulast%3DMcGee%26aufirst%3DD.%2BL.%26aulast%3DCastelli%26aufirst%3DW.%2BP.%26atitle%3DIs%2520Coffee%2520Consumption%2520a%2520Contributor%2520to%2520Cardiovascular%2520Disease%253F%2520Insights%2520from%2520the%2520Framingham%2520Study%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1989%26volume%3D149%26issue%3D5%26spage%3D1169%26epage%3D1172%26doi%3D10.1001%2Farchinte.149.5.1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhupathiraju, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satija, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>129</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.113.005925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FCIRCULATIONAHA.113.005925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24201300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisF2kt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=643-659&issue=6&author=M.+Dingauthor=S.+N.+Bhupathirajuauthor=A.+Satijaauthor=R.+M.+Van+Damauthor=F.+B.+Hu&title=Long-Term+Coffee+Consumption+and+Risk+of+Cardiovascular+Disease%3A+A+Systematic+Review+and+a+Dose-Response+Meta-Analysis+of+Prospective+Cohort+Studies&doi=10.1161%2FCIRCULATIONAHA.113.005925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies</span></div><div class="casAuthors">Ding, Ming; Bhupathiraju, Shilpa N.; Satija, Ambika; van Dam, Rob M.; Hu, Frank B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">643-659</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: Considerable controversy exists on the assocn. between coffee consumption and cardiovascular disease (CVD) risk.  A meta-anal. was performed to assess the dose-response relationship of long-term coffee consumption with CVD risk.  METHODS AND RESULTS-: PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality.  Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases.  A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001).  Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87-1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80-0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84-0.94) for the third highest category (median, 1.5 cups per day).  Looking at sep. outcomes, coffee consumption was nonlinearly assocd. with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks.  CONCLUSIONS-: A nonlinear assocn. between coffee consumption and CVD risk was obsd. in this meta-anal.  Moderate coffee consumption was inversely significantly assocd. with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not assocd. with elevated CVD risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxzV3Ypxq8a7Vg90H21EOLACvtfcHk0li3KmKWcM_vGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisF2kt7g%253D&md5=75a60de4fc8bfb784665cbaad4c4bdbf</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.113.005925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.113.005925%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DM.%26aulast%3DBhupathiraju%26aufirst%3DS.%2BN.%26aulast%3DSatija%26aufirst%3DA.%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DLong-Term%2520Coffee%2520Consumption%2520and%2520Risk%2520of%2520Cardiovascular%2520Disease%253A%2520A%2520Systematic%2520Review%2520and%2520a%2520Dose-Response%2520Meta-Analysis%2520of%2520Prospective%2520Cohort%2520Studies%26jtitle%3DCirculation%26date%3D2014%26volume%3D129%26issue%3D6%26spage%3D643%26epage%3D659%26doi%3D10.1161%2FCIRCULATIONAHA.113.005925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuster, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, J.</span></span> <span> </span><span class="NLM_article-title">Energy Drinks: A Contemporary Issues Paper</span>. <i>Curr. Sports Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1249/JSR.0000000000000454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1249%2FJSR.0000000000000454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29420350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1MvptlWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=65-72&issue=2&author=J.+P.+Higginsauthor=K.+Babuauthor=P.+A.+Deusterauthor=J.+Shearer&title=Energy+Drinks%3A+A+Contemporary+Issues+Paper&doi=10.1249%2FJSR.0000000000000454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Energy Drinks: A Contemporary Issues Paper</span></div><div class="casAuthors">Higgins John P; Babu Kavita; Deuster Patricia A; Shearer Jane</div><div class="citationInfo"><span class="NLM_cas:title">Current sports medicine reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since their introduction in 1987, energy drinks have become increasingly popular and the energy drink market has grown at record pace into a multibillion-dollar global industry.  Young people, students, office workers, athletes, weekend warriors, and service members frequently consume energy drinks.  Both health care providers and consumers must recognize the difference between energy drinks, traditional beverages (e.g., coffee, tea, soft drinks/sodas, juices, or flavored water), and sports drinks.  The research about energy drinks safety and efficacy is often contradictory, given the disparate protocols and types of products consumed: this makes it difficult to draw firm conclusions.  Also, much of the available literature is industry-sponsored.  After reports of adverse events associated with energy drink consumption, concerns including trouble sleeping, anxiety, cardiovascular events, seizures, and even death, have been raised about their safety.  This article will focus on energy drinks, their ingredients, side effects associated with their consumption, and suggested recommendations, which call for education, regulatory actions, changes in marketing, and additional research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5cspLFyBlzO2mnZh2OgS0fW6udTcc2eZxZk5Cx33oQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvptlWqsg%253D%253D&md5=2ba2cc57eecf4cc28651ad21cfea467a</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1249%2FJSR.0000000000000454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1249%252FJSR.0000000000000454%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%2BP.%26aulast%3DBabu%26aufirst%3DK.%26aulast%3DDeuster%26aufirst%3DP.%2BA.%26aulast%3DShearer%26aufirst%3DJ.%26atitle%3DEnergy%2520Drinks%253A%2520A%2520Contemporary%2520Issues%2520Paper%26jtitle%3DCurr.%2520Sports%2520Med.%2520Rep.%26date%3D2018%26volume%3D17%26issue%3D2%26spage%3D65%26epage%3D72%26doi%3D10.1249%2FJSR.0000000000000454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, C. L.</span></span> <span> </span><span class="NLM_article-title">Energy Beverages: Content and Safety</span>. <i>Mayo Clin. Proc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.4065/mcp.2010.0381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4065%2Fmcp.2010.0381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21037046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1yku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=1033-1041&issue=11&author=J.+P.+Higginsauthor=T.+D.+Tuttleauthor=C.+L.+Higgins&title=Energy+Beverages%3A+Content+and+Safety&doi=10.4065%2Fmcp.2010.0381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Energy Beverages: content and safety</span></div><div class="casAuthors">Higgins, John P.; Tuttle, Troy D.; Higgins, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1033-1041</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Quadrant HealthCom Inc.</span>)
        </div><div class="casAbstract">A review.  Exercise is making a resurgence in many countries, given its benefits for fitness as well as prevention of obesity.  This trend has spawned many supplements that purport to aid performance, muscle growth, and recovery.  Initially, sports drinks were developed to provide electrolyte and carbohydrate replacement.  Subsequently, energy beverages (EBs) contg. stimulants and additives have appeared in most gyms and grocery stores and are being used increasingly by "weekend warriors" and those seeking an edge in an endurance event.  Long-term exposure to the various components of EBs may result in significant alterations in the cardiovascular system, and the safety of EBs has not been fully established.  For this review, we searched the MEDLINE and EMBASE databases from 1976 through May 2010, using the following keywords: energy beverage, energy drink, power drink, exercise, caffeine, red bull, bitter orange, glucose, ginseng, guarana, and taurine.  Evidence regarding the effects of EBs is summarized, and practical recommendations are made to help in answering the patient who asks, "is it safe for me to drink an energy beverage when I exercise".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmXLsGq84H2bVg90H21EOLACvtfcHk0li3KmKWcM_vGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1yku7k%253D&md5=bd11cbdaeef8446897154a9b9bd1e19e</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2010.0381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2010.0381%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%2BP.%26aulast%3DTuttle%26aufirst%3DT.%2BD.%26aulast%3DHiggins%26aufirst%3DC.%2BL.%26atitle%3DEnergy%2520Beverages%253A%2520Content%2520and%2520Safety%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26issue%3D11%26spage%3D1033%26epage%3D1041%26doi%3D10.4065%2Fmcp.2010.0381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arria, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldeira, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Grady, K. E.</span></span> <span> </span><span class="NLM_article-title">Energy Drink Consumption and Increased Risk for Alcohol Dependence</span>. <i>Alcohol.: Clin. Exp. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1111/j.1530-0277.2010.01352.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1530-0277.2010.01352.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21073486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jvVenug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=365-375&issue=2&author=A.+M.+Arriaauthor=K.+M.+Caldeiraauthor=S.+J.+Kasperskiauthor=K.+B.+Vincentauthor=R.+R.+Griffithsauthor=K.+E.+O%E2%80%99Grady&title=Energy+Drink+Consumption+and+Increased+Risk+for+Alcohol+Dependence&doi=10.1111%2Fj.1530-0277.2010.01352.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Energy drink consumption and increased risk for alcohol dependence</span></div><div class="casAuthors">Arria Amelia M; Caldeira Kimberly M; Kasperski Sarah J; Vincent Kathryn B; Griffiths Roland R; O'Grady Kevin E</div><div class="citationInfo"><span class="NLM_cas:title">Alcoholism, clinical and experimental research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Energy drinks are highly caffeinated beverages that are increasingly consumed by young adults.  Prior research has established associations between energy drink use and heavier drinking and alcohol-related problems among college students.  This study investigated the extent to which energy drink use might pose additional risk for alcohol dependence over and above that from known risk factors.  METHODS:  Data were collected via personal interview from 1,097 fourth-year college students sampled from 1 large public university as part of an ongoing longitudinal study.  Alcohol dependence was assessed according to DSM-IV criteria.  RESULTS:  After adjustment for the sampling design, 51.3%(wt) of students were classified as "low-frequency" energy drink users (1 to 51 days in the past year) and 10.1%(wt) as "high-frequency" users (≥52 days).  Typical caffeine consumption varied widely depending on the brand consumed.  Compared to the low-frequency group, high-frequency users drank alcohol more frequently (141.6 vs. 103.1 days) and in higher quantities (6.15 vs. 4.64 drinks/typical drinking day).  High-frequency users were at significantly greater risk for alcohol dependence relative to both nonusers (AOR = 2.40, 95% CI = 1.27 to 4.56, p = 0.007) and low-frequency users (AOR = 1.86, 95% CI = 1.10, 3.14, p = 0.020), even after holding constant demographics, typical alcohol consumption, fraternity/sorority involvement, depressive symptoms, parental history of alcohol/drug problems, and childhood conduct problems.  Low-frequency energy drink users did not differ from nonusers on their risk for alcohol dependence.  CONCLUSIONS:  Weekly or daily energy drink consumption is strongly associated with alcohol dependence.  Further research is warranted to understand the possible mechanisms underlying this association.  College students who frequently consume energy drinks represent an important target population for alcohol prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTamH1wC0VwRmBAiYWy6n3SfW6udTcc2eZxZk5Cx33oQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jvVenug%253D%253D&md5=862e15bb1f7c7085fcad3bf57a37eee4</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1111%2Fj.1530-0277.2010.01352.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1530-0277.2010.01352.x%26sid%3Dliteratum%253Aachs%26aulast%3DArria%26aufirst%3DA.%2BM.%26aulast%3DCaldeira%26aufirst%3DK.%2BM.%26aulast%3DKasperski%26aufirst%3DS.%2BJ.%26aulast%3DVincent%26aufirst%3DK.%2BB.%26aulast%3DGriffiths%26aufirst%3DR.%2BR.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DK.%2BE.%26atitle%3DEnergy%2520Drink%2520Consumption%2520and%2520Increased%2520Risk%2520for%2520Alcohol%2520Dependence%26jtitle%3DAlcohol.%253A%2520Clin.%2520Exp.%2520Res.%26date%3D2011%26volume%3D35%26issue%3D2%26spage%3D365%26epage%3D375%26doi%3D10.1111%2Fj.1530-0277.2010.01352.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, T.</span></span> <span> </span><span class="NLM_article-title">Fatal Caffeine Overdose: Two Case Reports</span>. <i>Forensic Sci. Int.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>153</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.forsciint.2005.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.forsciint.2005.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15935584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVWltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2005&pages=67-69&issue=1&author=S.+Kerriganauthor=T.+Lindsey&title=Fatal+Caffeine+Overdose%3A+Two+Case+Reports&doi=10.1016%2Fj.forsciint.2005.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Fatal caffeine overdose: Two case reports</span></div><div class="casAuthors">Kerrigan, Sarah; Lindsey, Tania</div><div class="citationInfo"><span class="NLM_cas:title">Forensic Science International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-69</span>CODEN:
                <span class="NLM_cas:coden">FSINDR</span>;
        ISSN:<span class="NLM_cas:issn">0379-0738</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Caffeine is a mild central nervous stimulant that occurs naturally in coffee beans, cocoa beans and tea leaves.  In large doses, it can be profoundly toxic, resulting in arrhythmia, tachycardia, vomiting, convulsions, coma and death.  The av. cup of coffee or tea in the United States is reported to contain between 40 and 150 mg caffeine although specialty coffees may contain much higher doses.  Over-the-counter supplements that are used to combat fatigue typically contain 100-200 mg caffeine per tablet and doses of 32-200 mg are included in a variety of prescription drug mixts.  Fatal caffeine overdoses in adults are relatively rare and require the ingestion of a large quantity of the drug, typically in excess of 5 g.  Over a period of approx. 12 mo our office reported two cases of fatal caffeine intoxication.  In the first case, the femoral blood of a 39-yr-old female with a history of i.v. drug use contained 192 mg/L caffeine.  In the second case, femoral blood from a 29-yr-old male with a history of obesity and diabetes contained 567 mg/L caffeine.  In both cases, the cause of death was ruled as caffeine intoxication and the manner of death was accidental.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUACJ6OtnMFbVg90H21EOLACvtfcHk0lgxUFhrzuakYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVWltL4%253D&md5=5f97b7a1ccc51c7b668143423f98a3d6</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1016%2Fj.forsciint.2005.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.forsciint.2005.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DKerrigan%26aufirst%3DS.%26aulast%3DLindsey%26aufirst%3DT.%26atitle%3DFatal%2520Caffeine%2520Overdose%253A%2520Two%2520Case%2520Reports%26jtitle%3DForensic%2520Sci.%2520Int.%26date%3D2005%26volume%3D153%26issue%3D1%26spage%3D67%26epage%3D69%26doi%3D10.1016%2Fj.forsciint.2005.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, K. M.</span></span> <span> </span><span class="NLM_article-title">Caffeine Reduces Myocardial Blood Flow during Exercise</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">730.e1</span>– <span class="NLM_lpage">730.e8</span>, <span class="refDoi"> DOI: 10.1016/j.amjmed.2012.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.amjmed.2012.12.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=730.e1-730.e8&issue=8&author=J.+P.+Higginsauthor=K.+M.+Babu&title=Caffeine+Reduces+Myocardial+Blood+Flow+during+Exercise&doi=10.1016%2Fj.amjmed.2012.12.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2012.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2012.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%2BP.%26aulast%3DBabu%26aufirst%3DK.%2BM.%26atitle%3DCaffeine%2520Reduces%2520Myocardial%2520Blood%2520Flow%2520during%2520Exercise%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2013%26volume%3D126%26issue%3D8%26spage%3D730.e1%26epage%3D730.e8%26doi%3D10.1016%2Fj.amjmed.2012.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldfarb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tellier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanassoulis, G.</span></span> <span> </span><span class="NLM_article-title">Review of Published Cases of Adverse Cardiovascular Events after Ingestion of Energy Drinks</span>. <i>Am. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1016/j.amjcard.2013.08.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.amjcard.2013.08.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24176062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2c7hsVCitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=168-172&issue=1&author=M.+Goldfarbauthor=C.+Tellierauthor=G.+Thanassoulis&title=Review+of+Published+Cases+of+Adverse+Cardiovascular+Events+after+Ingestion+of+Energy+Drinks&doi=10.1016%2Fj.amjcard.2013.08.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Review of published cases of adverse cardiovascular events after ingestion of energy drinks</span></div><div class="casAuthors">Goldfarb Michael; Tellier Claudia; Thanassoulis George</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Energy drink (ED) consumption has been linked to several adverse event reports, but there is limited data on related cardiovascular (CV) complications.  We describe clinical characteristics, ED consumption profile, co-ingestions, and results of cardiovascular testing in a series of cardiovascular event reports temporally related to ED consumption from the literature.  We searched PubMed and Embase for case reports in peer-reviewed journals from January 1, 1980, to February 1, 2013, in which an acute CV event was associated temporally with ED consumption.  We identified 14 eligible articles involving 15 cases (5 atrial arrhythmias, 5 ventricular arrhythmias, 1 QT prolongation, 4 ST-segment elevations).  Two additional cases of cardiac arrest from our institution are included.  Of these 17 cases of ED-related acute CV events (13 male cases; 15 cases aged <30 years, age range 13 to 58 years), only 1 had minor previous cardiac disease.  Cardiac investigations did not reveal any predisposing cardiac abnormality in the majority of cases.  Of the 11 cases related to a serious event (i.e., cardiac arrest, ventricular arrhythmia, or ST-segment elevations), 5 reported acute heavy ED consumption, 4 reported co-ingestions with alcohol or other drugs, and 2 were found to have a channelopathy.  Potential mechanisms of ED-related cardiac events are reviewed.  In conclusion, several adverse CV events after consuming ED have been reported in the literature.  Although causality cannot be inferred from our series, physicians should routinely inquire about ED consumption in relevant cases, and vulnerable consumers such as youth should be advised that caution is warranted with heavy consumption and/or with concomitant alcohol or drug ingestion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUnr88hZ8OT0odMGTatQ7LfW6udTcc2eZd-H6OKVye6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7hsVCitA%253D%253D&md5=70d6f5d32c417510ec7222dce595d1d0</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1016%2Fj.amjcard.2013.08.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjcard.2013.08.058%26sid%3Dliteratum%253Aachs%26aulast%3DGoldfarb%26aufirst%3DM.%26aulast%3DTellier%26aufirst%3DC.%26aulast%3DThanassoulis%26aufirst%3DG.%26atitle%3DReview%2520of%2520Published%2520Cases%2520of%2520Adverse%2520Cardiovascular%2520Events%2520after%2520Ingestion%2520of%2520Energy%2520Drinks%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2014%26volume%3D113%26issue%3D1%26spage%3D168%26epage%3D172%26doi%3D10.1016%2Fj.amjcard.2013.08.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular Complications of Energy Drinks</span>. <i>Beverages</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.3390/beverages1020104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3390%2Fbeverages1020104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=104-126&issue=2&author=J.+Higginsauthor=S.+Yarlagaddaauthor=B.+Yang&title=Cardiovascular+Complications+of+Energy+Drinks&doi=10.3390%2Fbeverages1020104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.3390%2Fbeverages1020104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbeverages1020104%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DYarlagadda%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DCardiovascular%2520Complications%2520of%2520Energy%2520Drinks%26jtitle%3DBeverages%26date%3D2015%26volume%3D1%26issue%3D2%26spage%3D104%26epage%3D126%26doi%3D10.3390%2Fbeverages1020104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al Yacoub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luczkiewicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, C.</span></span> <span> </span><span class="NLM_article-title">Acute Kidney Injury and Hepatitis Associated with Energy Drink Consumption: A Case Report</span>. <i>J. Med. Case Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.1186/s13256-019-2340-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs13256-019-2340-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31992329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB38%252FlsFGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=23&issue=1&author=R.+Al+Yacoubauthor=D.+Luczkiewiczauthor=C.+Kerr&title=Acute+Kidney+Injury+and+Hepatitis+Associated+with+Energy+Drink+Consumption%3A+A+Case+Report&doi=10.1186%2Fs13256-019-2340-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Acute kidney injury and hepatitis associated with energy drink consumption: a case report</span></div><div class="casAuthors">Al Yacoub Raed; Al Yacoub Raed; Luczkiewicz Debra; Kerr Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical case reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  In the USA, energy drinks are commonly consumed among adults.  The side effects of these drinks are not well studied but consumers have reported multiple adverse events to the US Food and Drug Administration including acute kidney injury and acute hepatitis.  CASE PRESENTATION:  A 62-year-old white woman presented with progressive weakness, fatigue, confusion, and delirium secondary to acute kidney injury and acute hepatitis associated with excessive energy drink use.  Clinical improvement occurred with supportive care and discontinuation of energy drinks, with resolution of acute kidney injury and progressive improvement of liver function.  The defined mechanism of injury is unknown but thought due to energy drink ingredients.  CONCLUSION:  Multiple cases of energy drink-induced acute kidney injury or acute hepatitis are reported in the literature but this case is the first to report them simultaneously.  Ingredients and presumed doses to cause these events are outlined in this case report.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTExDWfDF9DFeIHSmpohpd0fW6udTcc2eZd-H6OKVye6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38%252FlsFGhsQ%253D%253D&md5=fd107bccd60a3999d12aeef71296336c</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1186%2Fs13256-019-2340-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13256-019-2340-0%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BYacoub%26aufirst%3DR.%26aulast%3DLuczkiewicz%26aufirst%3DD.%26aulast%3DKerr%26aufirst%3DC.%26atitle%3DAcute%2520Kidney%2520Injury%2520and%2520Hepatitis%2520Associated%2520with%2520Energy%2520Drink%2520Consumption%253A%2520A%2520Case%2520Report%26jtitle%3DJ.%2520Med.%2520Case%2520Rep.%26date%3D2020%26volume%3D14%26issue%3D1%26spage%3D23%26doi%3D10.1186%2Fs13256-019-2340-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond-Haley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Silva, A.</span></span> <span> </span><span class="NLM_article-title">Energy Drink-Induced Cardiomyopathy</span>. <i>BMJ. Case Rep.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e239370</span> <span class="refDoi"> DOI: 10.1136/bcr-2020-239370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1136%2Fbcr-2020-239370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33858880" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2021&issue=4&author=G.+Fiskauthor=M.+Hammond-Haleyauthor=A.+D%E2%80%99Silva&title=Energy+Drink-Induced+Cardiomyopathy&doi=10.1136%2Fbcr-2020-239370"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1136%2Fbcr-2020-239370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbcr-2020-239370%26sid%3Dliteratum%253Aachs%26aulast%3DFisk%26aufirst%3DG.%26aulast%3DHammond-Haley%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Silva%26aufirst%3DA.%26atitle%3DEnergy%2520Drink-Induced%2520Cardiomyopathy%26jtitle%3DBMJ.%2520Case%2520Rep.%26date%3D2021%26volume%3D14%26issue%3D4%26doi%3D10.1136%2Fbcr-2020-239370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendash, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezai-Zadeh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharia, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cracchiolo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shippy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span> <span> </span><span class="NLM_article-title">Caffeine Protects Alzheimer’s Mice against Cognitive Impairment and Reduces Brain β-Amyloid Production</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2006.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroscience.2006.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16938404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFCjsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2006&pages=941-952&issue=4&author=G.+W.+Arendashauthor=W.+Schleifauthor=K.+Rezai-Zadehauthor=E.+K.+Jacksonauthor=L.+C.+Zachariaauthor=J.+R.+Cracchioloauthor=D.+Shippyauthor=J.+Tan&title=Caffeine+Protects+Alzheimer%E2%80%99s+Mice+against+Cognitive+Impairment+and+Reduces+Brain+%CE%B2-Amyloid+Production&doi=10.1016%2Fj.neuroscience.2006.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production</span></div><div class="casAuthors">Arendash, G. W.; Schleif, W.; Rezai-Zadeh, K.; Jackson, E. K.; Zacharia, L. C.; Cracchiolo, J. R.; Shippy, D.; Tan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">941-952</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A recent epidemiol. study suggested that higher caffeine intake over decades reduces the risk of Alzheimer's disease (AD).  The present study sought to det. any long-term protective effects of dietary caffeine intake in a controlled longitudinal study involving AD transgenic mice.  Caffeine (an adenosine receptor antagonist) was added to the drinking water of amyloid precursor protein, Swedish mutation (APPsw) transgenic (Tg) mice between 4 and 9 mo of age, with behavioral testing done during the final 6 wk of treatment.  The av. daily intake of caffeine per mouse (1.5 mg) was the human equiv. of 500 mg caffeine, the amt. typically found in five cups of coffee per day.  Across multiple cognitive tasks of spatial learning/ref. memory, working memory, and recognition/identification, Tg mice given caffeine performed significantly better than Tg control mice and similar to non-transgenic controls.  In both behaviorally-tested and aged Tg mice, long-term caffeine administration resulted in lower hippocampal β-amyloid (Aβ) levels.  Expression of both Presenilin 1 (PS1) and β-secretase (BACE) was reduced in caffeine-treated Tg mice, indicating decreased Aβ prodn. as a likely mechanism of caffeine's cognitive protection.  The ability of caffeine to reduce Aβ prodn. was confirmed in SweAPP N2a neuronal cultures, wherein concn.-dependent decreases in both Aβ1-40 and Aβ1-42 were obsd.  Although adenosine A1 or A2A receptor densities in cortex or hippocampus were not affected by caffeine treatment, brain adenosine levels in Tg mice were restored back to normal by dietary caffeine and could be involved in the cognitive protection provided by caffeine.  Our data demonstrate that moderate daily intake of caffeine may delay or reduce the risk of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rlmKyoQ0fbVg90H21EOLACvtfcHk0liqV34JVtArjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFCjsb%252FF&md5=47bdc04139af30f1ff6c7da640627506</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2006.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2006.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DArendash%26aufirst%3DG.%2BW.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DRezai-Zadeh%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DZacharia%26aufirst%3DL.%2BC.%26aulast%3DCracchiolo%26aufirst%3DJ.%2BR.%26aulast%3DShippy%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DJ.%26atitle%3DCaffeine%2520Protects%2520Alzheimer%25E2%2580%2599s%2520Mice%2520against%2520Cognitive%2520Impairment%2520and%2520Reduces%2520Brain%2520%25CE%25B2-Amyloid%2520Production%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D142%26issue%3D4%26spage%3D941%26epage%3D952%26doi%3D10.1016%2Fj.neuroscience.2006.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendash, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamcarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runfeldt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezai-Zadeh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echeverria, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, H.</span></span> <span> </span><span class="NLM_article-title">Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer’s Disease Mice</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-1087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2009-1087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19581722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVemtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=661-680&issue=3&author=G.+W.+Arendashauthor=T.+Moriauthor=C.+Caoauthor=M.+Mamcarzauthor=M.+Runfeldtauthor=A.+Dicksonauthor=K.+Rezai-Zadehauthor=J.+Tanauthor=B.+A.+Citronauthor=X.+Linauthor=V.+Echeverriaauthor=H.+Potter&title=Caffeine+Reverses+Cognitive+Impairment+and+Decreases+Brain+Amyloid-%CE%B2+Levels+in+Aged+Alzheimer%E2%80%99s+Disease+Mice&doi=10.3233%2FJAD-2009-1087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice</span></div><div class="casAuthors">Arendash, Gary W.; Mori, Takashi; Cao, Chuanhai; Mamcarz, Malgorzata; Runfeldt, Melissa; Dickson, Alexander; Rezai-Zadeh, Kavon; Tan, Jun; Citron, Bruce A.; Lin, Xiaoyang; Echeverria, Valentina; Potter, Huntington</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-680</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We have recently shown that Alzheimer's disease (AD) transgenic mice given a moderate level of caffeine intake (the human equiv. of 5 cups of coffee per day) are protected from development of otherwise certain cognitive impairment and have decreased hippocampal amyloid-β (Aβ) levels due to suppression of both β-secretase (BACE1) and presenilin 1 (PS1)/γ-secretase expression.  To det. if caffeine intake can have beneficial effects in "aged" APPsw mice already demonstrating cognitive impairment, we administered caffeine in the drinking water of 18-19 mo old APPsw mice that were impaired in working memory.  At 4-5 wk into caffeine treatment, those impaired transgenic mice given caffeine (Tg/Caff) exhibited vastly superior working memory compared to the continuing impairment of control transgenic mice.  In addn., Tg/Caff mice had substantially reduced Aβ deposition in hippocampus (↓40%) and entorhinal cortex (↓46%), as well as correlated decreases in brain sol. Aβ levels.  Mechanistically, evidence is provided that caffeine suppression of BACE1 involves the cRaf-1/NFκB pathway.  We also detd. that caffeine concns. within human physiol. range effectively reduce active and total glycogen synthase kinase 3 levels in SweAPP N2a cells.  Even with pre-existing and substantial Aβ burden, aged APPsw mice exhibited memory restoration and reversal of AD pathol., suggesting a treatment potential of caffeine in cases of established AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKiZaJJpsEubVg90H21EOLACvtfcHk0liqV34JVtArjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVemtb4%253D&md5=8d175a445da877284e30e89fa052ee2c</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-1087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-1087%26sid%3Dliteratum%253Aachs%26aulast%3DArendash%26aufirst%3DG.%2BW.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DMamcarz%26aufirst%3DM.%26aulast%3DRunfeldt%26aufirst%3DM.%26aulast%3DDickson%26aufirst%3DA.%26aulast%3DRezai-Zadeh%26aufirst%3DK.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCitron%26aufirst%3DB.%2BA.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DEcheverria%26aufirst%3DV.%26aulast%3DPotter%26aufirst%3DH.%26atitle%3DCaffeine%2520Reverses%2520Cognitive%2520Impairment%2520and%2520Decreases%2520Brain%2520Amyloid-%25CE%25B2%2520Levels%2520in%2520Aged%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Mice%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D661%26epage%3D680%26doi%3D10.3233%2FJAD-2009-1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verreault, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurin, D.</span></span> <span> </span><span class="NLM_article-title">More Than the Epidemiology of Alzheimer’s Disease: Contributions of the Canadian Study of Health and Aging</span>. <i>Can. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1177/070674370404900202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1177%2F070674370404900202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15065741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2c7ntFGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2004&pages=83-91&issue=2&author=J.+Lindsayauthor=E.+Sykesauthor=I.+McDowellauthor=R.+Verreaultauthor=D.+Laurin&title=More+Than+the+Epidemiology+of+Alzheimer%E2%80%99s+Disease%3A+Contributions+of+the+Canadian+Study+of+Health+and+Aging&doi=10.1177%2F070674370404900202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">More than the epidemiology of Alzheimer's disease: contributions of the Canadian Study of Health and Aging</span></div><div class="casAuthors">Lindsay Joan; Sykes Elizabeth; McDowell Ian; Verreault Rene; Laurin Danielle</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of psychiatry. Revue canadienne de psychiatrie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-91</span>
        ISSN:<span class="NLM_cas:issn">0706-7437</span>.
    </div><div class="casAbstract">OBJECTIVE:  To highlight contributions to knowledge made by the Canadian Study of Health and Aging (CSHA).  METHOD:  The CSHA began in 1991, with follow-ups in 1996 and 2001.  It was national in scope, with 18 study centres and a coordinating centre.  It included 10 263 participants; of these, 9008 were in the community, and 1255 were in institutions.  In each phase, community participants were screened for cognitive impairment, and where appropriate, cognitive status was determined by a detailed clinical examination.  Data on possible risk factors for dementia were collected at baseline.  Data on caring for people with dementia were collected in each phase.  RESULTS:  The prevalence of dementia was established at 8% of those aged 65 years and over; incidence (new cases each year) was about 2%.  Cognitive impairment not dementia (CIND) was more than twice as common as dementia.  Factors affecting the risk of institutionalization, mortality, and the health of caregivers were examined.  The costs of dementia were conservatively estimated at dollar 3.9 billion in 1991.  Risk factors for Alzheimer's disease (AD) and vascular dementia are presented; it is noteworthy that physical activity appeared to protect against all forms of cognitive decline, particularly for women.  Clinical contributions include the development of norms for several neuropsychological tests.  Other topics include the health of those with CIND, predicting dementia, medication use, frailty and healthy aging, and urinary incontinence.  CONCLUSION:  The CSHA has contributed substantially to knowledge of the epidemiology of dementia, including AD, and to many other topics relevant to seniors' health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8VTvsviIPDvx2phytoz6_fW6udTcc2eY3Y-HxFN01Rbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7ntFGhsQ%253D%253D&md5=45e21ee8141a44b13e04827b26ffe3f3</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1177%2F070674370404900202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F070674370404900202%26sid%3Dliteratum%253Aachs%26aulast%3DLindsay%26aufirst%3DJ.%26aulast%3DSykes%26aufirst%3DE.%26aulast%3DMcDowell%26aufirst%3DI.%26aulast%3DVerreault%26aufirst%3DR.%26aulast%3DLaurin%26aufirst%3DD.%26atitle%3DMore%2520Than%2520the%2520Epidemiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Contributions%2520of%2520the%2520Canadian%2520Study%2520of%2520Health%2520and%2520Aging%26jtitle%3DCan.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D49%26issue%3D2%26spage%3D83%26epage%3D91%26doi%3D10.1177%2F070674370404900202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Gelder, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijhuis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmijn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampaoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissinen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kromhout, D.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption Is Inversely Associated with Cognitive Decline in Elderly European Men: The FINE Study</span>. <i>Eur. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/sj.ejcn.1602495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.ejcn.1602495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16929246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtlGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=226-232&issue=2&author=B.+M.+van+Gelderauthor=B.+Buijsseauthor=M.+Tijhuisauthor=S.+Kalmijnauthor=S.+Giampaoliauthor=A.+Nissinenauthor=D.+Kromhout&title=Coffee+Consumption+Is+Inversely+Associated+with+Cognitive+Decline+in+Elderly+European+Men%3A+The+FINE+Study&doi=10.1038%2Fsj.ejcn.1602495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study</span></div><div class="casAuthors">van Gelder B M; Buijsse B; Tijhuis M; Kalmijn S; Giampaoli S; Nissinen A; Kromhout D</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-32</span>
        ISSN:<span class="NLM_cas:issn">0954-3007</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate whether coffee consumption is associated with 10-year cognitive decline in elderly men, as results of previous studies obtained hitherto have been controversial and prospective information on this association has been lacking.  DESIGN, SUBJECTS AND SETTING:  Six hundred and seventy six healthy men born between 1900 and 1920 from Finland, Italy and the Netherlands participated in a 10-year prospective cohort study.  Cognitive functioning was assessed using the Mini-Mental State Examination (0-30 points, with a higher score indicating better cognitive performance).  Coffee consumption was estimated in cups per day.  A mixed longitudinal model was used to investigate the association between baseline coffee consumption and 10-year cognitive decline.  Multiple adjustments were made.  RESULTS:  Men who consumed coffee had a 10-year cognitive decline of 1.2 points (4%).  Non-consumers had an additional decline of 1.4 points (P<0.001).  An inverse and J-shaped association was observed between the number of cups of coffee consumed and cognitive decline, with the least cognitive decline for three cups of coffee per day (0.6 points).  This decline was 4.3 times smaller than the decline of non-consumers (P<0.001).  CONCLUSIONS:  Findings suggest that consuming coffee reduces cognitive decline in elderly men.  An inverse and J-shaped association may exist between the number of cups of coffee consumed and cognitive decline, with the least cognitive decline for men consuming three cups of coffee per day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR34N7dyCByTH6oPH0mYWL1fW6udTcc2eZqS_dfuozQGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtlGjsQ%253D%253D&md5=6e1d591de56e57b3ad20e5be146bb350</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1038%2Fsj.ejcn.1602495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ejcn.1602495%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGelder%26aufirst%3DB.%2BM.%26aulast%3DBuijsse%26aufirst%3DB.%26aulast%3DTijhuis%26aufirst%3DM.%26aulast%3DKalmijn%26aufirst%3DS.%26aulast%3DGiampaoli%26aufirst%3DS.%26aulast%3DNissinen%26aufirst%3DA.%26aulast%3DKromhout%26aufirst%3DD.%26atitle%3DCoffee%2520Consumption%2520Is%2520Inversely%2520Associated%2520with%2520Cognitive%2520Decline%2520in%2520Elderly%2520European%2520Men%253A%2520The%2520FINE%2520Study%26jtitle%3DEur.%2520J.%2520Clin.%2520Nutr.%26date%3D2007%26volume%3D61%26issue%3D2%26spage%3D226%26epage%3D232%26doi%3D10.1038%2Fsj.ejcn.1602495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higdon, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, B.</span></span> <span> </span><span class="NLM_article-title">Coffee and Health: A Review of Recent Human Research</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1080/10408390500400009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1080%2F10408390500400009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16507475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=101-123&issue=2&author=J.+V.+Higdonauthor=B.+Frei&title=Coffee+and+Health%3A+A+Review+of+Recent+Human+Research&doi=10.1080%2F10408390500400009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee and health: a review of recent human research</span></div><div class="casAuthors">Higdon, Jane V.; Frei, Balz</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-123</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Coffee is a complex mixt. of chems. that provides significant amt. of chlorogenic acid and caffeine.  Unfiltered coffee is a significant source of cafestol and kahweol, which are diterpenes that have been implicated in the cholesterol raising effects of coffee.  The results of epidemiol. research suggest that coffee consumption may help prevent several chronic diseases, including type 2 diabetes mellitus, Parkinson's disease and liver disease (cirrhosis and hepatocellular carcinoma).  Most prospective cohort studies have not found coffee consumption to be assocd. with significantly increased cardiovascular disease risk.  However, coffee consumption is assocd. with increases in several cardiovascular disease risk factors, including blood pressure and plasma homocysteine.  At present, there is little evidence that coffee consumption increases the risk of cancer.  For adults consuming moderate amts. of coffee (3-4 cups/d providing 300-400 mg/d of caffeine), there is little evidence of health risks and some evidence of health benefits.  However, some groups, including people with hypertension, children, adolescents, and the elderly, may be more vulnerable to the adverse effects of caffeine.  In addn., currently available evidence suggests that it may be prudent for pregnant women to limit coffee consumption to 3 cups/d providing no more than 300 mg/d of caffeine to exclude any increased probability of spontaneous abortion or impaired fetal growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY9IX4q-cSzbVg90H21EOLACvtfcHk0li0pUImImg2pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWqt70%253D&md5=98a39a36a1f1f296fd1b0570d8f4dee2</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1080%2F10408390500400009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408390500400009%26sid%3Dliteratum%253Aachs%26aulast%3DHigdon%26aufirst%3DJ.%2BV.%26aulast%3DFrei%26aufirst%3DB.%26atitle%3DCoffee%2520and%2520Health%253A%2520A%2520Review%2520of%2520Recent%2520Human%2520Research%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2006%26volume%3D46%26issue%3D2%26spage%3D101%26epage%3D123%26doi%3D10.1080%2F10408390500400009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manson, J. A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Coffee, Caffeine, and Risk of Type 2 Diabetes: A Prospective Cohort Study in Younger and Middle-Aged U.S. Women</span>. <i>Diabetes Care</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.2337/diacare.29.02.06.dc05-1512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2337%2Fdiacare.29.02.06.dc05-1512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16443894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD28%252Flsl2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=398-403&issue=2&author=R.+M.+Van+Damauthor=W.+C.+Willettauthor=J.+A.+E.+Mansonauthor=F.+B.+Hu&title=Coffee%2C+Caffeine%2C+and+Risk+of+Type+2+Diabetes%3A+A+Prospective+Cohort+Study+in+Younger+and+Middle-Aged+U.S.+Women&doi=10.2337%2Fdiacare.29.02.06.dc05-1512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women</span></div><div class="casAuthors">van Dam Rob M; Willett Walter C; Manson Joann E; Hu Frank B</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">398-403</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  High habitual coffee consumption has been associated with a lower risk of type 2 diabetes, but data on lower levels of consumption and on different types of coffee are sparse.  RESEARCH DESIGN AND METHODS:  This is a prospective cohort study including 88,259 U.S. women of the Nurses' Health Study II aged 26-46 years without history of diabetes at baseline.  Consumption of coffee and other caffeine-containing foods and drinks was assessed in 1991, 1995, and 1999.  We documented 1,263 incident cases of confirmed type 2 diabetes between 1991 and 2001.  RESULTS:  After adjustment for potential confounders, the relative risk of type 2 diabetes was 0.87 (95% CI 0.73-1.03) for one cup per day, 0.58 (0.49-0.68) for two to three cups per day, and 0.53 (0.41-0.68) for four or more cups per day compared with nondrinkers (P for trend <0.0001).  Associations were similar for caffeinated (0.87 [0.83-0.91] for a one-cup increment per day) and decaffeinated (0.81 [0.73-0.90]) coffee and for filtered (0.86 [0.82-0.90]) and instant (0.83 [0.74-0.93]) coffee.  Tea consumption was not substantially associated with risk of type 2 diabetes (0.88 [0.64-1.23] for four or more versus no cups per day; P for trend = 0.81).  CONCLUSIONS:  These results suggest that moderate consumption of both caffeinated and decaffeinated coffee may lower risk of type 2 diabetes in younger and middle-aged women.  Coffee constituents other than caffeine may affect the development of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYNejkz31lvCjiVMCqkKxVfW6udTcc2eZqS_dfuozQGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252Flsl2htA%253D%253D&md5=0c8b749fbd02d3514900d00222ae1261</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.29.02.06.dc05-1512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.29.02.06.dc05-1512%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26aulast%3DManson%26aufirst%3DJ.%2BA.%2BE.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DCoffee%252C%2520Caffeine%252C%2520and%2520Risk%2520of%2520Type%25202%2520Diabetes%253A%2520A%2520Prospective%2520Cohort%2520Study%2520in%2520Younger%2520and%2520Middle-Aged%2520U.S.%2520Women%26jtitle%3DDiabetes%2520Care%26date%3D2006%26volume%3D29%26issue%3D2%26spage%3D398%26epage%3D403%26doi%3D10.2337%2Fdiacare.29.02.06.dc05-1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cadden, I. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partovi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, E. M.</span></span> <span> </span><span class="NLM_article-title">Review Article: Possible Beneficial Effects of Coffee on Liver Disease and Function</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2036.2007.03319.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1365-2036.2007.03319.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17555416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslGmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1&author=I.+S.+H.+Caddenauthor=N.+Partoviauthor=E.+M.+Yoshida&title=Review+Article%3A+Possible+Beneficial+Effects+of+Coffee+on+Liver+Disease+and+Function&doi=10.1111%2Fj.1365-2036.2007.03319.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: possible beneficial effects of coffee on liver disease and function</span></div><div class="casAuthors">Cadden, I. S. H.; Partovi, N.; Yoshida, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Coffee is consumed by 50% of Americans every day.  After oil, coffee is the second most valuable commodity in the world.  In recent years a no. of studies have suggested potential health risks assocd. with coffee consumption; however, the results are controversial.  While coffee has been reported to increase cardiovascular risk factors, other investigators have demonstrated its protective effects on diseases ranging from type 2 diabetes to Parkinson's disease.  A no. of investigators have focused their attention on the relationship between the consumption of coffee and liver disease.  To examine the published literature to date in an attempt to establish the presence of an hepatoprotective effect of coffee.  Using PubMed, we identified published studies and review articles relating to the effect of coffee consumption on diseases of the liver.  A no. of studies have reported the beneficial effects of coffee on abnormal liver biochem., cirrhosis and hepatocellular carcinoma.  At the present time the mechanism of this effect remains unclear as does the "dose" required to achieve these benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVyemTisgsLrVg90H21EOLACvtfcHk0li1Wcsx9BBBuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslGmtbc%253D&md5=2f405eb87c95d3701d782fbb73cc42d7</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2007.03319.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2007.03319.x%26sid%3Dliteratum%253Aachs%26aulast%3DCadden%26aufirst%3DI.%2BS.%2BH.%26aulast%3DPartovi%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DE.%2BM.%26atitle%3DReview%2520Article%253A%2520Possible%2520Beneficial%2520Effects%2520of%2520Coffee%2520on%2520Liver%2520Disease%2520and%2520Function%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D26%26spage%3D1%26doi%3D10.1111%2Fj.1365-2036.2007.03319.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovitch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morens, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandinetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchette, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curb, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popper, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, L. R.</span></span> <span> </span><span class="NLM_article-title">Association of Coffee and Caffeine Intake with the Risk of Parkinson Disease</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">2674</span>– <span class="NLM_lpage">2679</span>, <span class="refDoi"> DOI: 10.1001/jama.283.20.2674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.283.20.2674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3c3otVSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=2674-2679&issue=20&author=G.+W.+Rossauthor=R.+D.+Abbottauthor=H.+Petrovitchauthor=D.+M.+Morensauthor=A.+Grandinettiauthor=K.+H.+Tungauthor=C.+M.+Tannerauthor=K.+H.+Masakiauthor=P.+L.+Blanchetteauthor=J.+D.+Curbauthor=J.+S.+Popperauthor=L.+R.+White&title=Association+of+Coffee+and+Caffeine+Intake+with+the+Risk+of+Parkinson+Disease&doi=10.1001%2Fjama.283.20.2674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">Association of coffee and caffeine intake with the risk of Parkinson disease</span></div><div class="casAuthors">Ross G W; Abbott R D; Petrovitch H; Morens D M; Grandinetti A; Tung K H; Tanner C M; Masaki K H; Blanchette P L; Curb J D; Popper J S; White L R</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2674-9</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">CONTEXT:  The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goal.  OBJECTIVE:  To explore the association of coffee and dietary caffeine intake with risk of PD.  DESIGN, SETTING, AND PARTICIPANTS:  Data were analyzed from 30 years of follow-up of 8004 Japanese-American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968.  MAIN OUTCOME MEASURE:  Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment).  RESULTS:  During follow-up, 102 men were identified as having PD.  Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10,000 person-years in men who drank no coffee to 1.9 per 10,000 person-years in men who drank at least 28 oz/d (P<.001 for trend).  Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from non-coffee sources (P=.03 for trend).  Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P=.049, P=.22, and P=.02, respectively, for trend).  Other nutrients in coffee, including niacin, were unrelated to PD incidence.  The relationship between caffeine and PD was unaltered by intake of milk and sugar.  CONCLUSIONS:  Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD.  This effect appears to be independent of smoking.  The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee.  JAMA. 2000;283:2674-2679.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTHsJbtAiOjbxanA7vODO6fW6udTcc2eYFeKbS6-UzFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3otVSnug%253D%253D&md5=4c6cba94893263f279475d47d532f188</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1001%2Fjama.283.20.2674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.283.20.2674%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DR.%2BD.%26aulast%3DPetrovitch%26aufirst%3DH.%26aulast%3DMorens%26aufirst%3DD.%2BM.%26aulast%3DGrandinetti%26aufirst%3DA.%26aulast%3DTung%26aufirst%3DK.%2BH.%26aulast%3DTanner%26aufirst%3DC.%2BM.%26aulast%3DMasaki%26aufirst%3DK.%2BH.%26aulast%3DBlanchette%26aufirst%3DP.%2BL.%26aulast%3DCurb%26aufirst%3DJ.%2BD.%26aulast%3DPopper%26aufirst%3DJ.%2BS.%26aulast%3DWhite%26aufirst%3DL.%2BR.%26atitle%3DAssociation%2520of%2520Coffee%2520and%2520Caffeine%2520Intake%2520with%2520the%2520Risk%2520of%2520Parkinson%2520Disease%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2000%26volume%3D283%26issue%3D20%26spage%3D2674%26epage%3D2679%26doi%3D10.1001%2Fjama.283.20.2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernán, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takkouche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caamaño-Isorna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestal-Otero, J. J.</span></span> <span> </span><span class="NLM_article-title">A Meta-Analysis of Coffee Drinking, Cigarette Smoking, and the Risk of Parkinson’s Disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1002/ana.10277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fana.10277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12205639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD38vkslGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2002&pages=276-284&issue=3&author=M.+A.+Hern%C3%A1nauthor=B.+Takkoucheauthor=F.+Caama%C3%B1o-Isornaauthor=J.+J.+Gestal-Otero&title=A+Meta-Analysis+of+Coffee+Drinking%2C+Cigarette+Smoking%2C+and+the+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1002%2Fana.10277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease</span></div><div class="casAuthors">Hernan Miguel A; Takkouche Bahi; Caamano-Isorna Francisco; Gestal-Otero Juan J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-84</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">We conducted a systematic review to summarize the epidemiological evidence on the association between cigarette smoking, coffee drinking, and the risk of Parkinson's disease.  Case-control and cohort studies that reported the relative risk of physician-confirmed Parkinson's disease by cigarette smoking or coffee drinking status were included.  Study-specific log relative risks were weighted by the inverse of their variances to obtain a pooled relative risk and its 95% confidence interval (CI).  Results for smoking were based on 44 case-control and 4 cohort studies, and for coffee 8 case-control and 5 cohort studies.  Compared with never smokers, the relative risk of Parkinson's disease was 0.59 (95% CI, 0.54-0.63) for ever smokers, 0.80 (95% CI, 0.69-0.93) for past smokers, and 0.39 (95% CI, 0.32-0.47) for current smokers.  The relative risk per 10 additional pack-years was 0.84 (95% CI, 0.81-0.88) in case-control studies and 0.78 (95% CI, 0.73-0.84) in cohort studies.  Compared with non-coffee drinkers, relative risk of Parkinson's disease was 0.69 (95% CI, 0.59-0.80) for coffee drinkers.  The relative risk per three additional cups of coffee per day was 0.75 (95% CI, 0.64-0.86) in case-control studies and 0.68 (95% CI, 0.46-1.00) in cohort studies.  This meta-analysis shows that there is strong epidemiological evidence that smokers and coffee drinkers have a lower risk of Parkinson's disease.  Further research is required on the biological mechanisms underlying this potentially protective effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIOJoTcbBsc-RS7coPn-RtfW6udTcc2eYFeKbS6-UzFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vkslGktg%253D%253D&md5=6e3d946102848894840229a2f4c77d1c</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1002%2Fana.10277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10277%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1n%26aufirst%3DM.%2BA.%26aulast%3DTakkouche%26aufirst%3DB.%26aulast%3DCaama%25C3%25B1o-Isorna%26aufirst%3DF.%26aulast%3DGestal-Otero%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520Meta-Analysis%2520of%2520Coffee%2520Drinking%252C%2520Cigarette%2520Smoking%252C%2520and%2520the%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2002%26volume%3D52%26issue%3D3%26spage%3D276%26epage%3D284%26doi%3D10.1002%2Fana.10277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz-Carneiro, A.</span></span> <span> </span><span class="NLM_article-title">Caffeine Exposure and the Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Observational Studies</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">s1</span>),  <span class="NLM_fpage">S221</span>– <span class="NLM_lpage">S238</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-091525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2010-091525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20182023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls12hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=S221-S238&issue=s1&author=J.+Costaauthor=N.+Lunetauthor=C.+Santosauthor=J.+Santosauthor=A.+Vaz-Carneiro&title=Caffeine+Exposure+and+the+Risk+of+Parkinson%E2%80%99s+Disease%3A+A+Systematic+Review+and+Meta-Analysis+of+Observational+Studies&doi=10.3233%2FJAD-2010-091525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine Exposure and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis of Observational Studiess</span></div><div class="casAuthors">Costa, Joao; Lunet, Nuno; Santos, Catarina; Santos, Joao; Vaz-Carneiro, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S221-S238</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Several studies conducted worldwide report an inverse assocn. between caffeine/coffee consumption and the risk of developing Parkinson's disease (PD).  However, heterogeneity and conflicting results between studies preclude a correct estn. of the strength of this assocn.  We conducted a systematic review and meta-anal. of published epidemiol. studies to better est. the effect of caffeine exposure on the incidence of PD.  Data sources searched included Medline, LILACS, Scopus, Web of Science and ref. lists, up to Sept. 2009.  Cohort, case-control and cross-sectional studies were included.  Three independent reviewers selected the studies and extd. the data on to standardized forms.  Twenty-six studies were included: 7 cohort, 2 nested case-control, 16 case-control, and 1 cross-sectional study.  Quant. data synthesis of the most precise ests. from each study was accomplished through random effects meta-anal.  Heterogeneity was quantified using the I2 statistic.  The summary RR for the assocn. between caffeine intake and PD was 0.75 [95% Confidence Interval (95%CI): 0.68-0.82], with low to moderate heterogeneity (I2 = 28.8%).  Publication bias for case-control/cross-sectional studies may exist (Egger's test, p = 0.053).  When considering only the cohort studies, the RR was 0.80 (95%CI: 0.71-90; I2 = 8.1%).  The neg. assocn. was weaker when only women were considered (RR=0.86, 95%CI: 0.73-1.02; I2 = 12.9%).  A linear relation was obsd. between levels of exposure to caffeine and the RR ests.: RR of 0.76 (95%CI: 0.72-0.80; I2 = 35.1%) per 300 mg increase in caffeine intake.  This study confirm an inverse assocn. between caffeine intake and the risk of PD, which can hardly by explained by bias or uncontrolled confounding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3s-mlGRYSCLVg90H21EOLACvtfcHk0ljGXDG99OWj-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls12hu7o%253D&md5=0d1ca8bce2d17a2064c7ea95a2ab43e9</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-091525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-091525%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DJ.%26aulast%3DLunet%26aufirst%3DN.%26aulast%3DSantos%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DJ.%26aulast%3DVaz-Carneiro%26aufirst%3DA.%26atitle%3DCaffeine%2520Exposure%2520and%2520the%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%2520of%2520Observational%2520Studies%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26issue%3Ds1%26spage%3DS221%26epage%3DS238%26doi%3D10.3233%2FJAD-2010-091525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sääksjärvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knekt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rissanen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laaksonen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reunanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Männistö, S.</span></span> <span> </span><span class="NLM_article-title">Prospective Study of Coffee Consumption and Risk of Parkinson’s Disease</span>. <i>Eur. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1038/sj.ejcn.1602788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.ejcn.1602788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17522612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1cvit1ygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=908-915&issue=7&author=K.+S%C3%A4%C3%A4ksj%C3%A4rviauthor=P.+Knektauthor=H.+Rissanenauthor=M.+A.+Laaksonenauthor=A.+Reunanenauthor=S.+M%C3%A4nnist%C3%B6&title=Prospective+Study+of+Coffee+Consumption+and+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1038%2Fsj.ejcn.1602788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of coffee consumption and risk of Parkinson's disease</span></div><div class="casAuthors">Saaksjarvi K; Knekt P; Rissanen H; Laaksonen M A; Reunanen A; Mannisto S</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">908-15</span>
        ISSN:<span class="NLM_cas:issn">0954-3007</span>.
    </div><div class="casAbstract">OBJECTIVE:  To examine the prediction of coffee consumption on the incidence of Parkinson's disease.  SUBJECTS AND METHODS:  The study population comprised 6710 men and women, aged 50-79 years and free from Parkinson's disease at the baseline.  At baseline, enquiries were made about coffee consumption in a self-administered questionnaire as the average number of cups per day.  During a 22-year follow-up, 101 incident cases of Parkinson's disease occurred.  Parkinson's disease cases were identified through a nationwide registry of patients receiving medication reimbursement, which is based on certificates from neurologist.  RESULTS:  After adjustments for age, sex, marital status, education, community density, alcohol consumption, leisure-time physical activity, smoking, body mass index, hypertension and serum cholesterol, the relative risk for subjects drinking 10 or more cups of coffee per day compared with non-drinkers was 0.26 (95% confidence interval 0.07-0.99, P-value for trend=0.18).  The association was stronger among overweight persons and among persons with lower serum cholesterol level (P-value for interaction=0.04 and 0.03, respectively).  CONCLUSIONS:  The results support the hypothesis that coffee consumption reduces the risk of Parkinson's disease, but protective effect of coffee may vary by exposure to other factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSF9-I_ElzX0myYR5VtavbzfW6udTcc2eb3e_cT0totYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvit1ygug%253D%253D&md5=1a46a5a4d3a9da7e0f7be1f5463470c5</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1038%2Fsj.ejcn.1602788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ejcn.1602788%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A4%25C3%25A4ksj%25C3%25A4rvi%26aufirst%3DK.%26aulast%3DKnekt%26aufirst%3DP.%26aulast%3DRissanen%26aufirst%3DH.%26aulast%3DLaaksonen%26aufirst%3DM.%2BA.%26aulast%3DReunanen%26aufirst%3DA.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DS.%26atitle%3DProspective%2520Study%2520of%2520Coffee%2520Consumption%2520and%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Clin.%2520Nutr.%26date%3D2008%26volume%3D62%26issue%3D7%26spage%3D908%26epage%3D915%26doi%3D10.1038%2Fsj.ejcn.1602788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ascherio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernán, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawachi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colditz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speizer, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span> <span> </span><span class="NLM_article-title">Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1002/ana.1052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fana.1052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=11456310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=56-63&issue=1&author=A.+Ascherioauthor=S.+M.+Zhangauthor=M.+A.+Hern%C3%A1nauthor=I.+Kawachiauthor=G.+A.+Colditzauthor=F.+E.+Speizerauthor=W.+C.+Willett&title=Prospective+Study+of+Caffeine+Consumption+and+Risk+of+Parkinson%E2%80%99s+Disease+in+Men+and+Women&doi=10.1002%2Fana.1052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of caffeine consumption and risk of Parkinson's disease in men and women</span></div><div class="casAuthors">Ascherio, Alberto; Zhang, Shumin M.; Hernan, Miguel A.; Kawachi, Ichiro; Colditz, Graham A.; Speizer, Frank E.; Willett, Walter C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Results of case-control studies and of a prospective investigation in men suggest that consumption of coffee could protect against the risk of Parkinson's disease, but the active constituent is not clear.  To address the hypothesis that caffeine is protective against Parkinson's disease, we examd. the relationship of coffee and caffeine consumption to the risk of this disease among participants in two ongoing cohorts, the Health Professionals' Follow-Up Study (HPFS) and the Nurses' Health Study (NHS).  The study population comprised 47,351 men and 88,565 women who were free of Parkinson's disease, stroke, or cancer at baseline.  A comprehensive life style and dietary questionnaire was completed by the participants at baseline and updated every two to four years.  During the follow-up (10 yr in men, 16 yr in women), we documented a total of 288 incident cases of Parkinson's disease.  Among men, after adjustment for age and smoking, the relative risk of Parkinson's disease was 0.42 (95% CI: 0.23-0.78; p for trend < 0.001) for men in the top one-fifth of caffeine intake compared to those in the bottom one-fifth.  An inverse assocn. was also obsd. with consumption of coffee (p for trend = 0.004), caffeine from non-coffee sources (p for trend < 0.001), and tea (p for trend = 0.02) but not decaffeinated coffee.  Among women, the relationship between caffeine or coffee intake and risk of Parkinson's disease was U-shaped, with the lowest risk obsd. at moderate intakes (1-3 cups of coffee/day, or the third quintile of caffeine consumption).  These results support a possible protective effect of moderate doses of caffeine on risk of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgS7GGPMwGrVg90H21EOLACvtfcHk0ljGXDG99OWj-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D&md5=6ed856feee3eb746e8149ce9c7c6a5a6</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1002%2Fana.1052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.1052%26sid%3Dliteratum%253Aachs%26aulast%3DAscherio%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DS.%2BM.%26aulast%3DHern%25C3%25A1n%26aufirst%3DM.%2BA.%26aulast%3DKawachi%26aufirst%3DI.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DSpeizer%26aufirst%3DF.%2BE.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26atitle%3DProspective%2520Study%2520of%2520Caffeine%2520Consumption%2520and%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%2520in%2520Men%2520and%2520Women%26jtitle%3DAnn.%2520Neurol.%26date%3D2001%26volume%3D50%26issue%3D1%26spage%3D56%26epage%3D63%26doi%3D10.1002%2Fana.1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref263"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref263'); return false;" data-citation="" class="refNumLink">263</a></strong><div class="NLM_citation" id="cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ascherio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzschild, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colditz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speizer, F. E.</span></span> <span> </span><span class="NLM_article-title">Caffeine, Postmenopausal Estrogen, and Risk of Parkinson’s Disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">790</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1212/01.WNL.0000046523.05125.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1212%2F01.WNL.0000046523.05125.87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12629235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3s7hs1Sntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=790-795&issue=5&author=A.+Ascherioauthor=H.+Chenauthor=M.+A.+Schwarzschildauthor=S.+M.+Zhangauthor=G.+A.+Colditzauthor=F.+E.+Speizer&title=Caffeine%2C+Postmenopausal+Estrogen%2C+and+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1212%2F01.WNL.0000046523.05125.87"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine, postmenopausal estrogen, and risk of Parkinson's disease</span></div><div class="casAuthors">Ascherio A; Chen H; Schwarzschild M A; Zhang S M; Colditz G A; Speizer F E</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">790-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Men who regularly consume caffeinated drinks have a lower risk of PD than do nondrinkers, but this relation has not been found in women.  Because this sex difference could be due to hormonal effects, the authors examined prospectively the risk of PD according to use of postmenopausal hormones and caffeine intake among participants in the Nurses' Health Study.  METHODS:  The study population comprised 77,713 women free of PD, stroke, or cancer at baseline, who were postmenopausal at baseline or reached menopause before the end of the study.  During 18 years of follow-up the authors documented 154 cases of PD.  RESULTS:  Overall, the risk of PD was similar in women using hormones and women who never used hormones (relative risk 1.02, 95% CI 0.69 to 1.52).  Use of hormones, however, was associated with a reduced risk of PD among women with low caffeine consumption (RR 0.39, 95% CI 0.13 to 1.17), and with increased risk among women with high caffeine consumption (RR 2.44, 95% CI 0.75 to 7.86; p for interaction = 0.01).  Among hormone users, women consuming six or more cups of coffee per day had a fourfold higher risk of PD (RR 3.92, 95% CI 1.49 to 10.34; p = 0.006) than did women who never drink coffee.  CONCLUSION:  These results suggest that caffeine reduces the risk of PD among women who do not use postmenopausal hormones, but increases risk among hormone users.  Clinical trials of caffeine or estrogens in women should avoid the combined use of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQg1RbL0sF_lUNoizSOkG_FfW6udTcc2ea42YmasygNDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7hs1Sntg%253D%253D&md5=1ad6b9ddc06cf305668f2ca64b86ec7c</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1212%2F01.WNL.0000046523.05125.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.WNL.0000046523.05125.87%26sid%3Dliteratum%253Aachs%26aulast%3DAscherio%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DZhang%26aufirst%3DS.%2BM.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DSpeizer%26aufirst%3DF.%2BE.%26atitle%3DCaffeine%252C%2520Postmenopausal%2520Estrogen%252C%2520and%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D60%26issue%3D5%26spage%3D790%26epage%3D795%26doi%3D10.1212%2F01.WNL.0000046523.05125.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref264"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref264'); return false;" data-citation="" class="refNumLink">264</a></strong><div class="NLM_citation" id="cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkelmayer, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stampfer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curhan, G. C.</span></span> <span> </span><span class="NLM_article-title">Habitual Caffeine Intake and the Risk of Hypertension in Women</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2330</span>– <span class="NLM_lpage">2335</span>, <span class="refDoi"> DOI: 10.1001/jama.294.18.2330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.294.18.2330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Srt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2005&pages=2330-2335&issue=18&author=W.+C.+Winkelmayerauthor=M.+J.+Stampferauthor=W.+C.+Willettauthor=G.+C.+Curhan&title=Habitual+Caffeine+Intake+and+the+Risk+of+Hypertension+in+Women&doi=10.1001%2Fjama.294.18.2330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Habitual caffeine intake and the risk of hypertension in women</span></div><div class="casAuthors">Winkelmayer, Wolfgang C.; Stampfer, Meir J.; Willett, Walter C.; Curhan, Gary C.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2330-2335</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Caffeine acutely increases blood pressure, but the assocn. between habitual consumption of caffeinated beverages and incident hypertension is uncertain.  The study examd. the assocn. between caffeine intake and incident hypertension in women.  Design, Setting, and Participants: Prospective cohort study conducted in the Nurses' Health Studies (NHSs) I and II of 155594 US women free from physician-diagnosed hypertension followed up over 12 years (1990 - 1991 to 2002 - 2003 questionnaires).  Caffeine intake and possible confounders were ascertained from regularly administered questionnaires.  We also tested the assocns. with types of caffeinated beverages.  Main Outcome Measure: Incident physician-diagnosed hypertension.  During follow-up, 19541 incident cases of physician-diagnosed hypertension were reported in NHS I and 13536 in NHS II.  In both cohorts, no linear assocn. between caffeine consumption and risk of incident hypertension was obsd. after multivariate adjustment (NHS I, P for trend =.29; NHS II, P for trend =.53).  Using categorical anal., an inverse U-shaped assocn. between caffeine consumption and incident hypertension was found.  Compared with participants in the lowest quintile of caffeine consumption, those in the third quintile had a 13% and 12% increased risk of hypertension, resp. (95% confidence interval in NHS I, 8% - 18%; in NHS 11, 6% - 18%).  When studying individual classes of caffeinated beverages, habitual coffee consumption was not assocd. with increased risk of hypertension.  By contrast, consumption of cola beverages was assocd. with an increased risk of hypertension, independent of whether it was sugared or diet cola (P for trend <.001).  No linear assocn. between caffeine consumption and incident hypertension was found.  Even though habitual coffee consumption was not assocd. with an increased risk of hypertension, consumption of sugared or diet cola was assocd. with it.  Further research to elucidate the role of cola beverages in hypertension is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Fjd0LbWTgbVg90H21EOLACvtfcHk0lhB-wSWSFURnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Srt77O&md5=36fe24e41b7777ff4ed92724947ab42d</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1001%2Fjama.294.18.2330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.294.18.2330%26sid%3Dliteratum%253Aachs%26aulast%3DWinkelmayer%26aufirst%3DW.%2BC.%26aulast%3DStampfer%26aufirst%3DM.%2BJ.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26aulast%3DCurhan%26aufirst%3DG.%2BC.%26atitle%3DHabitual%2520Caffeine%2520Intake%2520and%2520the%2520Risk%2520of%2520Hypertension%2520in%2520Women%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2005%26volume%3D294%26issue%3D18%26spage%3D2330%26epage%3D2335%26doi%3D10.1001%2Fjama.294.18.2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref265"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref265'); return false;" data-citation="" class="refNumLink">265</a></strong><div class="NLM_citation" id="cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassen, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugbjerg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, B.</span></span> <span> </span><span class="NLM_article-title">Reproductive Factors and Parkinson’s Disease Risk in Danish Women</span>. <i>Eur. J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1168</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1111/ene.12450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fene.12450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24750445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2cnlt12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1168-1177&issue=9&author=N.+Greeneauthor=C.+F.+Lassenauthor=K.+Rugbjergauthor=B.+Ritz&title=Reproductive+Factors+and+Parkinson%E2%80%99s+Disease+Risk+in+Danish+Women&doi=10.1111%2Fene.12450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Reproductive factors and Parkinson's disease risk in Danish women</span></div><div class="casAuthors">Greene N; Lassen C F; Rugbjerg K; Ritz B</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1168-77, e68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Parkinson's disease is more common in men than women by a ratio of about 1.5:1 and yet there is no consensus to date as to whether female reproductive factors including hormone use affect Parkinson's disease risk.  Our objective was to examine the relationship between Parkinson's disease and female reproductive factors in the largest population-based Parkinson's disease case-control study to date.  METHODS:  Seven hundred and forty-three female Parkinson's disease cases diagnosed between 1996 and 2009 were selected from the Danish National Hospital Register, diagnoses confirmed by medical record review, and the cases were matched by birth year to 765 female controls randomly selected from the Danish Civil Registration System.  Covariate information was collected in computer-assisted telephone interviews covering an extensive array of topics including reproductive and lifestyle factors.  RESULTS:  After adjusting for smoking, caffeine and alcohol use, education, age, and family Parkinson's disease history, inverse associations between Parkinson's disease and early menarche (first period at ≤11 years), oral contraceptives, high parity (≥4 children) and bilateral oophorectomy were found; adjusted odds ratios and 95% confidence limits were respectively 0.68 (0.45-1.03) for early menarche, 0.87 (0.69-1.10) for oral contraceptives, 0.79 (0.59-1.06) for high parity and 0.65 (0.45-0.94) for bilateral oophorectomy.  Little support for associations between Parkinson's disease and fertile life length, age at menopause or post-menopausal hormone treatment was found.  CONCLUSIONS:  Reproductive factors related to women's early- to mid-reproductive lives appear to be predictive of subsequent Parkinson's disease risk whereas factors occurring later in life seem less important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRs-BnPhDqJIkNoizSOkG_FfW6udTcc2ea42YmasygNDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnlt12nsg%253D%253D&md5=cae787b2cb02f99865897cf19ff994f2</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1111%2Fene.12450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fene.12450%26sid%3Dliteratum%253Aachs%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DLassen%26aufirst%3DC.%2BF.%26aulast%3DRugbjerg%26aufirst%3DK.%26aulast%3DRitz%26aufirst%3DB.%26atitle%3DReproductive%2520Factors%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%2520Risk%2520in%2520Danish%2520Women%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1168%26epage%3D1177%26doi%3D10.1111%2Fene.12450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref266"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref266'); return false;" data-citation="" class="refNumLink">266</a></strong><div class="NLM_citation" id="cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hameleers, P. A. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Boxtel, M. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogervorst, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houx, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buntinx, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolles, J.</span></span> <span> </span><span class="NLM_article-title">Habitual Caffeine Consumption and Its Relation to Memory, Attention, Planning Capacity and Psychomotor Performance across Multiple Age Groups</span>. <i>Hum. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1002/hup.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fhup.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12404609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2sbmvVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=573-581&issue=8&author=P.+A.+H.+M.+Hameleersauthor=M.+P.+J.+Van+Boxtelauthor=E.+Hogervorstauthor=W.+J.+Riedelauthor=P.+J.+Houxauthor=F.+Buntinxauthor=J.+Jolles&title=Habitual+Caffeine+Consumption+and+Its+Relation+to+Memory%2C+Attention%2C+Planning+Capacity+and+Psychomotor+Performance+across+Multiple+Age+Groups&doi=10.1002%2Fhup.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups</span></div><div class="casAuthors">Hameleers P. A. H. M; Van Boxtel M. P. J; Hogervorst E; Riedel W. J; Houx P. J; Buntinx F; Jolles J</div><div class="citationInfo"><span class="NLM_cas:title">Human psychopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">573-581</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The present study evaluated the association between habitual caffeine intake via coffee and tea and cognitive performance.  This was done as part of a larger research programme into the determinants of cognitive ageing (the Maastricht Aging Study: MAAS).  Possible withdrawal effects that may have explained in part the positive association between performance and intake in an earlier study were controlled for.  In addition, all cognitive tests in this study were administered under strict laboratory conditions.  A group of 1875 healthy adults, stratified for age (range 24 - 81 years), sex, and general ability, were screened for habitual intake of coffee and tea and took part in extensive cognitive testing.  Multiple regression analysis with control for age, sex, socio-demographic variables, and substance use showed that habitual caffeine consumption was significantly related to better long-term memory performance and faster locomotor speed.  No relationships were found between habitual caffeine consumption and short-term memory, information processing, planning, and attention as measured with the Stroop Test.  Moreover, no difference in sensitivity to caffeine intake between different age groups was found, suggesting that caffeine intake did not counteract age-related cognitive decline.  Several recommendations are made to improve the design of future studies in this field.  Copyright 2000 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdPn0U0pOQ9EodMGTatQ7LfW6udTcc2ebWNIkIwd7tB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbmvVCqtA%253D%253D&md5=75b18f4f40caa1eec8c190783c0343c7</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1002%2Fhup.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhup.218%26sid%3Dliteratum%253Aachs%26aulast%3DHameleers%26aufirst%3DP.%2BA.%2BH.%2BM.%26aulast%3DVan%2BBoxtel%26aufirst%3DM.%2BP.%2BJ.%26aulast%3DHogervorst%26aufirst%3DE.%26aulast%3DRiedel%26aufirst%3DW.%2BJ.%26aulast%3DHoux%26aufirst%3DP.%2BJ.%26aulast%3DBuntinx%26aufirst%3DF.%26aulast%3DJolles%26aufirst%3DJ.%26atitle%3DHabitual%2520Caffeine%2520Consumption%2520and%2520Its%2520Relation%2520to%2520Memory%252C%2520Attention%252C%2520Planning%2520Capacity%2520and%2520Psychomotor%2520Performance%2520across%2520Multiple%2520Age%2520Groups%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2000%26volume%3D15%26issue%3D8%26spage%3D573%26epage%3D581%26doi%3D10.1002%2Fhup.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref267"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref267'); return false;" data-citation="" class="refNumLink">267</a></strong><div class="NLM_citation" id="cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Boxtel, M. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolles, J.</span></span> <span> </span><span class="NLM_article-title">The Effects of Habitual Caffeine Use on Cognitive Change: A Longitudinal Perspective</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1016/S0091-3057(03)00171-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0091-3057%2803%2900171-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12957237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvV2qs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=921-927&issue=4&author=M.+P.+J.+Van+Boxtelauthor=J.+A.+J.+Schmittauthor=H.+Bosmaauthor=J.+Jolles&title=The+Effects+of+Habitual+Caffeine+Use+on+Cognitive+Change%3A+A+Longitudinal+Perspective&doi=10.1016%2FS0091-3057%2803%2900171-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of habitual caffeine use on cognitive change: a longitudinal perspective</span></div><div class="casAuthors">van Boxtel, M. P. J.; Schmitt, J. A. J.; Bosma, H.; Jolles, J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-927</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The efficiency of higher cortical functions, such as memory and speed of complex information processing, tends to decrease with advancing age in normal healthy individuals.  Recently, a high habitual intake of caffeine was found assocd. with better verbal memory performance and psychomotor speed in several cross-sectional population studies.  We tested the hypothesis that habitual caffeine intake can reduce or postpone age-related cognitive decline in healthy adults.  For this purpose, the cognitive performance of all participants in the Maastricht Aging Study (MAAS), aged between 24 and 81 yr, was reassessed after 6 yr.  Information on the intake of caffeine-contg. beverages was available from the baseline questionnaire.  After 6 yr, 1376 (75.6%) individuals were available for reassessment.  After correction for demog. characteristics, baseline performance and health status, there were small albeit significant assocns. between the overall estd. caffeine intake at baseline and the 6-yr change in complex motor speed (motor choice reaction time).  The earlier found assocn. between caffeine intake and verbal memory performance was not apparent in this longitudinal study.  These results imply that the longitudinal effect of habitual caffeine intake is limited and will not promote a substantial redn. in age-related cognitive decline at a population level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob6hoaLWQzBLVg90H21EOLACvtfcHk0ljgOo9LqRW3Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvV2qs78%253D&md5=2720b2734699b00b52e11a22980869b5</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2803%2900171-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252803%252900171-0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBoxtel%26aufirst%3DM.%2BP.%2BJ.%26aulast%3DSchmitt%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DBosma%26aufirst%3DH.%26aulast%3DJolles%26aufirst%3DJ.%26atitle%3DThe%2520Effects%2520of%2520Habitual%2520Caffeine%2520Use%2520on%2520Cognitive%2520Change%253A%2520A%2520Longitudinal%2520Perspective%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2003%26volume%3D75%26issue%3D4%26spage%3D921%26epage%3D927%26doi%3D10.1016%2FS0091-3057%2803%2900171-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref268"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref268'); return false;" data-citation="" class="refNumLink">268</a></strong><div class="NLM_citation" id="cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. J.</span></span> <span> </span><span class="NLM_article-title">Does Caffeine Intake Enhance Absolute Levels of Cognitive Performance?</span>. <i>Psychopharmacology (Berl).</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1007/BF02246949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF02246949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7870897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1993&pages=45-52&issue=1%E2%80%932&author=M.+J.+Jarvis&title=Does+Caffeine+Intake+Enhance+Absolute+Levels+of+Cognitive+Performance%3F&doi=10.1007%2FBF02246949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">Does caffeine intake enhance absolute levels of cognitive performance?</span></div><div class="casAuthors">Jarvis, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The relationship between habitual coffee and tea consumption and cognitive performance was examd. using data from a cross-sectional survey of a representative sample of 9003 British adults (the Health and Lifestyle Survey).  Subjects completed tests of simple reaction time, choice reaction time, incidental verbal memory, and visuo-spatial reasoning, in addn. to providing self-reports of usual coffee and tea intake.  After controlling extensively for potential confounding variables, a dose-response trend to improved performance with higher levels of coffee consumption was obsd. for all four tests.  Similar but weaker assocns. were found for tea consumption, which were significant for simple reaction time and visuo-spatial reasoning.  Estd. overall caffeine consumption showed a dose-response relationship to improved cognitive performance .  Older people appeared to be more susceptible to the performance-improving effects of caffeine than were younger.  The results suggest that tolerance to the performance-enhancing effects of caffeine, if it occurs at all, is incomplete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_q18Qjcu5LVg90H21EOLACvtfcHk0ljgOo9LqRW3Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKlur4%253D&md5=ea00b1194126df06be0295d387d689c9</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1007%2FBF02246949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246949%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DM.%2BJ.%26atitle%3DDoes%2520Caffeine%2520Intake%2520Enhance%2520Absolute%2520Levels%2520of%2520Cognitive%2520Performance%253F%26jtitle%3DPsychopharmacology%2520%2528Berl%2529.%26date%3D1993%26volume%3D110%26issue%3D1%25E2%2580%25932%26spage%3D45%26epage%3D52%26doi%3D10.1007%2FBF02246949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref269"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref269'); return false;" data-citation="" class="refNumLink">269</a></strong><div class="NLM_citation" id="cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dall’Igna, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, D. R.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Adenosine A2a Receptor Antagonists Prevent β-Amyloid (25–35)-Induced Cognitive Deficits in Mice</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>203</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2006.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.expneurol.2006.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17007839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2007&pages=241-245&issue=1&author=O.+P.+Dall%E2%80%99Ignaauthor=P.+Fettauthor=M.+W.+Gomesauthor=D.+O.+Souzaauthor=R.+A.+Cunhaauthor=D.+R.+Lara&title=Caffeine+and+Adenosine+A2a+Receptor+Antagonists+Prevent+%CE%B2-Amyloid+%2825%E2%80%9335%29-Induced+Cognitive+Deficits+in+Mice&doi=10.1016%2Fj.expneurol.2006.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25-35)-induced cognitive deficits in mice</span></div><div class="casAuthors">Dall'Igna, Oscar P.; Fett, Paulo; Gomes, Marcio W.; Souza, Diogo O.; Cunha, Rodrigo A.; Lara, Diogo R.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">241-245</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Consumption of caffeine, an adenosine receptor antagonist, was found to be inversely assocd. with the incidence of Alzheimer's disease.  Moreover, caffeine protects cultured neurons against β-amyloid-induced toxicity, an effect mimicked by adenosine A2A but not A1 receptor antagonists.  We now tested if caffeine administration would prevent β-amyloid-induced cognitive impairment in mice and if this was mimicked by A2A receptor blockade.  One week after icv administration of the 25-35 fragment of β-amyloid (Aβ, 3 nmol), mice displayed impaired performance in both inhibitory avoidance and spontaneous alternation tests.  Prolonged treatment with caffeine (1 mg/mL) had no effect alone but prevented the Aβ-induced cognitive impairment in both tasks when assocd. with acute caffeine (30 mg/kg) 30 min treatment before Aβ administration.  The same protective effect was obsd. after subchronic (4 days) treatment with daily injections of either caffeine (30 mg/kg) or the selective adenosine A2A receptor antagonist SCH58261 (0.5 mg/kg).  This provides the first direct in vivo evidence that caffeine and A2A receptor antagonists afford a protection against Aβ-induced amnesia, which prompts their interest for managing Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSWIvxJ5TG1rVg90H21EOLACvtfcHk0lipNowTU19Z6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73I&md5=508ab5a63a514e9ee2da575a42b95d64</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2006.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2006.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DDall%25E2%2580%2599Igna%26aufirst%3DO.%2BP.%26aulast%3DFett%26aufirst%3DP.%26aulast%3DGomes%26aufirst%3DM.%2BW.%26aulast%3DSouza%26aufirst%3DD.%2BO.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DLara%26aufirst%3DD.%2BR.%26atitle%3DCaffeine%2520and%2520Adenosine%2520A2a%2520Receptor%2520Antagonists%2520Prevent%2520%25CE%25B2-Amyloid%2520%252825%25E2%2580%259335%2529-Induced%2520Cognitive%2520Deficits%2520in%2520Mice%26jtitle%3DExp.%2520Neurol.%26date%3D2007%26volume%3D203%26issue%3D1%26spage%3D241%26epage%3D245%26doi%3D10.1016%2Fj.expneurol.2006.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref270"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref270'); return false;" data-citation="" class="refNumLink">270</a></strong><div class="NLM_citation" id="cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnouf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferry, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batalha, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariciniak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Jeugd, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaten, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Hooge, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeant, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buée, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span> <span> </span><span class="NLM_article-title">A2A Adenosine Receptor Deletion Is Protective in a Mouse Model of Tauopathy</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/mp.2014.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fmp.2014.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25450226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVemsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=97-107&issue=1&author=C.+Laurentauthor=S.+Burnoufauthor=B.+Ferryauthor=V.+L.+Batalhaauthor=J.+E.+Coelhoauthor=Y.+Baqiauthor=E.+Malikauthor=E.+Mariciniakauthor=S.+Parrotauthor=A.+Van+Der+Jeugdauthor=E.+Faivreauthor=V.+Flatenauthor=C.+Ledentauthor=R.+D%E2%80%99Hoogeauthor=N.+Sergeantauthor=M.+Hamdaneauthor=S.+Humezauthor=C.+E.+M%C3%BCllerauthor=L.+V.+Lopesauthor=L.+Bu%C3%A9eauthor=D.+Blum&title=A2A+Adenosine+Receptor+Deletion+Is+Protective+in+a+Mouse+Model+of+Tauopathy&doi=10.1038%2Fmp.2014.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor deletion is protective in a mouse model of Tauopathy</span></div><div class="casAuthors">Laurent, C.; Burnouf, S.; Ferry, B.; Batalha, V. L.; Coelho, J. E.; Baqi, Y.; Malik, E.; Marciniak, E.; Parrot, S.; Van der Jeugd, A.; Faivre, E.; Flaten, V.; Ledent, C.; D'Hooge, R.; Sergeant, N.; Hamdane, M.; Humez, S.; Muller, C. E.; Lopes, L. V.; Buee, L.; Blum, D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Consumption of caffeine, a non-selective adenosine A2A receptor (A2AR) antagonist, reduces the risk of developing Alzheimer's disease (AD) in humans and mitigates both amyloid and Tau burden in transgenic mouse models.  However, the impact of selective A2AR blockade on the progressive development of AD-related lesions and assocd. memory impairments has not been investigated.  In the present study, we removed the gene encoding A2AR from THY-Tau22 mice and analyzed the subsequent effects on both pathol. (Tau phosphorylation and aggregation, neuro-inflammation) and functional impairments (spatial learning and memory, hippocampal plasticity, neurotransmitter profile).  We found that deleting A2ARs protect from Tau pathol.-induced deficits in terms of spatial memory and hippocampal long-term depression.  These effects were concomitant with a normalization of the hippocampal glutamate/gamma-amino butyric acid ratio, together with a global redn. in neuro-inflammatory markers and a decrease in Tau hyperphosphorylation.  Addnl., oral therapy using a specific A2AR antagonist (MSX-3) significantly improved memory and reduced Tau hyperphosphorylation in THY-Tau22 mice.  By showing that A2AR genetic or pharmacol. blockade improves the pathol. phenotype in a Tau transgenic mouse model, the present data highlight A2A receptors as important mol. targets to consider against AD and Tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2xpjoIHTEZ7Vg90H21EOLACvtfcHk0lipNowTU19Z6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVemsr7I&md5=5d461cf97e43df149e7d2613a2679da9</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.151%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DC.%26aulast%3DBurnouf%26aufirst%3DS.%26aulast%3DFerry%26aufirst%3DB.%26aulast%3DBatalha%26aufirst%3DV.%2BL.%26aulast%3DCoelho%26aufirst%3DJ.%2BE.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DMalik%26aufirst%3DE.%26aulast%3DMariciniak%26aufirst%3DE.%26aulast%3DParrot%26aufirst%3DS.%26aulast%3DVan%2BDer%2BJeugd%26aufirst%3DA.%26aulast%3DFaivre%26aufirst%3DE.%26aulast%3DFlaten%26aufirst%3DV.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DHamdane%26aufirst%3DM.%26aulast%3DHumez%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DLopes%26aufirst%3DL.%2BV.%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DD.%26atitle%3DA2A%2520Adenosine%2520Receptor%2520Deletion%2520Is%2520Protective%2520in%2520a%2520Mouse%2520Model%2520of%2520Tauopathy%26jtitle%3DMol.%2520Psychiatry%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D97%26epage%3D107%26doi%3D10.1038%2Fmp.2014.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref271"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref271'); return false;" data-citation="" class="refNumLink">271</a></strong><div class="NLM_citation" id="cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koppelstaetter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeppel, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siedentopf, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ischebeck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haala, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottaghy, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhomberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golaszewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotwald, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolbitsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, B. J.</span></span> <span> </span><span class="NLM_article-title">Does Caffeine Modulate Verbal Working Memory Processes? An FMRI Study</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2007.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroimage.2007.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17936643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2snosVelsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=492-499&issue=1&author=F.+Koppelstaetterauthor=T.+D.+Poeppelauthor=C.+M.+Siedentopfauthor=A.+Ischebeckauthor=M.+Veriusauthor=I.+Haalaauthor=F.+M.+Mottaghyauthor=P.+Rhombergauthor=S.+Golaszewskiauthor=T.+Gotwaldauthor=I.+H.+Lorenzauthor=C.+Kolbitschauthor=S.+Felberauthor=B.+J.+Krause&title=Does+Caffeine+Modulate+Verbal+Working+Memory+Processes%3F+An+FMRI+Study&doi=10.1016%2Fj.neuroimage.2007.08.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Does caffeine modulate verbal working memory processes? An fMRI study</span></div><div class="casAuthors">Koppelstaetter F; Poeppel T D; Siedentopf C M; Ischebeck A; Verius M; Haala I; Mottaghy F M; Rhomberg P; Golaszewski S; Gotwald T; Lorenz I H; Kolbitsch C; Felber S; Krause B J</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">492-9</span>
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    </div><div class="casAbstract">To assess the effect of caffeine on the functional MRI signal during a 2-back verbal working memory task, we examined blood oxygenation level-dependent regional brain activity in 15 healthy right-handed males.  The subjects, all moderate caffeine consumers, underwent two scanning sessions on a 1.5-T MR-Scanner separated by a 24- to 48-h interval.  Each participant received either placebo or 100 mg caffeine 20 min prior to the performance of the working memory task in blinded crossover fashion.  The study was implemented as a blocked-design.  Analysis was performed using SPM2.  In both conditions, the characteristic working memory network of frontoparietal cortical activation including the precuneus and the anterior cingulate could be shown.  In comparison to placebo, caffeine caused an increased response in the bilateral medial frontopolar cortex (BA 10), extending to the right anterior cingulate cortex (BA 32).  These results suggest that caffeine modulates neuronal activity as evidenced by fMRI signal changes in a network of brain areas associated with executive and attentional functions during working memory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9V8O6sKsTrPh3YQQtAhNufW6udTcc2ebx5xdlyDMWQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snosVelsQ%253D%253D&md5=56c7a0df35cad8093f95683974a0b011</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2007.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2007.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DKoppelstaetter%26aufirst%3DF.%26aulast%3DPoeppel%26aufirst%3DT.%2BD.%26aulast%3DSiedentopf%26aufirst%3DC.%2BM.%26aulast%3DIschebeck%26aufirst%3DA.%26aulast%3DVerius%26aufirst%3DM.%26aulast%3DHaala%26aufirst%3DI.%26aulast%3DMottaghy%26aufirst%3DF.%2BM.%26aulast%3DRhomberg%26aufirst%3DP.%26aulast%3DGolaszewski%26aufirst%3DS.%26aulast%3DGotwald%26aufirst%3DT.%26aulast%3DLorenz%26aufirst%3DI.%2BH.%26aulast%3DKolbitsch%26aufirst%3DC.%26aulast%3DFelber%26aufirst%3DS.%26aulast%3DKrause%26aufirst%3DB.%2BJ.%26atitle%3DDoes%2520Caffeine%2520Modulate%2520Verbal%2520Working%2520Memory%2520Processes%253F%2520An%2520FMRI%2520Study%26jtitle%3DNeuroImage%26date%3D2008%26volume%3D39%26issue%3D1%26spage%3D492%26epage%3D499%26doi%3D10.1016%2Fj.neuroimage.2007.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref272"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref272'); return false;" data-citation="" class="refNumLink">272</a></strong><div class="NLM_citation" id="cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelligrino, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetri, F.</span></span> <span> </span><span class="NLM_article-title">Caffeine and the Control of Cerebral Hemodynamics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">s1</span>),  <span class="NLM_fpage">S51</span>– <span class="NLM_lpage">S62</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-091261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2010-091261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20182032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls12hurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=S51-S62&issue=s1&author=D.+A.+Pelligrinoauthor=H.+L.+Xuauthor=F.+Vetri&title=Caffeine+and+the+Control+of+Cerebral+Hemodynamics&doi=10.3233%2FJAD-2010-091261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and the Control of Cerebral Hemodynamics</span></div><div class="casAuthors">Pelligrino, Dale A.; Xu, Hao-Liang; Vetri, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S51-S62</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  While the influence of caffeine on the regulation of brain perfusion has been the subject of multiple publications, the mechanisms involved in that regulation remain unclear.  To some extent, that uncertainty is a function of a complex interplay of processes arising from multiple targets of caffeine located on a variety of different cells, many of which have influence, either directly or indirectly, on cerebral vascular smooth muscle tone.  Adding to that complexity are the target-specific functional changes that may occur when comparing acute and chronic caffeine exposure.  In the present review, we discuss some of the mechanisms behind caffeine influences on cerebrovascular function.  The major effects of caffeine on the cerebral circulation can largely be ascribed to its inhibitory effects on adenosine receptors.  Herein, we focus mostly on the A1, A2A, and A2B subtypes located in cells comprising the neurovascular unit (neurons, astrocytes, vascular smooth muscle); their roles in the coupling of increased neuronal (synaptic) activity to vasodilation; how caffeine, through blockade of these receptors, may interfere with the "neurovascular coupling" process; and receptor-linked changes that may occur in cerebrovascular regulation when comparing acute to chronic caffeine intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzMmH1_mB7gbVg90H21EOLACvtfcHk0livEusraJ3vIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls12hurc%253D&md5=47e0375b8d8d2cc6217cbca9942c4663</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-091261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-091261%26sid%3Dliteratum%253Aachs%26aulast%3DPelligrino%26aufirst%3DD.%2BA.%26aulast%3DXu%26aufirst%3DH.%2BL.%26aulast%3DVetri%26aufirst%3DF.%26atitle%3DCaffeine%2520and%2520the%2520Control%2520of%2520Cerebral%2520Hemodynamics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26issue%3Ds1%26spage%3DS51%26epage%3DS62%26doi%3D10.3233%2FJAD-2010-091261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref273"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref273'); return false;" data-citation="" class="refNumLink">273</a></strong><div class="NLM_citation" id="cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Groot, R. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, E. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veerman, E. C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligtenberg, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veltman, D. J.</span></span> <span> </span><span class="NLM_article-title">The Effect of Caffeine on Working Memory Load-Related Brain Activation in Middle-Aged Males</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2012.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22728314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVOnuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=160-167&author=E.+B.+Klaassenauthor=R.+H.+M.+De+Grootauthor=E.+A.+T.+Eversauthor=J.+Snelauthor=E.+C.+I.+Veermanauthor=A.+J.+M.+Ligtenbergauthor=J.+Jollesauthor=D.+J.+Veltman&title=The+Effect+of+Caffeine+on+Working+Memory+Load-Related+Brain+Activation+in+Middle-Aged+Males&doi=10.1016%2Fj.neuropharm.2012.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of caffeine on working memory load-related brain activation in middle-aged males</span></div><div class="casAuthors">Klaassen, Elissa B.; de Groot, Renate H. M.; Evers, Elisabeth A. T.; Snel, Jan; Veerman, Enno C. I.; Ligtenberg, Antoon J. M.; Jolles, Jelle; Veltman, Dick J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">160-167</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Caffeine is commonly consumed in an effort to enhance cognitive performance.  However, little is known about the usefulness of caffeine with regard to memory enhancement, with previous studies showing inconsistent effects on memory performance.  We aimed to det. the effect of caffeine on working memory (WM) load-related activation during encoding, maintenance and retrieval phases of a WM maintenance task using functional magnetic resonance imaging (fMRI). 20 healthy, male, habitual caffeine consumers aged 40-61 years were administered 100 mg of caffeine in a double-blind placebo-controlled crossover design.  Participants were scanned in a non-withdrawn state following a workday during which caffeinated products were consumed according to individual normal use (range = 145-595 mg).  Acute caffeine administration was assocd. with increased load-related activation compared to placebo in the left and right dorsolateral prefrontal cortex during WM encoding, but decreased load-related activation in the left thalamus during WM maintenance.  These findings are indicative of an effect of caffeine on the fronto-parietal network involved in the top-down cognitive control of WM processes during encoding and an effect on the prefrontal cortico-thalamic loop involved in the interaction between arousal and the top-down control of attention during maintenance.  Therefore, the effects of caffeine on WM may be attributed to both a direct effect of caffeine on WM processes, as well as an indirect effect on WM via arousal modulation.  Behavioral and fMRI results were more consistent with a detrimental effect of caffeine on WM at higher levels of WM load, than caffeine-related WM enhancement.This article is part of a Special Issue entitled 'Cognitive Enhancers'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj2d0dT-OF7LVg90H21EOLACvtfcHk0livEusraJ3vIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVOnuro%253D&md5=86da50bf8b24e6e9ebde1167f20dc667</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DKlaassen%26aufirst%3DE.%2BB.%26aulast%3DDe%2BGroot%26aufirst%3DR.%2BH.%2BM.%26aulast%3DEvers%26aufirst%3DE.%2BA.%2BT.%26aulast%3DSnel%26aufirst%3DJ.%26aulast%3DVeerman%26aufirst%3DE.%2BC.%2BI.%26aulast%3DLigtenberg%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DJolles%26aufirst%3DJ.%26aulast%3DVeltman%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Effect%2520of%2520Caffeine%2520on%2520Working%2520Memory%2520Load-Related%2520Brain%2520Activation%2520in%2520Middle-Aged%2520Males%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D160%26epage%3D167%26doi%3D10.1016%2Fj.neuropharm.2012.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref274"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref274'); return false;" data-citation="" class="refNumLink">274</a></strong><div class="NLM_citation" id="cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeister, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinanaj, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Ville, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovblad, K. O.</span></span> <span> </span><span class="NLM_article-title">Acute Caffeine Administration Impact on Working Memory-Related Brain Activation and Functional Connectivity in the Elderly: A BOLD and Perfusion MRI Study</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroscience.2013.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23876323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2013&pages=364-371&author=S.+Hallerauthor=C.+Rodriguezauthor=D.+Moserauthor=S.+Tomaauthor=J.+Hofmeisterauthor=I.+Sinanajauthor=D.+Van+De+Villeauthor=P.+Giannakopoulosauthor=K.+O.+Lovblad&title=Acute+Caffeine+Administration+Impact+on+Working+Memory-Related+Brain+Activation+and+Functional+Connectivity+in+the+Elderly%3A+A+BOLD+and+Perfusion+MRI+Study&doi=10.1016%2Fj.neuroscience.2013.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit274R"><div class="casContent"><span class="casTitleNuber">274</span><div class="casTitle"><span class="NLM_cas:atitle">Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: A BOLD and perfusion MRI study</span></div><div class="casAuthors">Haller, S.; Rodriguez, C.; Moser, D.; Toma, S.; Hofmeister, J.; Sinanaj, I.; Van De Ville, D.; Giannakopoulos, P.; Lovblad, K.-O.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">364-371</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In young individuals, caffeine-mediated blockade of adenosine receptors and vasoconstriction has direct repercussions on task-related activations, changes in functional connectivity, as well as global vascular effects.  To date, no study has explored the effect of caffeine on brain activation patterns during highly demanding cognitive tasks in the elderly.  This prospective, placebo-controlled crossover design comprises 24 healthy elderly individuals (mean age 68.8 ± 4.0 years, 17 females) performing a 2-back working memory (WM) task in functional magnetic resonance imaging (fMRI).  Analyses include complimentary assessment of task-related activations (general linear model, GLM), functional connectivity (tensorial independent component anal., TICA), and baseline perfusion (arterial spin labeling).  Despite a redn. in whole-brain global perfusion (-22.7%), caffeine-enhanced task-related GLM activation in a local and distributed network is most pronounced in the bilateral striatum and to a lesser degree in the right middle and inferior frontal gyrus, bilateral insula, left superior and inferior parietal lobule as well as in the cerebellum bilaterally.  TICA was significantly enhanced (+8.2%) in caffeine vs. placebo in a distributed and task-relevant network including the pre-frontal cortex, the supplementary motor area, the ventral premotor cortex and the parietal cortex as well as the occipital cortex (visual stimuli) and basal ganglia.  The inverse comparison of placebo vs. caffeine had no significant difference.  Activation strength of the task-relevant-network component correlated with response accuracy for caffeine yet not for placebo, indicating a selective cognitive effect of caffeine.  The present findings suggest that acute caffeine intake enhances WM-related brain activation as well as functional connectivity of blood oxygen level-dependent fMRI in elderly individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVri--Y5bs-LVg90H21EOLACvtfcHk0livEusraJ3vIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrfO&md5=00429b1c3b854ddb252723a837f8c804</span></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DC.%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DToma%26aufirst%3DS.%26aulast%3DHofmeister%26aufirst%3DJ.%26aulast%3DSinanaj%26aufirst%3DI.%26aulast%3DVan%2BDe%2BVille%26aufirst%3DD.%26aulast%3DGiannakopoulos%26aufirst%3DP.%26aulast%3DLovblad%26aufirst%3DK.%2BO.%26atitle%3DAcute%2520Caffeine%2520Administration%2520Impact%2520on%2520Working%2520Memory-Related%2520Brain%2520Activation%2520and%2520Functional%2520Connectivity%2520in%2520the%2520Elderly%253A%2520A%2520BOLD%2520and%2520Perfusion%2520MRI%2520Study%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D250%26spage%3D364%26epage%3D371%26doi%3D10.1016%2Fj.neuroscience.2013.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref275"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref275'); return false;" data-citation="" class="refNumLink">275</a></strong><div class="NLM_citation" id="cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. O.</span></span> <span> </span><span class="NLM_article-title">Regulation of Cerebrospinal Fluid Production by Caffeine Consumption</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">110</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-10-110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2F1471-2202-10-110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19725982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1MnisFansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=110&author=M.+E.+Hanauthor=H.+J.+Kimauthor=Y.+S.+Leeauthor=D.+H.+Kimauthor=J.+T.+Choiauthor=C.+S.+Panauthor=S.+Yoonauthor=S.+Y.+Baekauthor=B.+S.+Kimauthor=J.+B.+Kimauthor=S.+O.+Oh&title=Regulation+of+Cerebrospinal+Fluid+Production+by+Caffeine+Consumption&doi=10.1186%2F1471-2202-10-110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cerebrospinal fluid production by caffeine consumption</span></div><div class="casAuthors">Han Myoung-Eun; Kim Hak-Jin; Lee Young-Suk; Kim Dong-Hyun; Choi Joo-Taek; Pan Chul-Sik; Yoon Sik; Baek Sun-Yong; Kim Bong-Seon; Kim Jae-Bong; Oh Sae-Ock</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Caffeine is the most commonly consumed psycho-stimulant in the world.  The effects of caffeine on the body have been extensively studied; however, its effect on the structure of the brain has not been investigated to date.  RESULTS:  In the present study we found that the long-term consumption of caffeine can induce ventriculomegaly; this was observed in 40% of the study rats.  In the caffeine-treated rats with ventriculomegaly, there was increased production of CSF, associated with the increased expression of Na(+), K(+)-ATPase and increased cerebral blood flow (CBF).  In contrast to the chronic effects, acute treatment with caffeine decreased the production of CSF, suggesting 'effect inversion' associated with caffeine, which was mediated by increased expression of the A1 adenosine receptor, in the choroid plexus of rats chronically treated with caffeine.  The involvement of the A1 adenosine receptor in the effect inversion of caffeine was further supported by the induction of ventriculomegaly and Na+, K+-ATPase, in A1 agonist-treated rats.  CONCLUSION:  The results of this study show that long-term consumption of caffeine can induce ventriculomegaly, which is mediated in part by increased production of CSF.  Moreover, we also showed that adenosine receptor signaling can regulate the production of CSF by controlling the expression of Na(+), K(+)-ATPase and CBF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmFUcu8j2uSZI8NvIb08rbfW6udTcc2easolMqu_EoHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnisFansg%253D%253D&md5=6af132a10314fa46b2605295f1eb5c6a</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-10-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-10-110%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DM.%2BE.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BT.%26aulast%3DPan%26aufirst%3DC.%2BS.%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DBaek%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BB.%26aulast%3DOh%26aufirst%3DS.%2BO.%26atitle%3DRegulation%2520of%2520Cerebrospinal%2520Fluid%2520Production%2520by%2520Caffeine%2520Consumption%26jtitle%3DBMC%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D110%26doi%3D10.1186%2F1471-2202-10-110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref276"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref276'); return false;" data-citation="" class="refNumLink">276</a></strong><div class="NLM_citation" id="cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wostyn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span> <span> </span><span class="NLM_article-title">Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine’s Protective Effect against Alzheimer’s Disease</span>. <i>Int. J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">617420</span>, <span class="refDoi"> DOI: 10.4061/2011/617420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4061%2F2011%2F617420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21660211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3Mrpt1antw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=617420&author=P.+Wostynauthor=D.+Van+Damauthor=K.+Audenaertauthor=P.+P.+De+Deyn&title=Increased+Cerebrospinal+Fluid+Production+as+a+Possible+Mechanism+Underlying+Caffeine%E2%80%99s+Protective+Effect+against+Alzheimer%E2%80%99s+Disease&doi=10.4061%2F2011%2F617420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease</span></div><div class="casAuthors">Wostyn Peter; Van Dam Debby; Audenaert Kurt; De Deyn Peter Paul</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">617420</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD), the most common type of dementia among older people, is characterized by the accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles composed of hyperphosphorylated tau in the brain.  Despite major advances in understanding the molecular etiology of the disease, progress in the clinical treatment of AD patients has been extremely limited.  Therefore, new and more effective therapeutic approaches are needed.  Accumulating evidence from human and animal studies suggests that the long-term consumption of caffeine, the most commonly used psychoactive drug in the world, may be protective against AD.  The mechanisms underlying the suggested beneficial effect of caffeine against AD remain to be elucidated.  In recent studies, several potential neuroprotective effects of caffeine have been proposed.  Interestingly, a recent study in rats showed that the long-term consumption of caffeine increased cerebrospinal fluid (CSF) production, associated with the increased expression of Na(+)-K(+) ATPase and increased cerebral blood flow.  Compromised function of the choroid plexus and defective CSF production and turnover, with diminished clearance of Aβ, may be one mechanism implicated in the pathogenesis of late-onset AD.  If reduced CSF turnover is a risk factor for AD, then therapeutic strategies to improve CSF flow are reasonable.  In this paper, we hypothesize that long-term caffeine consumption could exert protective effects against AD at least in part by facilitating CSF production, turnover, and clearance.  Further, we propose a preclinical experimental design allowing evaluation of this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSWpsFFc4A4EQ0lWbKiCflfW6udTcc2easolMqu_EoHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mrpt1antw%253D%253D&md5=58b8cacfd1528a71ffa6c97a2cda0db9</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.4061%2F2011%2F617420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F617420%26sid%3Dliteratum%253Aachs%26aulast%3DWostyn%26aufirst%3DP.%26aulast%3DVan%2BDam%26aufirst%3DD.%26aulast%3DAudenaert%26aufirst%3DK.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26atitle%3DIncreased%2520Cerebrospinal%2520Fluid%2520Production%2520as%2520a%2520Possible%2520Mechanism%2520Underlying%2520Caffeine%25E2%2580%2599s%2520Protective%2520Effect%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2011%26volume%3D2011%26spage%3D617420%26doi%3D10.4061%2F2011%2F617420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref277"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref277'); return false;" data-citation="" class="refNumLink">277</a></strong><div class="NLM_citation" id="cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dall’lgna, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porciúncula, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, D. R.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by Caffeine and Adenosine A 2A Receptor Blockade of β-Amyloid Neurotoxicity</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1207</span>– <span class="NLM_lpage">1209</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0705185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.bjp.0705185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12711619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3s3gvF2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=1207-1209&issue=7&author=O.+P.+Dall%E2%80%99lgnaauthor=L.+O.+Porci%C3%BAnculaauthor=D.+O.+Souzaauthor=R.+A.+Cunhaauthor=D.+R.+Lara&title=Neuroprotection+by+Caffeine+and+Adenosine+A+2A+Receptor+Blockade+of+%CE%B2-Amyloid+Neurotoxicity&doi=10.1038%2Fsj.bjp.0705185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity</span></div><div class="casAuthors">Dall'Igna Oscar P; Porciuncula Lisiane O; Souza Diogo O; Cunha Rodrigo A; Lara Diogo R; Dall'lgna Oscar P</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1207-9</span>
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Adenosine is a neuromodulator in the nervous system and it has recently been observed that pharmacological blockade or gene disruption of adenosine A(2A) receptors confers neuroprotection under different neurotoxic situations in the brain.  We now observed that coapplication of either caffeine (1-25 micro M) or the selective A(2A) receptor antagonist, 4-(2-[7-amino-2(2-furyl)(1,2,4)triazolo (2,3-a)(1,3,5)triazin-5-ylamino]ethyl)phenol (ZM 241385, 50 nM), but not the A receptor antagonist, 8-cyclopentyltheophylline (200 nM), prevented the neuronal cell death caused by exposure of rat cultured cerebellar granule neurons to fragment 25-35 of beta-amyloid protein (25 micro M for 48 h), that by itself caused a near three-fold increase of propidium iodide-labeled cells.  This constitutes the first in vitro evidence to suggest that adenosine A(2A) receptors may be the molecular target responsible for the observed beneficial effects of caffeine consumption in the development of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNw1uz5FKyuR0LsK7uFuY7fW6udTcc2easolMqu_EoHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3gvF2ksQ%253D%253D&md5=a06ea97d86e4bd55a591daf536415516</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705185%26sid%3Dliteratum%253Aachs%26aulast%3DDall%25E2%2580%2599lgna%26aufirst%3DO.%2BP.%26aulast%3DPorci%25C3%25BAncula%26aufirst%3DL.%2BO.%26aulast%3DSouza%26aufirst%3DD.%2BO.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DLara%26aufirst%3DD.%2BR.%26atitle%3DNeuroprotection%2520by%2520Caffeine%2520and%2520Adenosine%2520A%25202A%2520Receptor%2520Blockade%2520of%2520%25CE%25B2-Amyloid%2520Neurotoxicity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D138%26issue%3D7%26spage%3D1207%26epage%3D1209%26doi%3D10.1038%2Fsj.bjp.0705185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref278"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref278'); return false;" data-citation="" class="refNumLink">278</a></strong><div class="NLM_citation" id="cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Facilitates Alzheimer’s Disease Pathogenesis by up-Regulating BACE1 Gene Expession</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">18727</span>– <span class="NLM_lpage">18732</span>, <span class="refDoi"> DOI: 10.1073/pnas.0606298103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.0606298103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17121991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaht7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=18727-18732&issue=49&author=X.+Sunauthor=G.+Heauthor=H.+Qingauthor=W.+Zhouauthor=F.+Dobieauthor=F.+Caiauthor=M.+Staufenbielauthor=L.+E.+Huangauthor=W.+Song&title=Hypoxia+Facilitates+Alzheimer%E2%80%99s+Disease+Pathogenesis+by+up-Regulating+BACE1+Gene+Expession&doi=10.1073%2Fpnas.0606298103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression</span></div><div class="casAuthors">Sun, Xiulian; He, Guiqiong; Qing, Hong; Zhou, Weihui; Dobie, Frederick; Cai, Fang; Staufenbiel, Matthias; Huang, L. Eric; Song, Weihong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">18727-18732</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mol. mechanism underlying the pathogenesis of the majority of cases of sporadic Alzheimer's disease (AD) is unknown.  A history of stroke was found to be assocd. with development of some AD cases, esp. in the presence of vascular risk factors.  Reduced cerebral perfusion is a common vascular component among AD risk factors, and hypoxia is a direct consequence of hypoperfusion.  Previously we showed that expression of the β-site β-amyloid precursor protein (APP) cleavage enzyme 1 (BACE1) gene BACE1 is tightly controlled at both the transcriptional and translational levels and that increased BACE1 maturation contributes to the AD pathogenesis in Down's syndrome.  Here we have identified a functional hypoxia-responsive element in the BACE1 gene promoter.  Hypoxia up-regulated β-secretase cleavage of APP and amyloid-β protein (Aβ) prodn. by increasing BACE1 gene transcription and expression both in vitro and in vivo.  Hypoxia treatment markedly increased Aβ deposition and neuritic plaque formation and potentiated the memory deficit in Swedish mutant APP transgenic mice.  Taken together, our results clearly demonstrate that hypoxia can facilitate AD pathogenesis, and they provide a mol. mechanism linking vascular factors to AD.  Our study suggests that interventions to improve cerebral perfusion may benefit AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMEtsQOrHoH7Vg90H21EOLACvtfcHk0ljd3LsGKX-yMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaht7jJ&md5=b575cb5e7ed3d5aceffb1242e6c32887</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0606298103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0606298103%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DQing%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DDobie%26aufirst%3DF.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%2BE.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DHypoxia%2520Facilitates%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Pathogenesis%2520by%2520up-Regulating%2520BACE1%2520Gene%2520Expession%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D49%26spage%3D18727%26epage%3D18732%26doi%3D10.1073%2Fpnas.0606298103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref279"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref279'); return false;" data-citation="" class="refNumLink">279</a></strong><div class="NLM_citation" id="cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Involvement of A7 NAChR Signaling Cascade in Epigallocatechin Gallate Suppression of β-Amyloid-Induced Apoptotic Cortical Neuronal Insults</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1007/s12035-013-8491-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs12035-013-8491-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23807728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=66-77&issue=1&author=X.+Zhangauthor=M.+Wuauthor=F.+Luauthor=N.+Luoauthor=Z.+P.+Heauthor=H.+Yang&title=Involvement+of+A7+NAChR+Signaling+Cascade+in+Epigallocatechin+Gallate+Suppression+of+%CE%B2-Amyloid-Induced+Apoptotic+Cortical+Neuronal+Insults&doi=10.1007%2Fs12035-013-8491-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit279R"><div class="casContent"><span class="casTitleNuber">279</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of α7 nAChR Signaling Cascade in Epigallocatechin Gallate Suppression of β-Amyloid-Induced Apoptotic Cortical Neuronal Insults</span></div><div class="casAuthors">Zhang, Xijing; Wu, Mingmei; Lu, Fan; Luo, Na; He, Zu-Ping; Yang, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-77</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Excessive generation and accumulation of the β-amyloid (Aβ) peptide in selectively vulnerable brain regions is a key pathogenic event in the Alzheimer's disease (AD), while epigallocatechin gallate (EGCG) is a very promising chem. to suppress a variety of Aβ-induced neurodegenerative disorders.  However, the precise mol. mechanism of EGCG responsible for protection against neurotoxicity still remains elusive.  To validate and further investigate the possible mechanism involved, we explored whether EGCG neuroprotection against neurotoxicity of Aβ is mediated through the α7 nicotinic acetylcholine receptor (α7 nAChR) signaling cascade.  It was shown in rat primary cortical neurons that short-term treatment with EGCG significantly attenuated the neurotoxicity of Aβ1-42, as demonstrated by increased cell viability, reduced no. of apoptotic cells, decreased reactive oxygen species (ROS) generation, and downregulated caspase-3 levels after treatment with 25-μM Aβ1-42.  In addn., EGCG markedly strengthened activation of α7nAChR as well as its downstream pathway signaling mols. phosphatidylinositol 3-kinase (PI3K) and Akt, subsequently leading to suppression of Bcl-2 downregulation in Aβ-treated neurons.  Conversely, administration of α7nAChR antagonist methyllycaconitine (MLA; 20 μM) to neuronal cultures significantly attenuated the neuroprotection of EGCG against Aβ-induced neurototoxicity, thus presenting new evidence that the α7nAChR activity together with PI3K/Akt transduction signaling may contribute to the mol. mechanism underlying the neuroprotective effects of EGCG against Aβ-induced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5vkj45XX0rVg90H21EOLACvtfcHk0ljd3LsGKX-yMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOksb0%253D&md5=cc90e55b93c9396492c57dd6e7b2e8f9</span></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8491-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8491-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DZ.%2BP.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DInvolvement%2520of%2520A7%2520NAChR%2520Signaling%2520Cascade%2520in%2520Epigallocatechin%2520Gallate%2520Suppression%2520of%2520%25CE%25B2-Amyloid-Induced%2520Apoptotic%2520Cortical%2520Neuronal%2520Insults%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26issue%3D1%26spage%3D66%26epage%3D77%26doi%3D10.1007%2Fs12035-013-8491-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262'],'ref263':['cit263'],'ref264':['cit264'],'ref265':['cit265'],'ref266':['cit266'],'ref267':['cit267'],'ref268':['cit268'],'ref269':['cit269'],'ref270':['cit270'],'ref271':['cit271'],'ref272':['cit272'],'ref273':['cit273'],'ref274':['cit274'],'ref275':['cit275'],'ref276':['cit276'],'ref277':['cit277'],'ref278':['cit278'],'ref279':['cit279']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. First Synthesis of Caffeine (1895) According to Fischer<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Common Pathway of Caffeine Biosynthesis in Plants<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Chemical Structures of Caffeine (<b>1</b>), Related Natural Xanthines <b>2</b>–<b>4</b>, Purines <b>5</b> and <b>6</b>, and Uric Acid (<b>7</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Properties, structure, and numbering of caffeine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Selected Xanthine-Derived A<sub>1</sub> Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Selected Xanthine-Derived A<sub>2A</sub> Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Selected Xanthine-Derived A<sub>2B</sub> Antagonists. Inset Shows 9-Deazaxanthines</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Selected Xanthine-Derived A<sub>3</sub> Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PSB36 bound to the A<sub>1</sub> receptor (pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S">5N2S</a>). Interacting amino acids are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superimposed structures of A<sub>1</sub> (green, pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S">5N2S</a>) and A<sub>2A</sub> (gray, pdb ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2R">5N2R</a>) receptor in complex with PSB36. The bulkier Met270 in A<sub>2A</sub> affects binding of bulky 8-substituents, while Thr270 of A<sub>1</sub> provides more space to ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0015.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. PDE Inhibitors with Structural Relationship to Caffeine (Examples)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IBMX (<b>48</b>) bound to PDE5 (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RKP">1RKP</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding of caffeine to ryanodine receptor (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRS">6JRS</a>). One binding site is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Glycogen phosphorylase with bound caffeine (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L5Q">1L5Q</a>). Caffeine is shown in magenta, and <i>N</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-glucopyranosylamine is yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/medium/jm1c00261_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Notum in complex with caffeine (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7TV4">7TV4</a>). Caffeine is shown in magenta, and the catalytic triad of Notum (Ser232, Asp340, and His389) is yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00261/20210602/images/large/jm1c00261_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00261&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 279 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nehlig, A.</span></span> <span> </span><span class="NLM_article-title">Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1124/pr.117.014407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fpr.117.014407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29514871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=384-411&issue=2&author=A.+Nehlig&title=Interindividual+Differences+in+Caffeine+Metabolism+and+Factors+Driving+Caffeine+Consumption&doi=10.1124%2Fpr.117.014407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Interindividual differences in caffeine metabolism and factors driving caffeine consumption</span></div><div class="casAuthors">Nehlig, Astrid</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-411</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  It has been known for decades that the metab., clearance, and pharmacokinetics of caffeine is affected by many factors such as age, sex and hormones, liver disease, obesity, smoking, and diet.  Caffeine also interacts with many medications.  All these factors will be reviewed in the present document and discussed in light of the most recent data concerning the genetic variability affecting caffeine levels and effects at the pharmacokinetic and pharmacodynamic levels that both critically drive the level of caffeine consumption.  The pharmacokinetics of caffeine are highly variable among individuals due to a polymorphism at the level of the CYP1A2 isoform of cytochrome P 450, which metabolizes 95% of the caffeine ingested.  Moreover there is a polymorphism at the level of another crit. enzyme, N-acetyltransferase 2.  At the pharmacodynamic level, there are several polymorphisms at the main brain target of caffeine, the adenosine A2A receptor or ADORA2.  Genetic studies, including genome-wide assocn. studies, identified several loci critically involved in caffeine consumption and its consequences on sleep, anxiety, and potentially in neurodegenerative and psychiatric diseases.  We start reaching a better picture on how a multiplicity of biol. mechanisms seems to drive the levels of caffeine consumption, although much more knowledge is still required to understand caffeine consumption and effects on body functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEvqJTyEt8T7Vg90H21EOLACvtfcHk0lhvjJn-ebmt6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsL0%253D&md5=884b0925563405b6293c6f79cc3d4417</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.014407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.014407%26sid%3Dliteratum%253Aachs%26aulast%3DNehlig%26aufirst%3DA.%26atitle%3DInterindividual%2520Differences%2520in%2520Caffeine%2520Metabolism%2520and%2520Factors%2520Driving%2520Caffeine%2520Consumption%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26issue%3D2%26spage%3D384%26epage%3D411%26doi%3D10.1124%2Fpr.117.014407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evan, J. C.</span></span>.  <i>Tea in China: The History of China’s National Drink</i>; <span class="NLM_publisher-name">Praeger Publishers Inc</span>, <span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=J.+C.+Evan&title=Tea+in+China%3A+The+History+of+China%E2%80%99s+National+Drink"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEvan%26aufirst%3DJ.%2BC.%26btitle%3DTea%2520in%2520China%253A%2520The%2520History%2520of%2520China%25E2%2580%2599s%2520National%2520Drink%26pub%3DPraeger%2520Publishers%2520Inc%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span> <i>Chocolate
in Health and Nutrition</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R. R.</span>, <span class="NLM_string-name">Preedy, V. R.</span>, <span class="NLM_string-name">Zibadi, S.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+R.+Watson&author=V.+R.+Preedy&author=S.+Zibadi&title=Chocolate%0Ain+Health+and+Nutrition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DChocolate%250Ain%2520Health%2520and%2520Nutrition%26aulast%3DWatson%26aufirst%3DR.%2BR.%26pub%3DHumana%2520Press%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, B. A.</span>; <span class="NLM_string-name">Bealer, B. K.</span></span>.  <i>The World of Caffeine: The Science and Culture of the World’s Most Popular Drug</i>; <span class="NLM_publisher-name">Routledge</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=B.+A.+Weinberg&author=B.+K.+Bealer&title=The+World+of+Caffeine%3A+The+Science+and+Culture+of+the+World%E2%80%99s+Most+Popular+Drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DB.%2BA.%26btitle%3DThe%2520World%2520of%2520Caffeine%253A%2520The%2520Science%2520and%2520Culture%2520of%2520the%2520World%25E2%2580%2599s%2520Most%2520Popular%2520Drug%26pub%3DRoutledge%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedlieb Ferdinand, Runge</span></span>.  <i>Neueste Phytochemische Entdeckungen Zur Begründung Einer Wissenschaftlichen Phytochemie</i>; <span class="NLM_publisher-name">G. Reimer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">1820</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1820&author=Runge+Friedlieb+Ferdinand&title=Neueste+Phytochemische+Entdeckungen+Zur+Begr%C3%BCndung+Einer+Wissenschaftlichen+Phytochemie"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFriedlieb%2BFerdinand%26aufirst%3DRunge%26btitle%3DNeueste%2520Phytochemische%2520Entdeckungen%2520Zur%2520Begr%25C3%25BCndung%2520Einer%2520Wissenschaftlichen%2520Phytochemie%26pub%3DG.%2520Reimer%26date%3D1820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, G. J.</span></span> <span> </span><span class="NLM_article-title">Ueber Theïn Und Caffeïn</span>. <i>J. Prakt. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1838</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1002/prac.18380150124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fprac.18380150124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1838&pages=280-284&issue=1&author=G.+J.+Mulder&title=Ueber+The%C3%AFn+Und+Caffe%C3%AFn&doi=10.1002%2Fprac.18380150124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fprac.18380150124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.18380150124%26sid%3Dliteratum%253Aachs%26aulast%3DMulder%26aufirst%3DG.%2BJ.%26atitle%3DUeber%2520The%25C3%25AFn%2520Und%2520Caffe%25C3%25AFn%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1838%26volume%3D15%26issue%3D1%26spage%3D280%26epage%3D284%26doi%3D10.1002%2Fprac.18380150124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jobst, C.</span></span> <span> </span><span class="NLM_article-title">Thein Identisch Mit Caffein</span>. <i>Ann. der Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1838</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1002/jlac.18380250106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fjlac.18380250106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1838&pages=63-66&issue=1&author=C.+Jobst&title=Thein+Identisch+Mit+Caffein&doi=10.1002%2Fjlac.18380250106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18380250106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18380250106%26sid%3Dliteratum%253Aachs%26aulast%3DJobst%26aufirst%3DC.%26atitle%3DThein%2520Identisch%2520Mit%2520Caffein%26jtitle%3DAnn.%2520der%2520Pharm.%26date%3D1838%26volume%3D25%26issue%3D1%26spage%3D63%26epage%3D66%26doi%3D10.1002%2Fjlac.18380250106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ach, L.</span></span> <span> </span><span class="NLM_article-title">Synthese Des Caffeïns</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1895</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">3135</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1002/cber.189502803156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcber.189502803156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaD28XovVejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1895&pages=3135-3143&issue=3&author=E.+Fischerauthor=L.+Ach&title=Synthese+Des+Caffe%C3%AFns&doi=10.1002%2Fcber.189502803156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of caffeine</span></div><div class="casAuthors">Fischer, Emil; Ach, Lorenz</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft</span>
        (<span class="NLM_cas:date">1895</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3135-43</span>CODEN:
                <span class="NLM_cas:coden">BDCGAS</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compare this vol., i, 12.  The synthesis of caffeine is effected by means of the following operations: (1) Production of dimethylbarbituric acid from malonic acid and dimethylcarbamide; (2) conversion of dimethylbarbituric acid into dimethylvioluric acid under the influence of nitrous acid; (3) reduction of dimethylvioluric acid to dimethyluramil, and transformation of the latter into dimethylpseudouric acid by means of potassium cyanate; (4) conversion of dimethylpseudouric acid into γ-dimethyluric acid (loc. cit.); (5) formation of chlorotheophylline by the action of phosphorus pentachloride on γ-dimethyluric acid; (6) reduction of chlorotheophylline to theophylline, and conversion of the latter into caffeine.  Chlorotheophylline, (the original abstract includes an equation), is obtained by heating an intimate mixture of γ-dimethyluric acid, phosphorus pentachloride (2 parts) and phosphorus oxychloride (4 parts) in sealed tubes at 150° for 2 1/2 hours; it crystallises from acetone in aggregates of colourless needles, which melt and decompose about 300°.  It is very sparingly soluble in chloroform, but dissolves more freely in acetone, and is readily soluble in hot alcohol; it dissolves in 150 parts of boiling water, forming an acid solution, and is readily soluble in ammonia, alkalis, and concentrated mineral acids.  Chlorine water produces the change characteristic of xanthine and its derivatives.  The sodium and silver derivatives crystallise in slender, white needles, the latter substance being insoluble in water, and gradually becoming dark when exposed to light.  When chlorotheophylline is reduced with hydriodic acid, theophylline is produced (Kossel, Abstr., 1888, 1114); the action of methylic iodide on the silver derivative gives rise to chlorocaffeine.  Bromotheophylline is formed when a mixture of phosphorus pentabromide and phosphorus oxychloride acts on γ-dimethyluric acid, chlorotheophylline being produced at the same time; it is also obtained by heating theophylline with bromine for four hours at 100° and subsequently at 150°.  Bromotheophylline separates from alcohol in colourless crystals, and melts and decomposes at 315-320° (uncorr.); it is very sparingly soluble in hot water, but dissolves readily in ammonia and alkalis.  Hydriodic acid readily converts it into theophylline.  Dimethylbarbituric acid is converted into the sodium derivative of dimethylvioluric acid by adding a concentrated solution of sodium nitrite to an aqueous solution of the acid at 60°; the sodium derivative contains 3H2O (compare Andreasch, Abstr., 1895, i, 337), which is removed at 115°.  Anhydrous dimethylvioluric acid melts at 141°, and in the hydrated condition at 124° (compare loc. cit., and Techow, Abstr., 1895, i, 84).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw4-VkpFnKw7Vg90H21EOLACvtfcHk0lhzRCvSE45Jdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaD28XovVejsA%253D%253D&md5=3adb031a9e71b9e69f68d3511cb1cba9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fcber.189502803156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.189502803156%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%26aulast%3DAch%26aufirst%3DL.%26atitle%3DSynthese%2520Des%2520Caffe%25C3%25AFns%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1895%26volume%3D28%26issue%3D3%26spage%3D3135%26epage%3D3143%26doi%3D10.1002%2Fcber.189502803156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E.</span></span> <span> </span><span class="NLM_article-title">Ueber Die Constitution Des Caffeïns, Xanthins, Hypoxanthins Und Verwandter Basen</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1897</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1002/cber.189703001110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcber.189703001110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaD28Xis1Cnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1897&pages=549-559&issue=1&author=E.+Fischer&title=Ueber+Die+Constitution+Des+Caffe%C3%AFns%2C+Xanthins%2C+Hypoxanthins+Und+Verwandter+Basen&doi=10.1002%2Fcber.189703001110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">About the structure of the Caffein, Xanthine, Hypoxanthine and related bases. [machine translation]</span></div><div class="casAuthors">Fischer, Emil</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1897</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">549-59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">[Machine Translation of Descriptors].  After conclusion of a comprehensive investigation of the bases specified in the heading (Liebig's Ann. 215. 253; C. 83. 66) the author for Caffein and Xanthine had set up Formulas I. and II., which stood with all at that time well-known transformations of these compounds in the best agreement; its newer investigations resulted in medico (Liebig's Ann. 175. 243; C. 75. 152) for purely speculative reasons for caffeine and Xanthine Formulas III. and IV., (equation or structure in original text) which derived from Fischer's by permutation of a CO and of a group of CH and different distribution of the bond within the rings differ, which earn advantage.  For the formulas of the author at that time following reasons seemed to speak: 1. From the effect products of C2H5I on the Ag-salt of the Hydroxycaffein (V. after Fischer) left itself excluding ethoxycaffein, however no Tetraalkyluric acid isolate, which one should have expected on the assumption of the formula VI. (of medico), more, since trimethyl uric acids had been transferred by CH3I easily in Tetramethyluric acid.  2. Hydroxycaffein becomes easily converted from alcohol and Br in Diethoxycaffein, with trimethyl- and Tetramethyluric acid did not succeed a similar reaction.  3. The Purine produced from uric acid by PCl5 (Report of the German Chemical Society, 17. 328) was equivalent compound up for the Xanthine compounds, but equipped with other characteristics than these.  Still the closer connection between the xanthine- and uric acid groups seemed to be missing at that time; (equation or structure in original text) particularly by the renewed investigations of the methyl uric acids, numerous and simple transitions between the two connecting rows are admit become, which today, contrary to which earlier conditions of the structure question, make a homogeneous building of the two liaison groups probable.  From these in particular the following observations are possible: 1. Published already (see Report of the German Chemical Society, 28. 3138; C. 96. I. 424) Transformation of γ-Dimethyluric acid turned around in Chlorotheophyllin and the transfer of the Bromotheobromine in δ-Dimethyluric acid (Report of the German Chemical Society, 28. 2482; C. 95. II. 1068).  2. The Hydroxycaffeine is recognized as (1.3.7)-trimethyl uric acid by the fact that it could be synthesized from Trimethyluramil (see the following paper), as well as from uric acid by methylation represented /or further in Tetramethyluric acid was transferable.  Therefore necessary the changes of the formulas of Hydroxycaffeine and Xanthine make naturally also similar modifications in the formulations of the methyl derivatives from which the Heteroxanthine as mono-, Theobromine, Theophyllin are possible here and to experiments the para-xanthine published as Dimethylxanthine; furthermore it must the adenine which 6-Amido-, as well as written the Hypoxanthine, which 6-Oxyxanthine is using the mudico's Xanthine formula, for which author intends to publish the experimental linings.  For all these formulas can be substituted naturally also tautomer; but it is advisable to use for O-containing products of the imide, for the guanine- and Adenine bases, as far as they are insoluble in alkalis, the amide formulas.  In order to be able to formulate all compounds through multiples transition of the linked groups of the uric acid and the Xanthine in uniform way, author makes the following nomenclature suggestions: One proceeds from the double ring available in the Purine body and designates the place of the substitution taken place, as (equation or structure in original text) it is shown by the accompanying pattern.  Purine is then for example the Tetrahydro derivative of this core, Hypoxanthine 6-Oxy-, uric acid 2.6.8-Trioxy-, caffeine 1.3.7-Trimethyl-2.6-dioxypurine.  The same numbering expand since the pseudo uric acids and the derivatives of the Alloxanee.  To conclusion refers to authors that the stated opens the realization in above that uric acid, Xanthine, Hypoxanthine and adenine close related descendants the same basic substance, the Purines are also physiological chemistry in new criteria, and that stands to hope to be able to produce on synthetic ways the same rich material for its research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzwCNGrLzE_bVg90H21EOLACvtfcHk0lhzRCvSE45Jdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaD28Xis1Cnt7k%253D&md5=a4c87335fcb1efe32d35c4f102dcf4a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fcber.189703001110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.189703001110%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%26atitle%3DUeber%2520Die%2520Constitution%2520Des%2520Caffe%25C3%25AFns%252C%2520Xanthins%252C%2520Hypoxanthins%2520Und%2520Verwandter%2520Basen%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1897%26volume%3D30%26issue%3D1%26spage%3D549%26epage%3D559%26doi%3D10.1002%2Fcber.189703001110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barboline, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkman, T. J.</span></span> <span> </span><span class="NLM_article-title">Convergent Evolution of Caffeine in Plants by Co-Option of Exapted Ancestral Enzymes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">10613</span>– <span class="NLM_lpage">10618</span>, <span class="refDoi"> DOI: 10.1073/pnas.1602575113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.1602575113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27638206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWls7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=10613-10618&issue=38&author=R.+Huangauthor=A.+J.+O%E2%80%99Donnellauthor=J.+J.+Barbolineauthor=T.+J.+Barkman&title=Convergent+Evolution+of+Caffeine+in+Plants+by+Co-Option+of+Exapted+Ancestral+Enzymes&doi=10.1073%2Fpnas.1602575113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Convergent evolution of caffeine in plants by co-option of exapted ancestral enzymes</span></div><div class="casAuthors">Huang, Ruiqi; O'Donnell, Andrew J.; Barboline, Jessica J.; Barkman, Todd J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">10613-10618</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Convergent evolution is a process that has occurred throughout the tree of life, but the historical genetic and biochem. context promoting the repeated independent origins of a trait is rarely understood.  The well-known stimulant caffeine, and its xanthine alkaloid precursors, has evolved multiple times in flowering plant history for various roles in plant defense and pollination.  We have shown that convergent caffeine prodn., surprisingly, has evolved by two previously unknown biochem. pathways in chocolate, citrus, and guarana plants using either caffeine synthase- or xanthine methyltransferase-like enzymes.  However, the pathway and enzyme lineage used by any given plant species is not predictable from phylogenetic relatedness alone.  Ancestral sequence resurrection reveals that this convergence was facilitated by co-option of genes maintained over 100 million y for alternative biochem. roles.  The ancient enzymes of the Citrus lineage were exapted for reactions currently used for various steps of caffeine biosynthesis and required very few mutations to acquire modern-day enzymic characteristics, allowing for the evolution of a complete pathway.  Future studies aimed at manipulating caffeine content of plants will require the use of different approaches given the metabolic and genetic diversity revealed by this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtgXD0WAjqqLVg90H21EOLACvtfcHk0lj8C8G_091mJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWls7nF&md5=fb98b3bb0fa35c8d5e72af0bfb1895e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1602575113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1602575113%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DA.%2BJ.%26aulast%3DBarboline%26aufirst%3DJ.%2BJ.%26aulast%3DBarkman%26aufirst%3DT.%2BJ.%26atitle%3DConvergent%2520Evolution%2520of%2520Caffeine%2520in%2520Plants%2520by%2520Co-Option%2520of%2520Exapted%2520Ancestral%2520Enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D38%26spage%3D10613%26epage%3D10618%26doi%3D10.1073%2Fpnas.1602575113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathanson, J. A.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Related Methylxanthines: Possible Naturally Occurring Pesticides</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span> (<span class="NLM_issue">4671</span>),  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1126/science.6207592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1126%2Fscience.6207592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6207592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2cXmtVKjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=184-187&issue=4671&author=J.+A.+Nathanson&title=Caffeine+and+Related+Methylxanthines%3A+Possible+Naturally+Occurring+Pesticides&doi=10.1126%2Fscience.6207592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and related methylxanthines:  possible naturally occurring pesticides</span></div><div class="casAuthors">Nathanson, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4671</span>),
    <span class="NLM_cas:pages">184-7</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Natural and synthetic methylxanthines (caffeine  [58-08-2], 3-isobutylmethylxanthine  [28822-58-4], etc.) inhibit insect feeding and are pesticidal at concns. known to occur in plants.  These effects are due primarily to inhibition of phosphodiesterase  [9025-82-5] activity and to an increase in intracellular cAMP  [60-92-4].  At lower concns., methylxanthines are potent synergists of other pesticides known to activate adenylate cyclase in insects.  These data suggest that methylxanthines may function as natural insecticides and that phosphodiesterase inhibitors, alone or in combination with other compds., may be useful in insect control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW4ccMAHlf3LVg90H21EOLACvtfcHk0lj8C8G_091mJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtVKjtL4%253D&md5=f5c7af1544f6481ba36362c12633f8a6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.6207592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6207592%26sid%3Dliteratum%253Aachs%26aulast%3DNathanson%26aufirst%3DJ.%2BA.%26atitle%3DCaffeine%2520and%2520Related%2520Methylxanthines%253A%2520Possible%2520Naturally%2520Occurring%2520Pesticides%26jtitle%3DScience%26date%3D1984%26volume%3D226%26issue%3D4671%26spage%3D184%26epage%3D187%26doi%3D10.1126%2Fscience.6207592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frischknecht, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulmer-Dufek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, T. W.</span></span> <span> </span><span class="NLM_article-title">Purine Alkaloid Formation in Buds and Developing Leaflets of Coffea Arabica: Expression of an Optimal Defence Strategy?</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(86)88009-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0031-9422%2886%2988009-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28XhvVegtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=613-616&issue=3&author=P.+M.+Frischknechtauthor=J.+Ulmer-Dufekauthor=T.+W.+Baumann&title=Purine+Alkaloid+Formation+in+Buds+and+Developing+Leaflets+of+Coffea+Arabica%3A+Expression+of+an+Optimal+Defence+Strategy%3F&doi=10.1016%2F0031-9422%2886%2988009-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Purine alkaloid formation in buds and developing leaflets of Coffea arabica:  expression of an optimal defense strategy?</span></div><div class="casAuthors">Frischknecht, Peter M.; Ulmer-Dufek, Jindra; Baumann, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-16</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    </div><div class="casAbstract">In buds and emergent leaflets of C. arabica, formation of the purine alkaloids caffeine and theobromine was studied to characterize the chem. defense strategy of a tissue with a high risk of predation.  As long as the leaflets were fully covered by a resin layer and by 2 stipules, their alkaloid content varied 1-3% dry wt.  With leaflet emergence, the alkaloid formation incredsed and the variation decreased.  Max. content of ∼4% was reached when the leaflets were fully open.  In the subsequent development period alkaloid content decreased.  Comparison between the investment in alkaloid formation with that in primary metabolic processes demonstrated that chem. defense is costly: influx of C atoms into caffeine was 15% of that into respiration.  A defense strategy which is based on an antagonism between mech. and chem. protection is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIie9tNHUN4rVg90H21EOLACvtfcHk0lh3Gjuzm5MS_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVegtb0%253D&md5=397630e3e073ccc61a58d78ee6068ee2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2886%2988009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252886%252988009-8%26sid%3Dliteratum%253Aachs%26aulast%3DFrischknecht%26aufirst%3DP.%2BM.%26aulast%3DUlmer-Dufek%26aufirst%3DJ.%26aulast%3DBaumann%26aufirst%3DT.%2BW.%26atitle%3DPurine%2520Alkaloid%2520Formation%2520in%2520Buds%2520and%2520Developing%2520Leaflets%2520of%2520Coffea%2520Arabica%253A%2520Expression%2520of%2520an%2520Optimal%2520Defence%2520Strategy%253F%26jtitle%3DPhytochemistry%26date%3D1986%26volume%3D25%26issue%3D3%26spage%3D613%26epage%3D616%26doi%3D10.1016%2F0031-9422%2886%2988009-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">López-González, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Oliver, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, R.</span></span> <span> </span><span class="NLM_article-title">Acute Caffeine Supplementation in Combat Sports: A Systematic Review</span>. <i>J. Int. Soc. Sports Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/s12970-018-0267-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs12970-018-0267-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30594211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKnurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=60&issue=1&author=L.+M.+L%C3%B3pez-Gonz%C3%A1lezauthor=A.+J.+S%C3%A1nchez-Oliverauthor=F.+Mataauthor=P.+Jodraauthor=J.+Antonioauthor=R.+Dom%C3%ADnguez&title=Acute+Caffeine+Supplementation+in+Combat+Sports%3A+A+Systematic+Review&doi=10.1186%2Fs12970-018-0267-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Acute caffeine supplementation in combat sports: a systematic review</span></div><div class="casAuthors">Lopez-Gonzalez, Luis M.; Sanchez-Oliver, Antonio J.; Mata, Fernando; Jodra, Pablo; Antonio, Jose; Dominguez, Raul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the International Society of Sports Nutrition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">JISSCV</span>;
        ISSN:<span class="NLM_cas:issn">1550-2783</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Caffeine used as a supplement has been shown to improve phys. and cognitive performance in several sport modalities due to its effects on the central nervous system.  This review assesses the direct effects of caffeine supplementation on performance in combat sports.  Using the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Anal.) guidelines, relevant studies were identified through the Medline, Scopus and SPORTDiscus databases.  Of 1053 search results, only 9 articles fulfilled the inclusion criteria.  Of these, three studies detected no ergogenic effect of caffeine supplementation, while six studies did observe a significant pos. effect.  Supplementation with 3-6 mg/kg of caffeine was found to increase the glycolytic contribution to energy metab. during the execution of real or simulated combats, as indicated by elevated blood lactate concns.  Caffeine intake was also noted to improve levels of strength, power and upper arm muscular endurance.  These effects were not paralleled by an increase in the exertion perceived by the athlete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Bnq5DdcIY7Vg90H21EOLACvtfcHk0lh3Gjuzm5MS_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKnurjF&md5=092ea9b1f0dc83c3610f3e936a3a90d4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2Fs12970-018-0267-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12970-018-0267-2%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Gonz%25C3%25A1lez%26aufirst%3DL.%2BM.%26aulast%3DS%25C3%25A1nchez-Oliver%26aufirst%3DA.%2BJ.%26aulast%3DMata%26aufirst%3DF.%26aulast%3DJodra%26aufirst%3DP.%26aulast%3DAntonio%26aufirst%3DJ.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DR.%26atitle%3DAcute%2520Caffeine%2520Supplementation%2520in%2520Combat%2520Sports%253A%2520A%2520Systematic%2520Review%26jtitle%3DJ.%2520Int.%2520Soc.%2520Sports%2520Nutr.%26date%3D2018%26volume%3D15%26issue%3D1%26spage%3D60%26doi%3D10.1186%2Fs12970-018-0267-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diel, P.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Doping—What Have We Learned since 2004</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2167</span>, <span class="refDoi"> DOI: 10.3390/nu12082167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3390%2Fnu12082167" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=2167&issue=8&author=P.+Diel&title=Caffeine+and+Doping%E2%80%94What+Have+We+Learned+since+2004&doi=10.3390%2Fnu12082167"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fnu12082167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu12082167%26sid%3Dliteratum%253Aachs%26aulast%3DDiel%26aufirst%3DP.%26atitle%3DCaffeine%2520and%2520Doping%25E2%2580%2594What%2520Have%2520We%2520Learned%2520since%25202004%26jtitle%3DNutrients%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2167%26doi%3D10.3390%2Fnu12082167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">1–3</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&issue=1%E2%80%933&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lh3Gjuzm5MS_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26issue%3D1%25E2%2580%25933%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span>; <span class="NLM_string-name">Leo, A.</span>; <span class="NLM_string-name">Hoekman, D. H.</span></span> <i>Exploring QSAR.; ACS professional reference book</i>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=C.+Hansch&author=A.+Leo&author=D.+H.+Hoekman&title=Exploring+QSAR.%3B+ACS+professional+reference+book"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26btitle%3DExploring%2520QSAR.%253B%2520ACS%2520professional%2520reference%2520book%26pub%3DAmerican%2520Chemical%2520Society%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maas, W. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greaves, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Sandt, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, F. M.</span></span> <span> </span><span class="NLM_article-title">Interactions of Skin Thickness and Physicochemical Properties of Test Compounds in Percutaneous Penetration Studies</span>. <i>Int. Arch. Occup. Environ. Health</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1007/s00420-005-0056-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00420-005-0056-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16435152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XislCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=405-413&issue=5&author=S.+C.+Wilkinsonauthor=W.+J.+M.+Maasauthor=J.+B.+Nielsenauthor=L.+C.+Greavesauthor=J.+J.+M.+van+de%0ASandtauthor=F.+M.+Williams&title=Interactions+of+Skin+Thickness+and+Physicochemical+Properties+of+Test+Compounds+in+Percutaneous+Penetration+Studies&doi=10.1007%2Fs00420-005-0056-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies</span></div><div class="casAuthors">Wilkinson, Simon C.; Maas, Wilfred J. M.; Nielsen, Jesper Bo; Greaves, Laura C.; Sandt, Johannes J. M.; Williams, Faith M.</div><div class="citationInfo"><span class="NLM_cas:title">International Archives of Occupational and Environmental Health</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">IAEHDW</span>;
        ISSN:<span class="NLM_cas:issn">0340-0131</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Objectives: To det. the effect of skin thickness on the percutaneous penetration and distribution of test compds. with varying physicochem. properties using in vitro systems.  Studies were carried out in accordance with OECD guidelines on skin absorption tests.  Methods: Percutaneous penetration of caffeine (log P -0.01), testosterone (log P 3.32), propoxur (log P 1.52) (finite dose in ethanol to water vehicle ratio) and butoxyethanol (log P 0.83) (undiluted finite dose or as an infinite dose 50% [vol./vol.] aq. soln.) through skin of varying thicknesses under occluded conditions was measured using flow through cells for 8-24 h.  Saline (adjusted to pH 7.4) was used as receptor fluid, with BSA added for studies with testosterone and propoxur.  Following exposure, the remaining surface dose was removed by swabbing and the skin digested prior to scintillation counting.  Results: The max. flux of caffeine was increased with decreasing skin thickness, although these differences were found to be non-significant.  The presence of caffeine in the skin membrane was not altered by skin thickness.  Maximum flux and cumulative dose absorbed of testosterone and butoxyethanol (in both finite and infinite doses) were markedly reduced with full thickness (about 1 mm thick) skin compared with split thickness skin (about 0.5 mm).  Maximum flux of propoxur (dissolved in 60% ethanol) was clearly higher through skin of 0.71 mm than through skin of 1.36 mm, but no difference was found between 0.56 and 0.71 mm.  The proportion of propoxur present in the membrane after 24 h increased significantly over the complete range of thicknesses tested (0.56-1.36 mm).  Conclusions: A complex relationship exists between skin thickness, lipophilicity and percutaneous penetration and distribution.  This has implications for risk assessment studies and for the validation of models with data from different sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgPg32WIZ40LVg90H21EOLACvtfcHk0lgvtwnjr9uSkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislCrsb0%253D&md5=802a1f2ab2d8cb3788665e13c96efd96</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs00420-005-0056-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00420-005-0056-5%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BC.%26aulast%3DMaas%26aufirst%3DW.%2BJ.%2BM.%26aulast%3DNielsen%26aufirst%3DJ.%2BB.%26aulast%3DGreaves%26aufirst%3DL.%2BC.%26aulast%3Dvan%2Bde%2BSandt%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DWilliams%26aufirst%3DF.%2BM.%26atitle%3DInteractions%2520of%2520Skin%2520Thickness%2520and%2520Physicochemical%2520Properties%2520of%2520Test%2520Compounds%2520in%2520Percutaneous%2520Penetration%2520Studies%26jtitle%3DInt.%2520Arch.%2520Occup.%2520Environ.%2520Health%26date%3D2006%26volume%3D79%26issue%3D5%26spage%3D405%26epage%3D413%26doi%3D10.1007%2Fs00420-005-0056-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies-Strickleton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span> <span> </span><span class="NLM_article-title">Assessment of the Nail Penetration of Antifungal Agents, with Different Physicochemical Properties</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>), <span class="NLM_elocation-id">e0229414</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0229414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1371%2Fjournal.pone.0229414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=32107486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&issue=2&author=H.+Davies-Strickletonauthor=J.+Cookauthor=S.+Hannamauthor=R.+Bennettauthor=A.+Gibbsauthor=D.+Edwardsauthor=C.+Riddenauthor=J.+Riddenauthor=D.+Cook&title=Assessment+of+the+Nail+Penetration+of+Antifungal+Agents%2C+with+Different+Physicochemical+Properties&doi=10.1371%2Fjournal.pone.0229414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the nail penetration of antifungal agents, with different physico-chemical properties</span></div><div class="casAuthors">Davies-Strickleton, Heather; Cook, Julie; Hannam, Sally; Bennett, Rhys; Gibbs, Alan; Edwards, David; Ridden, Christine; Ridden, John; Cook, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0229414</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Onychomycosis, or fungal nail infection, is a common fungal infection largely caused by dermatophyte fungi, such as Trichophyton rubrum or Trichophyton mentagrophytes, which affects a significant no. of people.  Treatment is either through oral antifungal medicines, which are efficacious but have significant safety concerns, or with topical antifungal treatments that require long treatment regimens and have only limited efficacy.  Thus, an efficacious topical therapy remains an unmet medical need.  Among the barriers to topical delivery through the nail are the physico-chem. properties of the antifungal drugs.  Here, we explore the ability of a range of antifungal compds. with different hydrophilicities to penetrate the nail.  Human nail disks were clamped within static diffusion (Franz) cells and dosed with equimolar concns. of antifungal drugs.  Using LC-MS/MS we quantified the amt. of drug that passed through the nail disk and that which remained assocd. with the nail.  Our data identified increased drug flux through the nail for the more hydrophilic compds. (caffeine as a hydrophilic control and fluconazole, with LogP -0.07 and 0.5, resp.), while less hydrophilic efinaconazole, amorolfine and terbinafine (LogP 2.7, 5.6 and 5.9 resp.) had much lower flux through the nail.  On the other hand, hydrophilicity alone did not account for the amt. of drug assocd. with/bound to the nail itself.  While there are other factors that are likely to combine to dictate nail penetration, this work supports earlier studies that implicate compd. hydrophilicity as a crit. factor for nail penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqavIxtE7TemLVg90H21EOLACvtfcHk0lgvtwnjr9uSkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVKmsLs%253D&md5=a5c6d78cf74b66d6b84152c49fee1381</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0229414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0229414%26sid%3Dliteratum%253Aachs%26aulast%3DDavies-Strickleton%26aufirst%3DH.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHannam%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DR.%26aulast%3DGibbs%26aufirst%3DA.%26aulast%3DEdwards%26aufirst%3DD.%26aulast%3DRidden%26aufirst%3DC.%26aulast%3DRidden%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DD.%26atitle%3DAssessment%2520of%2520the%2520Nail%2520Penetration%2520of%2520Antifungal%2520Agents%252C%2520with%2520Different%2520Physicochemical%2520Properties%26jtitle%3DPLoS%2520One%26date%3D2020%26volume%3D15%26issue%3D2%26doi%3D10.1371%2Fjournal.pone.0229414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, R. S.</span></span> <span> </span><span class="NLM_article-title">Caffeine</span>. In  <i>Reproductive and Developmental Toxicology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. C.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier Inc.</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FB978-0-12-382032-7.10027-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=355-364&author=R.+S.+Da+Silvaauthor=R.+C.+Gupta&title=Reproductive+and+Developmental+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-382032-7.10027-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-382032-7.10027-X%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSilva%26aufirst%3DR.%2BS.%26atitle%3DCaffeine%26btitle%3DReproductive%2520and%2520Developmental%2520Toxicology%26aulast%3DGupta%26aufirst%3DR.%2BC.%26pub%3DElsevier%2520Inc%26date%3D2011%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figgitt, D. P.</span></span> <span> </span><span class="NLM_article-title">Caffeine Citrate: A Review of Its Use in Apnoea of Prematurity</span>. <i>Paediatr. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.2165/00128072-200103010-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2165%2F00128072-200103010-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=11220405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3M3isFajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=61-79&issue=1&author=A.+M.+Comerauthor=C.+M.+Perryauthor=D.+P.+Figgitt&title=Caffeine+Citrate%3A+A+Review+of+Its+Use+in+Apnoea+of+Prematurity&doi=10.2165%2F00128072-200103010-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine citrate: a review of its use in apnoea of prematurity</span></div><div class="casAuthors">Comer A M; Perry C M; Figgitt D P</div><div class="citationInfo"><span class="NLM_cas:title">Paediatric drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-79</span>
        ISSN:<span class="NLM_cas:issn">1174-5878</span>.
    </div><div class="casAbstract">UNLABELLED:  Apnoea of prematurity is a common condition in neonates born at less than 37 weeks' gestational age; it affects approximately 90% of premature neonates weighing under 1000 g at birth, and 25% of infants with a birthweight of less than 2500 g.  Caffeine, a methylxanthine which occurs naturally in many plants, has been used for over 20 years to treat apnoea of prematurity.  In a recent double-blind, placebo-controlled trial, apnoea was eliminated or reduced by at least 50% in significantly more neonates receiving caffeine citrate as first-line treatment than those receiving placebo.  In a nonblind trial, caffeine citrate was more effective at reducing apnoeic episodes when compared with neonates receiving no treatment.  Caffeine as first-line treatment demonstrated similar efficacy to theophylline or aminophylline (theophylline ethylenediamine) in 4 small randomised studies.  Caffeine citrate was generally well tolerated in short term clinical trials, with very few adverse events reported.  Caffeine was associated with fewer adverse events than theophylline in randomised trials.  No differences in the incidence of individual adverse events were reported between caffeine citrate and placebo in a double-blind, randomised trial.  Long term tolerability data are not yet available.  CONCLUSIONS:  Caffeine citrate was generally well tolerated by neonates in clinical trials and it decreased the incidence of apnoea of prematurity compared with placebo.  It has demonstrated similar efficacy to theophylline, but is generally better tolerated and has a wider therapeutic index.  Caffeine citrate should, therefore, be considered the drug of choice when pharmacological treatment of apnoea of prematurity is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYck1WoRsGk--MdeMhXAHkfW6udTcc2eY9w7vqDgb16Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3isFajsA%253D%253D&md5=1163f61b74a5081ff0a6adbe57bb2abf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2165%2F00128072-200103010-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00128072-200103010-00005%26sid%3Dliteratum%253Aachs%26aulast%3DComer%26aufirst%3DA.%2BM.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26aulast%3DFiggitt%26aufirst%3DD.%2BP.%26atitle%3DCaffeine%2520Citrate%253A%2520A%2520Review%2520of%2520Its%2520Use%2520in%2520Apnoea%2520of%2520Prematurity%26jtitle%3DPaediatr.%2520Drugs%26date%3D2001%26volume%3D3%26issue%3D1%26spage%3D61%26epage%3D79%26doi%3D10.2165%2F00128072-200103010-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cates, C. J.</span></span> <span> </span><span class="NLM_article-title">Caffeine for Asthma</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">CD001112</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD001112.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD001112.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=CD001112&issue=1&author=E.+J.+Welshauthor=A.+Baraauthor=E.+Barleyauthor=C.+J.+Cates&title=Caffeine+for+Asthma&doi=10.1002%2F14651858.CD001112.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD001112.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD001112.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DWelsh%26aufirst%3DE.%2BJ.%26aulast%3DBara%26aufirst%3DA.%26aulast%3DBarley%26aufirst%3DE.%26aulast%3DCates%26aufirst%3DC.%2BJ.%26atitle%3DCaffeine%2520for%2520Asthma%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2010%26volume%3D2010%26issue%3D1%26spage%3DCD001112%26doi%3D10.1002%2F14651858.CD001112.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alfaro, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeiro, C. R.</span></span> <span> </span><span class="NLM_article-title">Chronic Coffee Consumption and Respiratory Disease: A Systematic Review</span>. <i>Clin. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1283</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1111/crj.12662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fcrj.12662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28671769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1cjjvFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=1283-1294&issue=3&author=T.+M.+Alfaroauthor=R.+A.+Monteiroauthor=R.+A.+Cunhaauthor=C.+R.+Cordeiro&title=Chronic+Coffee+Consumption+and+Respiratory+Disease%3A+A+Systematic+Review&doi=10.1111%2Fcrj.12662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic coffee consumption and respiratory disease: A systematic review</span></div><div class="casAuthors">Alfaro Tiago M; Monteiro Rita A; Cordeiro Carlos Robalo; Alfaro Tiago M; Cunha Rodrigo A; Alfaro Tiago M; Cordeiro Carlos Robalo</div><div class="citationInfo"><span class="NLM_cas:title">The clinical respiratory journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1283-1294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The widespread consumption of coffee means that any biological effects from its use can lead to significant public health consequences.  Chronic pulmonary diseases are extremely prevalent and responsible for one of every six deaths on a global level.  METHODS:  Major medical databases for studies reporting on the effects of coffee or caffeine consumption on a wide range of non-malignant respiratory outcomes, including incidence, prevalence, evolution or severity of respiratory disease in adults were searched.  Studies on lung function and respiratory mortality were also considered.  RESULTS:  Fifteen studies, including seven cohort, six cross-sectional, one case control and one randomized control trial were found.  Coffee consumption was generally associated with a reduction in prevalence of asthma.  The association of coffee with natural honey was an effective treatment for persistent post-infectious cough.  One case-control study found higher risk of chronic obstructive pulmonary disease (COPD) with coffee consumption.  No association was found with the evolution of COPD or sarcoidosis.  Coffee was associated with a reduction in respiratory mortality, and one study found improved lung function in coffee consumers.  Smoking was a significant confounder in most studies.  CONCLUSIONS:  Coffee consumption was associated with some positive effects on the respiratory system.  There was however limited available evidence, mostly from cross sectional and retrospective studies.  The only prospective cohort studies were those reporting on respiratory mortality.  These results suggest that coffee consumption may be a part of a healthy lifestyle leading to reduced respiratory morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAIXCrxKVgfIMcDoIzZtNkfW6udTcc2eY9w7vqDgb16Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjjvFygsw%253D%253D&md5=fc02a1772541074dc8075b1b115e0b3a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fcrj.12662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcrj.12662%26sid%3Dliteratum%253Aachs%26aulast%3DAlfaro%26aufirst%3DT.%2BM.%26aulast%3DMonteiro%26aufirst%3DR.%2BA.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DCordeiro%26aufirst%3DC.%2BR.%26atitle%3DChronic%2520Coffee%2520Consumption%2520and%2520Respiratory%2520Disease%253A%2520A%2520Systematic%2520Review%26jtitle%3DClin.%2520Respir.%2520J.%26date%3D2018%26volume%3D12%26issue%3D3%26spage%3D1283%26epage%3D1294%26doi%3D10.1111%2Fcrj.12662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Derry, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. A.</span></span> <span> </span><span class="NLM_article-title">Caffeine as an Analgesic Adjuvant for Acute Pain in Adults</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2017</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">CD009281</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD009281.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD009281.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2014&pages=CD009281&issue=10&author=C.+J.+Derryauthor=S.+Derryauthor=R.+A.+Moore&title=Caffeine+as+an+Analgesic+Adjuvant+for+Acute+Pain+in+Adults&doi=10.1002%2F14651858.CD009281.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD009281.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD009281.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DDerry%26aufirst%3DC.%2BJ.%26aulast%3DDerry%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DR.%2BA.%26atitle%3DCaffeine%2520as%2520an%2520Analgesic%2520Adjuvant%2520for%2520Acute%2520Pain%2520in%2520Adults%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D2017%26issue%3D10%26spage%3DCD009281%26doi%3D10.1002%2F14651858.CD009281.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garas, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K.</span></span> <span> </span><span class="NLM_article-title">Caffeine in the Management of Patients with Headache</span>. <i>J. Headache Pain</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107</span>, <span class="refDoi"> DOI: 10.1186/s10194-017-0806-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs10194-017-0806-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29067618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Cqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=107&issue=1&author=R.+B.+Liptonauthor=H.+C.+Dienerauthor=M.+S.+Robbinsauthor=S.+Y.+Garasauthor=K.+Patel&title=Caffeine+in+the+Management+of+Patients+with+Headache&doi=10.1186%2Fs10194-017-0806-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine in the management of patients with headache</span></div><div class="casAuthors">Lipton Richard B; Robbins Matthew S; Diener Hans-Christoph; Garas Sandy Yacoub; Patel Ketu</div><div class="citationInfo"><span class="NLM_cas:title">The journal of headache and pain</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Caffeinated headache medications, either alone or in combination with other treatments, are widely used by patients with headache.  Clinicians should be familiar with their use as well as the chemistry, pharmacology, dietary and medical sources, clinical benefits, and potential safety issues of caffeine.  In this review, we consider the role of caffeine in the over-the-counter treatment of headache.  The MEDLINE and Cochrane databases were searched by combining "caffeine" with the terms "headache," "migraine," and "tension-type." Studies that were not placebo-controlled or that involved medications available only with a prescription, as well as those not assessing patients with migraine and/or tension-type headache (TTH), were excluded.  Compared with analgesic medication alone, combinations of caffeine with analgesic medications, including acetaminophen, acetylsalicylic acid, and ibuprofen, showed significantly improved efficacy in the treatment of patients with TTH or migraine, with favorable tolerability in the vast majority of patients.  The most common adverse events were nervousness (6.5%), nausea (4.3%), abdominal pain/discomfort (4.1%), and dizziness (3.2%).  This review provides evidence for the role of caffeine as an analgesic adjuvant in the acute treatment of primary headache with over-the-counter drugs, caffeine doses of 130 mg enhance the efficacy of analgesics in TTH and doses of ≥100 mg enhance benefits in migraine.  Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCFnfg9pyrBsve_zCu79I8fW6udTcc2eapMX35UoHj4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Cqtw%253D%253D&md5=e108a78b1b7fc93c42779aef2fff92b2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1186%2Fs10194-017-0806-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs10194-017-0806-2%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DR.%2BB.%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DRobbins%26aufirst%3DM.%2BS.%26aulast%3DGaras%26aufirst%3DS.%2BY.%26aulast%3DPatel%26aufirst%3DK.%26atitle%3DCaffeine%2520in%2520the%2520Management%2520of%2520Patients%2520with%2520Headache%26jtitle%3DJ.%2520Headache%2520Pain%26date%3D2017%26volume%3D18%26issue%3D1%26spage%3D107%26doi%3D10.1186%2Fs10194-017-0806-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, H.</span></span> <span> </span><span class="NLM_article-title">Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1007/s12325-019-0891-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs12325-019-0891-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30758744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWnsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=597-607&issue=3&author=T.+Weiserauthor=H.+Weigmann&title=Effect+of+Caffeine+on+the+Bioavailability+and+Pharmacokinetics+of+an+Acetylsalicylic+Acid-Paracetamol+Combination%3A+Results+of+a+Phase+I+Study&doi=10.1007%2Fs12325-019-0891-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study</span></div><div class="casAuthors">Weiser, Thomas; Weigmann, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-607</span>CODEN:
                <span class="NLM_cas:coden">ADTHE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-238X</span>.
    
            (<span class="NLM_cas:orgname">Springer Healthcare Ltd.</span>)
        </div><div class="casAbstract">Introduction: Caffeine is used as an adjuvant in analgesic combinations to enhance their efficacy.  The present study aimed to det. the effect of caffeine on the pharmacokinetics of acetylsalicylic acid (ASA) and paracetamol when used as a fixed-dose ASA/paracetamol/caffeine combination.  In this single-center, two-way, cross-over phase I study, volunteers fasted overnight (≥ 12 h) and randomly received single oral doses of 250 mg ASA/200 mg paracetamol (ref.) or 250 mg ASA/200 mg paracetamol/50 mg caffeine (test).  Blood samples were collected before and up to 24 h after dosing.  The primary end points were the area under the concn.-time curve from zero to infinity (AUC0-∞) and max. plasma concn. (Cmax) for ASA, salicylic acid (SA) and paracetamol from the two combinations.  The main secondary end points were AUC0-∞ and Cmax of caffeine and time to reach Cmax (tmax) of all drugs.  Eighteen healthy male volunteers (32.5 ± 10.5 years) participated in the study.  The geometric means of Cmax for ASA, SA and paracetamol were similar in the test (3.71, 15.8 and 2.42 μg/mL, resp.) and ref. groups (3.89, 15.8, 2.42 μg/mL, resp.).  The geometric mean of AUC0-∞ for ASA, SA and paracetamol from the test combination was 2.86, 60.5 and 7.68 μg h/mL, resp., and that for the ref. was 2.96, 59.1 and 7.77 μg h/mL, resp.  The medians of tmax for ASA, SA and paracetamol were similar between the two groups.  The point ests. for the ratios of AUC0-∞ and Cmax for test vs. ref. regarding ASA, SA and paracetamol were within the predefined equivalence limits.  The two treatments were well tolerated.  Conclusion: Caffeine did not affect the pharmacokinetics of ASA and paracetamol when used as an adjuvant in ASA/paracetamol fixed-dose combination under fasting conditions, suggesting that caffeine enhances the analgesic efficacy of these drugs by pharmacodynamic rather than pharmacokinetic interactions.  Funding: Sanofi-Aventis Deutschland GmbH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7DmDSopsVzLVg90H21EOLACvtfcHk0ljXf-3Q0yS6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWnsbnO&md5=e6b8b57e9304d9b2d37bc23c8ef93835</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs12325-019-0891-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12325-019-0891-5%26sid%3Dliteratum%253Aachs%26aulast%3DWeiser%26aufirst%3DT.%26aulast%3DWeigmann%26aufirst%3DH.%26atitle%3DEffect%2520of%2520Caffeine%2520on%2520the%2520Bioavailability%2520and%2520Pharmacokinetics%2520of%2520an%2520Acetylsalicylic%2520Acid-Paracetamol%2520Combination%253A%2520Results%2520of%2520a%2520Phase%2520I%2520Study%26jtitle%3DAdv.%2520Ther.%26date%3D2019%26volume%3D36%26issue%3D3%26spage%3D597%26epage%3D607%26doi%3D10.1007%2Fs12325-019-0891-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horrigan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, T. J.</span></span> <span> </span><span class="NLM_article-title">Immunomodulatory Effects of Caffeine: Friend or Foe?</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2006.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.pharmthera.2006.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16540173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1SksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2006&pages=877-892&issue=3&author=L.+A.+Horriganauthor=J.+P.+Kellyauthor=T.+J.+Connor&title=Immunomodulatory+Effects+of+Caffeine%3A+Friend+or+Foe%3F&doi=10.1016%2Fj.pharmthera.2006.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory effects of caffeine: Friend or foe?</span></div><div class="casAuthors">Horrigan, Louise A.; Kelly, John P.; Connor, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">877-892</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Caffeine is a member of the methylxanthine family of drugs, and is the most widely consumed behaviorally active substance in the western world.  This article is focused on the impact of caffeine on immune function.  In this regard, a no. of in vitro and in vivo studies have demonstrated that caffeine modulates both innate and adaptive immune responses.  For instance studies indicate that caffeine and its major metabolite paraxanthine suppress neutrophil and monocyte chemotaxis, and also suppress prodn. of the pro-inflammatory cytokine tumor necrosis factor (TNF)-α from human blood.  Caffeine has also been reported to suppress human lymphocyte function as indicated by reduced T-cell proliferation and impaired prodn. of Th1 (interleukin [IL]-2 and interferon [IFN]-γ), Th2 (IL-4, IL-5) and Th3 (IL-10) cytokines.  Studies also indicate that caffeine suppresses antibody prodn.  The evidence suggests that at least some of the immunomodulatory actions of caffeine are mediated via inhibition of cAMP (cAMP)-phosphodiesterase (PDE), and consequential increase in intracellular cAMP concns.  Overall, these studies indicate that caffeine, like other members of the methylxanthine family, is largely anti-inflammatory in nature, and based on the pharmacokinetics of caffeine, we suggest that many of its immunomodulatory effects occur at concns. that are relevant to normal human consumption.  Finally, the potential of caffeine-induced immunomodulation to significantly impact upon health and well-being are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCGWMi-PmtGrVg90H21EOLACvtfcHk0ljXf-3Q0yS6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1SksLw%253D&md5=b363c9e254057ca860196f35df9e156d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHorrigan%26aufirst%3DL.%2BA.%26aulast%3DKelly%26aufirst%3DJ.%2BP.%26aulast%3DConnor%26aufirst%3DT.%2BJ.%26atitle%3DImmunomodulatory%2520Effects%2520of%2520Caffeine%253A%2520Friend%2520or%2520Foe%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2006%26volume%3D111%26issue%3D3%26spage%3D877%26epage%3D892%26doi%3D10.1016%2Fj.pharmthera.2006.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. E.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Headaches</span>. <i>Curr. Pain Headache Rep.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1007/s11916-008-0052-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs11916-008-0052-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18625110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1cvkvFOqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=311-315&issue=4&author=R.+E.+Shapiro&title=Caffeine+and+Headaches&doi=10.1007%2Fs11916-008-0052-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and headaches</span></div><div class="casAuthors">Shapiro Robert E</div><div class="citationInfo"><span class="NLM_cas:title">Current pain and headache reports</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Caffeine is the most widely consumed psychostimulant drug in the world.  With intermittent exposures, caffeine may act as a mild analgesic for headache or as an adjuvant for the actions of other analgesics.  Chronic repetitive exposures to caffeine increase the risks for development of analgesic-overuse headache, chronic daily headache, and physical dependency.  Cessation of caffeine use after chronic exposures leads to a withdrawal syndrome with headache as a dominant symptom.  At dosages achieved by common dietary intake, caffeine acts as a potent antagonist of central and peripheral nervous system adenosine receptors.  The complex effects of caffeine on headache disorders suggest important roles for adenosine in these disorders and in the induction of caffeine dependency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYF9lg_aw9nTUE-swuRqsHfW6udTcc2eYYmgrYGwwNirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvkvFOqtA%253D%253D&md5=c834ab2b0e7be0f715069f925b3730bf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs11916-008-0052-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11916-008-0052-z%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DR.%2BE.%26atitle%3DCaffeine%2520and%2520Headaches%26jtitle%3DCurr.%2520Pain%2520Headache%2520Rep.%26date%3D2008%26volume%3D12%26issue%3D4%26spage%3D311%26epage%3D315%26doi%3D10.1007%2Fs11916-008-0052-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, F. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pliássova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canas, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinho, P.</span></span> <span> </span><span class="NLM_article-title">Blockade of Adenosine A2A Receptors Recovers Early Deficits of Memory and Plasticity in the Triple Transgenic Mouse Model of Alzheimer’s Disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2018.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.nbd.2018.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29859867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVyqur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=72-81&author=A.+C.+Silvaauthor=C.+Lemosauthor=F.+Q.+Gon%C3%A7alvesauthor=A.+V.+Pli%C3%A1ssovaauthor=N.+J.+Machadoauthor=H.+B.+Silvaauthor=P.+M.+Canasauthor=R.+A.+Cunhaauthor=J.+P.+Lopesauthor=P.+Agostinho&title=Blockade+of+Adenosine+A2A+Receptors+Recovers+Early+Deficits+of+Memory+and+Plasticity+in+the+Triple+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.nbd.2018.05.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Silva, Antonio C.; Lemos, Cristina; Goncalves, Francisco Q.; Pliassova, Anna V.; Machado, Nuno J.; Silva, Henrique B.; Canas, Paula M.; Cunha, Rodrigo A.; Lopes, Joao Pedro; Agostinho, Paula</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) begins with a deficit of synaptic function and adenosine A2A receptors (A2AR) are mostly located in synapses controlling synaptic plasticity.  The over-activation of adenosine A2A receptors (A2AR) causes memory deficits and the blockade of A2AR prevents memory damage in AD models.  We now enquired if this prophylactic role of A2AR might be extended to a therapeutic potential.  We used the triple transgenic model of AD (3xTg-AD) and defined that the onset of memory dysfunction occurred at 4 mo of age in the absence of locomotor or emotional alterations.  At the onset of memory deficits, 3xTg mice displayed a decreased d. of markers of excitatory synapses (10.6±3.8% decrease of vGluT1) without neuronal or glial overt damage and an increase of synaptic A2AR in the hippocampus (130±22%).  After the onset of memory deficits in 3xTg-AD mice, a three weeks treatment with the selective A2AR antagonist normalized the up-regulation of hippocampal A2AR and restored hippocampal-dependent ref. memory, as well as the decrease of hippocampal synaptic plasticity (60.0±3.7% decrease of long-term potentiation amplitude) and the decrease of global (syntaxin-I) and glutamatergic synaptic markers (vGluT1).  These findings show a therapeutic-like ability of A2AR antagonists to recover synaptic and memory dysfunction in early AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW210tEsnrvrVg90H21EOLACvtfcHk0lizRDRKl8o5zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVyqur7F&md5=1aaf05e8fb2905ace7a9a1e4fd308fac</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2018.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2018.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DA.%2BC.%26aulast%3DLemos%26aufirst%3DC.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DF.%2BQ.%26aulast%3DPli%25C3%25A1ssova%26aufirst%3DA.%2BV.%26aulast%3DMachado%26aufirst%3DN.%2BJ.%26aulast%3DSilva%26aufirst%3DH.%2BB.%26aulast%3DCanas%26aufirst%3DP.%2BM.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DLopes%26aufirst%3DJ.%2BP.%26aulast%3DAgostinho%26aufirst%3DP.%26atitle%3DBlockade%2520of%2520Adenosine%2520A2A%2520Receptors%2520Recovers%2520Early%2520Deficits%2520of%2520Memory%2520and%2520Plasticity%2520in%2520the%2520Triple%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2018%26volume%3D117%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.nbd.2018.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cellai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buée, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mériaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Murcia, V.</span></span> <span> </span><span class="NLM_article-title">The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease</span>. <i>Front. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">520</span>, <span class="refDoi"> DOI: 10.3389/fnins.2018.00520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3389%2Ffnins.2018.00520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30123104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ps1elsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=520&author=L.+Cellaiauthor=K.+Carvalhoauthor=E.+Faivreauthor=A.+Deleauauthor=D.+Vieauauthor=L.+Bu%C3%A9eauthor=D.+Blumauthor=C.+M%C3%A9riauxauthor=V.+Gomez-Murcia&title=The+Adenosinergic+Signaling%3A+A+Complex+but+Promising+Therapeutic+Target+for+Alzheimer%E2%80%99s+Disease&doi=10.3389%2Ffnins.2018.00520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease</span></div><div class="casAuthors">Cellai Lucrezia; Carvalho Kevin; Faivre Emilie; Deleau Aude; Vieau Didier; Buee Luc; Blum David; Meriaux Celine; Gomez-Murcia Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">520</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disorder in elderly people.  AD is characterized by a progressive cognitive decline and it is neuropathologically defined by two hallmarks: extracellular deposits of aggregated β-amyloid (Aβ) peptides and intraneuronal fibrillar aggregates of hyper- and abnormally phosphorylated Tau proteins.  AD results from multiple genetic and environmental risk factors.  Epidemiological studies reported beneficial effects of caffeine, a non-selective adenosine receptors antagonist.  In the present review, we discuss the impact of caffeine and of adenosinergic system modulation on AD, in terms of pathology and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSidoXifVQq8fh3YQQtAhNufW6udTcc2eaOTFqr_6GDNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ps1elsQ%253D%253D&md5=2e3d1d744222ca1ead036f4eb3a37139</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2018.00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2018.00520%26sid%3Dliteratum%253Aachs%26aulast%3DCellai%26aufirst%3DL.%26aulast%3DCarvalho%26aufirst%3DK.%26aulast%3DFaivre%26aufirst%3DE.%26aulast%3DDeleau%26aufirst%3DA.%26aulast%3DVieau%26aufirst%3DD.%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DM%25C3%25A9riaux%26aufirst%3DC.%26aulast%3DGomez-Murcia%26aufirst%3DV.%26atitle%3DThe%2520Adenosinergic%2520Signaling%253A%2520A%2520Complex%2520but%2520Promising%2520Therapeutic%2520Target%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFront.%2520Neurosci.%26date%3D2018%26volume%3D12%26spage%3D520%26doi%3D10.3389%2Ffnins.2018.00520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Dose-Response Meta-Analysis on Coffee, Tea and Caffeine Consumption with Risk of Parkinson’s Disease</span>. <i>Geriatr. Gerontol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1111/ggi.12123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fggi.12123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23879665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3sfjt1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=430-439&issue=2&author=H.+Qiauthor=S.+Li&title=Dose-Response+Meta-Analysis+on+Coffee%2C+Tea+and+Caffeine+Consumption+with+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1111%2Fggi.12123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease</span></div><div class="casAuthors">Qi Hui; Li Shixue</div><div class="citationInfo"><span class="NLM_cas:title">Geriatrics & gerontology international</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.  METHODS:  A comprehensive search was carried out to identify eligible studies.  The fixed or random effect model was used based on heterogeneity test.  The dose-response relationship was assessed by restricted cubic spline.  RESULTS:  A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included.  A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81).  A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively.  The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women.  The aforementioned associations were weaker for USA relative to Europe or Asia.  CONCLUSIONS:  A linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall.  Further studies are required to confirm the findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkfKXUVxB-dDQLBVDQn4bCfW6udTcc2eaOTFqr_6GDNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfjt1GgsA%253D%253D&md5=f6e18bb9c111fd23b16778cee7ea5d61</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fggi.12123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fggi.12123%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DDose-Response%2520Meta-Analysis%2520on%2520Coffee%252C%2520Tea%2520and%2520Caffeine%2520Consumption%2520with%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DGeriatr.%2520Gerontol.%2520Int.%26date%3D2014%26volume%3D14%26issue%3D2%26spage%3D430%26epage%3D439%26doi%3D10.1111%2Fggi.12123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngandu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuomilehto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivipelto, M.</span></span> <span> </span><span class="NLM_article-title">Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-0920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2009-0920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19158424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Shs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=85-91&issue=1&author=M.+H.+Eskelinenauthor=T.+Nganduauthor=J.+Tuomilehtoauthor=H.+Soininenauthor=M.+Kivipelto&title=Midlife+Coffee+and+Tea+Drinking+and+the+Risk+of+Late-Life+Dementia%3A+A+Population-Based+CAIDE+Study&doi=10.3233%2FJAD-2009-0920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Midlife coffee and tea drinking and the risk late-life dementia: a population-based CAIDE study</span></div><div class="casAuthors">Eskelinen, Marjo H.; Ngandu, Tiia; Tuomilehto, Jaakko; Soininen, Hilkka; Kivipelto, Miia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-91</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Caffeine stimulates central nervous system on a short term.  However, the long-term impact of caffeine on cognition remains unclear.  We aimed to study the assocn. between coffee and/or tea consumption at midlife and dementia/Alzheimer's disease (AD) risk in late-life.  Participants of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of a population-based cohorts previously surveyed within the North Karelia Project and the FINMONICA study in 1972, 1977, 1982 or 1987 (midlife visit).  After an av. follow-up of 21 years, 1409 individuals (71%) aged 65 to 79 completed the re-examn. in 1998.  A total of 61 cases were identified as demented (48 with AD).  Coffee drinkers at midlife had lower risk of dementia and AD later in life compared with those drinking no or only little coffee adjusted for demog., lifestyle and vascular factors, apolipoprotein E ε4 allele and depressive symptoms.  The lowest risk (65% decreased) was found in people who drank 3-5 cups per day.  Tea drinking was relatively uncommon and was not assocd. with dementia/AD.  Coffee drinking at midlife is assocd. with a decreased risk of dementia/AD later in life.  This finding might open possibilities for prevention of dementia/AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLwiX93ksYmrVg90H21EOLACvtfcHk0lgJ3J3xm1uVeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Shs7w%253D&md5=449f5d791c2f76a32c680db749fe3a73</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-0920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-0920%26sid%3Dliteratum%253Aachs%26aulast%3DEskelinen%26aufirst%3DM.%2BH.%26aulast%3DNgandu%26aufirst%3DT.%26aulast%3DTuomilehto%26aufirst%3DJ.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DMidlife%2520Coffee%2520and%2520Tea%2520Drinking%2520and%2520the%2520Risk%2520of%2520Late-Life%2520Dementia%253A%2520A%2520Population-Based%2520CAIDE%2520Study%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D16%26issue%3D1%26spage%3D85%26epage%3D91%26doi%3D10.3233%2FJAD-2009-0920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mendonca, A.</span></span> <span> </span><span class="NLM_article-title">Does Caffeine Intake Protect from Alzheimer’s Disease?</span>. <i>Eur. J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1046/j.1468-1331.2002.00421.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1046%2Fj.1468-1331.2002.00421.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12099922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD38zls12rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=377-382&issue=4&author=L.+Maiaauthor=A.+de+Mendonca&title=Does+Caffeine+Intake+Protect+from+Alzheimer%E2%80%99s+Disease%3F&doi=10.1046%2Fj.1468-1331.2002.00421.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Does caffeine intake protect from Alzheimer's disease?</span></div><div class="casAuthors">Maia L; de Mendonca A</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-82</span>
        ISSN:<span class="NLM_cas:issn">1351-5101</span>.
    </div><div class="casAbstract">Caffeine is the most widely consumed behaviourally active substance in the western world.  Neuroprotective effects of caffeine in low doses, chronically administered, have been shown in different experimental models.  If caffeine intake could protect against neurodegeneration in Alzheimer's disease (AD), then higher levels of caffeine consumption in normal subjects as compared with AD patients should be detectable in the presumably long period before diagnosis when insidious pathogenic changes are taking place.  A case-control study was used: cases were 54 patients with probable AD fulfilling the National Institute of Neurologic and Communicative Disorders and Stroke and the AD and Related Disorders Association criteria, in a Dementia Clinics setting.  Controls were 54 accompanying persons, cognitively normal, matched for age (+/-3 years) and sex.  Patients with AD had an average daily caffeine intake of 73.9 +/- 97.9 mg during the 20 years that preceded diagnosis of AD, whereas the controls had an average daily caffeine intake of 198.7 +/- 135.7 mg during the corresponding 20 years of their lifetimes (P < 0.001, Wilcoxon signed ranks test).  Using a logistic regression model, caffeine exposure during this period was found to be significantly inversely associated with AD (odds ratio=0.40, 95% confidence interval=0.25-0.67), whereas hypertension, diabetes, stroke, head trauma, smoking habits, alcohol consumption, non-steroid anti-inflammatory drugs, vitamin E, gastric disorders, heart disease, education and family history of dementia were not statistically significantly associated with AD.  Caffeine intake was associated with a significantly lower risk for AD, independently of other possible confounding variables.  These results, if confirmed with future prospective studies, may have a major impact on the prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTathl5uVAgi42y4bB4mnvYfW6udTcc2eblTmSy7FDv87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zls12rug%253D%253D&md5=f59b88a0b6191aa60991a74d3fb7a431</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1046%2Fj.1468-1331.2002.00421.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1468-1331.2002.00421.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DL.%26aulast%3Dde%2BMendonca%26aufirst%3DA.%26atitle%3DDoes%2520Caffeine%2520Intake%2520Protect%2520from%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2002%26volume%3D9%26issue%3D4%26spage%3D377%26epage%3D382%26doi%3D10.1046%2Fj.1468-1331.2002.00421.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powderly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sznol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heist, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choueiri, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, B. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weise, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riese, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emens, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laport, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Aya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renouf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munneke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaffery, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willingham, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span> <span> </span><span class="NLM_article-title">Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-0980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1158%2F2159-8290.CD-19-0980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31732494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtleiurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=40-53&issue=1&author=L.+Fongauthor=A.+Hotsonauthor=J.+D.+Powderlyauthor=M.+Sznolauthor=R.+S.+Heistauthor=T.+K.+Choueiriauthor=S.+Georgeauthor=B.+G.+M.+Hughesauthor=M.+D.+Hellmannauthor=D.+R.+Shepardauthor=B.+I.+Riniauthor=S.+Kummarauthor=A.+M.+Weiseauthor=M.+J.+Rieseauthor=B.+Markmanauthor=L.+A.+Emensauthor=D.+Mahadevanauthor=J.+J.+Lukeauthor=G.+Laportauthor=J.+D.+Brodyauthor=L.+Hernandez-Ayaauthor=P.+Bonomiauthor=J.+W.+Goldmanauthor=L.+Berimauthor=D.+J.+Renoufauthor=R.+A.+Goodwinauthor=B.+Munnekeauthor=P.+Y.+Hoauthor=J.+Hsiehauthor=I.+McCafferyauthor=L.+Kweiauthor=S.+B.+Willinghamauthor=R.+A.+Miller&title=Adenosine+2A+Receptor+Blockade+as+an+Immunotherapy+for+Treatment-Refractory+Renal+Cell+Cancer&doi=10.1158%2F2159-8290.CD-19-0980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer</span></div><div class="casAuthors">Fong, Lawrence; Hotson, Andrew; Powderly, John D.; Sznol, Mario; Heist, Rebecca S.; Choueiri, Toni K.; George, Saby; Hughes, Brett G. M.; Hellmann, Matthew D.; Shepard, Dale R.; Rini, Brian I.; Kummar, Shivaani; Weise, Amy M.; Riese, Matthew J.; Markman, Ben; Emens, Leisha A.; Mahadevan, Daruka; Luke, Jason J.; Laport, Ginna; Brody, Joshua D.; Hernandez-Aya, Leonel; Bonomi, Philip; Goldman, Jonathan W.; Berim, Lyudmyla; Renouf, Daniel J.; Goodwin, Rachel A.; Munneke, Brian; Ho, Po Y.; Hsieh, Jessica; McCaffery, Ian; Kwei, Long; Willingham, Stephen B.; Miller, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-53</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Adenosine mediates immunosuppression within the tumor microenvironment through triggering adenosine 2A receptors (A2AR) on immune cells.  To det. whether this pathway could be targeted as an immunotherapy, we performed a phase I clin. trial with a small-mol. A2AR antagonist.  We find that this mol. can safely block adenosine signaling in vivo.  In a cohort of 68 patients with renal cell cancer (RCC), we also observe clin. responses alone and in combination with an anti-PD-L1 antibody, including subjects who had progressed on PD-1/PD-L1 inhibitors.  Durable clin. benefit is assocd. with increased recruitment of CD8+ T cells into the tumor.  Treatment can also broaden the circulating T-cell repertoire.  Clin. responses are assocd. with an adenosine-regulated gene-expression signature in pretreatment tumor biopsies.  A2AR signaling, therefore, represents a targetable immune checkpoint distinct from PD-1/PD-L1 that restricts antitumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-lTXPk20DrVg90H21EOLACvtfcHk0liuXGXK-UNVFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtleiurnO&md5=593bc9aef2c7eaa1dd223ae33cfcae4c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-0980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-0980%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DL.%26aulast%3DHotson%26aufirst%3DA.%26aulast%3DPowderly%26aufirst%3DJ.%2BD.%26aulast%3DSznol%26aufirst%3DM.%26aulast%3DHeist%26aufirst%3DR.%2BS.%26aulast%3DChoueiri%26aufirst%3DT.%2BK.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DB.%2BG.%2BM.%26aulast%3DHellmann%26aufirst%3DM.%2BD.%26aulast%3DShepard%26aufirst%3DD.%2BR.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DWeise%26aufirst%3DA.%2BM.%26aulast%3DRiese%26aufirst%3DM.%2BJ.%26aulast%3DMarkman%26aufirst%3DB.%26aulast%3DEmens%26aufirst%3DL.%2BA.%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DLuke%26aufirst%3DJ.%2BJ.%26aulast%3DLaport%26aufirst%3DG.%26aulast%3DBrody%26aufirst%3DJ.%2BD.%26aulast%3DHernandez-Aya%26aufirst%3DL.%26aulast%3DBonomi%26aufirst%3DP.%26aulast%3DGoldman%26aufirst%3DJ.%2BW.%26aulast%3DBerim%26aufirst%3DL.%26aulast%3DRenouf%26aufirst%3DD.%2BJ.%26aulast%3DGoodwin%26aufirst%3DR.%2BA.%26aulast%3DMunneke%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DP.%2BY.%26aulast%3DHsieh%26aufirst%3DJ.%26aulast%3DMcCaffery%26aufirst%3DI.%26aulast%3DKwei%26aufirst%3DL.%26aulast%3DWillingham%26aufirst%3DS.%2BB.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26atitle%3DAdenosine%25202A%2520Receptor%2520Blockade%2520as%2520an%2520Immunotherapy%2520for%2520Treatment-Refractory%2520Renal%2520Cell%2520Cancer%26jtitle%3DCancer%2520Discovery%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D40%26epage%3D53%26doi%3D10.1158%2F2159-8290.CD-19-0980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span>; <span class="NLM_string-name">Gao, Z. G.</span>; <span class="NLM_string-name">Matricon, P.</span>; <span class="NLM_string-name">Eddy, M. T.</span>; <span class="NLM_string-name">Carlsson, J.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2A Receptor Antagonists: From Caffeine to Selective Non-Xanthines</span>.  <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, in press. <span class="refDoi"> DOI: 10.1111/bph.15103</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fbph.15103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=K.+A.+Jacobson&author=Z.+G.+Gao&author=P.+Matricon&author=M.+T.+Eddy&author=J.+Carlsson&title=Adenosine+A2A+Receptor+Antagonists%3A+From+Caffeine+to+Selective+Non-Xanthines&doi=10.1111%2Fbph.15103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fbph.15103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.15103%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAdenosine%2520A2A%2520Receptor%2520Antagonists%253A%2520From%2520Caffeine%2520to%2520Selective%2520Non-Xanthines%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2020%26doi%3D10.1111%2Fbph.15103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawers, S. J. A.</span></span> <span> </span><span class="NLM_article-title">The Absolute Bioavailability of Caffeine in Man</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/BF00613933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00613933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6832208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3sXhsFCrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1983&pages=93-98&issue=1&author=J.+Blanchardauthor=S.+J.+A.+Sawers&title=The+Absolute+Bioavailability+of+Caffeine+in+Man&doi=10.1007%2FBF00613933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The absolute bioavailability of caffeine in man</span></div><div class="casAuthors">Blanchard, J.; Sawers, S. J. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-8</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">The abs. bioavailability of orally administered caffeine (I)  [58-08-2] was investigated in 10 healthy adult male volunteers, aged 18.8 to 30.0 yr.  The subjects were administered a 5 mg/kg dose as either an aq. oral soln. or an i.v. infusion on sep. occasions about 1 wk apart, in a randomized crossover fashion.  Plasma samples were collected for 24 h following each dose and assayed for I content by high-performance liq. chromatog.  The oral absorption was very rapid, reaching a mean peak plasma concn. after 29.8 min.  In addn., the variation in the max. plasma concn. was low, 10.0 μg/mL.  The abs. bioavailability was assessed by comparing the areas under the plasma concn. vs. time curves for the i.v. and oral doses.  The rapid absorption resulted in essentially complete bioavailability of oral I.  The caffeine plasma half-lives varied from 2.7 to 9.9 h, indicating substantial intersubject variability in its elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopPNXYznd0HLVg90H21EOLACvtfcHk0liuXGXK-UNVFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhsFCrur8%253D&md5=c6497e8f6c49264b7a7083cca9fb8ef0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF00613933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00613933%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DSawers%26aufirst%3DS.%2BJ.%2BA.%26atitle%3DThe%2520Absolute%2520Bioavailability%2520of%2520Caffeine%2520in%2520Man%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1983%26volume%3D24%26issue%3D1%26spage%3D93%26epage%3D98%26doi%3D10.1007%2FBF00613933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, M. J.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Caffeine and Other Components of Coffee</span>. In  <i>Caffeine, Coffee and Health</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garattini, S.</span></span>, Ed.; <span class="NLM_publisher-name">Raven Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=M.+J.+Arnaudauthor=S.+Garattini&title=Caffeine%2C+Coffee+and+Health"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArnaud%26aufirst%3DM.%2BJ.%26atitle%3DMetabolism%2520of%2520Caffeine%2520and%2520Other%2520Components%2520of%2520Coffee%26btitle%3DCaffeine%252C%2520Coffee%2520and%2520Health%26aulast%3DGarattini%26aufirst%3DS.%26pub%3DRaven%2520Press%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benowitz, N. L.</span></span> <span> </span><span class="NLM_article-title">Clinical Pharmacology of Caffeine</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1146/annurev.me.41.020190.001425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1146%2Fannurev.me.41.020190.001425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2184730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3cXktVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1990&pages=277-288&author=N.+L.+Benowitz&title=Clinical+Pharmacology+of+Caffeine&doi=10.1146%2Fannurev.me.41.020190.001425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of caffeine</span></div><div class="casAuthors">Benowitz, Neal L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">277-88</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    </div><div class="casAbstract">A review with 64 refs. discussing the human pharmacol. of caffeine, the evidence for its role in causing human disease including addiction, and its potential usefulness as a therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmiKDTT0MBZrVg90H21EOLACvtfcHk0liO5I5HO1rVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVSjs74%253D&md5=a1b4b507b5800039ca2ac271f26d362e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1146%2Fannurev.me.41.020190.001425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.me.41.020190.001425%26sid%3Dliteratum%253Aachs%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26atitle%3DClinical%2520Pharmacology%2520of%2520Caffeine%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D1990%26volume%3D41%26spage%3D277%26epage%3D288%26doi%3D10.1146%2Fannurev.me.41.020190.001425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doepker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Sohemy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, B. T.</span></span> <span> </span><span class="NLM_article-title">Caffeine: Friend or Foe?</span>. <i>Annu. Rev. Food Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1146/annurev-food-041715-033243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1146%2Fannurev-food-041715-033243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26735800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=117-137&author=C.+Doepkerauthor=H.+R.+Liebermanauthor=A.+P.+Smithauthor=J.+D.+Peckauthor=A.+El-Sohemyauthor=B.+T.+Welsh&title=Caffeine%3A+Friend+or+Foe%3F&doi=10.1146%2Fannurev-food-041715-033243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine: Friend or Foe?</span></div><div class="casAuthors">Doepker, Candace; Lieberman, Harris R.; Smith, Andrew Paul; Peck, Jennifer D.; El-Sohemy, Ahmed; Welsh, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Food Science and Technology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-137</span>CODEN:
                <span class="NLM_cas:coden">ARFSBV</span>;
        ISSN:<span class="NLM_cas:issn">1941-1413</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The debate on the safety of and regulatory approaches for caffeine continues among various stakeholders and regulatory authorities.  This decision-making process comes with significant challenges, particularly when considering the complexities of the available scientific data, making the formulation of clear science-based regulatory guidance more difficult.  To allow for discussions of a no. of key issues, the North American Branch of the International Life Sciences Institute (ILSI) convened a panel of subject matter experts for a caffeine-focused session entitled "Caffeine: Friend or Foe," which was held during the 2015 ILSI Annual Meeting.  The panelists' expertise covered topics ranging from the natural occurrence of caffeine in plants and interindividual metab. of caffeine in humans to specific behavioral, reproductive, and cardiovascular effects related to caffeine consumption.  Each presentation highlighted the potential risks, benefits, and challenges that inform whether caffeine exposure warrants concern.  This paper aims to summarize the key topics discussed during the session.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR98_X76IaZ7Vg90H21EOLACvtfcHk0liO5I5HO1rVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFGmug%253D%253D&md5=35c21bfe9200408b66889c21793566bb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1146%2Fannurev-food-041715-033243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-food-041715-033243%26sid%3Dliteratum%253Aachs%26aulast%3DDoepker%26aufirst%3DC.%26aulast%3DLieberman%26aufirst%3DH.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BP.%26aulast%3DPeck%26aufirst%3DJ.%2BD.%26aulast%3DEl-Sohemy%26aufirst%3DA.%26aulast%3DWelsh%26aufirst%3DB.%2BT.%26atitle%3DCaffeine%253A%2520Friend%2520or%2520Foe%253F%26jtitle%3DAnnu.%2520Rev.%2520Food%2520Sci.%2520Technol.%26date%3D2016%26volume%3D7%26spage%3D117%26epage%3D137%26doi%3D10.1146%2Fannurev-food-041715-033243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safranow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machoy, Z.</span></span> <span> </span><span class="NLM_article-title">Methylated Purines in Urinary Stones</span>. <i>Clin. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1373/clinchem.2005.048033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1373%2Fclinchem.2005.048033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15919878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvV2gsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2005&pages=1493-1498&issue=8&author=K.+Safranowauthor=Z.+Machoy&title=Methylated+Purines+in+Urinary+Stones&doi=10.1373%2Fclinchem.2005.048033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Methylated purines in urinary stones</span></div><div class="casAuthors">Safranow, Krzysztof; Machoy, Zygmunt</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1493-1498</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">The aim of the study was to measure the content of methylated purines that appear as admixts. in uric acid stones.  We analyzed urinary calculi from 48 residents of Western Pomerania who underwent surgery at the urol. ward in Szczecin.  Stone samples were dissolved in 0.1 mol/L NaOH.  Exts. were dild. in 50 mmol/L KH2PO4 and analyzed by reversed-phase HPLC with UV detection and use of a gradient of methanol concn. and pH.  Uric acid was the main component of 9 stones.  All 9 showed admixts. of 9 other purine derivs.: endogenous purine breakdown products (xanthine, hypoxanthine, and 2,8-dihydroxyadenine) and exogenous Me derivs. of uric acid and xanthine (1-, 3-, and 7-methyluric acid; 1,3-dimethyluric acid; and 3- and 7-methylxanthine).  Amts. of these purine derivs. ranged from the limit of detection to 12 mg/g of stone wt. and showed a strong pos. correlation (Spearman rank correlation coeffs., 0.63-0.94) with the uric acid content of the samples.  The main methylated purine in the stones was 1-methyluric acid.  Urinary purines at concns. below their satn. limits may coppt. in samples supersatd. with uric acid and appear as admixts. in urinary stones.  The amt. of each purine depends on its av. urinary excretion, similarity to the chem. structure of uric acid, and concn. of the latter in the stone.  These findings suggest that purines in stones represent a substitutional solid soln. with uric acid as solvent.  Methylxanthines, which are ubiquitous components of the diet, drugs, and uric acid calculi, may be involved in the pathogenesis of urolithiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTu6TiYKjuCLVg90H21EOLACvtfcHk0liO5I5HO1rVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvV2gsLw%253D&md5=0c09ae69b7f450595de8d6a51fcbce79</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2005.048033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2005.048033%26sid%3Dliteratum%253Aachs%26aulast%3DSafranow%26aufirst%3DK.%26aulast%3DMachoy%26aufirst%3DZ.%26atitle%3DMethylated%2520Purines%2520in%2520Urinary%2520Stones%26jtitle%3DClin.%2520Chem.%26date%3D2005%26volume%3D51%26issue%3D8%26spage%3D1493%26epage%3D1498%26doi%3D10.1373%2Fclinchem.2005.048033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.-K.</span></span> <span> </span><span class="NLM_article-title">Use of Caffeine Metabolite Ratios to Explore CYP1A2 and Xanthine Oxidase Activities</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5–1</span>),  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/clpt.1991.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fclpt.1991.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1934864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XhslGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1991&pages=508-519&issue=5%E2%80%931&author=W.+Kalowauthor=B.-K.+Tang&title=Use+of+Caffeine+Metabolite+Ratios+to+Explore+CYP1A2+and+Xanthine+Oxidase+Activities&doi=10.1038%2Fclpt.1991.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities</span></div><div class="casAuthors">Kalow, Werner; Tang, Bing Kou</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">508-19</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">Caffeine was used as a metabolic probe to screen healthy subjects for their activities of two enzymes, deduced to be CYP1A2 (an inducible cytochrome P 450) and xanthine oxidase.  A longitudinal study revealed modest effects of caffeine dose, ethanol intake, and time-of-day on the CYP1A2 index, without any effect on the xanthine oxidase index.  The coeffs. of intraindividual variation not accounted for were 5.0% for the xanthine oxidase and 17.2% for the CYP1A2 index.  In a population study, both indexes showed a log normal distribution, with CYP1A2 values of most subjects covering a 6.3-fold range but only a 1.7-fold range with xanthine oxidase.  The CYP1A2 index was 33% decreased in women who used oral contraceptives and substantially increased in cigarette smokers.  Neither the CYP1A2 nor the xanthine oxidase index differed between volunteers of Chinese and European extn.  Four of 178 subjects showed unexplained low xanthine oxidase values (i.e., values several std. deviations below the mean).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvwRV7rZPNbVg90H21EOLACvtfcHk0lj6nZqMx7l8Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhslGhug%253D%253D&md5=111b144fd741d35305154494189fc46a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1991.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1991.176%26sid%3Dliteratum%253Aachs%26aulast%3DKalow%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DB.-K.%26atitle%3DUse%2520of%2520Caffeine%2520Metabolite%2520Ratios%2520to%2520Explore%2520CYP1A2%2520and%2520Xanthine%2520Oxidase%2520Activities%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1991%26volume%3D50%26issue%3D5%25E2%2580%25931%26spage%3D508%26epage%3D519%26doi%3D10.1038%2Fclpt.1991.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitfield, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetterslev, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluud, C.</span></span> <span> </span><span class="NLM_article-title">Pentoxifylline for Alcoholic Hepatitis</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2009</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">CD007339</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD007339.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD007339.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2009&publication_year=2009&pages=CD007339&issue=4&author=K.+Whitfieldauthor=A.+Rambaldiauthor=J.+Wetterslevauthor=C.+Gluud&title=Pentoxifylline+for+Alcoholic+Hepatitis&doi=10.1002%2F14651858.CD007339.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD007339.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD007339.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DWhitfield%26aufirst%3DK.%26aulast%3DRambaldi%26aufirst%3DA.%26aulast%3DWetterslev%26aufirst%3DJ.%26aulast%3DGluud%26aufirst%3DC.%26atitle%3DPentoxifylline%2520for%2520Alcoholic%2520Hepatitis%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2009%26volume%3D2009%26issue%3D4%26spage%3DCD007339%26doi%3D10.1002%2F14651858.CD007339.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padowski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic Analysis and Comparison of Caffeine Administered Rapidly or Slowly in Coffee Chilled or Hot versus Chilled Energy Drink in Healthy Young Adults</span>. <i>Clin. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.3109/15563650.2016.1146740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3109%2F15563650.2016.1146740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC28bisVSgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=308-312&issue=4&author=J.+R.+Whiteauthor=J.+M.+Padowskiauthor=Y.+Zhongauthor=G.+Chenauthor=S.+Luoauthor=P.+Lazarusauthor=M.+E.+Laytonauthor=S.+McPherson&title=Pharmacokinetic+Analysis+and+Comparison+of+Caffeine+Administered+Rapidly+or+Slowly+in+Coffee+Chilled+or+Hot+versus+Chilled+Energy+Drink+in+Healthy+Young+Adults&doi=10.3109%2F15563650.2016.1146740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults</span></div><div class="casAuthors">White John R Jr; Padowski Jeannie M; Layton Matthew E; Zhong Yili; Chen Gang; Luo Shaman; Lazarus Philip; McPherson Sterling; McPherson Sterling</div><div class="citationInfo"><span class="NLM_cas:title">Clinical toxicology (Philadelphia, Pa.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">308-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  There is a paucity of data describing the impact of type of beverage (coffee versus energy drink), different rates of consumption and different temperature of beverages on the pharmacokinetic disposition of caffeine.  Additionally, there is concern that inordinately high levels of caffeine may result from the rapid consumption of cold energy drinks.  OBJECTIVE:  The objective of this study was to compare the pharmacokinetics of caffeine under various drink temperature, rate of consumption and vehicle (coffee versus energy drink) conditions.  MATERIALS:  Five caffeine (dose = 160 mg) conditions were evaluated in an open-label, group-randomized, crossover fashion.  After the administration of each caffeine dose, 10 serial plasma samples were harvested.  Caffeine concentration was measured via liquid chromatography-mass spectrometry (LC-MS), and those concentrations were assessed by non-compartmental pharmacokinetic analysis.  The calculated mean pharmacokinetic parameters were analyzed statistically by one-way repeated measures analysis of variance (RM ANOVA).  If differences were found, each group was compared to the other by all pair-wise multiple comparison.  RESULTS:  Twenty-four healthy subjects ranging in age from 18 to 30 completed the study.  The mean caffeine concentration time profiles were similar with overlapping SDs at all measured time points.  The ANOVA revealed significant differences in mean Cmax and Vd ss/F, but no pair-wise comparisons reached statistical significance.  No other differences in pharmacokinetic parameters were found.  DISCUSSION:  The results of this study are consistent with previous caffeine pharmacokinetic studies and suggest that while rate of consumption, temperature of beverage and vehicle (coffee versus energy drink) may be associated with slightly different pharmacokinetic parameters, the overall impact of these variables is small.  CONCLUSION:  This study suggests that caffeine absorption and exposure from coffee and energy drink is similar irrespective of beverage temperature or rate of consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxto5WiqPPpn6CEoQgWY10fW6udTcc2ebSU4wABneW_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bisVSgsg%253D%253D&md5=a452e407dd3d27e15d9a723e38c09432</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3109%2F15563650.2016.1146740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15563650.2016.1146740%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DPadowski%26aufirst%3DJ.%2BM.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DLazarus%26aufirst%3DP.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DMcPherson%26aufirst%3DS.%26atitle%3DPharmacokinetic%2520Analysis%2520and%2520Comparison%2520of%2520Caffeine%2520Administered%2520Rapidly%2520or%2520Slowly%2520in%2520Coffee%2520Chilled%2520or%2520Hot%2520versus%2520Chilled%2520Energy%2520Drink%2520in%2520Healthy%2520Young%2520Adults%26jtitle%3DClin.%2520Toxicol.%26date%3D2016%26volume%3D54%26issue%3D4%26spage%3D308%26epage%3D312%26doi%3D10.3109%2F15563650.2016.1146740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. K.</span></span> <span> </span><span class="NLM_article-title">Biotransformation of Caffeine, Paraxanthine, Theobromine and Theophylline by CDNA-Expressed Human CYP1A2 and CYP2E1</span>. <i>Pharmacogenetics</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1097/00008571-199204000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1097%2F00008571-199204000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1302044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFWlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=73-77&issue=2&author=L.+Guauthor=F.+J.+Gonzalezauthor=W.+Kalowauthor=B.+K.+Tang&title=Biotransformation+of+Caffeine%2C+Paraxanthine%2C+Theobromine+and+Theophylline+by+CDNA-Expressed+Human+CYP1A2+and+CYP2E1&doi=10.1097%2F00008571-199204000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of caffeine, paraxanthine, theobromine, and theophylline by cDNA-expressed human CYP1A2 and CYP2E1</span></div><div class="casAuthors">Gu, Lie; Gonzalez, Frank J.; Kalow, Werner; Tang, Bing K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-7</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    </div><div class="casAbstract">Six human cytochrome P450s expressed in HepG2 cells using vaccinia virus cDNA-directed expression, were used to study the biotransformation of caffeine and its metabolites.  CYP1A2 alone was responsible for caffeine 3-demethylation and paraxanthine 7-demethylation; in addn., 1A2 catalyzed virtually all reactions related to caffeine and its metabolites.  The metabolic profile of caffeine biotransformation by CYP1A2 averaged 81.5% for paraxanthine, 10.8% for theobromine and 5.4% for theophylline formation.  It remained quite uniform when caffeine concns. were varied.  The most striking finding was that CYP2E1 (the ethanol-inducible form) had major influences upon caffeine metab.: in particular, it catalyzed the formation of theophylline and theobromine from caffeine.  Thus, the in vivo metabolite profiling of caffeine may reveal CYP2E1 activities in addn. to the previously documented activities of CYP1A2, polymorphic N-acetyltransferase and xanthine oxidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtyvJD48_tgbVg90H21EOLACvtfcHk0lgllkMHwXlzYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFWlsr8%253D&md5=c833b02680c120f93e04e7f613463909</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2F00008571-199204000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008571-199204000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DL.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DKalow%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DB.%2BK.%26atitle%3DBiotransformation%2520of%2520Caffeine%252C%2520Paraxanthine%252C%2520Theobromine%2520and%2520Theophylline%2520by%2520CDNA-Expressed%2520Human%2520CYP1A2%2520and%2520CYP2E1%26jtitle%3DPharmacogenetics%26date%3D1992%26volume%3D2%26issue%3D2%26spage%3D73%26epage%3D77%26doi%3D10.1097%2F00008571-199204000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faber, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, U.</span></span> <span> </span><span class="NLM_article-title">Assessment of CYP1A2 Activity in Clinical Practice: Why, How, and When?</span>. <i>Basic Clin. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1111/j.1742-7843.2005.pto_973160.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1742-7843.2005.pto_973160.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16128905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVejsb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2005&pages=125-134&issue=3&author=M.+S.+Faberauthor=A.+Jetterauthor=U.+Fuhr&title=Assessment+of+CYP1A2+Activity+in+Clinical+Practice%3A+Why%2C+How%2C+and+When%3F&doi=10.1111%2Fj.1742-7843.2005.pto_973160.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of CYP1A2 activity in clinical practice: Why, how, and when?</span></div><div class="casAuthors">Faber, Mirko S.; Jetter, Alexander; Fuhr, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The cytochrome P 450 enzyme CYP1A2 mediates the rate-limiting step in the metab. of many drugs including theophylline, clozapine, and tacrine as well as in the bioactivation of procarcinogens.  CYP1A2 activity shows both pronounced intra- and interindividual variability, which is, among other factors, related to smoking causing enzyme induction, to drug intake and to dietary factors which may result in induction or inhibition.  In contrast to these exogenous factors, genetic influences on enzyme activity seem to be less pronounced.  Therefore, phenotyping of CYP1A2, i.e. the detn. of the actual activity of the enzyme in vivo, represents a useful approach both for scientific and clin. applications.  CYP1A2 is almost exclusively expressed in the liver.  Since liver tissue cannot be obtained for direct pheno- typing, a probe drug which is metabolized by CYP1A2 has to be given.  Proposed probe drugs include caffeine, theophylline, and melatonin.  Caffeine is most often used because of the predominating role of CYP1A2 in its overall metab. and the excellent tolerability.  Various urinary, plasma, saliva, and breath based CYP1A2 caffeine metrics have been applied.  While caffeine clearance is considered as the gold std., the salivary or plasma ratio of paraxanthine to caffeine in a sample taken approx. 6 h after a defined dose of caffeine is a more convenient, less expensive but also fully validated CYP1A2 phenotyping metric.  CYP1A2 phenotyping is applied frequently in epidemiol. and drug-drug interaction studies, but its clin. use and usefulness remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIAUShUtDBirVg90H21EOLACvtfcHk0lgllkMHwXlzYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVejsb3L&md5=401cfb163d198a74aaae618fffc8745b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2005.pto_973160.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2005.pto_973160.x%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DM.%2BS.%26aulast%3DJetter%26aufirst%3DA.%26aulast%3DFuhr%26aufirst%3DU.%26atitle%3DAssessment%2520of%2520CYP1A2%2520Activity%2520in%2520Clinical%2520Practice%253A%2520Why%252C%2520How%252C%2520and%2520When%253F%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D97%26issue%3D3%26spage%3D125%26epage%3D134%26doi%3D10.1111%2Fj.1742-7843.2005.pto_973160.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornelis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monda, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paynter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzato, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerwinkle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curhan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landi, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purdue, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimm, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolzenberg-Solomon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chasman, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporaso, N. E.</span></span> <span> </span><span class="NLM_article-title">Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e1002033</span> <span class="refDoi"> DOI: 10.1371/journal.pgen.1002033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1371%2Fjournal.pgen.1002033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21490707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&issue=4&author=M.+C.+Cornelisauthor=K.+L.+Mondaauthor=K.+Yuauthor=N.+Paynterauthor=E.+M.+Azzatoauthor=S.+N.+Bennettauthor=S.+I.+Berndtauthor=E.+Boerwinkleauthor=S.+Chanockauthor=N.+Chatterjeeauthor=D.+Couperauthor=G.+Curhanauthor=G.+Heissauthor=F.+B.+Huauthor=D.+J.+Hunterauthor=K.+Jacobsauthor=M.+K.+Jensenauthor=P.+Kraftauthor=M.+T.+Landiauthor=J.+A.+Nettletonauthor=M.+P.+Purdueauthor=P.+Rajaramanauthor=E.+B.+Rimmauthor=L.+M.+Roseauthor=N.+Rothmanauthor=D.+Silvermanauthor=R.+Stolzenberg-Solomonauthor=A.+Subarauthor=M.+Yeagerauthor=D.+I.+Chasmanauthor=R.+M.+van+Damauthor=N.+E.+Caporaso&title=Genome-Wide+Meta-Analysis+Identifies+Regions+on+7p21+%28AHR%29+and+15q24+%28CYP1A2%29+As+Determinants+of+Habitual+Caffeine+Consumption&doi=10.1371%2Fjournal.pgen.1002033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption</span></div><div class="casAuthors">Cornelis, Marilyn C.; Monda, Keri L.; Yu, Kai; Paynter, Nina; Azzato, Elizabeth M.; Bennett, Siiri N.; Berndt, Sonja I.; Boerwinkle, Eric; Chanock, Stephen; Chatterjee, Nilanjan; Couper, David; Curhan, Gary; Heiss, Gerardo; Hu, Frank B.; Hunter, David J.; Jacobs, Kevin; Jensen, Majken K.; Kraft, Peter; Landi, Maria Teresa; Nettleton, Jennifer A.; Purdue, Mark P.; Rajaraman, Preetha; Rimm, Eric B.; Rose, Lynda M.; Rothman, Nathaniel; Silverman, Debra; Stolzenberg-Solomon, Rachael; Subar, Amy; Yeager, Meredith; Chasman, Daniel I.; van Dam, Rob M.; Caporaso, Neil E.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1002033</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We report the first genome-wide assocn. study of habitual caffeine intake.  We included 47,341 individuals of European descent based on five population-based studies within the United States.  In a meta-anal. adjusted for age, sex, smoking, and eigenvectors of population variation, two loci achieved genome-wide significance: 7p21 (P = 2.4 × 10-19), near AHR, and 15q24 (P = 5.2 × 10-14), between CYP1A1 and CYP1A2.  Both the AHR and CYP1A2 genes are biol. plausible candidates as CYP1A2 metabolizes caffeine and AHR regulates CYP1A2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBu6lhAs0_g7Vg90H21EOLACvtfcHk0lgllkMHwXlzYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVWltb0%253D&md5=ad0355ce77db9599b2e0cb854483ce70</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1002033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1002033%26sid%3Dliteratum%253Aachs%26aulast%3DCornelis%26aufirst%3DM.%2BC.%26aulast%3DMonda%26aufirst%3DK.%2BL.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DPaynter%26aufirst%3DN.%26aulast%3DAzzato%26aufirst%3DE.%2BM.%26aulast%3DBennett%26aufirst%3DS.%2BN.%26aulast%3DBerndt%26aufirst%3DS.%2BI.%26aulast%3DBoerwinkle%26aufirst%3DE.%26aulast%3DChanock%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DN.%26aulast%3DCouper%26aufirst%3DD.%26aulast%3DCurhan%26aufirst%3DG.%26aulast%3DHeiss%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DF.%2BB.%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DM.%2BK.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DLandi%26aufirst%3DM.%2BT.%26aulast%3DNettleton%26aufirst%3DJ.%2BA.%26aulast%3DPurdue%26aufirst%3DM.%2BP.%26aulast%3DRajaraman%26aufirst%3DP.%26aulast%3DRimm%26aufirst%3DE.%2BB.%26aulast%3DRose%26aufirst%3DL.%2BM.%26aulast%3DRothman%26aufirst%3DN.%26aulast%3DSilverman%26aufirst%3DD.%26aulast%3DStolzenberg-Solomon%26aufirst%3DR.%26aulast%3DSubar%26aufirst%3DA.%26aulast%3DYeager%26aufirst%3DM.%26aulast%3DChasman%26aufirst%3DD.%2BI.%26aulast%3Dvan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DCaporaso%26aufirst%3DN.%2BE.%26atitle%3DGenome-Wide%2520Meta-Analysis%2520Identifies%2520Regions%2520on%25207p21%2520%2528AHR%2529%2520and%252015q24%2520%2528CYP1A2%2529%2520As%2520Determinants%2520of%2520Habitual%2520Caffeine%2520Consumption%26jtitle%3DPLoS%2520Genet.%26date%3D2011%26volume%3D7%26issue%3D4%26doi%3D10.1371%2Fjournal.pgen.1002033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neims, A. H.</span></span> <span> </span><span class="NLM_article-title">The Disposition of Caffeine during and after Pregnancy</span>. <i>Semin. Perinatol.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7302604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL38%252FmtF2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1981&pages=310-314&issue=4&author=A.+Aldridgeauthor=J.+Baileyauthor=A.+H.+Neims&title=The+Disposition+of+Caffeine+during+and+after+Pregnancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The disposition of caffeine during and after pregnancy</span></div><div class="casAuthors">Aldridge A; Bailey J; Neims A H</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in perinatology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">310-4</span>
        ISSN:<span class="NLM_cas:issn">0146-0005</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4UhLo9OyvVzslzEEsg76ufW6udTcc2eYAJhsvUta0_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252FmtF2htg%253D%253D&md5=14e5d10e6a9df125c17d77802da6bbdd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAldridge%26aufirst%3DA.%26aulast%3DBailey%26aufirst%3DJ.%26aulast%3DNeims%26aufirst%3DA.%2BH.%26atitle%3DThe%2520Disposition%2520of%2520Caffeine%2520during%2520and%2520after%2520Pregnancy%26jtitle%3DSemin.%2520Perinatol.%26date%3D1981%26volume%3D5%26issue%3D4%26spage%3D310%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. K.</span></span> <span> </span><span class="NLM_article-title">Caffeine as a Metabolic Probe: Exploration of the Enzyme-Inducing Effect of Cigarette Smoking</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1038/clpt.1991.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fclpt.1991.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1988240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXktVejsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1991&pages=44-48&issue=1&author=W.+Kalowauthor=B.+K.+Tang&title=Caffeine+as+a+Metabolic+Probe%3A+Exploration+of+the+Enzyme-Inducing+Effect+of+Cigarette+Smoking&doi=10.1038%2Fclpt.1991.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine as a metabolic probe:  exploration of the enzyme-inducing effect of cigarette smoking</span></div><div class="casAuthors">Kalow, Werner; Tang, Bing Kou</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-8</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">It has been learned that the primary metab. of caffeine in humans is catalyzed by cytochrome P-450IA2 and that the rate of caffeine metab. can be estd. from a metabolite ratio in a single urine sample.  A population of 178 students, including 19 smokers, was subjected to this caffeine test to establish the P 450IA2 index.  Both stated nos. of cigarettes smoked per day and urinary cotinine levels as a confirmatory measure correlated significantly with enzyme activity showing dose-effect relationships (r = 0.62 and 0.89, resp.).  Nevertheless, more nonsmokers than smokers had the highest enzyme indexes, suggesting that dietary elements or other factors may det. P 450IA2 activities in populations.  Because P 4501IA2 is a monooxygenase that may be confined to the liver, caffeine reveals directly the Ah-receptor-dependent enzyme induction only in liver, but it may also be a signal of induction elsewhere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWhwMJVnaj2bVg90H21EOLACvtfcHk0lgwwsx5ggCsWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVejsLw%253D&md5=08f09098b1187edd2659a14eeb0ce5a4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1991.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1991.8%26sid%3Dliteratum%253Aachs%26aulast%3DKalow%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DB.%2BK.%26atitle%3DCaffeine%2520as%2520a%2520Metabolic%2520Probe%253A%2520Exploration%2520of%2520the%2520Enzyme-Inducing%2520Effect%2520of%2520Cigarette%2520Smoking%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1991%26volume%3D49%26issue%3D1%26spage%3D44%26epage%3D48%26doi%3D10.1038%2Fclpt.1991.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopp, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berk, L. S.</span></span> <span> </span><span class="NLM_article-title">The Impact of Caffeine Use on Tobacco Cessation and Withdrawal</span>. <i>Addict. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/S0306-4603(96)00023-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0306-4603%2896%2900023-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=9022872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK2s7nsFaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=55-68&issue=1&author=J.+A.+Swansonauthor=J.+W.+Leeauthor=J.+W.+Hoppauthor=L.+S.+Berk&title=The+Impact+of+Caffeine+Use+on+Tobacco+Cessation+and+Withdrawal&doi=10.1016%2FS0306-4603%2896%2900023-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of caffeine use on tobacco cessation and withdrawal</span></div><div class="casAuthors">Swanson J A; Lee J W; Hopp J W; Berk L S</div><div class="citationInfo"><span class="NLM_cas:title">Addictive behaviors</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-68</span>
        ISSN:<span class="NLM_cas:issn">0306-4603</span>.
    </div><div class="casAbstract">Continuous caffeine consumption with smoking cessation has been associated with more than doubled caffeine plasma levels.  Such concentrations may be sufficient to produce caffeine toxicity symptoms in smoking abstinence conditions.  To test whether caffeine abstinence influences smoking cessation, 162 caffeine-using smokers were enlisted from American Lung Association smoking cessation programs.  Volunteers were randomly assigned by clinic to caffeine-use and caffeine-abstinence conditions and measured for 3 weeks post-smoking cessation, at 6 months and one year.  Results showed a significant linear increase in caffeine sputum levels across 3 weeks post cessation for those who quit smoking and continued using caffeine.  Three weeks after cessation, concentrations reached 203% of baseline for the caffeine user.  Typical nicotine withdrawal symptoms occurred during the first 16 days of cessation.  The caffeine abstainers, but not continued users of caffeine, reported increased fatigue during the first 3 days of cessation.  Among complete caffeine abstainers, compared with caffeine users, there was a significant increase in fatigue, a decrease in stimulation, and a marginal increase in caffeine craving immediately following tobacco cessation.  There were no differences between the groups on other withdrawal symptoms or in cessation success at 16 days, 6 months, or 12 months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJHacomfZ7VCO2kE7krGOBfW6udTcc2eYAJhsvUta0_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7nsFaisA%253D%253D&md5=c217976a9a1878611f0efaf6ea893233</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0306-4603%2896%2900023-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4603%252896%252900023-8%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DHopp%26aufirst%3DJ.%2BW.%26aulast%3DBerk%26aufirst%3DL.%2BS.%26atitle%3DThe%2520Impact%2520of%2520Caffeine%2520Use%2520on%2520Tobacco%2520Cessation%2520and%2520Withdrawal%26jtitle%3DAddict.%2520Behav.%26date%3D1997%26volume%3D22%26issue%3D1%26spage%3D55%26epage%3D68%26doi%3D10.1016%2FS0306-4603%2896%2900023-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rietveld, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broekman, M. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houben, J. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskes, T. K. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rossum, J. M.</span></span> <span> </span><span class="NLM_article-title">Rapid Onset of an Increase in Caffeine Residence Time in Young Women Due to Oral Contraceptive Steroids</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1007/BF00548769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00548769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6734698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2cXktFOmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1984&pages=371-373&issue=3&author=E.+C.+Rietveldauthor=M.+M.+M.+Broekmanauthor=J.+J.+G.+Houbenauthor=T.+K.+A.+B.+Eskesauthor=J.+M.+van+Rossum&title=Rapid+Onset+of+an+Increase+in+Caffeine+Residence+Time+in+Young+Women+Due+to+Oral+Contraceptive+Steroids&doi=10.1007%2FBF00548769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids</span></div><div class="casAuthors">Rietveld, E. C.; Broekman, M. M. M.; Houben, J. J. G.; Eskes, T. K. A. B.; Van Rossum, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-3</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">Oral contraceptive steroids (OCS) increased the residence time of caffeine  [58-08-2] in young women by a factor of 2.  The effect was already manifested during the 1st cycle 2 wk after starting OCS and was slightly increased in the 2nd cycle, after 6 wk on OCS.  Toxic effects attributed to OCS may in part be indirect and due to prolonged retention of absorbed toxic agents to which women are exposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodrp9CLkdkVbVg90H21EOLACvtfcHk0lgwwsx5ggCsWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktFOmu74%253D&md5=31b33a79bb69ad09b4afede00b7debfa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2FBF00548769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00548769%26sid%3Dliteratum%253Aachs%26aulast%3DRietveld%26aufirst%3DE.%2BC.%26aulast%3DBroekman%26aufirst%3DM.%2BM.%2BM.%26aulast%3DHouben%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DEskes%26aufirst%3DT.%2BK.%2BA.%2BB.%26aulast%3Dvan%2BRossum%26aufirst%3DJ.%2BM.%26atitle%3DRapid%2520Onset%2520of%2520an%2520Increase%2520in%2520Caffeine%2520Residence%2520Time%2520in%2520Young%2520Women%2520Due%2520to%2520Oral%2520Contraceptive%2520Steroids%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1984%26volume%3D26%26issue%3D3%26spage%3D371%26epage%3D373%26doi%3D10.1007%2FBF00548769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koren, G.</span></span> <span> </span><span class="NLM_article-title">Pregnancy-Induced Changes in Drug Metabolism in Epileptic Women</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>257</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2033516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1WmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1991&pages=735-740&issue=2&author=M.+Bologaauthor=B.+Tangauthor=J.+Kleinauthor=A.+Tesoroauthor=G.+Koren&title=Pregnancy-Induced+Changes+in+Drug+Metabolism+in+Epileptic+Women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pregnancy-induced changes in drug metabolism in epileptic women</span></div><div class="casAuthors">Bologa, Monica; Tang, Bing; Klein, Julia; Tesoro, Angelo; Koren, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">735-40</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The pharmacokinetics of antiepileptic drugs may be altered during pregnancy, resulting in decline of serum concns. and subsequent suboptimal control of seizures.  The authors investigated changes which may occur during pregnancy in hepatic drug handling by comparing metabolic ratios of 15 pregnant epileptic women to 15 nonpregnant epileptic women, as well as 10 pregnant nonepileptic and 10 nonpregnant nonepileptic controls.  The caffeine test was used to describe several enzyme activities: P 450 1A2, xanthine oxidase, n-acetyltransferase and hydroxylation.  For this end, ratios were calcd. among a no. of metabolites of the main demethylation pathway of caffeine.  In addn., D-glucaric acid excretion was measured for specific characterization of antiepileptic drug metab.  Paired comparison of epileptic women in late pregnancy and six to eight weeks post partum revealed statistically significant decreases in P 450 1A2, xanthine oxidase and n-acetyltransferase activities, and a significantly increased hydroxylation activity during pregnancy.  Twenty-one of the 30 epileptic women (70%) were found to be fast acetylators, whereas the normal distribution in the nonepileptic control groups was 50%.  Excretion of D-glucaric acid was significantly increased in all epileptic patient groups as compared to the matched nonepileptic control groups.  Importantly, it was also significantly increased in the pregnant nonepileptic control group as compared to the nonpregnant nonepileptic women.  Overall, the results suggest that enzymic pathways involved in antiepileptic drug metab. tend to be increased during pregnancy as a potential cause for obsd. lower serum concns. of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00V5Sjjlr7LVg90H21EOLACvtfcHk0lhoDA62BcXGLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1WmtbY%253D&md5=3409fdf38b2f145d51675c47dd45f12c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBologa%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DKlein%26aufirst%3DJ.%26aulast%3DTesoro%26aufirst%3DA.%26aulast%3DKoren%26aufirst%3DG.%26atitle%3DPregnancy-Induced%2520Changes%2520in%2520Drug%2520Metabolism%2520in%2520Epileptic%2520Women%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1991%26volume%3D257%26issue%3D2%26spage%3D735%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracken, M. B.</span></span> <span> </span><span class="NLM_article-title">Caffeine Metabolism, Genetics, and Perinatal Outcomes: A Review of Exposure Assessment Considerations during Pregnancy</span>. <i>Ann. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/j.annepidem.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.annepidem.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15967394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2MzhvVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=460-466&issue=6&author=L.+M.+Grossoauthor=M.+B.+Bracken&title=Caffeine+Metabolism%2C+Genetics%2C+and+Perinatal+Outcomes%3A+A+Review+of+Exposure+Assessment+Considerations+during+Pregnancy&doi=10.1016%2Fj.annepidem.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy</span></div><div class="casAuthors">Grosso Laura M; Bracken Michael B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of epidemiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">460-6</span>
        ISSN:<span class="NLM_cas:issn">1047-2797</span>.
    </div><div class="casAbstract">PURPOSE:  To review the methodologic issues complicating caffeine exposure assessment during pregnancy; to discuss maternal and fetal caffeine metabolism, including genetic polymorphisms affecting caffeine metabolism; and to discuss the endogenous and exogenous risk factors known to influence caffeine metabolism.  METHODS:  A review of the relevant literature.  RESULTS:  There is wide inter-individual variation in caffeine metabolism, primarily due to variations in CYP1A2 enzyme activity.  Some variability in CYP1A2 activity is due to genetic polymorphisms in the CYP1A2 gene which can cause increased or decreased inducibility of the enzyme.  Considerable evidence exists that maternal caffeine metabolism is influenced by a variety of endogenous and exogenous factors and studying the genetic polymorphisms may improve understanding of the potential effects of caffeine and its metabolites on perinatal outcomes.  There is substantial evidence that measurement of maternal, fetal, and neonatal caffeine metabolites may allow for a more precise measure of fetal caffeine exposure.  CONCLUSIONS:  Research on the genetic polymorphisms affecting caffeine metabolism may further explain the potential effects of caffeine and its metabolites on perinatal outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdfxHsWBUg242y4bB4mnvYfW6udTcc2eaBVtMj247ZXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzhvVWnsg%253D%253D&md5=28672e7206f538f68687d94a49f668f0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.annepidem.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.annepidem.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DGrosso%26aufirst%3DL.%2BM.%26aulast%3DBracken%26aufirst%3DM.%2BB.%26atitle%3DCaffeine%2520Metabolism%252C%2520Genetics%252C%2520and%2520Perinatal%2520Outcomes%253A%2520A%2520Review%2520of%2520Exposure%2520Assessment%2520Considerations%2520during%2520Pregnancy%26jtitle%3DAnn.%2520Epidemiol.%26date%3D2005%26volume%3D15%26issue%3D6%26spage%3D460%26epage%3D466%26doi%3D10.1016%2Fj.annepidem.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bättig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmén, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehlig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvartau, E. E.</span></span> <span> </span><span class="NLM_article-title">Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10049999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1MXitFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=83-133&issue=1&author=B.+B.+Fredholmauthor=K.+B%C3%A4ttigauthor=J.+Holm%C3%A9nauthor=A.+Nehligauthor=E.+E.+Zvartau&title=Actions+of+Caffeine+in+the+Brain+with+Special+Reference+to+Factors+That+Contribute+to+Its+Widespread+Use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of caffeine in the brain with special reference to factors that contribute to its widespread use</span></div><div class="casAuthors">Fredholm, Bertil B.; Battig, Karl; Holmen, Janet; Nehlig, Astrid; Zvartau, Edwin E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-133</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with ∼500 refs.  In the present review the authors discuss the evidence regarding caffeine and dependence in light of increasing knowledge regarding the actions of caffeine on specific neuronal brain substrates.  Because the use of caffeine is probably related to its diverse effects on several brain functions, these are also briefly presented.  Even though the authors have attempted to cover many of the aspects that are relevant to this complex issue, they are aware of several omissions and also realize that the complex-often somewhat contradictory-literature lends itself to more than one interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5xVwkaA1GLVg90H21EOLACvtfcHk0lhoDA62BcXGLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFWgurk%253D&md5=f690fde42bb886d14986ab75da34cf8a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DB%25C3%25A4ttig%26aufirst%3DK.%26aulast%3DHolm%25C3%25A9n%26aufirst%3DJ.%26aulast%3DNehlig%26aufirst%3DA.%26aulast%3DZvartau%26aufirst%3DE.%2BE.%26atitle%3DActions%2520of%2520Caffeine%2520in%2520the%2520Brain%2520with%2520Special%2520Reference%2520to%2520Factors%2520That%2520Contribute%2520to%2520Its%2520Widespread%2520Use%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26issue%3D1%26spage%3D83%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fenster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskenazi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windham, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, S. H.</span></span> <span> </span><span class="NLM_article-title">Caffeine Consumption during Pregnancy and Fetal Growth</span>. <i>Am. J. Public Health</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.2105/AJPH.81.4.458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2105%2FAJPH.81.4.458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2003624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK3M7ms1Siug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1991&pages=458-461&issue=4&author=L.+Fensterauthor=B.+Eskenaziauthor=G.+C.+Windhamauthor=S.+H.+Swan&title=Caffeine+Consumption+during+Pregnancy+and+Fetal+Growth&doi=10.2105%2FAJPH.81.4.458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine consumption during pregnancy and fetal growth</span></div><div class="casAuthors">Fenster L; Eskenazi B; Windham G C; Swan S H</div><div class="citationInfo"><span class="NLM_cas:title">American journal of public health</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-61</span>
        ISSN:<span class="NLM_cas:issn">0090-0036</span>.
    </div><div class="casAbstract">BACKGROUND:  The purpose of this study was to examine the association between maternal caffeine consumption and low birthweight, intrauterine growth retardation, and prematurity, adjusting for multiple confounders.  METHODS:  Data obtained from birth certificates and interviews on 1,230 women with singleton live births were analyzed to evaluate the potential influence of caffeine consumption during the first trimester on fetal growth.  RESULTS:  The crude odds ratio for intrauterine growth retardation in infants of women reporting heavy caffeine consumption (greater than 300 mg/day) was 3.86 (95% CI = 1.80, 8.40) which decreased to 2.90 (95% CI = 1.23, 6.87) after controlling for confounding factors.  The adjusted odds ratio for low birthweight and heavy maternal caffeine consumption was also elevated (OR = 2.05; 95% CI = 0.86, 4.88).  Women who reduced their caffeine intake from greater than 300 mg/day to less than that early in pregnancy had lower risks of delivering infants with either intrauterine growth retardation or low birthweight than women who continued to consume that amount.  Preterm delivery appeared to be unrelated to caffeine consumption.  CONCLUSIONS:  Taken together with studies reporting similar findings, these results suggest that heavy caffeine consumption increases the risk for fetal growth retardation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNs0s_KwT0gEEksK8CslK8fW6udTcc2eZOlPkQmwTZpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7ms1Siug%253D%253D&md5=13c4facaca1439c344bd00d6ea694716</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2105%2FAJPH.81.4.458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2105%252FAJPH.81.4.458%26sid%3Dliteratum%253Aachs%26aulast%3DFenster%26aufirst%3DL.%26aulast%3DEskenazi%26aufirst%3DB.%26aulast%3DWindham%26aufirst%3DG.%2BC.%26aulast%3DSwan%26aufirst%3DS.%2BH.%26atitle%3DCaffeine%2520Consumption%2520during%2520Pregnancy%2520and%2520Fetal%2520Growth%26jtitle%3DAm.%2520J.%2520Public%2520Health%26date%3D1991%26volume%3D81%26issue%3D4%26spage%3D458%26epage%3D461%26doi%3D10.2105%2FAJPH.81.4.458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, D.</span></span> <span> </span><span class="NLM_article-title">Caffeinated Beverages and Decreased Fertility</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>332</i></span> (<span class="NLM_issue">8626–8627</span>),  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(88)90933-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0140-6736%2888%2990933-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1988&pages=1453-1456&issue=8626%E2%80%938627&author=A.+Wilcoxauthor=C.+Weinbergauthor=D.+Baird&title=Caffeinated+Beverages+and+Decreased+Fertility&doi=10.1016%2FS0140-6736%2888%2990933-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2888%2990933-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252888%252990933-6%26sid%3Dliteratum%253Aachs%26aulast%3DWilcox%26aufirst%3DA.%26aulast%3DWeinberg%26aufirst%3DC.%26aulast%3DBaird%26aufirst%3DD.%26atitle%3DCaffeinated%2520Beverages%2520and%2520Decreased%2520Fertility%26jtitle%3DLancet%26date%3D1988%26volume%3D332%26issue%3D8626%25E2%2580%25938627%26spage%3D1453%26epage%3D1456%26doi%3D10.1016%2FS0140-6736%2888%2990933-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cnattingius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorello, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annerén, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekbom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljunger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blot, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granath, F.</span></span> <span> </span><span class="NLM_article-title">Caffeine Intake and the Risk of First-Trimester Spontaneous Abortion</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>343</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">1839</span>– <span class="NLM_lpage">1845</span>, <span class="refDoi"> DOI: 10.1056/NEJM200012213432503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1056%2FNEJM200012213432503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=11117975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1839-1845&issue=25&author=S.+Cnattingiusauthor=L.+B.+Signorelloauthor=G.+Anner%C3%A9nauthor=B.+Claussonauthor=A.+Ekbomauthor=E.+Ljungerauthor=W.+J.+Blotauthor=J.+K.+McLaughlinauthor=G.+Peterssonauthor=A.+Raneauthor=F.+Granath&title=Caffeine+Intake+and+the+Risk+of+First-Trimester+Spontaneous+Abortion&doi=10.1056%2FNEJM200012213432503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine intake and the risk of first-trimester spontaneous abortion</span></div><div class="casAuthors">Cnattingius, Sven; Signorello, Lisa B.; Anneren, Goran; Clausson, Britt; Ekbom, Anders; Ljunger, Elisabeth; Blot, William J.; McLaughlin, Joseph K.; Petersson, Gunnar; Rane, Anders; Granath, Fredrik</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">1839-1845</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Some epidemiol. studies have suggested that caffeine consumption may increase the risk of spontaneous abortion.  We performed a population-based, case-control study of early spontaneous abortions in 562 women in Sweden.  The women had spontaneous abortion at 6-12 completed weeks of gestation; 953 control women without spontaneous abortion were matched to the case patients according to the weeks of gestation.  Information on the ingestion of caffeine was obtained by interviews.  Blood plasma cotinine levels were measured as an indicator of cigarette smoking and fetal karyotypes were detd. from tissue samples.  Multivariate anal. was used to est. the relative risks assocd. with caffeine ingestion after adjustment for smoking and symptoms of pregnancy, such as nausea, vomiting, and fatigue.  Among nonsmokers, more spontaneous abortions occurred in women who ingested at least 100 mg caffeine/day than in women who ingested <100 mg/day.  There was an increase in the abortion risk pos. related to the caffeine amt. ingested (100-299 mg/day: odds ratio 1.3, 95%CI 0.9-1.8; 300-499 mg/day: odds ratio 1.4, 95%CI 0.9-2.0; ≥500 mg/day: odds ratio 2.2, 95%CI 1.3-3.8).  Among smokers the caffeine ingestion was not assocd. with increased risk of spontaneous abortion.  When the data were stratified according to the karyotyping results, the ingestion of moderate or high levels of caffeine was assocd. with excessive risk of spontaneous abortion when the fetus had a normal or unknown karyotype, but not when the fetal karyotype was abnormal.  Thus, ingestion of caffeine may increase the risk of early spontaneous abortions in nonsmoking women carrying fetuses with normal karyotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtFeK6aT3wB7Vg90H21EOLACvtfcHk0ljdKL6SoYA4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlSlug%253D%253D&md5=9490e16eda8b0eb160554ae868a7d32c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012213432503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012213432503%26sid%3Dliteratum%253Aachs%26aulast%3DCnattingius%26aufirst%3DS.%26aulast%3DSignorello%26aufirst%3DL.%2BB.%26aulast%3DAnner%25C3%25A9n%26aufirst%3DG.%26aulast%3DClausson%26aufirst%3DB.%26aulast%3DEkbom%26aufirst%3DA.%26aulast%3DLjunger%26aufirst%3DE.%26aulast%3DBlot%26aufirst%3DW.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DJ.%2BK.%26aulast%3DPetersson%26aufirst%3DG.%26aulast%3DRane%26aufirst%3DA.%26aulast%3DGranath%26aufirst%3DF.%26atitle%3DCaffeine%2520Intake%2520and%2520the%2520Risk%2520of%2520First-Trimester%2520Spontaneous%2520Abortion%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26issue%3D25%26spage%3D1839%26epage%3D1845%26doi%3D10.1056%2FNEJM200012213432503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wikoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brorby, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenenbein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doepker, C.</span></span> <span> </span><span class="NLM_article-title">Systematic Review of the Potential Adverse Effects of Caffeine Consumption in Healthy Adults, Pregnant Women, Adolescents, and Children</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2017.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.fct.2017.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28438661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFeksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2017&pages=585-648&author=D.+Wikoffauthor=B.+T.+Welshauthor=R.+Hendersonauthor=G.+P.+Brorbyauthor=J.+Brittauthor=E.+Myersauthor=J.+Goldbergerauthor=H.+R.+Liebermanauthor=C.+O%E2%80%99Brienauthor=J.+Peckauthor=M.+Tenenbeinauthor=C.+Weaverauthor=S.+Harveyauthor=J.+Urbanauthor=C.+Doepker&title=Systematic+Review+of+the+Potential+Adverse+Effects+of+Caffeine+Consumption+in+Healthy+Adults%2C+Pregnant+Women%2C+Adolescents%2C+and+Children&doi=10.1016%2Fj.fct.2017.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children</span></div><div class="casAuthors">Wikoff, Daniele; Welsh, Brian T.; Henderson, Rayetta; Brorby, Gregory P.; Britt, Janice; Myers, Esther; Goldberger, Jeffrey; Lieberman, Harris R.; O'Brien, Charles; Peck, Jennifer; Tenenbein, Milton; Weaver, Connie; Harvey, Seneca; Urban, Jonathan; Doepker, Candace</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">585-648</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To date, one of the most heavily cited assessments of caffeine safety in the peer-reviewed literature is that issued by Health Canada (Nawrot et al., 2003).  Since then, >10,000 papers have been published related to caffeine, including hundreds of reviews on specific human health effects; however, to date, none have compared the wide range of topics evaluated by Nawrot et al. (2003).  Thus, as an update to this foundational publication, we conducted a systematic review of data on potential adverse effects of caffeine published from 2001 to June 2015.  Subject matter experts and research team participants developed five PECO (population, exposure, comparator, and outcome) questions to address five types of outcomes (acute toxicity, cardiovascular toxicity, bone and calcium effects, behavior, and development and reprodn.) in four healthy populations (adults, pregnant women, adolescents, and children) relative to caffeine intake doses detd. not to be assocd. with adverse effects by Health Canada (comparators: 400 mg/day for adults [10 g for lethality], 300 mg/day for pregnant women, and 2.5 mg/kg/day for children and adolescents).  The a priori search strategy identified >5000 articles that were screened, with 381 meeting inclusion/exclusion criteria for the five outcomes (pharmacokinetics was addressed contextually, adding 46 more studies).  Data were extd. by the research team and rated for risk of bias and indirectness (internal and external validity).  Selected no- and low-effect intakes were assessed relative to the population-specific comparator.  Conclusions were drawn for the body of evidence for each outcome, as well as endpoints within an outcome, using a wt. of evidence approach.  When the total body of evidence was evaluated and when study quality, consistency, level of adversity, and magnitude of response were considered, the evidence generally supports that consumption of up to 400 mg caffeine/day in healthy adults is not assocd. with overt, adverse cardiovascular effects, behavioral effects, reproductive and developmental effects, acute effects, or bone status.  Evidence also supports consumption of up to 300 mg caffeine/day in healthy pregnant women as an intake that is generally not assocd. with adverse reproductive and developmental effects.  Limited data were identified for child and adolescent populations; the available evidence suggests that 2.5 mg caffeine/kg body wt./day remains an appropriate recommendation.  The results of this systematic review support a shift in caffeine research to focus on characterizing effects in sensitive populations and establishing better quant. characterization of interindividual variability (e.g., epigenetic trends), subpopulations (e.g., unhealthy populations, individuals with preexisting conditions), conditions (e.g., coexposures), and outcomes (e.g., exacerbation of risk-taking behavior) that could render individuals to be at greater risk relative to healthy adults and healthy pregnant women.  This review, being one of the first to apply systematic review methodologies to toxicol. assessments, also highlights the need for refined guidance and frameworks unique to the conduct of systematic review in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHt_MRvc12bVg90H21EOLACvtfcHk0lg99NQbt0oROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFeksb8%253D&md5=6ebef4642ff03f574e932b56fe4692f1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2017.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DWikoff%26aufirst%3DD.%26aulast%3DWelsh%26aufirst%3DB.%2BT.%26aulast%3DHenderson%26aufirst%3DR.%26aulast%3DBrorby%26aufirst%3DG.%2BP.%26aulast%3DBritt%26aufirst%3DJ.%26aulast%3DMyers%26aufirst%3DE.%26aulast%3DGoldberger%26aufirst%3DJ.%26aulast%3DLieberman%26aufirst%3DH.%2BR.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DPeck%26aufirst%3DJ.%26aulast%3DTenenbein%26aufirst%3DM.%26aulast%3DWeaver%26aufirst%3DC.%26aulast%3DHarvey%26aufirst%3DS.%26aulast%3DUrban%26aufirst%3DJ.%26aulast%3DDoepker%26aufirst%3DC.%26atitle%3DSystematic%2520Review%2520of%2520the%2520Potential%2520Adverse%2520Effects%2520of%2520Caffeine%2520Consumption%2520in%2520Healthy%2520Adults%252C%2520Pregnant%2520Women%252C%2520Adolescents%252C%2520and%2520Children%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2017%26volume%3D109%26spage%3D585%26epage%3D648%26doi%3D10.1016%2Fj.fct.2017.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatch, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracken, M. B.</span></span> <span> </span><span class="NLM_article-title">Association of Delayed Conception with Caffeine Consumption</span>. <i>Am. J. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.aje.a116826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Foxfordjournals.aje.a116826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8266910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK2c%252FptFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1993&pages=1082-1092&issue=12&author=E.+E.+Hatchauthor=M.+B.+Bracken&title=Association+of+Delayed+Conception+with+Caffeine+Consumption&doi=10.1093%2Foxfordjournals.aje.a116826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Association of delayed conception with caffeine consumption</span></div><div class="casAuthors">Hatch E E; Bracken M B</div><div class="citationInfo"><span class="NLM_cas:title">American journal of epidemiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1082-92</span>
        ISSN:<span class="NLM_cas:issn">0002-9262</span>.
    </div><div class="casAbstract">This cross-sectional study investigated the relation between intake of caffeine-containing beverages and time to conception in a population of 1,909 married women in New Haven, Connecticut, between May 12, 1980 and March 12, 1982.  Women were interviewed shortly after the first prenatal visit regarding the length of time taken to conceive the index pregnancy, consumption of caffeine during pregnancy, and other exposures occurring prior to and during pregnancy.  In logistic regression analyses, intake of caffeine from coffee, tea, and caffeinated soft drinks was associated with an increased risk of a delay of conception of 1 year or more.  Compared with no caffeine use, consumption of 1-150 mg/day of caffeine resulted in an odds ratio for delayed conception of 1.39 (95% confidence interval (CI) 0.90-2.13), consumption of 151-300 mg/day of caffeine was associated with an odds ratio of 1.88 (95% CI 1.13-3.11), and that of over 300 mg/day (the equivalent of approximately three cups of coffee) resulted in an odds ratio of 2.24 (95% CI 1.06-4.73), after controlling for last method of birth control used, parity, and number of cigarettes per day.  When the risk of conception for each cycle was examined using a discrete analogue of the Cox proportional hazards model, women who reported drinking over 300 mg/day of caffeine had a 27% lower chance of conceiving for each cycle, and those who reported drinking less than 300 mg/day had a 10% reduction in per cycle conception rates compared with women who consumed no caffeine.  Risks for coffee, tea, and colas were examined simultaneously in logistic models and were found not to improve the fit of a model that contained a variable for total caffeine intake from all sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFcGMC9lRoZK-9TkgmBqTqfW6udTcc2eahy3RSiCQiYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FptFaktg%253D%253D&md5=34e6a95423f3c8d4a334db58cfb074b1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.aje.a116826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.aje.a116826%26sid%3Dliteratum%253Aachs%26aulast%3DHatch%26aufirst%3DE.%2BE.%26aulast%3DBracken%26aufirst%3DM.%2BB.%26atitle%3DAssociation%2520of%2520Delayed%2520Conception%2520with%2520Caffeine%2520Consumption%26jtitle%3DAm.%2520J.%2520Epidemiol.%26date%3D1993%26volume%3D138%26issue%3D12%26spage%3D1082%26epage%3D1092%26doi%3D10.1093%2Foxfordjournals.aje.a116826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyngsø, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramlau-Hansen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingerslev, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesmodel, U. S.</span></span> <span> </span><span class="NLM_article-title">Association between Coffee or Caffeine Consumption and Fecundity and Fertility: A Systematic Review and Dose-Response Meta-Analysis</span>. <i>Clinical Epidemiology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">699</span>, <span class="refDoi"> DOI: 10.2147/CLEP.S146496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2147%2FCLEP.S146496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29276412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1MzltVSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=699&author=J.+Lyngs%C3%B8author=C.+H.+Ramlau-Hansenauthor=B.+Bayauthor=H.+J.+Ingerslevauthor=A.+Hulmanauthor=U.+S.+Kesmodel&title=Association+between+Coffee+or+Caffeine+Consumption+and+Fecundity+and+Fertility%3A+A+Systematic+Review+and+Dose-Response+Meta-Analysis&doi=10.2147%2FCLEP.S146496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis</span></div><div class="casAuthors">Lyngso Julie; Ramlau-Hansen Cecilia Host; Hulman Adam; Bay Bjorn; Ingerslev Hans Jakob; Hulman Adam; Kesmodel Ulrik Schioler</div><div class="citationInfo"><span class="NLM_cas:title">Clinical epidemiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-719</span>
        ISSN:<span class="NLM_cas:issn">1179-1349</span>.
    </div><div class="casAbstract">Objective:  The aim was to investigate whether coffee or caffeine consumption is associated with reproductive endpoints among women with natural fertility (ie, time to pregnancy [TTP] and spontaneous abortion [SAB]) and among women in fertility treatment (ie, clinical pregnancy rate or live birth rate).  Design:  This study was a systematic review and dose-response meta-analysis including data from case-control and cohort studies.  Methods:  An extensive literature search was conducted in MEDLINE and Embase, with no time and language restrictions.  Also, reference lists were searched manually.  Two independent reviewers assessed the manuscript quality using the Newcastle-Ottawa Scale (NOS).  A two-stage dose-response meta-analysis was applied to assess a potential association between coffee/caffeine consumption and the outcomes: TTP, SAB, clinical pregnancy, and live birth.  Heterogeneity between studies was assessed using Cochrane Q-test and I(2) statistics.  Publication bias was assessed using Egger's regression test.  Results:  The pooled results showed that coffee/caffeine consumption is associated with a significantly increased risk of SAB for 300 mg caffeine/day (relative risk [RR]: 1.37, 95% confidence interval [95% CI]: 1.19; 1.57) and for 600 mg caffeine/day (RR: 2.32, 95% CI: 1.62; 3.31).  No association was found between coffee/caffeine consumption and outcomes of fertility treatment (based on two studies).  No clear association was found between exposure to coffee/caffeine and natural fertility as measured by fecundability odds ratio (based on three studies) or waiting TTP (based on two studies).  Conclusion:  Results from this meta-analysis support the growing evidence of an association between coffee/caffeine intake and the risk of SAB.  However, viewing the reproductive capacity in a broader perspective, there seems to be little, if any, association between coffee/caffeine consumption and fecundity.  In general, results from this study are supportive of a precautionary principle advised by health organizations such as European Food Safety Authority (EFSA) and World Health Organization (WHO), although the advised limit of a maximum of two to three cups of coffee/200-300 mg caffeine per day may be too high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4SBByurJQWt1QT_1O5WBYfW6udTcc2eahy3RSiCQiYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzltVSqsQ%253D%253D&md5=7c51637a1e9c2c02badee3e27a3091e3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2147%2FCLEP.S146496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCLEP.S146496%26sid%3Dliteratum%253Aachs%26aulast%3DLyngs%25C3%25B8%26aufirst%3DJ.%26aulast%3DRamlau-Hansen%26aufirst%3DC.%2BH.%26aulast%3DBay%26aufirst%3DB.%26aulast%3DIngerslev%26aufirst%3DH.%2BJ.%26aulast%3DHulman%26aufirst%3DA.%26aulast%3DKesmodel%26aufirst%3DU.%2BS.%26atitle%3DAssociation%2520between%2520Coffee%2520or%2520Caffeine%2520Consumption%2520and%2520Fecundity%2520and%2520Fertility%253A%2520A%2520Systematic%2520Review%2520and%2520Dose-Response%2520Meta-Analysis%26jtitle%3DClinical%2520Epidemiology%26date%3D2017%26volume%3D9%26spage%3D699%26doi%3D10.2147%2FCLEP.S146496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sengpiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elind, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacelis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grove, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myhre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meltzer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brantsæter, A. L.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Intake during Pregnancy Is Associated with Birth Weight but Not with Gestational Length: Results from a Large Prospective Observational Cohort Study</span>. <i>BMC Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">42</span>, <span class="refDoi"> DOI: 10.1186/1741-7015-11-42</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2F1741-7015-11-42" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23421532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVaks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=42&issue=1&author=V.+Sengpielauthor=E.+Elindauthor=J.+Bacelisauthor=S.+Nilssonauthor=J.+Groveauthor=R.+Myhreauthor=M.+Haugenauthor=H.+M.+Meltzerauthor=J.+Alexanderauthor=B.+Jacobssonauthor=A.+L.+Brants%C3%A6ter&title=Maternal+Caffeine+Intake+during+Pregnancy+Is+Associated+with+Birth+Weight+but+Not+with+Gestational+Length%3A+Results+from+a+Large+Prospective+Observational+Cohort+Study&doi=10.1186%2F1741-7015-11-42"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study</span></div><div class="casAuthors">Sengpiel, Verena; Elind, Elisabeth; Bacelis, Jonas; Nilsson, Staffan; Grove, Jakob; Myhre, Ronny; Haugen, Margaretha; Meltzer, Helle Margrete; Alexander, Jan; Jacobsson, Bo; Brantsaeter, Anne-Lise</div><div class="citationInfo"><span class="NLM_cas:title">BMC Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42</span>CODEN:
                <span class="NLM_cas:coden">BMMECZ</span>;
        ISSN:<span class="NLM_cas:issn">1741-7015</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Pregnant women consume caffeine daily.  The aim of this study was to examine the assocn. between maternal caffeine intake from different sources and (a) gestational length, particularly the risk for spontaneous preterm delivery (PTD) and (b) birth wt. (BW) and the baby being small for gestational age (SGA).  Methods: This study is based on the Norwegian Mother and Child Cohort Study conducted by the Norwegian Institute of Public Health.  A total of 59,123 women with uncomplicated pregnancies giving birth to a live singleton were identified.  Caffeine intake from different sources was self-reported at gestational weeks 17, 22 and 30.  Spontaneous PTD was defined as spontaneous onset of delivery between 22+0 and 36+6 weeks (n = 1,451).  As there is no consensus, SGA was defined according to ultrasound-based (Marsal, n = 856), population-based (Skjaerven, n = 4,503) and customized (Gardosi, n = 4,733) growth curves.  Results: The main caffeine source was coffee, but tea and chocolate were the main sources in women with low caffeine intake.  Median pre-pregnancy caffeine intake was 126 mg/day (IQR 40 to 254), 44 mg/day (13 to 104) at gestational week 17 and 62 mg/day (21 to 130) at gestational week 30.  Coffee caffeine, but not caffeine from other sources, was assocd. with prolonged gestation (8 h/100 mg/day, P<10-7).  Neither total nor coffee caffeine was assocd. with spontaneous PTD risk.  Caffeine intake from different sources, measured repeatedly during pregnancy, was assocd. with lower BW (Marsal-28 g, Skjaerven-25 g, Gardosi-21 g per 100 mg/day addnl. total caffeine for a baby with expected BW 3,600 g, P<10-25).  Caffeine intake of 200 to 300 mg/day increased the odds for SGA (OR Marsal 1.62, Skjaerven 1.44, Gardosi 1.27, P<0.05), compared to 0 to 50 mg/day.  Conclusions: Coffee, but not caffeine, consumption was assocd. with marginally increased gestational length but not with spontaneous PTD risk.  Caffeine intake was consistently assocd. with decreased BW and increased odds of SGA.  The assocn. was strengthened by concordant results for caffeine sources, time of survey and different SGA definitions.  This might have clin. implications as even caffeine consumption below the recommended max. (200 mg/day in the Nordic countries and USA, 300 mg/day according to the World Health Organization (WHO)) was assocd. with increased risk for SGA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbGNyGRK_aFbVg90H21EOLACvtfcHk0lj_CfM2D-7r7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVaks7s%253D&md5=33982510eca48576aae531c04bde3ce0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-11-42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-11-42%26sid%3Dliteratum%253Aachs%26aulast%3DSengpiel%26aufirst%3DV.%26aulast%3DElind%26aufirst%3DE.%26aulast%3DBacelis%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DGrove%26aufirst%3DJ.%26aulast%3DMyhre%26aufirst%3DR.%26aulast%3DHaugen%26aufirst%3DM.%26aulast%3DMeltzer%26aufirst%3DH.%2BM.%26aulast%3DAlexander%26aufirst%3DJ.%26aulast%3DJacobsson%26aufirst%3DB.%26aulast%3DBrants%25C3%25A6ter%26aufirst%3DA.%2BL.%26atitle%3DMaternal%2520Caffeine%2520Intake%2520during%2520Pregnancy%2520Is%2520Associated%2520with%2520Birth%2520Weight%2520but%2520Not%2520with%2520Gestational%2520Length%253A%2520Results%2520from%2520a%2520Large%2520Prospective%2520Observational%2520Cohort%2520Study%26jtitle%3DBMC%2520Med.%26date%3D2013%26volume%3D11%26issue%3D1%26spage%3D42%26doi%3D10.1186%2F1741-7015-11-42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odouli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. K.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Consumption during Pregnancy and the Risk of Miscarriage: A Prospective Cohort Study</span>. <i>Am. J. Obstet. Gynecol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>198</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">279.e1</span>– <span class="NLM_lpage">279.e8</span>, <span class="refDoi"> DOI: 10.1016/j.ajog.2007.10.803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ajog.2007.10.803" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2008&pages=279.e1-279.e8&issue=3&author=X.+Wengauthor=R.+Odouliauthor=D.+K.+Li&title=Maternal+Caffeine+Consumption+during+Pregnancy+and+the+Risk+of+Miscarriage%3A+A+Prospective+Cohort+Study&doi=10.1016%2Fj.ajog.2007.10.803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ajog.2007.10.803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajog.2007.10.803%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DX.%26aulast%3DOdouli%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DD.%2BK.%26atitle%3DMaternal%2520Caffeine%2520Consumption%2520during%2520Pregnancy%2520and%2520the%2520Risk%2520of%2520Miscarriage%253A%2520A%2520Prospective%2520Cohort%2520Study%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D2008%26volume%3D198%26issue%3D3%26spage%3D279.e1%26epage%3D279.e8%26doi%3D10.1016%2Fj.ajog.2007.10.803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">CARE
Study Group</span> <span> </span><span class="NLM_article-title">Maternal Caffeine
Intake during Pregnancy and Risk of Fetal Growth Restriction: A Large
Prospective Observational Study</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>337</i></span> (<span class="NLM_issue">7682</span>),  <span class="NLM_fpage">1334</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1136/bmj.a2332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1136%2Fbmj.a2332" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2008&pages=1334-1338&issue=7682&author=CARE%0AStudy+Group&title=Maternal+Caffeine%0AIntake+during+Pregnancy+and+Risk+of+Fetal+Growth+Restriction%3A+A+Large%0AProspective+Observational+Study&doi=10.1136%2Fbmj.a2332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1136%2Fbmj.a2332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.a2332%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DMaternal%2520Caffeine%250AIntake%2520during%2520Pregnancy%2520and%2520Risk%2520of%2520Fetal%2520Growth%2520Restriction%253A%2520A%2520Large%250AProspective%2520Observational%2520Study%26jtitle%3DBMJ.%26date%3D2008%26volume%3D337%26issue%3D7682%26spage%3D1334%26epage%3D1338%26doi%3D10.1136%2Fbmj.a2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, M. F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, R. M.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Intake during Pregnancy Is Associated with Risk of Low Birth Weight: A Systematic Review and Dose-Response Meta-Analysis</span>. <i>BMC Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">174</span>, <span class="refDoi"> DOI: 10.1186/s12916-014-0174-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs12916-014-0174-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25238871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jtFSisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=174&issue=1&author=L.+W.+Chenauthor=Y.+Wuauthor=N.+Neelakantanauthor=M.+F.+F.+Chongauthor=A.+Panauthor=R.+M.+van+Dam&title=Maternal+Caffeine+Intake+during+Pregnancy+Is+Associated+with+Risk+of+Low+Birth+Weight%3A+A+Systematic+Review+and+Dose-Response+Meta-Analysis&doi=10.1186%2Fs12916-014-0174-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis</span></div><div class="casAuthors">Chen Ling-Wei; Wu Yi; Neelakantan Nithya; Chong Mary Foong-Fong; Pan An; van Dam Rob M</div><div class="citationInfo"><span class="NLM_cas:title">BMC medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Considerable controversy exists regarding the relation between maternal caffeine intake during pregnancy and risk of low birth weight (birth weight <2,500 g).  We aim to assess this association using a systematic review and dose-response meta-analysis of prospective studies.  METHODS:  Potential articles were identified by searching MEDLINE and SCOPUS databases through 17 July 2013.  Two authors independently extracted information on study design, participant characteristics and estimates of associations.  Random-effects models were used to derive the summary relative risks (RRs) and corresponding 95% confidence intervals (CIs).  Dose-response relationships were assessed using generalized least-squares trend estimation.  RESULTS:  In our meta-analysis, we included 13 prospective studies: 9 with low birth weight as a binary outcome variable (90,747 participants and 6,303 cases) and 6 with birth weight as a continuous outcome variable (10,015 participants; 2 studies reported both types of outcomes).  Compared with the reference category with no or very low caffeine intake, the RR (95% CI) of low birth weight was 1.13 (1.06 to 1.21; I 2 0.0%) for low intake (50 to 149 mg/day), 1.38 (1.18 to 1.62; I 2 31.9%) for moderate intake (150 to 349 mg/day), and 1.60 (1.24 to 2.08; I 2 65.8%) for high intake (≥350 mg/day).  In the dose-response analysis, each 100-mg/day increment in maternal caffeine intake (around one cup of coffee) was associated with 13% (RR 1.13, 1.06 to 1.21) higher risk of low birth weight.  The association persisted in strata defined according to various study characteristics.  Moderate (-33 g, 95% CI -63 to -4; I 2 0.3%) and high (-69 g, 95% CI -102 to -35; I 2 0.0%) caffeine intakes were also associated with a significantly lower birth weight as compared with the reference category.  CONCLUSIONS:  Higher maternal caffeine intake during pregnancy was associated with a higher risk of delivering low birth weight infants.  These findings support recommendations to restrict caffeine intake during pregnancy to low levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbXRvTXTiIAtts4TFFB11gfW6udTcc2ebGa_QM_zLPsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jtFSisg%253D%253D&md5=12bee1b413af1c1f311088a300daeefa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2Fs12916-014-0174-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12916-014-0174-6%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DNeelakantan%26aufirst%3DN.%26aulast%3DChong%26aufirst%3DM.%2BF.%2BF.%26aulast%3DPan%26aufirst%3DA.%26aulast%3Dvan%2BDam%26aufirst%3DR.%2BM.%26atitle%3DMaternal%2520Caffeine%2520Intake%2520during%2520Pregnancy%2520Is%2520Associated%2520with%2520Risk%2520of%2520Low%2520Birth%2520Weight%253A%2520A%2520Systematic%2520Review%2520and%2520Dose-Response%2520Meta-Analysis%26jtitle%3DBMC%2520Med.%26date%3D2014%26volume%3D12%26issue%3D1%26spage%3D174%26doi%3D10.1186%2Fs12916-014-0174-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldenburg, C. E.</span></span> <span> </span><span class="NLM_article-title">Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0132334</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0132334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1371%2Fjournal.pone.0132334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26193706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOlurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&issue=7&author=J.+Rheeauthor=R.+Kimauthor=Y.+Kimauthor=M.+Tamauthor=Y.+Laiauthor=N.+N.+Keumauthor=C.+E.+Oldenburg&title=Maternal+Caffeine+Consumption+during+Pregnancy+and+Risk+of+Low+Birth+Weight%3A+A+Dose-Response+Meta-Analysis+of+Observational+Studies&doi=10.1371%2Fjournal.pone.0132334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal caffeine consumption during pregnancy and risk of low birth weight: a dose-response meta-analysis of observational studies</span></div><div class="casAuthors">Rhee, Jongeun; Kim, Rockli; Kim, Yongjoo; Tam, Melanie; Lai, Yizhen; Keum, Na Na; Oldenburg, Catherine Elizabeth</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0132334/1-e0132334/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Epidemiol. studies have shown inconsistent conclusions about the effect of caffeine intake during pregnancy on the risk of low birth wt. (LBW).  We performed a meta-anal. and linear-dose response anal. examg. the assocn. between caffeine consumption during pregnancy and risk of LBW.  PubMed and EMBASE were searched for relevant articles published up to March 2014.  Eight cohort and four case-control studies met all inclusion criteria.  Using a random-effects model of the twelve studies, the pooled odds ratio (OR) for the risk of LBW comparing the highest vs. lowest level of caffeine intake during pregnancy was 1.38 (95% CI: 1.10, 1.73).  Linear dose-response anal. showed that every addnl. 100 mg of caffeine intake (1 cup of coffee or 2 cups of tea) per day during pregnancy was assocd. with a 3.0% increase in OR for LBW.  There was a moderate level of overall heterogeneity with an I-squared value of 55% (95% CI: 13, 76%), and no evidence of publication bias based on Egger's test (P = 0.20) and the funnel plot.  Thus, high caffeine intake during pregnancy is assocd. with a significant increase in the risk of LBW, and this risk appears to increase linearly as caffeine intake increases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSETANNwXBhbVg90H21EOLACvtfcHk0lgwPpIOatz1eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOlurnL&md5=05682508948aaeae5c4a6a28bce8478c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132334%26sid%3Dliteratum%253Aachs%26aulast%3DRhee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DKeum%26aufirst%3DN.%2BN.%26aulast%3DOldenburg%26aufirst%3DC.%2BE.%26atitle%3DMaternal%2520Caffeine%2520Consumption%2520during%2520Pregnancy%2520and%2520Risk%2520of%2520Low%2520Birth%2520Weight%253A%2520A%2520Dose-Response%2520Meta-Analysis%2520of%2520Observational%2520Studies%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0132334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehegan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C. M.</span></span> <span> </span><span class="NLM_article-title">Associations of Maternal Caffeine Intake with Birth Outcomes: Results from the Lifeways Cross Generation Cohort Study</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1301</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1093/ajcn/nqy219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fajcn%2Fnqy219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30339199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB3cvhtFehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2018&pages=1301-1308&issue=6&author=L.+W.+Chenauthor=R.+Fitzgeraldauthor=C.+M.+Murrinauthor=J.+Meheganauthor=C.+C.+Kelleherauthor=C.+M.+Phillips&title=Associations+of+Maternal+Caffeine+Intake+with+Birth+Outcomes%3A+Results+from+the+Lifeways+Cross+Generation+Cohort+Study&doi=10.1093%2Fajcn%2Fnqy219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study</span></div><div class="casAuthors">Chen Ling-Wei; Murrin Celine M; Mehegan John; Kelleher Cecily C; Phillips Catherine M; Fitzgerald Roisin</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1301-1308</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background:  Maternal caffeine intake is associated with adverse birth outcomes, but in most studies the primary caffeine source is coffee; the influence of tea caffeine remains unclear.  Objective:  The aim of the study was to examine the association between maternal caffeine intake and birth outcomes in a population with tea as the predominant caffeine source.  Design:  Data from 941 Irish mother-child pairs of the Lifeways Cross Generation Cohort Study were examined.  Maternal dietary intakes in early pregnancy were assessed using a validated food-frequency questionnaire.  Caffeine intake was derived from coffee, tea, soft drinks, and cocoa-containing foods and beverages.  Associations of maternal caffeine intake with continuous (birth weight, birth length, and gestational age) and binary [low birth weight (LBW) (<2500 g) and preterm birth (PB) (<37 wk gestational age)] birth outcomes were investigated using multiple linear and logistic regressions, respectively, with adjustment for potential confounders.  Results:  Tea was the predominant caffeine source (48%), followed by coffee (39%).  In the fully adjusted model, maternal caffeine intake was associated with lower birth weight [β (95% CI): -71.9 (-105.4, -38.4) g · 100 mg-1 · d-1 caffeine increment], shorter birth length [-0.30 (-0.49, -0.11) cm], smaller head circumference [-0.12 (-0.24, -0.01) cm], and shorter gestational age [-0.13 (-0.25, -0.02) wk]; higher risks for LBW [OR (95% CI): 1.47 (1.14, 1.90)] and PB [1.36 (1.07, 1.74)] were also observed (all P < 0.05).  The associations were robust to the exclusion of participants with pregnancy complications and in never smokers.  Similar higher risks of adverse birth outcomes were observed for the highest caffeine intake categories from coffee [ORLBW: 3.10 (1.08, 8.89); ORPB: 2.74 (1.05, 7.16)] and tea [ORLBW: 2.47 (1.02, 6.01); ORPB: 2.56 (1.14, 5.75)], compared with the lowest intake categories (all P < 0.05).  Conclusions:  Maternal caffeine intake from both coffee and tea is associated with adverse birth outcomes.  This prospective observational study was registered at ISRCTN Registry as ISRCTN16537904.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCK5v2qz4tkhBrI9DTGjC0fW6udTcc2eY3ljFxur7isrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvhtFehug%253D%253D&md5=715b3984927f8148419b98d39ade4450</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2Fnqy219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252Fnqy219%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BW.%26aulast%3DFitzgerald%26aufirst%3DR.%26aulast%3DMurrin%26aufirst%3DC.%2BM.%26aulast%3DMehegan%26aufirst%3DJ.%26aulast%3DKelleher%26aufirst%3DC.%2BC.%26aulast%3DPhillips%26aufirst%3DC.%2BM.%26atitle%3DAssociations%2520of%2520Maternal%2520Caffeine%2520Intake%2520with%2520Birth%2520Outcomes%253A%2520Results%2520from%2520the%2520Lifeways%2520Cross%2520Generation%2520Cohort%2520Study%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2018%26volume%3D108%26issue%3D6%26spage%3D1301%26epage%3D1308%26doi%3D10.1093%2Fajcn%2Fnqy219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mioranzza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioreze, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botton, P. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porciúncula, L. O.</span></span> <span> </span><span class="NLM_article-title">Prenatal Caffeine Intake Differently Affects Synaptic Proteins during Fetal Brain Development</span>. <i>Int. J. Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.ijdevneu.2014.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ijdevneu.2014.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24862851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqt7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=45-52&author=S.+Mioranzzaauthor=F.+Nunesauthor=D.+M.+Marquesauthor=G.+T.+Fiorezeauthor=A.+S.+Rochaauthor=P.+H.+S.+Bottonauthor=M.+S.+Costaauthor=L.+O.+Porci%C3%BAncula&title=Prenatal+Caffeine+Intake+Differently+Affects+Synaptic+Proteins+during+Fetal+Brain+Development&doi=10.1016%2Fj.ijdevneu.2014.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Prenatal caffeine intake differently affects synaptic proteins during fetal brain development</span></div><div class="casAuthors">Mioranzza, Sabrina; Nunes, Fernanda; Marques, Daniela M.; Fioreze, Gabriela T.; Rocha, Andreia S.; Botton, Paulo Henrique S.; Costa, Marcelo S.; Porciuncula, Lisiane O.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Developmental Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">IJDND6</span>;
        ISSN:<span class="NLM_cas:issn">0736-5748</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Caffeine is the psychostimulant most consumed worldwide.  However, little is known about its effects during fetal brain development.  In this study, adult female Wistar rats received caffeine in drinking water (0.1, 0.3 and 1.0 g/L) during the active cycle in weekdays, two weeks before mating and throughout pregnancy.  Cerebral cortex and hippocampus from embryonic stages 18 or 20 (E18 or E20, resp.) were collected for immunodetection of the following synaptic proteins: brain-derived neurotrophic factor (BDNF), TrkB receptor, Sonic Hedgehog (Shh), Growth Assocd. Protein 43 (GAP-43) and Synaptosomal-assocd. Protein 25 (SNAP-25).  Besides, the estn. of NeuN-stained nuclei (mature neurons) and non-neuronal nuclei was verified in both brain regions and embryonic periods.  Caffeine (1.0 g/L) decreased the body wt. of embryos at E20.  Cortical BDNF at E18 was decreased by caffeine (1.0 g/L), while it increased at E20, with no major effects on TrkB receptors.  In the hippocampus, caffeine decreased TrkB receptor only at E18, with no effects on BDNF.  Moderate and high doses of caffeine promoted an increase in Shh in both brain regions at E18, and in the hippocampus at E20.  Caffeine (0.3 g/L) decreased GAP-43 only in the hippocampus at E18.  The NeuN-stained nuclei increased in the cortex at E20 by lower dose and in the hippocampus at E18 by moderate dose.  Our data revealed that caffeine transitorily affect synaptic proteins during fetal brain development.  The increased no. of NeuN-stained nuclei by prenatal caffeine suggests a possible acceleration of the telencephalon maturation.  Although some modifications in the synaptic proteins were transient, our data suggest that caffeine even in lower doses may alter the fetal brain development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos5KPs_5Z3DLVg90H21EOLACvtfcHk0lgwPpIOatz1eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqt7jP&md5=668315a50ebc90e6fa92783cd20da286</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2014.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2014.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMioranzza%26aufirst%3DS.%26aulast%3DNunes%26aufirst%3DF.%26aulast%3DMarques%26aufirst%3DD.%2BM.%26aulast%3DFioreze%26aufirst%3DG.%2BT.%26aulast%3DRocha%26aufirst%3DA.%2BS.%26aulast%3DBotton%26aufirst%3DP.%2BH.%2BS.%26aulast%3DCosta%26aufirst%3DM.%2BS.%26aulast%3DPorci%25C3%25BAncula%26aufirst%3DL.%2BO.%26atitle%3DPrenatal%2520Caffeine%2520Intake%2520Differently%2520Affects%2520Synaptic%2520Proteins%2520during%2520Fetal%2520Brain%2520Development%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2014%26volume%3D36%26spage%3D45%26epage%3D52%26doi%3D10.1016%2Fj.ijdevneu.2014.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mejia, E. G.</span></span> <span> </span><span class="NLM_article-title">Caffeine (1, 3, 7-Trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters</span>. <i>J. Food Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">R77</span>– <span class="NLM_lpage">R87</span>, <span class="refDoi"> DOI: 10.1111/j.1750-3841.2010.01561.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1750-3841.2010.01561.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20492310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFOrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=R77-R87&issue=3&author=M.+A.+Heckmanauthor=J.+Weilauthor=E.+G.+de+Mejia&title=Caffeine+%281%2C+3%2C+7-Trimethylxanthine%29+in+Foods%3A+A+Comprehensive+Review+on+Consumption%2C+Functionality%2C+Safety%2C+and+Regulatory+Matters&doi=10.1111%2Fj.1750-3841.2010.01561.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters</span></div><div class="casAuthors">Heckman, Melanie A.; Weil, Jorge; Gonzalez de Mejia, Elvira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Food Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">R77-R87</span>CODEN:
                <span class="NLM_cas:coden">JFDSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1147</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Caffeine ranks as one of the top most commonly consumed dietary ingredients throughout the world.  It is naturally found in coffee beans, cacao beans, kola nuts, guarana berries, and tea leaves including yerba mate.  The total daily intake, as well as the major source of caffeine varies globally; however, coffee and tea are the 2 most prominent sources.  Soft drinks are also a common source of caffeine as well as energy drinks, a category of functional beverages.  Moderate caffeine consumption is considered safe and its use as a food ingredient has been approved, within certain limits, by numerous regulatory agencies around the world.  Performance benefits attributed to caffeine include phys. endurance, redn. of fatigue, and enhancing mental alertness and concn.  Caffeine has also been recently linked to wt. loss and consequent redn. of the overall risks for developing the metabolic syndrome.  However, the caloric contribution of caffeine-sweetened beverages needs to be considered in the overall energy balance.  Despite all these benefits the potential neg. effects of excessive caffeine intake should also be considered, particularly in children and pregnant women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_By0pNCLVbVg90H21EOLACvtfcHk0li1z2P-Z3O1Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFOrsrg%253D&md5=362fdeccf4490cb8e0c20525fdc3e8ac</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3841.2010.01561.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3841.2010.01561.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DM.%2BA.%26aulast%3DWeil%26aufirst%3DJ.%26aulast%3Dde%2BMejia%26aufirst%3DE.%2BG.%26atitle%3DCaffeine%2520%25281%252C%25203%252C%25207-Trimethylxanthine%2529%2520in%2520Foods%253A%2520A%2520Comprehensive%2520Review%2520on%2520Consumption%252C%2520Functionality%252C%2520Safety%252C%2520and%2520Regulatory%2520Matters%26jtitle%3DJ.%2520Food%2520Sci.%26date%3D2010%26volume%3D75%26issue%3D3%26spage%3DR77%26epage%3DR87%26doi%3D10.1111%2Fj.1750-3841.2010.01561.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djoumbou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neveu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dame, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, D. S.</span></span> <span> </span><span class="NLM_article-title">DrugBank 4.0: Shedding New Light on Drug Metabolism</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D1091</span>– <span class="NLM_lpage">D1097</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fnar%2Fgkt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24203711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Kh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=D1091-D1097&issue=D1&author=V.+Lawauthor=C.+Knoxauthor=Y.+Djoumbouauthor=T.+Jewisonauthor=A.+C.+Guoauthor=Y.+Liuauthor=A.+Maciejewskiauthor=D.+Arndtauthor=M.+Wilsonauthor=V.+Neveuauthor=A.+Tangauthor=G.+Gabrielauthor=C.+Lyauthor=S.+Adamjeeauthor=Z.+T.+Dameauthor=B.+Hanauthor=Y.+Zhouauthor=D.+S.+Wishart&title=DrugBank+4.0%3A+Shedding+New+Light+on+Drug+Metabolism&doi=10.1093%2Fnar%2Fgkt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank 4.0: shedding new light on drug metabolism</span></div><div class="casAuthors">Law, Vivian; Knox, Craig; Djoumbou, Yannick; Jewison, Tim; Guo, An Chi; Liu, Yifeng; Maciejewski, Adam; Arndt, David; Wilson, Michael; Neveu, Vanessa; Tang, Alexandra; Gabriel, Geraldine; Ly, Carol; Adamjee, Sakina; Dame, Zerihun T.; Han, Beomsoo; Zhou, You; Wishart, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1091-D1097</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank (http://www.drugbank.ca) is a comprehensive online database contg. extensive biochem. and pharmacol. information about drugs, their mechanisms and their targets.  Since it was first described in 2006, DrugBank has rapidly evolved, both in response to user requests and in response to changing trends in drug research and development.  Previous versions of DrugBank have been widely used to facilitate drug and in silico drug target discovery.  The latest update, DrugBank 4.0, has been further expanded to contain data on drug metab., absorption, distribution, metab., excretion and toxicity (ADMET) and other kinds of quant. structure activity relationships (QSAR) information.  These enhancements are intended to facilitate research in xenobiotic metab. (both prediction and characterization), pharmacokinetics, pharmacodynamics and drug design/discovery.  For this release, >1200 drug metabolites (including their structures, names, activity, abundance and other detailed data) have been added along with >1300 drug metab. reactions (including metabolizing enzymes and reaction types) and dozens of drug metab. pathways.  Another 30 predicted or measured ADMET parameters have been added to each DrugCard, bringing the av. no. of quant. ADMET values for Food and Drug Administration-approved drugs close to 40.  Referential NMR and MS spectra have been added for almost 400 drugs as well as spectral and mass matching tools to facilitate compd. identification.  This expanded collection of drug information is complemented by a no. of new or improved search tools, including one that provides a simple analyses of drug-target, -enzyme and -transporter assocns. to provide insight on drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_BsUO1phm7Vg90H21EOLACvtfcHk0li1z2P-Z3O1Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Kh&md5=0da9f3ecfc2061f814803cf4b070e54e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1068%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DV.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DDjoumbou%26aufirst%3DY.%26aulast%3DJewison%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaciejewski%26aufirst%3DA.%26aulast%3DArndt%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DNeveu%26aufirst%3DV.%26aulast%3DTang%26aufirst%3DA.%26aulast%3DGabriel%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%26aulast%3DAdamjee%26aufirst%3DS.%26aulast%3DDame%26aufirst%3DZ.%2BT.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWishart%26aufirst%3DD.%2BS.%26atitle%3DDrugBank%25204.0%253A%2520Shedding%2520New%2520Light%2520on%2520Drug%2520Metabolism%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26issue%3DD1%26spage%3DD1091%26epage%3DD1097%26doi%3D10.1093%2Fnar%2Fgkt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feunang, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayeeda, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assempour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iynkkaran, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIejewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Di</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span> <span> </span><span class="NLM_article-title">DrugBank 5.0: A Major Update to the DrugBank Database for 2018</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D1074</span>– <span class="NLM_lpage">D1082</span>, <span class="refDoi"> DOI: 10.1093/nar/gkx1037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fnar%2Fgkx1037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29126136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGisbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=D1074-D1082&issue=D1&author=D.+S.+Wishartauthor=Y.+D.+Feunangauthor=A.+C.+Guoauthor=E.+J.+Loauthor=A.+Marcuauthor=J.+R.+Grantauthor=T.+Sajedauthor=D.+Johnsonauthor=C.+Liauthor=Z.+Sayeedaauthor=N.+Assempourauthor=I.+Iynkkaranauthor=Y.+Liuauthor=A.+MacIejewskiauthor=N.+Galeauthor=A.+Wilsonauthor=L.+Chinauthor=R.+Cummingsauthor=Di+Leauthor=A.+Ponauthor=C.+Knoxauthor=M.+Wilson&title=DrugBank+5.0%3A+A+Major+Update+to+the+DrugBank+Database+for+2018&doi=10.1093%2Fnar%2Fgkx1037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank 5.0: a major update to the DrugBank database for 2018</span></div><div class="casAuthors">Wishart, David S.; Feunang, Yannick D.; Guo, An C.; Lo, Elvis J.; Marcu, Ana; Grant, Jason R.; Sajed, Tanvir; Johnson, Daniel; Li, Carin; Sayeeda, Zinat; Assempour, Nazanin; Iynkkaran, Ithayavani; Liu, Yifeng; Maciejewski, Adam; Gale, Nicola; Wilson, Alex; Chin, Lucy; Cummings, Ryan; Le, Diana; Pon, Allison; Knox, Craig; Wilson, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1074-D1082</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a web-enabled database contg. comprehensivemol. information about drugs, their mechanisms, their interactions and their targets.  First described in 2006, Drug- Bank has continued to evolve over the past 12 years in response to marked improvements to web stds. and changing needs for drug research and development.  This year's update, DrugBank 5.0, represents the most significant upgrade to the database in more than 10 years.  In many cases, existing data content has grown by 100% or more over the last update.  For instance, the total no. of investigational drugs in the database has grown by almost 300%, the no. of drug-drug interactions has grown by nearly 600% and the no. of SNP-assocd. drug effects has grown more than 3000%.  Significant improvements have been made to the quantity, quality and consistency of drug indications, drug binding data as well as drug-drug and drug-food interactions.  A great deal of brand new data have also been added to DrugBank 5.0.  This includes information on the influence of hundreds of drugs on metabolite levels (pharmacometabolomics), gene expression levels (pharmacotranscriptomics) and protein expression levels (pharmacoproteomics).  New data have also been added on the status of hundreds of newdrug clin. trials and existing drug repurposing trials.  Many other important improvements in the content, interface and performance of the DrugBank website have been made and these should greatly enhance its ease of use, utility and potential applications in many areas of pharmacol. research, pharmaceutical science and drug education.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc8rfBoMOOyLVg90H21EOLACvtfcHk0li1z2P-Z3O1Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGisbvI&md5=986b28c7ea546596a26dd3ba38f05fee</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkx1037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkx1037%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DFeunang%26aufirst%3DY.%2BD.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DLo%26aufirst%3DE.%2BJ.%26aulast%3DMarcu%26aufirst%3DA.%26aulast%3DGrant%26aufirst%3DJ.%2BR.%26aulast%3DSajed%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSayeeda%26aufirst%3DZ.%26aulast%3DAssempour%26aufirst%3DN.%26aulast%3DIynkkaran%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMacIejewski%26aufirst%3DA.%26aulast%3DGale%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DDi%26aulast%3DPon%26aufirst%3DA.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DM.%26atitle%3DDrugBank%25205.0%253A%2520A%2520Major%2520Update%2520to%2520the%2520DrugBank%2520Database%2520for%25202018%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26issue%3DD1%26spage%3DD1074%26epage%3DD1082%26doi%3D10.1093%2Fnar%2Fgkx1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. R.</span></span> <span> </span><span class="NLM_article-title">A Critical Review of Caffeine Withdrawal: Empirical Validation of Symptoms and Signs, Incidence, Severity, and Associated Features</span>. <i>Psychopharmacology (Berl).</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-2000-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00213-004-2000-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15448977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1aitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2004&pages=1-29&issue=1&author=L.+M.+Julianoauthor=R.+R.+Griffiths&title=A+Critical+Review+of+Caffeine+Withdrawal%3A+Empirical+Validation+of+Symptoms+and+Signs%2C+Incidence%2C+Severity%2C+and+Associated+Features&doi=10.1007%2Fs00213-004-2000-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features</span></div><div class="casAuthors">Juliano, Laura M.; Griffiths, Roland R.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Although reports of caffeine withdrawal in the medical literature date back more than 170 yr, the most rigorous exptl. investigations of the phenomenon were conducted only recently.  The purpose of this paper is to provide a comprehensive review and anal. of the literature regarding human caffeine withdrawal to empirically validate specific symptoms and signs, and to appraise important features of the syndrome.  A literature search identified 57 exptl. and 9 survey studies on caffeine withdrawal that met inclusion criteria.  The methodol. features of each study were examd. to assess the validity of the effects.  Of 49 symptom categories identified, the following 10 fulfilled validity criteria: headache, fatigue, decreased energy/activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concg., irritability, and foggy/not clearheaded.  In addn., flu-like symptoms, nausea/vomiting, and muscle pain/stiffness were judged likely to represent valid symptom categories.  In exptl. studies, the incidence of headache was 50 and the incidence of clin. significant distress or functional impairment was 13.  Typically, onset of symptoms occurred 12-24 h after abstinence, with peak intensity at 20-51 h, and for a duration of 2-9 days.  In general, the incidence or severity of symptoms increased with increases in daily dose; abstinence from doses as low as 100 mg/day produced symptoms.  Research is reviewed indicating that expectancies are not a prime determinant of caffeine withdrawal and that avoidance of withdrawal symptoms plays a central role in habitual caffeine consumption.  The caffeine-withdrawal syndrome was well characterized and there is sufficient empirical evidence to warrant inclusion of caffeine withdrawal as a disorder in the DSM and revision of diagnostic criteria in the ICD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotTkwQg8zkLbVg90H21EOLACvtfcHk0lhCKPyEFKVcdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot1aitL0%253D&md5=fdaa8e51d3ab3ce523377ef316aa21fe</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-2000-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-2000-x%26sid%3Dliteratum%253Aachs%26aulast%3DJuliano%26aufirst%3DL.%2BM.%26aulast%3DGriffiths%26aufirst%3DR.%2BR.%26atitle%3DA%2520Critical%2520Review%2520of%2520Caffeine%2520Withdrawal%253A%2520Empirical%2520Validation%2520of%2520Symptoms%2520and%2520Signs%252C%2520Incidence%252C%2520Severity%252C%2520and%2520Associated%2520Features%26jtitle%3DPsychopharmacology%2520%2528Berl%2529.%26date%3D2004%26volume%3D176%26issue%3D1%26spage%3D1%26epage%3D29%26doi%3D10.1007%2Fs00213-004-2000-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cappelletti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daria, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aromatario, M.</span></span> <span> </span><span class="NLM_article-title">Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.2174/1570159X13666141210215655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2174%2F1570159X13666141210215655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26074744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=71-88&issue=1&author=S.+Cappellettiauthor=P.+Dariaauthor=G.+Saniauthor=M.+Aromatario&title=Caffeine%3A+Cognitive+and+Physical+Performance+Enhancer+or+Psychoactive+Drug%3F&doi=10.2174%2F1570159X13666141210215655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?</span></div><div class="casAuthors">Cappelletti, Simone; Daria, Piacentino; Sani, Gabriele; Aromatario, Mariarosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-88</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Caffeine use is increasing worldwide.  The underlying motivations are mainly concn. and memory enhancement and phys. performance improvement.  Coffee and caffeine-contg. products affect the cardiovascular system, with their pos. inotropic and chronotropic effects, and the central nervous system, with their locomotor activity stimulation and anxiogenic-like effects.  Thus, it is of interest to examine whether these effects could be detrimental for health.  Furthermore, caffeine abuse and dependence are becoming more and more common and can lead to caffeine intoxication, which puts individuals at risk for premature and unnatural death.  The present review summarizes the main findings concerning caffeine's mechanisms of action (focusing on adenosine antagonism, intracellular calcium mobilization, and phosphodiesterases inhibition), use, abuse, dependence, intoxication, and lethal effects.  It also suggests that the concepts of toxic and LDs are relative, since doses below the toxic and/or lethal range may play a causal role in intoxication or death.  This could be due to caffeine's interaction with other substances or to the individuals' preexisting metab. alterations or diseases.be due to caffeine's interaction with other substances or to individuals' pre-existing diseases or metab. alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo2IZfYdKij7Vg90H21EOLACvtfcHk0lhCKPyEFKVcdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqtL4%253D&md5=e3f6b6342332a669d5beed115a8f5fff</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.2174%2F1570159X13666141210215655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X13666141210215655%26sid%3Dliteratum%253Aachs%26aulast%3DCappelletti%26aufirst%3DS.%26aulast%3DDaria%26aufirst%3DP.%26aulast%3DSani%26aufirst%3DG.%26aulast%3DAromatario%26aufirst%3DM.%26atitle%3DCaffeine%253A%2520Cognitive%2520and%2520Physical%2520Performance%2520Enhancer%2520or%2520Psychoactive%2520Drug%253F%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2015%26volume%3D13%26issue%3D1%26spage%3D71%26epage%3D88%26doi%3D10.2174%2F1570159X13666141210215655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goasduff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dréano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ménez, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthou, F.</span></span> <span> </span><span class="NLM_article-title">Induction of Liver and Kidney CYP1A1/1A2 by Caffeine in Rat</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1919</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(96)00522-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0006-2952%2896%2900522-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8951351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK28XnsFGms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=1915-1919&issue=12&author=T.+Goasduffauthor=Y.+Dr%C3%A9anoauthor=B.+Guilloisauthor=J.+F.+M%C3%A9nezauthor=F.+Berthou&title=Induction+of+Liver+and+Kidney+CYP1A1%2F1A2+by+Caffeine+in+Rat&doi=10.1016%2FS0006-2952%2896%2900522-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of liver and kidney CYP1A1/1A2 by caffeine in rat</span></div><div class="casAuthors">Goasduff, Thierry; Dreano, Yvonne; Guillois, Bernard; Menez, Jean-Francois; Berthou, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1915-1919</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Caffeine metab. by hepatic microsomal P 450 enzymes is well documented in exptl. animals and humans.  However, it induction effect on P 450 enzymes has not been thoroughly studied.  In a preliminary expt., the time-dependent incubation of 1 mM caffeine with rat hepatocyte culture resulted in an increase of its own metabolic rate.  The dose-dependent expression of rat hepatic and renal cytochromes (CYP) 1A1/1A2 was then investigated after per os administration of caffeine.  P 450 expression was monitored by using specific enzymic activities and Northern Blot anal.  Caffeine caused a dose-dependent elevation of hepatic CYP1A1/1A2 activities in microsomal prepns., which ranged from 1.7- to 6-fold for ethoxyresorufin O-deethylase and 3- to 8.9-fold for methoxyresorufin O-demethylase according to the dose regimen of 50 and 150 mg caffeine/kg/day for 3 days, resp.  Northern blot anal. demonstrated that caffeine treatment increased liver CYP1A1 and CYP1A2 mRNA levels over the dose regimen of 50-150 mg caffeine/kg/day for 3 days, resp.  The result of this study demonstrates that caffeine increases its own metab. in a dose-dependent manner and induces CYP1A1/1A2 expression through either transcriptional activation or mRNA stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriw9Wmg6PRLbVg90H21EOLACvtfcHk0lgLdZVV5-eKUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFGms74%253D&md5=16502972548696659c4dff65978d16f2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2896%2900522-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252896%252900522-9%26sid%3Dliteratum%253Aachs%26aulast%3DGoasduff%26aufirst%3DT.%26aulast%3DDr%25C3%25A9ano%26aufirst%3DY.%26aulast%3DGuillois%26aufirst%3DB.%26aulast%3DM%25C3%25A9nez%26aufirst%3DJ.%2BF.%26aulast%3DBerthou%26aufirst%3DF.%26atitle%3DInduction%2520of%2520Liver%2520and%2520Kidney%2520CYP1A1%252F1A2%2520by%2520Caffeine%2520in%2520Rat%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D52%26issue%3D12%26spage%3D1915%26epage%3D1919%26doi%3D10.1016%2FS0006-2952%2896%2900522-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badawy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.2174/1389200221999210101233135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2174%2F1389200221999210101233135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33397254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3MXnvFKqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2021&pages=40-49&issue=1&author=J.+Guoauthor=X.+Zhuauthor=S.+Badawyauthor=A.+Ihsanauthor=Z.+Liuauthor=C.+Xieauthor=X.+Wang&title=Metabolism+and+Mechanism+of+Human+Cytochrome+P450+Enzyme+1A2&doi=10.2174%2F1389200221999210101233135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2</span></div><div class="casAuthors">Guo, Jingchao; Zhu, Xiaohui; Badawy, Sara; Ihsan, Awais; Liu, Zhenli; Xie, Changqing; Wang, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-49</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human cytochrome P 450 enzyme 1A2 (CYP1A2) is one of the most important cytochrome P 450 (CYP) enzymes in the liver, accounting for 13% to 15% of hepatic CYP enzymes.  CYP1A2 metabolises many clin. drugs, such as phenacetin, caffeine, clozapine, tacrine, propranolol, and mexiletine.  CYP1A2 also metabolises certain precarcinogens such as aflatoxins, mycotoxins, nitrosamines, and endogenous substances such as steroids.  The regulation of CYP1A2 is influenced by many factors.  The transcription of CYP1A2 involves not only the arom. hydrocarbon receptor pathway but also many addnl. transcription factors, and CYP1A2 expression may be affected by transcription coactivators and compression factors.  Degrdn. of CYP1A2 mRNA and protein, alternative splicing, RNA stability, regulatory microRNAs, and DNA methylation are also known to affect the regulation of CYP1A2.  Many factors can lead to changes in the activity of CYP1A2.  Smoking, polycyclic arom. hydrocarbon ingestion, and certain drugs (e.g., omeprazole) increase its activity, while many clin. drugs such as theophylline, fluvoxamine, quinolone antibiotics, verapamil, cimetidine, and oral contraceptives can inhibit CYP1A2 activity.  Here, we review the drugs metabolised by CYP1A2, the metabolic mechanism of CYP1A2, and various factors that influence CYP1A2 metab.  The metabolic mechanism of CYP1A2 is of great significance in the development of personalised medicine and CYP1A2 target-based drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUP-Kq8Tl7TrVg90H21EOLACvtfcHk0lgLdZVV5-eKUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXnvFKqu74%253D&md5=6f52d0e40e54b352afb3fe7a39561565</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F1389200221999210101233135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200221999210101233135%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBadawy%26aufirst%3DS.%26aulast%3DIhsan%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMetabolism%2520and%2520Mechanism%2520of%2520Human%2520Cytochrome%2520P450%2520Enzyme%25201A2%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2021%26volume%3D22%26issue%3D1%26spage%3D40%26epage%3D49%26doi%3D10.2174%2F1389200221999210101233135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitez, J.</span></span> <span> </span><span class="NLM_article-title">Clinically Significant Pharmacokinetic Interactions between Dietary Caffeine and Medications</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.2165/00003088-200039020-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2165%2F00003088-200039020-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10976659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVemtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=127-153&issue=2&author=J.+A.+Carrilloauthor=J.+Benitez&title=Clinically+Significant+Pharmacokinetic+Interactions+between+Dietary+Caffeine+and+Medications&doi=10.2165%2F00003088-200039020-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Clinically significant pharmacokinetic interactions between dietary caffeine and medications</span></div><div class="casAuthors">Carrillo, Juan A.; Benitez, Julio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-153</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 268 refs. Caffeine from dietary sources (mainly coffee, tea and soft drinks) is the most frequently and widely consumed central nervous system (CNS) stimulant in the world today.  Because of its enormous popularity, the consumption of caffeine is generally thought to be safe and long-term caffeine intake may be disregarded as a medical problem.  However, it is clear that this compd. has many of the features usually assocd. with a drug of abuse.  Furthermore, physicians should be aware of the possible contribution of dietary caffeine to the signs and symptoms of patients.  The toxic effects of caffeine are extensions of their pharmacol. effects.  The most serious caffeine-related CNS effects include seizures and delirium.  Other symptoms affecting the cardiovascular system range from moderate increases in heart rate to more severe cardiac arrhythmia.  Although tolerance develops to many of the pharmacol. effects of caffeine, tolerance may be overwhelmed by the nonlinear accumulation of caffeine when its metab. becomes satd.  This might occur with high levels of consumption or as the result of pharmacokinetic interaction between caffeine and over-the-counter or prescription drugs.  The polycyclic arom. hydrocarbon-inducible cytochrome P 450 (CYP) 1A2 participates in the metab. of caffeine as well as of a no. of clin. important drugs.  A no. of drugs, including certain selective serotonin reuptake inhibitors (particularly fluvoxamine), antiarrhythmics (mexiletine), antipsychotics (clozapine), psoralens, idrocilamide and phenylpropanolamine, bronchodilators (furafylline and theophylline) and quinolones (enoxacin), have been reported to be potent inhibitors of this isoenzyme.  This has important clin. implications, since drugs that are metabolized by, or bind to, the same CYP isoenzyme have a high potential for pharmacokinetic interactions due to inhibition of drug metab.  Thus, pharmacokinetic interactions at the CYP1A2 enzyme level may cause toxic effects during concomitant administration of caffeine and certain drugs used for cardiovascular, CNS (an excessive dietary intake of caffeine has also been obsd. in psychiatric patients), gastrointestinal, infectious, respiratory and skin disorders.  Unless a lack of interaction has already been demonstrated for the potentially interacting drug, dietary caffeine intake should be considered when planning, or assessing response to, drug therapy.  Some of the reported interactions of caffeine, irresp. of clin. relevance, might inadvertently cause athletes to exceed the urinary caffeine concn. limit set by sports authorities at 12 mg/L.  Finally, caffeine is a useful and reliable probe drug for the assessment of CYP1A2 activity, which is of considerable interest for metabolic studies in human populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9dl0kTNxhlrVg90H21EOLACvtfcHk0lgLdZVV5-eKUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVemtrg%253D&md5=7aef9272a802b5fc43381a466d6ffd25</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2165%2F00003088-200039020-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200039020-00004%26sid%3Dliteratum%253Aachs%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26aulast%3DBenitez%26aufirst%3DJ.%26atitle%3DClinically%2520Significant%2520Pharmacokinetic%2520Interactions%2520between%2520Dietary%2520Caffeine%2520and%2520Medications%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2000%26volume%3D39%26issue%3D2%26spage%3D127%26epage%3D153%26doi%3D10.2165%2F00003088-200039020-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yartsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peisah, C.</span></span> <span> </span><span class="NLM_article-title">Caffeine-Clozapine Interaction Associated with Severe Toxicity and Multiorgan System Failure: A Case Report</span>. <i>BMC Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">192</span>, <span class="refDoi"> DOI: 10.1186/s12888-021-03199-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs12888-021-03199-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33849480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3MXhtFeiu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2021&pages=192&issue=1&author=A.+Yartsevauthor=C.+Peisah&title=Caffeine-Clozapine+Interaction+Associated+with+Severe+Toxicity+and+Multiorgan+System+Failure%3A+A+Case+Report&doi=10.1186%2Fs12888-021-03199-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report</span></div><div class="casAuthors">Yartsev, Alex; Peisah, Carmelle</div><div class="citationInfo"><span class="NLM_cas:title">BMC Psychiatry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192</span>CODEN:
                <span class="NLM_cas:coden">BPMSCU</span>;
        ISSN:<span class="NLM_cas:issn">1471-244X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Background: Caffeine is a known inhibitor of Clozapine metab. mediated by inhibition of CYP1A2.  Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clin. manifestations of toxicity resulting from their interaction.  We present a case of severe toxicity assocd. with the co-consumption of caffeine and Clozapine culminating in life-threatening complications requiring management in Intensive Care.  Case presentation: A 34 yr old male with a history of chronic schizophrenia, who had been managed stably on 400 mg Clozapine for the previous 5 years, changed his dietary behavior and began consuming caffeine-contg. energy drinks over the course of 3 wk.  The total daily dose of caffeine was estd. as 600 mg/day (four cans of Red Bull).  He subsequently presented to the Emergency Department with life-threatening Clozapine toxicity, resulting in a decreased level of consciousness, severe metabolic acidosis, acute respiratory failure, raised inflammatory markers and acute renal failure attributed to interstitial nephritis.  Maximum recorded Clozapine level was 1796 ng/mL.  Conclusions: This case describes the interaction between a common caffeine-contg. beverage and a commonly prescribed antipsychotic medication, assocd. with severe adverse effects.  We call for clin. and scientific attention to the possible interaction between these substances and draw attention to the implications for prescribing practices and patient counselling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Kkofylq2ZLVg90H21EOLACvtfcHk0lgLdZVV5-eKUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhtFeiu7nN&md5=7e2a133ec89a37442ffae566f7b7be34</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2Fs12888-021-03199-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12888-021-03199-x%26sid%3Dliteratum%253Aachs%26aulast%3DYartsev%26aufirst%3DA.%26aulast%3DPeisah%26aufirst%3DC.%26atitle%3DCaffeine-Clozapine%2520Interaction%2520Associated%2520with%2520Severe%2520Toxicity%2520and%2520Multiorgan%2520System%2520Failure%253A%2520A%2520Case%2520Report%26jtitle%3DBMC%2520Psychiatry%26date%3D2021%26volume%3D21%26issue%3D1%26spage%3D192%26doi%3D10.1186%2Fs12888-021-03199-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vainer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, G.</span></span> <span> </span><span class="NLM_article-title">Interaction between Caffeine and Clozapine</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1097/00004714-199408000-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1097%2F00004714-199408000-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7962690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK2M%252FltFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=284-285&issue=4&author=J.+L.+Vainerauthor=G.+Chouinard&title=Interaction+between+Caffeine+and+Clozapine&doi=10.1097%2F00004714-199408000-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between caffeine and clozapine</span></div><div class="casAuthors">Vainer J L; Chouinard G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">284-5</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlp3PdZ1FYL4YPsCkJIw00fW6udTcc2eZduR0WhTWL37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FltFOjtA%253D%253D&md5=5b89faaebcfde2542e88ab8b62f18731</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1097%2F00004714-199408000-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199408000-00014%26sid%3Dliteratum%253Aachs%26aulast%3DVainer%26aufirst%3DJ.%2BL.%26aulast%3DChouinard%26aufirst%3DG.%26atitle%3DInteraction%2520between%2520Caffeine%2520and%2520Clozapine%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1994%26volume%3D14%26issue%3D4%26spage%3D284%26epage%3D285%26doi%3D10.1097%2F00004714-199408000-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benítez, J.</span></span> <span> </span><span class="NLM_article-title">Effects of Caffeine Withdrawal from the Diet on the Metabolism of Clozapine in Schizophrenic Patients</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1097/00004714-199808000-00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1097%2F00004714-199808000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=9690697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1cXltFSms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=311-316&issue=4&author=J.+A.+Carrilloauthor=A.+G.+Herraizauthor=S.+I.+Ramosauthor=J.+Ben%C3%ADtez&title=Effects+of+Caffeine+Withdrawal+from+the+Diet+on+the+Metabolism+of+Clozapine+in+Schizophrenic+Patients&doi=10.1097%2F00004714-199808000-00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients</span></div><div class="casAuthors">Carrillo, Juan A.; Herraiz, Angustias G.; Ramos, Sara I.; Benitez, Julio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-314</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Both clozapine (CLZ) and caffeine are CYP1A2 substrates.  This study raises the hypothesis of whether caffeine withdrawal from the diet alters the metab. and/or clin. status of patients receiving CLZ.  Seven schizophrenic patients (six men and one woman) receiving monotherapy with CLZ at 271±102 mg/day (3.73±1.4 mg/kg) participated in the study.  CLZ, norclozapine (NOR), and clozapine-N-oxide (NOX) were assayed in plasma by high-performance liq. chromatog. at three different time points: A, with concomitant intake of caffeine from the diet; B, after caffeine withdrawal for 5 days; and C, after 2 wk of rechallenge to habitual caffeine intake.  The CYP1A2 activity was detd. by means of a urinary caffeine test.  After a caffeine-free diet for 5 days, CLZ concns. relative to time point A decreased from 486 to 306 ng/mL (-47%) (p < 0.02), NOX levels decreased from 66 to 49 ng/mL (-31%) (p < 0.03), and the NOR/CLZ ratio significantly increased from 0.47 to 1.04 (185%) (p < 0.02).  All parameters returned to initial figures at time point C.  The NOR/CLZ ratio was significantly correlated to the CYP1A2 index (rs = 0.96, p < 0.0005).  In conclusion, changes in the habitual caffeine intake alter the metab. of CLZ in schizophrenic patients.  Thus, patient intake of caffeine should be medically supervised, and the monitoring of CLZ and metabolite levels may be warranted.  Furthermore, in those patients who receive therapy with CLZ, the NOR/CLZ ratio may provide an addnl. and valuable est. of CYP1A2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooVUmmDypjk7Vg90H21EOLACvtfcHk0lg32548RNn_PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFSms7k%253D&md5=b023962024ae113ee8283f70550e848f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1097%2F00004714-199808000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199808000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26aulast%3DHerraiz%26aufirst%3DA.%2BG.%26aulast%3DRamos%26aufirst%3DS.%2BI.%26aulast%3DBen%25C3%25ADtez%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520Caffeine%2520Withdrawal%2520from%2520the%2520Diet%2520on%2520the%2520Metabolism%2520of%2520Clozapine%2520in%2520Schizophrenic%2520Patients%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1998%26volume%3D18%26issue%3D4%26spage%3D311%26epage%3D316%26doi%3D10.1097%2F00004714-199808000-00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umetsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span> <span> </span><span class="NLM_article-title">Influence of Usual Intake of Dietary Caffeine on Single-Dose Kinetics of Theophylline in Healthy Human Subjects</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1007/BF00271376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00271376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8491248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXks1ant74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=295-298&issue=3&author=J.+Satoauthor=H.+Nakataauthor=E.+Owadaauthor=T.+Kikutaauthor=M.+Umetsuauthor=K.+Ito&title=Influence+of+Usual+Intake+of+Dietary+Caffeine+on+Single-Dose+Kinetics+of+Theophylline+in+Healthy+Human+Subjects&doi=10.1007%2FBF00271376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects</span></div><div class="casAuthors">Sato, J.; Nakata, H.; Owada, E.; Kikuta, T.; Umetsu, M.; Ito, K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-80</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">The influence of usual multiple ingestions of dietary caffeine on oral single-dose pharmacokinetics of theophylline has been investigated in 6 healthy male subjects.  The subjects consumed 2 to 7 cups of regular instant coffee during the 24 h study period.  Their mean serum concns. of caffeine varied from 1.2 to 3.1 mg/L.  After their usual intake of dietary caffeine, the serum concns. of theophylline from 3 to 24 h after administration were significantly higher than after deprivation of dietary caffeine.  The apparent elimination of theophylline half-life was prolonged from 6.3 (0.61) h (mean with (SEM)) to 8.3 (0.47) h (32% increase, P < 0.01) and the total body clearance was reduced from 55.0 (1.31) mL·h-1·kg-1 to 42.5 (2.63) mL·h-1·kg-1 (23% decrease, P < 0.001).  Satn. of theophylline metab. and/or competition between theophylline and caffeine metab. in addn. to theophylline derived from caffeine may be the cause of the delayed elimination of theophylline.  The present study has indicated that a significant redn. in theophylline metab. may be caused by a conventional intake of dietary caffeine.  In bronchodilator therapy with theophylline, therefore, the daily consumption of caffeine should be taken into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeMtRI7J42ZLVg90H21EOLACvtfcHk0lg32548RNn_PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1ant74%253D&md5=c6aa742ce54a2eacfc8be04d1e039840</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2FBF00271376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00271376%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DJ.%26aulast%3DNakata%26aufirst%3DH.%26aulast%3DOwada%26aufirst%3DE.%26aulast%3DKikuta%26aufirst%3DT.%26aulast%3DUmetsu%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DK.%26atitle%3DInfluence%2520of%2520Usual%2520Intake%2520of%2520Dietary%2520Caffeine%2520on%2520Single-Dose%2520Kinetics%2520of%2520Theophylline%2520in%2520Healthy%2520Human%2520Subjects%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1993%26volume%3D44%26issue%3D3%26spage%3D295%26epage%3D298%26doi%3D10.1007%2FBF00271376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlinchey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">The {ChEMBL} Bioactivity Database: An Update</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">D1</span>),  <span class="NLM_fpage">D1083</span>– <span class="NLM_lpage">D1090</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt1031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fnar%2Fgkt1031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24214965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslWl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=D1083-D1090&issue=D1&author=A.+P.+Bentoauthor=A.+Gaultonauthor=A.+Herseyauthor=L.+J.+Bellisauthor=J.+Chambersauthor=M.+Daviesauthor=F.+A.+Kr%C3%BCgerauthor=Y.+Lightauthor=L.+Makauthor=S.+McGlincheyauthor=M.+Nowotkaauthor=G.+Papadatosauthor=R.+Santosauthor=J.+P.+Overington&title=The+%7BChEMBL%7D+Bioactivity+Database%3A+An+Update&doi=10.1093%2Fnar%2Fgkt1031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL bioactivity database: an update</span></div><div class="casAuthors">Bento, A. Patricia; Gaulton, Anna; Hersey, Anne; Bellis, Louisa J.; Chambers, Jon; Davies, Mark; Krueger, Felix A.; Light, Yvonne; Mak, Lora; McGlinchey, Shaun; Nowotka, Michal; Papadatos, George; Santos, Rita; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1083-D1090</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 Nucleic Acids Research Database Issue.  Since then, a variety of new data sources and improvements in functionality have contributed to the growth and utility of the resource.  In particular, more comprehensive tracking of compds. from research stages through clin. development to market is provided through the inclusion of data from United States Adopted Name applications; a new richer data model for representing drug targets has been developed; and a no. of methods have been put in place to allow users to more easily identify reliable data.  Finally, access to ChEMBL is now available via a new Resource Description Framework format, in addn. to the web-based interface, data downloads and web services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXb5k1IvJNaLVg90H21EOLACvtfcHk0liq6VCejcX8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslWl&md5=31b832d03d56ea3065d7aa29618362bc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt1031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt1031%26sid%3Dliteratum%253Aachs%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DKr%25C3%25BCger%26aufirst%3DF.%2BA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMak%26aufirst%3DL.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520%257BChEMBL%257D%2520Bioactivity%2520Database%253A%2520An%2520Update%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26issue%3DD1%26spage%3DD1083%26epage%3DD1090%26doi%3D10.1093%2Fnar%2Fgkt1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Gubareff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleator, W.</span></span> <span> </span><span class="NLM_article-title">Effects of Caffeine on Mammalian Atrial Muscle, and Its Interaction with Adexosine and Calcium</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=14301011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1965&pages=202-214&issue=2&author=T.+De%0AGubareffauthor=W.+Sleator&title=Effects+of+Caffeine+on+Mammalian+Atrial+Muscle%2C+and+Its+Interaction+with+Adexosine+and+Calcium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of caffeine on mammalian atrial muscle and its interaction with adenosine and calcium</span></div><div class="casAuthors">De Gubareff, Taisija; Sleator, William, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Caffeine (I), at 0.25-1.5 mM, exerted a pos. inotropic effect on isolated guinea pig atrium, while at higher concns. the contraction decreased.  The increased duration of transmembranal action potentials induced by I was proportional to drug concn., and at 2.5 mM was twice normal.  I probably releases catechol amines from the normal heart, but not following pretreatment with reserpine; however, the inotropic activity of I is not via this process.  The marked effect of I on the duration of the action potential as well as on contraction was dependent upon Ca in the medium, such that when both are present the strength of contraction and duration of action potential increase at a low frequency of elec. stimulation.  I antagonized the depressant effect of adenosine on contraction and action potential of the guinea pig and human atria, probably by altering the functions of Ca within the muscle cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphQKAWx4q3t7Vg90H21EOLACvtfcHk0liq6VCejcX8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D&md5=0ae31bc64f3f2a047e6be43a8d0a184a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGubareff%26aufirst%3DT.%26aulast%3DSleator%26aufirst%3DW.%26atitle%3DEffects%2520of%2520Caffeine%2520on%2520Mammalian%2520Atrial%2520Muscle%252C%2520and%2520Its%2520Interaction%2520with%2520Adexosine%2520and%2520Calcium%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1965%26volume%3D148%26issue%3D2%26spage%3D202%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Galen, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors: Pharmacology, Structure-Activity Relationships, and Therapeutic Potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1021/jm00081a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00081a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XpvVOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=407-422&issue=3&author=K.+A.+Jacobsonauthor=P.+J.+M.+van+Galenauthor=M.+Williams&title=Adenosine+Receptors%3A+Pharmacology%2C+Structure-Activity+Relationships%2C+and+Therapeutic+Potential&doi=10.1021%2Fjm00081a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors:  pharmacology, structure-activity relationships, and therapeutic potential</span></div><div class="casAuthors">Jacobson, Kenneth A.; Van Galen, Philip J. M.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-22</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review with 166 refs.  In the present perspective, advances in knowledge related to adenosine function at the mol. level is reviewed together with information on the structure-activity relationships for a no. of pharmacophore series interacting with adenosine receptors.  Therapeutic areas where improved adenosine ligands may represent potentially important therapeutic agents are also indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXuxlPOO4sJ7Vg90H21EOLACvtfcHk0liq6VCejcX8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvVOjsg%253D%253D&md5=b8120746a1b51bd727273454342d7d5a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm00081a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00081a001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3Dvan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DAdenosine%2520Receptors%253A%2520Pharmacology%252C%2520Structure-Activity%2520Relationships%252C%2520and%2520Therapeutic%2520Potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26issue%3D3%26spage%3D407%26epage%3D422%26doi%3D10.1021%2Fjm00081a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Caffeine Analogs: Biomedical Impact</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2153</span>– <span class="NLM_lpage">2169</span>, <span class="refDoi"> DOI: 10.1007/s00018-007-7051-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00018-007-7051-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17514358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVaisb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=2153-2169&issue=16&author=J.+W.+Daly&title=Caffeine+Analogs%3A+Biomedical+Impact&doi=10.1007%2Fs00018-007-7051-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine analogs: biomedical impact</span></div><div class="casAuthors">Daly, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2153-2169</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Caffeine, widely consumed in beverages, and many xanthine analogs have had a major impact on biomedical research.  Caffeine and various analogs, the latter designed to enhance potency and selectivity toward specific biol. targets, have played key roles in defining the nature and role of adenosine receptors, phosphodiesterases, and calcium release channels in physiol. processes.  Such xanthines and other caffeine-inspired heterocycles now provide important research tools and potential therapeutic agents for intervention in Alzheimer's disease, asthma, cancer, diabetes, and Parkinson's disease.  Such compds. also have activity as analgesics, antiinflammatories, antitussives, behavioral stimulants, diuretics/natriuretics, and lipolytics.  Adverse effects can include anxiety, hypertension, certain drug interactions, and withdrawal symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8c4-7mtTda7Vg90H21EOLACvtfcHk0liq6VCejcX8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVaisb%252FP&md5=9eb88ab530fe86279b4d352d1fed7447</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7051-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7051-9%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCaffeine%2520Analogs%253A%2520Biomedical%2520Impact%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26issue%3D16%26spage%3D2153%26epage%3D2169%26doi%3D10.1007%2Fs00018-007-7051-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Theophylline Analogues: Correlation of Behavioral Effects with Activity as Adenosine Receptor Antagonists and as Phosphodiesterase Inhibitors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(88)90517-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2888%2990517-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2456442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1cXkvVKitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1988&pages=387-398&issue=5&author=O.+H.+Choiauthor=M.+T.+Shamimauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Caffeine+and+Theophylline+Analogues%3A+Correlation+of+Behavioral+Effects+with+Activity+as+Adenosine+Receptor+Antagonists+and+as+Phosphodiesterase+Inhibitors&doi=10.1016%2F0024-3205%2888%2990517-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and theophylline analogs:  correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors</span></div><div class="casAuthors">Choi, Oksoon H.; Shamim, Mah T.; Padgett, William L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-98</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">The effects of caffeine analogs on open field behavior of mice and potencies as antagonists of adenosine receptors and as inhibitors of 3 classes of brain phosphodiesterase(PDE) have been compared.  1,7-Dimethyl-3-propargylxanthine, 1,3,7-tripropargylxanthine, and 3,7-dimethyl-1-propargylxanthine, which have high affinity for adenosine receptors and weaker activity as PDE inhibitors, all increase behavioral activity.  In contrast, 1,3,7-tripropylxanthine, a more potent inhibitor of the brain Ca-independent PDEs than 1,3,7-tripropargylxanthine, produces behavioral depression, even though both analogs are potent adenosine receptor antagonists.  7-Benzyl-3-isobutyl-1-methylxanthine, an active receptor antagonist and selective inhibitor of a brain Ca-dependent PDE, produces a slight behavioral activation.  Xanthines that are potent adenosine receptor antagonists and relatively weak inhibitors of the Ca-independent PDEs reverse the depressant effects of N6-cyclohexyladenosine, whereas xanthines, such as 1,3,7-tripropylxanthine, that are potent inhibitors of the Ca-independent PDEs, do not.  Apparently, the behavioral effects of xanthines may be detd. primarily by relative activity as adenosine receptor antagonists and as inhibitors of brain Ca-independent PDEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfmOYilDLJuLVg90H21EOLACvtfcHk0ljNKDeRom9abw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvVKitLs%253D&md5=d07acfd7fcc81fa7007a518e0208df58</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2888%2990517-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252888%252990517-6%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DO.%2BH.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCaffeine%2520and%2520Theophylline%2520Analogues%253A%2520Correlation%2520of%2520Behavioral%2520Effects%2520with%2520Activity%2520as%2520Adenosine%2520Receptor%2520Antagonists%2520and%2520as%2520Phosphodiesterase%2520Inhibitors%26jtitle%3DLife%2520Sci.%26date%3D1988%26volume%3D43%26issue%3D5%26spage%3D387%26epage%3D398%26doi%3D10.1016%2F0024-3205%2888%2990517-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, W.</span></span> <span> </span><span class="NLM_article-title">Adenosine 3′,5′-Phosphate in Biological Materials. I. Purification and Properties of Cyclic 3′,5′-Nucleotide Phosphodiesterase and Use of This Enzyme to Characterize Adenosine 3′,5′-Phosphate in Human Urine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)60316-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0021-9258%2818%2960316-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=13875173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaF3sXhsFKmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1962&pages=1244-1250&author=R.+Butcherauthor=W.+Sutherland&title=Adenosine+3%E2%80%B2%2C5%E2%80%B2-Phosphate+in+Biological+Materials.+I.+Purification+and+Properties+of+Cyclic+3%E2%80%B2%2C5%E2%80%B2-Nucleotide+Phosphodiesterase+and+Use+of+This+Enzyme+to+Characterize+Adenosine+3%E2%80%B2%2C5%E2%80%B2-Phosphate+in+Human+Urine&doi=10.1016%2FS0021-9258%2818%2960316-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic-3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine</span></div><div class="casAuthors">Butcher, R. W.; Sutherland, Earl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1244-50</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Steps leading to at least 80-fold purification of the sol. cyclic-3',5'-nucleotide phosphodiesterase from beef heart were described.  The enzyme required Mg, was stimulated by imidazole in an unknown fashion, and was inhibited competitively by the methyl xanthines, theophylline being approx. 6 times more potent than caffeine or theobromine.  The enzyme was specific for the 3',5'-cyclic bond.  The enzyme was found in all tissues contg. adenyl cyclase except avian red cells.  Approx. 60% of the total homogenate activity was found in the particulate fraction upon low-speed centrifugation.  This activity appeared identical with the sol. form by enzymic criteria, but was not elutable under the conditions used.  The cyclic 3',5'-nucleotide phosphodiesterase was a major (and to date the only) mechanism for the destruction of adenosine 3',5'-phosphate (I.).  The purified soluble enzyme was used in the detection of I from biol. sources, in which the low concns. of this compd. and the presence of known and unidentified interfering materials made identification by the standard I activity assay described above very difficult.  I was isolated from human urine and identified.  Daily levels of 2-7 micromoles were found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrCViBifWmvrVg90H21EOLACvtfcHk0ljNKDeRom9abw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXhsFKmsg%253D%253D&md5=6641bf56c4868abd5761f2143a41473f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2960316-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252960316-3%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DR.%26aulast%3DSutherland%26aufirst%3DW.%26atitle%3DAdenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Phosphate%2520in%2520Biological%2520Materials.%2520I.%2520Purification%2520and%2520Properties%2520of%2520Cyclic%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Nucleotide%2520Phosphodiesterase%2520and%2520Use%2520of%2520This%2520Enzyme%2520to%2520Characterize%2520Adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Phosphate%2520in%2520Human%2520Urine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1962%26volume%3D237%26spage%3D1244%26epage%3D1250%26doi%3D10.1016%2FS0021-9258%2818%2960316-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifsnyder, D. H.</span></span> <span> </span><span class="NLM_article-title">Primary Sequence of Cyclic Nucleotide Phosphodiesterase Isozymes and the Design of Selective Inhibitors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(90)90066-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0165-6147%2890%2990066-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2159198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3cXksFCksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=150-155&issue=4&author=J.+A.+Beavoauthor=D.+H.+Reifsnyder&title=Primary+Sequence+of+Cyclic+Nucleotide+Phosphodiesterase+Isozymes+and+the+Design+of+Selective+Inhibitors&doi=10.1016%2F0165-6147%2890%2990066-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors</span></div><div class="casAuthors">Beavo, Joseph A.; Reifsnyder, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">150-5</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 35 refs. on the unique sequences of phosphodiesterase isoenzyme catalytic and regulatory domains as well as the selective expression of isoenzymes in different cell types.  This information is discussed with regard to drug design and why many attempts to isolate isoenzyme-selective inhibitors may have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8XnjbS0pjALVg90H21EOLACvtfcHk0ljjapjwP_pqyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFCksL0%253D&md5=5641d6c3c21eb7c85893f8cd62dd6fd4</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2890%2990066-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252890%252990066-H%26sid%3Dliteratum%253Aachs%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DReifsnyder%26aufirst%3DD.%2BH.%26atitle%3DPrimary%2520Sequence%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%2520Isozymes%2520and%2520the%2520Design%2520of%2520Selective%2520Inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1990%26volume%3D11%26issue%3D4%26spage%3D150%26epage%3D155%26doi%3D10.1016%2F0165-6147%2890%2990066-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Caffeine Analogs: Effects on Ryanodine-Sensitive Calcium-Release Channels and GABAA Receptors</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1023/A:1023688604792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1023%2FA%3A1023688604792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12825831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=331-347&issue=3&author=D.+Shiauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Caffeine+Analogs%3A+Effects+on+Ryanodine-Sensitive+Calcium-Release+Channels+and+GABAA+Receptors&doi=10.1023%2FA%3A1023688604792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine analogs: Effects on ryanodine-sensitive calcium-release channels and GABAA receptors</span></div><div class="casAuthors">Shi, Dan; Padgett, William L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-347</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Caffeine at 0.3-10 mM enhanced the binding of [3H]ryanodine to calcium-release channels of rabbit muscle sarcoplasmic reticulum.  A variety of other xanthines were as efficacious as caffeine or nearly so, but none appeared markedly more potent.  Caffeine at 1 mM markedly inhibited binding of [3H]diazepam to GABAA receptors in rat cerebral cortical membranes.  Other xanthines also inhibited binding with certain dimethylpropargylxanthines being nearly fivefold more potent than caffeine.  Caffeine at 1 mM stimulated binding of [35S]TBPS to GABAA receptors as did certain other xanthines.  The dimethylpropargylxanthines had little effect.  1,3-Dipropy1-8-cyclopentylxan- thine at 100 μM had no effect on [3H]diazepam binding, but markedly inhibited [35S]TBPS binding.  Structure-activity relationships for xanthines do differ for calcium-release channels and for different sites on GABAA receptors, but no highly selective lead compds. were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUykeJpdK-ZrVg90H21EOLACvtfcHk0ljjapjwP_pqyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFWisbc%253D&md5=bf43cd8c8298c8d947642f271e779eea</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023688604792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023688604792%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DD.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCaffeine%2520Analogs%253A%2520Effects%2520on%2520Ryanodine-Sensitive%2520Calcium-Release%2520Channels%2520and%2520GABAA%2520Receptors%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2003%26volume%3D23%26issue%3D3%26spage%3D331%26epage%3D347%26doi%3D10.1023%2FA%3A1023688604792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marangos, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parma, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syapin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">Purinergic Inhibition of Diazepam Binding to Rat Brain (in Vitro)</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(79)90369-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2879%2990369-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=449624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE1MXhsl2qsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1979&pages=851-857&issue=9&author=P.+J.+Marangosauthor=S.+M.+Paulauthor=A.+M.+Parmaauthor=F.+K.+Goodwinauthor=P.+Syapinauthor=P.+Skolnick&title=Purinergic+Inhibition+of+Diazepam+Binding+to+Rat+Brain+%28in+Vitro%29&doi=10.1016%2F0024-3205%2879%2990369-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic inhibition of diazepam binding to rat brain (in vitro)</span></div><div class="casAuthors">Marangos, P. J.; Paul, S. M.; Parma, A. M.; Goodwin, F. K.; Syapin, P.; Skolnick, P.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">851-7</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">A wide spectrum of purines were able to inhibit specific 3H-labeled diazepam (I)  [439-14-5] binding by rat brain synaptosomes, whereas pyrimidines were inactive.  Preliminary structure activity relations indicated that the 2'-deoxypurines were more potent in I binding inhibition as were the 1-Me compds., whereas the 7-Me purines were inactive.  The xanthine stimulants caffeine  [58-08-2], theophylline  [58-55-9], and theobromine  [83-67-0] as well as the central nervous system convulsant pentylenetetrazol  [54-95-5] all competitively inhibited I-3H binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUqORNPO0XBbVg90H21EOLACvtfcHk0ljjapjwP_pqyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhsl2qsL8%253D&md5=83a0fe01eefa3d326d5ed9cda8871b29</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2879%2990369-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252879%252990369-2%26sid%3Dliteratum%253Aachs%26aulast%3DMarangos%26aufirst%3DP.%2BJ.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DParma%26aufirst%3DA.%2BM.%26aulast%3DGoodwin%26aufirst%3DF.%2BK.%26aulast%3DSyapin%26aufirst%3DP.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DPurinergic%2520Inhibition%2520of%2520Diazepam%2520Binding%2520to%2520Rat%2520Brain%2520%2528in%2520Vitro%2529%26jtitle%3DLife%2520Sci.%26date%3D1979%26volume%3D24%26issue%3D9%26spage%3D851%26epage%3D857%26doi%3D10.1016%2F0024-3205%2879%2990369-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nehlig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daval, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debry, G.</span></span> <span> </span><span class="NLM_article-title">Caffeine and the Central Nervous System: Mechanisms of Action, Biochemical, Metabolic and Psychostimulant Effects</span>. <i>Brain Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/0165-0173(92)90012-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0165-0173%2892%2990012-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1356551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1GlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1992&pages=139-170&issue=2&author=A.+Nehligauthor=J.+L.+Davalauthor=G.+Debry&title=Caffeine+and+the+Central+Nervous+System%3A+Mechanisms+of+Action%2C+Biochemical%2C+Metabolic+and+Psychostimulant+Effects&doi=10.1016%2F0165-0173%2892%2990012-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and the central nervous system:  mechanisms of action, biochemical, metabolic and psychostimulant effects</span></div><div class="casAuthors">Nehlig, Astrid; Daval, Jean Luc; Debry, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-70</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    </div><div class="casAbstract">A review with 656 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTsanrJialBbVg90H21EOLACvtfcHk0ljjapjwP_pqyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1GlsL0%253D&md5=327793efd92bd01cb0accf3572739d6c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2F0165-0173%2892%2990012-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0173%252892%252990012-B%26sid%3Dliteratum%253Aachs%26aulast%3DNehlig%26aufirst%3DA.%26aulast%3DDaval%26aufirst%3DJ.%2BL.%26aulast%3DDebry%26aufirst%3DG.%26atitle%3DCaffeine%2520and%2520the%2520Central%2520Nervous%2520System%253A%2520Mechanisms%2520of%2520Action%252C%2520Biochemical%252C%2520Metabolic%2520and%2520Psychostimulant%2520Effects%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D1992%26volume%3D17%26issue%3D2%26spage%3D139%26epage%3D170%26doi%3D10.1016%2F0165-0173%2892%2990012-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabiani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corradi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antollini, S. S.</span></span> <span> </span><span class="NLM_article-title">A Novel Pharmacological Activity of Caffeine in the Cholinergic System</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.03.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2018.03.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29614315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntlSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2018&pages=464-473&author=C.+Fabianiauthor=A.+P.+Murrayauthor=J.+Corradiauthor=S.+S.+Antollini&title=A+Novel+Pharmacological+Activity+of+Caffeine+in+the+Cholinergic+System&doi=10.1016%2Fj.neuropharm.2018.03.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pharmacological activity of caffeine in the cholinergic system</span></div><div class="casAuthors">Fabiani, Camila; Murray, Ana Paula; Corradi, Jeremias; Antollini, Silvia Susana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">464-473</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cholinergic deficit is regarded as an important factor responsible for Alzheimer's disease (AD) symptoms.  Acetylcholinesterase (AChE) and nicotinic receptor (AChR) are two mol. targets for the treatment of this disease.  We found here that methanolic exts. of Camellia sinensis exhibited anticholinesterase activity and induced AChR conformational changes.  From bioguided fractionation we confirmed that caffeine was the active compd. exerting such effects.  It is well-known that caffeine acts as an inhibitor of AChE and here we explored the effect of caffeine on the AChR by combining single channel recordings and fluorescent measurements.  From single channel recordings we obsd. that caffeine activated both muscle and α7 AChRs at low concns., and behaved as an open channel blocker which was evident at high concns.  Fluorescent measurements were performed with the conformational sensitive probe crystal violet (CrV) and AChR rich membranes from Torpedo californica.  Caffeine induced changes in the KD value of CrV in a concn.-dependent manner taking the AChR closer to a desensitized state.  In the presence of α-bungarotoxin, an AChR competitive antagonist, high concns. of caffeine increased the KD value of CrV, compatible with a competition with CrV mols. for the luminal channel.  Our electrophysiol. and fluorescent expts. show that caffeine has a dual effect on nicotinic receptors, behaving as an agonist and an ion channel blocker, probably through distinct AChR sites with quite different affinities.  Thus, caffeine or its derivs. can be considered for the design of promising multitarget-directed drugs for AD treatment by modulation of different targets in the cholinergic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUTOmUBsp6PrVg90H21EOLACvtfcHk0lhyMmgtCO1O3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntlSnsr4%253D&md5=aeb5d4e6254dd36441e953d56830d962</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.03.041%26sid%3Dliteratum%253Aachs%26aulast%3DFabiani%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DA.%2BP.%26aulast%3DCorradi%26aufirst%3DJ.%26aulast%3DAntollini%26aufirst%3DS.%2BS.%26atitle%3DA%2520Novel%2520Pharmacological%2520Activity%2520of%2520Caffeine%2520in%2520the%2520Cholinergic%2520System%26jtitle%3DNeuropharmacology%26date%3D2018%26volume%3D135%26spage%3D464%26epage%3D473%26doi%3D10.1016%2Fj.neuropharm.2018.03.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okello, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leylabi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDougall, G. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Acetylcholinesterase by Green and White Tea and Their Simulated Intestinal Metabolites</span>. <i>Food Funct.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1039/c2fo10174b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1039%2Fc2fo10174b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22418730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=651-661&issue=6&author=E.+J.+Okelloauthor=R.+Leylabiauthor=G.+J.+McDougall&title=Inhibition+of+Acetylcholinesterase+by+Green+and+White+Tea+and+Their+Simulated+Intestinal+Metabolites&doi=10.1039%2Fc2fo10174b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites</span></div><div class="casAuthors">Okello, Edward J.; Leylabi, Ramin; McDougall, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Food & Function</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">651-661</span>CODEN:
                <span class="NLM_cas:coden">FFOUAI</span>;
        ISSN:<span class="NLM_cas:issn">2042-6496</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">By 2034 it is forecast that 5% of the global population will be aged 85 years or over-approx. two and half fold increase on present day figures-which will inevitably lead to an increase in age-assocd. disorders such as Alzheimer's disease.  There is mounting evidence that green tea (Camellia sinensis) possesses numerous health-promoting properties, and may potentially be beneficial to those suffering from Alzheimer's and other diseases, including cardiovascular disease and cancer.  These beneficial properties are largely attributed to the high polyphenol content, particularly the catechins.  In this study, we measured acetylcholinesterase inhibition by white and green teas and their simulated intestinal digests.  We found that the potency with which the white and green tea exts. inhibited acetylcholinesterase varied through the simulated digestion procedure.  Initially, in the undigested ext. form, potency was high with IC50 values of 7.20 μg mL-1 and 8.06 μg mL-1 for green and white tea resp.  However, this decreased significantly after gastric digestion but activity was recovered after pancreatic digestion which could be related to relative increases in the levels of caffeine and specific phenolic components.  Of the pure tea compds. tested, EGCG was the most potent with an IC50 of 0.0096 μmol mL-1 but its breakdown product; γ-valerolactone was the least potent analyte.  Particularly interesting were the results of caffeine, which exhibited a strong inhibitory activity and pyrogallol, which recorded a much stronger potency than its parent compd. gallic acid, suggesting a pro-drug-like relationship.  Overall, the results indicate that further research is necessary to det. the full potential of digestion of tea and its metabolites and how inter-individual variation may indicate that some sections of society could potentially benefit more from drinking tea as a strategy to prevent the development of dementia.  We have also shown the activities of a no. of metabolites, however, further research is required to det. their potential bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUaWJGGhBfDbVg90H21EOLACvtfcHk0lhyMmgtCO1O3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOlt7Y%253D&md5=61e6c2a7024187d8236fa654cac5bd61</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1039%2Fc2fo10174b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2fo10174b%26sid%3Dliteratum%253Aachs%26aulast%3DOkello%26aufirst%3DE.%2BJ.%26aulast%3DLeylabi%26aufirst%3DR.%26aulast%3DMcDougall%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520Acetylcholinesterase%2520by%2520Green%2520and%2520White%2520Tea%2520and%2520Their%2520Simulated%2520Intestinal%2520Metabolites%26jtitle%3DFood%2520Funct.%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D651%26epage%3D661%26doi%3D10.1039%2Fc2fo10174b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohanka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobes, P.</span></span> <span> </span><span class="NLM_article-title">Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">9873</span>– <span class="NLM_lpage">9882</span>, <span class="refDoi"> DOI: 10.3390/ijms14059873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3390%2Fijms14059873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23698772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSktb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=9873-9882&issue=5&author=M.+Pohankaauthor=P.+Dobes&title=Caffeine+Inhibits+Acetylcholinesterase%2C+But+Not+Butyrylcholinesterase&doi=10.3390%2Fijms14059873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase</span></div><div class="casAuthors">Pohanka, Miroslav; Dobes, Petr</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">9873-9882, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Caffeine is an alkaloid with a stimulant effect in the body.  It can interfere in transmissions based on acetylcholine, epinephrine, norepinephrine, serotonin, dopamine and glutamate.  Clin. studies indicate that it can be involved in the slowing of Alzheimer disease pathol. and some other effects.  The effects are not well understood.  In the present work, we focused on the question whether caffeine can inhibit acetylcholinesterase (AChE) and/or butyrylcholinesterase (BChE), the two enzymes participating in cholinergic neurotransmission.  A std. Ellman test with human AChE and BChE was done for altering concns. of caffeine.  The test was supported by an in silico examn. as well.  Donepezil and tacrine were used as stds.  In compliance with Dixon's plot, caffeine was proved to be a non-competitive inhibitor of AChE and BChE.  However, inhibition of BChE was quite weak, as the inhibition const., Ki, was 13.9 ± 7.4 mol/L.  Inhibition of AChE was more relevant, as Ki was found to be 175 ± 9 μmol/L.  The predicted free energy of binding was -6.7 kcal/mol.  The proposed binding orientation of caffeine can interact with Trp86 and it can be stabilize by Tyr337 in comparison to the smaller Ala328 in the case of human BChE; thus, it can explain the lower binding affinity of caffeine for BChE with ref. to AChE.  The biol. relevance of the findings is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiLIqEGl-YA7Vg90H21EOLACvtfcHk0lhyMmgtCO1O3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSktb7F&md5=3cf094a17811a64e5bd15c9000bf3487</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3390%2Fijms14059873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms14059873%26sid%3Dliteratum%253Aachs%26aulast%3DPohanka%26aufirst%3DM.%26aulast%3DDobes%26aufirst%3DP.%26atitle%3DCaffeine%2520Inhibits%2520Acetylcholinesterase%252C%2520But%2520Not%2520Butyrylcholinesterase%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26issue%3D5%26spage%3D9873%26epage%3D9882%26doi%3D10.3390%2Fijms14059873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karadsheh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kussie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linthicum, D. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Acetylcholinesterase by Caffeine, Anabasine, Methyl Pyrrolidine and Their Derivatives</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/0378-4274(91)90015-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0378-4274%2891%2990015-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2003276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1991&pages=335-342&issue=3&author=N.+Karadshehauthor=P.+Kussieauthor=D.+S.+Linthicum&title=Inhibition+of+Acetylcholinesterase+by+Caffeine%2C+Anabasine%2C+Methyl+Pyrrolidine+and+Their+Derivatives&doi=10.1016%2F0378-4274%2891%2990015-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase by caffeine, anabasine, methylpyrrolidine and their derivatives</span></div><div class="casAuthors">Karadsheh, Naif; Kussie, Paul; Linthicum, D. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-42</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    </div><div class="casAbstract">The inhibition of acetylcholinesterase (AChE) by caffeine, anabasine, methylpyrrolidine, and several related compds. was examd.  Most of the compds. had moderate inhibitory activity, with I50 values in the range of 87-480 μM.  A structural feature common to these compds. is the N-Me determinant of the pyrrolidine ring, which may be important in binding to the AChE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptiFAHUP4DWLVg90H21EOLACvtfcHk0ljzPTZq2EF6Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrurc%253D&md5=0ec9b3f063d2fd07bdc4b037e25e6e28</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2891%2990015-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252891%252990015-X%26sid%3Dliteratum%253Aachs%26aulast%3DKaradsheh%26aufirst%3DN.%26aulast%3DKussie%26aufirst%3DP.%26aulast%3DLinthicum%26aufirst%3DD.%2BS.%26atitle%3DInhibition%2520of%2520Acetylcholinesterase%2520by%2520Caffeine%252C%2520Anabasine%252C%2520Methyl%2520Pyrrolidine%2520and%2520Their%2520Derivatives%26jtitle%3DToxicol.%2520Lett.%26date%3D1991%26volume%3D55%26issue%3D3%26spage%3D335%26epage%3D342%26doi%3D10.1016%2F0378-4274%2891%2990015-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Small Molecules Targeting Phosphoinositide 3-Kinases</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1355</span>, <span class="refDoi"> DOI: 10.1039/c2md20044a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1039%2Fc2md20044a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1337-1355&issue=11&author=P.+Wuauthor=Y.+Hu&title=Small+Molecules+Targeting+Phosphoinositide+3-Kinases&doi=10.1039%2Fc2md20044a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules targeting phosphoinositide 3-kinases</span></div><div class="casAuthors">Wu, Peng; Hu, Yongzhou</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1337-1355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is one of the most important signaling cascades in cancer, and PI3K is a well established target for anticancer therapy.  Since the discovery of the first two compds. that inhibit PI3K, wortmannin and LY294002, a wealth of PI3K inhibitors of various chemotypes have been identified, and nearly twenty of them are currently in various stages of clin. trials.  This review outlines the current landscape of the development of small mol. PI3K inhibitors with a focus on structure-activity relationships (SAR) and discussion of co-crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXN_CEz4XeS7Vg90H21EOLACvtfcHk0ljzPTZq2EF6Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrbN&md5=ada3308c67affb76bbfd051b96109103</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1039%2Fc2md20044a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20044a%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSmall%2520Molecules%2520Targeting%2520Phosphoinositide%25203-Kinases%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D1337%26epage%3D1355%26doi%3D10.1039%2Fc2md20044a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasazawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawajiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanida, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span> <span> </span><span class="NLM_article-title">Caffeine Induces Apoptosis by Enhancement of Autophagy via PI3K/Akt/MTOR/P70S6K Inhibition</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.4161/auto.7.2.14074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4161%2Fauto.7.2.14074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21081844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=176-187&issue=2&author=S.+Saikiauthor=Y.+Sasazawaauthor=Y.+Imamichiauthor=S.+Kawajiriauthor=T.+Fujimakiauthor=I.+Tanidaauthor=H.+Kobayashiauthor=F.+Satoauthor=S.+Satoauthor=K.+I.+Ishikawaauthor=M.+Imotoauthor=N.+Hattori&title=Caffeine+Induces+Apoptosis+by+Enhancement+of+Autophagy+via+PI3K%2FAkt%2FMTOR%2FP70S6K+Inhibition&doi=10.4161%2Fauto.7.2.14074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition</span></div><div class="casAuthors">Saiki, Shinji; Sasazawa, Yukiko; Imamichi, Yoko; Kawajiri, Sumihiro; Fujimaki, Takahiro; Tanida, Isei; Kobayashi, Hiroki; Sato, Fumiaki; Sato, Shigeto; Ishikawa, Kei-ichi; Imoto, Masaya; Hattori, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-187</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Caffeine is one of the most frequently ingested neuroactive compds.  All known mechanisms of apoptosis induced by caffeine act through cell cycle modulation or p53 induction.  It is currently unknown whether caffeine-induced apoptosis is assocd. with other cell death mechanisms, such as autophagy.  Herein we show that caffeine increases both the levels of microtubule-assocd. protein 1 light chain 3-II and the no. of autophagosomes, through the use of western blotting, electron microscopy and immunocytochem. techniques.  Phosphorylated p70 ribosomal protein S6 kinase (Thr389), S6 ribosomal protein (Ser235/236), 4E-BP1 (Thr37/46) and Akt (Ser473) were significantly decreased by caffeine.  In contrast, ERK1/2 (Thr202/204) was increased by caffeine, suggesting an inhibition of the Akt/mTOR/p70S6K pathway and activation of the ERK1/2 pathway.  Although insulin treatment phosphorylated Akt (Ser473) and led to autophagy suppression, the effect of insulin treatment was completely abolished by caffeine addn.  Caffeine-induced autophagy was not completely blocked by inhibition of ERK1/2 by U0126.  Caffeine induced redn. of mitochondrial membrane potentials and apoptosis in a dose-dependent manner, which was further attenuated by the inhibition of autophagy with 3-methyladenine or Atg7 siRNA knockdown.  Furthermore, there was a reduced no. of early apoptotic cells (annexin V pos., propidium iodide neg.) among autophagy-deficient mouse embryonic fibroblasts treated with caffeine than in their wild-type counterparts.  These results support previous studies on the use of caffeine in the treatment of human tumors and indicate a potential new target in the regulation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNgkWto6w8rVg90H21EOLACvtfcHk0li_pi6b-GRrKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSmu7g%253D&md5=6663d3e93235ddc1846ea055c7d27bb4</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.2.14074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.2.14074%26sid%3Dliteratum%253Aachs%26aulast%3DSaiki%26aufirst%3DS.%26aulast%3DSasazawa%26aufirst%3DY.%26aulast%3DImamichi%26aufirst%3DY.%26aulast%3DKawajiri%26aufirst%3DS.%26aulast%3DFujimaki%26aufirst%3DT.%26aulast%3DTanida%26aufirst%3DI.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DF.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DK.%2BI.%26aulast%3DImoto%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DN.%26atitle%3DCaffeine%2520Induces%2520Apoptosis%2520by%2520Enhancement%2520of%2520Autophagy%2520via%2520PI3K%252FAkt%252FMTOR%252FP70S6K%2520Inhibition%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26issue%3D2%26spage%3D176%26epage%3D187%26doi%3D10.4161%2Fauto.7.2.14074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tariqul
Islam, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scavello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotfi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charest, P. G.</span></span> <span> </span><span class="NLM_article-title">Caffeine Inhibits PI3K and MTORC2 in Dictyostelium and Differentially Affects Multiple Other CAMP Chemoattractant Signaling Effectors</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>457</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1007/s11010-019-03520-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs11010-019-03520-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30879206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1Gkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2019&pages=157-168&issue=1%E2%80%932&author=A.+F.+M.+Tariqul%0AIslamauthor=M.+Scavelloauthor=P.+Lotfiauthor=D.+Danielauthor=P.+Haldemanauthor=P.+G.+Charest&title=Caffeine+Inhibits+PI3K+and+MTORC2+in+Dictyostelium+and+Differentially+Affects+Multiple+Other+CAMP+Chemoattractant+Signaling+Effectors&doi=10.1007%2Fs11010-019-03520-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits PI3K and mTORC2 in Dictyostelium and differentially affects multiple other cAMP chemoattractant signaling effectors</span></div><div class="casAuthors">Tariqul Islam, A. F. M.; Scavello, Margarethakay; Lotfi, Pouya; Daniel, Dustin; Haldeman, Pearce; Charest, Pascale G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">157-168</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Caffeine is commonly used in Dictyostelium to inhibit the synthesis of the chemoattractant cAMP and, therefore, its secretion and the autocrine stimulation of cells, in order to prevent its interference with the study of chemoattractant-induced responses.  However, the mechanism through which caffeine inhibits cAMP synthesis in Dictyostelium has not been characterized.  Here, we report the effects of caffeine on the cAMP chemoattractant signaling network.  We found that caffeine inhibits phosphatidylinositol 3-kinase (PI3K) and mechanistic target of rapamycin complex 2 (mTORC2).  Both PI3K and mTORC2 are essential for the chemoattractant-stimulated cAMP prodn., thereby providing a mechanism for the caffeine-mediated inhibition of cAMP synthesis.  Our results also reveal that caffeine treatment of cells leads to an increase in cAMP-induced RasG and Rap1 activation, and inhibition of the PKA, cGMP, MyoII, and ERK1 responses.  Finally, we obsd. that caffeine has opposite effects on F-actin and ERK2 depending on the assay and Dictyostelium strain used, resp.  Altogether, our findings reveal that caffeine considerably affects the cAMP-induced chemotactic signaling pathways in Dictyostelium, most likely acting through multiple targets that include PI3K and mTORC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rg6bgrVZz7Vg90H21EOLACvtfcHk0li_pi6b-GRrKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1Gkt70%253D&md5=27cd3654e94ab6f29fd22478f2e99fa1</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1007%2Fs11010-019-03520-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-019-03520-z%26sid%3Dliteratum%253Aachs%26aulast%3DTariqul%2BIslam%26aufirst%3DA.%2BF.%2BM.%26aulast%3DScavello%26aufirst%3DM.%26aulast%3DLotfi%26aufirst%3DP.%26aulast%3DDaniel%26aufirst%3DD.%26aulast%3DHaldeman%26aufirst%3DP.%26aulast%3DCharest%26aufirst%3DP.%2BG.%26atitle%3DCaffeine%2520Inhibits%2520PI3K%2520and%2520MTORC2%2520in%2520Dictyostelium%2520and%2520Differentially%2520Affects%2520Multiple%2520Other%2520CAMP%2520Chemoattractant%2520Signaling%2520Effectors%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2019%26volume%3D457%26issue%3D1%25E2%2580%25932%26spage%3D157%26epage%3D168%26doi%3D10.1007%2Fs11010-019-03520-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McPhersonx, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdivia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takekura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzini-Armstrong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coronadot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, K. P.</span></span> <span> </span><span class="NLM_article-title">The Brain Ryanodine Receptor: A Caffeine-Sensitive Calcium Release Channel</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/0896-6273(91)90070-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0896-6273%2891%2990070-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1648939" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1991&pages=17-25&issue=1&author=P.+S.+McPhersonxauthor=Y.+K.+Kimauthor=H.+Valdiviaauthor=C.+M.+Knudsonauthor=H.+Takekuraauthor=C.+Franzini-Armstrongauthor=R.+Coronadotauthor=K.+P.+Campbell&title=The+Brain+Ryanodine+Receptor%3A+A+Caffeine-Sensitive+Calcium+Release+Channel&doi=10.1016%2F0896-6273%2891%2990070-G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2891%2990070-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252891%252990070-G%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhersonx%26aufirst%3DP.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DValdivia%26aufirst%3DH.%26aulast%3DKnudson%26aufirst%3DC.%2BM.%26aulast%3DTakekura%26aufirst%3DH.%26aulast%3DFranzini-Armstrong%26aufirst%3DC.%26aulast%3DCoronadot%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DK.%2BP.%26atitle%3DThe%2520Brain%2520Ryanodine%2520Receptor%253A%2520A%2520Caffeine-Sensitive%2520Calcium%2520Release%2520Channel%26jtitle%3DNeuron%26date%3D1991%26volume%3D7%26issue%3D1%26spage%3D17%26epage%3D25%26doi%3D10.1016%2F0896-6273%2891%2990070-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pessah, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stambuk, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Ca2+-Activated Ryanodine Binding: Mechanisms of Sensitivity and Intensity Modulation by Mg2+, Caffeine, and Adenine Nucleotides</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2436032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2sXitV2ksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1987&pages=232-238&issue=3&author=I.+N.+Pessahauthor=R.+A.+Stambukauthor=J.+E.+Casida&title=Ca2%2B-Activated+Ryanodine+Binding%3A+Mechanisms+of+Sensitivity+and+Intensity+Modulation+by+Mg2%2B%2C+Caffeine%2C+and+Adenine+Nucleotides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-activated ryanodine binding:  mechanisms of sensitivity and intensity modulation by magnesium, caffeine, and adenine nucleotides</span></div><div class="casAuthors">Pessah, Isaac N.; Stambuk, Roxanne A.; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The Ca2+-ryanodine receptor complex is a functional unit at the terminal cisternae (TC) of the sarcoplasmic reticulum (SR) whose proteins comprise the Ca2+-release channels which may be involved in excitation-contraction coupling.  Ca2+, Mg2+, caffeine, and adenine nucleotides, but not inositol 1,4,5-trisphosphate, may exert their inotropic effects on skeletal muscle SR by direct allosteric modulation of the [3H]ryanodine-binding site.  Micromolar Ca2+ is primarily responsible for activating [3H]ryanodine binding by regulating receptor site d., affinity, and cooperativity.  Mg2+ reduces the sensitivity to Ca2+ activation by directly competing with Ca2+ for the activator site.  However, inhibition by Mg2+ is overcome in the presence of β,γ-methyleneadenosine 5'-triphosphate (AMP-PCP; 1 mM) or caffeine (20 mM).  Caffeine dramatically increases the affinity of the Ca2+ activator site for Ca2+, whereas AMP-PCP or cAMP enhances the gating efficiency or the lifetime of the open state of the TC SR channel.  A kinetic model is proposed for 4 functional domains of the Ca2+-ryanodine receptor complex: (1) the Ca2+-regulatory domain which binds Ca2+ with micromolar affinity is primarily responsible for gating the Ca2+ channel of the TC SR in a cooperative manner and is inhibited by millimolar Mg2+ by direct competition for the activator site, which appears to contain crit. SH groups; (2) a Ca2+-activated alkaloid binding domain in close proximity to the channel which binds ryanodine with nanomolar affinity and rapidly occludes upon complex formation; (3) a domain which binds caffeine with low (greater than millimolar) affinity and directly influences the sensitivity of the Ca2+-regulatory site; and (4) a domain which binds adenine nucleotides with intermediate affinity (less than millimolar), does not require phosphorylation, and intensifies the Ca2+ signal which triggers opening of the Ca2+-release channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTZK2wcR8B37Vg90H21EOLACvtfcHk0li_pi6b-GRrKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXitV2ksL0%253D&md5=f6ca1a1771d3306f70c02ce31e99fd1a</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPessah%26aufirst%3DI.%2BN.%26aulast%3DStambuk%26aufirst%3DR.%2BA.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DCa2%252B-Activated%2520Ryanodine%2520Binding%253A%2520Mechanisms%2520of%2520Sensitivity%2520and%2520Intensity%2520Modulation%2520by%2520Mg2%252B%252C%2520Caffeine%252C%2520and%2520Adenine%2520Nucleotides%26jtitle%3DMol.%2520Pharmacol.%26date%3D1987%26volume%3D31%26issue%3D3%26spage%3D232%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">des
Georges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassucci, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Gating and Activation of RyR1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.08.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.cell.2016.08.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27662087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmtbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=145-157&issue=1&author=A.+des%0AGeorgesauthor=O.+B.+Clarkeauthor=R.+Zalkauthor=Q.+Yuanauthor=K.+J.+Condonauthor=R.+A.+Grassucciauthor=W.+A.+Hendricksonauthor=A.+R.+Marksauthor=J.+Frank&title=Structural+Basis+for+Gating+and+Activation+of+RyR1&doi=10.1016%2Fj.cell.2016.08.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Gating and Activation of RyR1</span></div><div class="casAuthors">des Georges, Amedee; Clarke, Oliver B.; Zalk, Ran; Yuan, Qi; Condon, Kendall J.; Grassucci, Robert A.; Hendrickson, Wayne A.; Marks, Andrew R.; Frank, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-157.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The type-1 ryanodine receptor (RyR1) is an intracellular calcium (Ca2+) release channel required for skeletal muscle contraction.  Here, we present cryo-EM reconstructions of RyR1 in multiple functional states revealing the structural basis of channel gating and ligand-dependent activation.  Binding sites for the channel activators Ca2+, ATP, and caffeine were identified at interdomain interfaces of the C-terminal domain.  Either ATP or Ca2+ alone induces conformational changes in the cytoplasmic assembly ("priming"), without pore dilation.  In contrast, in the presence of all three activating ligands, high-resoln. reconstructions of open and closed states of RyR1 were obtained from the same sample, enabling analyses of conformational changes assocd. with gating.  Gating involves global conformational changes in the cytosolic assembly accompanied by local changes in the transmembrane domain, which include bending of the S6 transmembrane segment and consequent pore dilation, displacement, and deformation of the S4-S5 linker and conformational changes in the pseudo-voltage-sensor domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiOulWfvkFxbVg90H21EOLACvtfcHk0lgWukRVo8tkGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmtbfP&md5=8fc42f8314d5a22cb145219f5cf965fc</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.08.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.08.075%26sid%3Dliteratum%253Aachs%26aulast%3Ddes%2BGeorges%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DO.%2BB.%26aulast%3DZalk%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DQ.%26aulast%3DCondon%26aufirst%3DK.%2BJ.%26aulast%3DGrassucci%26aufirst%3DR.%2BA.%26aulast%3DHendrickson%26aufirst%3DW.%2BA.%26aulast%3DMarks%26aufirst%3DA.%2BR.%26aulast%3DFrank%26aufirst%3DJ.%26atitle%3DStructural%2520Basis%2520for%2520Gating%2520and%2520Activation%2520of%2520RyR1%26jtitle%3DCell%26date%3D2016%26volume%3D167%26issue%3D1%26spage%3D145%26epage%3D157%26doi%3D10.1016%2Fj.cell.2016.08.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Molecular Basis for Allosteric Regulation of the Type 2 Ryanodine Receptor Channel Gating by Key Modulators</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">25575</span>– <span class="NLM_lpage">25582</span>, <span class="refDoi"> DOI: 10.1073/pnas.1914451116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.1914451116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31792195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1Kjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=25575-25582&issue=51&author=X.+Chiauthor=D.+Gongauthor=K.+Renauthor=G.+Zhouauthor=G.+Huangauthor=J.+Leiauthor=Q.+Zhouauthor=N.+Yan&title=Molecular+Basis+for+Allosteric+Regulation+of+the+Type+2+Ryanodine+Receptor+Channel+Gating+by+Key+Modulators&doi=10.1073%2Fpnas.1914451116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for allosteric regulation of the type 2 ryanodine receptor channel gating by key modulators</span></div><div class="casAuthors">Chi, Ximin; Gong, Deshun; Ren, Kang; Zhou, Gewei; Huang, Gaoxingyu; Lei, Jianlin; Zhou, Qiang; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">25575-25582</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The type 2 ryanodine receptor (RyR2) is responsible for releasing Ca2+ from the sarcoplasmic reticulum of cardiomyocytes, subsequently leading to muscle contraction.  Here, we report 4 cryo-electron microscopy (cryo-EM) structures of porcine RyR2 bound to distinct modulators that, together with our published structures, provide mechanistic insight into RyR2 regulation.  Ca2+ alone induces a contraction of the central domain that facilitates the dilation of the S6 bundle but is insufficient to open the pore.  The small-mol. agonist PCB95 helps Ca2+ to overcome the barrier for opening.  FKBP12.6 induces a relaxation of the central domain that decouples it from the S6 bundle, stabilizing RyR2 in a closed state even in the presence of Ca2+ and PCB95.  Although the channel is open when PCB95 is replaced by caffeine and ATP, neither of the modulators alone can sufficiently counter the antagonistic effect to open the channel.  Our study marks an important step toward mechanistic understanding of the sophisticated regulation of this key channel whose aberrant activity engenders life-threatening cardiac disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPg0k5Ov7yLVg90H21EOLACvtfcHk0lgWukRVo8tkGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1Kjtr0%253D&md5=0beff6206fe0c6a0ea1797f51f4d6211</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1914451116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1914451116%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DMolecular%2520Basis%2520for%2520Allosteric%2520Regulation%2520of%2520the%2520Type%25202%2520Ryanodine%2520Receptor%2520Channel%2520Gating%2520by%2520Key%2520Modulators%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D51%26spage%3D25575%26epage%3D25582%26doi%3D10.1073%2Fpnas.1914451116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, N.</span></span> <span> </span><span class="NLM_article-title">Modulation of Cardiac Ryanodine Receptor 2 by Calmodulin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>572</i></span> (<span class="NLM_issue">7769</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1377-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fs41586-019-1377-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31278385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlalsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=572&publication_year=2019&pages=347-351&issue=7769&author=D.+Gongauthor=X.+Chiauthor=J.+Weiauthor=G.+Zhouauthor=G.+Huangauthor=L.+Zhangauthor=R.+Wangauthor=J.+Leiauthor=S.+R.+W.+Chenauthor=N.+Yan&title=Modulation+of+Cardiac+Ryanodine+Receptor+2+by+Calmodulin&doi=10.1038%2Fs41586-019-1377-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cardiac ryanodine receptor 2 by calmodulin</span></div><div class="casAuthors">Gong, Deshun; Chi, Ximin; Wei, Jinhong; Zhou, Gewei; Huang, Gaoxingyu; Zhang, Lin; Wang, Ruiwu; Lei, Jianlin; Chen, S. R. Wayne; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">572</span>
        (<span class="NLM_cas:issue">7769</span>),
    <span class="NLM_cas:pages">347-351</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The high-conductance intracellular calcium (Ca2+) channel RyR2 is essential for the coupling of excitation and contraction in cardiac muscle.  Among various modulators, calmodulin (CaM) regulates RyR2 in a Ca2+-dependent manner.  Here we reveal the regulatory mechanism by which porcine RyR2 is modulated by human CaM through the structural detn. of RyR2 under eight conditions.  Apo-CaM and Ca2+-CaM bind to distinct but overlapping sites in an elongated cleft formed by the handle, helical and central domains.  The shift in CaM-binding sites on RyR2 is controlled by Ca2+ binding to CaM, rather than to RyR2.  Ca2+-CaM induces rotations and intradomain shifts of individual central domains, resulting in pore closure of the PCB95 and Ca2+-activated channel.  By contrast, the pore of the ATP, caffeine and Ca2+-activated channel remains open in the presence of Ca2+-CaM, which suggests that Ca2+-CaM is one of the many competing modulators of RyR2 gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorBb4kRKtSmrVg90H21EOLACvtfcHk0liONHaaB7iDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlalsL%252FE&md5=60af055b5123ddc58afdf25f4462dc42</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1377-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1377-y%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DD.%26aulast%3DChi%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%2BR.%2BW.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DModulation%2520of%2520Cardiac%2520Ryanodine%2520Receptor%25202%2520by%2520Calmodulin%26jtitle%3DNature%26date%3D2019%26volume%3D572%26issue%3D7769%26spage%3D347%26epage%3D351%26doi%3D10.1038%2Fs41586-019-1377-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantin, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noeske, T.</span></span> <span> </span><span class="NLM_article-title">Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs: Opportunities Provided by Physicochemical Property Modulation, in Silico Modeling, and Structural Modification</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2332</span>– <span class="NLM_lpage">2341</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.047068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fdmd.112.047068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22961681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslyjsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2332-2341&issue=12&author=D.+J.+Warnerauthor=H.+Chenauthor=L.+D.+Cantinauthor=J.+G.+Kennaauthor=S.+Stahlauthor=C.+L.+Walkerauthor=T.+Noeske&title=Mitigating+the+Inhibition+of+Human+Bile+Salt+Export+Pump+by+Drugs%3A+Opportunities+Provided+by+Physicochemical+Property+Modulation%2C+in+Silico+Modeling%2C+and+Structural+Modification&doi=10.1124%2Fdmd.112.047068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification</span></div><div class="casAuthors">Warner, Daniel J.; Chen, Hongming; Cantin, Louis-David; Kenna, J. Gerry; Stahl, Simone; Walker, Clare L.; Noeske, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2332-2341</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human bile salt export pump (BSEP) is a membrane protein expressed on the canalicular plasma membrane domain of hepatocytes, which mediates active transport of unconjugated and conjugated bile salts from liver cells into bile.  BSEP activity therefore plays an important role in bile flow.  In humans, genetically inherited defects in BSEP expression or activity cause cholestatic liver injury, and many drugs that cause cholestatic drug-induced liver injury (DILI) in humans have been shown to inhibit BSEP activity in vitro and in vivo.  These findings suggest that inhibition of BSEP activity by drugs could be one of the mechanisms that initiate human DILI.  To gain insight into the chem. features responsible for BSEP inhibition, we have used a recently described in vitro membrane vesicle BSEP inhibition assay to quantify transporter inhibition for a set of 624 compds.  The relationship between BSEP inhibition and mol. physicochem. properties was investigated, and our results show that lipophilicity and mol. size are significantly correlated with BSEP inhibition.  This data set was further used to build predictive BSEP classification models through multiple quant. structure-activity relationship modeling approaches.  The highest level of predictive accuracy was provided by a support vector machine model (accuracy = 0.87, κ = 0.74).  These analyses highlight the potential value that can be gained by combining computational methods with exptl. efforts in early stages of drug discovery projects to minimize the propensity of drug candidates to inhibit BSEP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBacqKvVpIzrVg90H21EOLACvtfcHk0liONHaaB7iDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslyjsrbN&md5=99d21620afb687aa3fc4cea7a1c136b3</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.047068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.047068%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCantin%26aufirst%3DL.%2BD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DC.%2BL.%26aulast%3DNoeske%26aufirst%3DT.%26atitle%3DMitigating%2520the%2520Inhibition%2520of%2520Human%2520Bile%2520Salt%2520Export%2520Pump%2520by%2520Drugs%253A%2520Opportunities%2520Provided%2520by%2520Physicochemical%2520Property%2520Modulation%252C%2520in%2520Silico%2520Modeling%252C%2520and%2520Structural%2520Modification%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2332%26epage%3D2341%26doi%3D10.1124%2Fdmd.112.047068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Bruyn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Westen, G. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustijns, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annaert, P. P.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Identification of Oatp1b1/3 Inhibitorss</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1267</span>, <span class="refDoi"> DOI: 10.1124/mol.112.084152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.112.084152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23571415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=1257-1267&issue=6&author=T.+De+Bruynauthor=G.+J.+P.+Van+Westenauthor=A.+P.+Ijzermanauthor=B.+Stiegerauthor=P.+De+Witteauthor=P.+F.+Augustijnsauthor=P.+P.+Annaert&title=Structure-Based+Identification+of+Oatp1b1%2F3+Inhibitorss&doi=10.1124%2Fmol.112.084152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based identification of OATP1B1/3 inhibitors</span></div><div class="casAuthors">De Bruyn, Tom; van Western, Gerard J. P.; IJzerman, Adriaan P.; Stieger, Bruno; de Witte, Peter; Augustijns, Patrick F.; Annaert, Pieter P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1257-1267</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Several recent studies show that inhibition of the hepatic transport proteins org. anion-transporting polypeptide 1B1 (OATP1B1) and 1B3 (OATP1B3) can result in clin. relevant drug-drug interactions (DDI).  To avoid late-stage development drug failures due to OATP1B-mediated DDI, predictive in vitro and in silico methods should be implemented at an early stage of the drug candidate evaluation process.  In the present study, we first developed a high-throughput in vitro transporter inhibition assay for the OATP1B subfamily.  A total of 2000 compds. were tested as potential modulators of the uptake of the OATP1B substrate sodium fluorescein, in OATP1B1- or 1B3-transfected Chinese hamster ovary cells.  At an equimolar substrate-inhibitor concn. of 10 μM, 212 and 139 mols. were identified as OATP1B1 and OATP1B3 inhibitors, resp. (min. 50% inhibition).  For 69 compds., previously not identified as OATP1B inhibitors, concn.-dependent inhibition was also detd., yielding Ki values ranging from 0.06 to 6.5 μM.  Based on these in vitro data, we subsequently developed a proteochemometrics-based in silico model, which predicted OATP1B inhibitors in the test group (20% of the dataset) with high specificity (86%) and sensitivity (78%).  Moreover, several physicochem. compd. properties and substructures related to OATP1B1/1B3 inhibition or inactivity were identified.  Finally, model performance was prospectively verified with a set of 54 compds. not included in the original dataset.  This validation indicated that 80 and 74% of the compds. were correctly classified for OATP1B1 and OATP1B3 inhibition, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoktLtqKIqWh7Vg90H21EOLACvtfcHk0liONHaaB7iDdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgtr8%253D&md5=bbf1617e8efba061f65b8f643baa5b98</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.084152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.084152%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruyn%26aufirst%3DT.%26aulast%3DVan%2BWesten%26aufirst%3DG.%2BJ.%2BP.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStieger%26aufirst%3DB.%26aulast%3DDe%2BWitte%26aufirst%3DP.%26aulast%3DAugustijns%26aufirst%3DP.%2BF.%26aulast%3DAnnaert%26aufirst%3DP.%2BP.%26atitle%3DStructure-Based%2520Identification%2520of%2520Oatp1b1%252F3%2520Inhibitorss%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26issue%3D6%26spage%3D1257%26epage%3D1267%26doi%3D10.1124%2Fmol.112.084152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakatis, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reese, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baines, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellens, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroso, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovatt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrton, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. E.</span></span> <span> </span><span class="NLM_article-title">Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for > 200 Compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1021/tx300075j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300075j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=2067-2082&issue=10&author=M.+Z.+Sakatisauthor=M.+J.+Reeseauthor=A.+W.+Harrellauthor=M.+A.+Taylorauthor=I.+A.+Bainesauthor=L.+Chenauthor=J.+C.+Bloomerauthor=E.+Y.+Yangauthor=H.+M.+Ellensauthor=J.+L.+Ambrosoauthor=C.+A.+Lovattauthor=A.+D.+Ayrtonauthor=S.+E.+Clarke&title=Preclinical+Strategy+to+Reduce+Clinical+Hepatotoxicity+Using+in+Vitro+Bioactivation+Data+for+%3E+200+Compounds&doi=10.1021%2Ftx300075j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds</span></div><div class="casAuthors">Sakatis, Melanie Z.; Reese, Melinda J.; Harrell, Andrew W.; Taylor, Maxine A.; Baines, Ian A.; Chen, Liangfu; Bloomer, Jackie C.; Yang, Eric Y.; Ellens, Harma M.; Ambroso, Jeffrey L.; Lovatt, Cerys A.; Ayrton, Andrew D.; Clarke, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2067-2082</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced liver injury is the most common cause of market withdrawal of pharmaceuticals, and thus, there is considerable need for better prediction models for DILI early in drug discovery.  We present a study involving 223 marketed drugs (51% assocd. with clin. hepatotoxicity; 49% non-hepatotoxic) to assess the concordance of in vitro bioactivation data with clin. hepatotoxicity and have used these data to develop a decision tree to help reduce late-stage candidate attrition.  Data to assess P 450 metab.-dependent inhibition (MDI) for all common drug-metabolizing P 450 enzymes were generated for 179 of these compds., GSH adduct data generated for 190 compds., covalent binding data obtained for 53 compds., and clin. dose data obtained for all compds.  Individual data for all 223 compds. are presented here and interrogated to det. what level of an alert to consider termination of a compd.  The anal. showed that 76% of drugs with a daily dose of <100 mg were non-hepatotoxic (p < 0.0001).  Drugs with a daily dose of ≥100 mg or with GSH adduct formation, marked P 450 MDI, or covalent binding ≥200 pmol eq/mg protein tended to be hepatotoxic (∼ 65% in each case).  Combining dose with each bioactivation assay increased this assocn. significantly (80-100%, p < 0.0001).  These analyses were then used to develop the decision tree and the tree tested using 196 of the compds. with sufficient data (49% hepatotoxic; 51% non-hepatotoxic).  The results of these outcome analyses demonstrated the utility of the tree in selectively terminating hepatotoxic compds. early; 45% of the hepatotoxic compds. evaluated using the tree were recommended for termination before candidate selection, whereas only 10% of the non-hepatotoxic compds. were recommended for termination.  An independent set of 10 GSK compds. with known clin. hepatotoxicity status were also assessed using the tree, with similar results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGEqQ7gmJubVg90H21EOLACvtfcHk0lgZZOKRj-CmpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ymsrzJ&md5=d18465cd8981dfac512527bb04de3605</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Ftx300075j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300075j%26sid%3Dliteratum%253Aachs%26aulast%3DSakatis%26aufirst%3DM.%2BZ.%26aulast%3DReese%26aufirst%3DM.%2BJ.%26aulast%3DHarrell%26aufirst%3DA.%2BW.%26aulast%3DTaylor%26aufirst%3DM.%2BA.%26aulast%3DBaines%26aufirst%3DI.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBloomer%26aufirst%3DJ.%2BC.%26aulast%3DYang%26aufirst%3DE.%2BY.%26aulast%3DEllens%26aufirst%3DH.%2BM.%26aulast%3DAmbroso%26aufirst%3DJ.%2BL.%26aulast%3DLovatt%26aufirst%3DC.%2BA.%26aulast%3DAyrton%26aufirst%3DA.%2BD.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26atitle%3DPreclinical%2520Strategy%2520to%2520Reduce%2520Clinical%2520Hepatotoxicity%2520Using%2520in%2520Vitro%2520Bioactivation%2520Data%2520for%2520%253E%2520200%2520Compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D10%26spage%3D2067%26epage%3D2082%26doi%3D10.1021%2Ftx300075j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, B. L.</span></span> <span> </span><span class="NLM_article-title">Identification of Small Molecule Compounds with Higher Binding Affinity to Guanine Deaminase (Cypin) than Guanine</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6755</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2010.07.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20716488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6748-6755&issue=18&author=J.+R.+Fern%C3%A1ndezauthor=E.+S.+Sweetauthor=W.+J.+Welshauthor=B.+L.+Firestein&title=Identification+of+Small+Molecule+Compounds+with+Higher+Binding+Affinity+to+Guanine+Deaminase+%28Cypin%29+than+Guanine&doi=10.1016%2Fj.bmc.2010.07.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine</span></div><div class="casAuthors">Fernandez, Jose R.; Sweet, Eric S.; Welsh, William J.; Firestein, Bonnie L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6748-6755</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Guanine deaminase (GDA; cypin) is an important metalloenzyme that processes the first step in purine catabolism, converting guanine to xanthine by hydrolytic deamination.  In higher eukaryotes, GDA also plays an important role in the development of neuronal morphol. by regulating dendritic arborization.  In addn. to its role in the maturing brain, GDA is thought to be involved in proper liver function since increased levels of GDA activity have been correlated with liver disease and transplant rejection.  Although mammalian GDA is an attractive and potential drug target for treatment of both liver diseases and cognitive disorders, prospective novel inhibitors and/or activators of this enzyme have not been actively pursued.  In this study, we employed the combination of protein structure anal. and exptl. kinetic studies to seek novel potential ligands for human guanine deaminase.  Using virtual screening and biochem. anal., we identified common small mol. compds. that demonstrate a higher binding affinity to GDA than does guanine.  In vitro anal. demonstrates that these compds. inhibit guanine deamination, and more surprisingly, affect GDA (cypin)-mediated microtubule assembly.  The results in this study provide evidence that an in silico drug discovery strategy coupled with in vitro validation assays can be successfully implemented to discover compds. that may possess therapeutic value for the treatment of diseases and disorders where GDA activity is abnormal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyxCCWhr_WrLVg90H21EOLACvtfcHk0lgZZOKRj-CmpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamt77E&md5=9deb171280c1ee8d9fb48174faca84a2</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.054%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DJ.%2BR.%26aulast%3DSweet%26aufirst%3DE.%2BS.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26aulast%3DFirestein%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520Small%2520Molecule%2520Compounds%2520with%2520Higher%2520Binding%2520Affinity%2520to%2520Guanine%2520Deaminase%2520%2528Cypin%2529%2520than%2520Guanine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26issue%3D18%26spage%3D6748%26epage%3D6755%26doi%3D10.1016%2Fj.bmc.2010.07.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitcheson, J. S.</span></span> <span> </span><span class="NLM_article-title">Direct Block of Human Ether-a-Go-Go-Related Gene Potassium Channels by Caffeine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>316</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.094755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fjpet.105.094755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16227470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=860-868&issue=2&author=S.+L.+Cockerillauthor=J.+S.+Mitcheson&title=Direct+Block+of+Human+Ether-a-Go-Go-Related+Gene+Potassium+Channels+by+Caffeine&doi=10.1124%2Fjpet.105.094755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Direct block of human ether-a-go-go-related gene potassium channels by caffeine</span></div><div class="casAuthors">Cockerill, S. L.; Mitcheson, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">860-868</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human ether-a-go-go-related gene (hERG) potassium channel is expressed in a variety of cell types, including neurons, tumor cells, and cardiac myocytes.  In the heart, it is important for repolarization of the cardiac action potential.  Attenuation of hERG current can cause long QT syndrome and cardiac arrhythmias such as torsades de pointes.  Caffeine is frequently used as a pharmacol. tool to study calcium-dependent transduction pathways in cellular prepns.  It raises cytosolic calcium by opening ryanodine receptors and may also inhibit phosphodiesterases to increase cytosolic cAMP.  In this study, we show 5 mM caffeine rapidly and reversibly attenuates hERG currents expressed in human embryonic kidney 293 cells to 61.1 ± 2.2% of control.  Caffeine-dependent inhibition of hERG current is not altered by raising cAMP with forskolin, buffering cytosolic calcium with BAPTA, or inhibition of protein kinase C.  Thus, the effects of caffeine are unlikely to be mediated by cAMP or intracellular calcium-dependent mechanisms.  Further expts. showed caffeine directly blocks hERG in an open state-dependent manner.  Furthermore, caffeine inhibition is greatly reduced by the pore mutants Y562A and F656A hERG, which disrupt block of most previously tested hERG antagonists.  Thus, caffeine attenuates hERG currents by binding to a drug receptor located within the inner cavity of the channel.  Dietary intake of caffeine is unlikely to cause long QT syndrome because plasma concns. do not reach sufficiently high levels to significantly inhibit hERG currents.  However, the effects of caffeine have implications for its use in examing calcium-dependent pathways in cellular prepns. expressing hERG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyYdul8sWTtLVg90H21EOLACvtfcHk0lgZZOKRj-CmpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqt7Y%253D&md5=c0da3b4b41da9abd6f8a4c8e149b0e03</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.094755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.094755%26sid%3Dliteratum%253Aachs%26aulast%3DCockerill%26aufirst%3DS.%2BL.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DDirect%2520Block%2520of%2520Human%2520Ether-a-Go-Go-Related%2520Gene%2520Potassium%2520Channels%2520by%2520Caffeine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26issue%3D2%26spage%3D860%26epage%3D868%26doi%3D10.1124%2Fjpet.105.094755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauly, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carty, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeller, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treadway, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletterick, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, Y. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myszka, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, V. L.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(02)00186-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS1074-5521%2802%2900186-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12204691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=915-924&issue=8&author=J.+L.+Ekstromauthor=T.+A.+Paulyauthor=M.+D.+Cartyauthor=W.+C.+Soellerauthor=J.+Culpauthor=D.+E.+Danleyauthor=D.+J.+Hooverauthor=J.+L.+Treadwayauthor=E.+M.+Gibbsauthor=R.+J.+Fletterickauthor=Y.+S.+N.+Dayauthor=D.+G.+Myszkaauthor=V.+L.+Rath&title=Structure-Activity+Analysis+of+the+Purine+Binding+Site+of+Human+Liver+Glycogen+Phosphorylase&doi=10.1016%2FS1074-5521%2802%2900186-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Analysis of the Purine Binding Site of Human Liver Glycogen Phosphorylase</span></div><div class="casAuthors">Ekstrom, Jennifer L.; Pauly, Thomas A.; Carty, Maynard D.; Soeller, Walter C.; Culp, Jeff; Danley, Dennis E.; Hoover, Dennis J.; Treadway, Judith L.; Gibbs, E. Michael; Fletterick, Robert J.; Day, Yasmina S. N.; Myszka, David G.; Rath, Virginia L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">915-924</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human liver glycogen phosphorylase (HLGP) catalyzes the breakdown of glycogen to maintain serum glucose levels and is a therapeutic target for diabetes.  HLGP is regulated by multiple interacting allosteric sites, each of which is a potential drug binding site.  We used surface plasmon resonance (SPR) to screen for compds. that bind to the purine allosteric inhibitor site.  We detd. the affinities of a series of compds. and solved the crystal structures of three representative ligands with KD values from 17-550 μM. The crystal structures reveal that the affinities are partly detd. by ligand-specific water-mediated hydrogen bonds and side chain movements.  These effects could not be predicted; both crystallog. and SPR studies were required to understand the important features of binding and together provide a basis for the design of new allosteric inhibitors targeting this site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX0KNJxlGrt7Vg90H21EOLACvtfcHk0lgmTD2INMDy_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVCiu7g%253D&md5=53286b2a1386828dad2b9c6a6a0254a5</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900186-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900186-2%26sid%3Dliteratum%253Aachs%26aulast%3DEkstrom%26aufirst%3DJ.%2BL.%26aulast%3DPauly%26aufirst%3DT.%2BA.%26aulast%3DCarty%26aufirst%3DM.%2BD.%26aulast%3DSoeller%26aufirst%3DW.%2BC.%26aulast%3DCulp%26aufirst%3DJ.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26aulast%3DTreadway%26aufirst%3DJ.%2BL.%26aulast%3DGibbs%26aufirst%3DE.%2BM.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26aulast%3DDay%26aufirst%3DY.%2BS.%2BN.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DRath%26aufirst%3DV.%2BL.%26atitle%3DStructure-Activity%2520Analysis%2520of%2520the%2520Purine%2520Binding%2520Site%2520of%2520Human%2520Liver%2520Glycogen%2520Phosphorylase%26jtitle%3DChem.%2520Biol.%26date%3D2002%26volume%3D9%26issue%3D8%26spage%3D915%26epage%3D924%26doi%3D10.1016%2FS1074-5521%2802%2900186-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickett, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucheron, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peat, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheckler, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiel, J. E.</span></span> <span> </span><span class="NLM_article-title">Anthranilimide Based Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes. Part 3: X-Ray Crystallographic Characterization, Core and Urea Optimization and in Vivo Efficacy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1182</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2008.12.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19138846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1177-1182&issue=4&author=S.+A.+Thomsonauthor=P.+Bankerauthor=D.+M.+Bickettauthor=J.+A.+Boucheronauthor=H.+L.+Carterauthor=D.+C.+Clancyauthor=J.+P.+Cooperauthor=S.+H.+Dickersonauthor=D.+M.+Garridoauthor=R.+T.+Nolteauthor=A.+J.+Peatauthor=L.+R.+Shecklerauthor=S.+M.+Sparksauthor=F.+X.+Tavaresauthor=L.+Wangauthor=T.+Y.+Wangauthor=J.+E.+Weiel&title=Anthranilimide+Based+Glycogen+Phosphorylase+Inhibitors+for+the+Treatment+of+Type+2+Diabetes.+Part+3%3A+X-Ray+Crystallographic+Characterization%2C+Core+and+Urea+Optimization+and+in+Vivo+Efficacy&doi=10.1016%2Fj.bmcl.2008.12.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy</span></div><div class="casAuthors">Thomson, Stephen A.; Banker, Pierette; Bickett, D. Mark; Boucheron, Joyce A.; Carter, H. Luke; Clancy, Daphne C.; Cooper, Joel P.; Dickerson, Scott H.; Garrido, Dulce M.; Nolte, Robert T.; Peat, Andrew J.; Sheckler, Lauren R.; Sparks, Steven M.; Tavares, Francis X.; Wang, Liping; Wang, Tony Y.; Weiel, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1177-1182</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Key binding interactions of the anthranilimide based glycogen phosphorylase a (GPa) inhibitor 2 (I) from X-ray crystallog. studies are described.  This series of compds. bind to the AMP site of GP.  Using the binding information the core and the Ph urea moieties were optimized.  This work culminated in the identification of compds. with single nanomolar potency as well as in vivo efficacy in a diabetic model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphRT7sQox7cbVg90H21EOLACvtfcHk0lgmTD2INMDy_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wrtbs%253D&md5=17be0404e673b2ced3c0a4cbdd80a9ca</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.085%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DS.%2BA.%26aulast%3DBanker%26aufirst%3DP.%26aulast%3DBickett%26aufirst%3DD.%2BM.%26aulast%3DBoucheron%26aufirst%3DJ.%2BA.%26aulast%3DCarter%26aufirst%3DH.%2BL.%26aulast%3DClancy%26aufirst%3DD.%2BC.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DGarrido%26aufirst%3DD.%2BM.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DPeat%26aufirst%3DA.%2BJ.%26aulast%3DSheckler%26aufirst%3DL.%2BR.%26aulast%3DSparks%26aufirst%3DS.%2BM.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%2BY.%26aulast%3DWeiel%26aufirst%3DJ.%2BE.%26atitle%3DAnthranilimide%2520Based%2520Glycogen%2520Phosphorylase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes.%2520Part%25203%253A%2520X-Ray%2520Crystallographic%2520Characterization%252C%2520Core%2520and%2520Urea%2520Optimization%2520and%2520in%2520Vivo%2520Efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D4%26spage%3D1177%26epage%3D1182%26doi%3D10.1016%2Fj.bmcl.2008.12.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnier-Maréchal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, S.</span></span> <span> </span><span class="NLM_article-title">Glycogen Phosphorylase Inhibitors: A Patent Review (2013–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1131268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1517%2F13543776.2016.1131268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26666989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvV2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=199-212&issue=2&author=M.+Donnier-Mar%C3%A9chalauthor=S.+Vidal&title=Glycogen+Phosphorylase+Inhibitors%3A+A+Patent+Review+%282013%E2%80%932015%29&doi=10.1517%2F13543776.2016.1131268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen phosphorylase inhibitors: a patent review (2013 - 2015)</span></div><div class="casAuthors">Donnier-Marechal, Marion; Vidal, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-212</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Control of glycemia is crucial in the treatment of type 2 diabetes complications.  Glycogen phosphorylase (GP) releases glucose from the liver into the blood stream.  Design of potent GP inhibitors is a therapeutic strategy in the context of type 2 diabetes.: Glucose-based inhibitors have found potential applications since they now reach low nanomolar Ki values.  Another set of patents disclose cholic acid/7-aza-indole conjugates for targeted drug delivery to the liver.  A series of benzazepinones have also been reported as potent GP inhibitors.  In vitro data are reported for GP inhibition but the in vivo biol. data at the cellular or animal levels are often missing, even though the literature reported for these mols. is also discussed.  A structural analogy between glucose-based GP inhibitors and C-glucosides targeting sodium glucose co-transporter 2 (SGLT2) is intriguing.  Cholic acid/7-aza-indole conjugates are promising in vivo drug delivery systems to the liver.  Benzazepinones were very recently described and no assocd. literature is available, making it very difficult to comment at present.  While industry has slowed down on GP inhibitors design, academic groups are pursuing investigations and have provided potential drug candidates which will resuscitate the interest for GP, including its potential for targeting cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Kt29l6dTNrVg90H21EOLACvtfcHk0lgmTD2INMDy_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvV2isg%253D%253D&md5=87f2746aa24058fcf3e0117a41b789fd</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1131268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1131268%26sid%3Dliteratum%253Aachs%26aulast%3DDonnier-Mar%25C3%25A9chal%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DS.%26atitle%3DGlycogen%2520Phosphorylase%2520Inhibitors%253A%2520A%2520Patent%2520Review%2520%25282013%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D199%26epage%3D212%26doi%3D10.1517%2F13543776.2016.1131268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Withers, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasvinsky, P. J.</span></span> <span> </span><span class="NLM_article-title">Identical Structural Changes Induced in Glycogen Phosphorylase by Two Nonexclusive Allosteric Inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">5342</span>– <span class="NLM_lpage">5348</span>, <span class="refDoi"> DOI: 10.1021/bi00591a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00591a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3cXitlKh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=5342-5348&issue=24&author=S.+G.+Withersauthor=B.+D.+Sykesauthor=N.+B.+Madsenauthor=P.+J.+Kasvinsky&title=Identical+Structural+Changes+Induced+in+Glycogen+Phosphorylase+by+Two+Nonexclusive+Allosteric+Inhibitors&doi=10.1021%2Fbi00591a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Identical structural changes induced in glycogen phosphorylase by two nonexclusive allosteric inhibitors</span></div><div class="casAuthors">Withers, Stephen G.; Sykes, Brian D.; Madsen, Neil B.; Kasvinsky, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5342-8</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Recent kinetic studies on the regulation of glycogen phosphorylase by the synergistic inhibitors, caffeine and glucose, in conjunction with x-ray crystallog. data, led to the proposal of a mol. mechanism for this process in which the 2 effectors bind at sep. sites.  These effects were studied in soln. at 2 different structural levels by other techniques.  Ultracentrifugation studies of the quaternary structure of phosphorylase a showed the formation of dimers from tetramers on addn. of these ligands independently and cooperative promotion of dimer formation when added together.  The effect of the ligands on tertiary structure was investigated by studying the protection against iodoacetamide inactivation of enzyme activity afforded by these ligands.  31P NMR studies of the catalytically essential pyridoxal phosphate residue of AMP-activated phosphorylase b indicated a conversion from the active to the inactive form, possibly involving a protonation of the coenzyme phosphate, on addn. of either of these ligands.  This suggests a similar active-site environment in the 2 cases, identical with that obsd. in the absence of the activator, AMP.  The effect of these ligands on the 31P resonance of the analogous 5'-thioadenosine 5'-phosphate activator was also similar.  Despite sep. and distant binding sites for the 2 inhibitors, the effects on the gross structure of the enzyme at the quaternary and tertiary levels and their effect on a catalytically essential group are both identical and cooperative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr__RpvvV3337Vg90H21EOLACvtfcHk0ljxNOHCjM1Hdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXitlKh&md5=c657e7a0bc75559d84fec38011340f8b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fbi00591a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00591a013%26sid%3Dliteratum%253Aachs%26aulast%3DWithers%26aufirst%3DS.%2BG.%26aulast%3DSykes%26aufirst%3DB.%2BD.%26aulast%3DMadsen%26aufirst%3DN.%2BB.%26aulast%3DKasvinsky%26aufirst%3DP.%2BJ.%26atitle%3DIdentical%2520Structural%2520Changes%2520Induced%2520in%2520Glycogen%2520Phosphorylase%2520by%2520Two%2520Nonexclusive%2520Allosteric%2520Inhibitors%26jtitle%3DBiochemistry%26date%3D1979%26volume%3D18%26issue%3D24%26spage%3D5342%26epage%3D5348%26doi%3D10.1021%2Fbi00591a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kakugawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langton, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bineva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijders, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span> <span> </span><span class="NLM_article-title">Notum Deacylates Wnt Proteins to Suppress Signalling Activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>519</i></span> (<span class="NLM_issue">7542</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1038/nature14259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fnature14259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25731175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=2015&pages=187-192&issue=7542&author=S.+Kakugawaauthor=P.+F.+Langtonauthor=M.+Zebischauthor=S.+A.+Howellauthor=T.+H.+Changauthor=Y.+Liuauthor=T.+Feiziauthor=G.+Binevaauthor=N.+O%E2%80%99Reillyauthor=A.+P.+Snijdersauthor=E.+Y.+Jonesauthor=J.+P.+Vincent&title=Notum+Deacylates+Wnt+Proteins+to+Suppress+Signalling+Activity&doi=10.1038%2Fnature14259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Notum deacylates Wnt proteins to suppress signalling activity</span></div><div class="casAuthors">Kakugawa, Satoshi; Langton, Paul F.; Zebisch, Matthias; Howell, Steven A.; Chang, Tao-Hsin; Liu, Yan; Feizi, Ten; Bineva, Ganka; O'Reilly, Nicola; Snijders, Ambrosius P.; Jones, E. Yvonne; Vincent, Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">519</span>
        (<span class="NLM_cas:issue">7542</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Signalling by Wnt proteins is finely balanced to ensure normal development and tissue homeostasis while avoiding diseases such as cancer.  This is achieved in part by Notum, a highly conserved secreted feedback antagonist.  Notum has been thought to act as a phospholipase, shedding glypicans and assocd. Wnt proteins from the cell surface.  However, this view fails to explain specificity, as glypicans bind many extracellular ligands.  Here we provide genetic evidence in Drosophila that Notum requires glypicans to suppress Wnt signalling, but does not cleave their glycophosphatidylinositol anchor.  Structural analyses reveal glycosaminoglycan binding sites on Notum, which probably help Notum to co-localize with Wnt proteins.  They also identify, at the active site of human and Drosophila Notum, a large hydrophobic pocket that accommodates palmitoleate.  Kinetic and mass spectrometric analyses of human proteins show that Notum is a carboxylesterase that removes an essential palmitoleate moiety from Wnt proteins and thus constitutes the first known extracellular protein deacylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqffMMn2oxsbLVg90H21EOLACvtfcHk0ljxNOHCjM1Hdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCnsb4%253D&md5=0668dc3cdc07e4bd527551424c4b91d4</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnature14259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14259%26sid%3Dliteratum%253Aachs%26aulast%3DKakugawa%26aufirst%3DS.%26aulast%3DLangton%26aufirst%3DP.%2BF.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DHowell%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DT.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DBineva%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DN.%26aulast%3DSnijders%26aufirst%3DA.%2BP.%26aulast%3DJones%26aufirst%3DE.%2BY.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26atitle%3DNotum%2520Deacylates%2520Wnt%2520Proteins%2520to%2520Suppress%2520Signalling%2520Activity%26jtitle%3DNature%26date%3D2015%26volume%3D519%26issue%3D7542%26spage%3D187%26epage%3D192%26doi%3D10.1038%2Fnature14259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span> <span> </span><span class="NLM_article-title">Caffeine Inhibits Notum Activity by Binding at the Catalytic Pocket</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">555</span>, <span class="refDoi"> DOI: 10.1038/s42003-020-01286-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fs42003-020-01286-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33033363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVagtLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=555&issue=1&author=Y.+Zhaoauthor=J.+Renauthor=J.+Hillierauthor=W.+Luauthor=E.+Y.+Jones&title=Caffeine+Inhibits+Notum+Activity+by+Binding+at+the+Catalytic+Pocket&doi=10.1038%2Fs42003-020-01286-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits Notum activity by binding at the catalytic pocket</span></div><div class="casAuthors">Zhao, Yuguang; Ren, Jingshan; Hillier, James; Lu, Weixian; Jones, Edith Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Communications Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">555</span>CODEN:
                <span class="NLM_cas:coden">CBOIDQ</span>;
        ISSN:<span class="NLM_cas:issn">2399-3642</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Notum inhibits Wnt signalling via enzymic delipidation of Wnt ligands.  Restoration of Wnt signalling by small mol. inhibition of Notum may be of therapeutic benefit in a no. of pathologies including Alzheimer's disease.  Here we report Notum activity can be inhibited by caffeine (IC50 19μM), but not by demethylated caffeine metabolites: paraxanthine, theobromine and theophylline.  Cellular luciferase assays show Notum-suppressed Wnt3a function can be restored by caffeine with an EC50 of 46μM.  The dissocn. const. (Kd) between Notum and caffeine is 85μM as measured by surface plasmon resonance.  High-resoln. crystal structures of Notum complexes with caffeine and its minor metabolite theophylline show both compds. bind at the center of the enzymic pocket, overlapping the position of the natural substrate palmitoleic lipid, but using different binding modes.  The structural information reported here may be of relevance for the design of more potent brain-accessible Notum inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNuUwQPa65-LVg90H21EOLACvtfcHk0ljvCbbzIWKLcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVagtLbK&md5=b0691d717c92ae19707ac18226deadfc</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fs42003-020-01286-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-020-01286-5%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHillier%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DE.%2BY.%26atitle%3DCaffeine%2520Inhibits%2520Notum%2520Activity%2520by%2520Binding%2520at%2520the%2520Catalytic%2520Pocket%26jtitle%3DCommun.%2520Biol.%26date%3D2020%26volume%3D3%26issue%3D1%26spage%3D555%26doi%3D10.1038%2Fs42003-020-01286-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopke, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadie, K.</span></span> <span> </span><span class="NLM_article-title">Notum Coordinates Synapse Development via Extracellular Regulation of Wingless Trans-Synaptic Signaling</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>144</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3499</span>– <span class="NLM_lpage">3510</span>, <span class="refDoi"> DOI: 10.1242/dev.148130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1242%2Fdev.148130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28860114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVGhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2017&pages=3499-3510&issue=19&author=D.+L.+Kopkeauthor=S.+C.+Limaauthor=C.+Alexandreauthor=K.+Broadie&title=Notum+Coordinates+Synapse+Development+via+Extracellular+Regulation+of+Wingless+Trans-Synaptic+Signaling&doi=10.1242%2Fdev.148130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Notum coordinates synapse development via extracellular regulation of Wingless trans-synaptic signaling</span></div><div class="casAuthors">Kopke, Danielle L.; Lima, Sofia C.; Alexandre, Cyrille; Broadie, Kendal</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3499-3510</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">1477-9129</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Synaptogenesis requires orchestrated communication between preand postsynaptic cells via coordinated trans-synaptic signaling across the extracellular synaptomatrix.  The first Wnt signaling ligand discovered, Drosophila Wingless (Wg; Wnt1 in mammals), plays crucial roles in synaptic development, regulating synapse architecture as well as functional differentiation.  Here, we investigate synaptogenic functions of the secreted extracellular deacylase Notum, which restricts Wg signaling by cleaving an essential palmitoleate moiety.  At the glutamatergic neuromuscular junction (NMJ) synapse, we find that Notum secreted from the postsynaptic muscle acts to strongly modulate synapse growth, structural architecture, ultrastructural development and functional differentiation.  In Notum null flies, we find upregulated extracellular Wg ligand and nuclear trans-synaptic signal transduction, as well as downstream misregulation of both pre- and postsynaptic mol. assembly.  Structural, functional and mol. synaptogenic defects are all phenocopied by Wg overexpression, suggesting that Notum acts solely by inhibiting Wg trans-synaptic signaling.  Moreover, these synaptic development phenotypes are suppressed by genetically correcting Wg levels in Notum null mutants, indicating that Notum normally functions to coordinate synaptic structural and functional differentiation via neg. regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3bUmmo78O57Vg90H21EOLACvtfcHk0ljvCbbzIWKLcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVGhsrk%253D&md5=81000278c27a5e13b8c815ab23cc280b</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1242%2Fdev.148130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.148130%26sid%3Dliteratum%253Aachs%26aulast%3DKopke%26aufirst%3DD.%2BL.%26aulast%3DLima%26aufirst%3DS.%2BC.%26aulast%3DAlexandre%26aufirst%3DC.%26aulast%3DBroadie%26aufirst%3DK.%26atitle%3DNotum%2520Coordinates%2520Synapse%2520Development%2520via%2520Extracellular%2520Regulation%2520of%2520Wingless%2520Trans-Synaptic%2520Signaling%26jtitle%3DDevelopment%26date%3D2017%26volume%3D144%26issue%3D19%26spage%3D3499%26epage%3D3510%26doi%3D10.1242%2Fdev.148130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amado, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abreu, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Notum Is Required for Neural and Head Induction via Wnt Deacylation, Oxidation, and Inactivation</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.devcel.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25771893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=719-730&issue=6&author=X.+Zhangauthor=S.+M.+Cheongauthor=N.+G.+Amadoauthor=A.+H.+Reisauthor=B.+T.+MacDonaldauthor=M.+Zebischauthor=E.+Y.+Jonesauthor=J.+G.+Abreuauthor=X.+He&title=Notum+Is+Required+for+Neural+and+Head+Induction+via+Wnt+Deacylation%2C+Oxidation%2C+and+Inactivation&doi=10.1016%2Fj.devcel.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Notum Is Required for Neural and Head Induction via Wnt Deacylation, Oxidation, and Inactivation</span></div><div class="casAuthors">Zhang, Xinjun; Cheong, Seong-Moon; Amado, Nathalia G.; Reis, Alice H.; MacDonald, Bryan T.; Zebisch, Matthias; Jones, E. Yvonne; Abreu, Jose Garcia; He, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Secreted Wnt morphogens are essential for embryogenesis and homeostasis and require a lipid/palmitoleoylate modification for receptor binding and activity.  Notum is a secreted Wnt antagonist that belongs to the α/β hydrolase superfamily, but its mechanism of action and roles in vertebrate embryogenesis are not fully understood.  Here, we report that Notum hydrolyzes the Wnt palmitoleoylate adduct extracellularly, resulting in inactivated Wnt proteins that form oxidized oligomers incapable of receptor binding.  Thus, Notum is a Wnt deacylase, and palmitoleoylation is obligatory for the Wnt structure that maintains its active monomeric conformation.  Notum is expressed in naive ectoderm and neural plate in Xenopus and is required for neural and head induction.  These findings suggest that Notum is a prerequisite for the "default" neural fate and that distinct mechanisms of Wnt inactivation by the Tiki protease in the Organizer and the Notum deacylase in presumptive neuroectoderm orchestrate vertebrate brain development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxen8RtuF37Vg90H21EOLACvtfcHk0ljvCbbzIWKLcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVaisLk%253D&md5=2f5bd637c5b10522452933e9592a888b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCheong%26aufirst%3DS.%2BM.%26aulast%3DAmado%26aufirst%3DN.%2BG.%26aulast%3DReis%26aufirst%3DA.%2BH.%26aulast%3DMacDonald%26aufirst%3DB.%2BT.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DE.%2BY.%26aulast%3DAbreu%26aufirst%3DJ.%2BG.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DNotum%2520Is%2520Required%2520for%2520Neural%2520and%2520Head%2520Induction%2520via%2520Wnt%2520Deacylation%252C%2520Oxidation%252C%2520and%2520Inactivation%26jtitle%3DDev.%2520Cell%26date%3D2015%26volume%3D32%26issue%3D6%26spage%3D719%26epage%3D730%26doi%3D10.1016%2Fj.devcel.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. G.</span></span> <span> </span><span class="NLM_article-title">NOTUM Is Involved in the Progression of Colorectal Cancer</span>. <i>Cancer Genomics Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.21873/cgp.20107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.21873%2Fcgp.20107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30343282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWlsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=485-497&issue=6&author=J.+H.+Yoonauthor=D.+Kimauthor=J.+Kimauthor=H.+Leeauthor=J.+Ghimauthor=B.+J.+Kangauthor=P.+Songauthor=P.+G.+Suhauthor=S.+H.+Ryuauthor=T.+G.+Lee&title=NOTUM+Is+Involved+in+the+Progression+of+Colorectal+Cancer&doi=10.21873%2Fcgp.20107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">NOTUM Is involved in the progression of colorectal cancer</span></div><div class="casAuthors">Yoon, Jong Hyuk; Kim, Dayea; Kim, Jaeyoon; Lee, Hyeongjoo; Ghim, Jaewang; Kang, Byung Jun; Song, Parkyong; Suh, Pann-Ghill; Ryu, Sung Ho; Lee, Taehoon G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Genomics & Proteomics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">485-497</span>CODEN:
                <span class="NLM_cas:coden">CGPAC7</span>;
        ISSN:<span class="NLM_cas:issn">1790-6245</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: There are limitations to current colorectal cancer (CRC)-specific diagnostic methods and therapies.  Tumorigenesis proceeds because of interaction between cancer cells and various surrounding cells; discovering new mol. mediators through studies of the CRC secretome is a promising approach for the development of CRC diagnostics and therapies.  Materials and Methods: A comparative secretomic anal. was performed using primary and metastatic human isogenic CRC cells.  Proliferation was detd. by MTT and thymidine incorporation assay, migration was detd. by wound-healing assay (ELISA).  The level of palmitoleoyl-protein carboxylesterase (NOTUM) in plasma from patients with CRC was detd. by ELISA.  Results: NOTUM expression was increased in metastatic cells.  Proliferation was suppressed by inhibiting expression of NOTUM.  Knockdown of NOTUM genes inhibited proliferation as well as migration, with possible involvement of p38 and c-JUN N-terminal kinase in this process.  The result was verified in patients with CRC.  Conclusion: NOTUM may be a new candidate for diagnostics and therapy of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUMxJxU9DSy7Vg90H21EOLACvtfcHk0lgs42x726-VFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWlsr%252FM&md5=9970defbfb6dc7da63d869e2ba28909f</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.21873%2Fcgp.20107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fcgp.20107%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DGhim%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DB.%2BJ.%26aulast%3DSong%26aufirst%3DP.%26aulast%3DSuh%26aufirst%3DP.%2BG.%26aulast%3DRyu%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BG.%26atitle%3DNOTUM%2520Is%2520Involved%2520in%2520the%2520Progression%2520of%2520Colorectal%2520Cancer%26jtitle%3DCancer%2520Genomics%2520Proteomics%26date%3D2018%26volume%3D15%26issue%3D6%26spage%3D485%26epage%3D497%26doi%3D10.21873%2Fcgp.20107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Robertis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arigoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loiacono, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feodorova, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashkova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belovejdov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signori, E.</span></span> <span> </span><span class="NLM_article-title">Novel Insights into Notum and Glypicans Regulation in Colorectal Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">41237</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.5652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.18632%2Foncotarget.5652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26517809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC28zmvFWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=41237-41257&issue=38&author=M.+De+Robertisauthor=M.+Arigoniauthor=L.+Loiaconoauthor=F.+Riccardoauthor=R.+A.+Calogeroauthor=Y.+Feodorovaauthor=D.+Tashkovaauthor=V.+Belovejdovauthor=V.+Sarafianauthor=F.+Cavalloauthor=E.+Signori&title=Novel+Insights+into+Notum+and+Glypicans+Regulation+in+Colorectal+Cancer&doi=10.18632%2Foncotarget.5652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insights into Notum and glypicans regulation in colorectal cancer</span></div><div class="casAuthors">De Robertis Mariangela; Signori Emanuela; De Robertis Mariangela; Signori Emanuela; Arigoni Maddalena; Riccardo Federica; Calogero Raffaele Adolfo; Cavallo Federica; Loiacono Luisa; Loiacono Luisa; Feodorova Yana; Sarafian Victoria; Feodorova Yana; Sarafian Victoria; Tashkova Dessislava; Belovejdov Vesselin</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">41237-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The connection between colorectal cancer (CRC) and Wnt signaling pathway activation is well known, but full elucidation of the underlying regulation of the Wnt/β-catenin pathway and its biological functions in CRC pathogenesis is still needed.  Here, the azoxymethane/dextran sulfate sodium salt (AOM/DSS) murine model has been used as an experimental platform able to mimic human sporadic CRC development with predictable timing.  We performed genome-wide expression profiling of AOM/DSS-induced tumors and normal colon mucosa to identify potential novel CRC biomarkers.  Remarkably, the enhanced expression of Notum, a conserved feedback antagonist of Wnt, was observed in tumors along with alterations in Glypican-1 and Glypican-3 levels.  These findings were confirmed in a set of human CRC samples.  Here, we provide the first demonstration of significant changes in Notum and glypicans gene expression during CRC development and present evidence to suggest them as potential new biomarkers of CRC pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0GkyBU1_ZNzUE-swuRqsHfW6udTcc2ebMXj3ufFha27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zmvFWmtA%253D%253D&md5=69b67b7e73f637ec243dfb8e98d39a6d</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5652%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRobertis%26aufirst%3DM.%26aulast%3DArigoni%26aufirst%3DM.%26aulast%3DLoiacono%26aufirst%3DL.%26aulast%3DRiccardo%26aufirst%3DF.%26aulast%3DCalogero%26aufirst%3DR.%2BA.%26aulast%3DFeodorova%26aufirst%3DY.%26aulast%3DTashkova%26aufirst%3DD.%26aulast%3DBelovejdov%26aufirst%3DV.%26aulast%3DSarafian%26aufirst%3DV.%26aulast%3DCavallo%26aufirst%3DF.%26aulast%3DSignori%26aufirst%3DE.%26atitle%3DNovel%2520Insights%2520into%2520Notum%2520and%2520Glypicans%2520Regulation%2520in%2520Colorectal%2520Cancer%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26issue%3D38%26spage%3D41237%26epage%3D41257%26doi%3D10.18632%2Foncotarget.5652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olssont, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Species Differences in Structure-Activity Relationships of Adenosine Agonists and Xanthine Antagonists at Brain A1 Adenosine Receptors</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>209</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(86)81096-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0014-5793%2886%2981096-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3803571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2sXnvVamtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=1986&pages=122-128&issue=1&author=D.+Ukenaauthor=K.+A.+Jacobsonauthor=W.+L.+Padgettauthor=C.+Ayalaauthor=M.+T.+Shamimauthor=K.+L.+Kirkauthor=R.+O.+Olssontauthor=J.+W.+Daly&title=Species+Differences+in+Structure-Activity+Relationships+of+Adenosine+Agonists+and+Xanthine+Antagonists+at+Brain+A1+Adenosine+Receptors&doi=10.1016%2F0014-5793%2886%2981096-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors</span></div><div class="casAuthors">Ukena, Dieter; Jacobson, Kenneth A.; Padgett, William L.; Ayala, Cristina; Shamim, Mah T.; Kirk, Kenneth L.; Olsson, Ray O.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-8</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">A series of 28 adenosine analogs and 17 xanthines were assessed as inhibitors of N6-[-[3H]phenylisopropyladenosine binding to A1 adenosine receptors in membranes from rat, calf, and guinea pig brain.  Potencies of N6-alkyl- and N6-cycloalkyladenosines are similar in the different species.  However, the presence of an aryl or heteroaryl moiety in the N6 substituent results in marked species differences with certain such analogs being about 30-fold more potent at receptors in calf than in guinea pig brain.  Potencies at receptors in rat brain are intermediate.  Conversely, 2-chloroadenosine  [146-77-0] and 5'-N-ethylcarboxamidoadenosine  [35920-39-9] are ∼10-fold less potent at receptors in calf brain than in guinea pig brain.  Potencies of xanthines, such as theophylline  [58-55-9], caffeine  [58-08-2] and 1,3-dipropylxanthine  [31542-62-8] are similar in the different species.  However, the presence of an 8-Ph or 8-cycloalkyl substituent results in marked species differences.  For example, a xanthine amine conjugate of 1,3-dipropyl-8-phenylxanthine is 9-fold more potent at receptors in calf than in rat brain and 110-fold more potent in calf than in guinea pig brain.  Such differences indicate that brain A1 adenosine receptors are not identical in recognition sites for either agonists or antagonists in different mammalian species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxPjE91iDPdbVg90H21EOLACvtfcHk0lgs42x726-VFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXnvVamtw%253D%253D&md5=e99c7825a1091b93962cdbec36bb7c13</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2886%2981096-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252886%252981096-1%26sid%3Dliteratum%253Aachs%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DAyala%26aufirst%3DC.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DOlssont%26aufirst%3DR.%2BO.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DSpecies%2520Differences%2520in%2520Structure-Activity%2520Relationships%2520of%2520Adenosine%2520Agonists%2520and%2520Xanthine%2520Antagonists%2520at%2520Brain%2520A1%2520Adenosine%2520Receptors%26jtitle%3DFEBS%2520Lett.%26date%3D1986%26volume%3D209%26issue%3D1%26spage%3D122%26epage%3D128%26doi%3D10.1016%2F0014-5793%2886%2981096-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of P2 and Adenosine Receptors: Common Scaffolds Adapted for Multiple Targets</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">114311</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2020.114311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bcp.2020.114311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33130128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlClsb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2021&pages=114311&author=K.+A.+Jacobsonauthor=A.+P.+Ijzermanauthor=C.+E.+M%C3%BCller&title=Medicinal+Chemistry+of+P2+and+Adenosine+Receptors%3A+Common+Scaffolds+Adapted+for+Multiple+Targets&doi=10.1016%2Fj.bcp.2020.114311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets</span></div><div class="casAuthors">Jacobson, Kenneth A.; IJzerman, Adriaan P.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114311</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prof. Geoffrey Burnstock originated the concept of purinergic signaling.  He demonstrated the interactions and biol. roles of ionotropic P2X and metabotropic P2Y receptors.  This review paper traces the historical origins of many currently used antagonists and agonists for P2 receptors, as well as adenosine receptors, in early attempts to identify ligands for these receptors - prior to the use of chem. libraries for screening.  Rather than presenting a general review of current purinergic ligands, we focus on common chem. scaffolds (privileged scaffolds) that can be adapted for multiple receptor targets.  By carefully analyzing the structure activity relationships, one can direct the selectivity of these scaffolds toward different receptor subtypes.  For example, the weak and non-selective P2 antagonist reactive blue 2 (RB-2) was derivatized using combinatorial synthetic approaches, leading to the identification of selective P2Y2, P2Y4, P2Y12 or P2X2 receptor antagonists.  A P2X4 antagonist NC-2600 is in a clin. trial, and A3 adenosine agonists show promise, for chronic pain.  P2X7 antagonists have been in clin. trials for depression (JNJ-54175446), inflammatory bowel disease (IBD), Crohn's disease, rheumatoid arthritis, inflammatory pain and chronic obstructive pulmonary disease (COPD).  P2X3 antagonists are in clin. trials for chronic cough, and an antagonist named after Burnstock, gefapixant, is expected to be the first P2X3 antagonist filed for approval.  We are seeing that the vision of Prof.  Burnstock to use purinergic signaling modulators, most recently at P2XRs, for treating disease is coming to fruition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fR4w2iV3LrVg90H21EOLACvtfcHk0lgs42x726-VFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlClsb7P&md5=cd6be9012dde12c5ea9856473968fbe3</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2020.114311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2020.114311%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520Chemistry%2520of%2520P2%2520and%2520Adenosine%2520Receptors%253A%2520Common%2520Scaffolds%2520Adapted%2520for%2520Multiple%2520Targets%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2021%26volume%3D187%26spage%3D114311%26doi%3D10.1016%2Fj.bcp.2020.114311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of Adenosine, P2Y and P2X Receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26686393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=31-49&author=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=Medicinal+Chemistry+of+Adenosine%2C+P2Y+and+P2X+Receptors&doi=10.1016%2Fj.neuropharm.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine, P2Y and P2X receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-49</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pharmacol. tool compds. are now available to define action at the adenosine (ARs), P2Y and P2X receptors.  We present a selection of the most commonly used agents to study purines in the nervous system.  Some of these compds., including A1 and A3 AR agonists, P2Y1R and P2Y12R antagonists, and P2X3, P2X4 and P2X7 antagonists, are potentially of clin. use in treatment of disorders of the nervous system, such as chronic pain, neurodegeneration and brain injury.  Agonists of the A2AAR and P2Y2R are already used clin., P2Y12R antagonists are widely used antithrombotics and an antagonist of the A2AAR is approved in Japan for treating Parkinson's disease.  The selectivity defined for some of the previously introduced compds. has been revised with updated pharmacol. characterization, for example, various AR agonists and antagonists were deemed A1AR or A3AR selective based on human data, but species differences indicated a redn. in selectivity ratios in other species.  Also, many of the P2R ligands still lack bioavailability due to charged groups or hydrolytic (either enzymic or chem.) instability.  X-ray crystallog. structures of AR and P2YRs have shifted the mode of ligand discovery to structure-based approaches rather than previous empirical approaches.  The X-ray structures can be utilized either for in silico screening of chem. diverse libraries for the discovery of novel ligands or for enhancement of the properties of known ligands by chem. modification.  Although X-ray structures of the zebrafish P2X4R have been reported, there is scant structural information about ligand recognition in these trimeric ion channels.  In summary, there are definitive, selective agonists and antagonists for all of the ARs and some of the P2YRs; while the pharmacochem. of P2XRs is still in nascent stages.  The therapeutic potential of selectively modulating these receptors is continuing to gain interest in such fields as cancer, inflammation, pain, diabetes, ischemic protection and many other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfj6lh6K1FbLVg90H21EOLACvtfcHk0ljlJJ9GWBlHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF&md5=ffcb23c7e271df86ef6b24d88aef2d82</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Adenosine%252C%2520P2Y%2520and%2520P2X%2520Receptors%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D104%26spage%3D31%26epage%3D49%26doi%3D10.1016%2Fj.neuropharm.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span>; <span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Xanthines as Adenosine Receptor Antagonists</span>.  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">199</span>. <span class="refDoi"> DOI: 10.1007/978-3-642-13443-2_6</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2F978-3-642-13443-2_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=151-199&author=C.+E.+M%C3%BCller&author=K.+A.+Jacobson&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-13443-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-13443-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DXanthines%2520as%2520Adenosine%2520Receptor%2520Antagonists%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D2011%26spage%3D151%26epage%3D199%26doi%3D10.1007%2F978-3-642-13443-2_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Adenosine A2A Receptor as a Drug Discovery Target</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3623</span>– <span class="NLM_lpage">3650</span>, <span class="refDoi"> DOI: 10.1021/jm4011669</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011669" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3623-3650&issue=9&author=M.+De+Lera+Ruizauthor=Y.+H.+Limauthor=J.+Zheng&title=Adenosine+A2A+Receptor+as+a+Drug+Discovery+Target&doi=10.1021%2Fjm4011669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A Receptor as a Drug Discovery Target</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Lim, Yeon-Hee; Zheng, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3623-3650</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications.  Herein the authors describe adenosine A2A receptor distribution, signaling pathways, pharmacol., and mol. structure, followed by a summary and SAR discussion of the most relevant series of adenosine A2A agonists and antagonists.  This review also provides an update of the A2A ligands that are undergoing or have undergone clin. studies, including the two currently marketed agonists adenosine and regadenoson.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQUPGC7zBCkbVg90H21EOLACvtfcHk0ljlJJ9GWBlHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7bJ&md5=846641d1ac3ad16b6335af6b4df15f08</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm4011669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011669%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DY.%2BH.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DAdenosine%2520A2A%2520Receptor%2520as%2520a%2520Drug%2520Discovery%2520Target%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D9%26spage%3D3623%26epage%3D3650%26doi%3D10.1021%2Fjm4011669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span> <span> </span><span class="NLM_article-title">The A3 Adenosine Receptor: History and Perspectives</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1124/pr.113.008540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fpr.113.008540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25387804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=74-102&issue=1&author=P.+A.+Boreaauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Merighiauthor=S.+Gessi&title=The+A3+Adenosine+Receptor%3A+History+and+Perspectives&doi=10.1124%2Fpr.113.008540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: history and perspectives</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Merighi, Stefania; Gessi, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-102, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  By general consensus, the omnipresent purine nucleoside adenosine is considered a major regulator of local tissue function, esp. when energy supply fails to meet cellular energy demand.  Adenosine mediation involves activation of a family of four G protein-coupled adenosine receptors (ARs): A1, A2A, A2B, and A3.  The A3 adenosine receptor (A3AR) is the only adenosine subtype to be overexpressed in inflammatory and cancer cells, thus making it a potential target for therapy.  Originally isolated as an orphan receptor, A3AR presented a twofold nature under different pathophysiol. conditions: it appeared to be protective/harmful under ischemic conditions, pro/anti-inflammatory, and pro/antitumoral depending on the systems investigated.  Until recently, the greatest and most intriguing challenge has been to understand whether, and in which cases, selective A3 agonists or antagonists would be the best choice.  Today, the choice has been made and A3AR agonists are now under clin. development for some disorders including rheumatoid arthritis, psoriasis, glaucoma, and hepatocellular carcinoma.  More specifically, the interest and relevance of these new agents derives from clin. data demonstrating that A3AR agonists are both effective and safe.  Thus, it will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTebUcia2x7Vg90H21EOLACvtfcHk0ljlJJ9GWBlHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D&md5=152673d44c951624ccb2ef090ffc670c</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008540%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26atitle%3DThe%2520A3%2520Adenosine%2520Receptor%253A%2520History%2520and%2520Perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26issue%3D1%26spage%3D74%26epage%3D102%26doi%3D10.1124%2Fpr.113.008540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, X.</span></span> <span> </span><span class="NLM_article-title">Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson’s Disease: A Recent Update and Challenge</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=783-791&issue=2&author=J.+Zhengauthor=X.+Zhangauthor=X.+Zhen&title=Development+of+Adenosine+A2A+Receptor+Antagonists+for+the+Treatment+of+Parkinson%E2%80%99s+Disease%3A+A+Recent+Update+and+Challenge&doi=10.1021%2Facschemneuro.8b00313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson's Disease: A Recent Update and Challenge</span></div><div class="casAuthors">Zheng, Jiyue; Zhang, Xiaohu; Zhen, Xuechu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">783-791</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurodegenerative disease with significant unmet medical needs.  The current dopamine-centered treatments aim to restore motor functions of patients without slowing the disease progression.  Long-term usage of these drugs is assocd. with diminished efficacy, motor fluctuation, and dyskinesia.  Furthermore, the nonmotor features assocd. with PD such as sleep disorder, pain, and psychiatric symptoms are poorly addressed by the dopaminergic treatments.  Adenosine receptor A2A antagonists have emerged as potential treatment for PD in the past decade.  Here we summarize the recent work (2015-2018) on adenosine receptor A2A antagonists and discuss the challenge and opportunity for the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBNiUzkD86SbVg90H21EOLACvtfcHk0lhHq-9tSsZ5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OktL7J&md5=10474b8ad7c20097676b02ee797a589e</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00313%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhen%26aufirst%3DX.%26atitle%3DDevelopment%2520of%2520Adenosine%2520A2A%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520Recent%2520Update%2520and%2520Challenge%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26issue%3D2%26spage%3D783%26epage%3D791%26doi%3D10.1021%2Facschemneuro.8b00313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creveling, C. R.</span></span> <span> </span><span class="NLM_article-title">A Radioisotopic Method for Measuring the Formation of Adenosine 3′,5′-Cyclic Monophosphate in Incubated Slices of Brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1609</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1969.tb10360.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1471-4159.1969.tb10360.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=4314281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE3cXlt1KgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1969&pages=1609-1619&issue=12&author=H.+Shimizuauthor=J.+W.+Dalyauthor=C.+R.+Creveling&title=A+Radioisotopic+Method+for+Measuring+the+Formation+of+Adenosine+3%E2%80%B2%2C5%E2%80%B2-Cyclic+Monophosphate+in+Incubated+Slices+of+Brain&doi=10.1111%2Fj.1471-4159.1969.tb10360.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain</span></div><div class="casAuthors">Shimizu, Hirotoshi; Daly, J. W.; Creveling, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1609-19</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">A simple and sensitive method for measuring the effect of neurohormones and other chem. agents on the formation of adenosine 3',5'-cyclic monophos phate (cyclic 3',5'-AMP) in incubated slices of brain was developed.  The principle of the method depends on pulse-labeling of adenosine 5'-triphosphate in slices of brain with adenine-8-14C followed by incubation in a medium contg. the test substance, sepn. by thin-layer chromatog. of the cyclic nucleotide formed in the slices, and radioassay.  The purity of the cyclic nucleotide was confirmed by chromatog. in a variety of systems and by hydrolysis with a specific, bovine-heart phosphodiesterase.  The method was used to study the effect of histamine, norepinephrine, and adenosine on the accumulation of 3',5'-AMP in incubated slices of brain .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrf9x4k6NIrVg90H21EOLACvtfcHk0lhHq-9tSsZ5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXlt1KgtQ%253D%253D&md5=fa236193917a4d30f4b7ace1c4a79f5b</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1969.tb10360.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1969.tb10360.x%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DCreveling%26aufirst%3DC.%2BR.%26atitle%3DA%2520Radioisotopic%2520Method%2520for%2520Measuring%2520the%2520Formation%2520of%2520Adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Cyclic%2520Monophosphate%2520in%2520Incubated%2520Slices%2520of%2520Brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1969%26volume%3D16%26issue%3D12%26spage%3D1609%26epage%3D1619%26doi%3D10.1111%2Fj.1471-4159.1969.tb10360.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Londos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, J.</span></span> <span> </span><span class="NLM_article-title">Two Distinct Adenosine-Sensitive Sites on Adenylate Cyclase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5482</span>– <span class="NLM_lpage">5486</span>, <span class="refDoi"> DOI: 10.1073/pnas.74.12.5482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.74.12.5482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=271970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE1cXosFWrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1977&pages=5482-5486&issue=12&author=C.+Londosauthor=J.+Wolff&title=Two+Distinct+Adenosine-Sensitive+Sites+on+Adenylate+Cyclase&doi=10.1073%2Fpnas.74.12.5482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Two distinct adenosine-sensitive sites on adenylate cyclase</span></div><div class="casAuthors">Londos, Constantine; Wolff, J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5482-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The effects of adenosine and adenosine analogs on adenylate cyclases from several tissues were examd.  2 Adenosine-reactive sites were identified: (1) the R site, occupancy of which usually leads to activation of cyclase and which requires integrity of the ribose ring for activity, and (2) the P site, which mediates inhibition and requires integrity of the purine ring for activity.  Biphasic effects of adenosine are explained by the presence of both sites on a single adenylate cyclase.  Comparison of these data with those in the literature indicates that adenosine-reactive P and R sites are present generally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXNkjWLZ6CubVg90H21EOLACvtfcHk0lhtFDKpKPhZ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXosFWrtQ%253D%253D&md5=602aba5d60ff5da9cfeb70a3513f44df</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1073%2Fpnas.74.12.5482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.74.12.5482%26sid%3Dliteratum%253Aachs%26aulast%3DLondos%26aufirst%3DC.%26aulast%3DWolff%26aufirst%3DJ.%26atitle%3DTwo%2520Distinct%2520Adenosine-Sensitive%2520Sites%2520on%2520Adenylate%2520Cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1977%26volume%3D74%26issue%3D12%26spage%3D5482%26epage%3D5486%26doi%3D10.1073%2Fpnas.74.12.5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamprecht, B.</span></span> <span> </span><span class="NLM_article-title">Adenosine Regulates Via Two Different Types of Receptors, the Accumulation of Cyclic Amp in Cultured Brain Cells</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">999</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1979.tb05236.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1471-4159.1979.tb05236.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=228008" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1979&pages=999-1005&issue=5&author=D.+Calkerauthor=M.+M%C3%BCllerauthor=B.+Hamprecht&title=Adenosine+Regulates+Via+Two+Different+Types+of+Receptors%2C+the+Accumulation+of+Cyclic+Amp+in+Cultured+Brain+Cells&doi=10.1111%2Fj.1471-4159.1979.tb05236.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1979.tb05236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1979.tb05236.x%26sid%3Dliteratum%253Aachs%26aulast%3DCalker%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DAdenosine%2520Regulates%2520Via%2520Two%2520Different%2520Types%2520of%2520Receptors%252C%2520the%2520Accumulation%2520of%2520Cyclic%2520Amp%2520in%2520Cultured%2520Brain%2520Cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1979%26volume%3D33%26issue%3D5%26spage%3D999%26epage%3D1005%26doi%3D10.1111%2Fj.1471-4159.1979.tb05236.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbracchio, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">IV. Nomenclature and Classification of Purinoreceptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7938164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=143-156&issue=2&author=B.+Bertilauthor=M.+P.+Abbracchioauthor=G.+Burnstockauthor=J.+W.+Dalyauthor=K.+T.+Hardenauthor=K.+A.+Jacobsonauthor=P.+Leffauthor=M.+Williams&title=IV.+Nomenclature+and+Classification+of+Purinoreceptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertil%26aufirst%3DB.%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DHarden%26aufirst%3DK.%2BT.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DIV.%2520Nomenclature%2520and%2520Classification%2520of%2520Purinoreceptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D1994%26volume%3D46%26issue%3D2%26spage%3D143%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butts-Lamb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W.</span></span> <span> </span><span class="NLM_article-title">Subclasses of Adenosine Receptors in the Central Nervous System: Interaction with Caffeine and Related Methylxanthines</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1007/BF00734999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00734999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6309393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1983&pages=69-80&issue=1&author=J.+W.+Dalyauthor=P.+Butts-Lambauthor=W.+Padgett&title=Subclasses+of+Adenosine+Receptors+in+the+Central+Nervous+System%3A+Interaction+with+Caffeine+and+Related+Methylxanthines&doi=10.1007%2FBF00734999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Subclasses of adenosine receptors in the central nervous system:  interaction with caffeine and related methylxanthines</span></div><div class="casAuthors">Daly, John W.; Butts-Lamb, Pamela; Padgett, William</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    </div><div class="casAbstract">The potencies of caffeine (I)  [58-08-2] and related methylxanthines as adenosine antagonists were assessed with respect to 3 apparent subtypes of adenosine receptors in rat brain prepns.: (1) the A1-adenosine receptor which binds with a very high affinity the ligand [3H]cyclohexyladenosine in rat brain membranes; (2) a ubiquitous low-affinity A2-adenosine receptor which activates cyclic AMP  [60-92-4] accumulation in rat brain slices, and (3) a relatively high-affinity A2-adenosine receptor which activates adenylate cyclase  [9012-42-4] in rat striatal membranes (this A2-adenosine system is present in striatal but not in cerebral cortical membranes).  Caffeine and other methylxanthines, thus, antagonize effectively both A1- and A2-adenosine receptors in brain prepns.  Theobromine  [83-67-0] appears less effective vs. A2-receptors than vs. A1-receptors.  The functional significance of antagonism of such adenosine receptors by caffeine in situ will depend both on the local levels of adenosine and on the affinity for adenosine for the receptor, since antagonism by xanthines is competitive in nature.  In addn., the functional significance of xanthine action will depend on the degree of inhibition of adenosine input which is required to alter the output signal.  For a stimulatory input to adenylate cyclase via an A2-adenosine receptor, profound antagonism by methylxanthines is probably required to alter the cyclic AMP-mediated output signal, while for inhibitory input to adenylate cyclase via an A1-adenosine receptor, presumably a lesser degree of antagonism by methylamines may be required to alter the cyclic AMP-mediated output signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDacfOvNrNcbVg90H21EOLACvtfcHk0lhtFDKpKPhZ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D&md5=94132d6b898b052e58f965cd417889b2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1007%2FBF00734999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00734999%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DButts-Lamb%26aufirst%3DP.%26aulast%3DPadgett%26aufirst%3DW.%26atitle%3DSubclasses%2520of%2520Adenosine%2520Receptors%2520in%2520the%2520Central%2520Nervous%2520System%253A%2520Interaction%2520with%2520Caffeine%2520and%2520Related%2520Methylxanthines%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D1983%26volume%3D3%26issue%3D1%26spage%3D69%26epage%3D80%26doi%3D10.1007%2FBF00734999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Characterization of an Adenosine Receptor: The A3 Adenosine Receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7432</span>– <span class="NLM_lpage">7436</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.16.7432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.89.16.7432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1323836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1Sqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=7432-7436&issue=16&author=Q.+Y.+Zhouauthor=L.+I.+Liauthor=M.+E.+Olahauthor=R.+A.+Johnsonauthor=G.+L.+Stilesauthor=O.+Civelli&title=Molecular+Cloning+and+Characterization+of+an+Adenosine+Receptor%3A+The+A3+Adenosine+Receptor&doi=10.1073%2Fpnas.89.16.7432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of an adenosine receptor:  The A3 adenosine receptor</span></div><div class="casAuthors">Zhou, Qun Yong; Li, Chuanyu; Olah, Mark E.; Johnson, Robert A.; Stiles, Gary L.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7432-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The authors have previously reported the selective amplification of several rat striatal cDNA sequences that encode guanine nucleotide-binding regulatory protein (G protein)-coupled receptors.  One of these sequences (R226) exhibited high sequence identity (58%) with the two previously cloned adenosine receptors.  A full-length cDNA clone for R226 has been isolated from a rat brain cDNA library.  The cDNA clone encodes a protein of 320 amino acids that can be organized into seven transmembrane stretches.  R226 has been expressed in COS-7 and CHO cells and membranes from the transfected cells were screened with adenosine receptor radioligands.  R226 could bind the nonselective adenosine agonist tritiated N-ethyladenosine 5'-uronic acid ([3H]NECA) and the A1-selective agonist radioiodinated N6-2-(4-amino-3-iodophenyl)-ethyladenosine ([125I]APNEA) but not the A1-selective antagonists tritiated 1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX) or 8-{4-[({[(2-aminoethyl)amino]carbonyl}methyl)oxy]-phenyl}-1,3-dipropylxanthine ([3H]XAC) or the A2-selective agonist ligands tritiated 2-[4-(2-carboxyethyl)phenyl]ethylamino 5'-N-ethylcarboxamidoadenosine ([3H]CGS21680) or radioiodinated 2-[4-({2-[(4-aminophenyl)methylcarbonylamino]ethylaminocarbonyl}ethyl)phenyl]ethylamino 5'-N-ethylcarboxamidoadenosine.  Extensive characterization with [125I]APNEA showed that R226 binds [125I]APNEA with high affinity (Kd = 15.5 nM) and the specific [125I]APNEA binding could be inhibited by adenosine ligands with a potency order of (R)-N6-phenyl-2-propyladenosine (R-PIA) = NECA > S-PIA > adenosine > ATP = ADP but not by antagonists XAC, isobutylmethylxanthine, and DPCPX.  In R226 stably transfected CHO cells, adenosine agonists R-PIA, NECA, and CGS21680 inhibited by 40-50% the forskolin-stimulated cAMP accumulation through a pertussis toxin-sensitive G protein with an EC50 of 18 nM, 23 nM, and 144 nM, resp.  Based on these observations the authors conclude that R226 encodes an adenosine receptor with non-A1 and non-A2 specificity, and name it the A3 adenosine receptor.  The mRNA analyses revealed that the highest expression of R226 was in the testis and low-level mRNAs were also found in the lung, kidneys, heart, and some parts of the central nervous system such as cortex, striatum, and olfactory bulb.  The high-expression level of the A3 receptor in the testis suggests a possible role for adenosine in reprodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB0MXPtRUdFrVg90H21EOLACvtfcHk0lhtFDKpKPhZ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1Sqsr0%253D&md5=8f00a5d4bc8e43bb8f1574e05006d0ae</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.16.7432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.16.7432%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DL.%2BI.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DMolecular%2520Cloning%2520and%2520Characterization%2520of%2520an%2520Adenosine%2520Receptor%253A%2520The%2520A3%2520Adenosine%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26issue%3D16%26spage%3D7432%26epage%3D7436%26doi%3D10.1073%2Fpnas.89.16.7432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haskó, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csóka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Németh, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span> <span> </span><span class="NLM_article-title">A2B Adenosine Receptors in Immunity and Inflammation</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/j.it.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.it.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19427267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=263-270&issue=6&author=G.+Hask%C3%B3author=B.+Cs%C3%B3kaauthor=Z.+H.+N%C3%A9methauthor=E.+S.+Viziauthor=P.+Pacher&title=A2B+Adenosine+Receptors+in+Immunity+and+Inflammation&doi=10.1016%2Fj.it.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptors in immunity and inflammation</span></div><div class="casAuthors">Hasko, Gyoergy; Csoka, Balazs; Nemeth, Zoltan H.; Vizi, E. Sylvester; Pacher, Pal</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A2B adenosine receptors are increasingly recognized as important orchestrators of inflammation.  A2B receptor activation promotes the inflammatory response of mast cells, epithelial cells, smooth muscle cells and fibroblasts, thereby contributing to the pathophysiol. of asthma and colitis.  A2B receptor stimulation limits endothelial cell inflammatory responses and permeability and suppresses macrophage activation thereby preventing tissue injury after episodes of hypoxia and ischemia.  A2B receptor stimulation also promotes the prodn. of angiogenic cytokines by endothelial cells, mast cells and dendritic cells, aiding granuloma tissue formation and inflammatory resoln., but can also contribute to tumor growth.  A2B receptors are, thus, potentially important pharmacol. targets in treating immune system dysfunction and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5JA17dyrT7Vg90H21EOLACvtfcHk0li8JwVrm1R3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ynt7s%253D&md5=4aebd9d9b7d823dcc0a89f94b539d127</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHask%25C3%25B3%26aufirst%3DG.%26aulast%3DCs%25C3%25B3ka%26aufirst%3DB.%26aulast%3DN%25C3%25A9meth%26aufirst%3DZ.%2BH.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26aulast%3DPacher%26aufirst%3DP.%26atitle%3DA2B%2520Adenosine%2520Receptors%2520in%2520Immunity%2520and%2520Inflammation%26jtitle%3DTrends%2520Immunol.%26date%3D2009%26volume%3D30%26issue%3D6%26spage%3D263%26epage%3D270%26doi%3D10.1016%2Fj.it.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hide, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M.</span></span> <span> </span><span class="NLM_article-title">Caffeine Analogs: Structure Activity Relationship at Adenosine Receptors</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1159/000138813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1159%2F000138813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1658821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3MXlt1Kgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1991&pages=309-321&author=J.+W.+Dalyauthor=I.+Hideauthor=C.+E.+M%C3%BCllerauthor=M.+Shamim&title=Caffeine+Analogs%3A+Structure+Activity+Relationship+at+Adenosine+Receptors&doi=10.1159%2F000138813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine analogs:  structure-activity relationships at adenosine receptors</span></div><div class="casAuthors">Daly, John W.; Hide, Izumi; Muller, Christa E.; Shamim, Mah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">309-21</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    </div><div class="casAbstract">Caffeine and analogs (I, e.g., R1, R2, R3 = Me, Et, Pr, allyl, propargyl) were antagonists at the 2 major classes (A1 and A2) of adenosine receptors.  Potency at both receptors increased as methyls were replaced with larger substituents.  Certain analogs with only one of the 3 Me groups of caffeine replaced by larger substituents were somewhat selective for A2 receptors.  None of the analogs were particularly selective for A1 receptors.  The presence of polar entities in the substituent at the 1- or 7-position was poorly tolerated at adenosine receptors.  Activity of caffeine analogs at A1 and A2 adenosine receptors in a variety of systems and cell types is presented and summarized.  Methods of prepn. (alkylation of the corresponding xanthines) are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrIiF_tALZLVg90H21EOLACvtfcHk0li8JwVrm1R3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt1Kgu70%253D&md5=34fd29aa4fa5b47a1a1dbf9b93a2e14a</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1159%2F000138813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000138813%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DHide%26aufirst%3DI.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DShamim%26aufirst%3DM.%26atitle%3DCaffeine%2520Analogs%253A%2520Structure%2520Activity%2520Relationship%2520at%2520Adenosine%2520Receptors%26jtitle%3DPharmacology%26date%3D1991%26volume%3D42%26spage%3D309%26epage%3D321%26doi%3D10.1159%2F000138813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors in Brain Membranes: Binding of N6-Cyclohexyl[3H]Adenosine and 1,3-Diethyl-8-[3H]Phenylxanthine</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5547</span>– <span class="NLM_lpage">5551</span>, <span class="refDoi"> DOI: 10.1073/pnas.77.9.5547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.77.9.5547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6254090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3MXisFKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1980&pages=5547-5551&issue=9&author=R.+F.+Brunsauthor=J.+W.+Dalyauthor=S.+H.+Snyder&title=Adenosine+Receptors+in+Brain+Membranes%3A+Binding+of+N6-Cyclohexyl%5B3H%5DAdenosine+and+1%2C3-Diethyl-8-%5B3H%5DPhenylxanthine&doi=10.1073%2Fpnas.77.9.5547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in brain membranes:  Binding of N6-cyclohexyl[3H]-adenosine and 1,3-diethyl-8-[3H]-phenylxanthine</span></div><div class="casAuthors">Bruns, Robert F.; Daly, John W.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5547-51</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">3H-labeled N6-cyclohexyladenosine (CHA) (I)  [36396-99-3] and 3H-labeled 1,3-diethyl-8-phenylxanthene (DPX) (II)  [75922-48-4] bind to adenosine  [58-61-7] receptors in brain membranes.  The agonist [3H]CHA has high affinity in both bovine and guinea pig brain (Kd 0.7 nM and 6 nM, resp.).  [3H]CHA binding kinetics are slow (dissocn. half-time (dt2) 60 min); binding is much higher at 25° than at 0° and is inhibited by guanine nucleotides.  Potencies of nucleosides and xanthines in cometing for [3H]CHA sites indicate that specific binding is entirely to A1 adenosine receptors.  In bovine brain, the antagonist [3H]DPX exhibits high-affinity binding (Kd, 5 nM) to the same A1 receptors that bind [3H]CHA.  Binding kinetics are rapid (dt2, 1 min), and binding is moderately higher at 0° than at 25°.  In guinea pig brain, [3H]DPX binding has only moderate affinity (Kd, 50 nM), and ∼60% of specific binding is to sites that resemble A2 adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ysUJP8-uhbVg90H21EOLACvtfcHk0li8JwVrm1R3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXisFKitw%253D%253D&md5=96131f75411af9eaff377fee23ccd0e5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.77.9.5547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.77.9.5547%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DAdenosine%2520Receptors%2520in%2520Brain%2520Membranes%253A%2520Binding%2520of%2520N6-Cyclohexyl%255B3H%255DAdenosine%2520and%25201%252C3-Diethyl-8-%255B3H%255DPhenylxanthine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1980%26volume%3D77%26issue%3D9%26spage%3D5547%26epage%3D5551%26doi%3D10.1073%2Fpnas.77.9.5547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Binding: Structure-Activity Analysis Generates Extremely Potent Xanthine Antagonists</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2077</span>– <span class="NLM_lpage">2080</span>, <span class="refDoi"> DOI: 10.1073/pnas.80.7.2077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.80.7.2077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6300892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL3sXksVOmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=2077-2080&issue=7&author=R.+F.+Brunsauthor=J.+W.+Dalyauthor=S.+H.+Snyder&title=Adenosine+Receptor+Binding%3A+Structure-Activity+Analysis+Generates+Extremely+Potent+Xanthine+Antagonists&doi=10.1073%2Fpnas.80.7.2077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor binding:  Structure-activity analysis generates extremely potent xanthine antagonists</span></div><div class="casAuthors">Bruns, Robert F.; Daly, John W.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2077-80</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Structure-activity anal. of alkylxanthine derivs. at adenosine  [58-61-7] receptor binding sites was employed in the designing of potent adenosine receptor antagonists.  Receptor affinities of xanthines were detd. by measuring inhibition of the binding of N6-[3H]cyclohexyladenosine to bovine brain membranes.  1,3-Di-Pr substitutions enhance potency compared to the 1,3-di-Me substitution in theophylline.  An 8-Ph substituent produces a considerable increase in potency, which is augmented by certain para substitutions on the 8-Ph ring.  Combining an ortho amino with a para-chloro substituent on the 8-Ph ring affords further increases in potency.  Combining all of these substituents results in 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (I)  [85872-51-1] a compd. of extraordinary receptor affinity, with a Ki for adenosine A1 receptors of 22 pM.  It is 4,000,000 times more potent than xanthine  [69-89-6] itself and 70,000 times more potent than theophylline  [58-55-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-hoXimS0Jv7Vg90H21EOLACvtfcHk0liwDoR-wH0sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksVOmsbc%253D&md5=b7ee3f5a1beaafbb6a44646bcfd1ecf9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.7.2077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.7.2077%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DAdenosine%2520Receptor%2520Binding%253A%2520Structure-Activity%2520Analysis%2520Generates%2520Extremely%2520Potent%2520Xanthine%2520Antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26issue%3D7%26spage%3D2077%26epage%3D2080%26doi%3D10.1073%2Fpnas.80.7.2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Functionalized Congeners of 1,3-Dipropyl-8-Phenylxanthine: Potent Antagonists for Adenosine Receptors That Modulate Membrane Adenylate Cyclase in Pheochromocytoma Cells, Platelets and Fat Cells</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(86)90596-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2886%2990596-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3005794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28XhsVais78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1986&pages=797-807&author=D.+Ukenaauthor=J.+W.+Dalyauthor=K.+L.+Kirkauthor=K.+A.+Jacobson&title=Functionalized+Congeners+of+1%2C3-Dipropyl-8-Phenylxanthine%3A+Potent+Antagonists+for+Adenosine+Receptors+That+Modulate+Membrane+Adenylate+Cyclase+in+Pheochromocytoma+Cells%2C+Platelets+and+Fat+Cells&doi=10.1016%2F0024-3205%2886%2990596-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized congeners of 1,3-dipropyl-8-phenylxanthine:  potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells</span></div><div class="casAuthors">Ukena, Dieter; Daly, John W.; Kirk, Kenneth L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">797-807</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">Amine, amino acid and peptide derivs. derived from 1,3-dipropyl-8-(p-carboxymethylphenyl)xanthine (I; R = H, D-Lys, L-Met, D-Tyr-D-Lys, etc.), a functionalized congener of 1,3-dipropyl-8-phenylxanthine, were investigated as antagonists at A2 adenosine receptors stimulatory to adenylate cyclase  [9012-42-4] in membranes from rat pheochromocytoma PC 12 cells and human platelets and at A1 adenosine receptors inhibitory to adenylate cyclase from rat fat cells.  The congeners and conjugates have affinity consts. ranging from 80 to 310 nM at A2 receptors of PC 12 cells and from 25 to 135 nM at those of platelets.  The affinity of the xanthine derivs. at A1 receptors of fat cells are in the 15-30 nM range.  Thus, the amino acid and peptide conjugates have high potencies at both receptor subclasses and show some selectivity toward A1 adenosine receptors.  Derivs. of the congeners should be useful as receptor probes and as radioiodinated ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSANp1xgCdIrVg90H21EOLACvtfcHk0liwDoR-wH0sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhsVais78%253D&md5=82e5ca7ff00c8efaa17c904ef50b4665</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2886%2990596-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252886%252990596-5%26sid%3Dliteratum%253Aachs%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionalized%2520Congeners%2520of%25201%252C3-Dipropyl-8-Phenylxanthine%253A%2520Potent%2520Antagonists%2520for%2520Adenosine%2520Receptors%2520That%2520Modulate%2520Membrane%2520Adenylate%2520Cyclase%2520in%2520Pheochromocytoma%2520Cells%252C%2520Platelets%2520and%2520Fat%2520Cells%26jtitle%3DLife%2520Sci.%26date%3D1986%26volume%3D38%26spage%3D797%26epage%3D807%26doi%3D10.1016%2F0024-3205%2886%2990596-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">[3H]Xanthine Amine Congener of 1,3-Dipropyl-8-Phenylxanthine: An Antagonist Radioligand for Adenosine Receptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4089</span>– <span class="NLM_lpage">4093</span>, <span class="refDoi"> DOI: 10.1073/pnas.83.11.4089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.83.11.4089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3012550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28Xls1Gmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=4089-4093&issue=11&author=K.+A.+Jacobsonauthor=D.+Ukenaauthor=K.+L.+Kirkauthor=J.+W.+Daly&title=%5B3H%5DXanthine+Amine+Congener+of+1%2C3-Dipropyl-8-Phenylxanthine%3A+An+Antagonist+Radioligand+for+Adenosine+Receptors&doi=10.1073%2Fpnas.83.11.4089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]Xanthine amine congener of 1,3-dipropyl-8-phenylxanthine:  an antagonist radioligand for adenosine receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Ukena, Dieter; Kirk, Kenneth L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4089-93</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">An amine-functionalized deriv. of 1,3-dipropyl-8-phenylxanthine  [85872-53-3] was prepd. as a 3H xanthine amine congener ([3H]XAC)  [104557-18-8] for use as an antagonist radioligand for adenosine receptors.  [3H]XAC has higher receptor affinity, higher specific activity, lower nonspecific membrane binding, and more favorable hydrophilicity than 3H-labeled 1,3-diethyl-8-phenylxanthine  [75922-48-4], the xanthine commonly used for adenosine receptor binding.  In rat cerebral cortical membranes, [3H]XAC exhibits saturable, specific binding with a dissocn. const. (Kd) of 1.23 nM and max. binding of 580 fmol/mg protein at 37°.  N6-(R-phenylisopropyl)adenosine  [38594-96-6] is a more potent inhibitor of [3H]XAC binding than is 5-N-ethylcarboxamidoadenosine  [35920-39-9], indicating that binding is to an A1-adenosine receptor.  In the absence of GTP  [86-01-1], the inhibition curves for adenosine agonists vs. [3H]XAC binding are biphasic, indicating that [3H]XAC is binding to low- and high-affinity agonist states of the A1 receptor.  In the presence of GTP, adenosine analogs exhibit monophasic, low-affinity inhibition of binding of [3H]XAC.  Inhibition of [3H]XAC binding by theophylline  [58-55-9] or by various 8-phenylxanthines is monophasic, and the potencies are commensurate with the potencies of these xanthines as adenosine receptor antagonists.  The receptor sites in calf brain membranes exhibit a higher affinity (Kd = 0.17 nM) for [3H]XAC, whereas sites in guinea pig exhibit a slightly lower affinity (Kd = 3.0 nM).  Densities of [3H]XAC binding sites are similar in brain membranes from all species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA69dnrLJszrVg90H21EOLACvtfcHk0liwDoR-wH0sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xls1Gmurk%253D&md5=5efa97d5bb9be6f9387b745199ac466d</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.11.4089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.11.4089%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D%255B3H%255DXanthine%2520Amine%2520Congener%2520of%25201%252C3-Dipropyl-8-Phenylxanthine%253A%2520An%2520Antagonist%2520Radioligand%2520for%2520Adenosine%2520Receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26issue%3D11%26spage%3D4089%26epage%3D4093%26doi%3D10.1073%2Fpnas.83.11.4089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fergus, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristol, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santay, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hays, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span> <span> </span><span class="NLM_article-title">Binding of the A1-Selective Adenosine Antagonist 8-Cyclopentyl-1,3-Dipropylxanthine to Rat Brain Membranes</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>335</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1007/BF00165037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00165037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3574492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2sXhsV2gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1987&pages=59-63&issue=1&author=R.+F.+Brunsauthor=J.+H.+Fergusauthor=E.+W.+Badgerauthor=J.+A.+Bristolauthor=L.+A.+Santayauthor=J.+D.+Hartmanauthor=S.+J.+Haysauthor=C.+C.+Huang&title=Binding+of+the+A1-Selective+Adenosine+Antagonist+8-Cyclopentyl-1%2C3-Dipropylxanthine+to+Rat+Brain+Membranes&doi=10.1007%2FBF00165037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes</span></div><div class="casAuthors">Bruns, Robert F.; Fergus, James H.; Badger, Edward W.; Bristol, James A.; Santay, Lisa A.; Hartman, Jon D.; Hays, Sheryl J.; Huang, Che C.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">PD 116948 (8-cyclopentyl-1,3-dipropylxanthine)(I)  [102146-07-6] is a very potent, very A1-selective adenosine antagonist, with a Ki of 0.46 nM for A1 receptors in rat whole-brain membranes and 340 nM for A2 receptors in rat striatal membranes.  Its 740-fold A1-selectivity is the highest reported for an adenosine antagonist.  3H-PD 116948  [107478-32-0] (117 Ci/mmol) was prepd. by redn. of the diallyl analog.  3H-PD 116948 bound to a single site in rat whole-brain membranes, with a Bmax of 46 pmol/g and Kd of 0.42 nM.  Nonspecific binding was extremely low, amounting to about 3% of total binding under std. conditions and <1% when higher tissue concns. were used.  Affinities of compds. for inhibition of 3H-PD 116948 binding were highly consistent with an A1 adenosine receptor.  Antagonists were equally potent in 3H-PD 116948 binding and in [3H]N6-cyclohexyladenosine (CHA) binding, whereas agonists were consistently about 12-fold more potent in CHA binding.  Hill coeffs. were 1.0 for antagonists and about 0.65 for agonists.  3H-PD 116948 should be a useful antagonist ligand for adenosine A1 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAoGVLUcIm0rVg90H21EOLACvtfcHk0liwDoR-wH0sRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsV2gs7s%253D&md5=016a6dfd75371e5be52e44e98ab27a91</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1007%2FBF00165037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00165037%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DFergus%26aufirst%3DJ.%2BH.%26aulast%3DBadger%26aufirst%3DE.%2BW.%26aulast%3DBristol%26aufirst%3DJ.%2BA.%26aulast%3DSantay%26aufirst%3DL.%2BA.%26aulast%3DHartman%26aufirst%3DJ.%2BD.%26aulast%3DHays%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26atitle%3DBinding%2520of%2520the%2520A1-Selective%2520Adenosine%2520Antagonist%25208-Cyclopentyl-1%252C3-Dipropylxanthine%2520to%2520Rat%2520Brain%2520Membranes%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1987%26volume%3D335%26issue%3D1%26spage%3D59%26epage%3D63%26doi%3D10.1007%2FBF00165037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, A.</span></span> <span> </span><span class="NLM_article-title">8-Polycycloalkyl-1,3-Dipropylxanthines as Potent and Selective Antagonists for A1-Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/jm00083a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00083a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XhvVOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=924-930&issue=5&author=J.+Shimadaauthor=F.+Suzukiauthor=H.+Nonakaauthor=A.+Ishii&title=8-Polycycloalkyl-1%2C3-Dipropylxanthines+as+Potent+and+Selective+Antagonists+for+A1-Adenosine+Receptors&doi=10.1021%2Fjm00083a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors</span></div><div class="casAuthors">Shimada, Junichi; Suzuki, Fumio; Nonaka, Hiromi; Ishii, Akio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">924-30</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">With the aim of characterizing the hydrophobic interactions between xanthines and the A1 receptor site, 1,3-dipropyl-8-substituted xanthines (I, R = e.g., heteraryl, alkyl, alicyclic, or noradamantyl group) were prepd.  Introduction of a quaternary carbon and the conformationally restricted cyclopental moiety into the 8-position of xanthine enhanced the adenosine A1 antagonism.  1,3-Dipropyl-8-(3-noradamantyl)xanthine was identified to be a selective and the most potent A1 receptor antagonist reported to date.  Under the structure-activity relation study, the 8-substituent of xanthine antagonists and the N6-substituent of adenosine agonists appears to bind to the same region of the A1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1zxD_KlyFpLVg90H21EOLACvtfcHk0libEKhVlfun_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhvVOntbY%253D&md5=fad39d18bb9720d99c31dbbe9b808b2c</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm00083a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00083a018%26sid%3Dliteratum%253Aachs%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DA.%26atitle%3D8-Polycycloalkyl-1%252C3-Dipropylxanthines%2520as%2520Potent%2520and%2520Selective%2520Antagonists%2520for%2520A1-Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26issue%3D5%26spage%3D924%26epage%3D930%26doi%3D10.1021%2Fjm00083a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belardinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyrpock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammels, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">S. P, B.</span></span> <span> </span><span class="NLM_article-title">1,3-Dipropyl-8-[2-(5,6-Epoxy)Norbornyl]Xanthine, a Potent, Specific and Selective A1 Adenosine Receptor Antagonist in the Guinea Pig Heart and Brain and in DDT1MF-2 Cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8531078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK28XhvVylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=1167-1176&author=L.+Belardinelliauthor=J.+C.+Shyrpockauthor=Y.+Zhangauthor=P.+J.+Scammelsauthor=R.+Olssonauthor=D.+Dennisauthor=P.+Milnerauthor=J.+Pfisterauthor=B.+S.+P&title=1%2C3-Dipropyl-8-%5B2-%285%2C6-Epoxy%29Norbornyl%5DXanthine%2C+a+Potent%2C+Specific+and+Selective+A1+Adenosine+Receptor+Antagonist+in+the+Guinea+Pig+Heart+and+Brain+and+in+DDT1MF-2+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells</span></div><div class="casAuthors">Belardinelli, Luiz; Shryock, John C.; Zhang, Yi; Schammells, Peter J.; Olsson, Ray; Dennis, Donn; Milner, Peter; Pfister, Juerg; Baker, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1167-76</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The objective of this study was to characterize the adenosine receptor (AdoR) antagonistic properties of a newly synthesized alkylxanthine, 1,3-dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine (ENX), and compare them to those of 1,3-dipropyl-8-(cyclopentyl)xanthine (CPX), 1,3-dipropyl-8-(3-noradamantyl)xanthine (NAX) and (±)-N6-endo-norbornan-2-yl-9-methyladenine (N-0861).  The potencies and selectivities of ENX, CPX, NAX and N-0861 were detd. by functional studies of guinea pig isolated perfused hearts, and by radioligand binding assays for A1 and A2a AdoRs in the guinea pig forebrain and striatum.  ENX competitively antagonized A1 AdoR-mediated prolongations of atrioventricular nodal conduction time caused by Ado or by 2-chloro-N6-cyclopentyladenosine, but not those caused by carbachol (0.14 μM) or MgCl2 (3 mM).  Schild anal. of 2-chloro-N6-cyclopentyladenosine-antagonist competition curves yielded pA2 values for ENX, CPX and NAX of 8.45, 8.55 and 8.79, resp.  ENX (30 μM) and N-0861 (30 μM) did not attenuate the A2 AdoR-mediated increase in coronary conductance caused by adenosine.  CPX and NAX attenuated the coronary vasodilation caused by adenosine with IC50 values of 1.5 and 7.1 μM, resp.  Radioligand binding assays revealed that ENX, CPX and NAX and N-0861 had a 400-, 209-, 110- and 10-fold greater affinity, resp., for A1 than for A2a AdoRs of guinea pig brain membranes.  Thus, ENX was equipotent with CPX and NAX and more potent than N-0861 (pA2 = 6.2) as an antagonist at A1 AdoRs, but had lower affinity for A2 AdoRs in guinea pig hearts and brain striatum than did either CPX or NAX.  In DDT1 MF-2 cells, all three alkylxanthines had similar affinities for A1 AdoRs, whereas the affinity of N-0861 for A1 AdoRs was significantly lower.  ENX appears to be the most A1 AdoR subtype-selective of the alkylxanthine class of AdoR antagonists reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0V5u05phkDrVg90H21EOLACvtfcHk0libEKhVlfun_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVylsw%253D%253D&md5=bba1e92023b4bbbed94d8c655e087e34</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShyrpock%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DScammels%26aufirst%3DP.%2BJ.%26aulast%3DOlsson%26aufirst%3DR.%26aulast%3DDennis%26aufirst%3DD.%26aulast%3DMilner%26aufirst%3DP.%26aulast%3DPfister%26aufirst%3DJ.%26aulast%3DS.%2BP%26aufirst%3DB.%26atitle%3D1%252C3-Dipropyl-8-%255B2-%25285%252C6-Epoxy%2529Norbornyl%255DXanthine%252C%2520a%2520Potent%252C%2520Specific%2520and%2520Selective%2520A1%2520Adenosine%2520Receptor%2520Antagonist%2520in%2520the%2520Guinea%2520Pig%2520Heart%2520and%2520Brain%2520and%2520in%2520DDT1MF-2%2520Cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D1167%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butts-Lamb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, J.</span></span> <span> </span><span class="NLM_article-title">1,3-Dialkyl-8-(p-Sulfophenyl)Xanthines: Potent Water-Soluble Antagonists for A1 -and A2-Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1021/jm00382a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00382a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2MXhtlWrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=487-492&issue=4&author=J.+W.+Dalyauthor=W.+Padgettauthor=M.+T.+Shamimauthor=P.+Butts-Lambauthor=J.+Waters&title=1%2C3-Dialkyl-8-%28p-Sulfophenyl%29Xanthines%3A+Potent+Water-Soluble+Antagonists+for+A1+-and+A2-Adenosine+Receptors&doi=10.1021%2Fjm00382a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Dialkyl-8-(p-sulfophenyl)xanthines:  potent water-soluble antagonists for A1- and A2-adenosine receptors</span></div><div class="casAuthors">Daly, John W.; Padgett, W.; Shamim, M. T.; Butts-Lamb, P.; Waters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-92</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">8-Aryl-1,3-dialkylxanthines I (R-R2 = Me, R3 = H, Ph; R = R1 = Me, Pr, R2 = H, R3 = substituted Ph; R = CH2CH2CHMe2, R1 = CH2CHMe2, R2 = H, R3 = H, Ph, 4-HO3SC6H4) were prepd.  These and some related compds. were tested for their potency and selectivity as A1- and A2-adenosine receptor antagonists.  Structure-activity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4iTyBT2D7ErVg90H21EOLACvtfcHk0libEKhVlfun_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtlWrsr0%253D&md5=e3a4454b7bbd6268db6b067e7b3def67</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm00382a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00382a018%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DPadgett%26aufirst%3DW.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DButts-Lamb%26aufirst%3DP.%26aulast%3DWaters%26aufirst%3DJ.%26atitle%3D1%252C3-Dialkyl-8-%2528p-Sulfophenyl%2529Xanthines%253A%2520Potent%2520Water-Soluble%2520Antagonists%2520for%2520A1%2520-and%2520A2-Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26issue%3D4%26spage%3D487%26epage%3D492%26doi%3D10.1021%2Fjm00382a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristol, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haleen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, R. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Xanthines as Adenosine Antagonists, a Practical Quantitative Structure-Activity Relationship Application</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1021/jm00146a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00146a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL2MXktlWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1071-1079&issue=8&author=H.+W.+Hamiltonauthor=D.+F.+Ortwineauthor=D.+F.+Worthauthor=E.+W.+Badgerauthor=J.+A.+Bristolauthor=R.+F.+Brunsauthor=S.+J.+Haleenauthor=R.+P.+Steffen&title=Synthesis+of+Xanthines+as+Adenosine+Antagonists%2C+a+Practical+Quantitative+Structure-Activity+Relationship+Application&doi=10.1021%2Fjm00146a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application</span></div><div class="casAuthors">Hamilton, Harriet W.; Ortwine, Daniel F.; Worth, Donald F.; Badger, Edward W.; Bristol, James A.; Bruns, Robert F.; Haleen, Stephen J.; Steffen, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1071-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The title xanthines I (R = C1-3 or allyl; R1 = NH2, SO2NH2, NMe2, SO2-morpholino, SO2NHCH2CH(OH)Me, etc.) were prepd. by treatment of appropriate diaminouracil with substituted benzoic acid to the amine amids followed by cyclization to either the phenylxanthine directly or the sulfonic acid which in turn was converted to the sulfonyl chloride and then reacted without isolation with amines to yield the (phenylsulfonamido)xanthines I; these and other previously prepd. xanthines were evaluated for adenosine A1 receptor binding affinity using rat and bovine brain membranes.  High potency as predicted by QSAR anal. was maintained by I; aq. soly. of these compds was also increased.  In vitro antagonism of adenosine receptors was demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2TI1qdEMzLbVg90H21EOLACvtfcHk0liC27qPI54n5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktlWqt7o%253D&md5=71b69160bfbdb3e7bc7dfa3bafe84b83</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm00146a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00146a016%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DH.%2BW.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DWorth%26aufirst%3DD.%2BF.%26aulast%3DBadger%26aufirst%3DE.%2BW.%26aulast%3DBristol%26aufirst%3DJ.%2BA.%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DHaleen%26aufirst%3DS.%2BJ.%26aulast%3DSteffen%26aufirst%3DR.%2BP.%26atitle%3DSynthesis%2520of%2520Xanthines%2520as%2520Adenosine%2520Antagonists%252C%2520a%2520Practical%2520Quantitative%2520Structure-Activity%2520Relationship%2520Application%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26issue%3D8%26spage%3D1071%26epage%3D1079%26doi%3D10.1021%2Fjm00146a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">8-Aryl- and 8-Cycloalkyl-1,3-Dipropylxanthines: Further Potent and Selective Antagonists for A1-Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1021/jm00398a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00398a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1cXpsVGisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=613-617&issue=3&author=M.+T.+Shamimauthor=D.+Ukenaauthor=W.+L.+Padgettauthor=O.+Hongauthor=J.+W.+Daly&title=8-Aryl-+and+8-Cycloalkyl-1%2C3-Dipropylxanthines%3A+Further+Potent+and+Selective+Antagonists+for+A1-Adenosine+Receptors&doi=10.1021%2Fjm00398a020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">8-Aryl- and 8-cycloalkyl-1,3-dipropylxanthines:  further potent and selective antagonists for A1-adenosine receptors</span></div><div class="casAuthors">Shamim, M. T.; Ukena, D.; Padgett, W. L.; Hong, O.; Daly, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 1,3-dipropylxanthines were prepd. with a variety of substituents, including aryl and cycloalkyl groups, at the 8-position.  Polar carboxylate and carboxamide moieties were introduced as aryl substituents to increase H2O soly.  1,3-Dipropyl-8-[2-hydroxy-4-[(carboxymethyl)oxy]phenyl]xanthine (I) is a functionalized congener with high potency (Ki = 37 nM) and selectivity (54-fold) for A1-adenosine receptors.  I was used to prep. a series of other analogs, some with higher potency and some with higher selectivity.  8-Cyclopentyl- and 8-cyclohexyl-1,3-dipropylxanthines were both very potent (Ki = 1-1.5 nM) and selective for A1 receptors, while 8-cycloalkylmethyl analogs were 10-fold less potent, but still very selective for A1 receptors.  8-Piperidinyl and 8-pyrazinyl analogs had very low activities as adenosine receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUnTSAgAEe5bVg90H21EOLACvtfcHk0liC27qPI54n5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXpsVGisA%253D%253D&md5=120b988d865b01fb8319c1630fba44f7</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fjm00398a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00398a020%26sid%3Dliteratum%253Aachs%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DHong%26aufirst%3DO.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D8-Aryl-%2520and%25208-Cycloalkyl-1%252C3-Dipropylxanthines%253A%2520Further%2520Potent%2520and%2520Selective%2520Antagonists%2520for%2520A1-Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26issue%3D3%26spage%3D613%26epage%3D617%26doi%3D10.1021%2Fjm00398a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiesman, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutterodt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fure, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span> <span> </span><span class="NLM_article-title">Potent and Orally Bioavailable 8-Bicyclo[2.2.2]Octylxanthines as Adenosine A1 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7119</span>– <span class="NLM_lpage">7131</span>, <span class="refDoi"> DOI: 10.1021/jm0605381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOjs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7119-7131&issue=24&author=W.+F.+Kiesmanauthor=J.+Zhaoauthor=P.+R.+Conlonauthor=J.+E.+Dowlingauthor=R.+C.+Petterauthor=F.+Lutterodtauthor=X.+Jinauthor=G.+Smitsauthor=M.+Fureauthor=A.+Jayarajauthor=J.+Kimauthor=G.+Sullivanauthor=J.+Linden&title=Potent+and+Orally+Bioavailable+8-Bicyclo%5B2.2.2%5DOctylxanthines+as+Adenosine+A1+Receptor+Antagonists&doi=10.1021%2Fjm0605381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists</span></div><div class="casAuthors">Kiesman, William F.; Zhao, Jin; Conlon, Patrick R.; Dowling, James E.; Petter, Russell C.; Lutterodt, Frank; Jin, Xiaowei; Smits, Glenn; Fure, Mary; Jayaraj, Andrew; Kim, John; Sullivan, Gail; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7119-7131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the search for a selective adenosine A1 receptor antagonist with greater aq. soly. than the compds. currently in clin. trials as diuretics, a series of 1,4-substituted 8-cyclohexyl and 8-bicyclo[2.2.2]octylxanthines were investigated.  The binding affinities of a variety of cyclohexyl and bicyclo[2.2.2]octylxanthines for the rat and human adenosine A1, A2A, A2B, and A3 receptors are presented.  Bicyclo[2.2.2]octylxanthine (I) exhibited good pharmaceutical properties and in vivo activity in a rat diuresis model (ED50 = 0.3 mg/kg po).  Optimization of the bridgehead substituent led to propionic acid 29 (BG9928), which retained high potency (hA1, Ki = 7 nM) and selectivity for the adenosine A1 receptor (915-fold vs. adenosine A2A receptor; 12-fold vs. adenosine A2B receptor) with improved oral efficacy in the rat diuresis model (ED50 = 0.01 mg/kg) as well as high oral bioavailability in rat, dog, and cynomolgus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEOLB4TaAywLVg90H21EOLACvtfcHk0liC27qPI54n5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOjs7nO&md5=4b4ba095879893ab5da18665ecc81b0a</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm0605381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605381%26sid%3Dliteratum%253Aachs%26aulast%3DKiesman%26aufirst%3DW.%2BF.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DConlon%26aufirst%3DP.%2BR.%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DLutterodt%26aufirst%3DF.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DSmits%26aufirst%3DG.%26aulast%3DFure%26aufirst%3DM.%26aulast%3DJayaraj%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSullivan%26aufirst%3DG.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DPotent%2520and%2520Orally%2520Bioavailable%25208-Bicyclo%255B2.2.2%255DOctylxanthines%2520as%2520Adenosine%2520A1%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D24%26spage%3D7119%26epage%3D7131%26doi%3D10.1021%2Fjm0605381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Analogs of Caffeine: Antagonists with Selectivity for A2 Adenosine Receptors</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(86)90023-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2886%2990023-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3016449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL28Xlt1Oltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1986&pages=743-750&author=D.+Ukenaauthor=M.+T.+Shamimauthor=W.+Padgettauthor=J.+W.+Daly&title=Analogs+of+Caffeine%3A+Antagonists+with+Selectivity+for+A2+Adenosine+Receptors&doi=10.1016%2F0024-3205%2886%2990023-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of caffeine:  antagonists with selectivity for A2 adenosine receptors</span></div><div class="casAuthors">Ukena, D.; Shamim, M. T.; Padgett, W.; Daly, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">743-50</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">Several analogs of caffeine  [58-08-2] were investigated as antagonists at A2 adenosine receptors stimulatory to adenylate cyclase  [9012-42-4] in membranes from rat pheochromocytoma PC12 cells and human platelets and at A1 adenosine receptors inhibitory to adenylate cyclase from rat fat cells.  1-Propargyl-3,7-dimethylxanthine  [14114-46-6] was 4-7-fold and 7-propyl-1,3-dimethylxanthine  [27760-74-3] was 3-4-fold more potent than caffeine at A2 receptors of PC12 cells and platelets.  At A1 receptors of fat cells, both compds. were about 50% as potent as caffeine.  These caffeine analogs are the first selective A2 receptor antagonists yet reported, and these results may provide the basis for the further development of highly potent and highly selective A2 adenosine receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr55ep6uG8QebVg90H21EOLACvtfcHk0lgjhgkuUMmiyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xlt1Oltr8%253D&md5=b7baf3552679918528c41df5be36dc31</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2886%2990023-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252886%252990023-8%26sid%3Dliteratum%253Aachs%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DPadgett%26aufirst%3DW.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DAnalogs%2520of%2520Caffeine%253A%2520Antagonists%2520with%2520Selectivity%2520for%2520A2%2520Adenosine%2520Receptors%26jtitle%3DLife%2520Sci.%26date%3D1986%26volume%3D39%26spage%3D743%26epage%3D750%26doi%3D10.1016%2F0024-3205%2886%2990023-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seale, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abla, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carney, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">3,7-Dimethyl-1-Propargylxanthine: A Potent and Selective in Vivo Antagonist of Adenosine Analogs</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(88)90478-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0024-3205%2888%2990478-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3193854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1988&pages=1671-1684&author=T.+W.+Sealeauthor=K.+A.+Ablaauthor=M.+T.+Shamimauthor=J.+M.+Carneyauthor=J.+W.+Daly&title=3%2C7-Dimethyl-1-Propargylxanthine%3A+A+Potent+and+Selective+in+Vivo+Antagonist+of+Adenosine+Analogs&doi=10.1016%2F0024-3205%2888%2990478-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">3,7-Dimethyl-1-propargylxanthine:  a potent and selective in vivo antagonist of adenosine analogs</span></div><div class="casAuthors">Seale, Thomas W.; Abla, Kathleen A.; Shamim, Mah T.; Carney, John M.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1671-84</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">3,7-Dimethyl-1-propargylxanthine (DMPX), a caffeine analog that exhibits in vivo selectivity for A2-adenosine receptors, compared to A1-adenosine receptors, was investigated with respect to in vivo potency and selectivity.  DMPX potently and selectively blocked the actions of the potent A2 adenosine agonist, 5'-N-ethylcarboxamidoadenosine (NECA), in DBA/2 mice, compared to blockade of the same responses elicited by the selective A1-adenosine agonist, N6-cyclohexyladenosine (CHA).  DMPX was 57-fold more potent against NECA-induced hypothermia than against CHA-induced hypothermia and 11-fold more potent against NECA-induced behavioral depression than against CHA-induced behavioral depression.  The hypothermia is mediated by peripheral receptors, based on blockade by 8-(p-sulfophenyl)theophylline (PSPT), while the behavioral depression is centrally mediated, based on lack of blockade by PSPT.  DMPX was 28- and 15-fold more potent than caffeine in blocking peripheral and central NECA responses, resp.  DMPX was equipotent with caffeine vs. CHA-induced hypothermia and 2.5-fold more potent than caffeine vs. CHA-induced behavioral depression.  The motor stimulating potency of DMPX (ED50 10 μmol/kg) was slightly greater than caffeine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF3qkqws9GZLVg90H21EOLACvtfcHk0lgjhgkuUMmiyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVCjsA%253D%253D&md5=60748b0f23a6f20df61abf6f7157c16f</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2888%2990478-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252888%252990478-X%26sid%3Dliteratum%253Aachs%26aulast%3DSeale%26aufirst%3DT.%2BW.%26aulast%3DAbla%26aufirst%3DK.%2BA.%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D3%252C7-Dimethyl-1-Propargylxanthine%253A%2520A%2520Potent%2520and%2520Selective%2520in%2520Vivo%2520Antagonist%2520of%2520Adenosine%2520Analogs%26jtitle%3DLife%2520Sci.%26date%3D1988%26volume%3D43%26spage%3D1671%26epage%3D1684%26doi%3D10.1016%2F0024-3205%2888%2990478-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamim, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">Effects of 8-Phenyl and 8-Cycloalkyl Substituents on the Activity of Mono-, Di-, and Trisubstituted Alkylxanthines with Substitution at the 1-, 3-, and 7-Positions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1231</span>– <span class="NLM_lpage">1237</span>, <span class="refDoi"> DOI: 10.1021/jm00126a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00126a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Cqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1231-1237&issue=6&author=M.+T.+Shamimauthor=D.+Ukenaauthor=W.+L.+Padgettauthor=J.+W.+Daly&title=Effects+of+8-Phenyl+and+8-Cycloalkyl+Substituents+on+the+Activity+of+Mono-%2C+Di-%2C+and+Trisubstituted+Alkylxanthines+with+Substitution+at+the+1-%2C+3-%2C+and+7-Positions&doi=10.1021%2Fjm00126a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions</span></div><div class="casAuthors">Shamim, Mah T.; Ukena, Dieter; Padgett, William L.; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1231-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The effects of 8-Ph and 8-cycloalkyl substituents on the activity of theophylline, caffeine, 1,3-dipropylxanthine, 1,3-dipropyl-7-methylxanthine, 3-propylxanthine, and 1-propylxanthine at A1 adenosine receptors of rat brain and fat cells and at A2 adenosine receptors of rat pheochromocytoma PC12 cells and human platelets were compared.  An 8-Ph substituent had little effect on the activity of caffeine or 1,3-dipropyl-7-methylxanthine at adenosine receptors, while markedly increasing the activity of theophylline, 1,3-dipropylxanthine, 1-isoamyl-3-isobutylxanthine, 1-methylxanthine, and 3-propylxanthine.  8-Phenyl-1-propylxanthine was potent (Ki = 20-70 nM) at all receptors.  A p-carboxy or p-sulfo substituent, which was introduced on the 8-Ph ring to increase water soly., in most cases decreased the activity and selectivity for the A1 receptor.  Among the 8-p-sulfo analogs, only 8-(p-sulfophenyl)theophylline and 1,3-dipropyl-8-(p-sulfophenyl)xanthine were selective for the A1 receptors.  The 8-p-sulfophenyl derivs. of caffeine, 1,3-dipropyl-7-methylxanthine, and 3-propylxanthine were somewhat selective for the A2 receptors.  8-Cycloalkyl substituents (cyclopentyl, cyclohexyl) markedly increased the activity of caffeine and 1,3-dipropyl-7-methylxanthine at the A2 receptor.  8-Cyclohexylcaffeine was potent (Ki = 190 nM) and very selective for the human platelet A2 receptor, but was not as selective for the rat PC12 A2 receptor.  Such A2 selectivity is in contrast to the marked A1 selectivity of 8-cycloalkyltheophyllines and 8-cycloalkyl-1,3-dipropylxanthines.  The apparent selectivity of certain xanthines is dependent on the assay systems that are compared.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVZkaAS8EWbrVg90H21EOLACvtfcHk0lgjhgkuUMmiyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Cqurc%253D&md5=51d806cb8b544b2e48ef403ca604c2b5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm00126a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00126a014%26sid%3Dliteratum%253Aachs%26aulast%3DShamim%26aufirst%3DM.%2BT.%26aulast%3DUkena%26aufirst%3DD.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DEffects%2520of%25208-Phenyl%2520and%25208-Cycloalkyl%2520Substituents%2520on%2520the%2520Activity%2520of%2520Mono-%252C%2520Di-%252C%2520and%2520Trisubstituted%2520Alkylxanthines%2520with%2520Substitution%2520at%2520the%25201-%252C%25203-%252C%2520and%25207-Positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26issue%3D6%26spage%3D1231%26epage%3D1237%26doi%3D10.1021%2Fjm00126a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichikawa, S.</span></span> <span> </span><span class="NLM_article-title">(E)-1,3-Dialkyl-7-Methyl-8-(3,4,5-Trimethoxystyryl)Xanthines: Potent and Selective Adenosine A2 Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2342</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1021/jm00090a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00090a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK38XktF2qs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2342-2345&author=J.+Shimadaauthor=F.+Suzukiauthor=H.+Nonakaauthor=A.+Ishiiauthor=S.+Ichikawa&title=%28E%29-1%2C3-Dialkyl-7-Methyl-8-%283%2C4%2C5-Trimethoxystyryl%29Xanthines%3A+Potent+and+Selective+Adenosine+A2+Antagonists&doi=10.1021%2Fjm00090a027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">(E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines:  potent and selective adenosine A2 antagonists</span></div><div class="casAuthors">Shimada, Junichi; Suzuki, Fumio; Nonaka, Hiromi; Ishii, Akio; Ichikawa, Shunji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2342-5</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 8-substituted 1,3,7-trialkylxanthines was tested for their hydrophobic interactions with the adenosine A2 receptor.  (E)-Styryl substitution at the 8-position increased the affinity at the A2 receptor and A2 selectivity.  Furthermore introduction of dimethoxy or trimethoxy group into the 8-styryl substituent of 1,3-dipropyl-7-methylxanthines enhanced the A2 selectivity in general.  No apparent differences in the affinity at the A2 receptor were obsd. among a series of (E)-1,3-dialkyl-7-methyl-8-(3,5,6-trimethoxystyryl)xanthine derivs.  This result is greatly contrasting with that of 1,3-disubstituted 8-alkyl- or 8-polycycloalkylxanthine derivs. where 1,3-disubstituents dramatically influenced affinity at the A1 receptor and its selectivity.  The most potent A2 antagonist, (E)-1,3-dipropyl-7-methyl-8-(3,4-dimethoxystyryl)xanthine (I) (Ki = 7.8 nM, A1/A2 = 190) produced a much larger shift of the NECA dose-response curve for blood pressure (A2) than for heart rate (A1) at the oral dose of 30 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJzjx_yPGaSrVg90H21EOLACvtfcHk0liceeNbUJVP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktF2qs7c%253D&md5=33d11a3027e9e5318aff945318919872</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjm00090a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00090a027%26sid%3Dliteratum%253Aachs%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DA.%26aulast%3DIchikawa%26aufirst%3DS.%26atitle%3D%2528E%2529-1%252C3-Dialkyl-7-Methyl-8-%25283%252C4%252C5-Trimethoxystyryl%2529Xanthines%253A%2520Potent%2520and%2520Selective%2520Adenosine%2520A2%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2342%26epage%3D2345%26doi%3D10.1021%2Fjm00090a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kase, H.</span></span> <span> </span><span class="NLM_article-title">KF17837 ((E)-8-(3,4-Dimethoxystyryl)- 1,3-Dipropyl-7-Methylxanthine), a Potent and Selective Adenosine A 2 Receptor Antagonist</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(94)90159-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0922-4106%2894%2990159-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8088373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1994&pages=335-341&author=H.+Nonakaauthor=M.+Ichimuraauthor=M.+Takedaauthor=Y.+Nonakaauthor=J.+Shimadaauthor=F.+Suzukiauthor=K.+Yamaguchiauthor=H.+Kase&title=KF17837+%28%28E%29-8-%283%2C4-Dimethoxystyryl%29-+1%2C3-Dipropyl-7-Methylxanthine%29%2C+a+Potent+and+Selective+Adenosine+A+2+Receptor+Antagonist&doi=10.1016%2F0922-4106%2894%2990159-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist</span></div><div class="casAuthors">Nonaka, Hiromi; Ichimura, Michio; Takeda, Masami; Nonaka, Yoshiko; Shimada, Jyunichi; Suzuki, Fumio; Yamaguchi, Kazuo; Kase, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-41</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">8-(3,4-Dimethoxystyryl)-1,3-dipropyl-7-methylxanthine exhibited high affinity and selectivity for adenosine A2A receptors in binding assay using rat striatal A2A receptors labeled with [3H]2-[p-(2-carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680).  The affinity was stereo selective: the E isomer, KF17837, showed a Ki value of 1.0±0.057 nM for the A2A receptors, whereas the Z isomer showed much lower affinity.  KF17837 had 62-fold selectivity for the A2A receptors vs. rat forebrain A1 receptors labeled with [3H]N6-cyclohexyladenosine (CHA).  KF17837 was rapidly photoisomerized to form a stable equil. mixt. (18% E - 82% Z), KF17837S, which showed Ki values of 7.9±0.055 nM and 390±68 nM for the A2A and A1 receptors, resp.  The inhibition type was competitive for [3H]CGS21680 binding.  In rat pheochromocytoma PC12 cells KF17837S antagonized cAMP accumulation induced by 1 μM CGS21680 via the A2A receptors, with an IC50 value of 53±10 nM. cAMP accumulation induced by 10 μM 5'-N-ethylcarboxamidoadenosine via the A2B receptors in Jurkat cells (human T-cell line) was inhibited by KF17837S with an IC50 value of 1500±290 nM.  These results indicate that KF17837S (and hence KF17837) is a highly potent and selective adenosine A2A receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaycIuJFo4rLVg90H21EOLACvtfcHk0liceeNbUJVP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kkt7w%253D&md5=7e8b90e1b5caca1113d9ffb5f3e321f9</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2894%2990159-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252894%252990159-7%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DIchimura%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKase%26aufirst%3DH.%26atitle%3DKF17837%2520%2528%2528E%2529-8-%25283%252C4-Dimethoxystyryl%2529-%25201%252C3-Dipropyl-7-Methylxanthine%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Adenosine%2520A%25202%2520Receptor%2520Antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1994%26volume%3D267%26spage%3D335%26epage%3D341%26doi%3D10.1016%2F0922-4106%2894%2990159-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bergen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Galen, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karton, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of 8-Styrylxanthines as A2-Selective Adenosine Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1342</span>, <span class="refDoi"> DOI: 10.1021/jm00062a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00062a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXisFCls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1333-1342&issue=10&author=K.+A.+Jacobsonauthor=C.+Gallo-Rodriguezauthor=N.+Melmanauthor=B.+Fischerauthor=M.+Maillardauthor=A.+Van+Bergenauthor=P.+J.+M.+Van+Galenauthor=Y.+Karton&title=Structure-Activity+Relationships+of+8-Styrylxanthines+as+A2-Selective+Adenosine+Antagonists&doi=10.1021%2Fjm00062a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gallo-Rodriguez, Carola; Melman, Neli; Fischer, Bilha; Maillard, Michel; van Bergen, Andrew; van Galen, Philip J. M.; Karton, Yishai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1333-42</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of substituted 8-styryl derivs. of 1,3,7-alkylxanthines I [i.e., R-R2 = H, Me, R3 = (un)substituted Ph]was synthesized as potential A2-selective adenosine receptor antagonists, and the potency at rat brain A1- and A2-receptors was studied in radioligand binding expts.  At the xanthine 7-position, only small hydrophobic substituents were tolerated in receptor binding.  7-Me analogs were roughly 1 order of magnitude more selective for A2 vs. A1 receptors than the corresponding 7-H analogs.  1,3-Dimethylxanthine derivs. tended to be more selective for A2-receptors than the corresponding 1,3-diallyl, di-Et, or di-Pr derivs.  Substitutions of the Ph ring at the 3-(monosubstituted) and 3,5-(disubstituted) positions were favored.  I (R - R2 = Me, R3 = 3-ClC6H4) was a moderately potent and high A2-selective adenosine antagonist.  I (R - R2 = Me, R3 = 3-HO2CCH2CH2CONHC6H4) was highly A2-selective and had enhanced water soly.  I [R, R1 = Pr, R2 = Me, R3 = 3,5-(MeO)2C6H3] was a potent and very A2-selective adenosine antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIguFj7oPkLVg90H21EOLACvtfcHk0liceeNbUJVP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisFCls7k%253D&md5=73e0889d05bd90ec0b3fa745054a92ca</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm00062a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00062a005%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DVan%2BBergen%26aufirst%3DA.%26aulast%3DVan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DKarton%26aufirst%3DY.%26atitle%3DStructure-Activity%2520Relationships%2520of%25208-Styrylxanthines%2520as%2520A2-Selective%2520Adenosine%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D10%26spage%3D1333%26epage%3D1342%26doi%3D10.1021%2Fjm00062a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikodijević, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgett, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span> <span> </span><span class="NLM_article-title">8-(3-Chlorostyryl)Caffeine (CSC) Is a Selective A2-Adenosine Antagonist in Vitro and in Vivo</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>323</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)81466-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0014-5793%2893%2981466-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8495727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXksVSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=1993&pages=141-144&issue=1%E2%80%932&author=K.+A.+Jacobsonauthor=O.+Nikodijevi%C4%87author=W.+L.+Padgettauthor=C.+Gallo-Rodriguezauthor=M.+Maillardauthor=J.+W.+Daly&title=8-%283-Chlorostyryl%29Caffeine+%28CSC%29+Is+a+Selective+A2-Adenosine+Antagonist+in+Vitro+and+in+Vivo&doi=10.1016%2F0014-5793%2893%2981466-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo</span></div><div class="casAuthors">Jacobson, Kenneth A.; Nikodijevic, Olga; Padgett, William L.; Gallo-Rodriguez, Carola; Maillard, Michel; Daly, John W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">141-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">An adenosine antagonist, 8-(3-chlorostyryl)caffeine (CSC), was shown previously to be 520-fold selective for A2a-adenosine receptors in radioligand binding assays in the rat brain.  In reversing agonist effects on adenylate cyclase, CSC was 22-fold selective for A2a receptors in rat pheochromocytoma cells (Kb 60 nM) vs. A1 receptors in rat adipocytes (Kb 1.3 μM).  Administered i.p. in NIH mice at a dose of 1 mg/kg, CSC shifted the curve for locomotor depression elicited by the A2a-selective agonist 2-[(2-aminoethylamino)carbonylethylphenylethylamino]-5'-N-ethylcarboxamidoadenosine (APEC) to the right (ED50 value for APEC shifted from 20 μg/kg i.p. to 190 μg/kg).  CSC had no effect on locomotor depression elicited by an ED50 dose of the A1-selective agonist N6-cyclohexyladenosine (CHA).  CSC alone at a dose of 5 mg/kg stimulated locomotor activity by 22% over control values.  Coadministration of CSC and the A1-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX), both at non-stimulatory doses, increased activity by 37% (P < 0.001) over CSC alone, suggesting a behavioral synergism of A1- and A2-antagonist effects in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobFlWRPu5O1rVg90H21EOLACvtfcHk0liceeNbUJVP4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVSrs70%253D&md5=cb3a114dbe97c33b56690662b20bfd25</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2981466-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252981466-D%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DNikodijevi%25C4%2587%26aufirst%3DO.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D8-%25283-Chlorostyryl%2529Caffeine%2520%2528CSC%2529%2520Is%2520a%2520Selective%2520A2-Adenosine%2520Antagonist%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D323%26issue%3D1%25E2%2580%25932%26spage%3D141%26epage%3D144%26doi%3D10.1016%2F0014-5793%2893%2981466-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Schyf, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonsalla, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzschild, M. A.</span></span> <span> </span><span class="NLM_article-title">8-(3-Chlorostyryl) Caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">36040</span>– <span class="NLM_lpage">36044</span>, <span class="refDoi"> DOI: 10.1074/jbc.M206830200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1074%2Fjbc.M206830200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12130655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=36040-36044&issue=39&author=J.+F.+Chenauthor=S.+Steynauthor=R.+Staalauthor=J.+P.+Petzerauthor=K.+Xuauthor=C.+J.+Van+Der+Schyfauthor=K.+Castagnoliauthor=P.+K.+Sonsallaauthor=N.+Castagnoliauthor=M.+A.+Schwarzschild&title=8-%283-Chlorostyryl%29+Caffeine+May+Attenuate+MPTP+Neurotoxicity+through+Dual+Actions+of+Monoamine+Oxidase+Inhibition+and+A2A+Receptor+Antagonism&doi=10.1074%2Fjbc.M206830200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism</span></div><div class="casAuthors">Chen, Jiang-Fan; Steyn, Salome; Staal, Roland; Petzer, Jacobus P.; Xu, Kui; Van der Schyf, Cornelis J.; Castagnoli, Kay; Sonsalla, Patricia K.; Castagnoli, Neal, Jr.; Schwarzschild, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36040-36044</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Caffeine and more specific antagonists of the adenosine A2A receptor recently have been found to be neuroprotective in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease.  Here we show that 8-(3-chlorostyryl)caffeine (CSC), a specific A2A antagonist closely related to caffeine, also attenuates MPTP-induced neurotoxicity.  Because the neurotoxicity of MPTP relies on its oxidative metab. to the mitochondrial toxin MPP+, we investigated the actions of CSC on striatal MPTP metab. in vivo.  CSC elevated striatal levels of MPTP but lowered levels of the oxidative intermediate MPDP+ and of MPP+, suggesting that CSC blocks the conversion of MPTP to MPDP+ in vivo.  In assessing the direct effects of CSC and A2A receptors on monoamine oxidase (MAO) activity, we found that CSC potently and specifically inhibited mouse brain mitochondrial MAO-B activity in vitro with a Ki value of 100 nm, whereas caffeine and another relatively specific A2A antagonist produced little or no inhibition.  The A2A receptor independence of MAO-B inhibition by CSC was further supported by the similarity of brain MAO activities derived from A2A receptor knockout and wild-type mice and was confirmed by demonstrating potent inhibition of A2A receptor knockout-derived MAO-B by CSC.  Together, these data indicate that CSC possesses dual actions of MAO-B inhibition and A2A receptor antagonism, a unique combination suggesting a new class of compds. with the potential for enhanced neuroprotective properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8ESRi-__yrVg90H21EOLACvtfcHk0ljLKuQBunA0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCjs7Y%253D&md5=27154cad8b81538a593504f7ca2f42ec</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M206830200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M206830200%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DVan%2BDer%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3D8-%25283-Chlorostyryl%2529%2520Caffeine%2520May%2520Attenuate%2520MPTP%2520Neurotoxicity%2520through%2520Dual%2520Actions%2520of%2520Monoamine%2520Oxidase%2520Inhibition%2520and%2520A2A%2520Receptor%2520Antagonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D39%26spage%3D36040%26epage%3D36044%26doi%3D10.1074%2Fjbc.M206830200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dungo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Istradefylline: First Global Approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1007/s40265-013-0066-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs40265-013-0066-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23700273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=875-882&issue=8&author=R.+Dungoauthor=E.+D.+Deeks&title=Istradefylline%3A+First+Global+Approval&doi=10.1007%2Fs40265-013-0066-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Istradefylline: First Global Approval</span></div><div class="casAuthors">Dungo, Rosselle; Deeks, Emma D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">875-882</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Kyowa Hakko Kirin is developing istradefylline, a selective adenosine A2A receptor antagonist, for the once-daily oral treatment of Parkinson's disease (PD).  Adenosine A2A receptors are considered to be present particularly in the basal ganglia of the brain; the degeneration or abnormality obsd. in PD is believed to occur in the basal ganglia, which is recognized to play a significant role in motor control.  Com. available dopamine replacement therapies effectively treat the early motor symptoms of PD; however, these agents are assocd. with development of motor complications, limiting usefulness in late stages of the disease.  Istradefylline is proposed to possess a clearly distinct action site from existing agents which act on dopamine metab. or dopamine receptors.  Kyowa Hakko Kirin has received approval for istradefylline in the adjunctive treatment of PD in Japan.  A New Drug Application was filed in the USA, but the FDA issued a non-approvable letter in Feb. 2008.  This article summarizes the milestones in the development of istradefylline leading to its first approval for the treatment of patients with PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsHgSlibdiR7Vg90H21EOLACvtfcHk0ljLKuQBunA0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmsL7L&md5=4933d804adda96e4447e3c3bc526e12e</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1007%2Fs40265-013-0066-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-013-0066-7%26sid%3Dliteratum%253Aachs%26aulast%3DDungo%26aufirst%3DR.%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DIstradefylline%253A%2520First%2520Global%2520Approval%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26issue%3D8%26spage%3D875%26epage%3D882%26doi%3D10.1007%2Fs40265-013-0066-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">FDA</span>. <span> </span><span class="NLM_article-title">Initial U.S. Approval for Nourianz</span>. <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease" class="extLink">https://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease</a>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=FDA&title=Initial+U.S.+Approval+for+Nourianz"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DInitial%2520U.S.%2520Approval%2520for%2520Nourianz%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Załuski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabikowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latacz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz-Maciej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaśko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroz-Płonka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcmdc.201900717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=32162782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlCis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=772-786&issue=9&author=K.+J.+Kuderauthor=M.+Za%C5%82uskiauthor=J.+Schabikowskiauthor=G.+Lataczauthor=A.+Olejarz-Maciejauthor=P.+Ja%C5%9Bkoauthor=A.+Doroz-P%C5%82onkaauthor=A.+Brockmannauthor=C.+E.+M%C3%BCllerauthor=K.+Kie%C4%87-Kononowicz&title=Novel%2C+Dual+Target-Directed+Annelated+Xanthine+Derivatives+Acting+on+Adenosine+Receptors+and+Monoamine+Oxidase+B&doi=10.1002%2Fcmdc.201900717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B</span></div><div class="casAuthors">Kuder, Kamil J.; Zaluski, Michal; Schabikowski, Jakub; Latacz, Gniewomir; Olejarz-Maciej, Agnieszka; Jasko, Piotr; Doroz-Plonka, Agata; Brockmann, Andreas; Mueller, Christa E.; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">772-786</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Annelated purinedione derivs. have been shown to act as possible multiple-target ligands, addressing adenosine receptors and monoaminooxidases.  In this study, based on our previous results, novel annelated pyrimido- and diazepino[2,1-f]purinedione derivs. were designed as dual-target-directed ligands combining A2A adenosine receptor (AR) antagonistic activity with blocking monoamine oxidase B.  A library of 19 novel compds. was synthesized and biol. evaluated in radioligand binding studies at AR subtypes and for their ability to inhibit MAO-B.  This allowed 9-(2-chloro-6-fluorobenzyl)-3-ethyl-1-methyl-6,7,8,9-tetrahydropyrimido[2,1-f]purine-2,4(1H,3H)-dione (13 e; Ki human A2AAR: 264 nM and IC50 human MAO-B: 243 nM) to be identified as the most potent dual-acting ligand from this series.  ADMET parameters were estd. in vitro, and anal. of the structure-activity relationships was complemented by mol.-docking studies based on previously published X-ray structures of the protein targets.  Such dual-acting ligands, by selectively blocking A2A AR, accompanied by the inhibition of dopamine metabolizing enzyme MAO-B, might provide symptomatic and neuroprotective effects in, among others, the treatment of Parkinson disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Lk4PTzMribVg90H21EOLACvtfcHk0lgu-GYOIA9uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlCis70%253D&md5=204271fa4c0b287fddc0d277aeb35997</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900717%26sid%3Dliteratum%253Aachs%26aulast%3DKuder%26aufirst%3DK.%2BJ.%26aulast%3DZa%25C5%2582uski%26aufirst%3DM.%26aulast%3DSchabikowski%26aufirst%3DJ.%26aulast%3DLatacz%26aufirst%3DG.%26aulast%3DOlejarz-Maciej%26aufirst%3DA.%26aulast%3DJa%25C5%259Bko%26aufirst%3DP.%26aulast%3DDoroz-P%25C5%2582onka%26aufirst%3DA.%26aulast%3DBrockmann%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DNovel%252C%2520Dual%2520Target-Directed%2520Annelated%2520Xanthine%2520Derivatives%2520Acting%2520on%2520Adenosine%2520Receptors%2520and%2520Monoamine%2520Oxidase%2520B%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26issue%3D9%26spage%3D772%26epage%3D786%26doi%3D10.1002%2Fcmdc.201900717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Załuski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabikowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz-Maciej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latacz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zygmunt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Synak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Novel Multi-Target Directed Ligands Based on Annelated Xanthine Scaffold with Aromatic Substituents Acting on Adenosine Receptor and Monoamine Oxidase B. Synthesis, in Vitro and in Silico Studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30808606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1GnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=1195-1210&issue=7&author=M.+Za%C5%82uskiauthor=J.+Schabikowskiauthor=M.+Schlenkauthor=A.+Olejarz-Maciejauthor=B.+Kubasauthor=T.+Karczauthor=K.+Kuderauthor=G.+Lataczauthor=M.+Zygmuntauthor=D.+Synakauthor=S.+Hinzauthor=C.+E.+M%C3%BCllerauthor=K.+Kie%C4%87-Kononowicz&title=Novel+Multi-Target+Directed+Ligands+Based+on+Annelated+Xanthine+Scaffold+with+Aromatic+Substituents+Acting+on+Adenosine+Receptor+and+Monoamine+Oxidase+B.+Synthesis%2C+in+Vitro+and+in+Silico+Studies&doi=10.1016%2Fj.bmc.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies</span></div><div class="casAuthors">Zaluski, Michal; Schabikowski, Jakub; Schlenk, Miriam; Olejarz-Maciej, Agnieszka; Kubas, Bartlomiej; Karcz, Tadeusz; Kuder, Kamil; Latacz, Gniewomir; Zygmunt, Malgorzata; Synak, David; Hinz, Sonja; Muller, Christa E.; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1195-1210</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N9-Benzyl-substituted imidazo-, pyrimido- and 1,3-diazepino[2,1-f]purinediones were designed as dual-target-directed ligands combining A2A adenosine receptor (AR) antagonistic activity with blockade of monoamine oxidase B (MAO-B).  A library of 37 novel compds. was synthesized and biol. evaluated in radioligand binding studies at AR subtypes and for their ability to inhibit MAO-B.  A systematic modification of the tricyclic structures based on a xanthine core by enlargement of the third heterocyclic ring or attachment of various substituted benzyl moieties resulted in the development of 9-(2-chloro-6-fluorobenzyl)-1,3-dimethyl-6,7,8,9-tetrahydropyrimido[2,1-f]purine-2,4(1H,3H)-dione (9u; Ki human A2AAR: 189 nM and IC50 human MAO-B: 570 nM) as the most potent dual acting ligand of the series displaying high selectivity vs. related targets.  Moreover, some potent, selective MAO-B inhibitors were identified in the group of pyrimido- and 1,3-diazepino[2,1-f]purinediones.  Compd. 10d (10-(3,4-dichlorobenzyl)-1,3-dimethyl-7,8,9,10-tetrahydro-1H-[1,3]diazepino[2,1-f]purine-2,4(3H,6H)-dione) displayed an IC50 value at human MAO-B of 83 nM.  Anal. of structure-activity relationships was complemented by mol. docking studies based on previously published x-ray structures of the protein targets.  An extended biol. profile was detd. for selected compds. including in vitro evaluation of potential hepatotoxicity calcd. in silico and antioxidant properties as an addnl. desirable activity.  The new mols. acting as dual target drugs may provide symptomatic relief as well as disease-modifying effects for neurodegenerative diseases, in particular Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqr5lfVzqb-rVg90H21EOLACvtfcHk0lgu-GYOIA9uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1GnsL0%253D&md5=45348a790e9af9f60749f6255ba68284</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DZa%25C5%2582uski%26aufirst%3DM.%26aulast%3DSchabikowski%26aufirst%3DJ.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DOlejarz-Maciej%26aufirst%3DA.%26aulast%3DKubas%26aufirst%3DB.%26aulast%3DKarcz%26aufirst%3DT.%26aulast%3DKuder%26aufirst%3DK.%26aulast%3DLatacz%26aufirst%3DG.%26aulast%3DZygmunt%26aufirst%3DM.%26aulast%3DSynak%26aufirst%3DD.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26atitle%3DNovel%2520Multi-Target%2520Directed%2520Ligands%2520Based%2520on%2520Annelated%2520Xanthine%2520Scaffold%2520with%2520Aromatic%2520Substituents%2520Acting%2520on%2520Adenosine%2520Receptor%2520and%2520Monoamine%2520Oxidase%2520B.%2520Synthesis%252C%2520in%2520Vitro%2520and%2520in%2520Silico%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1195%26epage%3D1210%26doi%3D10.1016%2Fj.bmc.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, C. G. A.</span></span> <span> </span><span class="NLM_article-title">Xanthine Derivatives as Adenosine Receptor Antagonists</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(82)90359-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0014-2999%2882%2990359-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6288418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaL38XlsFKmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1982&pages=673-676&issue=4&author=B.+B.+Fredholmauthor=C.+G.+A.+Persson&title=Xanthine+Derivatives+as+Adenosine+Receptor+Antagonists&doi=10.1016%2F0014-2999%2882%2990359-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthine derivatives as adenosine receptor antagonists</span></div><div class="casAuthors">Fredholm, Bertil B.; Persson, Carl G. A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">673-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The potency of a series of xanthine derivs. as adenosine  [58-61-7] antagonists was studied in fat cells (A1-receptors) and hippocampal slices (A2-receptors) and on L-[3H]phenylisopropyladenosine (PIA) binding in membranes from rat cortex.  The order of potency in all 3 tests systems was: 1,3-diethyl-8-phenylxanthine  [75922-48-4] > 8-phenyltheophylline  [961-45-5] > 8-p-sulfophenyltheophylline  [80206-91-3] > verophylline  [66172-75-6] > 1-isobutyl-3-methylxanthine  [76054-34-7] > theophylline  [58-55-9] > caffeine  [58-08-2] > theobromine  [83-67-0] ≃ pentoxifylline  [6493-05-6].  The alkylxanthines were somewhat more potent in the fat cell system than in the other 2 systems.  enprofylline  [41078-02-8] Was 20-30 times more potent in the hippocampal than in the other 2 systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprInbW0AGODrVg90H21EOLACvtfcHk0lgu-GYOIA9uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlsFKmsrY%253D&md5=57875dcc6eab45293d4ee93b1e481a59</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2882%2990359-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252882%252990359-4%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DPersson%26aufirst%3DC.%2BG.%2BA.%26atitle%3DXanthine%2520Derivatives%2520as%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1982%26volume%3D81%26issue%3D4%26spage%3D673%26epage%3D676%26doi%3D10.1016%2F0014-2999%2882%2990359-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feoktistov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polosa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holgate, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biaggioni, I.</span></span> <span> </span><span class="NLM_article-title">Adenosine A 2B Receptors: A Novel Therapeutic Target in Asthma? A Putative Role for Adenosine in Airway Inflammation</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(98)01179-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0165-6147%2898%2901179-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=9612090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1ams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=148-153&author=I.+Feoktistovauthor=R.+Polosaauthor=S.+T.+Holgateauthor=I.+Biaggioni&title=Adenosine+A+2B+Receptors%3A+A+Novel+Therapeutic+Target+in+Asthma%3F+A+Putative+Role+for+Adenosine+in+Airway+Inflammation&doi=10.1016%2FS0165-6147%2898%2901179-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2B receptors: a novel therapeutic target in asthma?</span></div><div class="casAuthors">Feoktistov, Igor; Polosa, Riccardo; Holgate, Stephen T.; Biaggiioni, Italo</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">148-153</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 67 refs.  Adenosine is an endogenous nucleoside that modulates many physiol. processes.  Its actions are mediated by interaction with specific cell membrane receptors.  Four subtypes of adenosine receptor have been cloned: A1, A2A, A2B and A3.  Significant advancement has been made in our understanding of the mol. pharmacol. and physiol. relevance of adenosine receptors but our knowledge of A2B receptors lags behind that of other receptor types.  Only recently have potentially important functions been discovered for the A2B receptors, prompting a renewed interest in this receptor types.  A2B receptors have been implicated in the regulation of vascular smooth muscle tone, cell growth, intestinal function and neurosecretion.  In this review, the authors focus on the role of A2B receptors in mast cell activation and the potential relevance of this action on asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSnNJf_gBTB7Vg90H21EOLACvtfcHk0lgu-GYOIA9uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1ams7k%253D&md5=ed92009a354ed2b5d5557e4f3e73a501</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2898%2901179-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252898%252901179-1%26sid%3Dliteratum%253Aachs%26aulast%3DFeoktistov%26aufirst%3DI.%26aulast%3DPolosa%26aufirst%3DR.%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DBiaggioni%26aufirst%3DI.%26atitle%3DAdenosine%2520A%25202B%2520Receptors%253A%2520A%2520Novel%2520Therapeutic%2520Target%2520in%2520Asthma%253F%2520A%2520Putative%2520Role%2520for%2520Adenosine%2520in%2520Airway%2520Inflammation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D148%26epage%3D153%26doi%3D10.1016%2FS0165-6147%2898%2901179-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A(2B) Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1021/jm990421v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990421v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1165-1172&issue=6&author=Y.+C.+Kimauthor=X.+D.+Jiauthor=N.+Melmanauthor=J.+Lindenauthor=K.+A.+Jacobson&title=Anilide+Derivatives+of+an+8-Phenylxanthine+Carboxylic+Congener+Are+Highly+Potent+and+Selective+Antagonists+at+Human+A%282B%29+Adenosine+Receptors&doi=10.1021%2Fjm990421v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors</span></div><div class="casAuthors">Kim, Yong-Chul; Ji, Xiao-duo; Melman, Neli; Linden, Joel; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">No highly selective antagonists of the A2B adenosine receptor (AR) have been reported; however such antagonists have therapeutic potential as antiasthmatic agents.  Here the synthesis of potent and selective A2B receptor Antagonists is reported.  The structure-activity relationships (SAR) of 8-phenyl-1,3-di-(n-propyl)xanthine derivs. in binding to recombinant human A2B ARs in HEK-293 cells (HEK-A2B) and at other AR subtypes were explored.  Various amide derivs. of 8-[4-[[carboxymethyl]oxy]phenyl]-1,3-di(n-propyl)xanthine, I (R1 = n-Pr, X = OCH2, R2 = OH) (II), were synthesized.  A comparison of aryl, alkyl, and aralkyl amides demonstrated that simple anilides, particularly those substituted in the para-position with electron-withdrawing groups, such as nitro, cyano, and acetyl, bind selectively to human A2B receptors in the range of 1-3 nM.  The unsubstituted anilide I (R1 = n-Pr, X = OCH2, R2 = NHPh) had a Ki value at A2B receptors of 1.48 nM but was only moderately selective vs. human A1/A2A receptors and nonselective vs. rat A1 receptors.  Highly potent and selective A2B antagonists were a p-aminoacetophenone deriv. I (R1 = n-Pr, X = OCH2, R2 = 4-MeOC6H4NH) (Ki value 1.39 nM) and a p-cyanoanilide I (R1 = n-Pr, X = OCH2, R2 = NHC6H4CN-4) (III) (Ki value 1.97 nM).  Compd. III was 400-, 245-, and 123-fold selective for human A2B receptors vs. human A1/A2A/A3 receptors, resp., and 8.5- and 310-fold selective vs. rat A1/A2A receptors, resp.  Substitution of the 1,3-di-Pr groups with 1,3-di-Et offered no disadvantage for selectivity, and high affinities at A2B receptors were maintained.  Substitution of the p-carboxymethyloxy group of II and its amides with acrylic acid decreased affinity at A2B receptors while increasing affinity at A1 receptors. 1,3-Di(cyclohexylmethyl) groups greatly reduced affinity at ARs, although the p-carboxymethyloxy deriv. I (R1 = cyclohexylmethyl, X = CH:CH, R2 = OH) was moderately selective for A2B receptors.  Several selective A2B antagonists inhibited NECA-stimulated calcium mobilization in HEK-A2B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1SbbnjfBwjbVg90H21EOLACvtfcHk0lhxdAcWS3To0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlGqu7s%253D&md5=af987bb9429d31d6b9aa660744185832</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm990421v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990421v%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DJi%26aufirst%3DX.%2BD.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAnilide%2520Derivatives%2520of%2520an%25208-Phenylxanthine%2520Carboxylic%2520Congener%2520Are%2520Highly%2520Potent%2520and%2520Selective%2520Antagonists%2520at%2520Human%2520A%25282B%2529%2520Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D6%26spage%3D1165%26epage%3D1172%26doi%3D10.1021%2Fjm990421v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayallah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval-Ramírez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reith, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1500</span>– <span class="NLM_lpage">1510</span>, <span class="refDoi"> DOI: 10.1021/jm011049y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011049y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1500-1510&issue=7&author=A.+M.+Hayallahauthor=J.+Sandoval-Ram%C3%ADrezauthor=U.+Reithauthor=U.+Schobertauthor=B.+Preissauthor=B.+Schumacherauthor=J.+W.+Dalyauthor=C.+E.+M%C3%BCller&title=1%2C8-Disubstituted+Xanthine+Derivatives%3A+Synthesis+of+Potent+A2B-Selective+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm011049y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists</span></div><div class="casAuthors">Hayallah, Alaa M.; Sandoval-Ramirez, Jesus; Reith, Ulrike; Schobert, Ulrike; Preiss, Birgit; Schumacher, Britta; Daly, John W.; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1500-1510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Unsubstituted xanthine derivs. bearing a cyclopentyl or a Ph residue in the 8-position were synthesized and developed as A2B adenosine receptor antagonists.  Compds. bearing polar substituents were prepd. to obtain water-sol. derivs.  1-Alkyl-8-phenylxanthine derivs. were found to exhibit high affinity for A2B adenosine receptors (ARs).  1,8-Disubstituted xanthine derivs. were equipotent to or more potent than 1,3,8-trisubstituted xanthines at A2B ARs, but generally less potent at A1 and A2A, and much less potent at A3 ARs.  Thus, the new compds. exhibited increased A2B selectivity vs. all other AR subtypes.  9-Deazaxanthines (pyrrolo[2,3-d]pyrimidindiones) appeared to be less potent at A2B ARs than the corresponding xanthine derivs.  1-Propyl-8-p-sulfophenylxanthine (I) was the most selective compd. of the present series, exhibiting a Ki value of 53 nM at human A2B ARs and showing greater than 180-fold selectivity vs. human A1 ARs.  Compd. I was also highly selective vs. rat A1 ARs (41-fold) and vs. the other human AR subtypes (A2A > 400-fold and A3 > 180-fold).  The compd. is highly water-sol. due to its sulfonate function.  1-Butyl-8-p-carboxyphenylxanthine, another polar analog bearing a carboxylate function, exhibited a Ki value of 24 nM for A2B ARs, 49-fold selectivity vs. human and 20-fold selectivity vs. rat A1 ARs, and greater than 150-fold selectivity vs. human A2A and A3 ARs.  8-[4-[(2-Hydroxyethylamino)-2-oxoethoxy]phenyl]-1-propylxanthine (II) and 1-butyl-8-[4-[(4-benzylpiperazino)-2-oxoethoxy]phenyl]xanthine (III) were among the most potent A2B antagonists showing Ki values at A2B ARs of 1 nM, 57-fold for II and 94-fold for III selectivity vs. human A1, ca. 30-fold selectivity vs. rat A1, and greater than 400-fold selectivity vs. human A2A and A3 ARs.  The new potent, selective, water-sol. A2B antagonists may be useful research tools for investigating A2B receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8eeBzBfHfLVg90H21EOLACvtfcHk0lhxdAcWS3To0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFKlu7k%253D&md5=759d610ad10c658403730fc7f00f6054</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm011049y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011049y%26sid%3Dliteratum%253Aachs%26aulast%3DHayallah%26aufirst%3DA.%2BM.%26aulast%3DSandoval-Ram%25C3%25ADrez%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DU.%26aulast%3DSchobert%26aufirst%3DU.%26aulast%3DPreiss%26aufirst%3DB.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D1%252C8-Disubstituted%2520Xanthine%2520Derivatives%253A%2520Synthesis%2520of%2520Potent%2520A2B-Selective%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D7%26spage%3D1500%26epage%3D1510%26doi%3D10.1021%2Fjm011049y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varkhedkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscopio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span> <span> </span><span class="NLM_article-title">The Discovery of a Selective, High Affinity A2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2004.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15664822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsVKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=609-612&issue=3&author=J.+Zablockiauthor=R.+Kallaauthor=T.+Perryauthor=V.+Palleauthor=V.+Varkhedkarauthor=D.+Xiaoauthor=A.+Piscopioauthor=T.+Maaauthor=A.+Gimbelauthor=J.+Haoauthor=N.+Chuauthor=K.+Leungauthor=D.+Zeng&title=The+Discovery+of+a+Selective%2C+High+Affinity+A2B+Adenosine+Receptor+Antagonist+for+the+Potential+Treatment+of+Asthma&doi=10.1016%2Fj.bmcl.2004.11.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma</span></div><div class="casAuthors">Zablocki, Jeff; Kalla, Rao; Perry, Thao; Palle, Venkata; Varkhedkar, Vaibhav; Xiao, Dengming; Piscopio, Anthony; Maa, Tenning; Gimbel, Art; Hao, Jia; Chu, Nancy; Leung, Kwan; Zeng, Dewan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">609-612</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine has been suggested to play a role in asthma, possibly via activation of A2B adenosine receptors on mast cells and other pulmonary cells.  We describe our initial efforts to discover a xanthine based selective A2B AdoR antagonist that resulted in the discovery of CVT-5440, a high affinity A2B AdoR antagonist with good selectivity (A2B AdoR Ki = 50 nM, selectivity A1 > 200: A2A > 200: A3 > 167).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbPzsAX_kykbVg90H21EOLACvtfcHk0lhxdAcWS3To0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsVKlug%253D%253D&md5=db2f9819adad03ad0e504247a379248c</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DZablocki%26aufirst%3DJ.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DPiscopio%26aufirst%3DA.%26aulast%3DMaa%26aufirst%3DT.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DD.%26atitle%3DThe%2520Discovery%2520of%2520a%2520Selective%252C%2520High%2520Affinity%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%2520for%2520the%2520Potential%2520Treatment%2520of%2520Asthma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D3%26spage%3D609%26epage%3D612%26doi%3D10.1016%2Fj.bmcl.2004.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttarolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaid, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2B Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1434</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1021/jm0309654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0309654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht1Gisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1434-1447&issue=6&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=D.+Pretiauthor=A.+Boveroauthor=R.+Romagnoliauthor=F.+Fruttaroloauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=K.+Varaniauthor=S.+Gessiauthor=S.+Merighiauthor=P.+A.+Borea&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+New+8-Heterocyclic+Xanthine+Derivatives+as+Highly+Potent+and+Selective+Human+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm0309654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Preti, Delia; Bovero, Andrea; Romagnoli, Romeo; Fruttarolo, Francesca; Zaid, Naser Abdel; Moorman, Allan R.; Varani, Katia; Gessi, Stefania; Merighi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1434-1447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of 8-heterocycle-substituted xanthines as potent and selective A2B adenosine receptor antagonists was reported.  The structure-activity relationships (SAR) of the xanthines synthesized in binding to recombinant human A2B adenosine receptors (ARs) in HEK-293 cells (HEK-A2B) and at other AR subtypes were explored.  The synthesized compds. showed A2B adenosine receptor affinity in the nanomolar range and good levels of selectivity evaluated in radioligand binding assays at human (h) A1, A2A, A2B, and A3 ARs.  Several heterocycles, such as pyrazole, isoxazole, pyridine, and pyridazine, were introduced at the 8-position of the xanthine nucleus and different spacers (substituted acetamide, oxyacetamide, and urea moieties) were investigated.  Various groups at the 3- and 4-positions of phenylacetamide moiety were studied.  This study allowed us to identify 2-(3,4-dimethoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide (MRE2028F20) [Ki(hA2B) = 38 nM, Ki(hA1,hA2A,hA3) >1000 nM], N-1,3-benzodioxol-5-yl-2-[[1-methyl-5-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-1H-pyrazol-3-yl]oxy]acetamide (I, MRE2029F20) [Ki(hA2B) = 5.5 nM, Ki(hA1,hA2A,hA3) > 1000 nM], and N-(3,4-dimethoxyphenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yloxy]acetamide (MRE2030F20) [Ki(hA2B) = 12 nM, Ki(hA1,hA2A, hA3) > 1000 nM], which showed high affinity at the A2B receptor subtype and very good selectivity vs the other ARs.  Substitution of the acetamide with an urea moiety afforded bioisosteric xanthines with good affinity and selectivity comparable to the acetamide derivs.  Substitution at the para-position of a 4-benzyloxy group of the phenylacetamido chain enhanced affinity at the A2B receptor but did not favor selectivity.  The derivs. with higher affinity at human A2B AR proved to be antagonists, in the cAMP assay, capable of inhibiting the stimulatory effect of NECA (100 nM) with IC50 values in the nanomolar range, a trend similar to that obsd. in the binding assay for I (IC50 = 38 nM) for MRE2029F20 (IC50 = 46 nM).  In conclusion, the 8-pyrazolo-1,3-dipropyl-1H-purine-2,6-dione derivs. described herein represent a new family of selective antagonists for the adenosine A2B receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSk9RD57PV_7Vg90H21EOLACvtfcHk0livV5h0JDx6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht1Gisr8%253D&md5=57188de913c339eb31b9f51cd4e61e7a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm0309654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309654%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBovero%26aufirst%3DA.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520New%25208-Heterocyclic%2520Xanthine%2520Derivatives%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Human%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D6%26spage%3D1434%26epage%3D1447%26doi%3D10.1021%2Fjm0309654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varkhedkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Novel 1,3-Disubstituted 8-(1-Benzyl-1H-Pyrazol-4-Yl) Xanthines: High Affinity and Selective A 2B Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3682</span>– <span class="NLM_lpage">3692</span>, <span class="refDoi"> DOI: 10.1021/jm051268+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051268%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3682-3692&author=R.+V.+Kallaauthor=E.+Elzeinauthor=T.+Perryauthor=X.+Liauthor=V.+Palleauthor=V.+Varkhedkarauthor=A.+Gimbelauthor=T.+Maaauthor=D.+Zengauthor=J.+Zablocki&title=Novel+1%2C3-Disubstituted+8-%281-Benzyl-1H-Pyrazol-4-Yl%29+Xanthines%3A+High+Affinity+and+Selective+A+2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm051268%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists</span></div><div class="casAuthors">Kalla, Rao V.; Elzein, Elfatih; Perry, Thao; Li, Xiaofen; Palle, Venkata; Varkhedkar, Vaibhav; Gimbel, Arthur; Maa, Tennig; Zeng, Dewan; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3682-3692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine has been suggested to induce bronchial hyperresponsiveness in asthmatics, which is believed to be an A2B adenosine receptor (AdoR) mediated pathway.  The authors hypothesize that a selective, high-affinity A2B AdoR antagonist may provide therapeutic benefit in the treatment of asthma.  In an attempt to identify a high-affinity, selective antagonist for the A2B AdoR, we synthesized 8-(C-4-pyrazolyl) xanthines.  Compd. I (R = H), 8-(1H-pyrazol-4-yl)-1,3-dipropylxanthine, is a N-1 unsubstituted pyrazole deriv. that has favorable binding affinity (Ki = 9 nM) for the A2B AdoR, but it is only 2-fold selective vs. the A1 AdoR.  Introduction of a benzyl group at the N-1-pyrazole position of I (R = H) resulted in I (R = CH2Ph), which had moderate selectivity.  The initial focus of the SAR study was on the prepn. of substituted benzyl derivs. of I (R = CH2Ph) because the corresponding Ph, phenethyl, and phenpropyl derivs. showed a decrease in A2B AdoR affinity and selectivity relative to I (R = CH2Ph).  The preferred substitution on the Ph ring of I (R = CH2Ph) contains an electron-withdrawing group, specifically F or CF3 at the m-position, as in I (R = CH2C6H4F-3) and I (R = CH2C6H4CF3-3) resp., increases the selectivity while retaining the affinity for the A2B AdoR.  Exploring disubstitutions on the Ph ring of the latter two derivs. led to the 2-chloro-5-trifluoromethylphenyl deriv., which retained the A2B AdoR affinity but enhanced the selectivity relative to I (R = CH2C6H4CF3-3).  After optimization of the substitution on the 8-pyrazole xanthine, 1,3-disubstitution of the xanthine core was explored with Me, Et, Bu, and iso-Bu groups.  In comparison to the corresponding di-Pr analogs, the smaller 1,3-dialkyl groups (Me and ethyl) increased the A2B AdoR binding selectivity of the xanthine derivs. while retaining the affinity.  However, the larger 1,3-dialkyl groups (iso-Bu and butyl) resulted in a decrease in both A2B AdoR affinity and selectivity.  This final SAR optimization led to the discovery of 1,3-di-Me deriv. II, 8-(1-(3-(trifluoromethyl) benzyl)-1H-pyrazol-4-yl)-1,3-dimethyl xanthine, a high-affinity (Ki = 1 nM) A2B AdoR antagonist with high selectivity (990-, 690-, and 1000-) for the human A1, A2A, and A3 AdoRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphOU_sdPwkFLVg90H21EOLACvtfcHk0livV5h0JDx6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKht7k%253D&md5=fcacb4bd15ff892c08c7c98d27455022</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm051268%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051268%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DMaa%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DNovel%25201%252C3-Disubstituted%25208-%25281-Benzyl-1H-Pyrazol-4-Yl%2529%2520Xanthines%253A%2520High%2520Affinity%2520and%2520Selective%2520A%25202B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3682%26epage%3D3692%26doi%3D10.1021%2Fjm051268%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2278</span>, <span class="refDoi"> DOI: 10.1021/jm7014815</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7014815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivV2hur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2267-2278&issue=7&author=E.+Elzeinauthor=R.+V.+Kallaauthor=X.+Liauthor=T.+Perryauthor=A.+Gimbelauthor=D.+Zengauthor=D.+Lustigauthor=K.+Leungauthor=J.+Zablocki&title=Discovery+of+a+Novel+A2B+Adenosine+Receptor+Antagonist+as+a+Clinical+Candidate+for+Chronic+Inflammatory+Airway+Diseases&doi=10.1021%2Fjm7014815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases</span></div><div class="casAuthors">Elzein, Elfatih; Kalla, Rao V.; Li, Xiaofen; Perry, Thao; Gimbel, Art; Zeng, Dewan; Lustig, David; Leung, Kwan; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2267-2278</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, the authors have reported a series of new 1,3-sym. (R1 = R3) substituted xanthines which have high affinity and selectivity for the human adenosine A2B receptors (hA2B-AdoR).  Unfortunately, this class of compds. had poor pharmacokinetic properties.  This prompted us to investigate the effect of differential alkyl substitution at the N-1 and N-3 positions (N1-R ≠ N3-R) on A2B-AdoR affinity and selectivity; the authors had the dual objectives of enhancing affinity and selectivity for the A2B-AdoR, as well as improving oral bioavailability.  This effort has led to the discovery of compd. (I), that displayed high affinity and selectivity for the hA2B-AdoR (Ki = 22 nM).  In addn., compd. I showed high functional potency in inhibiting the accumulation of cAMP induced by 5'-N-ethylcarboxamidoadenosine in HEK-A2B-AdoR and NIH3T3 cells with KB values of 6 and 2 nM, resp.  In a single ascending-dose phase I clin. study, compd. I had no serious adverse events and was well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzXnSletOZqrVg90H21EOLACvtfcHk0livV5h0JDx6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivV2hur4%253D&md5=e7b70a1caa958d5daea329c01c66ccf4</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm7014815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7014815%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DLustig%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520A2B%2520Adenosine%2520Receptor%2520Antagonist%2520as%2520a%2520Clinical%2520Candidate%2520for%2520Chronic%2520Inflammatory%2520Airway%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D7%26spage%3D2267%26epage%3D2278%26doi%3D10.1021%2Fjm7014815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gimbel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Selective, High Affinity A2B Adenosine Receptor Antagonists: N-1 Monosubstituted 8-(Pyrazol-4-Yl)Xanthines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2008.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18226896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlaisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1397-1401&issue=4&author=R.+V.+Kallaauthor=E.+Elzeinauthor=T.+Perryauthor=X.+Liauthor=A.+Gimbelauthor=M.+Yangauthor=D.+Zengauthor=J.+Zablocki&title=Selective%2C+High+Affinity+A2B+Adenosine+Receptor+Antagonists%3A+N-1+Monosubstituted+8-%28Pyrazol-4-Yl%29Xanthines&doi=10.1016%2Fj.bmcl.2008.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Selective, high affinity A2B adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines</span></div><div class="casAuthors">Kalla, Rao V.; Elzein, Elfatih; Perry, Thao; Li, Xiaofen; Gimbel, Art; Yang, Ming; Zeng, Dewan; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1397-1401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of N-1 monosubstituted 8-pyrazolyl xanthines have been synthesized and evaluated for their affinity for the adenosine receptors (AdoRs).  Two compds. I (CVT-7124) and II (CVT-6694) display good affinity for the A2B AdoR (Ki = 6 nM and 7 nM, resp.) and greater selectivity for the human A1, A2A, and A3 AdoRs (>1000-, >830-, and >1500-fold; >850-, >700-, and >1280-fold, resp.).  Compd. II has been shown to block the release of interleukin-6 and monocyte chemotactic protein-1 from bronchial smooth muscle cells (BSMC), a process believed to be promoted by activation of A2B AdoR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLgURZDRagVLVg90H21EOLACvtfcHk0liBcKJL7l5j_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlaisL0%253D&md5=b4a481f1341763cff12a2d3375a5fcd4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DKalla%26aufirst%3DR.%2BV.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGimbel%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DSelective%252C%2520High%2520Affinity%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%253A%2520N-1%2520Monosubstituted%25208-%2528Pyrazol-4-Yl%2529Xanthines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D4%26spage%3D1397%26epage%3D1401%26doi%3D10.1016%2Fj.bmcl.2008.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccagli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaid, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel 1,3-Dipropyl-8-(3-Benzimidazol-2-Yl-Methoxy-1-Methylpyrazol-5-Yl) Xanthines as Potent and Selective A2B Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1021/jm201292w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201292w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=797-811&issue=2&author=P.+G.+Baraldiauthor=S.+Baraldiauthor=G.+Saponaroauthor=D.+Pretiauthor=R.+Romagnoliauthor=L.+Piccagliauthor=A.+Cavalliauthor=M.+Recanatiniauthor=A.+R.+Moormanauthor=A.+N.+Zaidauthor=K.+Varaniauthor=P.+A.+Boreaauthor=M.+A.+Tabrizi&title=Novel+1%2C3-Dipropyl-8-%283-Benzimidazol-2-Yl-Methoxy-1-Methylpyrazol-5-Yl%29+Xanthines+as+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm201292w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Baraldi, Stefania; Saponaro, Giulia; Preti, Delia; Romagnoli, Romeo; Piccagli, Laura; Cavalli, Andrea; Recanatini, Maurizio; Moorman, Allan R.; Abdel  Zaid, Naser; Varani, Katia; Borea, Pier Andrea; Tabrizi, Mojgan Aghazadeh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-811</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists of the A2B adenosine receptor with known biol. activity were performed to identify the three-dimensional features responsible for A2B adenosine receptor antagonist activity.  On the basis of these and previous results on the potent antagonist effect of 8-pyrazolyl-xanthines at human A2BAR, a new series of compds. was synthesized and evaluated in binding studies against the human A1, A2A, A3, and A2BARs.  A remarkable improvement in selectivity with respect to the previous series, maintaining the potency at human A2B receptor, was achieved, as exemplified by the 8-[3-(4-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl-methoxy)-1-methyl-1H-pyrazol-5-yl]-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (I): Ki A2B = 9.4 nM, IC50 hA2B = 26 nM hA1/hA2B = 269, hA2A/hA2B > 106, hA3/hA2B >106.  This study also led to the identification of a series of pyrazole-xanthine compds. with a simplified structure, exemplified by 8-(3-hydroxy-1-methyl-1H-pyrazol-5-yl)-xanthine (II) displaying very high affinity at A2BAR with good selectivity over AR subtypes (Ki = 4.0 nM, IC50 hA2B = 20 nM hA1/hA2B = 183, hA2A,hA3/hA2B > 250).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNTK9UeGa9jbVg90H21EOLACvtfcHk0liBcKJL7l5j_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurrM&md5=c678e6895a09485ed65d35d90eb66894</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm201292w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201292w%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPiccagli%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DZaid%26aufirst%3DA.%2BN.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26atitle%3DNovel%25201%252C3-Dipropyl-8-%25283-Benzimidazol-2-Yl-Methoxy-1-Methylpyrazol-5-Yl%2529%2520Xanthines%2520as%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D2%26spage%3D797%26epage%3D811%26doi%3D10.1021%2Fjm201292w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barawkar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramdas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naykodi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quraishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouduri, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Novel Xanthine Derivatives as Potent and Selective A2B Adenosine Receptor Antagonists for the Treatment of Chronic Inflammatory Airway Diseases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ejmech.2017.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28415011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=218-229&author=S.+Basuauthor=D.+A.+Barawkarauthor=V.+Ramdasauthor=M.+Patelauthor=Y.+Wamanauthor=A.+Panmandauthor=S.+Kumarauthor=S.+Thoratauthor=M.+Naykodiauthor=A.+Goswamiauthor=B.+S.+Reddyauthor=V.+Prasadauthor=S.+Chaturvediauthor=A.+Quraishiauthor=S.+Menonauthor=S.+Paliwalauthor=A.+Kulkarniauthor=V.+Karandeauthor=I.+Ghoshauthor=S.+Mustafaauthor=S.+Deauthor=V.+Jainauthor=E.+R.+Banerjeeauthor=S.+R.+Rouduriauthor=V.+P.+Palleauthor=A.+Chughauthor=K.+A.+Mookhtiar&title=Design+and+Synthesis+of+Novel+Xanthine+Derivatives+as+Potent+and+Selective+A2B+Adenosine+Receptor+Antagonists+for+the+Treatment+of+Chronic+Inflammatory+Airway+Diseases&doi=10.1016%2Fj.ejmech.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases</span></div><div class="casAuthors">Basu, Sujay; Barawkar, Dinesh A.; Ramdas, Vidya; Patel, Meena; Waman, Yogesh; Panmand, Anil; Kumar, Santosh; Thorat, Sachin; Naykodi, Minakshi; Goswami, Arnab; Reddy, B. Srinivasa; Prasad, Vandna; Chaturvedi, Sandhya; Quraishi, Azfar; Menon, Suraj; Paliwal, Shalini; Kulkarni, Abhay; Karande, Vikas; Ghosh, Indraneel; Mustafa, Syed; De, Siddhartha; Jain, Vaibhav; Banerjee, Ena Ray; Rouduri, Sreekanth R.; Palle, Venkata P.; Chugh, Anita; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The identification of novel, potent and selective A2B adenosine receptor (A2BAdoR) antagonists has been shown to be potentially beneficial for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).  Towards this effort, the authors explored several prop-2-ynylated C8-aryl or heteroaryl substitutions on xanthine chemotype and found that 1-prop-2-ynyl-1H-pyrazol-4-yl moiety was better tolerated at the C8 position.  Compd. I (R1 = H, R2 = n-Pr), exhibited binding affinity (Ki) of 62 nM but was non-selective for A2BAdoR over other AdoRs.  Incorporation of substituted Ph on the terminal acetylene increased the binding affinity (Ki) significantly to <10 nM.  Various substitutions on terminal Ph group and different alkyl substitutions on N-1 and N-3 were explored to improve the potency, selectivity for A2BAdoR and the soly.  In general, compds. with meta-substituted Ph provided better selectivity for A2BAdoR compared to that of para-substituted analogs.  Substitutions such as basic amines like pyrrolidine, piperidine, piperazine or cycloalkyls with polar group were tried on terminal acetylene, keeping in mind the poor soly. of xanthine analogs in general.  However, these substitutions led to a decrease in affinity compared to compd. I (R1 = H, R2 = n-Pr).  Subsequent SAR optimization resulted in identification of compd. I [R1 = 3-(CF3O)C6H4, R2 = Et(II)] with high human A2BAdoR affinity (Ki = 13 nM), selectivity against other AdoR subtypes and with good pharmacokinetic properties.  It was found to be a potent functional A2BAdoR antagonist with a Ki of 8 nM in cAMP assay in hA2B-HEK293 cells and an IC50 of 107 nM in IL6 assay in NIH-3T3 cells.  Docking study was performed to rationalize the obsd. affinity data.  Structure-activity relationship (SAR) studies also led to identification of compd. I (R1 = 3-HO2CC6H4, R2 = n-Pr) as a potent A2BAdoR antagonist with Ki of 1.8 nM in cAMP assay and good aq. soly. of 529 μM at neutral pH.  Compd. II was further tested for in vivo efficacy and found to be efficacious in ovalbumin-induced allergic asthma model in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8O-mETdHU7LVg90H21EOLACvtfcHk0lhUiPNLV9vznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFWntrc%253D&md5=208780bfe877de2b9d9457b8e9d74376</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBarawkar%26aufirst%3DD.%2BA.%26aulast%3DRamdas%26aufirst%3DV.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DWaman%26aufirst%3DY.%26aulast%3DPanmand%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DThorat%26aufirst%3DS.%26aulast%3DNaykodi%26aufirst%3DM.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DQuraishi%26aufirst%3DA.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DKarande%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DBanerjee%26aufirst%3DE.%2BR.%26aulast%3DRouduri%26aufirst%3DS.%2BR.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%2520Xanthine%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Inflammatory%2520Airway%2520Diseases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D218%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barawkar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramdas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonagiri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quraishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusange, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouduri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span> <span> </span><span class="NLM_article-title">A2B adenosine Receptor Antagonists: Design, Synthesis and Biological Evaluation of Novel Xanthine Derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ejmech.2016.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27842891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVChsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=986-996&author=S.+Basuauthor=D.+A.+Barawkarauthor=V.+Ramdasauthor=Y.+Wamanauthor=M.+Patelauthor=A.+Panmandauthor=S.+Kumarauthor=S.+Thoratauthor=R.+Bonagiriauthor=D.+Jadhavauthor=P.+Mukhopadhyayauthor=V.+Prasadauthor=B.+S.+Reddyauthor=A.+Goswamiauthor=S.+Chaturvediauthor=S.+Menonauthor=A.+Quraishiauthor=I.+Ghoshauthor=S.+Dusangeauthor=S.+Paliwalauthor=A.+Kulkarniauthor=V.+Karandeauthor=R.+Thakreauthor=G.+Bedseauthor=S.+Rouduriauthor=J.+Gunduauthor=V.+P.+Palleauthor=A.+Chughauthor=K.+A.+Mookhtiar&title=A2B+adenosine+Receptor+Antagonists%3A+Design%2C+Synthesis+and+Biological+Evaluation+of+Novel+Xanthine+Derivatives&doi=10.1016%2Fj.ejmech.2016.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives</span></div><div class="casAuthors">Basu, Sujay; Barawkar, Dinesh A.; Ramdas, Vidya; Waman, Yogesh; Patel, Meena; Panmand, Anil; Kumar, Santosh; Thorat, Sachin; Bonagiri, Rajesh; Jadhav, Dilip; Mukhopadhyay, Partha; Prasad, Vandna; Reddy, B. Srinivasa; Goswami, Arnab; Chaturvedi, Sandhya; Menon, Suraj; Quraishi, Azfar; Ghosh, Indraneel; Dusange, Sushant; Paliwal, Shalini; Kulkarni, Abhay; Karande, Vikas; Thakre, Rhishikesh; Bedse, Gaurav; Rouduri, Sreekanth; Gundu, Jayasagar; Palle, Venkata P.; Chugh, Anita; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A2BAdoR is a low affinity adenosine receptor that functions by Gs mediated elevation of cAMP and subsequent downstream signaling.  The receptor has been implicated in lung inflammatory disorders like COPD and asthma.  Several potent and selective A2BAdoR antagonists have been reported in literature, however most of the compds. suffer from poor pharmacokinetic profile.  Therefore, with the aim to identify novel, potent and selective A2BAdoR antagonists with improved pharmacokinetic properties, the authors first explored more constrained form of MRS-1754.  To improve the metabolic stability, several linker modifications were attempted as replacement of amide linker along with different Ph or other heteroaryls between C8 position of xanthine head group and terminal Ph ring.  SAR optimization resulted in identification of two novel A2BAdoR antagonists I and II, with high binding affinity (Ki = 1 and 1.5 nM, resp.) and selectivity for A2BAdoR with very good functional potency of 0.9 nM and 4 nM, resp.  Compd. I and II also displayed good pharmacokinetic properties in mice with 27% and 65% oral bioavailability resp.  When evaluated in in vivo mice model of asthma, compd. II also inhibited airway inflammation and airway reactivity in ovalbumin induced allergic asthma at 3 mpk dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBa8gZOKDU1rVg90H21EOLACvtfcHk0lhUiPNLV9vznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVChsr%252FF&md5=ea13897bebb3cdce835603352e71098a</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBarawkar%26aufirst%3DD.%2BA.%26aulast%3DRamdas%26aufirst%3DV.%26aulast%3DWaman%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPanmand%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DThorat%26aufirst%3DS.%26aulast%3DBonagiri%26aufirst%3DR.%26aulast%3DJadhav%26aufirst%3DD.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DGoswami%26aufirst%3DA.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DQuraishi%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DI.%26aulast%3DDusange%26aufirst%3DS.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DKarande%26aufirst%3DV.%26aulast%3DThakre%26aufirst%3DR.%26aulast%3DBedse%26aufirst%3DG.%26aulast%3DRouduri%26aufirst%3DS.%26aulast%3DGundu%26aufirst%3DJ.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DA2B%2520adenosine%2520Receptor%2520Antagonists%253A%2520Design%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Xanthine%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.ejmech.2016.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárdenas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozoya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, B.</span></span> <span> </span><span class="NLM_article-title">New Pyrrolopyrimidin-6-Yl Benzenesulfonamides: Potent A2B Adenosine Receptor Antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3642</span>– <span class="NLM_lpage">3645</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2006.04.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16697192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVykt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3642-3645&issue=14&author=C.+Esteveauthor=A.+Nuedaauthor=J.+L.+D%C3%ADazauthor=J.+Beletaauthor=A.+C%C3%A1rdenasauthor=E.+Lozoyaauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=H.+Ryderauthor=B.+Vidal&title=New+Pyrrolopyrimidin-6-Yl+Benzenesulfonamides%3A+Potent+A2B+Adenosine+Receptor+Antagonists&doi=10.1016%2Fj.bmcl.2006.04.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">New pyrrolopyrimidin-6-yl benzenesulfonamides: Potent A2B adenosine receptor antagonists</span></div><div class="casAuthors">Esteve, Cristina; Nueda, Arsenio; Diaz, Jose Luis; Beleta, Jorge; Cardenas, Alvaro; Lozoya, Estrella; Cadavid, Maria Isabel; Loza, Maria Isabel; Ryder, Hamish; Vidal, Bernat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3642-3645</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new series of 4-(1,3-dialkyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)benzenesulfonamides has been identified as potent A2B adenosine receptor antagonists.  The products have been evaluated for their binding affinities for the human A2B, A1 and A3 adenosine receptors.  6-(4-[[4-(4-Bromobenzyl)-1-piperazinyl]sulfonyl]phenyl)-1,3-dimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione showed a high affinity for the A2B adenosine receptor (IC50 = 1 nM) and selectivity (A1: 183x; A3: 12660x).  Synthesis and SAR of this novel class of compds. showing improved absorption properties is presented herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhwXqSuUEXLVg90H21EOLACvtfcHk0lhUiPNLV9vznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVykt7s%253D&md5=a04df7f78252a5f6096272cc0a228bde</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.074%26sid%3Dliteratum%253Aachs%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DA.%26aulast%3DLozoya%26aufirst%3DE.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DRyder%26aufirst%3DH.%26aulast%3DVidal%26aufirst%3DB.%26atitle%3DNew%2520Pyrrolopyrimidin-6-Yl%2520Benzenesulfonamides%253A%2520Potent%2520A2B%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D14%26spage%3D3642%26epage%3D3645%26doi%3D10.1016%2Fj.bmcl.2006.04.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centeno, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raviña, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segarra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span> <span> </span><span class="NLM_article-title">1-, 3- and 8-Substituted-9-Deazaxanthines as Potent and Selective Antagonists at the Human A2B Adenosine Receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2852</span>– <span class="NLM_lpage">2869</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2008.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18226909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFersL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2852-2869&issue=6&author=A.+Stefanachiauthor=J.+M.+Breaauthor=M.+I.+Cadavidauthor=N.+B.+Centenoauthor=C.+Esteveauthor=M.+I.+Lozaauthor=A.+Martinezauthor=R.+Nietoauthor=E.+Ravi%C3%B1aauthor=F.+Sanzauthor=V.+Segarraauthor=E.+Soteloauthor=B.+Vidalauthor=A.+Carotti&title=1-%2C+3-+and+8-Substituted-9-Deazaxanthines+as+Potent+and+Selective+Antagonists+at+the+Human+A2B+Adenosine+Receptor&doi=10.1016%2Fj.bmc.2008.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">1-, 3- And 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor</span></div><div class="casAuthors">Stefanachi, Angela; Brea, Jose Manuel; Cadavid, Maria Isabel; Centeno, Nuria B.; Esteve, Cristina; Loza, Maria Isabel; Martinez, Ana; Nieto, Rosa; Ravina, Enrique; Sanz, Ferran; Segarra, Victor; Sotelo, Eddy; Vidal, Bernat; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2852-2869</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A large series of piperazin-, piperidin- and tetrahydroisoquinolinamides of 4-(1,3-dialkyl-9-deazaxanthin-8-yl)phenoxyacetic acid were prepd. through conventional or multiple parallel syntheses and evaluated for their binding affinity at the recombinant human adenosine receptors, chiefly at the hA2B and hA2A receptor subtypes.  Several ligands endowed with high binding affinity at hA2B receptors, excellent selectivity over hA2A and hA3 and a significant, but lower, selectivity over hA1 were identified.  Among them, piperazinamide derivs. (I and II), and piperidinamide deriv. (III) proved highly potent at hA2B (Ki = 11, 2 and 5.5 nM, resp.) and selective towards hA2A (hA2A/hA2B SI = 912, 159 and 630, resp.), hA3 (hA3/hA2B SI = > 100, 3090 and >180, resp.) and hA1 (hA1/hA2B SI = > 100, 44 and 120, resp.), SI being the selectivity index.  A no. of selected ligands tested in functional assays in vitro showed very interesting antagonist activities and efficacies at both A2A and A2B receptor subtypes, with pA2 values close to the corresponding pKis.  Structure-affinity and structure-selectivity relationships suggested that the binding potency at the hA2B receptor may be increased by lipophilic substituents at the N4-position of piperazinamides and that an ortho-methoxy substituent at the 8-Ph ring and alkyl groups at N1 larger than the ones at N3, in the 9-deazaxanthine ring, may strongly enhance the hA2A/hA2B SI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtlInuQjh9C7Vg90H21EOLACvtfcHk0lgvBSsrjhXe3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFersL0%253D&md5=457827960ff1b6818e352566f3f48b13</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DBrea%26aufirst%3DJ.%2BM.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DCenteno%26aufirst%3DN.%2BB.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DNieto%26aufirst%3DR.%26aulast%3DRavi%25C3%25B1a%26aufirst%3DE.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DSotelo%26aufirst%3DE.%26aulast%3DVidal%26aufirst%3DB.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3D1-%252C%25203-%2520and%25208-Substituted-9-Deazaxanthines%2520as%2520Potent%2520and%2520Selective%2520Antagonists%2520at%2520the%2520Human%2520A2B%2520Adenosine%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D6%26spage%3D2852%26epage%3D2869%26doi%3D10.1016%2Fj.bmc.2008.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvatore, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. G.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Characterization of the Human A3 Adenosine Receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">10365</span>– <span class="NLM_lpage">10369</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.21.10365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.90.21.10365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8234299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXps1Gqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=10365-10369&issue=21&author=C.+A.+Salvatoreauthor=M.+A.+Jacobsonauthor=H.+E.+Taylorauthor=J.+Lindenauthor=R.+G.+Johnson&title=Molecular+Cloning+and+Characterization+of+the+Human+A3+Adenosine+Receptor&doi=10.1073%2Fpnas.90.21.10365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of the human A3 adenosine receptor</span></div><div class="casAuthors">Salvatore, Christopher A.; Jacobson, Marlene A.; Taylor, Heidi E.; Linden, Joel; Johnson, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">10365-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The human A3 adenosine receptor was cloned from a striatal cDNA library using a probe derived from the homologous rat sequence.  The cDNA encodes a protein of 318 amino acids and exhibits 72% and 85% overall identity with the rat and sheep A3 adenosine receptor sequences, resp.  Specific and saturable binding of the adenosine receptor agonist N6-(4-amino-3-[125I]iodobenzyl)adenosine [125I]ABA was measured on the human A3 receptor stably expressed in Chinese hamster ovary cells with a Kd = 10 nM.  The potency order for adenosine receptor agonists was N-ethylcarboxamidoadenosine (NECA) ≥ (R)-N6-phenyl-2-propyladenosine [(R)-PIA] > N6-cyclopentyladenosine (CPA) > (S)-N6-phenyl-2-propyladenosine [(S)-PIA].  The human receptor was blocked by xanthine antagonists, most potently by 3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine (I-ABOPX) with a potency order of I-ABOPX > 1,3-dipropyl-8-(4-acrylate)phenylxanthine ≥ xanthine amino congener >> 1,3-dipropyl-8-cyclopentylxanthine.  Adenosine, NECA, (R)- and (S)-PIA, and CPA inhibited forskolin-stimulated cAMP accumulation by 30-40% in stably transfected cells; I-ABA is a partial agonist.  When measured in the presence of antagonists, the dose-response curves of NECA-induced inhibition of forskolin-stimulated cAMP accumulation were right-shifted.  Antagonist potencies detd. by Schild analyses correlated well with those established by competition for radioligand binding.  The A3 adenosine receptor transcript is widespread and, in contrast to the A1, A2a, and A2b transcripts, the most abundant expression is found in the lung and liver.  The tissue distribution of A3 mRNA is more similar to the widespread profile found in sheep than to the restricted profile found in the rat.  This raises the possibility that numerous physiol. effects of adenosine may be mediated by A3 adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNKbZQGAUkSLVg90H21EOLACvtfcHk0lgvBSsrjhXe3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXps1Gqtg%253D%253D&md5=7f663d6084176c057a12a655b2b6f157</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.21.10365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.21.10365%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DTaylor%26aufirst%3DH.%2BE.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26atitle%3DMolecular%2520Cloning%2520and%2520Characterization%2520of%2520the%2520Human%2520A3%2520Adenosine%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26issue%3D21%26spage%3D10365%26epage%3D10369%26doi%3D10.1073%2Fpnas.90.21.10365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Galen, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bergen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">A Binding Site Model and Structure-Activity Relationships for the Rat A3 Adenosine Receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8022403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXltVSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=1101-1111&issue=6&author=P.+J.+M.+Van+Galenauthor=A.+H.+Van+Bergenauthor=C.+Gallo-Rodriguezauthor=N.+Melmanauthor=M.+E.+Olahauthor=A.+D.+P.+Ijzermanauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=A+Binding+Site+Model+and+Structure-Activity+Relationships+for+the+Rat+A3+Adenosine+Receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">A binding site model and structure-activity relationships for the rat A3 adenosine receptor</span></div><div class="casAuthors">van Galen, Philip J. M.; van Bergen, Andrew H.; Gallo-Rodriguez, Carola; Melman, Neli; Olah, Mark E.; Ijzerman, Ad P.; Stiles, Gary L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1101-11</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">A novel adenosine receptor, the A3 receptor, has recently been cloned.  The authors have systematically investigated the hitherto largely unexplored structure-activity relationships (SARs) for binding at A3 receptors, using 125I-N6-2-(4-aminophenyl)ethyladenosine as a radioligand and membranes from Chinese hamster ovary cells stably transfected with the rat A3-cDNA.  As is the case for A1 and A2a receptors, substitutions at the N6 and 5' positions of adenosine, the prototypic agonist ligand, may yield fairly potent compds.  However, the highest affinity and A3 selectivity is found for N6,5'-disubstituted compds., in contrast to A2 and A2a receptors.  Thus, N6-benzyladenosine-5'-N-ethylcarboxamide is highly potent (Ki, 6.8 nM) and moderately selective (13- and 14-fold vs. A1 and A2a).  The N6 region of the A3 receptor also appears to tolerate hydrophilic substitutions, in sharp contrast to the other subtypes.  Potencies of N6,5'-disubstituted compds. in inhibition of adenylate cyclase via A3 receptors parallel their high affinity in the binding assay.  None of the typical xanthine or nonxanthine (A1/A2) antagonists tested show any appreciable affinity for rat A3 receptors.  1,3-Dialkylxanthines did not antagonize the A3 agonist-induced inhibition of adenylate cyclase.  A His residue in helix 6 that is absent in A3 receptors but present in A1/A2 receptors may be causal in this respect.  In a mol. model for the rat A3 receptor, this mutation, together with an increased bulkiness of residues surrounding the ligand, make antagonist binding unfavorable when compared with a previously developed A1 receptor model.  Second, this A3 receptor model predicted similarities with A1 and A2 receptors in the binding requirements for the ribose moiety and that xanthine-7-ribosides would bind to rat A3 receptors.  This hypothesis was supported exptl. by the moderate affinity (Ki, 6 μM) of 7-riboside of 1,3-dibutylxanthine, which appears to be a partial agonist at rat A3 receptors.  The model presented here which is consistent with the detailed SAR found in this study, may serve to suggest future chem. modification, site-directed mutagenesis, and SAR studies to further define essential characteristics of the ligand-receptor interaction and to develop even more potent and selective A3 receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsMJrWbI3Jj7Vg90H21EOLACvtfcHk0lgvBSsrjhXe3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVSjt7o%253D&md5=3d5617160ac27215f47f172f0e82be52</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGalen%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DVan%2BBergen%26aufirst%3DA.%2BH.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DIjzerman%26aufirst%3DA.%2BD.%2BP.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DA%2520Binding%2520Site%2520Model%2520and%2520Structure-Activity%2520Relationships%2520for%2520the%2520Rat%2520A3%2520Adenosine%2520Receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26issue%3D6%26spage%3D1101%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.-d.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of 1,3-Dialkylxanthine Derivatives at Rat A3 Adenosine Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3373</span>– <span class="NLM_lpage">3382</span>, <span class="refDoi"> DOI: 10.1021/jm00046a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00046a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFSksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3373-3382&issue=20&author=H.+O.+Kimauthor=X.-d.+Jiauthor=N.+Melmanauthor=M.+E.+Olahauthor=G.+L.+Stilesauthor=K.+A.+Jacobson&title=Structure-Activity+Relationships+of+1%2C3-Dialkylxanthine+Derivatives+at+Rat+A3+Adenosine+Receptors&doi=10.1021%2Fjm00046a022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of 1,3-Dialkylxanthine Derivatives at Rat A3 Adenosine Receptors</span></div><div class="casAuthors">Kim, Hea Ok; Ji, Xiao-duo; Melman, Neli; Olah, Mark E.; Stiles, Gary L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3373-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">1,3-Dialkylxanthine analogs contg. carboxylic acid and other charged groups on 8-position substituents were synthesized.  These derivs. were examd. for affinity in radioligand binding assays at rat brain A3 adenosine receptors stably expressed in CHO cells using the new radioligand [125I]AB-MECA (N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide), and at rat brain A1 and A2a receptors using [3H]PIA and [3H]CGS 21680, resp.  A synthetic strategy for introducing multiple carboxylate groups at the 8-position using iminodiacetic acid derivs. was explored.  The presence of a sulfonate, a carboxylate, or multiple carboxylate groups did not result in a significant enhancement of affinity at rat A3 receptors, although as previously obsd. an anionic group tended to diminish potency at A1 and A2a receptors.  The rat A3 receptor affinity was not highly dependent on the distance of a carboxylate group from the xanthine pharmacophore.  2-Thio vs 2-oxo substitution favored A3 potency, and 8-alkyl vs 8-aryl substitution favored A3 selectivity, although few derivs. were truly selective for rat A3 receptors.  1,3-Dimethyl-8-(3-carboxypropyl)-2-thioxanthine was 7-fold selective for A3 vs A2a receptors.  1,3,7-Trimethyl-8-(trans-2-carboxyvinyl)xanthine was somewhat selective for A3 vs A1 receptors.  For 8-arylxanthines affinity at A3 receptors was enhanced by 1,3-dialkyl substituents, in the order di-Bu > di-Pr > diallyl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBQ4LLbrICcrVg90H21EOLACvtfcHk0lhq72BWYI6p6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFSksA%253D%253D&md5=7b196fe5655f2507ac2a8da74ee506be</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm00046a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00046a022%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJi%26aufirst%3DX.-d.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DStiles%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-Activity%2520Relationships%2520of%25201%252C3-Dialkylxanthine%2520Derivatives%2520at%2520Rat%2520A3%2520Adenosine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D20%26spage%3D3373%26epage%3D3382%26doi%3D10.1021%2Fjm00046a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priego, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Frijtag Drabbe Kuenzel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Pérez, M. J.</span></span> <span> </span><span class="NLM_article-title">Pyrido[2,1-f]Purine-2,4-Dione Derivatives as a Novel Class of Highly Potent Human A3 Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3337</span>– <span class="NLM_lpage">3344</span>, <span class="refDoi"> DOI: 10.1021/jm0208469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0208469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFCkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3337-3344&issue=16&author=E.+M.+Priegoauthor=J.+Von+Frijtag+Drabbe+Kuenzelauthor=A.+P.+Ijzermanauthor=M.+J.+Camarasaauthor=M.+J.+P%C3%A9rez-P%C3%A9rez&title=Pyrido%5B2%2C1-f%5DPurine-2%2C4-Dione+Derivatives+as+a+Novel+Class+of+Highly+Potent+Human+A3+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm0208469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[2,1-f]purine-2,4-dione Derivatives as a Novel Class of Highly Potent Human A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Priego, Eva-Maria; von Kuenzel, Jacobien; Ijzerman, Ad P.; Camarasa, Maria-Jose; Perez-Perez, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3337-3344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyridopurinediones I [R = H, MeO, Me3C, Ph; R1 = H, Et, EtCH2, c-C3H5CH2, Me2CHCH2, c-C6H11CH2, H2C:CHCH2, HC≡CCH2, (E)-MeO2CCH:CHCH2, 3-(phthalimido)propyl, H2N(CH2)3, PhCH2, 4-MeOC6H4CH2 ; R2 = H, Me, PhCH2, 4-MeOC6H4CH2, 3-BrC6H4CH2] were prepd. and evaluated as human adenosine receptors antagonists selective for the human adenosine A3 receptor.  I were prepd. in two steps from aminopyrimidinedione II (R2 = PhCH2).  In the key step, II was treated with N-bromosuccinimide in acetonitrile to give a presumed 5,5-dibromo-6-iminopyrimidinedione which was not isolated but treated with 4-substituted pyridines 4-RC5H4N (R = H, MeO, Me3C, Ph) to provide pyridopurines I (R = H, MeO, Me3C, Ph; R1 = H; R2 = PhCH2) in 58-74% yields.  I (R = H, MeO, Me3C, Ph; R1 = H; R2 = PhCH2) were alkylated with a variety of alkylating agents with DBU as the base in acetonitrile to give I.  When II (R2 = Me) was used, the difficultly isolated products I (R1 = H, EtCH2; R2 = Me) were prepd.  Debenzylation of I (R = H; R1 = EtCH2; R2 = PhCH2) with aluminum chloride in toluene gave I (R = R2 = H; R1 = EtCH2) which was alkylated with 4-MeOC6H4CH2Br and 3-MeC6H4CH2Br to give I (R = H; R1 = EtCH2; R2 = 4-MeOC6H4CH2, 3-MeC6H4CH2).  I act as adenosine receptor antagonists with selectivities for the human adenosine A3 receptor and binding affinities for adenosine receptors in the low nanomolar range.  E.g., I (R = H; R1 = EtCH2; R2 = PhCH2), a potential lead compd. for the development of adenosine A3 receptor antagonists, exhibited a Ki value of 4.0 ± 0.3 nM against the hA3 receptor.  While xanthine derivs. have traditionally been considered poor A3 antagonists, the described pyrido[2,1-f]purine-2,4-dione derivs. represent a new family of adenosine receptor antagonists which deserves further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq07sRZ55ABobVg90H21EOLACvtfcHk0lhq72BWYI6p6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFCkuro%253D&md5=bd0ec10c561e266c06786951906fe4d9</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm0208469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208469%26sid%3Dliteratum%253Aachs%26aulast%3DPriego%26aufirst%3DE.%2BM.%26aulast%3DVon%2BFrijtag%2BDrabbe%2BKuenzel%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DM.%2BJ.%26atitle%3DPyrido%255B2%252C1-f%255DPurine-2%252C4-Dione%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Highly%2520Potent%2520Human%2520A3%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D16%26spage%3D3337%26epage%3D3344%26doi%3D10.1021%2Fjm0208469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttarolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaid, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span> <span> </span><span class="NLM_article-title">New Pyrrolo[2,1-f]Purine-2,4-Dione and Imidazo[2,1-f]Purine-2,4-Dione Derivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4697</span>– <span class="NLM_lpage">4701</span>, <span class="refDoi"> DOI: 10.1021/jm058008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlyrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4697-4701&issue=14&author=P.+G.+Baraldiauthor=D.+Pretiauthor=M.+A.+Tabriziauthor=F.+Fruttaroloauthor=R.+Romagnoliauthor=N.+A.+Zaidauthor=A.+R.+Moormanauthor=S.+Merighiauthor=K.+Varaniauthor=P.+A.+Borea&title=New+Pyrrolo%5B2%2C1-f%5DPurine-2%2C4-Dione+and+Imidazo%5B2%2C1-f%5DPurine-2%2C4-Dione+Derivatives+as+Potent+and+Selective+Human+A3+Adenosine+Receptor+Antagonists&doi=10.1021%2Fjm058008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">New Pyrrolo[2,1-f]purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione Derivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Preti, Delia; Tabrizi, Mojgan Aghazadeh; Fruttarolo, Francesca; Romagnoli, Romeo; Zaid, Naser Abdel; Moorman, Allan R.; Merighi, Stefania; Varani, Katia; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4697-4701</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. presenting an addnl. fused ring on the xanthine nucleus have been reported to exhibit antagonistic activity with various levels of affinity and selectivity toward the four adenosine receptors subtypes A1, A2A, A2B, and A3.  This paper reports synthesis and biol. evaluation of new 1-benzyl-3-propyl-1H,6H-pyrrolo[2,1-f]purine-2,4-diones and 1-benzyl-3-propyl-1H,8H-imidazo[2,1-f]purine-2,4-diones, among which we identified potent and selective A3 adenosine receptors antagonists.  In particular, 1-benzyl-7-methyl-3-propyl-1H,8H-imidazo[2,1-f]purine-2,4-dione (I) shows a Ki (hA3) value from binding assay of 0.8 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJWWi0pAc7zbVg90H21EOLACvtfcHk0lhq72BWYI6p6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlyrsLY%253D&md5=9448663f56a0b82f395ccb0100ae6353</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm058008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058008c%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DFruttarolo%26aufirst%3DF.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DZaid%26aufirst%3DN.%2BA.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DNew%2520Pyrrolo%255B2%252C1-f%255DPurine-2%252C4-Dione%2520and%2520Imidazo%255B2%252C1-f%255DPurine-2%252C4-Dione%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520Human%2520A3%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D14%26spage%3D4697%26epage%3D4701%26doi%3D10.1021%2Fjm058008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catarzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabri, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenzi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filacchioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trincavelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tralli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montopoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span> <span> </span><span class="NLM_article-title">2-Aryl-8-Chloro-1,2,4-Triazolo[1,5-a]Quinoxalin-4-Amines as Highly Potent A 1 and A 3 Adenosine Receptor Antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmc.2004.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15653338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=705-715&issue=3&author=D.+Catarziauthor=V.+Colottaauthor=F.+Varanoauthor=F.+R.+Calabriauthor=O.+Lenziauthor=G.+Filacchioniauthor=L.+Trincavelliauthor=C.+Martiniauthor=A.+Tralliauthor=C.+Montopoliauthor=S.+Moro&title=2-Aryl-8-Chloro-1%2C2%2C4-Triazolo%5B1%2C5-a%5DQuinoxalin-4-Amines+as+Highly+Potent+A+1+and+A+3+Adenosine+Receptor+Antagonists&doi=10.1016%2Fj.bmc.2004.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists</span></div><div class="casAuthors">Catarzi, Daniela; Colotta, Vittoria; Varano, Flavia; Calabri, Francesca Romana; Lenzi, Ombretta; Filacchioni, Guido; Trincavelli, Letizia; Martini, Claudia; Tralli, Andrea; Montopoli, Christian; Moro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-715</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Some 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxaline derivs., obtained by introducing different substituents on either the 4-amino moiety (acyl or carbamoyl groups) or the 2-Ph ring (4-OCH3) of previously reported 8-chloro-2-phenyl-1,2,4-triazolo[1,5-a]quinoxalin-4-amine, have been synthesized and tested in radioligand binding assays at bovine A1 and A2A and at cloned human A1 and A3 adenosine receptors.  The rationally designed 8-chloro-2-(4-methoxy-phenyl)-1,2,4-triazolo[1,5-a]quinoxalin-4-acetylamine can be considered one of the most potent and hA3 vs. hA1 selective AR antagonists reported till now.  The structure-activity relationships of these compds. are in agreement with those of previously reported 2-aryl-1,2,4-triazolo[4,3-a]quinoxalines (series A) and 2-arylpyrazolo[3,4-c]quinolines (series B), thus suggesting a similar AR binding mode.  In fact, the importance for the A3 receptor-ligand interaction of both a strong acidic NH proton donor and a C=O proton acceptor at position-4, able to engage hydrogen-bonding interactions with specific sites on the A3 AR, has been confirmed.  Using our recently published hA3 receptor model, to better elucidate our exptl. results, we decided to theor. depict the putative TM binding motif of the herein reported 1,2,4-triazolo[1,5-a]quinoxaline derivs. on human A3 receptor.  Structure-activity relationships have been explained analyzing the three-dimensional structure of the antagonist-receptor models obtained by mol. docking simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJz8GN4HAYbVg90H21EOLACvtfcHk0lhc5oZtIq9MiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVanug%253D%253D&md5=67a6bcd7a854fd7eedd2fc8caca9da11</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DColotta%26aufirst%3DV.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DCalabri%26aufirst%3DF.%2BR.%26aulast%3DLenzi%26aufirst%3DO.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DTralli%26aufirst%3DA.%26aulast%3DMontopoli%26aufirst%3DC.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3D2-Aryl-8-Chloro-1%252C2%252C4-Triazolo%255B1%252C5-a%255DQuinoxalin-4-Amines%2520as%2520Highly%2520Potent%2520A%25201%2520and%2520A%25203%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D3%26spage%3D705%26epage%3D715%26doi%3D10.1016%2Fj.bmc.2004.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diekmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qurishi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">2-Phenylimidazo[2,1-i]Purin-5-Ones: Structure-Activity Relationships and Characterization of Potent and Selective Inverse Agonists at Human A3 Adenosine Receptors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00456-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0968-0896%2802%2900456-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12517430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvV2k" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=347-356&issue=3&author=V.+Ozolaauthor=M.+Thorandauthor=M.+Diekmannauthor=R.+Qurishiauthor=B.+Schumacherauthor=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=2-Phenylimidazo%5B2%2C1-i%5DPurin-5-Ones%3A+Structure-Activity+Relationships+and+Characterization+of+Potent+and+Selective+Inverse+Agonists+at+Human+A3+Adenosine+Receptors&doi=10.1016%2FS0968-0896%2802%2900456-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">2-Phenylimidazo[2,1-i]purin-5-ones Structure-Activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors</span></div><div class="casAuthors">Ozola, Vita; Thorand, Mark; Diekmann, Martina; Qurishi, Ramatullah; Schumacher, Britta; Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Structure-activity relationships of 2-phenyl-imidazo[2,1-i]purin-5-ones as ligands for human A3 adenosine receptors (ARs) were investigated.  An Et group in the 8-position of the imidazoline ring of 4-methyl-2-phenyl-imidazopurinone leading to chiral compds. was found to increase affinity for human A3 ARs by several thousand-fold.  Pr substitution instead of Me at N4 decreased A3 affinity but increased A1 affinity leading to potent A1-selective AR antagonists.  The most potent A1 antagonist of the present series was (S)-8-ethyl-2-phenyl-4-propyl-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one exhibiting a Ki value of 7.4 nM at rat A1 ARs and greater than 100-fold selectivity vs. rat A2A and human A3 ARs.  At human A1 ARs 2-phenylimidazo[2,1-i]purin-5-ones were generally less potent and therefore less A1-selective (S-3: Ki=98 nM).  2-, 3-, Or 4-Mono-chlorination of the 2-Ph ring reduced A3 affinity but led to an increase in affinity for A1 ARs, whereas di- (3,4-dichloro) or polychlorination (2,3,5-trichloro) increased A3 affinity.  The most potent and selective A3 antagonist of the present series was the trichlorophenyl deriv. (R)-8-ethyl-4-methyl-2-(2,3,5-trichlorophenyl)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one exhibiting a subnanomolar Ki value at human A3 ARs and greater than 800-fold selectivity vs. the other AR subtypes.  Methylation of 4-alkyl-2-phenyl-substituted imidazo[2,1-i]purin-5-ones led exclusively to the N9-Me derivs., which exhibited largely reduced AR affinities as compared to the unmethylated compds.  [35S]GTPγS binding studies of the most potent 2-phenyl-imidazo[2,1-i]purin-5-ones at membranes of Chinese hamster ovary cells expressing the human A3 AR revealed that the compds. were inverse agonists at A3 receptors under std. test conditions.  Due to their high A3 affinity, selectivity, and relatively high water-soly., 2-phenyl-imidazo[2,1-i]purin-5-ones may become useful research tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiZMo1EGPgHrVg90H21EOLACvtfcHk0lhc5oZtIq9MiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvV2k&md5=1c9f9a31339f3a9e03d2155dcdbe64d6</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900456-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900456-X%26sid%3Dliteratum%253Aachs%26aulast%3DOzola%26aufirst%3DV.%26aulast%3DThorand%26aufirst%3DM.%26aulast%3DDiekmann%26aufirst%3DM.%26aulast%3DQurishi%26aufirst%3DR.%26aulast%3DSchumacher%26aufirst%3DB.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D2-Phenylimidazo%255B2%252C1-i%255DPurin-5-Ones%253A%2520Structure-Activity%2520Relationships%2520and%2520Characterization%2520of%2520Potent%2520and%2520Selective%2520Inverse%2520Agonists%2520at%2520Human%2520A3%2520Adenosine%2520Receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26issue%3D3%26spage%3D347%26epage%3D356%26doi%3D10.1016%2FS0968-0896%2802%2900456-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, W. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhoven, J. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duijl, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenselink, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paasman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]Purine-2,4-Dione Derivatives as Human Adenosine A3 Receptor Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7555</span>– <span class="NLM_lpage">7568</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00950</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00950" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtleht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7555-7568&issue=17&author=L.+Xiaauthor=W.+A.+C.+Burgerauthor=J.+P.+D.+Van+Veldhovenauthor=B.+J.+Kuiperauthor=T.+T.+Van+Duijlauthor=E.+B.+Lenselinkauthor=E.+Paasmanauthor=L.+H.+Heitmanauthor=A.+P.+Ijzerman&title=Structure-Affinity+Relationships+and+Structure-Kinetics+Relationships+of+Pyrido%5B2%2C1-f%5DPurine-2%2C4-Dione+Derivatives+as+Human+Adenosine+A3+Receptor+Antagonists&doi=10.1021%2Facs.jmedchem.7b00950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists</span></div><div class="casAuthors">Xia, Lizi; Burger, Wessel A. C.; van Veldhoven, Jacobus P. D.; Kuiper, Boaz J.; van Duijl, Tirsa T.; Lenselink, Eelke B.; Paasman, Ellen; Heitman, Laura H.; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7555-7568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivs. as human adenosine A3 receptor (hA3R) antagonists to det. their kinetic profiles and affinities.  Many compds. showed high affinities and a diverse range of kinetic profiles.  We found hA3R antagonists with very short residence time (RT) at the receptor (2.2 min for II 5) and much longer RTs (e.g., 376 min for I or 391 min for 31).  Two representative antagonists (I) and (II) were tested in [35S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism.  From a kon-koff-KD kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA3R antagonists.  Addnl., we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compds.' binding kinetics.  Knowledge of target binding kinetics appears useful for developing and triaging new hA3R antagonists in the early phase of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgiyuuEVYMqbVg90H21EOLACvtfcHk0lhc5oZtIq9MiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtleht7fN&md5=a5e396ed21c6d4349d8128e5a590e21b</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00950%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DL.%26aulast%3DBurger%26aufirst%3DW.%2BA.%2BC.%26aulast%3DVan%2BVeldhoven%26aufirst%3DJ.%2BP.%2BD.%26aulast%3DKuiper%26aufirst%3DB.%2BJ.%26aulast%3DVan%2BDuijl%26aufirst%3DT.%2BT.%26aulast%3DLenselink%26aufirst%3DE.%2BB.%26aulast%3DPaasman%26aufirst%3DE.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DStructure-Affinity%2520Relationships%2520and%2520Structure-Kinetics%2520Relationships%2520of%2520Pyrido%255B2%252C1-f%255DPurine-2%252C4-Dione%2520Derivatives%2520as%2520Human%2520Adenosine%2520A3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D17%26spage%3D7555%26epage%3D7568%26doi%3D10.1021%2Facs.jmedchem.7b00950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhoven, J. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offringa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenselink, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Es, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3552</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b02026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b02026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3539-3552&issue=7&author=X.+Yangauthor=J.+P.+D.+Van+Veldhovenauthor=J.+Offringaauthor=B.+J.+Kuiperauthor=E.+B.+Lenselinkauthor=L.+H.+Heitmanauthor=D.+Van+Der+Esauthor=A.+P.+Ijzerman&title=Development+of+Covalent+Ligands+for+G+Protein-Coupled+Receptors%3A+A+Case+for+the+Human+Adenosine+A3+Receptor&doi=10.1021%2Facs.jmedchem.8b02026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 Receptor</span></div><div class="casAuthors">Yang, Xue; van Veldhoven, Jacobus P. D.; Offringa, Jelle; Kuiper, Boaz J.; Lenselink, Eelke B.; Heitman, Laura H.; van der Es, Daan; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3539-3552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of covalent ligands for G protein-coupled receptors (GPCRs) is not a trivial process.  Here, we report a streamlined workflow thereto from synthesis to validation, exemplified by the discovery of a covalent antagonist for the human adenosine A3 receptor (hA3AR).  Based on the 1H,3H-pyrido[2,1-f]purine-2,4-dione scaffold, a series of ligands bearing a fluorosulfonyl warhead and a varying linker was synthesized.  This series was subjected to an affinity screen, revealing compd. I as the most potent antagonist.  In addn., a nonreactive methylsulfonyl deriv. was developed as a reversible control compd.  A series of assays, comprising time-dependent affinity detn., washout expts., and [35S]GTPγS binding assays, then validated I as the covalent antagonist.  A combined in silico hA3AR-homol. model and site-directed mutagenesis study was performed to demonstrate that amino acid residue Y2657.36 was the unique anchor point of the covalent interaction.  This workflow might be applied to other GPCRs to guide the discovery of covalent ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbDNSsfDVVrVg90H21EOLACvtfcHk0lhGEqk1NsAOuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D&md5=47d46258dd0c33b21b5cc2e140684a40</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b02026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b02026%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DVan%2BVeldhoven%26aufirst%3DJ.%2BP.%2BD.%26aulast%3DOffringa%26aufirst%3DJ.%26aulast%3DKuiper%26aufirst%3DB.%2BJ.%26aulast%3DLenselink%26aufirst%3DE.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DVan%2BDer%2BEs%26aufirst%3DD.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DDevelopment%2520of%2520Covalent%2520Ligands%2520for%2520G%2520Protein-Coupled%2520Receptors%253A%2520A%2520Case%2520for%2520the%2520Human%2520Adenosine%2520A3%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D7%26spage%3D3539%26epage%3D3552%26doi%3D10.1021%2Facs.jmedchem.8b02026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deflorian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Errey, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiez-Vandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, R. M.</span></span> <span> </span><span class="NLM_article-title">Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1016/j.str.2017.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.str.2017.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=28712806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOlsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1275-1285&issue=8&author=R.+K.+Y.+Chengauthor=E.+Segalaauthor=N.+Robertsonauthor=F.+Deflorianauthor=A.+S.+Dor%C3%A9author=J.+C.+Erreyauthor=C.+Fiez-Vandalauthor=F.+H.+Marshallauthor=R.+M.+Cooke&title=Structures+of+Human+A1+and+A2A+Adenosine+Receptors+with+Xanthines+Reveal+Determinants+of+Selectivity&doi=10.1016%2Fj.str.2017.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human A1 and A2a Adenosine Receptors with Xanthines Reveal Determinants of Selectivity</span></div><div class="casAuthors">Cheng, Robert K. Y.; Segala, Elena; Robertson, Nathan; Deflorian, Francesca; Dore, Andrew S.; Errey, James C.; Fiez-Vandal, Cedric; Marshall, Fiona H.; Cooke, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1275-1285.e4</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The adenosine A1 and A2a receptors belong to the purinergic family of G protein-coupled receptors, and regulate diverse functions of the cardiovascular, respiratory, renal, inflammation, and CNS.  Xanthines such as caffeine and theophylline are weak, non-selective antagonists of adenosine receptors.  Here we report the structure of a thermostabilized human A1 receptor at 3.3 Å resoln. with PSB36, an A1-selective xanthine-based antagonist.  This is compared with structures of the A2a receptor with PSB36 (2.8 Å resoln.), caffeine (2.1 Å), and theophylline (2.0 Å) to highlight features of ligand recognition which are common across xanthines.  The structures of A1R and A2aR were analyzed to identify the differences that are important selectivity determinants for xanthine ligands, and the role of T2707.35 in A1R (M2707.35 in A2aR) in conferring selectivity was confirmed by mutagenesis.  The structural differences confirmed to lead to selectivity can be utilized in the design of new subtype-selective A1R or A2aR antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDdYCktAYdKLVg90H21EOLACvtfcHk0lhGEqk1NsAOuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOlsbfJ&md5=e759fd60b25beac2d9429809f3b51b02</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2017.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2017.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DR.%2BK.%2BY.%26aulast%3DSegala%26aufirst%3DE.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26atitle%3DStructures%2520of%2520Human%2520A1%2520and%2520A2A%2520Adenosine%2520Receptors%2520with%2520Xanthines%2520Reveal%2520Determinants%2520of%2520Selectivity%26jtitle%3DStructure%26date%3D2017%26volume%3D25%26issue%3D8%26spage%3D1275%26epage%3D1285%26doi%3D10.1016%2Fj.str.2017.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Errey, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurrell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span> <span> </span><span class="NLM_article-title">Structure of the Adenosine A 2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1283</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.1016/j.str.2011.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.str.2011.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21885291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1283-1293&issue=9&author=A.+S.+Dor%C3%A9author=N.+Robertsonauthor=J.+C.+Erreyauthor=I.+Ngauthor=K.+Hollensteinauthor=B.+Tehanauthor=E.+Hurrellauthor=K.+Bennettauthor=M.+Congreveauthor=F.+Magnaniauthor=C.+G.+Tateauthor=M.+Weirauthor=F.+H.+Marshall&title=Structure+of+the+Adenosine+A+2A+Receptor+in+Complex+with+ZM241385+and+the+Xanthines+XAC+and+Caffeine&doi=10.1016%2Fj.str.2011.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine</span></div><div class="casAuthors">Dore, Andrew S.; Robertson, Nathan; Errey, James C.; Ng, Irene; Hollenstein, Kaspar; Tehan, Ben; Hurrell, Edward; Bennett, Kirstie; Congreve, Miles; Magnani, Francesca; Tate, Christopher G.; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1283-1293</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Methylxanthines, including caffeine and theophylline, are among the most widely consumed stimulant drugs in the world.  These effects are mediated primarily via blockade of adenosine receptors.  Xanthine analogs with improved properties have been developed as potential treatments for diseases such as Parkinson's disease.  Here we report the structures of a thermostabilized adenosine A2A receptor in complex with the xanthines xanthine amine congener and caffeine, as well as the A2A selective inverse agonist ZM241385.  The receptor is crystd. in the inactive state conformation as defined by the presence of a salt bridge known as the ionic lock.  The complete third intracellular loop, responsible for G protein coupling, is visible consisting of extended helixes 5 and 6.  The structures provide new insight into the features that define the ligand binding pocket of the adenosine receptor for ligands of diverse chemotypes as well as the cytoplasmic regions that interact with signal transduction proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsexwFu6LD7Vg90H21EOLACvtfcHk0lhGEqk1NsAOuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaru7fE&md5=a25db14aa70c2b42b9c3eb98c3c16bae</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2011.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2011.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DI.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMagnani%26aufirst%3DF.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DStructure%2520of%2520the%2520Adenosine%2520A%25202A%2520Receptor%2520in%2520Complex%2520with%2520ZM241385%2520and%2520the%2520Xanthines%2520XAC%2520and%2520Caffeine%26jtitle%3DStructure%26date%3D2011%26volume%3D19%26issue%3D9%26spage%3D1283%26epage%3D1293%26doi%3D10.1016%2Fj.str.2011.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekhar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cyclic Nucleotide Phosphodiesterases by Methylxanthines and Related Compounds</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-13443-2_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2F978-3-642-13443-2_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2011&pages=93-133&author=S.+H.+Francisauthor=K.+R.+Sekharauthor=H.+Keauthor=J.+D.+Corbin&title=Inhibition+of+Cyclic+Nucleotide+Phosphodiesterases+by+Methylxanthines+and+Related+Compounds&doi=10.1007%2F978-3-642-13443-2_4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds</span></div><div class="casAuthors">Francis, Sharron H.; Sekhar, Konjeti R.; Ke, Hengming; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">Methylxanthines</span>),
    <span class="NLM_cas:pages">93-133</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Naturally occurring methylxanthines were the first inhibitors of cyclic nucleotide (cN) phosphodiesterases (PDEs) to be discovered.  To improve potency and specificity for inhibition of various PDEs in research and for treatment of diseases, thousands of compds. with related structures have now been synthesized.  All known PDE inhibitors contain one or more rings that mimic the purine in the cN substrate and directly compete with cN for access to the catalytic site; this review focuses on inhibitors that contain a nucleus that is closely related to the xanthine ring of theophylline and caffeine and the purine ring of cNs.  The specificity and potency of these compds. for blocking PDE action have been improved by appending groups at positions on the rings as well as by modification of the no. and distribution of nitrogens and carbons in those rings.  Several of these inhibitors are highly selective for particular PDEs; potent and largely selective PDE5 inhibitors are used clin. for treatment of erectile dysfunction [sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra)] and pulmonary hypertension [sildenafil (Revatio) and tadalafil (Adenocirca)].  Related compds. target other PDEs and show therapeutic promise for a no. of maladies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6BhLDIuIfLLVg90H21EOLACvtfcHk0ljyjuyOJa3B-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOns7k%253D&md5=022fb1b7ad6cc60fab1690c8ad0f7158</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-13443-2_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-13443-2_4%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DSekhar%26aufirst%3DK.%2BR.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DInhibition%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%2520by%2520Methylxanthines%2520and%2520Related%2520Compounds%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2011%26volume%3D200%26spage%3D93%26epage%3D133%26doi%3D10.1007%2F978-3-642-13443-2_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meskini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Némoz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okyayuz-Baklouti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigent, A. F.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase Inhibitory Profile of Some Related Xanthine Derivatives Pharmacologically Active on the Peripheral Microcirculation</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(94)90477-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0006-2952%2894%2990477-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=8135854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXitlGktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1994&pages=781-788&issue=5&author=N.+Meskiniauthor=G.+N%C3%A9mozauthor=I.+Okyayuz-Bakloutiauthor=M.+Lagardeauthor=A.+F.+Prigent&title=Phosphodiesterase+Inhibitory+Profile+of+Some+Related+Xanthine+Derivatives+Pharmacologically+Active+on+the+Peripheral+Microcirculation&doi=10.1016%2F0006-2952%2894%2990477-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation</span></div><div class="casAuthors">Meskini, Nadia; Nemoz, Georges; Okyayuz-Baklouti, Ismahan; Lagarde, Michel; Prigent, Annie France</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-8</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The cyclic nucleotide phosphodiestrerase (PDE) inhibitory profile of four related xanthine derivs.: pentoxifylline (BL 191), propentofylline (HWA 285), torbafylline (HWA 448) and albifylline (HWA 138), pharmacol. active on the peripheral and/or cerebral microcirculation was established using the four main PDE isoforms present in rat heart cytosol.  HPLC on a Mono Q ion-exchange column resolved four sep. cyclic nucleotide PDE activities: a calmodulin-activated fraction (PDEI), a cGMP-stimulated fraction (PDE III).  Among the four compds. studied, only torbafylline and pentoxifylline inhibited more efficiently the calcium plus calmodulin-stimulated than the basal activity of PDE I.  The four xanthine derivs. inhibited more potently the cGMP-stimulated than the basal activity of the cGMP-stimulated PDE II, propentofylline being the most inhibitory (IC50: 20 μM).  Except for propentofylline, which exhibited a marked selectivity toward the rolipram-sensitive PDE IV vs. the cGMP-inhibited PDE III, the other xanthines modestly (IC50 in the 10-4 M range) inhibited both cAMP-specific isoforms with similar potency.  Propentofylline proved to be the best inhibitor whatever the considered isoform whereas torbafylline exhibited the weakest inhibitory potency with, however, some selectivity for PDE I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7ocyhzeb1G7Vg90H21EOLACvtfcHk0ljyjuyOJa3B-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlGktLo%253D&md5=e9a43a2fe5aa80cd60feb26880f966e1</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2894%2990477-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252894%252990477-4%26sid%3Dliteratum%253Aachs%26aulast%3DMeskini%26aufirst%3DN.%26aulast%3DN%25C3%25A9moz%26aufirst%3DG.%26aulast%3DOkyayuz-Baklouti%26aufirst%3DI.%26aulast%3DLagarde%26aufirst%3DM.%26aulast%3DPrigent%26aufirst%3DA.%2BF.%26atitle%3DPhosphodiesterase%2520Inhibitory%2520Profile%2520of%2520Some%2520Related%2520Xanthine%2520Derivatives%2520Pharmacologically%2520Active%2520on%2520the%2520Peripheral%2520Microcirculation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1994%26volume%3D47%26issue%3D5%26spage%3D781%26epage%3D788%26doi%3D10.1016%2F0006-2952%2894%2990477-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garst, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. N.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Separated Forms of Phosphodiesterases from Pig Coronary Arteries by Uracils and by 7-Substituted Derivatives of 1-Methyl-3-Isobutylxanthine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/jm00226a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00226a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE28XhtlSisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1976&pages=499-503&issue=4&author=J.+E.+Garstauthor=G.+L.+Kramerauthor=Y.+J.+Wuauthor=J.+N.+Wells&title=Inhibition+of+Separated+Forms+of+Phosphodiesterases+from+Pig+Coronary+Arteries+by+Uracils+and+by+7-Substituted+Derivatives+of+1-Methyl-3-Isobutylxanthine&doi=10.1021%2Fjm00226a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of separated forms of phosphodiesterases from pig coronary arteries by uracils and by 7-substituted derivatives of 1-methyl-3-isobutylxanthine</span></div><div class="casAuthors">Garst, J. E.; Kramer, G. L.; Wu, Y. J.; Wells, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-503</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 15 title xanthine derivs. (I; R = alkyl, aralkyl, alicyclicalkyl, propargyl, 4-picolyl), prepd. by alkylation of 1-methyl-3-isobutylxanthine (I, R = H)(MIX) [28822-58-4] were tested for specificity of inhibition of chromatog.-sepd. cyclic nucleotide phosphodiesterase [50812-31-2] activity fractions I and II.  I were generally much less potent than MIX as inhibitors of activity fraction II, but some retained the potency of MIX as inhibitors of activity fraction I.  1-Methyl-3-isobutyl-7-benzylxanthine (I, R = PhCH2) [58481-23-5] was 20-30 times more potent as an inhibitor of activity fraction I than of II, while retaining the potency of MIX against activity fraction I.  A series of 1,3-dialkyluracils had low potency as phosphodiesterase inhibitors.  Structure-activity relations were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpACF8c5N-9frVg90H21EOLACvtfcHk0ljyjuyOJa3B-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XhtlSisb0%253D&md5=dc68ab852947fee03f7faf5a37071d6a</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fjm00226a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00226a010%26sid%3Dliteratum%253Aachs%26aulast%3DGarst%26aufirst%3DJ.%2BE.%26aulast%3DKramer%26aufirst%3DG.%2BL.%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DWells%26aufirst%3DJ.%2BN.%26atitle%3DInhibition%2520of%2520Separated%2520Forms%2520of%2520Phosphodiesterases%2520from%2520Pig%2520Coronary%2520Arteries%2520by%2520Uracils%2520and%2520by%25207-Substituted%2520Derivatives%2520of%25201-Methyl-3-Isobutylxanthine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1976%26volume%3D19%26issue%3D4%26spage%3D499%26epage%3D503%26doi%3D10.1021%2Fjm00226a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manallack, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span> <span> </span><span class="NLM_article-title">The next Generation of Phosphodiesterase Inhibitors: Structural Clues to Ligand and Substrate Selectivity of Phosphodiesterases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3449</span>– <span class="NLM_lpage">3462</span>, <span class="refDoi"> DOI: 10.1021/jm040217u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040217u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVCqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3449-3462&issue=10&author=D.+T.+Manallackauthor=R.+A.+Hughesauthor=P.+E.+Thompson&title=The+next+Generation+of+Phosphodiesterase+Inhibitors%3A+Structural+Clues+to+Ligand+and+Substrate+Selectivity+of+Phosphodiesterases&doi=10.1021%2Fjm040217u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Next Generation of Phosphodiesterase Inhibitors: Structural Clues to Ligand and Substrate Selectivity of Phosphodiesterases</span></div><div class="casAuthors">Manallack, David T.; Hughes, Richard A.; Thompson, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3449-3462</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of phosphodiesterase isoforms and their inhibitors based on information provided by crystallog. data as it relates to homol. and structural alignment, cyclic nucleotide substrate specificity, inhibitor selectivity, and the prospects for the design of isoform-selective PDE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrNnu36vgL0LVg90H21EOLACvtfcHk0lgGPTi0MVqCCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVCqtLs%253D&md5=42d23b20ec29971e7e3556bc0183803c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Fjm040217u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040217u%26sid%3Dliteratum%253Aachs%26aulast%3DManallack%26aufirst%3DD.%2BT.%26aulast%3DHughes%26aufirst%3DR.%2BA.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3DThe%2520next%2520Generation%2520of%2520Phosphodiesterase%2520Inhibitors%253A%2520Structural%2520Clues%2520to%2520Ligand%2520and%2520Substrate%2520Selectivity%2520of%2520Phosphodiesterases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D10%26spage%3D3449%26epage%3D3462%26doi%3D10.1021%2Fjm040217u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanev, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Graaf, C.</span></span> <span> </span><span class="NLM_article-title">PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7065</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7029-7065&issue=15&author=C.+Jansenauthor=A.+J.+Kooistraauthor=G.+K.+Kanevauthor=R.+Leursauthor=I.+J.+P.+De+Eschauthor=C.+De+Graaf&title=PDEStrIAn%3A+A+Phosphodiesterase+Structure+and+Ligand+Interaction+Annotated+Database+As+a+Tool+for+Structure-Based+Drug+Design&doi=10.1021%2Facs.jmedchem.5b01813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design</span></div><div class="casAuthors">Jansen, Chimed; Kooistra, Albert J.; Kanev, Georgi K.; Leurs, Rob; de Esch, Iwan J. P.; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7029-7065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A systematic anal. is presented of the 220 phosphodiesterase (PDE) catalytic domain crystal structures present in the Protein Data Bank (PDB) with a focus on PDE-ligand interactions.  The consistent structural alignment of 57 PDE ligand binding site residues enables the systematic anal. of PDE-ligand interaction fingerprints (IFPs), the identification of subtype-specific PDE-ligand interaction features, and the classification of ligands according to their binding modes.  We illustrate how systematic mining of this phosphodiesterase structure and ligand interaction annotated (PDEStrIAn) database provides new insights into how conserved and selective PDE interaction hot spots can accommodate the large diversity of chem. scaffolds in PDE ligands.  A substructure anal. of the cocrystd. PDE ligands in combination with those in the ChEMBL database provides a toolbox for scaffold hopping and ligand design.  These analyses lead to an improved understanding of the structural requirements of PDE binding that will be useful in future drug discovery studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1I6fmiCv-rVg90H21EOLACvtfcHk0lgGPTi0MVqCCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCju7k%253D&md5=67669586d18089a73f4e7de21cf7c33b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01813%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DC.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DKanev%26aufirst%3DG.%2BK.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DDe%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DDe%2BGraaf%26aufirst%3DC.%26atitle%3DPDEStrIAn%253A%2520A%2520Phosphodiesterase%2520Structure%2520and%2520Ligand%2520Interaction%2520Annotated%2520Database%2520As%2520a%2520Tool%2520for%2520Structure-Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D15%26spage%3D7029%26epage%3D7065%26doi%3D10.1021%2Facs.jmedchem.5b01813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Staveren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Phosphodiesterase 2 Increases Neuronal CGMP, Synaptic Plasticity and Memory Performance</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2004.07.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15555642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSltLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&issue=7&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.+J.+Van+Der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+Van+Staverenauthor=J.+De+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+Phosphodiesterase+2+Increases+Neuronal+CGMP%2C+Synaptic+Plasticity+and+Memory+Performance&doi=10.1016%2Fj.neuropharm.2004.07.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance</span></div><div class="casAuthors">Boess, Frank G.; Hendrix, Martin; van der Staay, Franz-Josef; Erb, Christina; Schreiber, Rudy; van Staveren, Wilma; de Vente, Jan; Prickaerts, Jos; Blokland, Arjan; Koenig, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1081-1092</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An essential element of the signaling cascade leading to synaptic plasticity is the intracellular second messenger mol. cGMP.  Using the novel, potent, and selective inhibitor Bay 60-7550, the authors show that the enzyme 3',5'-cyclic nucleotide phosphodiesterase type 2 (PDE2) is responsible for the degrdn. of newly synthesized cGMP in cultured neurons and hippocampal slices.  Inhibition of PDE2 enhanced long-term potentiation of synaptic transmission without altering basal synaptic transmission.  Inhibition of PDE2 also improved the performance of rats in social and object recognition memory tasks, and reversed MK801-induced deficits in spontaneous alternation in mice in a T-maze.  The authors' data provide strong evidence that inhibition of PDE2 can improve memory functions by enhancing neuronal plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZrzoDQq-IbVg90H21EOLACvtfcHk0lgGPTi0MVqCCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSltLnO&md5=3bcff5e6acf5fa371255587f9e40beb8</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3DVan%2BDer%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DVan%2BStaveren%26aufirst%3DW.%26aulast%3DDe%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520Phosphodiesterase%25202%2520Increases%2520Neuronal%2520CGMP%252C%2520Synaptic%2520Plasticity%2520and%2520Memory%2520Performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26issue%3D7%26spage%3D1081%26epage%3D1092%26doi%3D10.1016%2Fj.neuropharm.2004.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turko, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related Compounds</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/mol.56.1.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.56.1.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10385692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK1MXksFOmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=124-130&issue=1&author=I.+V.+Turkoauthor=S.+A.+Ballardauthor=S.+H.+Francisauthor=J.+D.+Corbin&title=Inhibition+of+Cyclic+GMP-Binding+Cyclic+GMP-Specific+Phosphodiesterase+%28Type+5%29+by+Sildenafil+and+Related+Compounds&doi=10.1124%2Fmol.56.1.124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds</span></div><div class="casAuthors">Turko, Illarion V.; Ballard, Stephen A.; Francis, Sharron H.; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-130</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The cGMP-binding cGMP-specific phosphodiesterase (PDE5) degrades cGMP and regulates the intracellular level of cGMP in many tissues, including the smooth muscle of the corpus cavernosum of the penis.  Sildenafil (Viagra), a specific PDE5 inhibitor, promotes penile erection by blocking the activity of PDE5, which causes cGMP to accumulate in the corpus cavernosum.  In the present study, sildenafil, like other PDE5 inhibitors, stimulates cGMP binding to the allosteric sites of PDE5 by interacting at the catalytic site of this enzyme, but the drug does not compete with cGMP for binding at the allosteric sites.  Both sildenafil and zaprinast are competitive inhibitors of PDE5, and double-inhibition anal. shows that these two inhibitors added together interact with the catalytic site of PDE5 in a mutually exclusive manner.  After site-directed mutagenesis of each of 23 conserved amino acid residues in the catalytic domain of PDE5, the pattern of changes in the IC50 values for sildenafil or UK-122764 is similar to that found for zaprinast.  However, among the three inhibitors, sildenafil exhibits the most similar pattern of changes in the IC50 to that found for the affinity of cGMP, implying similar interactions with the catalytic domain.  This may explain in part the stronger inhibitory potency of sildenafil for wild-type PDE5 compared with the other inhibitors [sildenafil (Ki = 1 nM) > UK-122764 (Ki = 5 nM) > zaprinast (Ki = 130 nM)].  The affinity of each of these inhibitors for PDE5 is much higher than that of cGMP itself (Km = 2000 nM).  It is concluded that residues such as Tyr602, His607, His643, and Asp754 may form important interactions for sildenafil in PDE5, but because these amino acids are conserved in all mammalian PDEs, the selectivity and potency of sildenafil is likely to be provided by a nonconserved residue or residues in the PDE5 catalytic domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhinP8Q5VgrVg90H21EOLACvtfcHk0lj7F5rNTSN6Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFOmt7s%253D&md5=71f697fb049ca955fdb18253d5747ada</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1124%2Fmol.56.1.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.56.1.124%26sid%3Dliteratum%253Aachs%26aulast%3DTurko%26aufirst%3DI.%2BV.%26aulast%3DBallard%26aufirst%3DS.%2BA.%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DInhibition%2520of%2520Cyclic%2520GMP-Binding%2520Cyclic%2520GMP-Specific%2520Phosphodiesterase%2520%2528Type%25205%2529%2520by%2520Sildenafil%2520and%2520Related%2520Compounds%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D56%26issue%3D1%26spage%3D124%26epage%3D130%26doi%3D10.1124%2Fmol.56.1.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asberom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemulapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamanda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Optimization of Purine Based PDE1/PDE5 Inhibitors to a Potent and Selective PDE5 Inhibitor for the Treatment of Male ED</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2365</span>– <span class="NLM_lpage">2369</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.02.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bmcl.2005.02.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15837326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2365-2369&issue=9&author=C.+D.+Boyleauthor=R.+Xuauthor=T.+Asberomauthor=S.+Chackalamannilauthor=J.+W.+Claderauthor=W.+J.+Greenleeauthor=H.+Guzikauthor=Y.+Huauthor=Z.+Huauthor=C.+M.+Lankinauthor=D.+A.+Pissarnitskiauthor=A.+W.+Stamfordauthor=Y.+Wangauthor=J.+Skellauthor=S.+Kurowskiauthor=S.+Vemulapalliauthor=J.+Palamandaauthor=M.+Chintalaauthor=P.+Wuauthor=J.+Myersauthor=P.+Wang&title=Optimization+of+Purine+Based+PDE1%2FPDE5+Inhibitors+to+a+Potent+and+Selective+PDE5+Inhibitor+for+the+Treatment+of+Male+ED&doi=10.1016%2Fj.bmcl.2005.02.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED</span></div><div class="casAuthors">Boyle, Craig D.; Xu, Ruo; Asberom, Theodros; Chackalamannil, Samuel; Clader, John W.; Greenlee, William J.; Guzik, Henry; Hu, Yuequing; Hu, Zhiyong; Lankin, Claire M.; Pissarnitski, Dmitri A.; Stamford, Andrew W.; Wang, Yuguang; Skell, Jeffrey; Kurowski, Stanley; Vemulapalli, Subbarao; Palamanda, Jairam; Chintala, Madhu; Wu, Ping; Myers, Joyce; Wang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2365-2369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In search of a PDE5 inhibitor for erectile dysfunction, an SAR was developed from a PDE1/PDE5 purine series of leads, which had modest PDE5 potency and poor isoenzyme selectivity.  A compd. (I) with PDE5 inhibition and in vivo activity similar to sildenafil was discovered from this effort.  In addn., purine I demonstrated superior overall PDE isoenzyme selectivity when compared to the approved PDE5 inhibitors sildenafil, vardenafil, and tadalafil, which may result in a more favorable side-effect profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkcOMSHgdvhLVg90H21EOLACvtfcHk0lj7F5rNTSN6Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWqtr8%253D&md5=6733bdb0a77c94d339fdbba2ed9b8d8e</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.02.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.02.083%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DGuzik%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLankin%26aufirst%3DC.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSkell%26aufirst%3DJ.%26aulast%3DKurowski%26aufirst%3DS.%26aulast%3DVemulapalli%26aufirst%3DS.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DChintala%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DOptimization%2520of%2520Purine%2520Based%2520PDE1%252FPDE5%2520Inhibitors%2520to%2520a%2520Potent%2520and%2520Selective%2520PDE5%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Male%2520ED%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D9%26spage%3D2365%26epage%3D2369%26doi%3D10.1016%2Fj.bmcl.2005.02.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerreiro, S.</span>; <span class="NLM_string-name">Marien, M.</span>; <span class="NLM_string-name">Michel, P. P.</span></span> <span> </span><span class="NLM_article-title">Methylxanthines and Ryanodine Receptor Channels</span>.  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">150</span>. <span class="refDoi"> DOI: 10.1007/978-3-642-13443-2_5</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2F978-3-642-13443-2_5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=135-150&author=S.+Guerreiro&author=M.+Marien&author=P.+P.+Michel&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-13443-2_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-13443-2_5%26sid%3Dliteratum%253Aachs%26aulast%3DGuerreiro%26aufirst%3DS.%26atitle%3DMethylxanthines%2520and%2520Ryanodine%2520Receptor%2520Channels%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D2011%26spage%3D135%26epage%3D150%26doi%3D10.1007%2F978-3-642-13443-2_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Caffeine Contracture</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">903</span>, <span class="refDoi"> DOI: 10.1073/pnas.46.6.897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.46.6.897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16590687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD28zitF2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=897-903&issue=6&author=D.+Conwayauthor=T.+Sakai&title=Caffeine+Contracture&doi=10.1073%2Fpnas.46.6.897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">CAFFEINE CONTRACTURE</span></div><div class="casAuthors">Conway D; Sakai T</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">897-903</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtFsnkpUn5Fg5nADWVYHg1fW6udTcc2eY83tmg7N5hHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zitF2msw%253D%253D&md5=c57fa1c2c5f92250b871888e3651ca2f</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.6.897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.6.897%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DD.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DCaffeine%2520Contracture%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D6%26spage%3D897%26epage%3D903%26doi%3D10.1073%2Fpnas.46.6.897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span> <span> </span><span class="NLM_article-title">Calcium Release from the Sarcoplasmic Reticulum</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1152/physrev.1977.57.1.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1152%2Fphysrev.1977.57.1.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=13441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaE2sXhtVWqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1977&pages=71-108&issue=1&author=M.+Endo&title=Calcium+Release+from+the+Sarcoplasmic+Reticulum&doi=10.1152%2Fphysrev.1977.57.1.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium release from the sarcoplasmic reticulum</span></div><div class="casAuthors">Endo, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-108</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    </div><div class="casAbstract">A review with 198 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFj7N17UF3orVg90H21EOLACvtfcHk0lj2rhYso1eAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtVWqtL4%253D&md5=cae2cf0c5c9d75b37f074c5e61c24e06</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1977.57.1.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1977.57.1.71%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DM.%26atitle%3DCalcium%2520Release%2520from%2520the%2520Sarcoplasmic%2520Reticulum%26jtitle%3DPhysiol.%2520Rev.%26date%3D1977%26volume%3D57%26issue%3D1%26spage%3D71%26epage%3D108%26doi%3D10.1152%2Fphysrev.1977.57.1.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabiato, A.</span></span> <span> </span><span class="NLM_article-title">Calcium-Induced Release of Calcium from the Cardiac Sarcoplasmic Reticulum</span>. <i>Am. J. Physiol. - Cell Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>245</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">C1</span>– <span class="NLM_lpage">C14</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.1983.245.1.C1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1152%2Fajpcell.1983.245.1.C1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1983&pages=C1-C14&issue=1&author=A.+Fabiato&title=Calcium-Induced+Release+of+Calcium+from+the+Cardiac+Sarcoplasmic+Reticulum&doi=10.1152%2Fajpcell.1983.245.1.C1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.1983.245.1.C1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.1983.245.1.C1%26sid%3Dliteratum%253Aachs%26aulast%3DFabiato%26aufirst%3DA.%26atitle%3DCalcium-Induced%2520Release%2520of%2520Calcium%2520from%2520the%2520Cardiac%2520Sarcoplasmic%2520Reticulum%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Cell%2520Physiol.%26date%3D1983%26volume%3D245%26issue%3D1%26spage%3DC1%26epage%3DC14%26doi%3D10.1152%2Fajpcell.1983.245.1.C1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. J.</span></span> <span> </span><span class="NLM_article-title">Adenosine Discriminates between the Caffeine and Adenine Nucleotide Sites on the Sheep Cardiac Sarcoplasmic Reticulum Calcium-Release Channel</span>. <i>J. Membr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1007/BF00233486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF00233486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7516436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2cXitFSrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1994&pages=169-177&issue=2&author=S.+J.+McGarryauthor=A.+J.+Williams&title=Adenosine+Discriminates+between+the+Caffeine+and+Adenine+Nucleotide+Sites+on+the+Sheep+Cardiac+Sarcoplasmic+Reticulum+Calcium-Release+Channel&doi=10.1007%2FBF00233486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel</span></div><div class="casAuthors">McGarry, S. J.; Williams, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-77</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    </div><div class="casAbstract">Calcium-release channels of sheep cardiac sarcoplasmic reticulum were incorporated into phosphatidylethanolamine bilayers and single channel currents were recorded under voltage-clamp conditions.  The effect of adenosine on single channel conductance and gating was investigated, as were the interactions between adenosine and caffeine and adenosine and α,β-methylene ATP.  Addn. of adenosine (0.5-5 mM) to the cytosolic but not the luminal side of the membrane increased the open probability of single calcium-activated calcium-release channels by increasing the frequency and duration of open events, yielding an EC50 of 0.75 mM at 10 μM activating Ca2+.  Addn. of 1 mM caffeine potentiated the effects of adenosine at 10 or 100 μM-activating cytosolic calcium, but had no effect on the inability of adenosine to activate the channel at 80 pM calcium, suggesting discrete sites of action on the calcium-release channel for adenosine and caffeine.  In contrast, addn. of 100 μM α,β-methylene-ATP decreased single channel open probability in the presence of adenosine, suggesting that these compds. act on the same site on the channel.  Activation of single channel opening by adenosine, or by adenosine together with caffeine, had no effect on single channel conductance or the Ca2+/Tris+ permeability ratio.  Channels activated by adenosine were characteristically modified by ryanodine and blocked by micromolar ruthenium red or millimolar magnesium.  These results show that adenosine activates the sheep cardiac sarcoplasmic reticulum Ca2+-release channel by increasing the frequency and duration of open events in a Ca2+-dependent manner.  The receptor site on the channel for adenosine is distinct from that for caffeine but probably the same as that for adenine nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHZZOcP9pPrrVg90H21EOLACvtfcHk0lj2rhYso1eAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFSrurc%253D&md5=5fb132c81172118ba6d302686223ce17</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1007%2FBF00233486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00233486%26sid%3Dliteratum%253Aachs%26aulast%3DMcGarry%26aufirst%3DS.%2BJ.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26atitle%3DAdenosine%2520Discriminates%2520between%2520the%2520Caffeine%2520and%2520Adenine%2520Nucleotide%2520Sites%2520on%2520the%2520Sheep%2520Cardiac%2520Sarcoplasmic%2520Reticulum%2520Calcium-Release%2520Channel%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1994%26volume%3D137%26issue%3D2%26spage%3D169%26epage%3D177%26doi%3D10.1007%2FBF00233486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garaschuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhratsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, A.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor-mediated Intracellular Calcium Release in Rat Cerebellar Purkinje Neurones</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>487</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1113/jphysiol.1995.sp020857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1113%2Fjphysiol.1995.sp020857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7473240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVWltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=1995&pages=1-16&issue=1&author=M.+Kanoauthor=O.+Garaschukauthor=A.+Verkhratskyauthor=A.+Konnerth&title=Ryanodine+Receptor-mediated+Intracellular+Calcium+Release+in+Rat+Cerebellar+Purkinje+Neurones&doi=10.1113%2Fjphysiol.1995.sp020857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurons</span></div><div class="casAuthors">Kano, Masanobu; Garaschuk, Olga; Verkhratsky, Alexej; Konnerth, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Ryanodine receptor-mediated Ca2+ release was investigated in Purkinje neurons of rat cerebellar slices by using whole-cell patch-clamp recordings combined with fluorometric digital imaging of cytoplasmic Ca2+ concn. ([Ca2+]i).  Caffeine caused a transient increase in [Ca2+]i in the somata and dendrites of Purkinje neurons.  Caffeine-induced Ca2+ transients were not assocd. with a membrane inward current and persisted in Ca2+-free external solns., indicating that they are caused by Ca2+ released from intracellular stores.  The amplitudes of the caffeine-mediated elevations in [Ca2+]i were strongly dependent on the baseline level of [Ca2+]i.  Intracellular application of Ruthenium Red through the patch pipet blocked caffeine-induced Ca2+ transients in Purkinje neurons.  Ryanodine when applied either intra- or extracellularly caused a use-dependent block of caffeine-induced Ca2+ release.  Depolarization-induced Ca2+ transients were strongly prolonged by caffeine.  Several lines of evidence suggest that these prolongations reflect Ca2+-induced Ca2+ release.  Despite the presence of skeletal muscle type ryanodine receptors in Purkinje neurons, depolarizing pulses failed to induce any changes in [Ca2+]i when the influx of Ca2+ through voltage-gated channels was prevented by using Ca2+-free soln., or when applying blockers of voltage-gated Ca2+ channels.  Dendritic Ca2+ transients produced by stimulation of the excitatory climbing fiber synaptic input were also prolonged by caffeine, indicating that ryanodine receptor-mediated release of Ca2+ may be involved in synaptic signaling in cerebellar Purkinje neurons.  Ryanodine receptor-mediated release of Ca2+ in cerebellar Purkinje neurons can be explained by a model in which release of Ca2+ is strongly facilitated by the co-operative action of Ca2+, caffeine and/or ryanodine.  The results suggest that Ca2+ release in these central neurons becomes prominent only during episodes of intensive elec. activity assocd. with increased Ca2+ entry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDlewuwaPUVbVg90H21EOLACvtfcHk0lj2rhYso1eAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVWltL0%253D&md5=00e3b73480a1b2222080c6d22599877f</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.1995.sp020857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.1995.sp020857%26sid%3Dliteratum%253Aachs%26aulast%3DKano%26aufirst%3DM.%26aulast%3DGaraschuk%26aufirst%3DO.%26aulast%3DVerkhratsky%26aufirst%3DA.%26aulast%3DKonnerth%26aufirst%3DA.%26atitle%3DRyanodine%2520Receptor-mediated%2520Intracellular%2520Calcium%2520Release%2520in%2520Rat%2520Cerebellar%2520Purkinje%2520Neurones%26jtitle%3DJ.%2520Physiol.%26date%3D1995%26volume%3D487%26issue%3D1%26spage%3D1%26epage%3D16%26doi%3D10.1113%2Fjphysiol.1995.sp020857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkovsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avshalumov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, M. E.</span></span> <span> </span><span class="NLM_article-title">Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6568</span>– <span class="NLM_lpage">6579</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0181-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1523%2FJNEUROSCI.0181-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19458227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFent7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=6568-6579&issue=20&author=J.+C.+Patelauthor=P.+Witkovskyauthor=M.+V.+Avshalumovauthor=M.+E.+Rice&title=Mobilization+of+Calcium+from+Intracellular+Stores+Facilitates+Somatodendritic+Dopamine+Release&doi=10.1523%2FJNEUROSCI.0181-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release</span></div><div class="casAuthors">Patel, Jyoti C.; Witkovsky, Paul; Avshalumov, Marat V.; Rice, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6568-6579</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Somatodendritic dopamine (DA) release in the substantia nigra pars compacta (SNc) shows a limited dependence on extracellular calcium concn. ([Ca2+]o), suggesting the involvement of intracellular Ca2+ stores.  Here, using immunocytochem. we demonstrate the presence of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2 (SERCA2) that sequesters cytosolic Ca2+ into the endoplasmic reticulum (ER), as well as inositol 1,4,5-triphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) in DAergic neurons.  Notably, RyRs were clustered at the plasma membrane, poised for activation by Ca2+ entry.  Using fast-scan cyclic voltammetry to monitor evoked extracellular DA concn. ([DA]o) in midbrain slices, we found that SERCA inhibition by cyclopiazonic acid (CPA) decreased evoked [DA]o in the SNc, indicating a functional role for ER Ca2+ stores in somatodendritic DA release.  Implicating IP3R-dependent stores, an IP3R antagonist, 2-APB, also decreased evoked [DA]o.  Moreover, DHPG, an agonist of group I metabotropic glutamate receptors (mGluR1s, which couple to IP3 prodn.), increased somatodendritic DA release, whereas CPCCOEt, an mGluR1 antagonist, suppressed it.  Release suppression by mGluR1 blockade was prevented by 2-APB or CPA, indicating facilitation of DA release by endogenous glutamate acting via mGluR1s and IP3R-gated Ca2+ stores.  Similarly, activation of RyRs by caffeine increased [Ca2+]i and elevated evoked [DA]o.  The increase in DA release was prevented by a RyR blocker, dantrolene, and by CPA.  Importantly, the efficacy of dantrolene was enhanced in low [Ca2+]o, suggesting a mechanism for maintenance of somatodendritic DA release with limited Ca2+ entry.  Thus, both mGluR1-linked IP3R- and RyR-dependent ER Ca2+ stores facilitate somatodendritic DA release in the SNC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozPtqTNkN8r7Vg90H21EOLACvtfcHk0liGMT0lbrnZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFent7w%253D&md5=7ddfd25ed499f21e5ba1c7158fb15e4f</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0181-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0181-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DWitkovsky%26aufirst%3DP.%26aulast%3DAvshalumov%26aufirst%3DM.%2BV.%26aulast%3DRice%26aufirst%3DM.%2BE.%26atitle%3DMobilization%2520of%2520Calcium%2520from%2520Intracellular%2520Stores%2520Facilitates%2520Somatodendritic%2520Dopamine%2520Release%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26issue%3D20%26spage%3D6568%26epage%3D6579%26doi%3D10.1523%2FJNEUROSCI.0181-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayaraghavan, S.</span></span> <span> </span><span class="NLM_article-title">Modulation of Presynaptic Store Calcium Induces Release of Glutamate and Postsynaptic Firing</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(03)00322-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0896-6273%2803%2900322-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12818178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFanu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=929-939&issue=6&author=G.+Sharmaauthor=S.+Vijayaraghavan&title=Modulation+of+Presynaptic+Store+Calcium+Induces+Release+of+Glutamate+and+Postsynaptic+Firing&doi=10.1016%2FS0896-6273%2803%2900322-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing</span></div><div class="casAuthors">Sharma, Geeta; Vijayaraghavan, Sukumar</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Action potential-independent transmitter release is random and produces small depolarizations in the postsynaptic neuron.  This process is, therefore, not thought to play a significant role in impulse propagation across synapses.  Here we show that calcium flux through presynaptic neuronal nicotinic receptors leads to mobilization of store calcium by calcium-induced calcium release.  Recruitment of store calcium induces vesicular release of glutamate in a manner consistent with synchronization across multiple active zones in the CA3 region of the rat hippocampus.  This modulation of action potential-independent release of glutamate is sufficient to drive the postsynaptic pyramidal cell above its firing threshold, thus providing a mechanism for impulse propagation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWdXbptOfIcbVg90H21EOLACvtfcHk0liGMT0lbrnZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFanu7c%253D&md5=145a0950c72034047ef044a2f0137aa9</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900322-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900322-2%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DVijayaraghavan%26aufirst%3DS.%26atitle%3DModulation%2520of%2520Presynaptic%2520Store%2520Calcium%2520Induces%2520Release%2520of%2520Glutamate%2520and%2520Postsynaptic%2520Firing%26jtitle%3DNeuron%26date%3D2003%26volume%3D38%26issue%3D6%26spage%3D929%26epage%3D939%26doi%3D10.1016%2FS0896-6273%2803%2900322-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magkos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavouras, S. A.</span></span> <span> </span><span class="NLM_article-title">Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">7–8</span>),  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1080/1040-830491379245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1080%2F1040-830491379245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16371327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlakt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=535-562&issue=7%E2%80%938&author=F.+Magkosauthor=S.+A.+Kavouras&title=Caffeine+Use+in+Sports%2C+Pharmacokinetics+in+Man%2C+and+Cellular+Mechanisms+of+Action&doi=10.1080%2F1040-830491379245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action</span></div><div class="casAuthors">Magkos, Faidon; Kavouras, Stavros A.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">535-562</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Caffeine is the most widely consumed psychoactive drug' in the world and probably one of the most commonly used stimulants in sports.  This is not surprising, since it is one of the few ergogenic aids with documented efficiency and minimal side effects.  Caffeine is rapidly and completely absorbed by the gastrointestinal tract and is readily distributed throughout all tissues of the body.  Peak plasma concns. after normal consumption are usually around 50 μM, and half-lives for elimination range between 2.5-10 h.  The parent compd. is extensively metabolized in the liver microsomes to more than 25 derivs., while considerably less than 5% of the ingested dose is excreted unchanged in the urine.  There is, however, considerable inter-individual variability in the handling of caffeine by the body, due to both environmental and genetic factors.  Evidence from in vitro studies provides a wealth of different cellular actions that could potentially contribute to the obsd. effects of caffeine in humans in vivo.  These include potentiation of muscle contractility via induction of sarcoplasmic reticulum calcium release, inhibition of phosphodiesterase isoenzymes and concomitant cyclic monophosphate accumulation, inhibition of glycogen phosphorylase enzymes in liver and muscle, non-selective adenosine receptor antagonism, stimulation of the cellular membrane sodium/potassium pump, impairment of phosphoinositide metab., as well as other, less thoroughly characterized actions.  Not all, however, seem to account for the obsd. effects in vivo, although a variable degree of contribution cannot be readily discounted on the basis of exptl. data.  The most physiol. relevant mechanism of action is probably the blockade of adenosine receptors, but evidence suggests that, at least under certain conditions, other biochem. mechanisms may also be operational.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wG3KDOhjELVg90H21EOLACvtfcHk0liGMT0lbrnZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlakt7%252FP&md5=78c8ace2edd019067154b02c839ef9db</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1080%2F1040-830491379245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1040-830491379245%26sid%3Dliteratum%253Aachs%26aulast%3DMagkos%26aufirst%3DF.%26aulast%3DKavouras%26aufirst%3DS.%2BA.%26atitle%3DCaffeine%2520Use%2520in%2520Sports%252C%2520Pharmacokinetics%2520in%2520Man%252C%2520and%2520Cellular%2520Mechanisms%2520of%2520Action%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2005%26volume%3D45%26issue%3D7%25E2%2580%25938%26spage%3D535%26epage%3D562%26doi%3D10.1080%2F1040-830491379245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span>; <span class="NLM_string-name">Wei, H.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease</span>.  <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, in press. <span class="refDoi"> DOI: 10.1007/s10571-020-00936-w</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs10571-020-00936-w" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Sun&author=H.+Wei&title=Ryanodine+Receptors%3A+A+Potential+Treatment+Target+in+Various+Neurodegenerative+Disease&doi=10.1007%2Fs10571-020-00936-w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1007%2Fs10571-020-00936-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-020-00936-w%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DRyanodine%2520Receptors%253A%2520A%2520Potential%2520Treatment%2520Target%2520in%2520Various%2520Neurodegenerative%2520Disease%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2020%26doi%3D10.1007%2Fs10571-020-00936-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaaban, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos-Platt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilles, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Girolami, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engle, E. C.</span></span> <span> </span><span class="NLM_article-title">RYR1Mutations as a Cause of Ophthalmoplegia, Facial Weakness, and Malignant Hyperthermia</span>. <i>JAMA Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1532</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.1001/jamaophthalmol.2013.4392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjamaophthalmol.2013.4392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24091937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Slsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2013&pages=1532-1540&issue=12&author=S.+Shaabanauthor=L.+Ramos-Plattauthor=F.+H.+Gillesauthor=W.+M.+Chanauthor=C.+Andrewsauthor=U.+De+Girolamiauthor=J.+Demerauthor=E.+C.+Engle&title=RYR1Mutations+as+a+Cause+of+Ophthalmoplegia%2C+Facial+Weakness%2C+and+Malignant+Hyperthermia&doi=10.1001%2Fjamaophthalmol.2013.4392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">RYB1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia</span></div><div class="casAuthors">Shaaban, Sherin; Ramos-Platt, Leigh; Gilles, Floyd H.; Chan, Wai-Man; Andrews, Caroline; De Girolami, Umberto; Demer, Joseph; Engle, Elizabeth C.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA Ophthalmology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1532-1540</span>CODEN:
                <span class="NLM_cas:coden">JOAPB7</span>;
        ISSN:<span class="NLM_cas:issn">2168-6165</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Importance: Total ophthalmoplegia can result from ryanodine receptor 1 (RYR1) mutations without overt assocd. skeletal myopathy.  Patients carrying RYR1 mutations are at high risk of developing malignant hyperthermia.  Ophthalmologists should be familiar with these important clin. assocns.  Objective: To det. the genetic cause of congenital ptosis, ophthalmoplegia, facial paralysis, and mild hypotonia segregating in 2 pedigrees diagnosed with atypical Moebius syndrome or congenital fibrosis of the extraocular muscles.  Design, setting, and participants: Clin. data including medical and family histories were collected at research labs. at Boston Children's Hospital and Jules Stein Eye Institute (Engle and Demer labs) for affected and unaffected family members from 2 pedigrees in which patients presented with total ophthalmoplegia, facial weakness, and myopathy.  Intervention Homozygosity mapping and whole-exome sequencing were conducted to identify causative mutations in affected family members.  Histories, phys. examns., and clin. data were reviewed.  Main outcome and measure: Mutations in RYR1.  Results: Missense mutations resulting in 2 homozygous RYR1 amino acid substitutions (E989G and R3772W) and 2 compd. heterozygous RYR1 substitutions (H283R and R3772W) were identified in a consanguineous and a nonconsanguineous pedigree, resp.  Orbital magnetic resonance imaging revealed marked hypoplasia of extraocular muscles and intraorbital cranial nerves.  Skeletal muscle biopsy specimens revealed nonspecific myopathic changes.  Clin., the patients' ophthalmoplegia and facial weakness were far more significant than their hypotonia and limb weakness and were accompanied by an unrecognized susceptibility to malignant hyperthermia.  Conclusions and relevance: Affected children presenting with severe congenital ophthalmoplegia and facial weakness in the setting of only mild skeletal myopathy harbored recessive mutations in RYR1, encoding the ryanodine receptor 1, and were susceptible to malignant hyperthermia.  While ophthalmoplegia occurs rarely in RYR1-related myopathies, these children were atypical because they lacked significant weakness, respiratory insufficiency, orscoliosis.  RYR1-assocd. myopathies should be included in the differential diagnosis of congenital ophthalmoplegia and facial weakness, even without clin. skeletal myopathy.  These patients should also be considered susceptible to malignant hyperthermia, a life-threatening anesthetic complication avoidable if anticipated presurgically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HKzsbF-fSLVg90H21EOLACvtfcHk0lidxI2ILc6P6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Slsw%253D%253D&md5=5a032ff9eab9370f3b642c85574aeb71</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1001%2Fjamaophthalmol.2013.4392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaophthalmol.2013.4392%26sid%3Dliteratum%253Aachs%26aulast%3DShaaban%26aufirst%3DS.%26aulast%3DRamos-Platt%26aufirst%3DL.%26aulast%3DGilles%26aufirst%3DF.%2BH.%26aulast%3DChan%26aufirst%3DW.%2BM.%26aulast%3DAndrews%26aufirst%3DC.%26aulast%3DDe%2BGirolami%26aufirst%3DU.%26aulast%3DDemer%26aufirst%3DJ.%26aulast%3DEngle%26aufirst%3DE.%2BC.%26atitle%3DRYR1Mutations%2520as%2520a%2520Cause%2520of%2520Ophthalmoplegia%252C%2520Facial%2520Weakness%252C%2520and%2520Malignant%2520Hyperthermia%26jtitle%3DJAMA%2520Ophthalmol.%26date%3D2013%26volume%3D131%26issue%3D12%26spage%3D1532%26epage%3D1540%26doi%3D10.1001%2Fjamaophthalmol.2013.4392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawal, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witherspoon, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bönnemann, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meilleur, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, R. T.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor 1-Related Disorders: An Historical Perspective and Proposal for a Unified Nomenclature</span>. <i>Skeletal Muscle</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>, <span class="refDoi"> DOI: 10.1186/s13395-020-00243-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs13395-020-00243-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33190635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFOrs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=32&issue=1&author=T.+A.+Lawalauthor=J.+J.+Toddauthor=J.+W.+Witherspoonauthor=C.+G.+B%C3%B6nnemannauthor=J.+J.+Dowlingauthor=S.+L.+Hamiltonauthor=K.+G.+Meilleurauthor=R.+T.+Dirksen&title=Ryanodine+Receptor+1-Related+Disorders%3A+An+Historical+Perspective+and+Proposal+for+a+Unified+Nomenclature&doi=10.1186%2Fs13395-020-00243-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature</span></div><div class="casAuthors">Lawal, Tokunbor A.; Todd, Joshua J.; Witherspoon, Jessica W.; Bonnemann, Carsten G.; Dowling, James J.; Hamilton, Susan L.; Meilleur, Katherine G.; Dirksen, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Skeletal Muscle</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32</span>CODEN:
                <span class="NLM_cas:coden">SMKUAK</span>;
        ISSN:<span class="NLM_cas:issn">2044-5040</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: The RYR1 gene, which encodes the sarcoplasmic reticulum calcium release channel or type 1 ryanodine receptor (RyR1) of skeletal muscle, was sequenced in 1988 and RYR1 variations that impair calcium homeostasis and increase susceptibility to malignant hyperthermia were first identified in 1991.  Since then, RYR1-related myopathies (RYR1-RM) have been described as rare, histopathol. and clin. heterogeneous, and slowly progressive neuromuscular disorders.  RYR1 variants can lead to dysfunctional RyR1-mediated calcium release, malignant hyperthermia susceptibility, elevated oxidative stress, deleterious post-translational modifications, and decreased RyR1 expression.  RYR1-RM-affected individuals can present with delayed motor milestones, contractures, scoliosis, ophthalmoplegia, and respiratory insufficiency.  Historically, RYR1-RM-affected individuals were diagnosed based on morphol. features obsd. in muscle biopsies including central cores, cores and rods, central nuclei, fiber type disproportion, and multi-minicores.  However, these histopathol. features are not always specific to RYR1-RM and often change over time.  As addnl. phenotypes were assocd. with RYR1 variations (including King-Denborough syndrome, exercise-induced rhabdomyolysis, lethal multiple pterygium syndrome, adult-onset distal myopathy, atypical periodic paralysis with or without myalgia, mild calf-predominant myopathy, and dusty core disease) the overlap among diagnostic categories is ever increasing.  With the continuing emergence of new clin. subtypes along the RYR1 disease spectrum and reports of adult-onset phenotypes, nuanced nomenclatures have been reported (RYR1- [related, related congenital, congenital] myopathies).  In this narrative review, we provide historical highlights of RYR1 research, accounts of the main diagnostic disease subtypes and propose RYR1-related disorders (RYR1-RD) as a unified nomenclature to describe this complex and evolving disease spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1p69qhbebr7Vg90H21EOLACvtfcHk0lidxI2ILc6P6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFOrs7fN&md5=ed3045f95d7d7ba0fddc21e40dd5d6df</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1186%2Fs13395-020-00243-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13395-020-00243-4%26sid%3Dliteratum%253Aachs%26aulast%3DLawal%26aufirst%3DT.%2BA.%26aulast%3DTodd%26aufirst%3DJ.%2BJ.%26aulast%3DWitherspoon%26aufirst%3DJ.%2BW.%26aulast%3DB%25C3%25B6nnemann%26aufirst%3DC.%2BG.%26aulast%3DDowling%26aufirst%3DJ.%2BJ.%26aulast%3DHamilton%26aufirst%3DS.%2BL.%26aulast%3DMeilleur%26aufirst%3DK.%2BG.%26aulast%3DDirksen%26aufirst%3DR.%2BT.%26atitle%3DRyanodine%2520Receptor%25201-Related%2520Disorders%253A%2520An%2520Historical%2520Perspective%2520and%2520Proposal%2520for%2520a%2520Unified%2520Nomenclature%26jtitle%3DSkeletal%2520Muscle%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D32%26doi%3D10.1186%2Fs13395-020-00243-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawal, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meilleur, K. G.</span></span> <span> </span><span class="NLM_article-title">Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1007/s13311-018-00677-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs13311-018-00677-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30406384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB3cvnvVaksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=885-899&issue=4&author=T.+A.+Lawalauthor=J.+J.+Toddauthor=K.+G.+Meilleur&title=Ryanodine+Receptor+1-Related+Myopathies%3A+Diagnostic+and+Therapeutic+Approaches&doi=10.1007%2Fs13311-018-00677-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches</span></div><div class="casAuthors">Lawal Tokunbor A; Todd Joshua J; Meilleur Katherine G</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-899</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ryanodine receptor type 1-related myopathies (RYR1-RM) are the most common class of congenital myopathies.  Historically, RYR1-RM classification and diagnosis have been guided by histopathologic findings on muscle biopsy.  Main histological subtypes of RYR1-RM include central core disease, multiminicore disease, core-rod myopathy, centronuclear myopathy, and congenital fiber-type disproportion.  A range of RYR1-RM clinical phenotypes has also emerged more recently and includes King Denborough syndrome, RYR1 rhabdomyolysis-myalgia syndrome, atypical periodic paralysis, congenital neuromuscular disease with uniform type 1 fibers, and late-onset axial myopathy.  This expansion of the RYR1-RM disease spectrum is due, in part, to implementation of next-generation sequencing methods, which include the entire RYR1 coding sequence rather than being restricted to hotspot regions.  These methods enhance diagnostic capabilities, especially given historic limitations of histopathologic and clinical overlap across RYR1-RM.  Both dominant and recessive modes of inheritance have been documented, with the latter typically associated with a more severe clinical phenotype.  As with all congenital myopathies, no FDA-approved treatments exist to date.  Here, we review histopathologic, clinical, imaging, and genetic diagnostic features of the main RYR1-RM subtypes.  We also discuss the current state of treatments and focus on disease-modulating (nongenetic) therapeutic strategies under development for RYR1-RM.  Finally, perspectives for future approaches to treatment development are broached.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnjQX0Y77ZcbmQt-ICR3qNfW6udTcc2eYNw-2OH516Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvnvVaksQ%253D%253D&md5=4bd3c9e663cf88b2f2a8264f3df685a6</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1007%2Fs13311-018-00677-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-018-00677-1%26sid%3Dliteratum%253Aachs%26aulast%3DLawal%26aufirst%3DT.%2BA.%26aulast%3DTodd%26aufirst%3DJ.%2BJ.%26aulast%3DMeilleur%26aufirst%3DK.%2BG.%26atitle%3DRyanodine%2520Receptor%25201-Related%2520Myopathies%253A%2520Diagnostic%2520and%2520Therapeutic%2520Approaches%26jtitle%3DNeurotherapeutics%26date%3D2018%26volume%3D15%26issue%3D4%26spage%3D885%26epage%3D899%26doi%3D10.1007%2Fs13311-018-00677-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangopadhyay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parness, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemoto, N.</span></span> <span> </span><span class="NLM_article-title">Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">6580</span>– <span class="NLM_lpage">6587</span>, <span class="refDoi"> DOI: 10.1074/jbc.M408375200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1074%2Fjbc.M408375200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15611117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsV2qsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=6580-6587&issue=8&author=S.+Kobayashiauthor=M.+L.+Bannisterauthor=J.+P.+Gangopadhyayauthor=T.+Hamadaauthor=J.+Parnessauthor=N.+Ikemoto&title=Dantrolene+Stabilizes+Domain+Interactions+within+the+Ryanodine+Receptor&doi=10.1074%2Fjbc.M408375200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor</span></div><div class="casAuthors">Kobayashi, Shigeki; Bannister, Mark L.; Gangopadhyay, Jaya P.; Hamada, Tomoyo; Parness, Jerome; Ikemoto, Noriaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">6580-6587</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Interdomain interactions between N-terminal and central domains serving as a "domain switch" are believed to be essential to the functional regulation of the skeletal muscle ryanodine receptor-1 Ca2+ channel.  Mutational destabilization of the domain switch in malignant hyperthermia (MH), a genetic sensitivity to volatile anesthetics, causes functional instability of the channel.  Dantrolene, a drug used to treat MH, binds to a region within this proposed domain switch.  To explore its mechanism of action, the effect of dantrolene on MH-like channel activation by the synthetic domain peptide DP4 or anti-DP4 antibody was examd.  A fluorescence probe, methylcoumarin acetate, was covalently attached to the domain switch using DP4 as a delivery vehicle.  The magnitude of domain unzipping was detd. from the accessibility of methylcoumarin acetate to a macromol. fluorescence quencher.  The Stern-Volmer quenching const. (Kq) increased with the addn. of DP4 or anti-DP4 antibody.  This increase was reversed by dantrolene at both 37 °C and 22 °C and was unaffected by calmodulin.  [3H]Ryanodine binding to the sarcoplasmic reticulum and activation of sarcoplasmic reticulum Ca2+ release, both measures of channel activation, were enhanced by DP4.  These activities were inhibited by dantrolene at 37 °C, yet required the presence of calmodulin at 22 °C.  These results suggest that the mechanism of action of dantrolene involves stabilization of domain-domain interactions within the domain switch, preventing domain unzipping-induced channel dysfunction.  We suggest that temp. and calmodulin primarily affect the coupling between the domain switch and the downstream mechanism of regulation of Ca2+ channel opening rather than the domain switch itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHRQCHl_S5tbVg90H21EOLACvtfcHk0lidxI2ILc6P6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsV2qsLk%253D&md5=bf78a6332752bca9981e2b265298c0bf</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M408375200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M408375200%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DBannister%26aufirst%3DM.%2BL.%26aulast%3DGangopadhyay%26aufirst%3DJ.%2BP.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DParness%26aufirst%3DJ.%26aulast%3DIkemoto%26aufirst%3DN.%26atitle%3DDantrolene%2520Stabilizes%2520Domain%2520Interactions%2520within%2520the%2520Ryanodine%2520Receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D8%26spage%3D6580%26epage%3D6587%26doi%3D10.1074%2Fjbc.M408375200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diszházi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, Z. É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mótyán, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csernoch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jóna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nánási, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almássy, J.</span></span> <span> </span><span class="NLM_article-title">Dantrolene Requires MG2+ and ATP to Inhibit the Ryanodine Receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>96</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1124/mol.119.116475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.119.116475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31337666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVCqsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2019&pages=401-407&issue=3&author=G.+Diszh%C3%A1ziauthor=Z.+%C3%89.+Magyarauthor=J.+A.+M%C3%B3ty%C3%A1nauthor=L.+Csernochauthor=I.+J%C3%B3naauthor=P.+P.+N%C3%A1n%C3%A1siauthor=J.+Alm%C3%A1ssy&title=Dantrolene+Requires+MG2%2B+and+ATP+to+Inhibit+the+Ryanodine+Receptor&doi=10.1124%2Fmol.119.116475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Dantrolene requires Mg2+ and ATP To inhibit the ryanodine receptor</span></div><div class="casAuthors">Diszhazi, Gyula; Magyar, Zsuzsanna Edua; Motyan, Janos Andras; Csernoch, Laszlo; Jona, Istvan; Nanasi, Peter Pal; Almassy, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-407</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome.  Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca2+ release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers.  Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purifn. procedure of RyR.  Recently, Mg2+ was demonstrated to be the essential factor for dantrolene to inhibit Ca2+ release in skinned muscle fibers.  The aim of the present study was to confirm these results in Ca2+ release and bilayer expts., using SR vesicles and solubilized channels, resp.  Our Ca2+ release expts. demonstrated that the effect of dantrolene and Mg2+ was cooperative and that ATP enhanced the inhibiting effect of dantrolene.  Namely, 10μM dantrolene reduced RyR channel open probability by ~ 50% in the presence of 3 mM free Mg2+ and 1 mM ATP, whereas channel activity further decreased to ~ 20% of control when [ATP] was increased to 2 mM.  Our data provide important complementary information that supports the direct, Mg2+-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGoZEK4fzkd7Vg90H21EOLACvtfcHk0lh5YuRj_chDnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVCqsbrN&md5=b5d97a62139c30d22dd44b0280f71f66</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1124%2Fmol.119.116475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.119.116475%26sid%3Dliteratum%253Aachs%26aulast%3DDiszh%25C3%25A1zi%26aufirst%3DG.%26aulast%3DMagyar%26aufirst%3DZ.%2B%25C3%2589.%26aulast%3DM%25C3%25B3ty%25C3%25A1n%26aufirst%3DJ.%2BA.%26aulast%3DCsernoch%26aufirst%3DL.%26aulast%3DJ%25C3%25B3na%26aufirst%3DI.%26aulast%3DN%25C3%25A1n%25C3%25A1si%26aufirst%3DP.%2BP.%26aulast%3DAlm%25C3%25A1ssy%26aufirst%3DJ.%26atitle%3DDantrolene%2520Requires%2520MG2%252B%2520and%2520ATP%2520to%2520Inhibit%2520the%2520Ryanodine%2520Receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2019%26volume%3D96%26issue%3D3%26spage%3D401%26epage%3D407%26doi%3D10.1124%2Fmol.119.116475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, N.</span></span> <span> </span><span class="NLM_article-title">Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases</span>. <i>Curr. Protoc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e71</span> <span class="refDoi"> DOI: 10.1002/cpph.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fcpph.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31834676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVyhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&issue=1&author=T.+Murayamaauthor=N.+Kurebayashi&title=Assays+for+Modulators+of+Ryanodine+Receptor+%28RyR%29%2FCa2%2B+Release+Channel+Activity+for+Drug+Discovery+for+Skeletal+Muscle+and+Heart+Diseases&doi=10.1002%2Fcpph.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases</span></div><div class="casAuthors">Murayama, Takashi; Kurebayashi, Nagomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Protocols in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e71</span>CODEN:
                <span class="NLM_cas:coden">CPPUCS</span>;
        ISSN:<span class="NLM_cas:issn">1934-8290</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The ryanodine receptor (RyR) is a Ca2+ release channel that is present in the sarcoplasmic reticulum and endoplasmic reticulum (ER) and that plays a central role in excitation-contraction coupling in skeletal and cardiac muscle.  Hyperactivation of RyR by genetic mutations or posttranslational modification can cause various skeletal muscle and arrhythmogenic heart diseases.  Inhibitors of RyR are therefore expected to be potential drugs for treatment of such diseases.  This article describes assays to evaluate RyR channel activity, including an ER Ca2+ measurement assay that is compatible with high-throughput screening and a [3H]-ryanodine binding assay that provides a quant. measure of RyR channel activity as a second screen for compd. hits by John Wiley & Sons, Inc.  Basic Protocol 1: [Ca2+]ER assay for ryanodine receptor (RyR) channel activity Support Protocol 1: Detn. of dose dependence and isoform selectivity of RyR inhibitors using [Ca2+]ER assay Basic Protocol 2: [3H]-Ryanodine binding assay for RyR channel activity Support Protocol 2: Isolation of microsomes from RyR-expressing HEK293 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzpPh_EWql3bVg90H21EOLACvtfcHk0lh5YuRj_chDnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVyhsA%253D%253D&md5=5d4b7b637c0cef86386a8e1c470abde3</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1002%2Fcpph.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpph.71%26sid%3Dliteratum%253Aachs%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DKurebayashi%26aufirst%3DN.%26atitle%3DAssays%2520for%2520Modulators%2520of%2520Ryanodine%2520Receptor%2520%2528RyR%2529%252FCa2%252B%2520Release%2520Channel%2520Activity%2520for%2520Drug%2520Discovery%2520for%2520Skeletal%2520Muscle%2520and%2520Heart%2520Diseases%26jtitle%3DCurr.%2520Protoc.%2520Pharmacol.%26date%3D2019%26volume%3D87%26issue%3D1%26doi%3D10.1002%2Fcpph.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigami-Yuasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akima, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanemaru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyamada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span> <span> </span><span class="NLM_article-title">Efficient High-Throughput Screening by Endoplasmic Reticulum Ca 2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca 2+ -Release Channels</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1124/mol.117.111468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.117.111468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29674523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVGgtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2018&pages=722-730&issue=1&author=T.+Murayamaauthor=N.+Kurebayashiauthor=M.+Ishigami-Yuasaauthor=S.+Moriauthor=Y.+Suzukiauthor=R.+Akimaauthor=H.+Ogawaauthor=J.+Suzukiauthor=K.+Kanemaruauthor=H.+Oyamadaauthor=Y.+Kiuchiauthor=M.+Iinoauthor=H.+Kagechikaauthor=T.+Sakurai&title=Efficient+High-Throughput+Screening+by+Endoplasmic+Reticulum+Ca+2%2B+Measurement+to+Identify+Inhibitors+of+Ryanodine+Receptor+Ca+2%2B+-Release+Channels&doi=10.1124%2Fmol.117.111468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+ -release channels</span></div><div class="casAuthors">Murayama, Takashi; Kurebayashi, Nagomi; Ishigami-Yuasa, Mari; Mori, Shuichi; Suzuki, Yukina; Akima, Ryunosuke; Ogawa, Haruo; Suzuki, Junji; Kanemaru, Kazunori; Oyamada, Hideto; Kiuchi, Yuji; Iino, Masamitsu; Kagechika, Hiroyuki; Sakurai, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">722-730</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Genetic mutations in ryanodine receptors (RyRs), Ca2+ -release channels in the sarcoplasmic reticulum essential for muscle contractions, cause various skeletal muscle and cardiac diseases.  Because the main underlying mechanism of the pathogenesis is overactive Ca2+ release by gain-of-function of the RyR channel, inhibition of RyRs is expected to be a promising treatment of these diseases.  Here, to identify inhibitors specific to skeletal muscle type 1 RyR (RyR1), we developed a novel high-throughput screening (HTS) platform using time-lapse fluorescence measurement of Ca2+ concns. in the endoplasmic reticulum (ER) ([Ca2+]ER).  Because expression of RyR1 carrying disease-assocd. mutation reduces [Ca2+]ER in HEK293 cells through Ca2+ leakage from RyR1 channels, specific drugs that inhibit RyR1 will increase [Ca2+]ER by preventing such Ca2+ leakage.  RyR1 carrying the R2163C mutation and R-CEPIA1er, a genetically encoded ER Ca2+ indicator, were stably expressed in HEK293 cells, and timelapse fluorescence was measured using a fluorometer.  False positives were effectively excluded by using cells expressing wild-type (WT) RyR1.  By screening 1535 compds. in a library of well characterized drugs, we successfully identified four compds. that significantly increased [Ca2+]ER.  They include dantrolene, a known RyR1 inhibitor, and three structurally different compds.: oxolinic acid, 9-aminoacridine, and alexidine.  All the hit compds., except for oxolinic acid, inhibited [3H]ryanodine binding of WT and mutant RyR1.  Interestingly, they showed different dose dependencies and isoform specificities.  The highly quant. nature and good correlation with the channel activity validated this HTS platform by [Ca2+]ER measurement to explore drugs for RyR-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFnmIb-2uFbLVg90H21EOLACvtfcHk0lh5YuRj_chDnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVGgtrbN&md5=3e1b82bea234058403fb5486dbc20349</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1124%2Fmol.117.111468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.117.111468%26sid%3Dliteratum%253Aachs%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DKurebayashi%26aufirst%3DN.%26aulast%3DIshigami-Yuasa%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DAkima%26aufirst%3DR.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DJ.%26aulast%3DKanemaru%26aufirst%3DK.%26aulast%3DOyamada%26aufirst%3DH.%26aulast%3DKiuchi%26aufirst%3DY.%26aulast%3DIino%26aufirst%3DM.%26aulast%3DKagechika%26aufirst%3DH.%26aulast%3DSakurai%26aufirst%3DT.%26atitle%3DEfficient%2520High-Throughput%2520Screening%2520by%2520Endoplasmic%2520Reticulum%2520Ca%25202%252B%2520Measurement%2520to%2520Identify%2520Inhibitors%2520of%2520Ryanodine%2520Receptor%2520Ca%25202%252B%2520-Release%2520Channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2018%26volume%3D94%26issue%3D1%26spage%3D722%26epage%3D730%26doi%3D10.1124%2Fmol.117.111468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebbeck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essawy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitu, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillispie, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bers, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornea, R. L.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1177/1087057116674312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1177%2F1087057116674312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=27760856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=176-186&issue=2&author=R.+T.+Rebbeckauthor=M.+M.+Essawyauthor=F.+R.+Nituauthor=B.+D.+Grantauthor=G.+D.+Gillispieauthor=D.+D.+Thomasauthor=D.+M.+Bersauthor=R.+L.+Cornea&title=High-Throughput+Screens+to+Discover+Small-Molecule+Modulators+of+Ryanodine+Receptor+Calcium+Release+Channels&doi=10.1177%2F1087057116674312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels</span></div><div class="casAuthors">Rebbeck, Robyn T.; Essawy, Maram M.; Nitu, Florentin R.; Grant, Benjamin D.; Gillispie, Gregory D.; Thomas, David D.; Bers, Donald M.; Cornea, Razvan L.</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-186</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Using time-resolved fluorescence resonance energy transfer (FRET), we have developed and validated the first high-throughput screening (HTS) method to discover compds. that modulate an intracellular Ca2+ channel, the ryanodine receptor (RyR), for therapeutic applications.  Intracellular Ca2+ regulation is crit. for striated muscle function, and RyR is a central player.  At resting [Ca2+], an increased propensity of channel opening due to RyR dysregulation is assocd. with severe cardiac and skeletal myopathies, diabetes, and neurol. disorders.  This leaky state of the RyR is an attractive target for pharmacol. agents to treat such pathologies.  Our FRET-based HTS detects RyR binding of accessory proteins calmodulin (CaM) or FKBP12.6.  Under conditions that mimic a pathol. state, we carried out a screen of the 727-compd. NIH Clin. Collection, which yielded six compds. that reproducibly changed FRET by >3 SD.  Dose-response of FRET and [3H]ryanodine binding readouts reveal that five hits reproducibly alter RyR1 structure and activity.  One compd. increased FRET and inhibited RyR1, which was only significant at nM [Ca2+], and accentuated without CaM present.  These properties characterize a compd. that could mitigate RyR1 leak.  An excellent Z' factor and the tight correlation between structural and functional readouts validate this first HTS method to identify RyR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq49RRx7DV_OLVg90H21EOLACvtfcHk0lixv64j_ccs_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKks7g%253D&md5=7cb6c96a25212ff69c187245097a2d57</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1177%2F1087057116674312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057116674312%26sid%3Dliteratum%253Aachs%26aulast%3DRebbeck%26aufirst%3DR.%2BT.%26aulast%3DEssawy%26aufirst%3DM.%2BM.%26aulast%3DNitu%26aufirst%3DF.%2BR.%26aulast%3DGrant%26aufirst%3DB.%2BD.%26aulast%3DGillispie%26aufirst%3DG.%2BD.%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DBers%26aufirst%3DD.%2BM.%26aulast%3DCornea%26aufirst%3DR.%2BL.%26atitle%3DHigh-Throughput%2520Screens%2520to%2520Discover%2520Small-Molecule%2520Modulators%2520of%2520Ryanodine%2520Receptor%2520Calcium%2520Release%2520Channels%26jtitle%3DSLAS%2520Discovery%26date%3D2017%26volume%3D22%26issue%3D2%26spage%3D176%26epage%3D186%26doi%3D10.1177%2F1087057116674312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebbeck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janicek, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bers, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launikonis, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornea, R. L.</span></span> <span> </span><span class="NLM_article-title">RyR1-Targeted Drug Discovery Pipeline Integrating FRET-Based High-Throughput Screening and Human Myofiber Dynamic Ca2+ Assays</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1791</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-58461-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fs41598-020-58461-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=32019969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVWqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=1791&issue=1&author=R.+T.+Rebbeckauthor=D.+P.+Singhauthor=K.+A.+Janicekauthor=D.+M.+Bersauthor=D.+D.+Thomasauthor=B.+S.+Launikonisauthor=R.+L.+Cornea&title=RyR1-Targeted+Drug+Discovery+Pipeline+Integrating+FRET-Based+High-Throughput+Screening+and+Human+Myofiber+Dynamic+Ca2%2B+Assays&doi=10.1038%2Fs41598-020-58461-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca2+ assays</span></div><div class="casAuthors">Rebbeck, Robyn T.; Singh, Daniel P.; Janicek, Kevyn A.; Bers, Donald M.; Thomas, David D.; Launikonis, Bradley S.; Cornea, Razvan L.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1791</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Elevated cytoplasmic [Ca2+] is characteristic in severe skeletal and cardiac myopathies, diabetes, and neurodegeneration, and partly results from increased Ca2+ leak from sarcoplasmic reticulum stores via dysregulated ryanodine receptor (RyR) channels.  Consequently, RyR is recognized as a high-value target for drug discovery to treat such pathologies.  Using a FRET-based high-throughput screening assay that we previously reported, we identified small-mol. compds. that modulate the skeletal muscle channel isoform (RyR1) interaction with calmodulin and FK506 binding protein 12.6.  Two such compds., chloroxine and myricetin, increase FRET and inhibit [3H]ryanodine binding to RyR1 at nanomolar Ca2+.  Both compds. also decrease RyR1 Ca2+ leak in human skinned skeletal muscle fibers.  Furthermore, we identified compd. concns. that reduced leak by > 50% but only slightly affected Ca2+ release in excitation-contraction coupling, which is essential for normal muscle contraction.  This report demonstrates a pipeline that effectively filters small-mol. RyR1 modulators towards clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9YDeOX50NT7Vg90H21EOLACvtfcHk0lixv64j_ccs_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVWqtrk%253D&md5=392c447e24fc668a1970f4f282921519</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-58461-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-58461-1%26sid%3Dliteratum%253Aachs%26aulast%3DRebbeck%26aufirst%3DR.%2BT.%26aulast%3DSingh%26aufirst%3DD.%2BP.%26aulast%3DJanicek%26aufirst%3DK.%2BA.%26aulast%3DBers%26aufirst%3DD.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DLaunikonis%26aufirst%3DB.%2BS.%26aulast%3DCornea%26aufirst%3DR.%2BL.%26atitle%3DRyR1-Targeted%2520Drug%2520Discovery%2520Pipeline%2520Integrating%2520FRET-Based%2520High-Throughput%2520Screening%2520and%2520Human%2520Myofiber%2520Dynamic%2520Ca2%252B%2520Assays%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D1791%26doi%3D10.1038%2Fs41598-020-58461-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iinuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigami-Yuasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span> <span> </span><span class="NLM_article-title">Structural Development of a Type-1 Ryanodine Receptor (RyR1) Ca2+-Release Channel Inhibitor Guided by Endoplasmic Reticulum Ca2+ Assay</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.06.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.ejmech.2019.06.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31299492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKltLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2019&pages=837-848&author=S.+Moriauthor=H.+Iinumaauthor=N.+Manakaauthor=M.+Ishigami-Yuasaauthor=T.+Murayamaauthor=Y.+Nishijimaauthor=A.+Sakuraiauthor=R.+Araiauthor=N.+Kurebayashiauthor=T.+Sakuraiauthor=H.+Kagechika&title=Structural+Development+of+a+Type-1+Ryanodine+Receptor+%28RyR1%29+Ca2%2B-Release+Channel+Inhibitor+Guided+by+Endoplasmic+Reticulum+Ca2%2B+Assay&doi=10.1016%2Fj.ejmech.2019.06.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay</span></div><div class="casAuthors">Mori, Shuichi; Iinuma, Hiroto; Manaka, Noriaki; Ishigami-Yuasa, Mari; Murayama, Takashi; Nishijima, Yoshiaki; Sakurai, Akiko; Arai, Ryota; Kurebayashi, Nagomi; Sakurai, Takashi; Kagechika, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">837-848</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Type-1 ryanodine receptor (RyR1) is a calcium-release channel localized on sarcoplasmic reticulum (SR) of the skeletal muscle, and mediates muscle contraction by releasing Ca2+ from the SR.  Genetic mutations of RyR1 are assocd. with skeletal muscle diseases such as malignant hyperthermia and central core diseases, in which over-activation of RyR1 causes leakage of Ca2+ from the SR.  We recently developed an efficient high-throughput screening system based on the measurement of Ca2+ in endoplasmic reticulum, and used it to identify oxolinic acid (1) as a novel RyR1 channel inhibitor.  Here, we designed and synthesized a series of quinolone derivs. based on 1 as a lead compd.  Derivs. bearing a long alkyl chain at the nitrogen atom of the quinolone ring and having a suitable substituent at the 7-position of quinolone exhibited potent RyR1 channel-inhibitory activity.  Among the synthesized compds., 14h showed more potent activity than dantrolene, a known RyR1 inhibitor, and exhibited high RyR1 selectivity over RyR2 and RyR3.  These compds. may be promising leads for clin. applicable RyR1 channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofK-KQdzPVg7Vg90H21EOLACvtfcHk0lixv64j_ccs_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKltLrP&md5=109b86328b161ee79c377d3a773cadc8</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.06.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.06.076%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DS.%26aulast%3DIinuma%26aufirst%3DH.%26aulast%3DManaka%26aufirst%3DN.%26aulast%3DIshigami-Yuasa%26aufirst%3DM.%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DNishijima%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DArai%26aufirst%3DR.%26aulast%3DKurebayashi%26aufirst%3DN.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DStructural%2520Development%2520of%2520a%2520Type-1%2520Ryanodine%2520Receptor%2520%2528RyR1%2529%2520Ca2%252B-Release%2520Channel%2520Inhibitor%2520Guided%2520by%2520Endoplasmic%2520Reticulum%2520Ca2%252B%2520Assay%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D179%26spage%3D837%26epage%3D848%26doi%3D10.1016%2Fj.ejmech.2019.06.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, C. C.</span></span> <span> </span><span class="NLM_article-title">The Insecticide Chlorantraniliprole Is a Weak Activator of Mammalian Skeletal Ryanodine Receptor/Ca 2+ Release Channel</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>508</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.11.180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.bbrc.2018.11.180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=30527809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSnsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2019&pages=633-639&issue=2&author=J.+Chenauthor=L.+Xueauthor=R.+Weiauthor=S.+Liuauthor=C.+C.+Yin&title=The+Insecticide+Chlorantraniliprole+Is+a+Weak+Activator+of+Mammalian+Skeletal+Ryanodine+Receptor%2FCa+2%2B+Release+Channel&doi=10.1016%2Fj.bbrc.2018.11.180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">The insecticide chlorantraniliprole is a weak activator of mammalian skeletal ryanodine receptor/Ca2+ release channel</span></div><div class="casAuthors">Chen, Jian; Xue, Liang; Wei, Risheng; Liu, Shangzhong; Yin, Chang-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">633-639</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chlorantraniliprobe (Chlo), a potent insecticide, demolishes intracellular Ca2+ homeostasis of insects by inducing uncontrolled Ca2+ release through ryanodine receptors (RyRs).  Chlo is lethal to insects but has low toxicity to mammals.  In this study, we investigated the effects of Chlo on RyR1 from mammalian skeletal muscle.  Ca2+ release assay indicated that Chlo at high concns. promoted Ca2+ release from sarcoplasmic reticulum through RyR1 channels.  Single channel recording of purified RyR1 showed that Chlo activated RyR1 channel, increased channel open probability Po, reduced channel mean close time Tc, but did not change the channel mean open time To, suggesting that Chlo destabilized the closed RyR1 channel, rendered the channel easy to open.  The dissocn. const. Kd values of Chlo for RyR1 were of micromolar level, approx. 100-fold larger than that for insect RyR.  The Kd values were smaller for open states than for closed/blocked states of the RyR1 channel.  The maximal binding capacity Bmax did not change in the presence of either channel activators or inhibitors/blockers.  Our results demonstrate that the insecticide Chlo is a weak activator of mammalian RyR1.  It can interact with mammalian RyR1 and activate RyR1 channel but with much lower affinity compared with insect RyR; Chlo has a binding site distinct from all known RyR channel modulators and represents a novel type of RyR channel modulator.  Our data provide biochem. and pharmacol. insights into its high specificity to insect RyR and high selectivity of poisoning to insects over mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4TKEDjR1hoLVg90H21EOLACvtfcHk0lhu5Cuo5dpwrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSnsL3P&md5=0f46200977b88b1f3522d76a57256a63</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.11.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.11.180%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYin%26aufirst%3DC.%2BC.%26atitle%3DThe%2520Insecticide%2520Chlorantraniliprole%2520Is%2520a%2520Weak%2520Activator%2520of%2520Mammalian%2520Skeletal%2520Ryanodine%2520Receptor%252FCa%25202%252B%2520Release%2520Channel%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2019%26volume%3D508%26issue%3D2%26spage%3D633%26epage%3D639%26doi%3D10.1016%2Fj.bbrc.2018.11.180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Sylvester, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juettner, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copello, J. A.</span></span> <span> </span><span class="NLM_article-title">Eudistomin D and Penaresin Derivatives as Modulators of Ryanodine Receptor Channels and Sarcoplasmic Reticulum Ca2+ ATPase in Striated Muscle</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1124%2Fmol.113.089342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24423447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=564-575&issue=4&author=P.+L.+Diaz-Sylvesterauthor=M.+Portaauthor=V.+V.+Juettnerauthor=Y.+Lvauthor=S.+Fleischerauthor=J.+A.+Copello&title=Eudistomin+D+and+Penaresin+Derivatives+as+Modulators+of+Ryanodine+Receptor+Channels+and+Sarcoplasmic+Reticulum+Ca2%2B+ATPase+in+Striated+Muscle&doi=10.1124%2Fmol.113.089342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Eudistomin D and penaresin derivatives as modulators of ryanodine receptor channels and sarcoplasmic reticulum Ca2+ ATPase in striated muscle</span></div><div class="casAuthors">Diaz-Sylvester, Paula L.; Porta, Maura; Juettner, Vanessa V.; Lv, Yuanzhao; Fleischer, Sidney; Copello, Julio A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-575, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Eudistomin D (EuD) and penaresin (Pen) derivs. are bioactive alkaloids from marine sponges found to induce Ca2+ release from striated muscle sarcoplasmic reticulum (SR).  Although these alkaloids are believed to affect ryanodine receptor (RyR) gating in a "caffeine-like" manner, no single-channel study confirmed this assumption.  Here, EuD and MBED (9-methyl-7-bromoeudistomin D) were contrasted against caffeine on their ability to modulate the SR Ca2+ loading/leak from cardiac and skeletal muscle SR microsomes as well as the function of RyRs in planar bilayers.  The effects of these alkaloids on [3H]ryanodine binding and SR Ca2+ ATPase (SERCA) activity were also tested.  MBED (1-5 μM) fully mimicked maximal activating effects of caffeine (20 mM) on SR Ca2+ leak.  At the single-channel level, MBED mimicked the agonistic action of caffeine on cardiac RyR gating (i.e., stabilized long openings characteristic of "high-open-probability" mode).  EuD was a partial agonist at the maximal doses tested.  The tested Pen derivs. displayed mild to no agonism on RyRs, SR Ca2+ leak, or [3H]ryanodine binding studies.  Unlike caffeine, EuD and some Pen derivs. significantly inhibited SERCA at concns. required to modulate RyRs.  Instead, MBED's affinity for RyRs (EC50 ∼ 0.5 μM)wasmuch larger than forSERCA (IC50>285 μM).  In conclusion, MBED is a potent RyR agonist and, potentially, a better choice than caffeine for microsomal and cell studies due to its reported lack of effects on adenosine receptors and phosphodiesterases.  As a high-affinity caffeine-like probe, MBED could also help identify the caffeine-binding site in RyRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94X4V1opkCrVg90H21EOLACvtfcHk0lhu5Cuo5dpwrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVyntbk%253D&md5=4eb34b00a4ca2d4b8e8c1e5f84be3179</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089342%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz-Sylvester%26aufirst%3DP.%2BL.%26aulast%3DPorta%26aufirst%3DM.%26aulast%3DJuettner%26aufirst%3DV.%2BV.%26aulast%3DLv%26aufirst%3DY.%26aulast%3DFleischer%26aufirst%3DS.%26aulast%3DCopello%26aufirst%3DJ.%2BA.%26atitle%3DEudistomin%2520D%2520and%2520Penaresin%2520Derivatives%2520as%2520Modulators%2520of%2520Ryanodine%2520Receptor%2520Channels%2520and%2520Sarcoplasmic%2520Reticulum%2520Ca2%252B%2520ATPase%2520in%2520Striated%2520Muscle%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26issue%3D4%26spage%3D564%26epage%3D575%26doi%3D10.1124%2Fmol.113.089342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oikonomakos, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skamnaki, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsitsanou, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavalas, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span> <span> </span><span class="NLM_article-title">A New Allosteric Site in Glycogen Phosphorylase b as a Target for Drug Interactions</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(00)00144-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0969-2126%2800%2900144-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10873856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Kktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=575-584&issue=6&author=N.+G.+Oikonomakosauthor=V.+T.+Skamnakiauthor=K.+E.+Tsitsanouauthor=N.+G.+Gavalasauthor=L.+N.+Johnson&title=A+New+Allosteric+Site+in+Glycogen+Phosphorylase+b+as+a+Target+for+Drug+Interactions&doi=10.1016%2FS0969-2126%2800%2900144-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">A new allosteric site in glycogen phosphorylase b as a target for drug interactions</span></div><div class="casAuthors">Oikonomakos, Nikos G.; Skamnaki, Vicky T.; Tsitsanou, Katerina E.; Gavalas, Nikos G.; Johnson, Louise N.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">575-584</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: In muscle and liver, glycogen concns. are regulated by the coordinated activities of glycogen phosphorylase (GP) and glycogen synthase.  GP exists in two forms: the dephosphorylated low-activity form GPb and the phosphorylated high-activity form GPa.  In both forms, allosteric effectors can promote equil. between a less active T state and a more active R state.  GP is a possible target for drugs that aim to prevent unwanted glycogen breakdown and to stimulate glycogen synthesis in non-insulin-dependent diabetes.  As a result of a data bank search, 5-chloro-1H-indole-2-carboxylic acid (1-(4-fluorobenzyl)-2-(4-hydroxypiperidin-1-yl)-2-oxoethyl)amide, CP320626, was identified as a potent inhibitor of human liver GP.  Structural studies have been carried out in order to establish the mechanism of this unusual inhibitor.  Results: The structure of the cocrystd. GPb-CP320626 complex has been detd. to 2.3 Å resoln.  CP320626 binds at a site located at the subunit interface in the region of the central cavity of the dimeric structure.  The site has not previously been obsd. to bind ligands and is some 15 Å from the AMP allosteric site and 33 Å from the catalytic site.  The contacts between GPb and CP320626 comprise six hydrogen bonds and extensive van der Waals interactions that create a tight binding site in the T-state conformation of GPb.  In the R-state conformation of GPa these interactions are significantly diminished.  Conclusions: CP320626 inhibits GPb by binding at a new allosteric site.  Although over 30 Å from the catalytic site, the inhibitor exerts its effects by stabilizing the T state at the expense of the R state and thereby shifting the allosteric equil. between the two states.  The new allosteric binding site offers a further recognition site in the search for improved GP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxgArGOkliWrVg90H21EOLACvtfcHk0lhu5Cuo5dpwrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Kktbw%253D&md5=f04106a022d7bcb3013d131d4a974a10</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2900144-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252900144-1%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomakos%26aufirst%3DN.%2BG.%26aulast%3DSkamnaki%26aufirst%3DV.%2BT.%26aulast%3DTsitsanou%26aufirst%3DK.%2BE.%26aulast%3DGavalas%26aufirst%3DN.%2BG.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26atitle%3DA%2520New%2520Allosteric%2520Site%2520in%2520Glycogen%2520Phosphorylase%2520b%2520as%2520a%2520Target%2520for%2520Drug%2520Interactions%26jtitle%3DStructure%26date%3D2000%26volume%3D8%26issue%3D6%26spage%3D575%26epage%3D584%26doi%3D10.1016%2FS0969-2126%2800%2900144-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonka, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, D. J.</span></span> <span> </span><span class="NLM_article-title">The Effect of Glucose on the Sedimentation and Catalytic Activity of Glycogen Phosphorylase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(65)90895-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0006-291X%2865%2990895-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=14265745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaF2MXksFaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1965&pages=131-135&issue=1&author=J.+H.+Wangauthor=M.+L.+Shonkaauthor=D.+J.+Graves&title=The+Effect+of+Glucose+on+the+Sedimentation+and+Catalytic+Activity+of+Glycogen+Phosphorylase&doi=10.1016%2F0006-291X%2865%2990895-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of glucose on the sedimentation and catalytic activity of glycogen phosphorylase</span></div><div class="casAuthors">Wang, Jerry H.; Shonka, Mary Louise; Graves, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Phosphorylase activity was measured according to Krebs, et al. (CA 61, 5968e), and expressed as micromoles of PO43- released after 30 sec. of reaction.  Inclusion of 0.025M glucose in the assay inhibited phosphorylase a activity 60% at 20°; stimulation of activity by 3-fold could be achieved if the enzyme was preincubated in 0.05M glucose at 20°.  No increase in activity was observed with preincubation without glucose.  Two boundaries with s20,w of 8.9 and 13.9 S appeared during centrifugation at 20°with the enzyme in 0.05M glucose.  In the absence of glucose, only 13.9 S is evident.  These data suggest that activation is related to the conversion of the tetrameric form of phosphorylase a to dimeric species.  The incubation with glucose was unsuccessful at 30°.  Addn. of 0.032M glucose 1-phosphate (I) or 10-3M AMP to incubated enzyme results in a slow decrease of catalytic activity and a decrease in the amt. of the 8.9 S component.  AMP had the greater effect.  Activation and the relative amts. of the 2 components were dependent on concn. of glucose and I; with 0.16M I and 0.05M glucose at 20° no activation or 8.9 S component could be detected, suggesting that glucose and I compete for a single binding site.  Inhibition by AMP may be due to the binding of AMP to a different site, resulting in decreased affinity of enzyme for glucose and (or) decrease in the Km for I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowpGQWVkxrcLVg90H21EOLACvtfcHk0lhCJFm2H-KaYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXksFaruw%253D%253D&md5=776cd05cbbae6210835ccbc47abec3b7</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2865%2990895-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252865%252990895-8%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DShonka%26aufirst%3DM.%2BL.%26aulast%3DGraves%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Effect%2520of%2520Glucose%2520on%2520the%2520Sedimentation%2520and%2520Catalytic%2520Activity%2520of%2520Glycogen%2520Phosphorylase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1965%26volume%3D18%26issue%3D1%26spage%3D131%26epage%3D135%26doi%3D10.1016%2F0006-291X%2865%2990895-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardern, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loxham, S. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poucher, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, A. D.</span></span> <span> </span><span class="NLM_article-title">Sensitivity of Glycogen Phosphorylase Isoforms to Indole Site Inhibitors Is Markedly Dependent on the Activation State of the Enzyme</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.bjp.0706925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17016495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=775-785&issue=6&author=S.+Freemanauthor=J.+B.+Bartlettauthor=G.+Conveyauthor=I.+Hardernauthor=J.+L.+Teagueauthor=S.+J.+G.+Loxhamauthor=J.+M.+Allenauthor=S.+M.+Poucherauthor=A.+D.+Charles&title=Sensitivity+of+Glycogen+Phosphorylase+Isoforms+to+Indole+Site+Inhibitors+Is+Markedly+Dependent+on+the+Activation+State+of+the+Enzyme&doi=10.1038%2Fsj.bjp.0706925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme</span></div><div class="casAuthors">Freeman, S.; Bartlett, J. B.; Convey, G.; Hardern, I.; Teague, J. L.; Loxham, S. J. G.; Allen, J. M.; Poucher, S. M.; Charles, A. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of hepatic glycogen phosphorylase is a potential treatment for glycemic control in type 2 diabetes.  Selective inhibition of the liver phosphorylase isoform could minimize adverse effects in other tissues.  The authors investigated the potential selectivity of two indole site phosphorylase inhibitors, GPi688 and GPi819.  The activity of glycogen phosphorylase was modulated using the allosteric effectors glucose or caffeine to promote the less active T state, and AMP to promote the more active R state.  In vitro potency of indole site inhibitors against liver and muscle glycogen phosphorylase a was examd. at different effector concns. using purified recombinant enzymes.  The potency of GPi819 was compared with its in vivo efficacy at raising glycogen concns. in liver and muscle of Zucker (fa/fa) rats.  In vitro potency of indole site inhibitors depended upon the activity state of phosphorylase a.  Both inhibitors showed selectivity for liver phosphorylase a when the isoform specific activities were equal.  After 5 days dosing of GPi819 (37.5 μmol kg-1), where free compd. levels in plasma and tissue were at steady state, glycogen elevation was 1.5-fold greater in soleus muscle than in liver (P<0.05).  The in vivo selectivity of GPi819 did not match that seen in vitro when the specific activities of phosphorylase a isoforms are equal.  This suggests T state promoters may be important physiol. regulators in skeletal muscle.  The greater efficacy of indole site inhibitors in skeletal muscle has implications for the overall safety profile of such drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_FYUITO7qMbVg90H21EOLACvtfcHk0lhCJFm2H-KaYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsbvM&md5=372b2bb8776afac052129887cac654f1</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706925%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DS.%26aulast%3DBartlett%26aufirst%3DJ.%2BB.%26aulast%3DConvey%26aufirst%3DG.%26aulast%3DHardern%26aufirst%3DI.%26aulast%3DTeague%26aufirst%3DJ.%2BL.%26aulast%3DLoxham%26aufirst%3DS.%2BJ.%2BG.%26aulast%3DAllen%26aufirst%3DJ.%2BM.%26aulast%3DPoucher%26aufirst%3DS.%2BM.%26aulast%3DCharles%26aufirst%3DA.%2BD.%26atitle%3DSensitivity%2520of%2520Glycogen%2520Phosphorylase%2520Isoforms%2520to%2520Indole%2520Site%2520Inhibitors%2520Is%2520Markedly%2520Dependent%2520on%2520the%2520Activation%2520State%2520of%2520the%2520Enzyme%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26issue%3D6%26spage%3D775%26epage%3D785%26doi%3D10.1038%2Fsj.bjp.0706925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriaud-Kolar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A. L.</span></span> <span> </span><span class="NLM_article-title">Glycogen Phosphorylase Inhibitors: A Patent Review (2008–2012)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1017</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.794790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1517%2F13543776.2013.794790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23627914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1017-1032&issue=8&author=N.+Gaboriaud-Kolarauthor=A.+L.+Skaltsounis&title=Glycogen+Phosphorylase+Inhibitors%3A+A+Patent+Review+%282008%E2%80%932012%29&doi=10.1517%2F13543776.2013.794790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen phosphorylase inhibitors: a patent review (2008 - 2012)</span></div><div class="casAuthors">Gaboriaud-Kolar, Nicolas; Skaltsounis, Alexios-Leandros</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1017-1032</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Glycogen phosphorylase (GP) is the enzyme responsible for the synthesis of glucose-1-phosphate, the source of energy for muscles and the rest of the body.  The binding of different ligands in catalytic or allosteric sites assures activation and deactivation of the enzyme.  A description of the regulation mechanism and the implications in glycogen metab. are given.  Areas covered: Deregulation of GP has been obsd. in diseases such as diabetes mellitus or cancers.  Therefore, it appears as an attractive therapeutic target for the treatment of such pathologies.  Nos. of inhibitors have been published in academic literature or patented in the last two decades.  This review presents the main patent claims published between 2008 and 2012.  Expert opinion: Good inhibitors with interesting IC50 and in vivo results are presented.  However, such therapeutic strategy raises questions and some answers are proposed to bring new insights in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHR9-NDBkHybVg90H21EOLACvtfcHk0lhCJFm2H-KaYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsbzF&md5=4706aeb5cbacef7727fe06e52b505e55</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.794790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.794790%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriaud-Kolar%26aufirst%3DN.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26atitle%3DGlycogen%2520Phosphorylase%2520Inhibitors%253A%2520A%2520Patent%2520Review%2520%25282008%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26issue%3D8%26spage%3D1017%26epage%3D1032%26doi%3D10.1517%2F13543776.2013.794790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janda, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, K. C.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Wnt Recognition by Frizzled</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>337</i></span> (<span class="NLM_issue">6090</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1126/science.1222879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1126%2Fscience.1222879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22653731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=59-64&issue=6090&author=C.+Y.+Jandaauthor=D.+Waghrayauthor=A.+M.+Levinauthor=C.+Thomasauthor=K.+C.+Garcia&title=Structural+Basis+of+Wnt+Recognition+by+Frizzled&doi=10.1126%2Fscience.1222879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Wnt Recognition by Frizzled</span></div><div class="casAuthors">Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6090</span>),
    <span class="NLM_cas:pages">59-64</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Wnts are lipid-modified morphogens that play crit. roles in development, principally through engagement of Frizzled receptors.  The 3.25 angstrom structure of Xenopus Wnt8 (XWnt8) in complex with mouse Frizzled-8 (Fz8) cysteine-rich domain (CRD) reveals an unusual two-domain Wnt structure, not obviously related to known protein folds, resembling a "hand" with "thumb" and "index" fingers extended to grasp the Fz8-CRD at two distinct binding sites.  One site is dominated by a palmitoleic acid lipid group projecting from serine 187 at the tip of Wnt's thumb into a deep groove in the Fz8-CRD.  In the second binding site, the conserved tip of Wnt's "index finger" forms hydrophobic amino acid contacts with a depression on the opposite side of the Fz8-CRD.  The conservation of amino acids in both interfaces appears to facilitate ligand-receptor cross-reactivity, which has important implications for understanding Wnt's functional pleiotropy and for developing Wnt-based drugs for cancer and regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKMgZd5hKMfLVg90H21EOLACvtfcHk0lhCJFm2H-KaYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D&md5=8a32c44b73fe281cccedc285311759ce</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222879%26sid%3Dliteratum%253Aachs%26aulast%3DJanda%26aufirst%3DC.%2BY.%26aulast%3DWaghray%26aufirst%3DD.%26aulast%3DLevin%26aufirst%3DA.%2BM.%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DStructural%2520Basis%2520of%2520Wnt%2520Recognition%2520by%2520Frizzled%26jtitle%3DScience%26date%3D2012%26volume%3D337%26issue%3D6090%26spage%3D59%26epage%3D64%26doi%3D10.1126%2Fscience.1222879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawynok, J.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>152</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">726</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2010.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.pain.2010.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21041029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M3pvFCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=726-729&issue=4&author=J.+Sawynok&title=Caffeine+and+Pain&doi=10.1016%2Fj.pain.2010.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and pain</span></div><div class="casAuthors">Sawynok Jana</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">726-729</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrp1qUka64qOQ4Pl9hzjQhfW6udTcc2eZHQ-DYEDdwZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3pvFCqsA%253D%253D&md5=8661c777a4201623d3177f96d5ad96eb</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DSawynok%26aufirst%3DJ.%26atitle%3DCaffeine%2520and%2520Pain%26jtitle%3DPain%26date%3D2011%26volume%3D152%26issue%3D4%26spage%3D726%26epage%3D729%26doi%3D10.1016%2Fj.pain.2010.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawynok, J.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Targets for Pain</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2015.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroscience.2015.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26500181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWrtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2016&pages=1-18&author=J.+Sawynok&title=Adenosine+Receptor+Targets+for+Pain&doi=10.1016%2Fj.neuroscience.2015.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor targets for pain</span></div><div class="casAuthors">Sawynok, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The main focus for the development of adenosine targets as analgesics to date has been A1Rs due to its antinociceptive profile in various preclin. pain models.  The usefulness of systemic A1R agonists may be limited by other effects (cardiovascular, motor), but enhanced selectivity for pain might occur with partial agonists, potent and highly selective agonists, or allosteric modulators.  A2AR agonists exhibit some peripheral pronociceptive effects, but also act on immune cells to suppress inflammation and on spinal glia to suppress pain signaling and may be useful for inflammatory and neuropathic pain.  A2BR agonists exhibit peripheral proinflammatory effects on immune cells, but also spinal antinociceptive effects similar to A2AR agonists.  A3Rs are now demonstrated to produce antinociception in several preclin. neuropathic pain models, with mechanistic actions on glial cells, and may be useful for neuropathic pain.  Endogenous adenosine levels can be augmented by inhibition of metab. (via adenosine kinase) or increased generation (via nucleotidases), and these approaches have implications for pain.  Endogenous adenosine contributes to antinociception by several pharmacol. agents, herbal remedies, acupuncture, transcutaneous elec. nerve stimulation, exercise, joint mobilization, and water immersion via spinal and/or peripheral effects, such that this system appears to constitute a major pain regulatory system.  Finally, caffeine inhibits A1-, A2A- and A3Rs with similar potency, and dietary caffeine intake will need attention in trials of: (a) agonists and/or modulators acting at these receptors, (b) some pharmacol. and herbal analgesics, and (c) manipulations that enhance endogenous adenosine levels, all of which are inhibited by caffeine and/or A1R antagonists in preclin. studies.  All adenosine receptors have effects on spinal glial cells in regulating nociception, and gender differences in the involvement of such cells in chronic neuropathic pain indicate gender may also need attention in preclin. and human trials evaluating the efficacy of adenosine-based analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQGeFtvKD2HLVg90H21EOLACvtfcHk0lg-dtcpvYZWfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWrtb%252FJ&md5=753380b50c812db8e53e2d67f7e80818</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2015.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2015.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DSawynok%26aufirst%3DJ.%26atitle%3DAdenosine%2520Receptor%2520Targets%2520for%2520Pain%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D338%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.neuroscience.2015.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laska, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvers, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, A.</span></span> <span> </span><span class="NLM_article-title">Caffeine as an Analgesic Adjuvant</span>. <i>JAMA J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>251</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1001/jama.1984.03340370043028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.1984.03340370043028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=6366275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL2c7jvFWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1984&pages=1711-1718&issue=13&author=E.+M.+Laskaauthor=A.+Sunshineauthor=F.+Muellerauthor=W.+B.+Elversauthor=C.+Siegelauthor=A.+Rubin&title=Caffeine+as+an+Analgesic+Adjuvant&doi=10.1001%2Fjama.1984.03340370043028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine as an analgesic adjuvant</span></div><div class="casAuthors">Laska E M; Sunshine A; Mueller F; Elvers W B; Siegel C; Rubin A</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1711-8</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">Thirty clinical studies involving more than 10,000 patients conducted during the last 20 years have been analyzed to assess the value of caffeine as an analgesic adjuvant.  Although most studies included patients with postpartum uterine cramping or episiotomy pain, some involved patients with pain from oral surgery or headache.  In 21 of 26 studies, the relative potency estimates of an analgesic with caffeine to an analgesic without caffeine is greater than one.  The pooled relative potency estimates in each of several major categories of combination analgesics are significantly greater than one.  The overall pooled relative potency estimate is 1.41, with 95% confidence limits of 1.23 to 1.63; that is, to obtain the same amount of response from an analgesic without caffeine requires a dose that is approximately 40% greater than one with caffeine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCcEoxVZT2GiA3UY9EwTNrfW6udTcc2eZHQ-DYEDdwZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7jvFWjtA%253D%253D&md5=e58efd67b06f2ea2b7a4f1328e757e54</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1001%2Fjama.1984.03340370043028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.1984.03340370043028%26sid%3Dliteratum%253Aachs%26aulast%3DLaska%26aufirst%3DE.%2BM.%26aulast%3DSunshine%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DF.%26aulast%3DElvers%26aufirst%3DW.%2BB.%26aulast%3DSiegel%26aufirst%3DC.%26aulast%3DRubin%26aufirst%3DA.%26atitle%3DCaffeine%2520as%2520an%2520Analgesic%2520Adjuvant%26jtitle%3DJAMA%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1984%26volume%3D251%26issue%3D13%26spage%3D1711%26epage%3D1718%26doi%3D10.1001%2Fjama.1984.03340370043028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camann, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mushlin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. H.</span></span> <span> </span><span class="NLM_article-title">Effects of Oral Caffeine on Postdural Puncture Headache. A Double-Blind, Placebo-Controlled Trial</span>. <i>Anesth. Analg.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1213/00000539-199002000-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1213%2F00000539-199002000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2405733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK3c7ksFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1990&pages=181-184&issue=2&author=W.+R.+Camannauthor=R.+S.+Murrayauthor=P.+S.+Mushlinauthor=D.+H.+Lambert&title=Effects+of+Oral+Caffeine+on+Postdural+Puncture+Headache.+A+Double-Blind%2C+Placebo-Controlled+Trial&doi=10.1213%2F00000539-199002000-00009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial</span></div><div class="casAuthors">Camann W R; Murray R S; Mushlin P S; Lambert D H</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia and analgesia</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-4</span>
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    </div><div class="casAbstract">Forty postpartum patients with postdural puncture headache (PDPH) were randomly assigned to receive oral caffeine (300 mg) or a placebo.  Intensity of headache, quantitated using a visual analogue pain scale (VAS), was assessed immediately before drug administration and 4 and 24 h later.  Relief of PDPH measured as delta VAS (initial VAS - VAS at 4 h) was significantly better in the caffeine than in the placebo group (P = 0.014).  Six patients (30%) whose PDPH was relieved by caffeine at 4 h had recurrence of symptoms the following day.  Our study demonstrates that caffeine administered orally provides relief, albeit if sometimes transient, from PDPH with minimal side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVPZePAWGMbskU0YCbOU3EfW6udTcc2eZOU6Cp24XlVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7ksFKhsw%253D%253D&md5=665bdfbf57ca69c06b709169eda9aaa9</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1213%2F00000539-199002000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252F00000539-199002000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DCamann%26aufirst%3DW.%2BR.%26aulast%3DMurray%26aufirst%3DR.%2BS.%26aulast%3DMushlin%26aufirst%3DP.%2BS.%26aulast%3DLambert%26aufirst%3DD.%2BH.%26atitle%3DEffects%2520of%2520Oral%2520Caffeine%2520on%2520Postdural%2520Puncture%2520Headache.%2520A%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial%26jtitle%3DAnesth.%2520Analg.%26date%3D1990%26volume%3D70%26issue%3D2%26spage%3D181%26epage%3D184%26doi%3D10.1213%2F00000539-199002000-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sechzer, P. H.</span></span> <span> </span><span class="NLM_article-title">Post-Spinal Anesthesia Headache Treated with Caffeine. Part II: Intracranial Vascular Distention, a Key Factor</span>. <i>Curr. Ther. Res. - Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1979&pages=440-448&issue=4&author=P.+H.+Sechzer&title=Post-Spinal+Anesthesia+Headache+Treated+with+Caffeine.+Part+II%3A+Intracranial+Vascular+Distention%2C+a+Key+Factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSechzer%26aufirst%3DP.%2BH.%26atitle%3DPost-Spinal%2520Anesthesia%2520Headache%2520Treated%2520with%2520Caffeine.%2520Part%2520II%253A%2520Intracranial%2520Vascular%2520Distention%252C%2520a%2520Key%2520Factor%26jtitle%3DCurr.%2520Ther.%2520Res.%2520-%2520Clin.%2520Exp.%26date%3D1979%26volume%3D26%26issue%3D4%26spage%3D440%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrath, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pageler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span> <span> </span><span class="NLM_article-title">The Fixed Combination of Acetylsalicylic Acid, Paracetamol and Caffeine Is More Effective than Single Substances and Dual Combination for the Treatment of Headache: A Multicentre, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Parallel Group St</span>. <i>Cephalalgia</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1111/j.1468-2982.2005.00948.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1468-2982.2005.00948.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16162254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2MvptFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=776-787&issue=10&author=H.+C.+Dienerauthor=V.+Pfaffenrathauthor=L.+Pagelerauthor=H.+Peilauthor=B.+Aicher&title=The+Fixed+Combination+of+Acetylsalicylic+Acid%2C+Paracetamol+and+Caffeine+Is+More+Effective+than+Single+Substances+and+Dual+Combination+for+the+Treatment+of+Headache%3A+A+Multicentre%2C+Randomized%2C+Double-Blind%2C+Single-Dose%2C+Placebo-Controlled+Parallel+Group+St&doi=10.1111%2Fj.1468-2982.2005.00948.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study</span></div><div class="casAuthors">Diener H C; Pfaffenrath V; Pageler L; Peil H; Aicher B</div><div class="citationInfo"><span class="NLM_cas:title">Cephalalgia : an international journal of headache</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">776-87</span>
        ISSN:<span class="NLM_cas:issn">0333-1024</span>.
    </div><div class="casAbstract">We investigated efficacy, safety, and tolerability of two tablets of the fixed combination of 250 mg acetylsalicylic acid (ASA) + 200 mg paracetamol + 50 mg caffeine (Thomapyrin) in comparison with two tablets of 250 mg ASA + 200 mg paracetamol, two tablets of 500 mg ASA, two tablets of 500 mg paracetamol, two tablets of 50 mg caffeine, and placebo in patients who were used to treating their episodic tension-type headache or migraine attacks with non-prescription analgesics.  For the primary endpoint "time to 50% pain relief" in the intention-to-treat dataset (n = 1743 patients), the fixed combination of ASA, paracetamol and caffeine was statistically significantly superior to the combination without caffeine (P = 0.0181), the mono-substances ASA (P = 0.0398), paracetamol (P = 0.0016), caffeine (P < 0.0001) and placebo (P < 0.0001).  All active treatments except caffeine differed significantly (P < 0.0001) from placebo.  The superior efficacy of the triple combination could also be shown for all secondary endpoints such as time until reduction of pain intensity to 10 mm, weighted sum of pain intensity difference (%SPIDweighted), extent of impairment of daily activities, global assessment of efficacy.  All treatments were well tolerated.  The incidence of adverse events observed was low.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVaif3jmcvKy-bLEOO4dYpfW6udTcc2eZOU6Cp24XlVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvptFGqtg%253D%253D&md5=376f63ffc3b7b19b26b1ac2b6de44632</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-2982.2005.00948.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-2982.2005.00948.x%26sid%3Dliteratum%253Aachs%26aulast%3DDiener%26aufirst%3DH.%2BC.%26aulast%3DPfaffenrath%26aufirst%3DV.%26aulast%3DPageler%26aufirst%3DL.%26aulast%3DPeil%26aufirst%3DH.%26aulast%3DAicher%26aufirst%3DB.%26atitle%3DThe%2520Fixed%2520Combination%2520of%2520Acetylsalicylic%2520Acid%252C%2520Paracetamol%2520and%2520Caffeine%2520Is%2520More%2520Effective%2520than%2520Single%2520Substances%2520and%2520Dual%2520Combination%2520for%2520the%2520Treatment%2520of%2520Headache%253A%2520A%2520Multicentre%252C%2520Randomized%252C%2520Double-Blind%252C%2520Single-Dose%252C%2520Placebo-Controlled%2520Parallel%2520Group%2520St%26jtitle%3DCephalalgia%26date%3D2005%26volume%3D25%26issue%3D10%26spage%3D776%26epage%3D787%26doi%3D10.1111%2Fj.1468-2982.2005.00948.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eichenwald, E. C.</span></span> <span> </span><span class="NLM_article-title">Apnea of Prematurity</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e20153757</span> <span class="refDoi"> DOI: 10.1542/peds.2015-3757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1542%2Fpeds.2015-3757" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2016&issue=1&author=E.+C.+Eichenwald&title=Apnea+of+Prematurity&doi=10.1542%2Fpeds.2015-3757"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1542%2Fpeds.2015-3757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1542%252Fpeds.2015-3757%26sid%3Dliteratum%253Aachs%26aulast%3DEichenwald%26aufirst%3DE.%2BC.%26atitle%3DApnea%2520of%2520Prematurity%26jtitle%3DPediatrics%26date%3D2016%26volume%3D137%26issue%3D1%26doi%3D10.1542%2Fpeds.2015-3757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson-Smart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Paoli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughton, D.</span></span> <span> </span><span class="NLM_article-title">Methylxanthine Treatment for Apnoea in Preterm Infants</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">CD000140</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD000140.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2F14651858.CD000140.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=CD000140&issue=12&author=D.+J.+Henderson-Smartauthor=A.+G.+De+Paoliauthor=D.+Haughton&title=Methylxanthine+Treatment+for+Apnoea+in+Preterm+Infants&doi=10.1002%2F14651858.CD000140.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD000140.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD000140.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson-Smart%26aufirst%3DD.%2BJ.%26aulast%3DDe%2BPaoli%26aufirst%3DA.%2BG.%26aulast%3DHaughton%26aufirst%3DD.%26atitle%3DMethylxanthine%2520Treatment%2520for%2520Apnoea%2520in%2520Preterm%2520Infants%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2010%26volume%3D2010%26issue%3D12%26spage%3DCD000140%26doi%3D10.1002%2F14651858.CD000140.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrington, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solimano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tin, W.</span></span> <span> </span><span class="NLM_article-title">Caffeine Therapy for Apnea of Prematurity</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>354</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">2112</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa054065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1056%2FNEJMoa054065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16707748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=2112-2121&issue=20&author=B.+Schmidtauthor=R.+S.+Robertsauthor=P.+Davisauthor=L.+W.+Doyleauthor=K.+J.+Barringtonauthor=A.+Ohlssonauthor=A.+Solimanoauthor=W.+Tin&title=Caffeine+Therapy+for+Apnea+of+Prematurity&doi=10.1056%2FNEJMoa054065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine therapy for apnea of prematurity</span></div><div class="casAuthors">Schmidt, Barbara; Roberts, Robin S.; Davis, Peter; Doyle, Lex W.; Barrington, Keith J.; Ohisson, Arne; Solimano, Alfonso; Tin, Win</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2112-2121</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Methylxanthines reduce the frequency of apnea of prematurity and the need for mech. ventilation during the first seven days of therapy.  It is uncertain whether methylxanthines have other short- and long-term benefits or risks in infants with very low birth wt.  We randomly assigned 2006 infants with birth wts. of 500 to 1250 g during the first 10 days of life to receive either caffeine or placebo, until drug therapy for apnea of prematurity was no longer needed.  We evaluated the short-term outcomes before the first discharge home.  Of 963 infants who were assigned to caffeine and who remained alive at a postmenstrual age of 36 wk, 350 (36 %) received supplemental oxygen, as did 447 of the 954 infants (47 %) assigned to placebo (adjusted odds ratio, 0.63; 95 % confidence interval, 0.52 to 0.76; P < 0.001).  Pos. airway pressure was discontinued one week earlier in the infants assigned to caffeine (median postmenstrual age, 31.0 wk; interquartile range, 29.4 to 33.0) than in the infants in the placebo group (median postmenstrual age, 32.0 wk; interquartile range, 30.3 to 34.0; P < 0.001).  Caffeine reduced wt. gain temporarily.  The mean difference in wt. gain between the group receiving caffeine and the group receiving placebo was greatest after two weeks (mean difference, -23 g; 95 % confidence interval, -32 to -13; P < 0.001).  The rates of death, ultrasonog. signs of brain injury, and necrotizing enterocolitis did not differ significantly between the two groups.  Caffeine therapy for apnea of prematurity reduces the rate of bronchopulmonary dysplasia in infants with very low birth wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNSIdmBG-w6bVg90H21EOLACvtfcHk0liLmgkdeoUBTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCku7Y%253D&md5=f220f76e59c2997ad5c489ec96b02b55</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa054065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa054065%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DR.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DDoyle%26aufirst%3DL.%2BW.%26aulast%3DBarrington%26aufirst%3DK.%2BJ.%26aulast%3DOhlsson%26aufirst%3DA.%26aulast%3DSolimano%26aufirst%3DA.%26aulast%3DTin%26aufirst%3DW.%26atitle%3DCaffeine%2520Therapy%2520for%2520Apnea%2520of%2520Prematurity%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26issue%3D20%26spage%3D2112%26epage%3D2121%26doi%3D10.1056%2FNEJMoa054065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsted, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzma, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. L.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Cause-Specific Mortality Association with Age at Death and Compression of Mortality</span>. <i>J. Clin. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1016/0895-4356(92)90051-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0895-4356%2892%2990051-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1619453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaK38zhsl2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1992&pages=733-742&issue=7&author=K.+D.+Lindstedauthor=J.+W.+Kuzmaauthor=J.+L.+Anderson&title=Coffee+Consumption+and+Cause-Specific+Mortality+Association+with+Age+at+Death+and+Compression+of+Mortality&doi=10.1016%2F0895-4356%2892%2990051-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality</span></div><div class="casAuthors">Lindsted K D; Kuzma J W; Anderson J L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical epidemiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">733-42</span>
        ISSN:<span class="NLM_cas:issn">0895-4356</span>.
    </div><div class="casAbstract">The relationship between reported coffee consumption and specific causes of death was examined in 9484 males enrolled in the Adventist Mortality Study in 1960 and followed through 1985.  Coffee consumption was divided into three levels: less than 1 cup per day, 1-2 cups per day, and greater than or equal to 3 cups per day.  Approximately one third of the subjects did not drink coffee.  Cause-specific mortality rates were compared using survival analysis including Cox's proportional hazard model, and controlling for potential confounders such as body mass index, heart disease and hypertension at baseline, race, physical activity, marital status, educational level, smoking history, and dietary pattern.  Inclusion of interaction terms between coffee consumption and attained age as time-dependent covariates allowed the hazard ratio to vary with age.  Univariate analyses showed a statistically significant association (p less than 0.05) for coffee consumption and mortality for most endpoints.  Multivariate analyses showed a small but statistically significant association between coffee consumption and mortality from ischemic heart disease, other cardiovascular diseases, all cardiovascular diseases, and all causes of death.  For the major causes of death, the hazard ratios decreased from about 2.5 at 30 years of age to 1.0 around 95 years of age.  These results indicate that abstinence from coffee leads to compression of mortality rather than an increase in lifespan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRU5pswIOAcyxjv2lLSLOxFfW6udTcc2ebg2zhhR3I6Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zhsl2ksA%253D%253D&md5=2fa8c808bf4130b53fc3d01ec01bcae9</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1016%2F0895-4356%2892%2990051-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0895-4356%252892%252990051-N%26sid%3Dliteratum%253Aachs%26aulast%3DLindsted%26aufirst%3DK.%2BD.%26aulast%3DKuzma%26aufirst%3DJ.%2BW.%26aulast%3DAnderson%26aufirst%3DJ.%2BL.%26atitle%3DCoffee%2520Consumption%2520and%2520Cause-Specific%2520Mortality%2520Association%2520with%2520Age%2520at%2520Death%2520and%2520Compression%2520of%2520Mortality%26jtitle%3DJ.%2520Clin.%2520Epidemiol.%26date%3D1992%26volume%3D45%26issue%3D7%26spage%3D733%26epage%3D742%26doi%3D10.1016%2F0895-4356%2892%2990051-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bidel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jousilahti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antikainen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuomilehto, J.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Risk of Total and Cardiovascular Mortality among Patients with Type 2 Diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2618</span>– <span class="NLM_lpage">2626</span>, <span class="refDoi"> DOI: 10.1007/s00125-006-0435-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs00125-006-0435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17019600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2618-2626&issue=11&author=S.+Bidelauthor=G.+Huauthor=Q.+Qiaoauthor=P.+Jousilahtiauthor=R.+Antikainenauthor=J.+Tuomilehto&title=Coffee+Consumption+and+Risk+of+Total+and+Cardiovascular+Mortality+among+Patients+with+Type+2+Diabetes&doi=10.1007%2Fs00125-006-0435-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes</span></div><div class="casAuthors">Bidel, S.; Hu, G.; Qiao, Q.; Jousilahti, P.; Antikainen, R.; Tuomilehto, J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2618-2626</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Aims/hypothesis: Higher habitual coffee drinking has been assocd. with a lower risk of developing type 2 diabetes.  The relation between coffee consumption and risk of cardiovascular disease (CVD) has been examd. in many studies, but the issue remains controversial.  This study was designed to assess the assocn. between coffee consumption and CVD mortality among patients with type 2 diabetes.  Methods: We prospectively followed 3,837 randomly ascertained Finnish patients with type 2 diabetes aged 25 to 74 years.  Coffee consumption and other study parameters were detd. at baseline.  The International Classification of Diseases was used to identify CHD, CVD and stroke cases using computerized record linkage to the national Death Registry.  The assocns. between coffee consumption at baseline and risk of total, CVD, CHD, and stroke mortality were analyzed by using Cox proportional hazards models.  Results: During the av. follow-up of 20.8 years, 1,471 deaths were recorded, of which 909 were coded as CVD, 598 as CHD and 210 as stroke.  The resp. multivariate-adjusted hazard ratios in participants who drank 0-2, 3-4, 5-6, and ≥7 cups of coffee daily were 1.00, 0.77, 0.68 and 0.70 for total mortality (P<0.001 for trend), 1.00, 0.79, 0.70 and 0.71 for CVD mortality (P=0.006 for trend), 1.00, 0.78, 0.70 and 0.63 for CHD mortality (p=0.01 for trend), and 1.00, 0.77, 0.64 and 0.90 for stroke mortality (p=0.12 for trend).  Conclusions/interpretation: In this large prospective study we found that in type 2 diabetic patients coffee drinking is assocd. with reduced total, CVD and CHD mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1FT1Qo9pV9LVg90H21EOLACvtfcHk0liTPnK6VjaVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOqsrvP&md5=afea74c732ea9c3b2026c1151dfc3eeb</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1007%2Fs00125-006-0435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-006-0435-9%26sid%3Dliteratum%253Aachs%26aulast%3DBidel%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DJousilahti%26aufirst%3DP.%26aulast%3DAntikainen%26aufirst%3DR.%26aulast%3DTuomilehto%26aufirst%3DJ.%26atitle%3DCoffee%2520Consumption%2520and%2520Risk%2520of%2520Total%2520and%2520Cardiovascular%2520Mortality%2520among%2520Patients%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetologia%26date%3D2006%26volume%3D49%26issue%3D11%26spage%3D2618%26epage%3D2626%26doi%3D10.1007%2Fs00125-006-0435-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsugane, S.</span></span> <span> </span><span class="NLM_article-title">The Impact of Green Tea and Coffee Consumption on the Reduced Risk of Stroke Incidence in Japanese Population: The Japan Public Health Center-Based Study Cohort</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1374</span>, <span class="refDoi"> DOI: 10.1161/STROKEAHA.111.677500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FSTROKEAHA.111.677500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23493733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1ehtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=1369-1374&issue=5&author=Y.+Kokuboauthor=H.+Isoauthor=I.+Saitoauthor=K.+Yamagishiauthor=H.+Yatsuyaauthor=J.+Ishiharaauthor=M.+Inoueauthor=S.+Tsugane&title=The+Impact+of+Green+Tea+and+Coffee+Consumption+on+the+Reduced+Risk+of+Stroke+Incidence+in+Japanese+Population%3A+The+Japan+Public+Health+Center-Based+Study+Cohort&doi=10.1161%2FSTROKEAHA.111.677500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of Green Tea and Coffee Consumption on the Reduced Risk of Stroke Incidence in Japanese Population: The Japan Public Health Center-Based Study Cohort</span></div><div class="casAuthors">Kokubo, Yoshihiro; Iso, Hiroyasu; Saito, Isao; Yamagishi, Kazumasa; Yatsuya, Hiroshi; Ishihara, Junko; Inoue, Manami; Tsugane, Shoichiro</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1369-1374</span>CODEN:
                <span class="NLM_cas:coden">SJCCA7</span>;
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND AND PURPOSE-: Few prospective studies have examd. the impact of both green tea and coffee consumption on strokes.  We investigated the assocn. of the combination of those consumption with stroke incidence in a general population.  METHODS-: We studied 82 369 Japanese (aged 45-74 years; without cardiovascular disease [CVD] or cancer in 1995 and 1998 for Cohort I and II, resp.) who received 13 years of mean follow-up through the end of 2007.  Green tea and coffee consumption was assessed by self-administered food frequency questionnaire at baseline.  RESULTS-: In the 1 066 718 person-years of follow-up, we documented the incidence of strokes (n=3425) and coronary heart disease (n=910).  Compared with seldom drinking green tea, the multivariable-adjusted hazard ratios (95% confidence intervals) of all strokes were 0.86 (0.78-0.95) and 0.80 (0.73-0.89) in green tea 2 to 3 and ≥4 cups/d, resp.  Higher green tea consumption was assocd. with inverse risks of CVD and strokes subtypes.  Compared with seldom drinking coffee, the multivariable-adjusted hazard ratios (95% confidence intervals) of all strokes were 0.89 (0.80-0.99), 0.80 (0.72-0.90), and 0.81 (0.72-0.91) for coffee 3 to 6 times/wk and 1 and ≥2 times/day, resp.  Coffee consumption was assocd. with an inverse risk of CVD and cerebral infarction.  Higher green tea or coffee consumption reduced the risks of CVD and stroke subtypes (esp. in intracerebral hemorrhage, P for interaction between green tea and coffee=0.04).  None of the significant assocn. was obsd. in coronary heart disease.  CONCLUSIONS-: Higher green tea and coffee consumption were inversely assocd. with risk of CVD and stroke in general population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpET44sXcXut7Vg90H21EOLACvtfcHk0liTPnK6VjaVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1ehtb4%253D&md5=d0a0eca5139ea00b8daa4674464cd0a6</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1161%2FSTROKEAHA.111.677500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FSTROKEAHA.111.677500%26sid%3Dliteratum%253Aachs%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DI.%26aulast%3DYamagishi%26aufirst%3DK.%26aulast%3DYatsuya%26aufirst%3DH.%26aulast%3DIshihara%26aufirst%3DJ.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DTsugane%26aufirst%3DS.%26atitle%3DThe%2520Impact%2520of%2520Green%2520Tea%2520and%2520Coffee%2520Consumption%2520on%2520the%2520Reduced%2520Risk%2520of%2520Stroke%2520Incidence%2520in%2520Japanese%2520Population%253A%2520The%2520Japan%2520Public%2520Health%2520Center-Based%2520Study%2520Cohort%26jtitle%3DStroke%26date%3D2013%26volume%3D44%26issue%3D5%26spage%3D1369%26epage%3D1374%26doi%3D10.1161%2FSTROKEAHA.111.677500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, I.</span></span> <span> </span><span class="NLM_article-title">Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in Japan: The Ohsaki Study</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1001/jama.296.10.1255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.296.10.1255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1GmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=1255-1265&issue=10&author=S.+Kuriyamaauthor=T.+Shimazuauthor=K.+Ohmoriauthor=N.+Kikuchiauthor=N.+Nakayaauthor=Y.+Nishinoauthor=Y.+Tsubonoauthor=I.+Tsuji&title=Green+Tea+Consumption+and+Mortality+Due+to+Cardiovascular+Disease%2C+Cancer%2C+and+All+Causes+in+Japan%3A+The+Ohsaki+Study&doi=10.1001%2Fjama.296.10.1255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. The Ohsaki Study</span></div><div class="casAuthors">Kuriyama, Shinichi; Shimazu, Taichi; Ohmori, Kaori; Kikuchi, Nobutaka; Nakaya, Naoki; Nishino, Yoshikazu; Tsubono, Yoshitaka; Tsuji, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1255-1265</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Green tea polyphenols have been extensively studied as cardiovascular disease and cancer chemopreventive agents in vitro and in animal studies.  However, the effects of green tea consumption in humans remain unclear.  The assocns. between green tea consumption and all-cause and cause-specific mortality was investigated.  The Ohsaki National Health Insurance Cohort Study, a population-based, prospective cohort study initiated in 1994 among 40 530 Japanese adults aged 40 to 79 years without history of stroke, coronary heart disease, or cancer at baseline.  Participants were followed up for up to 11 years (1995-2005) for all-cause mortality and for up to 7 years (1995-2001) for cause-specific mortality.  Mortality due to cardiovascular disease, cancer, and all causes were measured.  Over 11 years of follow-up (follow-up rate, 86.1%), 4209 participants died, and over 7 years of follow-up (follow-up rate, 89.6%), 892 participants died of cardiovascular disease and 1134 participants died of cancer.  Green tea consumption was inversely assocd. with mortality due to all causes and due to cardiovascular disease.  The inverse assocn. with all-cause mortality was stronger in women (P = .03 for interaction with sex).  In men, the multivariate hazard ratios of mortality due to all causes assocd. with different green tea consumption frequencies were 1.00 (ref.) for less than 1 cup/d, 0.93 (95% confidence interval [CI], 0.83-1.05) for 1 to 2 cups/d, 0.95 (95% CI, 0.85-1.06) for 3 to 4 cups/d, and 0.88 (95% CI, 0.79-0.98) for 5 or more cups/d, resp. (P = .03 for trend).  The corresponding data for women were 1.00, 0.98 (95% CI, 0.84-1.15), 0.82 (95% CI, 0.70-0.95), and 0.77 (95% CI, 0.67-0.89), resp. (P < .001 for trend).  The inverse assocn. with cardiovascular disease mortality was stronger than that with all-cause mortality.  This inverse assocn. was also stronger in women (P = .08 for interaction with sex).  In women, the multivariate hazard ratios of cardiovascular disease mortality across increasing green tea consumption categories were 1.00, 0.84 (95% CI, 0.63-1.12), 0.69 (95% CI, 0.52-0.93), and 0.69 (95% CI, 0.53-0.90), resp. (P = .004 for trend).  Among the types of cardiovascular disease mortality, the strongest inverse assocn. was obsd. for stroke mortality.  In contrast, the hazard ratios of cancer mortality were not significantly different from 1.00 in all green tea categories compared with the lowest-consumption category.  Green tea consumption is assocd. with reduced mortality due to all causes and due to cardiovascular disease but not with reduced mortality due to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA23k72VL9TrVg90H21EOLACvtfcHk0liCXGUAhABuhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1GmsL8%253D&md5=c8a1794a12ca0991889b23f89d45423a</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1001%2Fjama.296.10.1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.296.10.1255%26sid%3Dliteratum%253Aachs%26aulast%3DKuriyama%26aufirst%3DS.%26aulast%3DShimazu%26aufirst%3DT.%26aulast%3DOhmori%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DN.%26aulast%3DNakaya%26aufirst%3DN.%26aulast%3DNishino%26aufirst%3DY.%26aulast%3DTsubono%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DI.%26atitle%3DGreen%2520Tea%2520Consumption%2520and%2520Mortality%2520Due%2520to%2520Cardiovascular%2520Disease%252C%2520Cancer%252C%2520and%2520All%2520Causes%2520in%2520Japan%253A%2520The%2520Ohsaki%2520Study%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26issue%3D10%26spage%3D1255%26epage%3D1265%26doi%3D10.1001%2Fjama.296.10.1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yorifuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa-Takata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, H.</span></span> <span> </span><span class="NLM_article-title">Green Tea Consumption and Mortality among Japanese Elderly People: The Prospective Shizuoka Elderly Cohort</span>. <i>Ann. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/j.annepidem.2009.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.annepidem.2009.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19628408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1Mngs1ehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=732-739&issue=10&author=E.+Suzukiauthor=T.+Yorifujiauthor=S.+Takaoauthor=H.+Komatsuauthor=M.+Sugiyamaauthor=T.+Ohtaauthor=K.+Ishikawa-Takataauthor=H.+Doi&title=Green+Tea+Consumption+and+Mortality+among+Japanese+Elderly+People%3A+The+Prospective+Shizuoka+Elderly+Cohort&doi=10.1016%2Fj.annepidem.2009.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort</span></div><div class="casAuthors">Suzuki Etsuji; Yorifuji Takashi; Takao Soshi; Komatsu Hirokazu; Sugiyama Masumi; Ohta Toshiki; Ishikawa-Takata Kazuko; Doi Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Annals of epidemiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">732-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To investigate the association between green tea consumption and mortality from all causes, cancer, and cardiovascular disease (CVD) among elderly people.  METHODS:  In a population-based, prospective cohort study, a total of 14,001 elderly residents (aged 65-84 years), randomly chosen from all 74 municipalities in Shizuoka, Japan, completed questionnaires that included items about frequency of green tea consumption.  They were followed for up to 6 years, from December 1999 to March 2006.  Consequently, 12,251 subjects were analyzed to estimate the hazard ratios (HRs) for all-cause mortality, cancer, and CVD.  RESULTS:  Among 64,002 person-years, 1,224 deaths were identified (follow-up rate, 71.6%).  The multivariate HRs and 95% confidence intervals (CIs) for CVD mortality compared those who consumed seven or more cups per day with those who consumed less than one cup per day, were 0.24 (0.14-0.40), 0.30 (0.15-0.61), and 0.18 (0.08-0.40) for total participants, men, and women, respectively.  Although green tea consumption was not inversely associated with cancer mortality, green tea consumption and colorectal cancer mortality were inversely associated with a moderate dose-response relationship.  CONCLUSIONS:  Green tea consumption is associated with reduced mortality from all causes and CVD.  This study also suggests that green tea could have protective effects against colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtuwNXKmMdGjAEfvC7EH1LfW6udTcc2eYK9GpTe_XzX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mngs1ehsA%253D%253D&md5=f17f41909d39dd684b3f973edca6389f</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.annepidem.2009.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.annepidem.2009.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DE.%26aulast%3DYorifuji%26aufirst%3DT.%26aulast%3DTakao%26aufirst%3DS.%26aulast%3DKomatsu%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DIshikawa-Takata%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26atitle%3DGreen%2520Tea%2520Consumption%2520and%2520Mortality%2520among%2520Japanese%2520Elderly%2520People%253A%2520The%2520Prospective%2520Shizuoka%2520Elderly%2520Cohort%26jtitle%3DAnn.%2520Epidemiol.%26date%3D2009%26volume%3D19%26issue%3D10%26spage%3D732%26epage%3D739%26doi%3D10.1016%2Fj.annepidem.2009.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satija, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhupathiraju, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Garcia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Association of Coffee Consumption with Total and Cause-Specific Mortality in 3 Large Prospective Cohorts</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2305</span>– <span class="NLM_lpage">2315</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.115.017341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FCIRCULATIONAHA.115.017341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=26572796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2015&pages=2305-2315&issue=24&author=M.+Dingauthor=A.+Satijaauthor=S.+N.+Bhupathirajuauthor=Y.+Huauthor=Q.+Sunauthor=J.+Hanauthor=E.+Lopez-Garciaauthor=W.+Willettauthor=R.+M.+Van+Damauthor=F.+B.+Hu&title=Association+of+Coffee+Consumption+with+Total+and+Cause-Specific+Mortality+in+3+Large+Prospective+Cohorts&doi=10.1161%2FCIRCULATIONAHA.115.017341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts</span></div><div class="casAuthors">Ding, Ming; Satija, Ambika; Bhupathiraju, Shilpa N.; Hu, Yang; Sun, Qi; Han, Jiali; Lopez-Garcia, Esther; Willett, Walter; van Dam, Rob M.; Hu, Frank B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2305-2315</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: The assocn. between consumption of caffeinated and decaffeinated coffee and risk of mortality remains inconclusive.  METHODS AND RESULTS-: We examd. the assocns. of consumption of total, caffeinated, and decaffeinated coffee with risk of subsequent total and cause-specific mortality among 74 890 women in the Nurses' Health Study (NHS), 93 054 women in the Nurses' Health Study II, and 40 557 men in the Health Professionals Follow-up Study.  Coffee consumption was assessed at baseline using a semiquant. food frequency questionnaire.  During 4 690 072 person-years of follow-up, 19 524 women and 12 432 men died.  Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly assocd. with mortality.  Compared with nondrinkers, coffee consumption of 1 to 5 cups per day was assocd. with lower risk of mortality, whereas coffee consumption of more than 5 cups per day was not assocd. with risk of mortality.  However, when restricting to never smokers compared with nondrinkers, the hazard ratios (and 95% confidence intervals) of mortality were 0.94 (0.89-0.99) for 1.0 or less cup per day, 0.92 (0.87-0.97) for 1.1 to 3.0 cups per day, 0.85 (0.79-0.92) for 3.1 to 5.0 cup per day, and 0.88 (0.78-0.99) for more than 5.0 cup per day (P value for nonlinearity = 0.32; P value for trend < 0.001).  Significant inverse assocns. were obsd. for caffeinated (P value for trend < 0.001) and decaffeinated coffee (P value for trend = 0.022).  Significant inverse assocns. were obsd. between coffee consumption and deaths attributed to cardiovascular disease, neurol. diseases, and suicide.  No significant assocn. between coffee consumption and total cancer mortality was found.  CONCLUSIONS-: Higher consumption of total coffee, caffeinated coffee, and decaffeinated coffee was assocd. with lower risk of total mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKaIIbk2_pELVg90H21EOLACvtfcHk0liCXGUAhABuhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrtr3M&md5=81fb65afad8b2c5bbf85a7cec25663a5</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.115.017341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.115.017341%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DM.%26aulast%3DSatija%26aufirst%3DA.%26aulast%3DBhupathiraju%26aufirst%3DS.%2BN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLopez-Garcia%26aufirst%3DE.%26aulast%3DWillett%26aufirst%3DW.%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DAssociation%2520of%2520Coffee%2520Consumption%2520with%2520Total%2520and%2520Cause-Specific%2520Mortality%2520in%25203%2520Large%2520Prospective%2520Cohorts%26jtitle%3DCirculation%26date%3D2015%26volume%3D132%26issue%3D24%26spage%3D2305%26epage%3D2315%26doi%3D10.1161%2FCIRCULATIONAHA.115.017341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abnet, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, R.</span></span> <span> </span><span class="NLM_article-title">Association of Coffee Drinking with Total and Cause-Specific Mortality</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>366</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1891</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1112010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1056%2FNEJMoa1112010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22591295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38Xntlalsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=1891-1904&issue=20&author=N.+D.+Freedmanauthor=Y.+Parkauthor=C.+C.+Abnetauthor=A.+R.+Hollenbeckauthor=R.+Sinha&title=Association+of+Coffee+Drinking+with+Total+and+Cause-Specific+Mortality&doi=10.1056%2FNEJMoa1112010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Association of coffee drinking with total and cause-specific mortality</span></div><div class="casAuthors">Freedman, Neal D.; Park, Yikyung; Abnet, Christian C.; Hollenbeck, Albert R.; Sinha, Rashmi</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1891-1904</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Coffee is one of the most widely consumed beverages, but the assocn. between coffee consumption and the risk of death remains unclear.  METHODS We examd. the assocn. of coffee drinking with subsequent total and cause-specific mortality among 229,119 men and 173,141 women in the National Institutes of Health-AARP Diet and Health Study who were 50 to 71 years of age at baseline.  Participants with cancer, heart disease, and stroke were excluded.  Coffee consumption was assessed once at baseline.  RESULTS During 5,148,760 person-years of follow-up between 1995 and 2008, a total of 33,731 men and 18,784 women died.  In age-adjusted models, the risk of death was increased among coffee drinkers.  However, coffee drinkers were also more likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders, there was a significant inverse assocn. between coffee consumption and mortality.  Adjusted hazard ratios for death among men who drank coffee as compared with those who did not were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for drinking less than 1 cup per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups of coffee per day (P<0.001 for trend); the resp. hazard ratios among women were 1.01 (95% CI, 0.96 to 1.07), 0.95 (95% CI, 0.90 to 1.01), 0.87 (95% CI, 0.83 to 0.92), 0.84 (95% CI, 0.79 to 0.90), and 0.85 (95% CI, 0.78 to 0.93) (P<0.001 for trend).  Inverse assocns. were obsd. for deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections, but not for deaths due to cancer.  Results were similar in subgroups, including persons who had never smoked and persons who reported very good to excellent health at baseline.  CONCLUSIONS In this large prospective study, coffee consumption was inversely assocd. with total and cause-specific mortality.  Whether this was a causal or associational finding cannot be detd. from our data.  (Funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiol. and Genetics.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvkpzgWBJMnrVg90H21EOLACvtfcHk0lhGSN1X7qlsmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xntlalsr4%253D&md5=37ff9c15b8d4a508e67e23230185397f</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1112010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1112010%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DN.%2BD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DAbnet%26aufirst%3DC.%2BC.%26aulast%3DHollenbeck%26aufirst%3DA.%2BR.%26aulast%3DSinha%26aufirst%3DR.%26atitle%3DAssociation%2520of%2520Coffee%2520Drinking%2520with%2520Total%2520and%2520Cause-Specific%2520Mortality%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26issue%3D20%26spage%3D1891%26epage%3D1904%26doi%3D10.1056%2FNEJMoa1112010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnoll, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokolis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokolis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassotis, J.</span></span> <span> </span><span class="NLM_article-title">Caffeinated Beverage Intake and the Risk of Heart Disease Mortality in the Elderly: A Prospective Analysis</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1093/ajcn/85.2.392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fajcn%2F85.2.392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17284734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=392-398&issue=2&author=J.+A.+Greenbergauthor=C.+C.+Dunbarauthor=R.+Schnollauthor=R.+Kokolisauthor=S.+Kokolisauthor=J.+Kassotis&title=Caffeinated+Beverage+Intake+and+the+Risk+of+Heart+Disease+Mortality+in+the+Elderly%3A+A+Prospective+Analysis&doi=10.1093%2Fajcn%2F85.2.392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis</span></div><div class="casAuthors">Greenberg, James A.; Dunbar, Christopher C.; Schnoll, Roseanne; Kokolis, Rodamanthos; Kokolis, Spyro; Kassotis, John</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">392-398</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Motivated by the possibility that caffeine could ameliorate the effect of postprandial hypotension on a high risk of coronary events and mortality in aging, we hypothesized that caffeinated beverage consumption decreases the risk of cardiovascular disease (CVD) mortality in the elderly.  The objective of the study was to use prospective cohort study data to test whether the consumption of caffeinated beverages exhibits this protective effect.  Cox regression analyses were conducted for 426 CVD deaths that occurred during an 8.8-y follow-up in the prospective first National Health and Nutrition Examn. Survey Epidemiol. Follow-up Study.  The anal. involved 6594 participants aged 32-86 y with no history of CVD at baseline.  Participants aged ≥65 y with higher caffeinated beverage intake exhibited lower relative risk of CVD and heart disease mortality than did participants with lower caffeinated beverage intake.  It was a dose-response protective effect: the relative risk (95% CI) for heart disease mortality was 1.00 (referent), 0.77 (0.54, 1.10), 0.68 (0.49, 0.94), and 0.47 (0.32, 0.69) for <0.5, 0.5-2, 2-4, and ≥4 servings/d, resp. (P for trend = 0.003).  A similar protective effect was found for caffeine intake in mg/d.  The protective effective was found only in participants who were not severely hypertensive.  No significant protective effect was found in participants aged <65 y or in cerebrovascular disease mortality for those aged ≥65 y.  Habitual intake of caffeinated beverages provided protection against the risk of heart disease mortality among elderly participants in this prospective epidemiol. anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfC9DNc-TbrVg90H21EOLACvtfcHk0lhGSN1X7qlsmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFWhu78%253D&md5=67b584f2901c7ef8485360eb0f72597d</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F85.2.392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F85.2.392%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberg%26aufirst%3DJ.%2BA.%26aulast%3DDunbar%26aufirst%3DC.%2BC.%26aulast%3DSchnoll%26aufirst%3DR.%26aulast%3DKokolis%26aufirst%3DR.%26aulast%3DKokolis%26aufirst%3DS.%26aulast%3DKassotis%26aufirst%3DJ.%26atitle%3DCaffeinated%2520Beverage%2520Intake%2520and%2520the%2520Risk%2520of%2520Heart%2520Disease%2520Mortality%2520in%2520the%2520Elderly%253A%2520A%2520Prospective%2520Analysis%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2007%26volume%3D85%26issue%3D2%26spage%3D392%26epage%3D398%26doi%3D10.1093%2Fajcn%2F85.2.392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mineharu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamakoshi, A.</span></span> <span> </span><span class="NLM_article-title">Coffee, Green Tea, Black Tea and Oolong Tea Consumption and Risk of Mortality from Cardiovascular Disease in Japanese Men and Women</span>. <i>J. Epidemiol. Community Health</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1136/jech.2009.097311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1136%2Fjech.2009.097311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19996359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=230-240&issue=3&author=Y.+Mineharuauthor=A.+Koizumiauthor=Y.+Wadaauthor=H.+Isoauthor=Y.+Watanabeauthor=C.+Dateauthor=A.+Yamamotoauthor=S.+Kikuchiauthor=Y.+Inabaauthor=H.+Toyoshimaauthor=T.+Kondoauthor=A.+Tamakoshi&title=Coffee%2C+Green+Tea%2C+Black+Tea+and+Oolong+Tea+Consumption+and+Risk+of+Mortality+from+Cardiovascular+Disease+in+Japanese+Men+and+Women&doi=10.1136%2Fjech.2009.097311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women</span></div><div class="casAuthors">Mineharu Yohei; Koizumi Akio; Wada Yasuhiko; Iso Hiroyasu; Watanabe Yoshiyuki; Date Chigusa; Yamamoto Akio; Kikuchi Shogo; Inaba Yutaka; Toyoshima Hideaki; Kondo Takaaki; Tamakoshi Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of epidemiology and community health</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The effects of coffee and green, black and oolong teas and caffeine intake on cardiovascular disease (CVD) mortality have not been well defined in Asian countries.  METHODS:  To examine the relationship between the consumption of these beverages and risk of mortality from CVD, 76,979 individuals aged 40-79 years free of stroke, coronary heart disease (CHD) and cancer at entry were prospectively followed.  The daily consumption of beverages was assessed by questionnaires.  RESULTS:  1362 deaths were documented from strokes and 650 deaths from CHD after 1,010,787 person-years of follow-up.  Compared with non-drinkers of coffee, the multivariable HR and 95% CI for those drinking 1-6 cups/week, 1-2 cups/day and ≥ 3 cups/day were 0.78 (0.50 to 1.20), 0.67 (0.47 to 0.96) and 0.45 (0.17 to 0.87) for strokes among men (p = 0.009 for trend).  Compared with non-drinkers of green tea, the multivariable HR for those drinking 1-6 cups/week, 1-2 cups/day, 3-5 cups/day and ≥ 6 cups/day were 0.34 (0.06-1.75), 0.28 (0.07-1.11), 0.39 (0.18-0.85) and 0.42 (0.17-0.88) for CHD among women (p = 0.038 for trend).  As for oolong tea, the multivariable HR of those drinking 1-6 cups/week and ≥ 1 cups/day were 1.00 (0.65-1.55) and 0.39 (0.17-0.88) for total CVD among men (p = 0.049 for trend).  Risk reduction for total CVD across categories of caffeine intake was most prominently observed in the second highest quintile, with a 38% lower risk among men and 22% among women.  CONCLUSIONS:  Consumption of coffee, green tea and oolong tea and total caffeine intake was associated with a reduced risk of mortality from CVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfNcJfxKztMeb6AVA-44PTfW6udTcc2ebDpCQtsl26x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvVehtg%253D%253D&md5=809c5f892219634630a7093aad3a87de</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1136%2Fjech.2009.097311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjech.2009.097311%26sid%3Dliteratum%253Aachs%26aulast%3DMineharu%26aufirst%3DY.%26aulast%3DKoizumi%26aufirst%3DA.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DDate%26aufirst%3DC.%26aulast%3DYamamoto%26aufirst%3DA.%26aulast%3DKikuchi%26aufirst%3DS.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DToyoshima%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DTamakoshi%26aufirst%3DA.%26atitle%3DCoffee%252C%2520Green%2520Tea%252C%2520Black%2520Tea%2520and%2520Oolong%2520Tea%2520Consumption%2520and%2520Risk%2520of%2520Mortality%2520from%2520Cardiovascular%2520Disease%2520in%2520Japanese%2520Men%2520and%2520Women%26jtitle%3DJ.%2520Epidemiol.%2520Community%2520Health%26date%3D2011%26volume%3D65%26issue%3D3%26spage%3D230%26epage%3D240%26doi%3D10.1136%2Fjech.2009.097311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakizaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori-Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hozawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, I.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Japanese Women</span>. <i>J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.3945/jn.109.109314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3945%2Fjn.109.109314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20335629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=1007-1013&issue=5&author=K.+Sugiyamaauthor=S.+Kuriyamaauthor=M.+Akhterauthor=M.+Kakizakiauthor=N.+Nakayaauthor=K.+Ohmori-Matsudaauthor=T.+Shimazuauthor=M.+Nagaiauthor=Y.+Sugawaraauthor=A.+Hozawaauthor=A.+Fukaoauthor=I.+Tsuji&title=Coffee+Consumption+and+Mortality+Due+to+All+Causes%2C+Cardiovascular+Disease%2C+and+Cancer+in+Japanese+Women&doi=10.3945%2Fjn.109.109314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women</span></div><div class="casAuthors">Sugiyama, Kemmyo; Kuriyama, Shinichi; Akhter, Munira; Kakizaki, Masako; Nakaya, Naoki; Ohmori-Matsuda, Kaori; Shimazu, Taichi; Nagai, Masato; Sugawara, Yumi; Hozawa, Atsushi; Fukao, Akira; Tsuji, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1007-1013</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Coffee contains various compds. that have recently been reported to exert beneficial health effects.  However, the conclusion of its relation with mortality has not yet been reached.  In this study, we aimed to investigate the assocns. between coffee consumption and all-cause and cause-specific mortality in Japan.  We included 37,742 participants (18,287 men and 19,455 women) aged 40-64 y without a history of cancer, myocardial infarction, or stroke at baseline in our anal., based on the Miyagi Cohort Study initiated in 1990.  The outcomes were mortality due to all causes, cardiovascular disease (CVD), and cancer.  During the 10.3 y of follow-up, 2454 participants died, including 426 due to CVD and 724 due to cancer.  In women, the multivariate hazard ratios (HR) (95% CI) for all-cause mortality in participants who drank coffee never, occasionally, 1-2 cups (150-300 mL)/d, and ≥3 cups/d were 1.00, 0.88 (0.73-1.06), 0.82 (0.66-1.02), and 0.75 (0.53-1.05), resp. (P-trend = 0.04).  For CVD mortality in women, the multivariate HR (95% CI) were 1.00, 0.56 (0.36-0.86), 0.48 (0.29-0.80), and 0.45 (0.20-1.03), resp. (P-trend = 0.006).  Of the specific CVD diseases, there was a strong inverse assocn. between coffee consumption and mortality due to coronary heart disease (CHD) in women (P-trend = 0.02) but not in men.  Death due to cancer was not assocd. with coffee consumption in either men or women, except for colorectal cancer in women.  Our results suggest that coffee may have favorable effects on morality due to all causes and to CVD, esp. CHD, in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgzgfVUXlWjrVg90H21EOLACvtfcHk0lhsg2dKt3czVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWrtr4%253D&md5=3654dc2f8c3d4620d3369a843276162a</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.3945%2Fjn.109.109314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3945%252Fjn.109.109314%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DK.%26aulast%3DKuriyama%26aufirst%3DS.%26aulast%3DAkhter%26aufirst%3DM.%26aulast%3DKakizaki%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DN.%26aulast%3DOhmori-Matsuda%26aufirst%3DK.%26aulast%3DShimazu%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DM.%26aulast%3DSugawara%26aufirst%3DY.%26aulast%3DHozawa%26aufirst%3DA.%26aulast%3DFukao%26aufirst%3DA.%26aulast%3DTsuji%26aufirst%3DI.%26atitle%3DCoffee%2520Consumption%2520and%2520Mortality%2520Due%2520to%2520All%2520Causes%252C%2520Cardiovascular%2520Disease%252C%2520and%2520Cancer%2520in%2520Japanese%2520Women%26jtitle%3DJ.%2520Nutr.%26date%3D2010%26volume%3D140%26issue%3D5%26spage%3D1007%26epage%3D1013%26doi%3D10.3945%2Fjn.109.109314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomhoff, R.</span></span> <span> </span><span class="NLM_article-title">Consumption of Coffee Is Associated with Reduced Risk of Death Attributed to Inflammatory and Cardiovascular Diseases in the Iowa Women’s Health Study</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1093/ajcn/83.5.1039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fajcn%2F83.5.1039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16685044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvFOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1039-1046&issue=5&author=L.+F.+Andersenauthor=D.+R.+Jacobsauthor=M.+H.+Carlsenauthor=R.+Blomhoff&title=Consumption+of+Coffee+Is+Associated+with+Reduced+Risk+of+Death+Attributed+to+Inflammatory+and+Cardiovascular+Diseases+in+the+Iowa+Women%E2%80%99s+Health+Study&doi=10.1093%2Fajcn%2F83.5.1039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study</span></div><div class="casAuthors">Andersen, Lene Frost; Jacobs, David R., Jr.; Carlsen, Monica H.; Blomhoff, Rune</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1039-1046</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutrition</span>)
        </div><div class="casAbstract">Coffee is the major source of dietary antioxidants.  The assocn. between coffee consumption and risk of death from diseases assocd. with inflammatory or oxidative stress has not been studied.  We studied the relation of coffee drinking with total mortality and mortality attributed to cardiovascular disease, cancer, and other diseases with a major inflammatory component.  A total of 41,836 postmenopausal women aged 55-69 yr at baseline were followed for 15 yr.  After exclusions for cardiovascular disease, cancer, diabetes, colitis, and liver cirrhosis at baseline, 27,312 participants remained, resulting in 410,235 person-years of follow-up and 4265 deaths.  The major outcome measure was disease-specific mortality.  In the fully adjusted model, similar to the relation of coffee intake to total mortality, the hazard ratio of death attributed to cardiovascular disease was 0.76 (95% CI: 0.64, 0.91) for consumption of 1-3 cups/d, 0.81 (95% CI: 0.66, 0.99) for 4-5 cups/d, and 0.87 (95% CI: 0.69, 1.09) for ≥6 cups/d.  The hazard ratio for death from other inflammatory diseases was 0.72 (95% CI: 0.55, 0.93) for consumption of 1-3 cups/d, 0.67 (95% CI: 0.50, 0.90) for 4-5 cups/d, and 0.68 (95% CI: 0.49, 0.94) for ≥6 cups/d.  Consumption of coffee, a major source of dietary antioxidants, may inhibit inflammation and thereby reduce the risk of cardiovascular and other inflammatory diseases in postmenopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmMzFvNbakKrVg90H21EOLACvtfcHk0lhsg2dKt3czVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvFOrsLk%253D&md5=6f50c58baa8fad9a2ca123db4e4683eb</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F83.5.1039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F83.5.1039%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DL.%2BF.%26aulast%3DJacobs%26aufirst%3DD.%2BR.%26aulast%3DCarlsen%26aufirst%3DM.%2BH.%26aulast%3DBlomhoff%26aufirst%3DR.%26atitle%3DConsumption%2520of%2520Coffee%2520Is%2520Associated%2520with%2520Reduced%2520Risk%2520of%2520Death%2520Attributed%2520to%2520Inflammatory%2520and%2520Cardiovascular%2520Diseases%2520in%2520the%2520Iowa%2520Women%25E2%2580%2599s%2520Health%2520Study%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2006%26volume%3D83%26issue%3D5%26spage%3D1039%26epage%3D1046%26doi%3D10.1093%2Fajcn%2F83.5.1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Happonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Läärä, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltunen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luukinen, H.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Mortality in a 14-Year Follow-up of an Elderly Northern Finnish Population</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1354</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1017/S0007114507871650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1017%2FS0007114507871650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18062826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFaku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1354-1361&issue=6&author=P.+Happonenauthor=E.+L%C3%A4%C3%A4r%C3%A4author=L.+Hiltunenauthor=H.+Luukinen&title=Coffee+Consumption+and+Mortality+in+a+14-Year+Follow-up+of+an+Elderly+Northern+Finnish+Population&doi=10.1017%2FS0007114507871650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population</span></div><div class="casAuthors">Happonen, Pertti; Laara, Esa; Hiltunen, Liisa; Luukinen, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1354-1361</span>CODEN:
                <span class="NLM_cas:coden">BJNUAV</span>;
        ISSN:<span class="NLM_cas:issn">0007-1145</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The present study assessed the relationship between coffee consumption and mortality in a home-dwelling elderly population.  A population-based cohort of 817 men and women born in 1920 or earlier and living in northern Finland provided complete data on daily coffee consumption and other variables at the baseline examn. in 1991-1992.  Deaths were monitored through to the end of 2005 by national death certificates, resulting in 6960 person-years of follow-up.  Hazard rate ratios for mortality by daily coffee intake were estd. by Poisson regression models adjusted for some known predictors of mortality.  During 14·5 years of follow-up, 623 deaths occurred.  The total mortality rate was inversely related to the no. of cups (av. vol., 125 mL) of coffee consumed daily.  After adjustment for age, sub-period of follow-up, sex, marital status, basic educational level, previous occupational group, current smoking, BMI, history of myocardial infarction, self-rated health and presence of diabetes, cognitive impairment or phys. disability, the estd. relative risk redn. of total mortality per an increment of one more cup of coffee per d reported at baseline was 4 (95 % CI 0, 8) %.  The obsd. assocns. between coffee consumption and mortality from CVD, cancer, and other or unknown causes, resp., were qual. similar to that of total mortality but the ests. were less precise.  The effect of coffee consumption at baseline appeared to attenuate after 10 years since the start of follow-up.  The present study provides evidence for daily (caffeine-contg.) coffee intake being inversely assocd. with mortality in the elderly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTpEr5OWHtQbVg90H21EOLACvtfcHk0lhsg2dKt3czVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFaku7g%253D&md5=ef15536217a98d44fcfb24e4fbc864f3</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1017%2FS0007114507871650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114507871650%26sid%3Dliteratum%253Aachs%26aulast%3DHapponen%26aufirst%3DP.%26aulast%3DL%25C3%25A4%25C3%25A4r%25C3%25A4%26aufirst%3DE.%26aulast%3DHiltunen%26aufirst%3DL.%26aulast%3DLuukinen%26aufirst%3DH.%26atitle%3DCoffee%2520Consumption%2520and%2520Mortality%2520in%2520a%252014-Year%2520Follow-up%2520of%2520an%2520Elderly%2520Northern%2520Finnish%2520Population%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2008%26volume%3D99%26issue%3D6%26spage%3D1354%26epage%3D1361%26doi%3D10.1017%2FS0007114507871650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjelke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuch, I.</span></span> <span> </span><span class="NLM_article-title">Coffee Drinking, Mortality, and Cancer Incidence: Results from a Norwegian Prospective Study</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1093/jnci/76.5.823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1093%2Fjnci%2F76.5.823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3457969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL283gtFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1986&pages=823-831&issue=5&author=B.+K.+Jacobsenauthor=E.+Bjelkeauthor=G.+Kvaleauthor=I.+Heuch&title=Coffee+Drinking%2C+Mortality%2C+and+Cancer+Incidence%3A+Results+from+a+Norwegian+Prospective+Study&doi=10.1093%2Fjnci%2F76.5.823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study</span></div><div class="casAuthors">Jacobsen B K; Bjelke E; Kvale G; Heuch I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-31</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">Relationships between coffee consumption and occurrence of cancer as well as mortality were explored in a Norwegian study of 13,664 men and 2,891 women who in 1967-69 reported their coffee consumption.  No statistically significant positive associations were found between coffee consumption and disease.  A weak negative association was found with total cancer incidence even when the first 4 of the 11 1/2 years of follow-up were excluded, and strong negative associations with coffee drinking were noted for cancer of the kidney and nonmelanoma skin cancer.  For cancer of the pancreas and bladder, no increase in incidence was found among those with a high coffee consumption.  In subjects less than 65 years of age at start of follow-up, coffee drinking showed a significant inverse association with colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmloqQcarDdEodMGTatQ7LfW6udTcc2eZaQ-7sG87zJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL283gtFajsg%253D%253D&md5=1fd5c742c3860b3d5444db3ed4d65f6c</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F76.5.823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F76.5.823%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DB.%2BK.%26aulast%3DBjelke%26aufirst%3DE.%26aulast%3DKvale%26aufirst%3DG.%26aulast%3DHeuch%26aufirst%3DI.%26atitle%3DCoffee%2520Drinking%252C%2520Mortality%252C%2520and%2520Cancer%2520Incidence%253A%2520Results%2520from%2520a%2520Norwegian%2520Prospective%2520Study%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1986%26volume%3D76%26issue%3D5%26spage%3D823%26epage%3D831%26doi%3D10.1093%2Fjnci%2F76.5.823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazbec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šimić, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čorović, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraković, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlović, M.</span></span> <span> </span><span class="NLM_article-title">Impact of Coffee and Other Selected Factors on General Mortality and Mortality Due to Cardiovascular Disease in Croatia</span>. <i>J. Heal. Popul. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.3329/jhpn.v21i4.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3329%2Fjhpn.v21i4.226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15038588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2c7ksFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=332-340&issue=4&author=A.+Jazbecauthor=D.+%C5%A0imi%C4%87author=N.+%C4%8Corovi%C4%87author=Z.+Durakovi%C4%87author=M.+Pavlovi%C4%87&title=Impact+of+Coffee+and+Other+Selected+Factors+on+General+Mortality+and+Mortality+Due+to+Cardiovascular+Disease+in+Croatia&doi=10.3329%2Fjhpn.v21i4.226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia</span></div><div class="casAuthors">Jazbec Anamarija; Simic Diana; Corovic Naima; Durakovic Zijad; Pavlovic Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of health, population, and nutrition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-40</span>
        ISSN:<span class="NLM_cas:issn">1606-0997</span>.
    </div><div class="casAbstract">In Croatia, the mortality rate is higher than that in the countries of the European Union (EU), and consumption of coffee is moderate compared to the EU countries.  The study examined the effects of coffee consumption on all-cause (general) mortality, mortality due to cardiovascular disease, and survival.  Analyses were based on data obtained from an epidemiological longitudinal study started in 1969 with follow-ups in 1972, including 1,571 men and 1,793 women aged 35-59 years, and in 1982, including 1,093 men and 1,330 women.  The sample was age- and gender-stratified and included urban and rural populations from three coastal and three continental regions of Croatia.  During the observation period from spring 1972 to the end of 1999, 568 men and 382 women died.  In total, 254 men and 181 women died due to cardiovascular disease.  The sample was classified in 4 groups: non-drinkers, consumption of coffee sometimes, regularly 1-2 cup(s), and regularly more than 2 cups per day.  Apart from coffee, the effects of diastolic blood pressure, smoking habit, well-being, stomach ulcer, and resident status were analyzed.  Data on general mortality and mortality due to cardiovascular disease were also analyzed.  The influence of region and the effects of diastolic pressure and smoking habit on general mortality and cardiovascular disease-associated mortality were confirmed in both the sexes.  No significant effects of coffee consumption on general mortality and mortality due to cardiovascular disease were found among men.  Positive effects of coffee on general mortality (p = 0.0089) but not on cardiovascular disease-associated mortality were observed among women.  Women who regularly drank coffee 1-2 cup(s) per day had a significantly lower risk of all-cause death adjusted for age, region, smoking, diastolic blood pressure, feeling of well-being, and history of stomach ulcer (relative risk = 0.631; p = 0.0033; confidence interval: 0.464-0.857).  The role of coffee consumption on mortality was less relevant than other variables.  However, it cannot be completely neglected in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnYoqWgtS-nzC850By6mxpfW6udTcc2ebgOQiTf2cvF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7ksFeitQ%253D%253D&md5=460b78ae3ba531a9fc51ac5ad34d7935</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.3329%2Fjhpn.v21i4.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3329%252Fjhpn.v21i4.226%26sid%3Dliteratum%253Aachs%26aulast%3DJazbec%26aufirst%3DA.%26aulast%3D%25C5%25A0imi%25C4%2587%26aufirst%3DD.%26aulast%3D%25C4%258Corovi%25C4%2587%26aufirst%3DN.%26aulast%3DDurakovi%25C4%2587%26aufirst%3DZ.%26aulast%3DPavlovi%25C4%2587%26aufirst%3DM.%26atitle%3DImpact%2520of%2520Coffee%2520and%2520Other%2520Selected%2520Factors%2520on%2520General%2520Mortality%2520and%2520Mortality%2520Due%2520to%2520Cardiovascular%2520Disease%2520in%2520Croatia%26jtitle%3DJ.%2520Heal.%2520Popul.%2520Nutr.%26date%3D2003%26volume%3D21%26issue%3D4%26spage%3D332%26epage%3D340%26doi%3D10.3329%2Fjhpn.v21i4.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Garcia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Artalejo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">The Relationship of Coffee Consumption with Mortality</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-148-12-200806170-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.7326%2F0003-4819-148-12-200806170-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18559841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1czpt12gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2008&pages=904-914&issue=12&author=E.+Lopez-Garciaauthor=R.+M.+Van+Damauthor=T.+Y.+Liauthor=F.+Rodriguez-Artalejoauthor=F.+B.+Hu&title=The+Relationship+of+Coffee+Consumption+with+Mortality&doi=10.7326%2F0003-4819-148-12-200806170-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of coffee consumption with mortality</span></div><div class="casAuthors">Lopez-Garcia Esther; van Dam Rob M; Li Tricia Y; Rodriguez-Artalejo Fernando; Hu Frank B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">904-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Coffee consumption has been linked to various beneficial and detrimental health effects, but data on its relation with mortality are sparse.  OBJECTIVE:  To assess the association between coffee consumption and mortality from cardiovascular disease (CVD), cancer, and all causes during 18 years of follow-up in men and 24 years of follow-up in women.  DESIGN:  Sex-specific Cox proportional hazard models were used to investigate the association between coffee consumption and incidence of all-cause and disease-specific mortality in a prospective cohort study.  SETTING:  Health Professionals Follow-up Study and Nurses' Health Study.  PARTICIPANTS:  41,736 men and 86,214 women with no history of CVD or cancer at baseline.  MEASUREMENTS:  Coffee consumption was assessed first in 1986 for men and in 1980 for women and then every 2 to 4 years through 2004.  Investigators documented 6888 deaths (2049 due to CVD and 2491 due to cancer) among men and 11,095 deaths (2368 due to CVD and 5011 due to cancer) among women.  RESULTS:  After adjustment for age, smoking, and other CVD and cancer risk factors, the relative risks for all-cause mortality in men across categories of coffee consumption (<1 cup per month, 1 cup per month to 4 cups per week, 5 to 7 cups per week, 2 to 3 cups per day, 4 to 5 cups per day, and >or=6 cups per day) were 1.0, 1.07 (95% CI, 0.99 to 1.16), 1.02 (CI, 0.95 to 1.11), 0.97 (CI, 0.89 to 1.05), 0.93 (CI, 0.81 to 1.07), and 0.80 (CI, 0.62 to 1.04), respectively (P for trend = 0.008).  For women, the relative risks were 1.0, 0.98 (CI, 0.91 to 1.05), 0.93 (CI, 0.87 to 0.98), 0.82 (CI, 0.77 to 0.87), 0.74 (CI, 0.68 to 0.81), and 0.83 (CI, 0.73 to 0.95), respectively (P for trend < 0.001).  This inverse association was mainly due to a moderately reduced risk for CVD mortality and was independent of caffeine intake.  By contrast, coffee consumption was not statistically significantly associated with risk for cancer death after adjustment for potential confounders.  Decaffeinated coffee consumption was associated with a small reduction in all-cause and CVD mortality.  LIMITATION:  Coffee consumption was estimated from self-report; thus, some measurement error is inevitable.  CONCLUSION:  Regular coffee consumption was not associated with an increased mortality rate in either men or women.  The possibility of a modest benefit of coffee consumption on all-cause and CVD mortality needs to be further investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnsiFnd6fIPOxsqfvU0ziafW6udTcc2ebgOQiTf2cvF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czpt12gtw%253D%253D&md5=67b57e5b9753dd234c00b53eba7b0fa9</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-148-12-200806170-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-148-12-200806170-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Garcia%26aufirst%3DE.%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DLi%26aufirst%3DT.%2BY.%26aulast%3DRodriguez-Artalejo%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DThe%2520Relationship%2520of%2520Coffee%2520Consumption%2520with%2520Mortality%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2008%26volume%3D148%26issue%3D12%26spage%3D904%26epage%3D914%26doi%3D10.7326%2F0003-4819-148-12-200806170-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annegers, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curb, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span> <span> </span><span class="NLM_article-title">Mortality Patterns among Hypertensives by Reported Level of Caffeine Consumption</span>. <i>Prev. Med.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/0091-7435(88)90006-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2F0091-7435%2888%2990006-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=3043418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL1czgtlyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1988&pages=310-320&issue=3&author=J.+B.+Martinauthor=J.+F.+Annegersauthor=J.+D.+Curbauthor=S.+Heydenauthor=C.+Howsonauthor=E.+S.+Leeauthor=M.+Lee&title=Mortality+Patterns+among+Hypertensives+by+Reported+Level+of+Caffeine+Consumption&doi=10.1016%2F0091-7435%2888%2990006-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality patterns among hypertensives by reported level of caffeine consumption</span></div><div class="casAuthors">Martin J B; Annegers J F; Curb J D; Heyden S; Howson C; Lee E S; Lee M</div><div class="citationInfo"><span class="NLM_cas:title">Preventive medicine</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-20</span>
        ISSN:<span class="NLM_cas:issn">0091-7435</span>.
    </div><div class="casAbstract">The effect of caffeine consumption on mortality was evaluated in a historical cohort study of 10,064 diagnosed hypertensive individuals participating in the Hypertension Detection and Follow-up Program from 1973 to 1979.  Total caffeine intake level from beverages (coffee and tea) and certain medications, was estimated at the 1-year visit.  No evidence was found supporting an association between increased level of caffeine consumption and increased all-cause mortality or cardiovascular disease mortality during the following 4 years.  Cigarette smoking was significantly associated with mortality; the association being more pronounced among non- and low-caffeine consumers for all-cause mortality and among non-caffeine consumers for all cardiovascular mortality except cerebrovascular mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGHrYRt2cOHBJ5E29YNGvQfW6udTcc2ebgOQiTf2cvF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1czgtlyhsw%253D%253D&md5=b559d6238e1b36021179a0f36c9ddc78</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1016%2F0091-7435%2888%2990006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-7435%252888%252990006-0%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DJ.%2BB.%26aulast%3DAnnegers%26aufirst%3DJ.%2BF.%26aulast%3DCurb%26aufirst%3DJ.%2BD.%26aulast%3DHeyden%26aufirst%3DS.%26aulast%3DHowson%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DM.%26atitle%3DMortality%2520Patterns%2520among%2520Hypertensives%2520by%2520Reported%2520Level%2520of%2520Caffeine%2520Consumption%26jtitle%3DPrev.%2520Med.%26date%3D1988%26volume%3D17%26issue%3D3%26spage%3D310%26epage%3D320%26doi%3D10.1016%2F0091-7435%2888%2990006-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paganini-Hill, A.</span></span> <span> </span><span class="NLM_article-title">Lifestyle Practices and Cardiovascular Disease Mortality in the Elderly: The Leisure World Cohort Study</span>. <i>Cardiol. Res. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">983764</span>, <span class="refDoi"> DOI: 10.4061/2011/983764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4061%2F2011%2F983764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21274456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ltVCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=983764&issue=1&author=A.+Paganini-Hill&title=Lifestyle+Practices+and+Cardiovascular+Disease+Mortality+in+the+Elderly%3A+The+Leisure+World+Cohort+Study&doi=10.4061%2F2011%2F983764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Lifestyle practices and cardiovascular disease mortality in the elderly: the leisure world cohort study</span></div><div class="casAuthors">Paganini-Hill Annlia</div><div class="citationInfo"><span class="NLM_cas:title">Cardiology research and practice</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">983764</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Modifiable behavioral risk factors are major contributing causes of death, but whether the effects are maintained in older adults is uncertain.  We explored the association of smoking, alcohol consumption, caffeine intake, physical activity, and body mass index on cardiovascular disease (CVD) mortality in 13,296 older adults and calculated risk estimates using Cox regression analysis in four age groups (<70, 70-74, 75-79, and 80+ years).  The most important factor was current smoking, which increased risk in all age-sex groups.  In women, alcohol consumption (≤3 drinks/day) was related to decreased (15-30%) risk in those <80 years old; in men, 4+ drinks/day was associated with reduced (15-30%) risk.  Active 70+ year olds had 20-40% lower risk.  Both underweight and obese women were at increased risk.  Lifestyle practices impact CVD death rates in older adults, even those aged 80+ years.  Not smoking, moderate alcohol consumption, physical activity, and normal weight are important health promoters in our aging population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3q23NVQS6dsvLc4ARHEmzfW6udTcc2eaDFqVb1ORWyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ltVCitg%253D%253D&md5=e45d54216f419c343364204a77356ab5</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.4061%2F2011%2F983764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F983764%26sid%3Dliteratum%253Aachs%26aulast%3DPaganini-Hill%26aufirst%3DA.%26atitle%3DLifestyle%2520Practices%2520and%2520Cardiovascular%2520Disease%2520Mortality%2520in%2520the%2520Elderly%253A%2520The%2520Leisure%2520World%2520Cohort%2520Study%26jtitle%3DCardiol.%2520Res.%2520Pract.%26date%3D2011%26volume%3D2011%26issue%3D1%26spage%3D983764%26doi%3D10.4061%2F2011%2F983764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silletta, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfisi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levantesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boccanelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chieffo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggioni, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchioli, R.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption and Risk of Cardiovascular Events after Acute Myocardial Infarction: Results from the GISSI (Gruppo Italiano per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico)-Prevenzione Trial</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">2944</span>– <span class="NLM_lpage">2951</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.712976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FCIRCULATIONAHA.107.712976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=18056527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWjsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=2944-2951&issue=25&author=M.+G.+Sillettaauthor=R.+Marfisiauthor=G.+Levantesiauthor=A.+Boccanelliauthor=C.+Chieffoauthor=M.+Franzosiauthor=E.+Geraciauthor=A.+P.+Maggioniauthor=G.+Nicolosiauthor=C.+Schweigerauthor=L.+Tavazziauthor=G.+Tognoniauthor=R.+Marchioli&title=Coffee+Consumption+and+Risk+of+Cardiovascular+Events+after+Acute+Myocardial+Infarction%3A+Results+from+the+GISSI+%28Gruppo+Italiano+per+Lo+Studio+Della+Sopravvivenza+Nell%E2%80%99Infarto+Miocardico%29-Prevenzione+Trial&doi=10.1161%2FCIRCULATIONAHA.107.712976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption and risk of cardiovascular events after acute myocardial infarction: Results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione Trial</span></div><div class="casAuthors">Silletta, Maria Giuseppina; Marfisi, RosaMaria; Levantesi, Giacomo; Boccanelli, Alessandro; Chieffo, Carmelo; Franzosi, MariaGrazia; Geraci, Enrico; Maggioni, Aldo Pietro; Nicolosi, Gianluigi; Schweiger, Carlo; Tavazzi, Luigi; Tognoni, Gianni; Marchioli, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2944-2951</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background- The relation between coffee consumption and cardiovascular disease has been studied extensively, but results are still debated.  In addn., little evidence is available on patients with established coronary heart disease.  Methods and Results- Prospectively ascertained information among 11 231 Italian patients (9584 males and 1647 females) with recent (≤3 mo) myocardial infarction enrolled in the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial was used.  Usual dietary habits were assessed at baseline and updated at 0.5 and 1.5 years.  Coffee consumption was categorized as never/almost never, <2 cups per day, 2 to 4 cups per day, and >4 cups per day.  Medication use and fasting glucose were assessed at 0.5, 1, 1.5, 2.5, and 3.5 years.  Risk was evaluated with Cox proportional hazards with time-varying covariates.  The main outcome measure was the cumulative incidence of cardiovascular events (cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke).  A total of 1167 cardiovascular events occurred during 36 961 person-years of follow-up.  After multivariable adjustment for potential confounders in the time-dependent anal., the relative risk of cardiovascular events across categories of coffee consumption was 1.02 (95% CI 0.87 to 1.20) for <2 cups per day, 0.91 (95% CI 0.75 to 1.09) for 2 to 4 cups per day, and 0.88 (95% CI 0.64 to 1.20) for >4 cups per day compared with abstainers (P for trend=0.18).  Ultimately, coffee consumption did not change the risk of coronary heart disease events, stroke, and sudden death.  Conclusions- No assocn. between moderate coffee intake and cardiovascular events was obsd. in post-myocardial infarction patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGognzT3a-JLUbVg90H21EOLACvtfcHk0lj-zuOotnabEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWjsr7I&md5=6f040d8dfb6ca43dd327a5ecf35e3a32</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.712976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.712976%26sid%3Dliteratum%253Aachs%26aulast%3DSilletta%26aufirst%3DM.%2BG.%26aulast%3DMarfisi%26aufirst%3DR.%26aulast%3DLevantesi%26aufirst%3DG.%26aulast%3DBoccanelli%26aufirst%3DA.%26aulast%3DChieffo%26aufirst%3DC.%26aulast%3DFranzosi%26aufirst%3DM.%26aulast%3DGeraci%26aufirst%3DE.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26aulast%3DNicolosi%26aufirst%3DG.%26aulast%3DSchweiger%26aufirst%3DC.%26aulast%3DTavazzi%26aufirst%3DL.%26aulast%3DTognoni%26aufirst%3DG.%26aulast%3DMarchioli%26aufirst%3DR.%26atitle%3DCoffee%2520Consumption%2520and%2520Risk%2520of%2520Cardiovascular%2520Events%2520after%2520Acute%2520Myocardial%2520Infarction%253A%2520Results%2520from%2520the%2520GISSI%2520%2528Gruppo%2520Italiano%2520per%2520Lo%2520Studio%2520Della%2520Sopravvivenza%2520Nell%25E2%2580%2599Infarto%2520Miocardico%2529-Prevenzione%2520Trial%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26issue%3D25%26spage%3D2944%26epage%3D2951%26doi%3D10.1161%2FCIRCULATIONAHA.107.712976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, P. W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannel, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelli, W. P.</span></span> <span> </span><span class="NLM_article-title">Is Coffee Consumption a Contributor to Cardiovascular Disease? Insights from the Framingham Study</span>. <i>Arch. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1001/archinte.149.5.1169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Farchinte.1989.00390050125025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=2719508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADyaL1M3ksF2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1989&pages=1169-1172&issue=5&author=P.+W.+F.+Wilsonauthor=R.+J.+Garrisonauthor=W.+B.+Kannelauthor=D.+L.+McGeeauthor=W.+P.+Castelli&title=Is+Coffee+Consumption+a+Contributor+to+Cardiovascular+Disease%3F+Insights+from+the+Framingham+Study&doi=10.1001%2Farchinte.149.5.1169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study</span></div><div class="casAuthors">Wilson P W; Garrison R J; Kannel W B; McGee D L; Castelli W P</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1169-72</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">Reported coffee consumption during 1954 to 1958 and 1971 to 1973 was used to test for association with cardiovascular disease (CVD) incidence and lipid values in the Framingham cohort.  Multivariate analysis was employed, regressing CVD on age, systolic pressure, cigarette use, body mass index, total cholesterol, and coffee intake.  In pooled analyses (2648 men with 549 CVD cases and 3566 women with 462 CVD cases) coffee intake was not associated with CVD incidence in either smokers or nonsmokers, irrespective of sex.  Similarly, multivariate analyses for individuals with existing cardiovascular disease showed no association between coffee intake and subsequent cardiovascular disease.  In men significant negative associations between coffee and total cholesterol, and very-low-density lipoprotein cholesterol were seen, whereas in women positive associations with low-density lipoprotein cholesterol were observed.  Although inconsistent effects on the lipid profile were seen, no increase in primary or secondary CVD was seen with coffee drinking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIus0oc_XleCnGiHuhFGv8fW6udTcc2eaDFqVb1ORWyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ksF2hsA%253D%253D&md5=a4fb53a024886eee0d82d3aea5cda608</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1001%2Farchinte.1989.00390050125025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.1989.00390050125025%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DP.%2BW.%2BF.%26aulast%3DGarrison%26aufirst%3DR.%2BJ.%26aulast%3DKannel%26aufirst%3DW.%2BB.%26aulast%3DMcGee%26aufirst%3DD.%2BL.%26aulast%3DCastelli%26aufirst%3DW.%2BP.%26atitle%3DIs%2520Coffee%2520Consumption%2520a%2520Contributor%2520to%2520Cardiovascular%2520Disease%253F%2520Insights%2520from%2520the%2520Framingham%2520Study%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1989%26volume%3D149%26issue%3D5%26spage%3D1169%26epage%3D1172%26doi%3D10.1001%2Farchinte.149.5.1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhupathiraju, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satija, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>129</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.113.005925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1161%2FCIRCULATIONAHA.113.005925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24201300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisF2kt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=643-659&issue=6&author=M.+Dingauthor=S.+N.+Bhupathirajuauthor=A.+Satijaauthor=R.+M.+Van+Damauthor=F.+B.+Hu&title=Long-Term+Coffee+Consumption+and+Risk+of+Cardiovascular+Disease%3A+A+Systematic+Review+and+a+Dose-Response+Meta-Analysis+of+Prospective+Cohort+Studies&doi=10.1161%2FCIRCULATIONAHA.113.005925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies</span></div><div class="casAuthors">Ding, Ming; Bhupathiraju, Shilpa N.; Satija, Ambika; van Dam, Rob M.; Hu, Frank B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">643-659</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: Considerable controversy exists on the assocn. between coffee consumption and cardiovascular disease (CVD) risk.  A meta-anal. was performed to assess the dose-response relationship of long-term coffee consumption with CVD risk.  METHODS AND RESULTS-: PubMed and EMBASE were searched for prospective cohort studies of the relationship between coffee consumption and CVD risk, which included coronary heart disease, stroke, heart failure, and CVD mortality.  Thirty-six studies were included with 1 279 804 participants and 36 352 CVD cases.  A nonlinear relationship of coffee consumption with CVD risk was identified (P for heterogeneity=0.09, P for trend <0.001, P for nonlinearity <0.001).  Compared with the lowest category of coffee consumption (median, 0 cups per day), the relative risk of CVD was 0.95 (95% confidence interval, 0.87-1.03) for the highest category (median, 5 cups per day) category, 0.85 (95% confidence interval, 0.80-0.90) for the second highest category (median, 3.5 cups per day), and 0.89 (95% confidence interval, 0.84-0.94) for the third highest category (median, 1.5 cups per day).  Looking at sep. outcomes, coffee consumption was nonlinearly assocd. with both coronary heart disease (P for heterogeneity=0.001, P for trend <0.001, P for nonlinearity <0.001) and stroke (P for heterogeneity=0.07, P for trend <0.001, P for nonlinearity <0.001; P for trend differences >0.05) risks.  CONCLUSIONS-: A nonlinear assocn. between coffee consumption and CVD risk was obsd. in this meta-anal.  Moderate coffee consumption was inversely significantly assocd. with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not assocd. with elevated CVD risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxzV3Ypxq8a7Vg90H21EOLACvtfcHk0lhrBqXrDKbU-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisF2kt7g%253D&md5=75a60de4fc8bfb784665cbaad4c4bdbf</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.113.005925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.113.005925%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DM.%26aulast%3DBhupathiraju%26aufirst%3DS.%2BN.%26aulast%3DSatija%26aufirst%3DA.%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DLong-Term%2520Coffee%2520Consumption%2520and%2520Risk%2520of%2520Cardiovascular%2520Disease%253A%2520A%2520Systematic%2520Review%2520and%2520a%2520Dose-Response%2520Meta-Analysis%2520of%2520Prospective%2520Cohort%2520Studies%26jtitle%3DCirculation%26date%3D2014%26volume%3D129%26issue%3D6%26spage%3D643%26epage%3D659%26doi%3D10.1161%2FCIRCULATIONAHA.113.005925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuster, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, J.</span></span> <span> </span><span class="NLM_article-title">Energy Drinks: A Contemporary Issues Paper</span>. <i>Curr. Sports Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1249/JSR.0000000000000454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1249%2FJSR.0000000000000454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=29420350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC1MvptlWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=65-72&issue=2&author=J.+P.+Higginsauthor=K.+Babuauthor=P.+A.+Deusterauthor=J.+Shearer&title=Energy+Drinks%3A+A+Contemporary+Issues+Paper&doi=10.1249%2FJSR.0000000000000454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Energy Drinks: A Contemporary Issues Paper</span></div><div class="casAuthors">Higgins John P; Babu Kavita; Deuster Patricia A; Shearer Jane</div><div class="citationInfo"><span class="NLM_cas:title">Current sports medicine reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since their introduction in 1987, energy drinks have become increasingly popular and the energy drink market has grown at record pace into a multibillion-dollar global industry.  Young people, students, office workers, athletes, weekend warriors, and service members frequently consume energy drinks.  Both health care providers and consumers must recognize the difference between energy drinks, traditional beverages (e.g., coffee, tea, soft drinks/sodas, juices, or flavored water), and sports drinks.  The research about energy drinks safety and efficacy is often contradictory, given the disparate protocols and types of products consumed: this makes it difficult to draw firm conclusions.  Also, much of the available literature is industry-sponsored.  After reports of adverse events associated with energy drink consumption, concerns including trouble sleeping, anxiety, cardiovascular events, seizures, and even death, have been raised about their safety.  This article will focus on energy drinks, their ingredients, side effects associated with their consumption, and suggested recommendations, which call for education, regulatory actions, changes in marketing, and additional research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5cspLFyBlzO2mnZh2OgS0fW6udTcc2ebURGMu1TuYtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvptlWqsg%253D%253D&md5=2ba2cc57eecf4cc28651ad21cfea467a</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1249%2FJSR.0000000000000454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1249%252FJSR.0000000000000454%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%2BP.%26aulast%3DBabu%26aufirst%3DK.%26aulast%3DDeuster%26aufirst%3DP.%2BA.%26aulast%3DShearer%26aufirst%3DJ.%26atitle%3DEnergy%2520Drinks%253A%2520A%2520Contemporary%2520Issues%2520Paper%26jtitle%3DCurr.%2520Sports%2520Med.%2520Rep.%26date%3D2018%26volume%3D17%26issue%3D2%26spage%3D65%26epage%3D72%26doi%3D10.1249%2FJSR.0000000000000454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, C. L.</span></span> <span> </span><span class="NLM_article-title">Energy Beverages: Content and Safety</span>. <i>Mayo Clin. Proc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.4065/mcp.2010.0381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4065%2Fmcp.2010.0381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21037046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1yku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=1033-1041&issue=11&author=J.+P.+Higginsauthor=T.+D.+Tuttleauthor=C.+L.+Higgins&title=Energy+Beverages%3A+Content+and+Safety&doi=10.4065%2Fmcp.2010.0381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Energy Beverages: content and safety</span></div><div class="casAuthors">Higgins, John P.; Tuttle, Troy D.; Higgins, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Mayo Clinic Proceedings</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1033-1041</span>CODEN:
                <span class="NLM_cas:coden">MACPAJ</span>;
        ISSN:<span class="NLM_cas:issn">0025-6196</span>.
    
            (<span class="NLM_cas:orgname">Quadrant HealthCom Inc.</span>)
        </div><div class="casAbstract">A review.  Exercise is making a resurgence in many countries, given its benefits for fitness as well as prevention of obesity.  This trend has spawned many supplements that purport to aid performance, muscle growth, and recovery.  Initially, sports drinks were developed to provide electrolyte and carbohydrate replacement.  Subsequently, energy beverages (EBs) contg. stimulants and additives have appeared in most gyms and grocery stores and are being used increasingly by "weekend warriors" and those seeking an edge in an endurance event.  Long-term exposure to the various components of EBs may result in significant alterations in the cardiovascular system, and the safety of EBs has not been fully established.  For this review, we searched the MEDLINE and EMBASE databases from 1976 through May 2010, using the following keywords: energy beverage, energy drink, power drink, exercise, caffeine, red bull, bitter orange, glucose, ginseng, guarana, and taurine.  Evidence regarding the effects of EBs is summarized, and practical recommendations are made to help in answering the patient who asks, "is it safe for me to drink an energy beverage when I exercise".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmXLsGq84H2bVg90H21EOLACvtfcHk0lhrBqXrDKbU-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1yku7k%253D&md5=bd11cbdaeef8446897154a9b9bd1e19e</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.4065%2Fmcp.2010.0381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4065%252Fmcp.2010.0381%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%2BP.%26aulast%3DTuttle%26aufirst%3DT.%2BD.%26aulast%3DHiggins%26aufirst%3DC.%2BL.%26atitle%3DEnergy%2520Beverages%253A%2520Content%2520and%2520Safety%26jtitle%3DMayo%2520Clin.%2520Proc.%26date%3D2010%26volume%3D85%26issue%3D11%26spage%3D1033%26epage%3D1041%26doi%3D10.4065%2Fmcp.2010.0381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arria, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldeira, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Grady, K. E.</span></span> <span> </span><span class="NLM_article-title">Energy Drink Consumption and Increased Risk for Alcohol Dependence</span>. <i>Alcohol.: Clin. Exp. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1111/j.1530-0277.2010.01352.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1530-0277.2010.01352.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21073486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jvVenug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=365-375&issue=2&author=A.+M.+Arriaauthor=K.+M.+Caldeiraauthor=S.+J.+Kasperskiauthor=K.+B.+Vincentauthor=R.+R.+Griffithsauthor=K.+E.+O%E2%80%99Grady&title=Energy+Drink+Consumption+and+Increased+Risk+for+Alcohol+Dependence&doi=10.1111%2Fj.1530-0277.2010.01352.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Energy drink consumption and increased risk for alcohol dependence</span></div><div class="casAuthors">Arria Amelia M; Caldeira Kimberly M; Kasperski Sarah J; Vincent Kathryn B; Griffiths Roland R; O'Grady Kevin E</div><div class="citationInfo"><span class="NLM_cas:title">Alcoholism, clinical and experimental research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Energy drinks are highly caffeinated beverages that are increasingly consumed by young adults.  Prior research has established associations between energy drink use and heavier drinking and alcohol-related problems among college students.  This study investigated the extent to which energy drink use might pose additional risk for alcohol dependence over and above that from known risk factors.  METHODS:  Data were collected via personal interview from 1,097 fourth-year college students sampled from 1 large public university as part of an ongoing longitudinal study.  Alcohol dependence was assessed according to DSM-IV criteria.  RESULTS:  After adjustment for the sampling design, 51.3%(wt) of students were classified as "low-frequency" energy drink users (1 to 51 days in the past year) and 10.1%(wt) as "high-frequency" users (≥52 days).  Typical caffeine consumption varied widely depending on the brand consumed.  Compared to the low-frequency group, high-frequency users drank alcohol more frequently (141.6 vs. 103.1 days) and in higher quantities (6.15 vs. 4.64 drinks/typical drinking day).  High-frequency users were at significantly greater risk for alcohol dependence relative to both nonusers (AOR = 2.40, 95% CI = 1.27 to 4.56, p = 0.007) and low-frequency users (AOR = 1.86, 95% CI = 1.10, 3.14, p = 0.020), even after holding constant demographics, typical alcohol consumption, fraternity/sorority involvement, depressive symptoms, parental history of alcohol/drug problems, and childhood conduct problems.  Low-frequency energy drink users did not differ from nonusers on their risk for alcohol dependence.  CONCLUSIONS:  Weekly or daily energy drink consumption is strongly associated with alcohol dependence.  Further research is warranted to understand the possible mechanisms underlying this association.  College students who frequently consume energy drinks represent an important target population for alcohol prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTamH1wC0VwRmBAiYWy6n3SfW6udTcc2eYHaO3zxwXedbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jvVenug%253D%253D&md5=862e15bb1f7c7085fcad3bf57a37eee4</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1111%2Fj.1530-0277.2010.01352.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1530-0277.2010.01352.x%26sid%3Dliteratum%253Aachs%26aulast%3DArria%26aufirst%3DA.%2BM.%26aulast%3DCaldeira%26aufirst%3DK.%2BM.%26aulast%3DKasperski%26aufirst%3DS.%2BJ.%26aulast%3DVincent%26aufirst%3DK.%2BB.%26aulast%3DGriffiths%26aufirst%3DR.%2BR.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DK.%2BE.%26atitle%3DEnergy%2520Drink%2520Consumption%2520and%2520Increased%2520Risk%2520for%2520Alcohol%2520Dependence%26jtitle%3DAlcohol.%253A%2520Clin.%2520Exp.%2520Res.%26date%3D2011%26volume%3D35%26issue%3D2%26spage%3D365%26epage%3D375%26doi%3D10.1111%2Fj.1530-0277.2010.01352.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, T.</span></span> <span> </span><span class="NLM_article-title">Fatal Caffeine Overdose: Two Case Reports</span>. <i>Forensic Sci. Int.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>153</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.forsciint.2005.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.forsciint.2005.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15935584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVWltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2005&pages=67-69&issue=1&author=S.+Kerriganauthor=T.+Lindsey&title=Fatal+Caffeine+Overdose%3A+Two+Case+Reports&doi=10.1016%2Fj.forsciint.2005.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Fatal caffeine overdose: Two case reports</span></div><div class="casAuthors">Kerrigan, Sarah; Lindsey, Tania</div><div class="citationInfo"><span class="NLM_cas:title">Forensic Science International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-69</span>CODEN:
                <span class="NLM_cas:coden">FSINDR</span>;
        ISSN:<span class="NLM_cas:issn">0379-0738</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Caffeine is a mild central nervous stimulant that occurs naturally in coffee beans, cocoa beans and tea leaves.  In large doses, it can be profoundly toxic, resulting in arrhythmia, tachycardia, vomiting, convulsions, coma and death.  The av. cup of coffee or tea in the United States is reported to contain between 40 and 150 mg caffeine although specialty coffees may contain much higher doses.  Over-the-counter supplements that are used to combat fatigue typically contain 100-200 mg caffeine per tablet and doses of 32-200 mg are included in a variety of prescription drug mixts.  Fatal caffeine overdoses in adults are relatively rare and require the ingestion of a large quantity of the drug, typically in excess of 5 g.  Over a period of approx. 12 mo our office reported two cases of fatal caffeine intoxication.  In the first case, the femoral blood of a 39-yr-old female with a history of i.v. drug use contained 192 mg/L caffeine.  In the second case, femoral blood from a 29-yr-old male with a history of obesity and diabetes contained 567 mg/L caffeine.  In both cases, the cause of death was ruled as caffeine intoxication and the manner of death was accidental.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUACJ6OtnMFbVg90H21EOLACvtfcHk0lgn_Qmbfnf2nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVWltL4%253D&md5=5f97b7a1ccc51c7b668143423f98a3d6</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1016%2Fj.forsciint.2005.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.forsciint.2005.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DKerrigan%26aufirst%3DS.%26aulast%3DLindsey%26aufirst%3DT.%26atitle%3DFatal%2520Caffeine%2520Overdose%253A%2520Two%2520Case%2520Reports%26jtitle%3DForensic%2520Sci.%2520Int.%26date%3D2005%26volume%3D153%26issue%3D1%26spage%3D67%26epage%3D69%26doi%3D10.1016%2Fj.forsciint.2005.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, K. M.</span></span> <span> </span><span class="NLM_article-title">Caffeine Reduces Myocardial Blood Flow during Exercise</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">730.e1</span>– <span class="NLM_lpage">730.e8</span>, <span class="refDoi"> DOI: 10.1016/j.amjmed.2012.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.amjmed.2012.12.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=730.e1-730.e8&issue=8&author=J.+P.+Higginsauthor=K.+M.+Babu&title=Caffeine+Reduces+Myocardial+Blood+Flow+during+Exercise&doi=10.1016%2Fj.amjmed.2012.12.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2012.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2012.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%2BP.%26aulast%3DBabu%26aufirst%3DK.%2BM.%26atitle%3DCaffeine%2520Reduces%2520Myocardial%2520Blood%2520Flow%2520during%2520Exercise%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2013%26volume%3D126%26issue%3D8%26spage%3D730.e1%26epage%3D730.e8%26doi%3D10.1016%2Fj.amjmed.2012.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldfarb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tellier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanassoulis, G.</span></span> <span> </span><span class="NLM_article-title">Review of Published Cases of Adverse Cardiovascular Events after Ingestion of Energy Drinks</span>. <i>Am. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1016/j.amjcard.2013.08.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.amjcard.2013.08.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24176062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2c7hsVCitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=168-172&issue=1&author=M.+Goldfarbauthor=C.+Tellierauthor=G.+Thanassoulis&title=Review+of+Published+Cases+of+Adverse+Cardiovascular+Events+after+Ingestion+of+Energy+Drinks&doi=10.1016%2Fj.amjcard.2013.08.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Review of published cases of adverse cardiovascular events after ingestion of energy drinks</span></div><div class="casAuthors">Goldfarb Michael; Tellier Claudia; Thanassoulis George</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Energy drink (ED) consumption has been linked to several adverse event reports, but there is limited data on related cardiovascular (CV) complications.  We describe clinical characteristics, ED consumption profile, co-ingestions, and results of cardiovascular testing in a series of cardiovascular event reports temporally related to ED consumption from the literature.  We searched PubMed and Embase for case reports in peer-reviewed journals from January 1, 1980, to February 1, 2013, in which an acute CV event was associated temporally with ED consumption.  We identified 14 eligible articles involving 15 cases (5 atrial arrhythmias, 5 ventricular arrhythmias, 1 QT prolongation, 4 ST-segment elevations).  Two additional cases of cardiac arrest from our institution are included.  Of these 17 cases of ED-related acute CV events (13 male cases; 15 cases aged <30 years, age range 13 to 58 years), only 1 had minor previous cardiac disease.  Cardiac investigations did not reveal any predisposing cardiac abnormality in the majority of cases.  Of the 11 cases related to a serious event (i.e., cardiac arrest, ventricular arrhythmia, or ST-segment elevations), 5 reported acute heavy ED consumption, 4 reported co-ingestions with alcohol or other drugs, and 2 were found to have a channelopathy.  Potential mechanisms of ED-related cardiac events are reviewed.  In conclusion, several adverse CV events after consuming ED have been reported in the literature.  Although causality cannot be inferred from our series, physicians should routinely inquire about ED consumption in relevant cases, and vulnerable consumers such as youth should be advised that caution is warranted with heavy consumption and/or with concomitant alcohol or drug ingestion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUnr88hZ8OT0odMGTatQ7LfW6udTcc2eYHaO3zxwXedbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7hsVCitA%253D%253D&md5=70d6f5d32c417510ec7222dce595d1d0</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1016%2Fj.amjcard.2013.08.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjcard.2013.08.058%26sid%3Dliteratum%253Aachs%26aulast%3DGoldfarb%26aufirst%3DM.%26aulast%3DTellier%26aufirst%3DC.%26aulast%3DThanassoulis%26aufirst%3DG.%26atitle%3DReview%2520of%2520Published%2520Cases%2520of%2520Adverse%2520Cardiovascular%2520Events%2520after%2520Ingestion%2520of%2520Energy%2520Drinks%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2014%26volume%3D113%26issue%3D1%26spage%3D168%26epage%3D172%26doi%3D10.1016%2Fj.amjcard.2013.08.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlagadda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular Complications of Energy Drinks</span>. <i>Beverages</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.3390/beverages1020104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3390%2Fbeverages1020104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=104-126&issue=2&author=J.+Higginsauthor=S.+Yarlagaddaauthor=B.+Yang&title=Cardiovascular+Complications+of+Energy+Drinks&doi=10.3390%2Fbeverages1020104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.3390%2Fbeverages1020104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbeverages1020104%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DYarlagadda%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DCardiovascular%2520Complications%2520of%2520Energy%2520Drinks%26jtitle%3DBeverages%26date%3D2015%26volume%3D1%26issue%3D2%26spage%3D104%26epage%3D126%26doi%3D10.3390%2Fbeverages1020104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al Yacoub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luczkiewicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, C.</span></span> <span> </span><span class="NLM_article-title">Acute Kidney Injury and Hepatitis Associated with Energy Drink Consumption: A Case Report</span>. <i>J. Med. Case Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.1186/s13256-019-2340-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2Fs13256-019-2340-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=31992329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BB38%252FlsFGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=23&issue=1&author=R.+Al+Yacoubauthor=D.+Luczkiewiczauthor=C.+Kerr&title=Acute+Kidney+Injury+and+Hepatitis+Associated+with+Energy+Drink+Consumption%3A+A+Case+Report&doi=10.1186%2Fs13256-019-2340-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Acute kidney injury and hepatitis associated with energy drink consumption: a case report</span></div><div class="casAuthors">Al Yacoub Raed; Al Yacoub Raed; Luczkiewicz Debra; Kerr Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical case reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  In the USA, energy drinks are commonly consumed among adults.  The side effects of these drinks are not well studied but consumers have reported multiple adverse events to the US Food and Drug Administration including acute kidney injury and acute hepatitis.  CASE PRESENTATION:  A 62-year-old white woman presented with progressive weakness, fatigue, confusion, and delirium secondary to acute kidney injury and acute hepatitis associated with excessive energy drink use.  Clinical improvement occurred with supportive care and discontinuation of energy drinks, with resolution of acute kidney injury and progressive improvement of liver function.  The defined mechanism of injury is unknown but thought due to energy drink ingredients.  CONCLUSION:  Multiple cases of energy drink-induced acute kidney injury or acute hepatitis are reported in the literature but this case is the first to report them simultaneously.  Ingredients and presumed doses to cause these events are outlined in this case report.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTExDWfDF9DFeIHSmpohpd0fW6udTcc2eYfO9EdXOlERbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38%252FlsFGhsQ%253D%253D&md5=fd107bccd60a3999d12aeef71296336c</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1186%2Fs13256-019-2340-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13256-019-2340-0%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BYacoub%26aufirst%3DR.%26aulast%3DLuczkiewicz%26aufirst%3DD.%26aulast%3DKerr%26aufirst%3DC.%26atitle%3DAcute%2520Kidney%2520Injury%2520and%2520Hepatitis%2520Associated%2520with%2520Energy%2520Drink%2520Consumption%253A%2520A%2520Case%2520Report%26jtitle%3DJ.%2520Med.%2520Case%2520Rep.%26date%3D2020%26volume%3D14%26issue%3D1%26spage%3D23%26doi%3D10.1186%2Fs13256-019-2340-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond-Haley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Silva, A.</span></span> <span> </span><span class="NLM_article-title">Energy Drink-Induced Cardiomyopathy</span>. <i>BMJ. Case Rep.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e239370</span> <span class="refDoi"> DOI: 10.1136/bcr-2020-239370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1136%2Fbcr-2020-239370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=33858880" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2021&issue=4&author=G.+Fiskauthor=M.+Hammond-Haleyauthor=A.+D%E2%80%99Silva&title=Energy+Drink-Induced+Cardiomyopathy&doi=10.1136%2Fbcr-2020-239370"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1136%2Fbcr-2020-239370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbcr-2020-239370%26sid%3Dliteratum%253Aachs%26aulast%3DFisk%26aufirst%3DG.%26aulast%3DHammond-Haley%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Silva%26aufirst%3DA.%26atitle%3DEnergy%2520Drink-Induced%2520Cardiomyopathy%26jtitle%3DBMJ.%2520Case%2520Rep.%26date%3D2021%26volume%3D14%26issue%3D4%26doi%3D10.1136%2Fbcr-2020-239370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendash, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezai-Zadeh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharia, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cracchiolo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shippy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span> <span> </span><span class="NLM_article-title">Caffeine Protects Alzheimer’s Mice against Cognitive Impairment and Reduces Brain β-Amyloid Production</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2006.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroscience.2006.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16938404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFCjsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2006&pages=941-952&issue=4&author=G.+W.+Arendashauthor=W.+Schleifauthor=K.+Rezai-Zadehauthor=E.+K.+Jacksonauthor=L.+C.+Zachariaauthor=J.+R.+Cracchioloauthor=D.+Shippyauthor=J.+Tan&title=Caffeine+Protects+Alzheimer%E2%80%99s+Mice+against+Cognitive+Impairment+and+Reduces+Brain+%CE%B2-Amyloid+Production&doi=10.1016%2Fj.neuroscience.2006.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production</span></div><div class="casAuthors">Arendash, G. W.; Schleif, W.; Rezai-Zadeh, K.; Jackson, E. K.; Zacharia, L. C.; Cracchiolo, J. R.; Shippy, D.; Tan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">941-952</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A recent epidemiol. study suggested that higher caffeine intake over decades reduces the risk of Alzheimer's disease (AD).  The present study sought to det. any long-term protective effects of dietary caffeine intake in a controlled longitudinal study involving AD transgenic mice.  Caffeine (an adenosine receptor antagonist) was added to the drinking water of amyloid precursor protein, Swedish mutation (APPsw) transgenic (Tg) mice between 4 and 9 mo of age, with behavioral testing done during the final 6 wk of treatment.  The av. daily intake of caffeine per mouse (1.5 mg) was the human equiv. of 500 mg caffeine, the amt. typically found in five cups of coffee per day.  Across multiple cognitive tasks of spatial learning/ref. memory, working memory, and recognition/identification, Tg mice given caffeine performed significantly better than Tg control mice and similar to non-transgenic controls.  In both behaviorally-tested and aged Tg mice, long-term caffeine administration resulted in lower hippocampal β-amyloid (Aβ) levels.  Expression of both Presenilin 1 (PS1) and β-secretase (BACE) was reduced in caffeine-treated Tg mice, indicating decreased Aβ prodn. as a likely mechanism of caffeine's cognitive protection.  The ability of caffeine to reduce Aβ prodn. was confirmed in SweAPP N2a neuronal cultures, wherein concn.-dependent decreases in both Aβ1-40 and Aβ1-42 were obsd.  Although adenosine A1 or A2A receptor densities in cortex or hippocampus were not affected by caffeine treatment, brain adenosine levels in Tg mice were restored back to normal by dietary caffeine and could be involved in the cognitive protection provided by caffeine.  Our data demonstrate that moderate daily intake of caffeine may delay or reduce the risk of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rlmKyoQ0fbVg90H21EOLACvtfcHk0lgSYXVBetxIHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFCjsb%252FF&md5=47bdc04139af30f1ff6c7da640627506</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2006.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2006.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DArendash%26aufirst%3DG.%2BW.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DRezai-Zadeh%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DZacharia%26aufirst%3DL.%2BC.%26aulast%3DCracchiolo%26aufirst%3DJ.%2BR.%26aulast%3DShippy%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DJ.%26atitle%3DCaffeine%2520Protects%2520Alzheimer%25E2%2580%2599s%2520Mice%2520against%2520Cognitive%2520Impairment%2520and%2520Reduces%2520Brain%2520%25CE%25B2-Amyloid%2520Production%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D142%26issue%3D4%26spage%3D941%26epage%3D952%26doi%3D10.1016%2Fj.neuroscience.2006.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendash, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamcarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runfeldt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezai-Zadeh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echeverria, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, H.</span></span> <span> </span><span class="NLM_article-title">Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer’s Disease Mice</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-1087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2009-1087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19581722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVemtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=661-680&issue=3&author=G.+W.+Arendashauthor=T.+Moriauthor=C.+Caoauthor=M.+Mamcarzauthor=M.+Runfeldtauthor=A.+Dicksonauthor=K.+Rezai-Zadehauthor=J.+Tanauthor=B.+A.+Citronauthor=X.+Linauthor=V.+Echeverriaauthor=H.+Potter&title=Caffeine+Reverses+Cognitive+Impairment+and+Decreases+Brain+Amyloid-%CE%B2+Levels+in+Aged+Alzheimer%E2%80%99s+Disease+Mice&doi=10.3233%2FJAD-2009-1087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice</span></div><div class="casAuthors">Arendash, Gary W.; Mori, Takashi; Cao, Chuanhai; Mamcarz, Malgorzata; Runfeldt, Melissa; Dickson, Alexander; Rezai-Zadeh, Kavon; Tan, Jun; Citron, Bruce A.; Lin, Xiaoyang; Echeverria, Valentina; Potter, Huntington</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-680</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We have recently shown that Alzheimer's disease (AD) transgenic mice given a moderate level of caffeine intake (the human equiv. of 5 cups of coffee per day) are protected from development of otherwise certain cognitive impairment and have decreased hippocampal amyloid-β (Aβ) levels due to suppression of both β-secretase (BACE1) and presenilin 1 (PS1)/γ-secretase expression.  To det. if caffeine intake can have beneficial effects in "aged" APPsw mice already demonstrating cognitive impairment, we administered caffeine in the drinking water of 18-19 mo old APPsw mice that were impaired in working memory.  At 4-5 wk into caffeine treatment, those impaired transgenic mice given caffeine (Tg/Caff) exhibited vastly superior working memory compared to the continuing impairment of control transgenic mice.  In addn., Tg/Caff mice had substantially reduced Aβ deposition in hippocampus (↓40%) and entorhinal cortex (↓46%), as well as correlated decreases in brain sol. Aβ levels.  Mechanistically, evidence is provided that caffeine suppression of BACE1 involves the cRaf-1/NFκB pathway.  We also detd. that caffeine concns. within human physiol. range effectively reduce active and total glycogen synthase kinase 3 levels in SweAPP N2a cells.  Even with pre-existing and substantial Aβ burden, aged APPsw mice exhibited memory restoration and reversal of AD pathol., suggesting a treatment potential of caffeine in cases of established AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKiZaJJpsEubVg90H21EOLACvtfcHk0lgSYXVBetxIHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVemtb4%253D&md5=8d175a445da877284e30e89fa052ee2c</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-1087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-1087%26sid%3Dliteratum%253Aachs%26aulast%3DArendash%26aufirst%3DG.%2BW.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DMamcarz%26aufirst%3DM.%26aulast%3DRunfeldt%26aufirst%3DM.%26aulast%3DDickson%26aufirst%3DA.%26aulast%3DRezai-Zadeh%26aufirst%3DK.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCitron%26aufirst%3DB.%2BA.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DEcheverria%26aufirst%3DV.%26aulast%3DPotter%26aufirst%3DH.%26atitle%3DCaffeine%2520Reverses%2520Cognitive%2520Impairment%2520and%2520Decreases%2520Brain%2520Amyloid-%25CE%25B2%2520Levels%2520in%2520Aged%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Mice%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D661%26epage%3D680%26doi%3D10.3233%2FJAD-2009-1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verreault, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurin, D.</span></span> <span> </span><span class="NLM_article-title">More Than the Epidemiology of Alzheimer’s Disease: Contributions of the Canadian Study of Health and Aging</span>. <i>Can. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1177/070674370404900202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1177%2F070674370404900202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=15065741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2c7ntFGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2004&pages=83-91&issue=2&author=J.+Lindsayauthor=E.+Sykesauthor=I.+McDowellauthor=R.+Verreaultauthor=D.+Laurin&title=More+Than+the+Epidemiology+of+Alzheimer%E2%80%99s+Disease%3A+Contributions+of+the+Canadian+Study+of+Health+and+Aging&doi=10.1177%2F070674370404900202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">More than the epidemiology of Alzheimer's disease: contributions of the Canadian Study of Health and Aging</span></div><div class="casAuthors">Lindsay Joan; Sykes Elizabeth; McDowell Ian; Verreault Rene; Laurin Danielle</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of psychiatry. Revue canadienne de psychiatrie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-91</span>
        ISSN:<span class="NLM_cas:issn">0706-7437</span>.
    </div><div class="casAbstract">OBJECTIVE:  To highlight contributions to knowledge made by the Canadian Study of Health and Aging (CSHA).  METHOD:  The CSHA began in 1991, with follow-ups in 1996 and 2001.  It was national in scope, with 18 study centres and a coordinating centre.  It included 10 263 participants; of these, 9008 were in the community, and 1255 were in institutions.  In each phase, community participants were screened for cognitive impairment, and where appropriate, cognitive status was determined by a detailed clinical examination.  Data on possible risk factors for dementia were collected at baseline.  Data on caring for people with dementia were collected in each phase.  RESULTS:  The prevalence of dementia was established at 8% of those aged 65 years and over; incidence (new cases each year) was about 2%.  Cognitive impairment not dementia (CIND) was more than twice as common as dementia.  Factors affecting the risk of institutionalization, mortality, and the health of caregivers were examined.  The costs of dementia were conservatively estimated at dollar 3.9 billion in 1991.  Risk factors for Alzheimer's disease (AD) and vascular dementia are presented; it is noteworthy that physical activity appeared to protect against all forms of cognitive decline, particularly for women.  Clinical contributions include the development of norms for several neuropsychological tests.  Other topics include the health of those with CIND, predicting dementia, medication use, frailty and healthy aging, and urinary incontinence.  CONCLUSION:  The CSHA has contributed substantially to knowledge of the epidemiology of dementia, including AD, and to many other topics relevant to seniors' health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8VTvsviIPDvx2phytoz6_fW6udTcc2eYKQbk7VrXzqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7ntFGhsQ%253D%253D&md5=45e21ee8141a44b13e04827b26ffe3f3</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1177%2F070674370404900202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F070674370404900202%26sid%3Dliteratum%253Aachs%26aulast%3DLindsay%26aufirst%3DJ.%26aulast%3DSykes%26aufirst%3DE.%26aulast%3DMcDowell%26aufirst%3DI.%26aulast%3DVerreault%26aufirst%3DR.%26aulast%3DLaurin%26aufirst%3DD.%26atitle%3DMore%2520Than%2520the%2520Epidemiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Contributions%2520of%2520the%2520Canadian%2520Study%2520of%2520Health%2520and%2520Aging%26jtitle%3DCan.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D49%26issue%3D2%26spage%3D83%26epage%3D91%26doi%3D10.1177%2F070674370404900202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Gelder, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijhuis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmijn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampaoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissinen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kromhout, D.</span></span> <span> </span><span class="NLM_article-title">Coffee Consumption Is Inversely Associated with Cognitive Decline in Elderly European Men: The FINE Study</span>. <i>Eur. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/sj.ejcn.1602495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.ejcn.1602495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16929246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtlGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=226-232&issue=2&author=B.+M.+van+Gelderauthor=B.+Buijsseauthor=M.+Tijhuisauthor=S.+Kalmijnauthor=S.+Giampaoliauthor=A.+Nissinenauthor=D.+Kromhout&title=Coffee+Consumption+Is+Inversely+Associated+with+Cognitive+Decline+in+Elderly+European+Men%3A+The+FINE+Study&doi=10.1038%2Fsj.ejcn.1602495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study</span></div><div class="casAuthors">van Gelder B M; Buijsse B; Tijhuis M; Kalmijn S; Giampaoli S; Nissinen A; Kromhout D</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-32</span>
        ISSN:<span class="NLM_cas:issn">0954-3007</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate whether coffee consumption is associated with 10-year cognitive decline in elderly men, as results of previous studies obtained hitherto have been controversial and prospective information on this association has been lacking.  DESIGN, SUBJECTS AND SETTING:  Six hundred and seventy six healthy men born between 1900 and 1920 from Finland, Italy and the Netherlands participated in a 10-year prospective cohort study.  Cognitive functioning was assessed using the Mini-Mental State Examination (0-30 points, with a higher score indicating better cognitive performance).  Coffee consumption was estimated in cups per day.  A mixed longitudinal model was used to investigate the association between baseline coffee consumption and 10-year cognitive decline.  Multiple adjustments were made.  RESULTS:  Men who consumed coffee had a 10-year cognitive decline of 1.2 points (4%).  Non-consumers had an additional decline of 1.4 points (P<0.001).  An inverse and J-shaped association was observed between the number of cups of coffee consumed and cognitive decline, with the least cognitive decline for three cups of coffee per day (0.6 points).  This decline was 4.3 times smaller than the decline of non-consumers (P<0.001).  CONCLUSIONS:  Findings suggest that consuming coffee reduces cognitive decline in elderly men.  An inverse and J-shaped association may exist between the number of cups of coffee consumed and cognitive decline, with the least cognitive decline for men consuming three cups of coffee per day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR34N7dyCByTH6oPH0mYWL1fW6udTcc2eYKQbk7VrXzqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtlGjsQ%253D%253D&md5=6e1d591de56e57b3ad20e5be146bb350</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1038%2Fsj.ejcn.1602495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ejcn.1602495%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGelder%26aufirst%3DB.%2BM.%26aulast%3DBuijsse%26aufirst%3DB.%26aulast%3DTijhuis%26aufirst%3DM.%26aulast%3DKalmijn%26aufirst%3DS.%26aulast%3DGiampaoli%26aufirst%3DS.%26aulast%3DNissinen%26aufirst%3DA.%26aulast%3DKromhout%26aufirst%3DD.%26atitle%3DCoffee%2520Consumption%2520Is%2520Inversely%2520Associated%2520with%2520Cognitive%2520Decline%2520in%2520Elderly%2520European%2520Men%253A%2520The%2520FINE%2520Study%26jtitle%3DEur.%2520J.%2520Clin.%2520Nutr.%26date%3D2007%26volume%3D61%26issue%3D2%26spage%3D226%26epage%3D232%26doi%3D10.1038%2Fsj.ejcn.1602495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higdon, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, B.</span></span> <span> </span><span class="NLM_article-title">Coffee and Health: A Review of Recent Human Research</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1080/10408390500400009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1080%2F10408390500400009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16507475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=101-123&issue=2&author=J.+V.+Higdonauthor=B.+Frei&title=Coffee+and+Health%3A+A+Review+of+Recent+Human+Research&doi=10.1080%2F10408390500400009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee and health: a review of recent human research</span></div><div class="casAuthors">Higdon, Jane V.; Frei, Balz</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-123</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Coffee is a complex mixt. of chems. that provides significant amt. of chlorogenic acid and caffeine.  Unfiltered coffee is a significant source of cafestol and kahweol, which are diterpenes that have been implicated in the cholesterol raising effects of coffee.  The results of epidemiol. research suggest that coffee consumption may help prevent several chronic diseases, including type 2 diabetes mellitus, Parkinson's disease and liver disease (cirrhosis and hepatocellular carcinoma).  Most prospective cohort studies have not found coffee consumption to be assocd. with significantly increased cardiovascular disease risk.  However, coffee consumption is assocd. with increases in several cardiovascular disease risk factors, including blood pressure and plasma homocysteine.  At present, there is little evidence that coffee consumption increases the risk of cancer.  For adults consuming moderate amts. of coffee (3-4 cups/d providing 300-400 mg/d of caffeine), there is little evidence of health risks and some evidence of health benefits.  However, some groups, including people with hypertension, children, adolescents, and the elderly, may be more vulnerable to the adverse effects of caffeine.  In addn., currently available evidence suggests that it may be prudent for pregnant women to limit coffee consumption to 3 cups/d providing no more than 300 mg/d of caffeine to exclude any increased probability of spontaneous abortion or impaired fetal growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY9IX4q-cSzbVg90H21EOLACvtfcHk0ljpo_b55g4ejg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWqt70%253D&md5=98a39a36a1f1f296fd1b0570d8f4dee2</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1080%2F10408390500400009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408390500400009%26sid%3Dliteratum%253Aachs%26aulast%3DHigdon%26aufirst%3DJ.%2BV.%26aulast%3DFrei%26aufirst%3DB.%26atitle%3DCoffee%2520and%2520Health%253A%2520A%2520Review%2520of%2520Recent%2520Human%2520Research%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2006%26volume%3D46%26issue%3D2%26spage%3D101%26epage%3D123%26doi%3D10.1080%2F10408390500400009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manson, J. A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Coffee, Caffeine, and Risk of Type 2 Diabetes: A Prospective Cohort Study in Younger and Middle-Aged U.S. Women</span>. <i>Diabetes Care</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.2337/diacare.29.02.06.dc05-1512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.2337%2Fdiacare.29.02.06.dc05-1512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=16443894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD28%252Flsl2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=398-403&issue=2&author=R.+M.+Van+Damauthor=W.+C.+Willettauthor=J.+A.+E.+Mansonauthor=F.+B.+Hu&title=Coffee%2C+Caffeine%2C+and+Risk+of+Type+2+Diabetes%3A+A+Prospective+Cohort+Study+in+Younger+and+Middle-Aged+U.S.+Women&doi=10.2337%2Fdiacare.29.02.06.dc05-1512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women</span></div><div class="casAuthors">van Dam Rob M; Willett Walter C; Manson Joann E; Hu Frank B</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">398-403</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  High habitual coffee consumption has been associated with a lower risk of type 2 diabetes, but data on lower levels of consumption and on different types of coffee are sparse.  RESEARCH DESIGN AND METHODS:  This is a prospective cohort study including 88,259 U.S. women of the Nurses' Health Study II aged 26-46 years without history of diabetes at baseline.  Consumption of coffee and other caffeine-containing foods and drinks was assessed in 1991, 1995, and 1999.  We documented 1,263 incident cases of confirmed type 2 diabetes between 1991 and 2001.  RESULTS:  After adjustment for potential confounders, the relative risk of type 2 diabetes was 0.87 (95% CI 0.73-1.03) for one cup per day, 0.58 (0.49-0.68) for two to three cups per day, and 0.53 (0.41-0.68) for four or more cups per day compared with nondrinkers (P for trend <0.0001).  Associations were similar for caffeinated (0.87 [0.83-0.91] for a one-cup increment per day) and decaffeinated (0.81 [0.73-0.90]) coffee and for filtered (0.86 [0.82-0.90]) and instant (0.83 [0.74-0.93]) coffee.  Tea consumption was not substantially associated with risk of type 2 diabetes (0.88 [0.64-1.23] for four or more versus no cups per day; P for trend = 0.81).  CONCLUSIONS:  These results suggest that moderate consumption of both caffeinated and decaffeinated coffee may lower risk of type 2 diabetes in younger and middle-aged women.  Coffee constituents other than caffeine may affect the development of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYNejkz31lvCjiVMCqkKxVfW6udTcc2eb5toA7ZAuc27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252Flsl2htA%253D%253D&md5=0c8b749fbd02d3514900d00222ae1261</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.29.02.06.dc05-1512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.29.02.06.dc05-1512%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDam%26aufirst%3DR.%2BM.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26aulast%3DManson%26aufirst%3DJ.%2BA.%2BE.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DCoffee%252C%2520Caffeine%252C%2520and%2520Risk%2520of%2520Type%25202%2520Diabetes%253A%2520A%2520Prospective%2520Cohort%2520Study%2520in%2520Younger%2520and%2520Middle-Aged%2520U.S.%2520Women%26jtitle%3DDiabetes%2520Care%26date%3D2006%26volume%3D29%26issue%3D2%26spage%3D398%26epage%3D403%26doi%3D10.2337%2Fdiacare.29.02.06.dc05-1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cadden, I. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partovi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, E. M.</span></span> <span> </span><span class="NLM_article-title">Review Article: Possible Beneficial Effects of Coffee on Liver Disease and Function</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2036.2007.03319.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fj.1365-2036.2007.03319.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17555416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslGmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1&author=I.+S.+H.+Caddenauthor=N.+Partoviauthor=E.+M.+Yoshida&title=Review+Article%3A+Possible+Beneficial+Effects+of+Coffee+on+Liver+Disease+and+Function&doi=10.1111%2Fj.1365-2036.2007.03319.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: possible beneficial effects of coffee on liver disease and function</span></div><div class="casAuthors">Cadden, I. S. H.; Partovi, N.; Yoshida, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Coffee is consumed by 50% of Americans every day.  After oil, coffee is the second most valuable commodity in the world.  In recent years a no. of studies have suggested potential health risks assocd. with coffee consumption; however, the results are controversial.  While coffee has been reported to increase cardiovascular risk factors, other investigators have demonstrated its protective effects on diseases ranging from type 2 diabetes to Parkinson's disease.  A no. of investigators have focused their attention on the relationship between the consumption of coffee and liver disease.  To examine the published literature to date in an attempt to establish the presence of an hepatoprotective effect of coffee.  Using PubMed, we identified published studies and review articles relating to the effect of coffee consumption on diseases of the liver.  A no. of studies have reported the beneficial effects of coffee on abnormal liver biochem., cirrhosis and hepatocellular carcinoma.  At the present time the mechanism of this effect remains unclear as does the "dose" required to achieve these benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVyemTisgsLrVg90H21EOLACvtfcHk0lgu06sdmCv9qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslGmtbc%253D&md5=2f405eb87c95d3701d782fbb73cc42d7</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2007.03319.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2007.03319.x%26sid%3Dliteratum%253Aachs%26aulast%3DCadden%26aufirst%3DI.%2BS.%2BH.%26aulast%3DPartovi%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DE.%2BM.%26atitle%3DReview%2520Article%253A%2520Possible%2520Beneficial%2520Effects%2520of%2520Coffee%2520on%2520Liver%2520Disease%2520and%2520Function%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D26%26spage%3D1%26doi%3D10.1111%2Fj.1365-2036.2007.03319.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovitch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morens, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandinetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchette, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curb, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popper, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, L. R.</span></span> <span> </span><span class="NLM_article-title">Association of Coffee and Caffeine Intake with the Risk of Parkinson Disease</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">2674</span>– <span class="NLM_lpage">2679</span>, <span class="refDoi"> DOI: 10.1001/jama.283.20.2674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.283.20.2674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3c3otVSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=2674-2679&issue=20&author=G.+W.+Rossauthor=R.+D.+Abbottauthor=H.+Petrovitchauthor=D.+M.+Morensauthor=A.+Grandinettiauthor=K.+H.+Tungauthor=C.+M.+Tannerauthor=K.+H.+Masakiauthor=P.+L.+Blanchetteauthor=J.+D.+Curbauthor=J.+S.+Popperauthor=L.+R.+White&title=Association+of+Coffee+and+Caffeine+Intake+with+the+Risk+of+Parkinson+Disease&doi=10.1001%2Fjama.283.20.2674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">Association of coffee and caffeine intake with the risk of Parkinson disease</span></div><div class="casAuthors">Ross G W; Abbott R D; Petrovitch H; Morens D M; Grandinetti A; Tung K H; Tanner C M; Masaki K H; Blanchette P L; Curb J D; Popper J S; White L R</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2674-9</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">CONTEXT:  The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goal.  OBJECTIVE:  To explore the association of coffee and dietary caffeine intake with risk of PD.  DESIGN, SETTING, AND PARTICIPANTS:  Data were analyzed from 30 years of follow-up of 8004 Japanese-American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968.  MAIN OUTCOME MEASURE:  Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment).  RESULTS:  During follow-up, 102 men were identified as having PD.  Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10,000 person-years in men who drank no coffee to 1.9 per 10,000 person-years in men who drank at least 28 oz/d (P<.001 for trend).  Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from non-coffee sources (P=.03 for trend).  Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P=.049, P=.22, and P=.02, respectively, for trend).  Other nutrients in coffee, including niacin, were unrelated to PD incidence.  The relationship between caffeine and PD was unaltered by intake of milk and sugar.  CONCLUSIONS:  Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD.  This effect appears to be independent of smoking.  The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee.  JAMA. 2000;283:2674-2679.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTHsJbtAiOjbxanA7vODO6fW6udTcc2eb5toA7ZAuc27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3otVSnug%253D%253D&md5=4c6cba94893263f279475d47d532f188</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1001%2Fjama.283.20.2674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.283.20.2674%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DR.%2BD.%26aulast%3DPetrovitch%26aufirst%3DH.%26aulast%3DMorens%26aufirst%3DD.%2BM.%26aulast%3DGrandinetti%26aufirst%3DA.%26aulast%3DTung%26aufirst%3DK.%2BH.%26aulast%3DTanner%26aufirst%3DC.%2BM.%26aulast%3DMasaki%26aufirst%3DK.%2BH.%26aulast%3DBlanchette%26aufirst%3DP.%2BL.%26aulast%3DCurb%26aufirst%3DJ.%2BD.%26aulast%3DPopper%26aufirst%3DJ.%2BS.%26aulast%3DWhite%26aufirst%3DL.%2BR.%26atitle%3DAssociation%2520of%2520Coffee%2520and%2520Caffeine%2520Intake%2520with%2520the%2520Risk%2520of%2520Parkinson%2520Disease%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2000%26volume%3D283%26issue%3D20%26spage%3D2674%26epage%3D2679%26doi%3D10.1001%2Fjama.283.20.2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernán, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takkouche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caamaño-Isorna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestal-Otero, J. J.</span></span> <span> </span><span class="NLM_article-title">A Meta-Analysis of Coffee Drinking, Cigarette Smoking, and the Risk of Parkinson’s Disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1002/ana.10277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fana.10277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12205639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD38vkslGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2002&pages=276-284&issue=3&author=M.+A.+Hern%C3%A1nauthor=B.+Takkoucheauthor=F.+Caama%C3%B1o-Isornaauthor=J.+J.+Gestal-Otero&title=A+Meta-Analysis+of+Coffee+Drinking%2C+Cigarette+Smoking%2C+and+the+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1002%2Fana.10277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease</span></div><div class="casAuthors">Hernan Miguel A; Takkouche Bahi; Caamano-Isorna Francisco; Gestal-Otero Juan J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-84</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">We conducted a systematic review to summarize the epidemiological evidence on the association between cigarette smoking, coffee drinking, and the risk of Parkinson's disease.  Case-control and cohort studies that reported the relative risk of physician-confirmed Parkinson's disease by cigarette smoking or coffee drinking status were included.  Study-specific log relative risks were weighted by the inverse of their variances to obtain a pooled relative risk and its 95% confidence interval (CI).  Results for smoking were based on 44 case-control and 4 cohort studies, and for coffee 8 case-control and 5 cohort studies.  Compared with never smokers, the relative risk of Parkinson's disease was 0.59 (95% CI, 0.54-0.63) for ever smokers, 0.80 (95% CI, 0.69-0.93) for past smokers, and 0.39 (95% CI, 0.32-0.47) for current smokers.  The relative risk per 10 additional pack-years was 0.84 (95% CI, 0.81-0.88) in case-control studies and 0.78 (95% CI, 0.73-0.84) in cohort studies.  Compared with non-coffee drinkers, relative risk of Parkinson's disease was 0.69 (95% CI, 0.59-0.80) for coffee drinkers.  The relative risk per three additional cups of coffee per day was 0.75 (95% CI, 0.64-0.86) in case-control studies and 0.68 (95% CI, 0.46-1.00) in cohort studies.  This meta-analysis shows that there is strong epidemiological evidence that smokers and coffee drinkers have a lower risk of Parkinson's disease.  Further research is required on the biological mechanisms underlying this potentially protective effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIOJoTcbBsc-RS7coPn-RtfW6udTcc2eb5toA7ZAuc27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vkslGktg%253D%253D&md5=6e3d946102848894840229a2f4c77d1c</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1002%2Fana.10277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10277%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1n%26aufirst%3DM.%2BA.%26aulast%3DTakkouche%26aufirst%3DB.%26aulast%3DCaama%25C3%25B1o-Isorna%26aufirst%3DF.%26aulast%3DGestal-Otero%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520Meta-Analysis%2520of%2520Coffee%2520Drinking%252C%2520Cigarette%2520Smoking%252C%2520and%2520the%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2002%26volume%3D52%26issue%3D3%26spage%3D276%26epage%3D284%26doi%3D10.1002%2Fana.10277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz-Carneiro, A.</span></span> <span> </span><span class="NLM_article-title">Caffeine Exposure and the Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Observational Studies</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">s1</span>),  <span class="NLM_fpage">S221</span>– <span class="NLM_lpage">S238</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-091525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2010-091525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20182023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls12hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=S221-S238&issue=s1&author=J.+Costaauthor=N.+Lunetauthor=C.+Santosauthor=J.+Santosauthor=A.+Vaz-Carneiro&title=Caffeine+Exposure+and+the+Risk+of+Parkinson%E2%80%99s+Disease%3A+A+Systematic+Review+and+Meta-Analysis+of+Observational+Studies&doi=10.3233%2FJAD-2010-091525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine Exposure and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis of Observational Studiess</span></div><div class="casAuthors">Costa, Joao; Lunet, Nuno; Santos, Catarina; Santos, Joao; Vaz-Carneiro, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S221-S238</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Several studies conducted worldwide report an inverse assocn. between caffeine/coffee consumption and the risk of developing Parkinson's disease (PD).  However, heterogeneity and conflicting results between studies preclude a correct estn. of the strength of this assocn.  We conducted a systematic review and meta-anal. of published epidemiol. studies to better est. the effect of caffeine exposure on the incidence of PD.  Data sources searched included Medline, LILACS, Scopus, Web of Science and ref. lists, up to Sept. 2009.  Cohort, case-control and cross-sectional studies were included.  Three independent reviewers selected the studies and extd. the data on to standardized forms.  Twenty-six studies were included: 7 cohort, 2 nested case-control, 16 case-control, and 1 cross-sectional study.  Quant. data synthesis of the most precise ests. from each study was accomplished through random effects meta-anal.  Heterogeneity was quantified using the I2 statistic.  The summary RR for the assocn. between caffeine intake and PD was 0.75 [95% Confidence Interval (95%CI): 0.68-0.82], with low to moderate heterogeneity (I2 = 28.8%).  Publication bias for case-control/cross-sectional studies may exist (Egger's test, p = 0.053).  When considering only the cohort studies, the RR was 0.80 (95%CI: 0.71-90; I2 = 8.1%).  The neg. assocn. was weaker when only women were considered (RR=0.86, 95%CI: 0.73-1.02; I2 = 12.9%).  A linear relation was obsd. between levels of exposure to caffeine and the RR ests.: RR of 0.76 (95%CI: 0.72-0.80; I2 = 35.1%) per 300 mg increase in caffeine intake.  This study confirm an inverse assocn. between caffeine intake and the risk of PD, which can hardly by explained by bias or uncontrolled confounding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3s-mlGRYSCLVg90H21EOLACvtfcHk0lh5R4F_DfIm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls12hu7o%253D&md5=0d1ca8bce2d17a2064c7ea95a2ab43e9</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-091525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-091525%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DJ.%26aulast%3DLunet%26aufirst%3DN.%26aulast%3DSantos%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DJ.%26aulast%3DVaz-Carneiro%26aufirst%3DA.%26atitle%3DCaffeine%2520Exposure%2520and%2520the%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%2520of%2520Observational%2520Studies%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26issue%3Ds1%26spage%3DS221%26epage%3DS238%26doi%3D10.3233%2FJAD-2010-091525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sääksjärvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knekt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rissanen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laaksonen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reunanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Männistö, S.</span></span> <span> </span><span class="NLM_article-title">Prospective Study of Coffee Consumption and Risk of Parkinson’s Disease</span>. <i>Eur. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1038/sj.ejcn.1602788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.ejcn.1602788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17522612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1cvit1ygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=908-915&issue=7&author=K.+S%C3%A4%C3%A4ksj%C3%A4rviauthor=P.+Knektauthor=H.+Rissanenauthor=M.+A.+Laaksonenauthor=A.+Reunanenauthor=S.+M%C3%A4nnist%C3%B6&title=Prospective+Study+of+Coffee+Consumption+and+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1038%2Fsj.ejcn.1602788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of coffee consumption and risk of Parkinson's disease</span></div><div class="casAuthors">Saaksjarvi K; Knekt P; Rissanen H; Laaksonen M A; Reunanen A; Mannisto S</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">908-15</span>
        ISSN:<span class="NLM_cas:issn">0954-3007</span>.
    </div><div class="casAbstract">OBJECTIVE:  To examine the prediction of coffee consumption on the incidence of Parkinson's disease.  SUBJECTS AND METHODS:  The study population comprised 6710 men and women, aged 50-79 years and free from Parkinson's disease at the baseline.  At baseline, enquiries were made about coffee consumption in a self-administered questionnaire as the average number of cups per day.  During a 22-year follow-up, 101 incident cases of Parkinson's disease occurred.  Parkinson's disease cases were identified through a nationwide registry of patients receiving medication reimbursement, which is based on certificates from neurologist.  RESULTS:  After adjustments for age, sex, marital status, education, community density, alcohol consumption, leisure-time physical activity, smoking, body mass index, hypertension and serum cholesterol, the relative risk for subjects drinking 10 or more cups of coffee per day compared with non-drinkers was 0.26 (95% confidence interval 0.07-0.99, P-value for trend=0.18).  The association was stronger among overweight persons and among persons with lower serum cholesterol level (P-value for interaction=0.04 and 0.03, respectively).  CONCLUSIONS:  The results support the hypothesis that coffee consumption reduces the risk of Parkinson's disease, but protective effect of coffee may vary by exposure to other factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSF9-I_ElzX0myYR5VtavbzfW6udTcc2ebB0QCSjk0hX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvit1ygug%253D%253D&md5=1a46a5a4d3a9da7e0f7be1f5463470c5</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1038%2Fsj.ejcn.1602788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ejcn.1602788%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A4%25C3%25A4ksj%25C3%25A4rvi%26aufirst%3DK.%26aulast%3DKnekt%26aufirst%3DP.%26aulast%3DRissanen%26aufirst%3DH.%26aulast%3DLaaksonen%26aufirst%3DM.%2BA.%26aulast%3DReunanen%26aufirst%3DA.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DS.%26atitle%3DProspective%2520Study%2520of%2520Coffee%2520Consumption%2520and%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Clin.%2520Nutr.%26date%3D2008%26volume%3D62%26issue%3D7%26spage%3D908%26epage%3D915%26doi%3D10.1038%2Fsj.ejcn.1602788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ascherio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernán, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawachi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colditz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speizer, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span> <span> </span><span class="NLM_article-title">Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1002/ana.1052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fana.1052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=11456310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=56-63&issue=1&author=A.+Ascherioauthor=S.+M.+Zhangauthor=M.+A.+Hern%C3%A1nauthor=I.+Kawachiauthor=G.+A.+Colditzauthor=F.+E.+Speizerauthor=W.+C.+Willett&title=Prospective+Study+of+Caffeine+Consumption+and+Risk+of+Parkinson%E2%80%99s+Disease+in+Men+and+Women&doi=10.1002%2Fana.1052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of caffeine consumption and risk of Parkinson's disease in men and women</span></div><div class="casAuthors">Ascherio, Alberto; Zhang, Shumin M.; Hernan, Miguel A.; Kawachi, Ichiro; Colditz, Graham A.; Speizer, Frank E.; Willett, Walter C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Results of case-control studies and of a prospective investigation in men suggest that consumption of coffee could protect against the risk of Parkinson's disease, but the active constituent is not clear.  To address the hypothesis that caffeine is protective against Parkinson's disease, we examd. the relationship of coffee and caffeine consumption to the risk of this disease among participants in two ongoing cohorts, the Health Professionals' Follow-Up Study (HPFS) and the Nurses' Health Study (NHS).  The study population comprised 47,351 men and 88,565 women who were free of Parkinson's disease, stroke, or cancer at baseline.  A comprehensive life style and dietary questionnaire was completed by the participants at baseline and updated every two to four years.  During the follow-up (10 yr in men, 16 yr in women), we documented a total of 288 incident cases of Parkinson's disease.  Among men, after adjustment for age and smoking, the relative risk of Parkinson's disease was 0.42 (95% CI: 0.23-0.78; p for trend < 0.001) for men in the top one-fifth of caffeine intake compared to those in the bottom one-fifth.  An inverse assocn. was also obsd. with consumption of coffee (p for trend = 0.004), caffeine from non-coffee sources (p for trend < 0.001), and tea (p for trend = 0.02) but not decaffeinated coffee.  Among women, the relationship between caffeine or coffee intake and risk of Parkinson's disease was U-shaped, with the lowest risk obsd. at moderate intakes (1-3 cups of coffee/day, or the third quintile of caffeine consumption).  These results support a possible protective effect of moderate doses of caffeine on risk of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgS7GGPMwGrVg90H21EOLACvtfcHk0lh5R4F_DfIm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D&md5=6ed856feee3eb746e8149ce9c7c6a5a6</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1002%2Fana.1052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.1052%26sid%3Dliteratum%253Aachs%26aulast%3DAscherio%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DS.%2BM.%26aulast%3DHern%25C3%25A1n%26aufirst%3DM.%2BA.%26aulast%3DKawachi%26aufirst%3DI.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DSpeizer%26aufirst%3DF.%2BE.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26atitle%3DProspective%2520Study%2520of%2520Caffeine%2520Consumption%2520and%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%2520in%2520Men%2520and%2520Women%26jtitle%3DAnn.%2520Neurol.%26date%3D2001%26volume%3D50%26issue%3D1%26spage%3D56%26epage%3D63%26doi%3D10.1002%2Fana.1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref263"><div class="reference"><strong class="refLabel"><a href="#ref263" class="rightTabRefNumLink">263</a></strong><div class="NLM_citation" id="rightTab-cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ascherio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzschild, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colditz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speizer, F. E.</span></span> <span> </span><span class="NLM_article-title">Caffeine, Postmenopausal Estrogen, and Risk of Parkinson’s Disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">790</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1212/01.WNL.0000046523.05125.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1212%2F01.WNL.0000046523.05125.87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12629235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3s7hs1Sntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=790-795&issue=5&author=A.+Ascherioauthor=H.+Chenauthor=M.+A.+Schwarzschildauthor=S.+M.+Zhangauthor=G.+A.+Colditzauthor=F.+E.+Speizer&title=Caffeine%2C+Postmenopausal+Estrogen%2C+and+Risk+of+Parkinson%E2%80%99s+Disease&doi=10.1212%2F01.WNL.0000046523.05125.87"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine, postmenopausal estrogen, and risk of Parkinson's disease</span></div><div class="casAuthors">Ascherio A; Chen H; Schwarzschild M A; Zhang S M; Colditz G A; Speizer F E</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">790-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Men who regularly consume caffeinated drinks have a lower risk of PD than do nondrinkers, but this relation has not been found in women.  Because this sex difference could be due to hormonal effects, the authors examined prospectively the risk of PD according to use of postmenopausal hormones and caffeine intake among participants in the Nurses' Health Study.  METHODS:  The study population comprised 77,713 women free of PD, stroke, or cancer at baseline, who were postmenopausal at baseline or reached menopause before the end of the study.  During 18 years of follow-up the authors documented 154 cases of PD.  RESULTS:  Overall, the risk of PD was similar in women using hormones and women who never used hormones (relative risk 1.02, 95% CI 0.69 to 1.52).  Use of hormones, however, was associated with a reduced risk of PD among women with low caffeine consumption (RR 0.39, 95% CI 0.13 to 1.17), and with increased risk among women with high caffeine consumption (RR 2.44, 95% CI 0.75 to 7.86; p for interaction = 0.01).  Among hormone users, women consuming six or more cups of coffee per day had a fourfold higher risk of PD (RR 3.92, 95% CI 1.49 to 10.34; p = 0.006) than did women who never drink coffee.  CONCLUSION:  These results suggest that caffeine reduces the risk of PD among women who do not use postmenopausal hormones, but increases risk among hormone users.  Clinical trials of caffeine or estrogens in women should avoid the combined use of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQg1RbL0sF_lUNoizSOkG_FfW6udTcc2eYEvx0LyqzYjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7hs1Sntg%253D%253D&md5=1ad6b9ddc06cf305668f2ca64b86ec7c</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1212%2F01.WNL.0000046523.05125.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.WNL.0000046523.05125.87%26sid%3Dliteratum%253Aachs%26aulast%3DAscherio%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DZhang%26aufirst%3DS.%2BM.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DSpeizer%26aufirst%3DF.%2BE.%26atitle%3DCaffeine%252C%2520Postmenopausal%2520Estrogen%252C%2520and%2520Risk%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D60%26issue%3D5%26spage%3D790%26epage%3D795%26doi%3D10.1212%2F01.WNL.0000046523.05125.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref264"><div class="reference"><strong class="refLabel"><a href="#ref264" class="rightTabRefNumLink">264</a></strong><div class="NLM_citation" id="rightTab-cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkelmayer, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stampfer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curhan, G. C.</span></span> <span> </span><span class="NLM_article-title">Habitual Caffeine Intake and the Risk of Hypertension in Women</span>. <i>J. Am. Med. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2330</span>– <span class="NLM_lpage">2335</span>, <span class="refDoi"> DOI: 10.1001/jama.294.18.2330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1001%2Fjama.294.18.2330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Srt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2005&pages=2330-2335&issue=18&author=W.+C.+Winkelmayerauthor=M.+J.+Stampferauthor=W.+C.+Willettauthor=G.+C.+Curhan&title=Habitual+Caffeine+Intake+and+the+Risk+of+Hypertension+in+Women&doi=10.1001%2Fjama.294.18.2330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Habitual caffeine intake and the risk of hypertension in women</span></div><div class="casAuthors">Winkelmayer, Wolfgang C.; Stampfer, Meir J.; Willett, Walter C.; Curhan, Gary C.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2330-2335</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Caffeine acutely increases blood pressure, but the assocn. between habitual consumption of caffeinated beverages and incident hypertension is uncertain.  The study examd. the assocn. between caffeine intake and incident hypertension in women.  Design, Setting, and Participants: Prospective cohort study conducted in the Nurses' Health Studies (NHSs) I and II of 155594 US women free from physician-diagnosed hypertension followed up over 12 years (1990 - 1991 to 2002 - 2003 questionnaires).  Caffeine intake and possible confounders were ascertained from regularly administered questionnaires.  We also tested the assocns. with types of caffeinated beverages.  Main Outcome Measure: Incident physician-diagnosed hypertension.  During follow-up, 19541 incident cases of physician-diagnosed hypertension were reported in NHS I and 13536 in NHS II.  In both cohorts, no linear assocn. between caffeine consumption and risk of incident hypertension was obsd. after multivariate adjustment (NHS I, P for trend =.29; NHS II, P for trend =.53).  Using categorical anal., an inverse U-shaped assocn. between caffeine consumption and incident hypertension was found.  Compared with participants in the lowest quintile of caffeine consumption, those in the third quintile had a 13% and 12% increased risk of hypertension, resp. (95% confidence interval in NHS I, 8% - 18%; in NHS 11, 6% - 18%).  When studying individual classes of caffeinated beverages, habitual coffee consumption was not assocd. with increased risk of hypertension.  By contrast, consumption of cola beverages was assocd. with an increased risk of hypertension, independent of whether it was sugared or diet cola (P for trend <.001).  No linear assocn. between caffeine consumption and incident hypertension was found.  Even though habitual coffee consumption was not assocd. with an increased risk of hypertension, consumption of sugared or diet cola was assocd. with it.  Further research to elucidate the role of cola beverages in hypertension is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Fjd0LbWTgbVg90H21EOLACvtfcHk0lgHwf7Iwlew-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Srt77O&md5=36fe24e41b7777ff4ed92724947ab42d</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1001%2Fjama.294.18.2330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.294.18.2330%26sid%3Dliteratum%253Aachs%26aulast%3DWinkelmayer%26aufirst%3DW.%2BC.%26aulast%3DStampfer%26aufirst%3DM.%2BJ.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26aulast%3DCurhan%26aufirst%3DG.%2BC.%26atitle%3DHabitual%2520Caffeine%2520Intake%2520and%2520the%2520Risk%2520of%2520Hypertension%2520in%2520Women%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2005%26volume%3D294%26issue%3D18%26spage%3D2330%26epage%3D2335%26doi%3D10.1001%2Fjama.294.18.2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref265"><div class="reference"><strong class="refLabel"><a href="#ref265" class="rightTabRefNumLink">265</a></strong><div class="NLM_citation" id="rightTab-cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassen, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugbjerg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, B.</span></span> <span> </span><span class="NLM_article-title">Reproductive Factors and Parkinson’s Disease Risk in Danish Women</span>. <i>Eur. J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1168</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1111/ene.12450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1111%2Fene.12450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=24750445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2cnlt12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1168-1177&issue=9&author=N.+Greeneauthor=C.+F.+Lassenauthor=K.+Rugbjergauthor=B.+Ritz&title=Reproductive+Factors+and+Parkinson%E2%80%99s+Disease+Risk+in+Danish+Women&doi=10.1111%2Fene.12450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Reproductive factors and Parkinson's disease risk in Danish women</span></div><div class="casAuthors">Greene N; Lassen C F; Rugbjerg K; Ritz B</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1168-77, e68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Parkinson's disease is more common in men than women by a ratio of about 1.5:1 and yet there is no consensus to date as to whether female reproductive factors including hormone use affect Parkinson's disease risk.  Our objective was to examine the relationship between Parkinson's disease and female reproductive factors in the largest population-based Parkinson's disease case-control study to date.  METHODS:  Seven hundred and forty-three female Parkinson's disease cases diagnosed between 1996 and 2009 were selected from the Danish National Hospital Register, diagnoses confirmed by medical record review, and the cases were matched by birth year to 765 female controls randomly selected from the Danish Civil Registration System.  Covariate information was collected in computer-assisted telephone interviews covering an extensive array of topics including reproductive and lifestyle factors.  RESULTS:  After adjusting for smoking, caffeine and alcohol use, education, age, and family Parkinson's disease history, inverse associations between Parkinson's disease and early menarche (first period at ≤11 years), oral contraceptives, high parity (≥4 children) and bilateral oophorectomy were found; adjusted odds ratios and 95% confidence limits were respectively 0.68 (0.45-1.03) for early menarche, 0.87 (0.69-1.10) for oral contraceptives, 0.79 (0.59-1.06) for high parity and 0.65 (0.45-0.94) for bilateral oophorectomy.  Little support for associations between Parkinson's disease and fertile life length, age at menopause or post-menopausal hormone treatment was found.  CONCLUSIONS:  Reproductive factors related to women's early- to mid-reproductive lives appear to be predictive of subsequent Parkinson's disease risk whereas factors occurring later in life seem less important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRs-BnPhDqJIkNoizSOkG_FfW6udTcc2eYEvx0LyqzYjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnlt12nsg%253D%253D&md5=cae787b2cb02f99865897cf19ff994f2</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1111%2Fene.12450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fene.12450%26sid%3Dliteratum%253Aachs%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DLassen%26aufirst%3DC.%2BF.%26aulast%3DRugbjerg%26aufirst%3DK.%26aulast%3DRitz%26aufirst%3DB.%26atitle%3DReproductive%2520Factors%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%2520Risk%2520in%2520Danish%2520Women%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1168%26epage%3D1177%26doi%3D10.1111%2Fene.12450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref266"><div class="reference"><strong class="refLabel"><a href="#ref266" class="rightTabRefNumLink">266</a></strong><div class="NLM_citation" id="rightTab-cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hameleers, P. A. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Boxtel, M. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogervorst, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houx, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buntinx, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolles, J.</span></span> <span> </span><span class="NLM_article-title">Habitual Caffeine Consumption and Its Relation to Memory, Attention, Planning Capacity and Psychomotor Performance across Multiple Age Groups</span>. <i>Hum. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1002/hup.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1002%2Fhup.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12404609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC2sbmvVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=573-581&issue=8&author=P.+A.+H.+M.+Hameleersauthor=M.+P.+J.+Van+Boxtelauthor=E.+Hogervorstauthor=W.+J.+Riedelauthor=P.+J.+Houxauthor=F.+Buntinxauthor=J.+Jolles&title=Habitual+Caffeine+Consumption+and+Its+Relation+to+Memory%2C+Attention%2C+Planning+Capacity+and+Psychomotor+Performance+across+Multiple+Age+Groups&doi=10.1002%2Fhup.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups</span></div><div class="casAuthors">Hameleers P. A. H. M; Van Boxtel M. P. J; Hogervorst E; Riedel W. J; Houx P. J; Buntinx F; Jolles J</div><div class="citationInfo"><span class="NLM_cas:title">Human psychopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">573-581</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The present study evaluated the association between habitual caffeine intake via coffee and tea and cognitive performance.  This was done as part of a larger research programme into the determinants of cognitive ageing (the Maastricht Aging Study: MAAS).  Possible withdrawal effects that may have explained in part the positive association between performance and intake in an earlier study were controlled for.  In addition, all cognitive tests in this study were administered under strict laboratory conditions.  A group of 1875 healthy adults, stratified for age (range 24 - 81 years), sex, and general ability, were screened for habitual intake of coffee and tea and took part in extensive cognitive testing.  Multiple regression analysis with control for age, sex, socio-demographic variables, and substance use showed that habitual caffeine consumption was significantly related to better long-term memory performance and faster locomotor speed.  No relationships were found between habitual caffeine consumption and short-term memory, information processing, planning, and attention as measured with the Stroop Test.  Moreover, no difference in sensitivity to caffeine intake between different age groups was found, suggesting that caffeine intake did not counteract age-related cognitive decline.  Several recommendations are made to improve the design of future studies in this field.  Copyright 2000 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdPn0U0pOQ9EodMGTatQ7LfW6udTcc2eZzhDjVoWSFrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbmvVCqtA%253D%253D&md5=75b18f4f40caa1eec8c190783c0343c7</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1002%2Fhup.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhup.218%26sid%3Dliteratum%253Aachs%26aulast%3DHameleers%26aufirst%3DP.%2BA.%2BH.%2BM.%26aulast%3DVan%2BBoxtel%26aufirst%3DM.%2BP.%2BJ.%26aulast%3DHogervorst%26aufirst%3DE.%26aulast%3DRiedel%26aufirst%3DW.%2BJ.%26aulast%3DHoux%26aufirst%3DP.%2BJ.%26aulast%3DBuntinx%26aufirst%3DF.%26aulast%3DJolles%26aufirst%3DJ.%26atitle%3DHabitual%2520Caffeine%2520Consumption%2520and%2520Its%2520Relation%2520to%2520Memory%252C%2520Attention%252C%2520Planning%2520Capacity%2520and%2520Psychomotor%2520Performance%2520across%2520Multiple%2520Age%2520Groups%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2000%26volume%3D15%26issue%3D8%26spage%3D573%26epage%3D581%26doi%3D10.1002%2Fhup.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref267"><div class="reference"><strong class="refLabel"><a href="#ref267" class="rightTabRefNumLink">267</a></strong><div class="NLM_citation" id="rightTab-cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Boxtel, M. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolles, J.</span></span> <span> </span><span class="NLM_article-title">The Effects of Habitual Caffeine Use on Cognitive Change: A Longitudinal Perspective</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1016/S0091-3057(03)00171-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2FS0091-3057%2803%2900171-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12957237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvV2qs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=921-927&issue=4&author=M.+P.+J.+Van+Boxtelauthor=J.+A.+J.+Schmittauthor=H.+Bosmaauthor=J.+Jolles&title=The+Effects+of+Habitual+Caffeine+Use+on+Cognitive+Change%3A+A+Longitudinal+Perspective&doi=10.1016%2FS0091-3057%2803%2900171-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of habitual caffeine use on cognitive change: a longitudinal perspective</span></div><div class="casAuthors">van Boxtel, M. P. J.; Schmitt, J. A. J.; Bosma, H.; Jolles, J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-927</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The efficiency of higher cortical functions, such as memory and speed of complex information processing, tends to decrease with advancing age in normal healthy individuals.  Recently, a high habitual intake of caffeine was found assocd. with better verbal memory performance and psychomotor speed in several cross-sectional population studies.  We tested the hypothesis that habitual caffeine intake can reduce or postpone age-related cognitive decline in healthy adults.  For this purpose, the cognitive performance of all participants in the Maastricht Aging Study (MAAS), aged between 24 and 81 yr, was reassessed after 6 yr.  Information on the intake of caffeine-contg. beverages was available from the baseline questionnaire.  After 6 yr, 1376 (75.6%) individuals were available for reassessment.  After correction for demog. characteristics, baseline performance and health status, there were small albeit significant assocns. between the overall estd. caffeine intake at baseline and the 6-yr change in complex motor speed (motor choice reaction time).  The earlier found assocn. between caffeine intake and verbal memory performance was not apparent in this longitudinal study.  These results imply that the longitudinal effect of habitual caffeine intake is limited and will not promote a substantial redn. in age-related cognitive decline at a population level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob6hoaLWQzBLVg90H21EOLACvtfcHk0liKhsg7c2BY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvV2qs78%253D&md5=2720b2734699b00b52e11a22980869b5</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2803%2900171-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252803%252900171-0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBoxtel%26aufirst%3DM.%2BP.%2BJ.%26aulast%3DSchmitt%26aufirst%3DJ.%2BA.%2BJ.%26aulast%3DBosma%26aufirst%3DH.%26aulast%3DJolles%26aufirst%3DJ.%26atitle%3DThe%2520Effects%2520of%2520Habitual%2520Caffeine%2520Use%2520on%2520Cognitive%2520Change%253A%2520A%2520Longitudinal%2520Perspective%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2003%26volume%3D75%26issue%3D4%26spage%3D921%26epage%3D927%26doi%3D10.1016%2FS0091-3057%2803%2900171-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref268"><div class="reference"><strong class="refLabel"><a href="#ref268" class="rightTabRefNumLink">268</a></strong><div class="NLM_citation" id="rightTab-cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. J.</span></span> <span> </span><span class="NLM_article-title">Does Caffeine Intake Enhance Absolute Levels of Cognitive Performance?</span>. <i>Psychopharmacology (Berl).</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1007/BF02246949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2FBF02246949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=7870897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1993&pages=45-52&issue=1%E2%80%932&author=M.+J.+Jarvis&title=Does+Caffeine+Intake+Enhance+Absolute+Levels+of+Cognitive+Performance%3F&doi=10.1007%2FBF02246949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">Does caffeine intake enhance absolute levels of cognitive performance?</span></div><div class="casAuthors">Jarvis, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The relationship between habitual coffee and tea consumption and cognitive performance was examd. using data from a cross-sectional survey of a representative sample of 9003 British adults (the Health and Lifestyle Survey).  Subjects completed tests of simple reaction time, choice reaction time, incidental verbal memory, and visuo-spatial reasoning, in addn. to providing self-reports of usual coffee and tea intake.  After controlling extensively for potential confounding variables, a dose-response trend to improved performance with higher levels of coffee consumption was obsd. for all four tests.  Similar but weaker assocns. were found for tea consumption, which were significant for simple reaction time and visuo-spatial reasoning.  Estd. overall caffeine consumption showed a dose-response relationship to improved cognitive performance .  Older people appeared to be more susceptible to the performance-improving effects of caffeine than were younger.  The results suggest that tolerance to the performance-enhancing effects of caffeine, if it occurs at all, is incomplete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_q18Qjcu5LVg90H21EOLACvtfcHk0liKhsg7c2BY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKlur4%253D&md5=ea00b1194126df06be0295d387d689c9</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1007%2FBF02246949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246949%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DM.%2BJ.%26atitle%3DDoes%2520Caffeine%2520Intake%2520Enhance%2520Absolute%2520Levels%2520of%2520Cognitive%2520Performance%253F%26jtitle%3DPsychopharmacology%2520%2528Berl%2529.%26date%3D1993%26volume%3D110%26issue%3D1%25E2%2580%25932%26spage%3D45%26epage%3D52%26doi%3D10.1007%2FBF02246949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref269"><div class="reference"><strong class="refLabel"><a href="#ref269" class="rightTabRefNumLink">269</a></strong><div class="NLM_citation" id="rightTab-cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dall’Igna, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, D. R.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Adenosine A2a Receptor Antagonists Prevent β-Amyloid (25–35)-Induced Cognitive Deficits in Mice</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>203</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2006.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.expneurol.2006.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17007839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2007&pages=241-245&issue=1&author=O.+P.+Dall%E2%80%99Ignaauthor=P.+Fettauthor=M.+W.+Gomesauthor=D.+O.+Souzaauthor=R.+A.+Cunhaauthor=D.+R.+Lara&title=Caffeine+and+Adenosine+A2a+Receptor+Antagonists+Prevent+%CE%B2-Amyloid+%2825%E2%80%9335%29-Induced+Cognitive+Deficits+in+Mice&doi=10.1016%2Fj.expneurol.2006.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25-35)-induced cognitive deficits in mice</span></div><div class="casAuthors">Dall'Igna, Oscar P.; Fett, Paulo; Gomes, Marcio W.; Souza, Diogo O.; Cunha, Rodrigo A.; Lara, Diogo R.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">241-245</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Consumption of caffeine, an adenosine receptor antagonist, was found to be inversely assocd. with the incidence of Alzheimer's disease.  Moreover, caffeine protects cultured neurons against β-amyloid-induced toxicity, an effect mimicked by adenosine A2A but not A1 receptor antagonists.  We now tested if caffeine administration would prevent β-amyloid-induced cognitive impairment in mice and if this was mimicked by A2A receptor blockade.  One week after icv administration of the 25-35 fragment of β-amyloid (Aβ, 3 nmol), mice displayed impaired performance in both inhibitory avoidance and spontaneous alternation tests.  Prolonged treatment with caffeine (1 mg/mL) had no effect alone but prevented the Aβ-induced cognitive impairment in both tasks when assocd. with acute caffeine (30 mg/kg) 30 min treatment before Aβ administration.  The same protective effect was obsd. after subchronic (4 days) treatment with daily injections of either caffeine (30 mg/kg) or the selective adenosine A2A receptor antagonist SCH58261 (0.5 mg/kg).  This provides the first direct in vivo evidence that caffeine and A2A receptor antagonists afford a protection against Aβ-induced amnesia, which prompts their interest for managing Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSWIvxJ5TG1rVg90H21EOLACvtfcHk0liKhsg7c2BY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73I&md5=508ab5a63a514e9ee2da575a42b95d64</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2006.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2006.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DDall%25E2%2580%2599Igna%26aufirst%3DO.%2BP.%26aulast%3DFett%26aufirst%3DP.%26aulast%3DGomes%26aufirst%3DM.%2BW.%26aulast%3DSouza%26aufirst%3DD.%2BO.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DLara%26aufirst%3DD.%2BR.%26atitle%3DCaffeine%2520and%2520Adenosine%2520A2a%2520Receptor%2520Antagonists%2520Prevent%2520%25CE%25B2-Amyloid%2520%252825%25E2%2580%259335%2529-Induced%2520Cognitive%2520Deficits%2520in%2520Mice%26jtitle%3DExp.%2520Neurol.%26date%3D2007%26volume%3D203%26issue%3D1%26spage%3D241%26epage%3D245%26doi%3D10.1016%2Fj.expneurol.2006.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref270"><div class="reference"><strong class="refLabel"><a href="#ref270" class="rightTabRefNumLink">270</a></strong><div class="NLM_citation" id="rightTab-cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnouf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferry, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batalha, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariciniak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Jeugd, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaten, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Hooge, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeant, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buée, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span> <span> </span><span class="NLM_article-title">A2A Adenosine Receptor Deletion Is Protective in a Mouse Model of Tauopathy</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/mp.2014.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fmp.2014.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=25450226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVemsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=97-107&issue=1&author=C.+Laurentauthor=S.+Burnoufauthor=B.+Ferryauthor=V.+L.+Batalhaauthor=J.+E.+Coelhoauthor=Y.+Baqiauthor=E.+Malikauthor=E.+Mariciniakauthor=S.+Parrotauthor=A.+Van+Der+Jeugdauthor=E.+Faivreauthor=V.+Flatenauthor=C.+Ledentauthor=R.+D%E2%80%99Hoogeauthor=N.+Sergeantauthor=M.+Hamdaneauthor=S.+Humezauthor=C.+E.+M%C3%BCllerauthor=L.+V.+Lopesauthor=L.+Bu%C3%A9eauthor=D.+Blum&title=A2A+Adenosine+Receptor+Deletion+Is+Protective+in+a+Mouse+Model+of+Tauopathy&doi=10.1038%2Fmp.2014.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor deletion is protective in a mouse model of Tauopathy</span></div><div class="casAuthors">Laurent, C.; Burnouf, S.; Ferry, B.; Batalha, V. L.; Coelho, J. E.; Baqi, Y.; Malik, E.; Marciniak, E.; Parrot, S.; Van der Jeugd, A.; Faivre, E.; Flaten, V.; Ledent, C.; D'Hooge, R.; Sergeant, N.; Hamdane, M.; Humez, S.; Muller, C. E.; Lopes, L. V.; Buee, L.; Blum, D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Consumption of caffeine, a non-selective adenosine A2A receptor (A2AR) antagonist, reduces the risk of developing Alzheimer's disease (AD) in humans and mitigates both amyloid and Tau burden in transgenic mouse models.  However, the impact of selective A2AR blockade on the progressive development of AD-related lesions and assocd. memory impairments has not been investigated.  In the present study, we removed the gene encoding A2AR from THY-Tau22 mice and analyzed the subsequent effects on both pathol. (Tau phosphorylation and aggregation, neuro-inflammation) and functional impairments (spatial learning and memory, hippocampal plasticity, neurotransmitter profile).  We found that deleting A2ARs protect from Tau pathol.-induced deficits in terms of spatial memory and hippocampal long-term depression.  These effects were concomitant with a normalization of the hippocampal glutamate/gamma-amino butyric acid ratio, together with a global redn. in neuro-inflammatory markers and a decrease in Tau hyperphosphorylation.  Addnl., oral therapy using a specific A2AR antagonist (MSX-3) significantly improved memory and reduced Tau hyperphosphorylation in THY-Tau22 mice.  By showing that A2AR genetic or pharmacol. blockade improves the pathol. phenotype in a Tau transgenic mouse model, the present data highlight A2A receptors as important mol. targets to consider against AD and Tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2xpjoIHTEZ7Vg90H21EOLACvtfcHk0lhvXbLIKnkrMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVemsr7I&md5=5d461cf97e43df149e7d2613a2679da9</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.151%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DC.%26aulast%3DBurnouf%26aufirst%3DS.%26aulast%3DFerry%26aufirst%3DB.%26aulast%3DBatalha%26aufirst%3DV.%2BL.%26aulast%3DCoelho%26aufirst%3DJ.%2BE.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DMalik%26aufirst%3DE.%26aulast%3DMariciniak%26aufirst%3DE.%26aulast%3DParrot%26aufirst%3DS.%26aulast%3DVan%2BDer%2BJeugd%26aufirst%3DA.%26aulast%3DFaivre%26aufirst%3DE.%26aulast%3DFlaten%26aufirst%3DV.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DHamdane%26aufirst%3DM.%26aulast%3DHumez%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DLopes%26aufirst%3DL.%2BV.%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DD.%26atitle%3DA2A%2520Adenosine%2520Receptor%2520Deletion%2520Is%2520Protective%2520in%2520a%2520Mouse%2520Model%2520of%2520Tauopathy%26jtitle%3DMol.%2520Psychiatry%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D97%26epage%3D107%26doi%3D10.1038%2Fmp.2014.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref271"><div class="reference"><strong class="refLabel"><a href="#ref271" class="rightTabRefNumLink">271</a></strong><div class="NLM_citation" id="rightTab-cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koppelstaetter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeppel, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siedentopf, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ischebeck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haala, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottaghy, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhomberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golaszewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotwald, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolbitsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, B. J.</span></span> <span> </span><span class="NLM_article-title">Does Caffeine Modulate Verbal Working Memory Processes? An FMRI Study</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2007.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroimage.2007.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17936643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD2snosVelsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=492-499&issue=1&author=F.+Koppelstaetterauthor=T.+D.+Poeppelauthor=C.+M.+Siedentopfauthor=A.+Ischebeckauthor=M.+Veriusauthor=I.+Haalaauthor=F.+M.+Mottaghyauthor=P.+Rhombergauthor=S.+Golaszewskiauthor=T.+Gotwaldauthor=I.+H.+Lorenzauthor=C.+Kolbitschauthor=S.+Felberauthor=B.+J.+Krause&title=Does+Caffeine+Modulate+Verbal+Working+Memory+Processes%3F+An+FMRI+Study&doi=10.1016%2Fj.neuroimage.2007.08.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Does caffeine modulate verbal working memory processes? An fMRI study</span></div><div class="casAuthors">Koppelstaetter F; Poeppel T D; Siedentopf C M; Ischebeck A; Verius M; Haala I; Mottaghy F M; Rhomberg P; Golaszewski S; Gotwald T; Lorenz I H; Kolbitsch C; Felber S; Krause B J</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">492-9</span>
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    </div><div class="casAbstract">To assess the effect of caffeine on the functional MRI signal during a 2-back verbal working memory task, we examined blood oxygenation level-dependent regional brain activity in 15 healthy right-handed males.  The subjects, all moderate caffeine consumers, underwent two scanning sessions on a 1.5-T MR-Scanner separated by a 24- to 48-h interval.  Each participant received either placebo or 100 mg caffeine 20 min prior to the performance of the working memory task in blinded crossover fashion.  The study was implemented as a blocked-design.  Analysis was performed using SPM2.  In both conditions, the characteristic working memory network of frontoparietal cortical activation including the precuneus and the anterior cingulate could be shown.  In comparison to placebo, caffeine caused an increased response in the bilateral medial frontopolar cortex (BA 10), extending to the right anterior cingulate cortex (BA 32).  These results suggest that caffeine modulates neuronal activity as evidenced by fMRI signal changes in a network of brain areas associated with executive and attentional functions during working memory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9V8O6sKsTrPh3YQQtAhNufW6udTcc2eatn_UFFgJzyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snosVelsQ%253D%253D&md5=56c7a0df35cad8093f95683974a0b011</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2007.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2007.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DKoppelstaetter%26aufirst%3DF.%26aulast%3DPoeppel%26aufirst%3DT.%2BD.%26aulast%3DSiedentopf%26aufirst%3DC.%2BM.%26aulast%3DIschebeck%26aufirst%3DA.%26aulast%3DVerius%26aufirst%3DM.%26aulast%3DHaala%26aufirst%3DI.%26aulast%3DMottaghy%26aufirst%3DF.%2BM.%26aulast%3DRhomberg%26aufirst%3DP.%26aulast%3DGolaszewski%26aufirst%3DS.%26aulast%3DGotwald%26aufirst%3DT.%26aulast%3DLorenz%26aufirst%3DI.%2BH.%26aulast%3DKolbitsch%26aufirst%3DC.%26aulast%3DFelber%26aufirst%3DS.%26aulast%3DKrause%26aufirst%3DB.%2BJ.%26atitle%3DDoes%2520Caffeine%2520Modulate%2520Verbal%2520Working%2520Memory%2520Processes%253F%2520An%2520FMRI%2520Study%26jtitle%3DNeuroImage%26date%3D2008%26volume%3D39%26issue%3D1%26spage%3D492%26epage%3D499%26doi%3D10.1016%2Fj.neuroimage.2007.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref272"><div class="reference"><strong class="refLabel"><a href="#ref272" class="rightTabRefNumLink">272</a></strong><div class="NLM_citation" id="rightTab-cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelligrino, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetri, F.</span></span> <span> </span><span class="NLM_article-title">Caffeine and the Control of Cerebral Hemodynamics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">s1</span>),  <span class="NLM_fpage">S51</span>– <span class="NLM_lpage">S62</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-091261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.3233%2FJAD-2010-091261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=20182032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls12hurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=S51-S62&issue=s1&author=D.+A.+Pelligrinoauthor=H.+L.+Xuauthor=F.+Vetri&title=Caffeine+and+the+Control+of+Cerebral+Hemodynamics&doi=10.3233%2FJAD-2010-091261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and the Control of Cerebral Hemodynamics</span></div><div class="casAuthors">Pelligrino, Dale A.; Xu, Hao-Liang; Vetri, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S51-S62</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  While the influence of caffeine on the regulation of brain perfusion has been the subject of multiple publications, the mechanisms involved in that regulation remain unclear.  To some extent, that uncertainty is a function of a complex interplay of processes arising from multiple targets of caffeine located on a variety of different cells, many of which have influence, either directly or indirectly, on cerebral vascular smooth muscle tone.  Adding to that complexity are the target-specific functional changes that may occur when comparing acute and chronic caffeine exposure.  In the present review, we discuss some of the mechanisms behind caffeine influences on cerebrovascular function.  The major effects of caffeine on the cerebral circulation can largely be ascribed to its inhibitory effects on adenosine receptors.  Herein, we focus mostly on the A1, A2A, and A2B subtypes located in cells comprising the neurovascular unit (neurons, astrocytes, vascular smooth muscle); their roles in the coupling of increased neuronal (synaptic) activity to vasodilation; how caffeine, through blockade of these receptors, may interfere with the "neurovascular coupling" process; and receptor-linked changes that may occur in cerebrovascular regulation when comparing acute to chronic caffeine intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzMmH1_mB7gbVg90H21EOLACvtfcHk0lhvXbLIKnkrMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls12hurc%253D&md5=47e0375b8d8d2cc6217cbca9942c4663</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-091261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-091261%26sid%3Dliteratum%253Aachs%26aulast%3DPelligrino%26aufirst%3DD.%2BA.%26aulast%3DXu%26aufirst%3DH.%2BL.%26aulast%3DVetri%26aufirst%3DF.%26atitle%3DCaffeine%2520and%2520the%2520Control%2520of%2520Cerebral%2520Hemodynamics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26issue%3Ds1%26spage%3DS51%26epage%3DS62%26doi%3D10.3233%2FJAD-2010-091261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref273"><div class="reference"><strong class="refLabel"><a href="#ref273" class="rightTabRefNumLink">273</a></strong><div class="NLM_citation" id="rightTab-cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Groot, R. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, E. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veerman, E. C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligtenberg, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veltman, D. J.</span></span> <span> </span><span class="NLM_article-title">The Effect of Caffeine on Working Memory Load-Related Brain Activation in Middle-Aged Males</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuropharm.2012.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=22728314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVOnuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=160-167&author=E.+B.+Klaassenauthor=R.+H.+M.+De+Grootauthor=E.+A.+T.+Eversauthor=J.+Snelauthor=E.+C.+I.+Veermanauthor=A.+J.+M.+Ligtenbergauthor=J.+Jollesauthor=D.+J.+Veltman&title=The+Effect+of+Caffeine+on+Working+Memory+Load-Related+Brain+Activation+in+Middle-Aged+Males&doi=10.1016%2Fj.neuropharm.2012.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of caffeine on working memory load-related brain activation in middle-aged males</span></div><div class="casAuthors">Klaassen, Elissa B.; de Groot, Renate H. M.; Evers, Elisabeth A. T.; Snel, Jan; Veerman, Enno C. I.; Ligtenberg, Antoon J. M.; Jolles, Jelle; Veltman, Dick J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">160-167</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Caffeine is commonly consumed in an effort to enhance cognitive performance.  However, little is known about the usefulness of caffeine with regard to memory enhancement, with previous studies showing inconsistent effects on memory performance.  We aimed to det. the effect of caffeine on working memory (WM) load-related activation during encoding, maintenance and retrieval phases of a WM maintenance task using functional magnetic resonance imaging (fMRI). 20 healthy, male, habitual caffeine consumers aged 40-61 years were administered 100 mg of caffeine in a double-blind placebo-controlled crossover design.  Participants were scanned in a non-withdrawn state following a workday during which caffeinated products were consumed according to individual normal use (range = 145-595 mg).  Acute caffeine administration was assocd. with increased load-related activation compared to placebo in the left and right dorsolateral prefrontal cortex during WM encoding, but decreased load-related activation in the left thalamus during WM maintenance.  These findings are indicative of an effect of caffeine on the fronto-parietal network involved in the top-down cognitive control of WM processes during encoding and an effect on the prefrontal cortico-thalamic loop involved in the interaction between arousal and the top-down control of attention during maintenance.  Therefore, the effects of caffeine on WM may be attributed to both a direct effect of caffeine on WM processes, as well as an indirect effect on WM via arousal modulation.  Behavioral and fMRI results were more consistent with a detrimental effect of caffeine on WM at higher levels of WM load, than caffeine-related WM enhancement.This article is part of a Special Issue entitled 'Cognitive Enhancers'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj2d0dT-OF7LVg90H21EOLACvtfcHk0li5KC_irZqgGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVOnuro%253D&md5=86da50bf8b24e6e9ebde1167f20dc667</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DKlaassen%26aufirst%3DE.%2BB.%26aulast%3DDe%2BGroot%26aufirst%3DR.%2BH.%2BM.%26aulast%3DEvers%26aufirst%3DE.%2BA.%2BT.%26aulast%3DSnel%26aufirst%3DJ.%26aulast%3DVeerman%26aufirst%3DE.%2BC.%2BI.%26aulast%3DLigtenberg%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DJolles%26aufirst%3DJ.%26aulast%3DVeltman%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Effect%2520of%2520Caffeine%2520on%2520Working%2520Memory%2520Load-Related%2520Brain%2520Activation%2520in%2520Middle-Aged%2520Males%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D160%26epage%3D167%26doi%3D10.1016%2Fj.neuropharm.2012.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref274"><div class="reference"><strong class="refLabel"><a href="#ref274" class="rightTabRefNumLink">274</a></strong><div class="NLM_citation" id="rightTab-cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeister, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinanaj, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Ville, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovblad, K. O.</span></span> <span> </span><span class="NLM_article-title">Acute Caffeine Administration Impact on Working Memory-Related Brain Activation and Functional Connectivity in the Elderly: A BOLD and Perfusion MRI Study</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1016%2Fj.neuroscience.2013.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23876323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2013&pages=364-371&author=S.+Hallerauthor=C.+Rodriguezauthor=D.+Moserauthor=S.+Tomaauthor=J.+Hofmeisterauthor=I.+Sinanajauthor=D.+Van+De+Villeauthor=P.+Giannakopoulosauthor=K.+O.+Lovblad&title=Acute+Caffeine+Administration+Impact+on+Working+Memory-Related+Brain+Activation+and+Functional+Connectivity+in+the+Elderly%3A+A+BOLD+and+Perfusion+MRI+Study&doi=10.1016%2Fj.neuroscience.2013.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit274R"><div class="casContent"><span class="casTitleNuber">274</span><div class="casTitle"><span class="NLM_cas:atitle">Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: A BOLD and perfusion MRI study</span></div><div class="casAuthors">Haller, S.; Rodriguez, C.; Moser, D.; Toma, S.; Hofmeister, J.; Sinanaj, I.; Van De Ville, D.; Giannakopoulos, P.; Lovblad, K.-O.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">364-371</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In young individuals, caffeine-mediated blockade of adenosine receptors and vasoconstriction has direct repercussions on task-related activations, changes in functional connectivity, as well as global vascular effects.  To date, no study has explored the effect of caffeine on brain activation patterns during highly demanding cognitive tasks in the elderly.  This prospective, placebo-controlled crossover design comprises 24 healthy elderly individuals (mean age 68.8 ± 4.0 years, 17 females) performing a 2-back working memory (WM) task in functional magnetic resonance imaging (fMRI).  Analyses include complimentary assessment of task-related activations (general linear model, GLM), functional connectivity (tensorial independent component anal., TICA), and baseline perfusion (arterial spin labeling).  Despite a redn. in whole-brain global perfusion (-22.7%), caffeine-enhanced task-related GLM activation in a local and distributed network is most pronounced in the bilateral striatum and to a lesser degree in the right middle and inferior frontal gyrus, bilateral insula, left superior and inferior parietal lobule as well as in the cerebellum bilaterally.  TICA was significantly enhanced (+8.2%) in caffeine vs. placebo in a distributed and task-relevant network including the pre-frontal cortex, the supplementary motor area, the ventral premotor cortex and the parietal cortex as well as the occipital cortex (visual stimuli) and basal ganglia.  The inverse comparison of placebo vs. caffeine had no significant difference.  Activation strength of the task-relevant-network component correlated with response accuracy for caffeine yet not for placebo, indicating a selective cognitive effect of caffeine.  The present findings suggest that acute caffeine intake enhances WM-related brain activation as well as functional connectivity of blood oxygen level-dependent fMRI in elderly individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVri--Y5bs-LVg90H21EOLACvtfcHk0li5KC_irZqgGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWisrfO&md5=00429b1c3b854ddb252723a837f8c804</span></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DC.%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DToma%26aufirst%3DS.%26aulast%3DHofmeister%26aufirst%3DJ.%26aulast%3DSinanaj%26aufirst%3DI.%26aulast%3DVan%2BDe%2BVille%26aufirst%3DD.%26aulast%3DGiannakopoulos%26aufirst%3DP.%26aulast%3DLovblad%26aufirst%3DK.%2BO.%26atitle%3DAcute%2520Caffeine%2520Administration%2520Impact%2520on%2520Working%2520Memory-Related%2520Brain%2520Activation%2520and%2520Functional%2520Connectivity%2520in%2520the%2520Elderly%253A%2520A%2520BOLD%2520and%2520Perfusion%2520MRI%2520Study%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D250%26spage%3D364%26epage%3D371%26doi%3D10.1016%2Fj.neuroscience.2013.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref275"><div class="reference"><strong class="refLabel"><a href="#ref275" class="rightTabRefNumLink">275</a></strong><div class="NLM_citation" id="rightTab-cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. O.</span></span> <span> </span><span class="NLM_article-title">Regulation of Cerebrospinal Fluid Production by Caffeine Consumption</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">110</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-10-110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1186%2F1471-2202-10-110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=19725982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD1MnisFansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=110&author=M.+E.+Hanauthor=H.+J.+Kimauthor=Y.+S.+Leeauthor=D.+H.+Kimauthor=J.+T.+Choiauthor=C.+S.+Panauthor=S.+Yoonauthor=S.+Y.+Baekauthor=B.+S.+Kimauthor=J.+B.+Kimauthor=S.+O.+Oh&title=Regulation+of+Cerebrospinal+Fluid+Production+by+Caffeine+Consumption&doi=10.1186%2F1471-2202-10-110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cerebrospinal fluid production by caffeine consumption</span></div><div class="casAuthors">Han Myoung-Eun; Kim Hak-Jin; Lee Young-Suk; Kim Dong-Hyun; Choi Joo-Taek; Pan Chul-Sik; Yoon Sik; Baek Sun-Yong; Kim Bong-Seon; Kim Jae-Bong; Oh Sae-Ock</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Caffeine is the most commonly consumed psycho-stimulant in the world.  The effects of caffeine on the body have been extensively studied; however, its effect on the structure of the brain has not been investigated to date.  RESULTS:  In the present study we found that the long-term consumption of caffeine can induce ventriculomegaly; this was observed in 40% of the study rats.  In the caffeine-treated rats with ventriculomegaly, there was increased production of CSF, associated with the increased expression of Na(+), K(+)-ATPase and increased cerebral blood flow (CBF).  In contrast to the chronic effects, acute treatment with caffeine decreased the production of CSF, suggesting 'effect inversion' associated with caffeine, which was mediated by increased expression of the A1 adenosine receptor, in the choroid plexus of rats chronically treated with caffeine.  The involvement of the A1 adenosine receptor in the effect inversion of caffeine was further supported by the induction of ventriculomegaly and Na+, K+-ATPase, in A1 agonist-treated rats.  CONCLUSION:  The results of this study show that long-term consumption of caffeine can induce ventriculomegaly, which is mediated in part by increased production of CSF.  Moreover, we also showed that adenosine receptor signaling can regulate the production of CSF by controlling the expression of Na(+), K(+)-ATPase and CBF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmFUcu8j2uSZI8NvIb08rbfW6udTcc2ebdI2sf6WQkD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnisFansg%253D%253D&md5=6af132a10314fa46b2605295f1eb5c6a</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-10-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-10-110%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DM.%2BE.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BT.%26aulast%3DPan%26aufirst%3DC.%2BS.%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DBaek%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BB.%26aulast%3DOh%26aufirst%3DS.%2BO.%26atitle%3DRegulation%2520of%2520Cerebrospinal%2520Fluid%2520Production%2520by%2520Caffeine%2520Consumption%26jtitle%3DBMC%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D110%26doi%3D10.1186%2F1471-2202-10-110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref276"><div class="reference"><strong class="refLabel"><a href="#ref276" class="rightTabRefNumLink">276</a></strong><div class="NLM_citation" id="rightTab-cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wostyn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Deyn, P. P.</span></span> <span> </span><span class="NLM_article-title">Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine’s Protective Effect against Alzheimer’s Disease</span>. <i>Int. J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">617420</span>, <span class="refDoi"> DOI: 10.4061/2011/617420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.4061%2F2011%2F617420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=21660211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BC3Mrpt1antw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=617420&author=P.+Wostynauthor=D.+Van+Damauthor=K.+Audenaertauthor=P.+P.+De+Deyn&title=Increased+Cerebrospinal+Fluid+Production+as+a+Possible+Mechanism+Underlying+Caffeine%E2%80%99s+Protective+Effect+against+Alzheimer%E2%80%99s+Disease&doi=10.4061%2F2011%2F617420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease</span></div><div class="casAuthors">Wostyn Peter; Van Dam Debby; Audenaert Kurt; De Deyn Peter Paul</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">617420</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD), the most common type of dementia among older people, is characterized by the accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles composed of hyperphosphorylated tau in the brain.  Despite major advances in understanding the molecular etiology of the disease, progress in the clinical treatment of AD patients has been extremely limited.  Therefore, new and more effective therapeutic approaches are needed.  Accumulating evidence from human and animal studies suggests that the long-term consumption of caffeine, the most commonly used psychoactive drug in the world, may be protective against AD.  The mechanisms underlying the suggested beneficial effect of caffeine against AD remain to be elucidated.  In recent studies, several potential neuroprotective effects of caffeine have been proposed.  Interestingly, a recent study in rats showed that the long-term consumption of caffeine increased cerebrospinal fluid (CSF) production, associated with the increased expression of Na(+)-K(+) ATPase and increased cerebral blood flow.  Compromised function of the choroid plexus and defective CSF production and turnover, with diminished clearance of Aβ, may be one mechanism implicated in the pathogenesis of late-onset AD.  If reduced CSF turnover is a risk factor for AD, then therapeutic strategies to improve CSF flow are reasonable.  In this paper, we hypothesize that long-term caffeine consumption could exert protective effects against AD at least in part by facilitating CSF production, turnover, and clearance.  Further, we propose a preclinical experimental design allowing evaluation of this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSWpsFFc4A4EQ0lWbKiCflfW6udTcc2eZEKP7E_wH2l7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mrpt1antw%253D%253D&md5=58b8cacfd1528a71ffa6c97a2cda0db9</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.4061%2F2011%2F617420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F617420%26sid%3Dliteratum%253Aachs%26aulast%3DWostyn%26aufirst%3DP.%26aulast%3DVan%2BDam%26aufirst%3DD.%26aulast%3DAudenaert%26aufirst%3DK.%26aulast%3DDe%2BDeyn%26aufirst%3DP.%2BP.%26atitle%3DIncreased%2520Cerebrospinal%2520Fluid%2520Production%2520as%2520a%2520Possible%2520Mechanism%2520Underlying%2520Caffeine%25E2%2580%2599s%2520Protective%2520Effect%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2011%26volume%3D2011%26spage%3D617420%26doi%3D10.4061%2F2011%2F617420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref277"><div class="reference"><strong class="refLabel"><a href="#ref277" class="rightTabRefNumLink">277</a></strong><div class="NLM_citation" id="rightTab-cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dall’lgna, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porciúncula, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, D. R.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by Caffeine and Adenosine A 2A Receptor Blockade of β-Amyloid Neurotoxicity</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1207</span>– <span class="NLM_lpage">1209</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0705185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1038%2Fsj.bjp.0705185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=12711619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A280%3ADC%252BD3s3gvF2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=1207-1209&issue=7&author=O.+P.+Dall%E2%80%99lgnaauthor=L.+O.+Porci%C3%BAnculaauthor=D.+O.+Souzaauthor=R.+A.+Cunhaauthor=D.+R.+Lara&title=Neuroprotection+by+Caffeine+and+Adenosine+A+2A+Receptor+Blockade+of+%CE%B2-Amyloid+Neurotoxicity&doi=10.1038%2Fsj.bjp.0705185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity</span></div><div class="casAuthors">Dall'Igna Oscar P; Porciuncula Lisiane O; Souza Diogo O; Cunha Rodrigo A; Lara Diogo R; Dall'lgna Oscar P</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1207-9</span>
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Adenosine is a neuromodulator in the nervous system and it has recently been observed that pharmacological blockade or gene disruption of adenosine A(2A) receptors confers neuroprotection under different neurotoxic situations in the brain.  We now observed that coapplication of either caffeine (1-25 micro M) or the selective A(2A) receptor antagonist, 4-(2-[7-amino-2(2-furyl)(1,2,4)triazolo (2,3-a)(1,3,5)triazin-5-ylamino]ethyl)phenol (ZM 241385, 50 nM), but not the A receptor antagonist, 8-cyclopentyltheophylline (200 nM), prevented the neuronal cell death caused by exposure of rat cultured cerebellar granule neurons to fragment 25-35 of beta-amyloid protein (25 micro M for 48 h), that by itself caused a near three-fold increase of propidium iodide-labeled cells.  This constitutes the first in vitro evidence to suggest that adenosine A(2A) receptors may be the molecular target responsible for the observed beneficial effects of caffeine consumption in the development of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNw1uz5FKyuR0LsK7uFuY7fW6udTcc2eZEKP7E_wH2l7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3gvF2ksQ%253D%253D&md5=a06ea97d86e4bd55a591daf536415516</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705185%26sid%3Dliteratum%253Aachs%26aulast%3DDall%25E2%2580%2599lgna%26aufirst%3DO.%2BP.%26aulast%3DPorci%25C3%25BAncula%26aufirst%3DL.%2BO.%26aulast%3DSouza%26aufirst%3DD.%2BO.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DLara%26aufirst%3DD.%2BR.%26atitle%3DNeuroprotection%2520by%2520Caffeine%2520and%2520Adenosine%2520A%25202A%2520Receptor%2520Blockade%2520of%2520%25CE%25B2-Amyloid%2520Neurotoxicity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D138%26issue%3D7%26spage%3D1207%26epage%3D1209%26doi%3D10.1038%2Fsj.bjp.0705185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref278"><div class="reference"><strong class="refLabel"><a href="#ref278" class="rightTabRefNumLink">278</a></strong><div class="NLM_citation" id="rightTab-cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Facilitates Alzheimer’s Disease Pathogenesis by up-Regulating BACE1 Gene Expession</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">18727</span>– <span class="NLM_lpage">18732</span>, <span class="refDoi"> DOI: 10.1073/pnas.0606298103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1073%2Fpnas.0606298103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=17121991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaht7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=18727-18732&issue=49&author=X.+Sunauthor=G.+Heauthor=H.+Qingauthor=W.+Zhouauthor=F.+Dobieauthor=F.+Caiauthor=M.+Staufenbielauthor=L.+E.+Huangauthor=W.+Song&title=Hypoxia+Facilitates+Alzheimer%E2%80%99s+Disease+Pathogenesis+by+up-Regulating+BACE1+Gene+Expession&doi=10.1073%2Fpnas.0606298103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression</span></div><div class="casAuthors">Sun, Xiulian; He, Guiqiong; Qing, Hong; Zhou, Weihui; Dobie, Frederick; Cai, Fang; Staufenbiel, Matthias; Huang, L. Eric; Song, Weihong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">18727-18732</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mol. mechanism underlying the pathogenesis of the majority of cases of sporadic Alzheimer's disease (AD) is unknown.  A history of stroke was found to be assocd. with development of some AD cases, esp. in the presence of vascular risk factors.  Reduced cerebral perfusion is a common vascular component among AD risk factors, and hypoxia is a direct consequence of hypoperfusion.  Previously we showed that expression of the β-site β-amyloid precursor protein (APP) cleavage enzyme 1 (BACE1) gene BACE1 is tightly controlled at both the transcriptional and translational levels and that increased BACE1 maturation contributes to the AD pathogenesis in Down's syndrome.  Here we have identified a functional hypoxia-responsive element in the BACE1 gene promoter.  Hypoxia up-regulated β-secretase cleavage of APP and amyloid-β protein (Aβ) prodn. by increasing BACE1 gene transcription and expression both in vitro and in vivo.  Hypoxia treatment markedly increased Aβ deposition and neuritic plaque formation and potentiated the memory deficit in Swedish mutant APP transgenic mice.  Taken together, our results clearly demonstrate that hypoxia can facilitate AD pathogenesis, and they provide a mol. mechanism linking vascular factors to AD.  Our study suggests that interventions to improve cerebral perfusion may benefit AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMEtsQOrHoH7Vg90H21EOLACvtfcHk0lgJmVpLNI_8uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaht7jJ&md5=b575cb5e7ed3d5aceffb1242e6c32887</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0606298103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0606298103%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DQing%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DDobie%26aufirst%3DF.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%2BE.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DHypoxia%2520Facilitates%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Pathogenesis%2520by%2520up-Regulating%2520BACE1%2520Gene%2520Expession%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D49%26spage%3D18727%26epage%3D18732%26doi%3D10.1073%2Fpnas.0606298103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref279"><div class="reference"><strong class="refLabel"><a href="#ref279" class="rightTabRefNumLink">279</a></strong><div class="NLM_citation" id="rightTab-cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Involvement of A7 NAChR Signaling Cascade in Epigallocatechin Gallate Suppression of β-Amyloid-Induced Apoptotic Cortical Neuronal Insults</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1007/s12035-013-8491-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=10.1007%2Fs12035-013-8491-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=23807728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=66-77&issue=1&author=X.+Zhangauthor=M.+Wuauthor=F.+Luauthor=N.+Luoauthor=Z.+P.+Heauthor=H.+Yang&title=Involvement+of+A7+NAChR+Signaling+Cascade+in+Epigallocatechin+Gallate+Suppression+of+%CE%B2-Amyloid-Induced+Apoptotic+Cortical+Neuronal+Insults&doi=10.1007%2Fs12035-013-8491-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit279R"><div class="casContent"><span class="casTitleNuber">279</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of α7 nAChR Signaling Cascade in Epigallocatechin Gallate Suppression of β-Amyloid-Induced Apoptotic Cortical Neuronal Insults</span></div><div class="casAuthors">Zhang, Xijing; Wu, Mingmei; Lu, Fan; Luo, Na; He, Zu-Ping; Yang, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-77</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Excessive generation and accumulation of the β-amyloid (Aβ) peptide in selectively vulnerable brain regions is a key pathogenic event in the Alzheimer's disease (AD), while epigallocatechin gallate (EGCG) is a very promising chem. to suppress a variety of Aβ-induced neurodegenerative disorders.  However, the precise mol. mechanism of EGCG responsible for protection against neurotoxicity still remains elusive.  To validate and further investigate the possible mechanism involved, we explored whether EGCG neuroprotection against neurotoxicity of Aβ is mediated through the α7 nicotinic acetylcholine receptor (α7 nAChR) signaling cascade.  It was shown in rat primary cortical neurons that short-term treatment with EGCG significantly attenuated the neurotoxicity of Aβ1-42, as demonstrated by increased cell viability, reduced no. of apoptotic cells, decreased reactive oxygen species (ROS) generation, and downregulated caspase-3 levels after treatment with 25-μM Aβ1-42.  In addn., EGCG markedly strengthened activation of α7nAChR as well as its downstream pathway signaling mols. phosphatidylinositol 3-kinase (PI3K) and Akt, subsequently leading to suppression of Bcl-2 downregulation in Aβ-treated neurons.  Conversely, administration of α7nAChR antagonist methyllycaconitine (MLA; 20 μM) to neuronal cultures significantly attenuated the neuroprotection of EGCG against Aβ-induced neurototoxicity, thus presenting new evidence that the α7nAChR activity together with PI3K/Akt transduction signaling may contribute to the mol. mechanism underlying the neuroprotective effects of EGCG against Aβ-induced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5vkj45XX0rVg90H21EOLACvtfcHk0lgSGoi-XABVRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOksb0%253D&md5=cc90e55b93c9396492c57dd6e7b2e8f9</span></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8491-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8491-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DZ.%2BP.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DInvolvement%2520of%2520A7%2520NAChR%2520Signaling%2520Cascade%2520in%2520Epigallocatechin%2520Gallate%2520Suppression%2520of%2520%25CE%25B2-Amyloid-Induced%2520Apoptotic%2520Cortical%2520Neuronal%2520Insults%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26issue%3D1%26spage%3D66%26epage%3D77%26doi%3D10.1007%2Fs12035-013-8491-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RFM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RFM','PDB','3RFM'); return false;">PDB: 3RFM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T15" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T15','PDB','5T15'); return false;">PDB: 5T15</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9S" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9S','PDB','5T9S'); return false;">PDB: 5T9S</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9R','PDB','5T9R'); return false;">PDB: 5T9R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9%2520V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9%2520V','PDB','5T9%20V'); return false;">PDB: 5T9 V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9M','PDB','5T9M'); return false;">PDB: 5T9M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T9N','PDB','5T9N'); return false;">PDB: 5T9N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TA3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TA3','PDB','5TA3'); return false;">PDB: 5TA3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TAZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TAZ','PDB','5TAZ'); return false;">PDB: 5TAZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TAS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TAS','PDB','5TAS'); return false;">PDB: 5TAS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TB4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TB4','PDB','5TB4'); return false;">PDB: 5TB4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JI0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JI0','PDB','6JI0'); return false;">PDB: 6JI0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JII" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JII','PDB','6JII'); return false;">PDB: 6JII</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JI8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JI8','PDB','6JI8'); return false;">PDB: 6JI8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JIU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JIU','PDB','6JIU'); return false;">PDB: 6JIU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JIY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JIY','PDB','6JIY'); return false;">PDB: 6JIY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRS','PDB','6JRS'); return false;">PDB: 6JRS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JRR','PDB','6JRR'); return false;">PDB: 6JRR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JV2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JV2','PDB','6JV2'); return false;">PDB: 6JV2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JHN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JHN','PDB','6JHN'); return false;">PDB: 6JHN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TV4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TV4','PDB','6TV4'); return false;">PDB: 6TV4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DDS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DDS','PDB','3DDS'); return false;">PDB: 3DDS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DDW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DDW','PDB','3DDW'); return false;">PDB: 3DDW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DD1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DD1','PDB','3DD1'); return false;">PDB: 3DD1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L7X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L7X','PDB','1L7X'); return false;">PDB: 1L7X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L5Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L5Q','PDB','1L5Q'); return false;">PDB: 1L5Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3REY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3REY','PDB','3REY'); return false;">PDB: 3REY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MZJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MZJ','PDB','5MZJ'); return false;">PDB: 5MZJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MZP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MZP','PDB','5MZP'); return false;">PDB: 5MZP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2R','PDB','5N2R'); return false;">PDB: 5N2R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N2S','PDB','5N2S'); return false;">PDB: 5N2S</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RKP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RKP','PDB','1RKP'); return false;">PDB: 1RKP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7TV4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7TV4','PDB','7TV4'); return false;">PDB: 7TV4</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00261&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00261%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00261" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799f5542f923d0c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
